Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,protein targeting to ER (GO:0045047),-0.6102707543799101,-2.435626944539567,0.0,0.0,0.0,78/99,31.20%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;SGTB;RPLP2;SPCS1;RPL17;RPL23;RPL28;RPL31;CHMP4B;CHMP4A;EDEM1;RPS10;SGTA;RPS11;RPS27;RPS16;SRPRA;RPL10;RPL15;RPL12;RPL9;RPS8;SEC61G;GET3;SEC63;RPS27A;RPL10A;RPS17
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6245160908082681,-2.4058135516068035,0.0,0.0,0.0,54/87,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.606882350108358,-2.3565130599960487,0.0,0.0,0.0,54/91,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;ARL6IP1;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,cytoplasmic translation (GO:0002181),-0.5944254167134337,-2.337299081208687,0.0,0.0,0.0,53/91,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;EIF4A1;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPL17;RPL23
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5650668637171777,-2.329504010708588,0.0,0.0,0.0,58/110,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;SMG7;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,peptide biosynthetic process (GO:0043043),-0.5306448316646116,-2.271767251369574,0.0,0.00032451940762500217,0.002,77/153,23.08%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;GGT5;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;MRPS5;GGTA1;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;RPL32;MRPS12;RPL5;RPSA;MRPS33;RPLP0;MRPL55;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;RPS21;GGT1;RPL37A;RPLP2;MRPS21;MRPS7;RPL17;RPL23;PCSK1;MRPL34;EIF4EBP2;RPL28;PABPC4;RPL31;EEF1A2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.8145379312582162,-2.1559559847874166,0.0,0.0017037268900312614,0.013,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,heme catabolic process (GO:0042167),-0.8145379312582162,-2.1559559847874166,0.0,0.0017037268900312614,0.013,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,extracellular structure organization (GO:0043062),0.6383467907333935,2.1334519690952867,0.0,0.002026198234233446,0.002,54/204,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;TGFBR1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,external encapsulating structure organization (GO:0045229),0.6352123202406559,2.1191021174094518,0.0,0.001013099117116723,0.002,53/205,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,translation (GO:0006412),-0.4686684104334149,-2.0761054324510786,0.0,0.00605769560900004,0.049,91/208,23.08%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;WARS2;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;NOA1;GTPBP1;LARS1;RPS9;YARS1;RPS5;GFM2;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;QARS1;RPL13A;MRPS5;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;KARS1;NDUFA7;RPSA;FASTKD2;MRPS33;FARS2;RPLP0;AIMP1;MRPL55;MRPL57;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;MARS2;RPS21;RPL37A;RPLP2;MRPS21;AIMP2;MRPS7;RPL17;RPL23;MRPL34;EIF4EBP2;TARS1;RPL28;PABPC4;RPL31;EEF1A2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.7167643246086363,2.026890466258712,0.0,0.010468690876872806,0.025,15/43,8.95%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;WNT4;YAP1;RUNX2;ACVR1;WWTR1;BMP2;CCN4
prerank,diterpenoid metabolic process (GO:0016101),0.6939048586108614,2.0160081819871807,0.0,0.011650639846842316,0.037,10/55,4.30%,ALDH1A1;RBP4;GPC6;AKR1B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1
prerank,retinoid metabolic process (GO:0001523),0.6762648740149529,2.0112100624189564,0.0,0.011144090288283955,0.042,15/71,7.28%,ALDH1A1;RBP4;GPC6;AKR1B1;CYP26B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1;CYP1B1;ALDH1A2;SDC1;ADH1A
prerank,regulation of exocytosis (GO:0017157),-0.5772141031399921,-2.0015975812883635,0.0,0.020834145969525143,0.169,20/46,19.34%,STXBP6;IL1RAPL1;RAB27A;STXBP5L;RAB21;RAB3C;RIMS2;SYT1;CADPS;RAB12;RAB8B;RAB27B;LGI3;NSF;CPLX1;CFTR;RAB15;RAB3A;CLASP1;ANXA1
prerank,extracellular matrix organization (GO:0030198),0.5827000047894203,1.996148383460938,0.0,0.015365336609603635,0.072,68/276,7.82%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;GSN;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;DPT;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;GAS6;COL13A1;TGFBR1;VTN;COL9A2;SH3PXD2B;ITGB8;MMP11;SMOC2;COL20A1;ECM2;ITGB5;CYP1B1;ADAMTS9;SERPINH1;TNC;SMOC1;TIMP2;COLQ;SCUBE1;FLRT2
prerank,skeletal system development (GO:0001501),0.5997332046768657,1.9590763405839142,0.0,0.03184025796652558,0.169,28/148,5.51%,IGF1;RBP4;BMP6;FBN1;COL1A2;IGF2;COL1A1;GJA1;TRPS1;CDH11;MATN3;AHSG;SOX5;GLI2;SULF2;FGFR1;ANKH;FGFR2;GNAS;COL13A1;TGFBR1;NPR3;COL9A2;SULF1;SH3PXD2B;ITGB8;CREB3L2;TBX3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.8328808041754246,1.9530462348816406,0.0,0.032419171747735134,0.194,9/17,9.52%,IGF1;NRP1;DOCK4;PDGFRB;VTN;IGFBP5;DOCK5;CCN4;S100A11
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8802427360749109,1.9515904094309233,0.0,0.029379874396384967,0.197,5/13,4.05%,LTBP1;GREM2;FBN1;FBN2;FSTL1
prerank,negative regulation of reproductive process (GO:2000242),0.8308331573892854,1.941479802125891,0.0,0.0340401303351219,0.236,3/17,4.15%,IGF1;GJA1;SULF1
prerank,collagen fibril organization (GO:0030199),0.6304049911758798,1.9088094598903917,0.0,0.06060174718752763,0.409,22/88,6.32%,COL4A4;COL4A5;COL4A6;COL1A2;COL1A1;DDR2;COL4A3;COL22A1;LOXL1;LUM;COL5A1;COL8A2;LOX;COL11A1;DPT;ADAMTS2;COL13A1;TGFBR1;COL9A2;COL20A1;CYP1B1;SERPINH1
prerank,regulation of activated T cell proliferation (GO:0046006),0.7440369830030428,1.8912232083723202,0.0,0.07817748187084046,0.526,3/30,0.46%,IGF1;IGFBP2;IGF2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7734809159721163,-1.8900061577971108,0.0,0.10408222455463707,0.618,6/11,6.82%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNQ1;ATP1B1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8276438170276519,1.886470721803022,0.0,0.07987896884958778,0.564,3/18,0.46%,IGF1;IGFBP2;IGF2
prerank,positive regulation of nuclear division (GO:0051785),0.7574591715429603,1.8837862206059148,0.0,0.0790217311351044,0.586,13/25,13.25%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;NPM2;SIRT2;DRD3;RGCC;INSR;EGF
prerank,positive regulation of neutrophil migration (GO:1902624),0.7910438254237855,1.882880634288728,0.0,0.07517195449006085,0.597,5/18,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,chloride transport (GO:0006821),-0.4880836467193091,-1.8822458769769435,0.0,0.10506315821859445,0.649,27/74,14.00%,SLC4A10;SLC12A2;SLC26A7;SLC12A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;CLIC5;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;CLIC1;GABRB2;SLC4A8;GABRA3;SLC26A6;ANO3;ANO2;CFTR;SLC12A5
prerank,actin cytoskeleton reorganization (GO:0031532),0.6256673671388073,1.8687105553822072,0.0013054830287206266,0.09073568967676651,0.681,13/63,5.11%,NRP1;AUTS2;PHACTR1;NRK;ANTXR1;GSN;NEDD9;PARVA;KIT;DTNBP1;THSD7A;MCU;PTK7
prerank,primary alcohol metabolic process (GO:0034308),0.7440827056912566,1.866741943870874,0.0,0.08784165286059116,0.693,5/25,7.28%,IGF1;RBP4;DHRS3;CYP1B1;ADH1A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7189147229599828,-1.8666904516164842,0.0,0.11742609949753924,0.723,7/15,6.82%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNN2;KCNQ1;ATP1B1
prerank,cell junction assembly (GO:0034329),-0.46170349831070306,-1.8666030581509911,0.0,0.10903852096200073,0.723,28/100,6.25%,PKP4;DNM3;FN1;ADGRL3;SHANK3;CTNND2;CLDN5;CDH2;GPM6A;ITGA6;NLGN1;LIMS2;CDH1;ACTB;SPOCK2;KIRREL3;TJP1;GJC1;NRCAM;MYO9A;DNER;CDH12;CDH6;NRXN1;CDH8;CDH9;OPHN1;CDK5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8181398653874593,1.8613394323277634,0.0,0.09117892054050508,0.728,6/16,5.12%,IGF1;IGFBP2;CILP;IGFBP4;PHIP;IGFBP5
prerank,regulation of phospholipase activity (GO:0010517),0.8913855556154351,1.860973980653373,0.0017211703958691911,0.08696656105354607,0.732,4/10,3.02%,PDPK1;LRP1;FGFR1;FGFR2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7837948916097041,1.859414423650533,0.0,0.08464443123510222,0.737,5/19,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7945839743677862,1.858894997217738,0.0,0.0815786003354466,0.743,5/17,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5604434401903297,-1.85509912354337,0.0,0.1181899682570258,0.776,20/37,19.53%,GRM7;GRID2;GRM3;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRM5;GRIN2B;GRIN3A;GRIA2;GRM8;HOMER1;APP;CDK5R1;HOMER3;GRM1;GRIN1;DAGLB
prerank,eye development (GO:0001654),0.6545136055488984,1.8543096236267944,0.0013458950201884253,0.08463982623911533,0.768,12/54,6.98%,RBP4;LAMA1;FBN1;PBX1;COL5A1;FBN2;SHROOM2;SH3PXD2B;CPAMD8;SKI;CACNA1C;SMOC1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6045176097279983,1.8495351860957894,0.0,0.08761104973674619,0.795,18/85,8.60%,IGF1;TCF7L2;BMP6;MTSS1;ANGPT1;TGFBR3;MCC;TGFA;LAMC1;EPGN;FGFR2;YAP1;NUPR1;SFRP1;ZFP36L1;NR1D1;OSR1;EGFR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5324186041829839,-1.8493245927647868,0.0,0.1182264766903836,0.803,22/46,17.45%,GRM7;MEF2C;SHANK3;GRM3;CDH2;NLGN1;PTK2B;GRIK1;TSHZ3;NRXN1;GRM5;OPHN1;CDK5;SYT1;TPRG1L;GRM8;HOMER1;NLGN3;CACNG3;CACNG4;GRM1;DGKZ
prerank,negative regulation of peptidase activity (GO:0010466),0.6609426854244208,1.8482945184405135,0.0013245033112582781,0.08602900002849508,0.806,13/47,7.13%,TIMP3;LRP1;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,cellular response to zinc ion (GO:0071294),-0.711567134157504,-1.8313587923846624,0.002380952380952381,0.13916155774036856,0.864,10/15,5.93%,GLRA1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;GLRA2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7459077276787808,1.829148175204667,0.0,0.11646587450373848,0.891,5/21,5.12%,IGF1;GJA1;BMPR1A;MMP2;IGFBP5
prerank,regulation of stress fiber assembly (GO:0051492),0.6027505568584325,1.8290130859471088,0.0012642225031605564,0.11214227919468958,0.892,21/74,7.55%,NRP1;PHLDB2;CCN2;ROCK2;PPM1E;PIK3R1;CGNL1;ARHGAP6;DLC1;TPM1;ARHGAP28;ARHGEF10L;TGFBR1;ASAP3;APOA1;SFRP1;CDC42;ALMS1;ARHGEF18;LPAR1;CARMIL1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.6159944284831816,1.8230165896640955,0.0025284450063211127,0.11819489699695104,0.907,18/65,10.37%,LTBP1;PDPK1;FBN1;SMAD3;LDLRAD4;FBN2;ADAMTSL2;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;SKI;EMILIN1;SPRY2;LEMD3;FAM89B;SPRED3
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.609735969108711,1.8181073616601187,0.0,0.12330863539763542,0.93,15/74,6.31%,IGF1;TCF7L2;EYA2;GDNF;AR;EYA1;SERPINE1;BCL2;SH3RF1;CFLAR;TGFBR1;RFFL;ACVR1;PHIP;SRC
prerank,regulation of glucose import (GO:0046324),0.689311727872623,1.8170333314128535,0.0014947683109118087,0.12139722179243492,0.935,11/30,12.56%,IGF1;ENPP1;PID1;PIK3R1;PRKAG2;APPL2;OSBPL8;CREBL2;RHOQ;SELENOS;INSR
prerank,regulation of osteoblast proliferation (GO:0033688),0.780511314137589,1.816289375087235,0.001639344262295082,0.11832997687923326,0.936,7/17,8.76%,NELL1;MN1;CCN1;FGFR2;NPR3;SFRP1;BMP2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7526155858782517,1.8148113171851479,0.0,0.11716001080204685,0.938,11/20,11.08%,IGF1;NRP1;LRP1;SERPINE1;BMPR1A;PDGFRB;VTN;IGFBP5;CCN4;S100A11;IGFBP3
prerank,cellular response to copper ion (GO:0071280),-0.6746142437925213,-1.807173956498233,0.0,0.17329336367175116,0.941,8/16,4.62%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6016213225897382,1.8069530248160794,0.0012853470437017994,0.12980332438058012,0.954,29/74,15.87%,EPHA3;PHLDB2;COL1A1;SMAD3;LDLRAD4;DAG1;OLFM1;NKX2-1;TGFBR1;AXIN2;SFRP1;PDPN;CRB2;WWTR1;DAB2;BMP2;SPRY2;USF3;FOXA1;SPRED3;RGCC;VASN;PTEN;MDK;HPN;GLIPR2;SPRED1;BMP5;SDHAF2
prerank,positive regulation of phospholipase activity (GO:0010518),0.7287308771267588,1.8038926278008276,0.005961251862891207,0.13228618471684728,0.958,11/22,10.16%,PDPK1;FGFR1;FGFR2;KIT;PDGFRA;PDGFRB;NTF3;AGTR1;NTRK3;ARL1;FGF2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7260931317032793,-1.8038179493769206,0.0024390243902439024,0.1716536866648038,0.946,6/12,10.38%,PDE4D;CAV1;GJD3;CAMK2D;CALM1;CALM3
prerank,membrane repolarization during action potential (GO:0086011),-0.7164010331552326,-1.8037470401711277,0.002398081534772182,0.16321703606499485,0.946,5/13,6.82%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,response to copper ion (GO:0046688),-0.6293693950866617,-1.7937147327876939,0.0,0.17361788307937617,0.965,8/20,4.62%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7320526140190949,1.7912090514541,0.003169572107765452,0.15658340766024648,0.976,8/23,5.92%,NREP;TGFBR3;SMAD3;ITGA3;SMURF2;ENG;DKK3;BCL9
prerank,regulation of bone mineralization (GO:0030500),0.6256761433688789,1.7907453540044682,0.0026917900403768506,0.15323847788616948,0.976,18/55,9.41%,NELL1;BMP6;DDR2;ENPP1;SLC8A1;ADGRV1;AHSG;FBN2;BMPR1A;CCN1;ANKH;KL;WNT4;ACVR1;BCOR;OSR1;BMP2;TRPM4
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7661161085122521,-1.7904128227442297,0.0,0.1714347525189898,0.966,3/10,1.90%,CAV1;ANK3;KCNAB1
prerank,regulation of osteoblast differentiation (GO:0045667),0.5833581566903746,1.7882777847852884,0.0,0.15469460685529518,0.979,27/82,15.02%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;FGFR2;WNT4;YAP1;RUNX2;ACVR1;SKI;SMOC1;WWTR1;BMP2;CCN4;TRPM4;DNAI3;REST;TMEM64;LRP3;TMEM119;TWIST2;BMP4;SUFU
prerank,synapse assembly (GO:0007416),-0.480399473761837,-1.7868616516451927,0.0,0.17041501762151204,0.968,18/67,6.25%,DNM3;ADGRL3;GRID2;SHANK3;CDH2;GPM6A;NLGN1;CDH1;SPOCK2;KIRREL3;NRCAM;GABRA2;GABRB3;DNER;NRXN1;GABRG2;LRRTM3;CDK5
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6906346018063161,1.7837148391105644,0.0,0.16130180807931394,0.983,10/30,5.92%,NREP;TGFBR3;SMAD3;ITGA3;FSTL1;TWSG1;SMURF2;ENG;DKK3;BCL9
prerank,neurotransmitter uptake (GO:0001504),0.8161817672126529,1.7813709068456045,0.0034602076124567475,0.16257574779415201,0.987,4/12,4.20%,SLC1A3;GLUL;ATP1A2;SLC22A2
prerank,establishment of endothelial barrier (GO:0061028),-0.5793916394488948,-1.7805398777472705,0.0,0.17532160996940743,0.97,13/29,10.46%,PDE4D;PECAM1;RAP1A;F11R;PPP1R16B;TJP2;TJP1;RDX;PDE2A;RAP1B;ROBO4;SOX18;MSN
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.8027113438258762,1.7764578020444524,0.0017211703958691911,0.17134363529492067,0.989,3/13,4.03%,IGF1;CCL19;SLC2A10
prerank,positive regulation of protein processing (GO:0010954),0.7504217399779847,1.773092081719968,0.0016155088852988692,0.1759753166431748,0.99,3/19,1.20%,CCBE1;CLEC3B;GSN
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8453903042735385,1.7727665798805752,0.007017543859649123,0.17267162513199172,0.99,5/10,4.70%,LYN;GAS6;CCL19;RAPGEF2;AXL
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.6343735749401493,1.7703191622225936,0.001366120218579235,0.1748560833328363,0.99,9/46,6.81%,IGF1;TCF7L2;OGN;ELN;IL6R;PDGFRB;IGFBP5;VIP;IL12B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.7245484012496402,1.7692715938565122,0.003115264797507788,0.16907242765882044,0.99,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.7245484012496402,1.7692715938565122,0.003115264797507788,0.16907242765882044,0.99,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6980827391044683,1.7662416800707288,0.0030211480362537764,0.17317240908581855,0.993,5/26,2.08%,EYA2;GDNF;EYA1;BCL2;FGFR1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6468187869447093,1.7655076321251795,0.0013986013986013986,0.17121375079272622,0.993,11/40,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;WNT6;ACVR1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.49398708889544285,-1.7646930687656832,0.0,0.20176020610861636,0.988,23/54,21.54%,NSA2;RPL3;RPL7;RPL35A;PAK1IP1;RPL11;MAK16;RPL26;RPL6;MALSU1;RPL7A;NVL;PPAN;SNU13;RPL14;RPL5;RPLP0;NPM1;RRP15;NOP16;RPF1;RRS1;RPF2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.6672462089731473,1.7608817883679928,0.002861230329041488,0.17931854372966,0.995,12/34,13.25%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;DRD3;ANAPC5;RGCC;INSR;EGF
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7938829150076125,1.760868775446555,0.003527336860670194,0.1755827407352921,0.995,2/13,0.46%,IGF1;IGF2
prerank,neuron cell-cell adhesion (GO:0007158),-0.691128717563294,-1.7576781529831895,0.006944444444444444,0.20924012882405912,0.989,9/14,21.03%,NLGN1;NRXN3;NCAM2;CNTN4;NRXN1;RET;NLGN3;CDK5R1;ASTN1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.8001112149314555,1.7508916445767826,0.00539568345323741,0.19676865913469088,0.998,2/12,0.46%,IGF1;IGF2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.6325132819143602,1.750791145233044,0.004054054054054054,0.1931372156871321,0.998,13/47,7.13%,TIMP3;AHSG;SERPINE1;SERPING1;RECK;VTN;FETUB;MT3;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.5095616387109403,1.7453335941335888,0.0,0.2040699456890215,0.998,57/248,13.39%,IGFBP2;TCF7L2;LYPD6;WLS;BICC1;LRRK1;COL1A1;RNF220;DAAM2;CDK14;TBL1XR1;RBMS3;MCC;ZEB2;IGFBP4;LGR4;DACT1;NKD1;KANK1;GLI3;FGFR2;APOE;SEMA5A;TMEM170B;TLE1;SMURF2;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;PTK7;DKK3;USP47;ZNRF3;ADGRA2;LRRK2;WWTR1;STK4;DAB2;EGFR;BMP2;PRKN;TRPM4;STK11;INVS;DDX3X;LZTS2;JADE1;TMEM64;WNK1;GLI1;BTRC;UBAC2;KLHL12;EGF;TNKS2
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.6638719115117782,1.7433939107515153,0.005925925925925926,0.2054253286707448,0.999,12/33,6.96%,TCF7L2;PDPK1;ANGPT1;SERPINE1;YAP1;GAS6;NUPR1;SEMA5A;CAST;NEUROD1;CDH5;NFE2L2
prerank,regulation of steroid metabolic process (GO:0019218),0.7055019015447349,1.7418104280356492,0.004629629629629629,0.20585027155150923,0.999,6/23,6.58%,RORA;EPHX2;APOE;STAR;GNB3;NR5A1
prerank,defense response to tumor cell (GO:0002357),0.8209301328379806,1.7415156996231622,0.007380073800738007,0.20273238999191315,0.999,3/10,1.83%,DAPK1;RBMS3;DLEC1
prerank,positive regulation of protein secretion (GO:0050714),0.5860044816453667,1.7408659250177314,0.002635046113306983,0.20053836523726845,0.999,9/69,4.68%,IGF1;TCF7L2;RBP4;BMP6;WLS;SLC30A8;MYO18A;MYH10;MCU
prerank,positive regulation of bone mineralization (GO:0030501),0.6533017456352375,1.7405304928691372,0.008595988538681949,0.19786187578402856,0.999,10/35,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,regulation of smooth muscle contraction (GO:0006940),-0.6241283658937745,-1.7383800630034434,0.00804289544235925,0.24818523140921,0.995,7/20,16.47%,PLCE1;CAV1;KCNB2;CHRM3;ADRB2;CHRM2;CTTN
prerank,myoblast differentiation (GO:0045445),0.7782455695218767,1.7367483115203517,0.0033613445378151263,0.20405949058977366,1.0,5/14,7.40%,IGF1;TCF7L2;EPAS1;SDC1;DDX17
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6130821557948817,1.7365130721884436,0.002785515320334262,0.20113510919998392,1.0,9/49,7.08%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5479359764137429,1.7340934453286012,0.002386634844868735,0.20394200362703935,1.0,23/113,10.16%,IGF1;TCF7L2;NRP1;BMP6;AREG;TGFA;LAMC1;EPGN;FGFR2;VASH2;YAP1;TGFBR1;SEMA5A;NOTCH2;SFRP1;VIP;AKT3;OSR1;EGFR;BMP2;ITGB3;ARNT;FGF2
prerank,regulation of neuroinflammatory response (GO:0150077),0.73109884027502,1.7307327267848602,0.00974025974025974,0.2095257824050236,1.0,5/19,8.69%,IGF1;DAGLA;NUPR1;NR1D1;CD200
prerank,positive regulation of dendrite extension (GO:1903861),-0.6272979470973299,-1.7303052332564544,0.005235602094240838,0.2595228062692517,0.998,6/17,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,sympathetic nervous system development (GO:0048485),0.755511583300814,1.727267872689937,0.01335559265442404,0.215790111945862,1.0,3/15,3.20%,NRP1;GDNF;ASCL1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.720021395082394,-1.7271950541102334,0.007425742574257425,0.2592014840971698,0.998,7/11,9.51%,ADIPOR2;CD34;KDR;PRCP;GATA2;MCAM;VEGFA
prerank,retinol metabolic process (GO:0042572),0.7728291188980321,1.7227252956735692,0.015126050420168067,0.2251367683166808,1.0,4/14,7.28%,RBP4;DHRS3;CYP1B1;ADH1A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5260263539714553,1.721811166191907,0.0011494252873563218,0.2242004427117675,1.0,28/152,6.62%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;SEMA5A;LBX2;SULF1;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;SKI;ADGRA2;LRRK2;WNT5B
prerank,cAMP biosynthetic process (GO:0006171),0.8337200755339643,1.7206909583112513,0.0017211703958691911,0.2234833333664671,1.0,5/10,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7535256766900827,1.7203552612094057,0.008278145695364239,0.22099588279381563,1.0,8/17,14.66%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A;AKAP13
prerank,positive regulation of stress fiber assembly (GO:0051496),0.6140295672830753,1.7202015550394856,0.005563282336578581,0.21798516003294824,1.0,15/44,11.52%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6929239073713412,1.7199541191900891,0.0015748031496062992,0.2152457601814411,1.0,3/24,0.63%,IGF1;IGF2;ENPP1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6295899040382231,-1.7185887324695224,0.008264462809917356,0.2721419752343268,0.998,10/18,23.02%,SHANK3;NLGN1;PTK2B;TSHZ3;NRXN1;NLGN3;CACNG3;CACNG4;RELN;CCL2
prerank,regulation of small molecule metabolic process (GO:0062012),0.6700256112474897,1.7173422908338287,0.0030864197530864196,0.21918697369148868,1.0,7/28,10.77%,PDK1;RORA;EPHX2;APOE;GNB3;PRKN;NCOR2
prerank,regulation of dendrite extension (GO:1903859),-0.619209373555291,-1.7172510390666316,0.005449591280653951,0.26716321941928,0.998,6/18,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,protein oxidation (GO:0018158),0.8089699812124336,1.7163080618538387,0.00528169014084507,0.21885877448901267,1.0,3/11,4.30%,LOXL1;LOX;APOA1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4147543007538574,-1.7144876585190303,0.0,0.26684622415114634,0.999,33/107,11.60%,GRM7;SLC12A2;GRID2;MEF2C;MCTP1;GRM3;CDH2;NRG3;NLGN1;RIMS1;NGF;GRIK1;GRIK2;PXK;DLGAP2;GRM5;OPHN1;CDK5;RIMS2;SYT1;TMEM108;CLSTN2;LRP8;SLC4A8;TPRG1L;LRRC4C;BCR;SYN3;GRID1;CLSTN3;GRM8;CX3CR1;HOMER1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.6288504355267993,-1.712621048265193,0.007352941176470588,0.26339175193418357,0.999,9/16,21.76%,CAV1;TRIM14;HS3ST5;TRIM25;EXOC2;TRIM68;TRIM6;TRIM62;NECTIN2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5266306651923567,1.7116913597726682,0.0,0.22786046428408127,1.0,21/129,6.60%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;KANK1;FGFR2;SEMA5A;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;ADGRA2;LRRK2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5754685986268349,-1.7085275235911028,0.011834319526627219,0.2672417321791893,0.999,12/25,22.69%,MEF2C;SHANK3;NLGN1;SHANK1;ADRB2;GSG1L;NLGN3;CACNG3;CACNG4;SHISA9;MINK1;RELN
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.546953707937447,-1.705728817310526,0.002967359050445104,0.26675495306775177,0.999,7/27,7.81%,UTRN;NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4
prerank,regulation of protein processing (GO:0070613),0.6929466660308705,1.7042275176061792,0.010638297872340425,0.24638285148245717,1.0,8/21,15.32%,CCBE1;RUNX1;LRRK2;RNF139;SNX12;CLN3;GAS1;NLRC4
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.694258553444564,1.7037628280767798,0.012718600953895072,0.24428352461476982,1.0,9/21,9.78%,BMP6;CILP;BMPR1A;TGFBR1;SLC2A10;WWTR1;DAB2;RBPMS;FAM89B
prerank,regulation of mitotic nuclear division (GO:0007088),0.5958610467345813,1.699760137666105,0.004005340453938585,0.2520535091106017,1.0,15/55,13.25%,IGF1;IGF2;TGFA;OBSL1;EPGN;PDGFRB;TOM1L2;PHIP;CD28;DRD3;L3MBTL1;RGCC;NME6;INSR;EGF
prerank,diol biosynthetic process (GO:0034312),-0.6372413353068422,-1.6989512083870844,0.019184652278177457,0.2765987084323768,0.999,6/15,10.72%,ACER3;ACER2;GCH1;DHFR;SPTLC2;SPR
prerank,sulfur compound catabolic process (GO:0044273),0.6218001901238248,1.6989356829632347,0.0045045045045045045,0.25104322311580207,1.0,11/38,8.05%,FMOD;OGN;LUM;DCN;BGN;GALNS;CHAC2;NUDT7;DPEP1;OMD;CSPG5
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7991822646646594,1.6938786944716528,0.005607476635514018,0.2635948822855431,1.0,3/11,1.19%,IGF1;GHR;PIK3R1
prerank,regulation of membrane repolarization (GO:0060306),-0.67917218286051,-1.6912220690769764,0.00966183574879227,0.2888310435810526,0.999,7/13,14.78%,CAV1;KCNJ2;NEDD4L;KCNQ1;AKAP6;CASQ2;CACNA2D1
prerank,lung development (GO:0030324),0.6443440997041778,1.6901122460058522,0.004341534008683068,0.27157721464498685,1.0,14/33,14.89%,RBP4;ERRFI1;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;RCN3;CCDC40;ABCA3;BMP4
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5151543924376186,-1.686822230043873,0.0031446540880503146,0.29419392298088687,1.0,10/37,3.96%,HMCN1;GRID2;CADM1;NLGN1;IL1RAPL1;TENM2;TENM3;TENM4;PTPRD;NECTIN1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7942110338136771,1.6861336730747745,0.020869565217391306,0.2811547406969774,1.0,2/10,2.73%,RUNX1;SH3RF1
prerank,keratan sulfate catabolic process (GO:0042340),0.7794379827290804,1.6860913800396375,0.018018018018018018,0.27771904259217656,1.0,5/11,7.98%,FMOD;OGN;LUM;GALNS;OMD
prerank,epidermis development (GO:0008544),0.5794582218292647,1.686074839457559,0.003973509933774834,0.2742420837916598,1.0,5/56,4.52%,SVEP1;CCN2;FGFR2;TGM5;EDAR
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7468336301140379,1.6851827583631769,0.012027491408934709,0.2735240978825513,1.0,4/14,8.69%,IGF1;LDLR;NR1D1;CD200
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5909298386658838,1.6848724414400502,0.01094391244870041,0.27102277492348487,1.0,16/51,11.52%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SYNPO2;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,positive regulation of T cell proliferation (GO:0042102),0.5940651511291981,1.678189063006127,0.005369127516778523,0.28962279882256364,1.0,6/55,7.09%,IGF1;IGFBP2;IGF2;CCL19;IL12B;CD28
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.7649012218295327,1.6767887437819424,0.021015761821366025,0.29036885418180397,1.0,1/12,0.15%,RBP4
prerank,activation of protein kinase B activity (GO:0032148),0.650346236882628,1.6763623655408335,0.012084592145015106,0.28861264134051406,1.0,8/29,8.16%,IGF1;PDPK1;GAS6;MT3;NTF3;OSBPL8;ADRA2C;NTRK3
prerank,ethanol metabolic process (GO:0006067),0.766817640824075,1.676283557615578,0.015873015873015872,0.2855747628954904,1.0,3/12,8.58%,ALDH1A1;ADH1A;ALDH2
prerank,cell-matrix adhesion (GO:0007160),0.5381918740969273,1.6760792840149126,0.0024390243902439024,0.28304340101120357,1.0,25/95,11.27%,ITGBL1;ADAMTS12;FBLN5;ACTN2;DLC1;ITGA11;RHOD;ITGA3;NID2;COL13A1;VTN;ITGB8;ECM2;ITGB5;ADAMTS9;SRC;EMILIN1;VCL;CD63;ITGB6;ITGB3;ITGAV;LYVE1;TRIP6;SGCE
prerank,proteoglycan metabolic process (GO:0006029),0.6639412476217503,1.6748951886917418,0.010687022900763359,0.2833882771741675,1.0,5/26,4.15%,IGF1;ADAMTS12;GAL3ST3;SULF2;SULF1
prerank,eye morphogenesis (GO:0048592),0.7071904107335053,1.673091482588029,0.015723270440251572,0.2860738631958347,1.0,8/19,5.81%,FBN1;COL5A1;FBN2;NKD1;SHROOM2;MFAP5;RARG;SKI
prerank,negative regulation of protein catabolic process (GO:0042177),0.6138241654877409,1.6722124282975368,0.009602194787379973,0.28550043771241046,1.0,13/40,14.42%,NELL1;TIMP3;CDK5RAP3;SNRNP70;CST3;TIMP2;SIRT2;IRAK3;EGFR;SNX12;PTPN3;BANP;FLNA
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5474586040008516,-1.6710903378903514,0.008403361344537815,0.3328320970664734,1.0,12/28,18.87%,OCLN;NAV3;MET;RPS3;MECP2;PAK1;FES;GIT1;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.6454349259649104,1.6710452950889405,0.005917159763313609,0.28626804052661536,1.0,6/32,5.19%,IGF1;ZBTB20;PID1;PFKFB4;NUPR1;PRKAA2
prerank,triglyceride catabolic process (GO:0019433),-0.5739665524599072,-1.6696956826085128,0.01837270341207349,0.3289896624650366,1.0,10/19,37.15%,PNPLA3;PNPLA2;FABP7;FABP3;LIPH;LIPC;LPL;FABP4;FABP12;FABP5
prerank,positive regulation of behavior (GO:0048520),-0.7140764783224195,-1.6690586084456647,0.008771929824561403,0.3228888954793741,1.0,3/10,1.44%,MEF2C;SGIP1;NLGN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6775466830052284,1.668442946083122,0.013782542113323124,0.291594418412321,1.0,8/22,14.45%,SH3D19;TIMP3;APOE;SNX33;TIMP2;ADRA2A;PTPN3;SNX9
prerank,regulation of cell differentiation (GO:0045595),0.5011648586983314,1.6662685066956402,0.0,0.29586898998578387,1.0,27/148,7.78%,EPHA3;PHLDB2;IGF2;CCN2;NREP;TRPS1;GDNF;AR;DAG1;RUNX1;FGFR1;FGFR2;RUNX2;TGFBR1;CSF1;CDK5RAP3;NEUROD4;NTF3;NEUROD1;GNB3;BCL6;ZFP36L1;SIK1;SMOC1;DDX17;PPP1R13L;NR1D1
prerank,negative regulation of receptor binding (GO:1900121),-0.7089683023097507,-1.6657508934336998,0.02830188679245283,0.3248671069903147,1.0,3/10,6.54%,B2M;ADAM15;ATP2A3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6705202270894374,1.6652870932169714,0.013513513513513514,0.2959338775870204,1.0,7/24,9.70%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7365337135649215,1.6646061380808046,0.011804384485666104,0.29501661843442617,1.0,2/15,0.75%,IGF1;ROCK2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.7011437081267595,1.6643912983452167,0.021311475409836064,0.2926576744319393,1.0,8/19,8.91%,ROBO1;CCBE1;DCN;SMOC2;IL12B;MYO1C;CD63;SPRY2
prerank,rRNA processing (GO:0006364),-0.38467973149643175,-1.6625479427207541,0.0,0.32659482244120863,1.0,65/172,20.65%,NSA2;RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;MAK16;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;LSM6;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;PRKDC;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP15;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.8032169992926964,1.660686682601336,0.01841620626151013,0.30175579327953733,1.0,3/10,4.30%,NELL1;EPHA4;CDK5RAP3
prerank,response to histamine (GO:0034776),-0.724808686566565,-1.660541550280153,0.011210762331838564,0.3250799411472636,1.0,6/10,11.62%,DIAPH1;GABRB3;GABRB1;GABRG2;GABRB2;HRH1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3704535453529852,-1.6600060830348091,0.0,0.31945690486605216,1.0,84/224,23.35%,GRM7;DLG2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;KCND2;GRIK1;GRIK2;GRIN2A;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;NRXN1;GABRG2;PRKACB;SLC1A1;LRP6;CHRM3;GLRA2;GRM5;CDK5;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;GLRA3;SYT5;CHRM1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.5685459709278448,1.65914165772926,0.0026595744680851063,0.3036686271151415,1.0,12/63,6.42%,IGF1;TCF7L2;AR;FGFR1;SH3RF1;SP100;CFLAR;TGFBR1;ACVR1;PHIP;SRC;PML
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5693937966100474,1.6590973072242288,0.004037685060565276,0.3006836828618062,1.0,9/57,7.08%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,melanosome transport (GO:0032402),-0.6021722701124658,-1.6587239208413354,0.008,0.3097365129074462,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,pigment granule transport (GO:0051904),-0.6021722701124658,-1.6587239208413354,0.008,0.3097365129074462,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6585604721684751,1.657455286600484,0.01466275659824047,0.30297803596439216,1.0,7/26,9.70%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,outflow tract septum morphogenesis (GO:0003148),0.6555540529522024,1.6567995713417794,0.014423076923076924,0.302420217450513,1.0,7/24,5.69%,NRP1;ROBO1;BMPR1A;PARVA;FGFR2;ACVR1;ENG
prerank,cellular biogenic amine catabolic process (GO:0042402),0.802236241756819,1.6556062118906505,0.017699115044247787,0.3036889987111476,1.0,7/10,11.59%,SMOX;SLC44A1;COMT;HNMT;ALDH7A1;LRTOMT;SARDH
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7208085566314868,-1.6550817705633565,0.017777777777777778,0.31391167948825993,1.0,7/10,23.02%,KDR;IL33;NAMPT;JAK2;NOD2;TLR4;CCL2
prerank,organic anion transport (GO:0015711),-0.4364280232969436,-1.6546289011612563,0.004807692307692308,0.3087769049326628,1.0,19/76,13.10%,SLC4A10;ABCG2;SLC26A7;LRRC8C;ABCC4;SLCO2A1;SLCO1C1;LRRC8D;SLCO2B1;CA4;SLC22A6;SLC39A8;ABCC6;SLC4A8;SLC26A6;SLC52A3;SLC35A2;SLC25A4;CFTR
prerank,inorganic anion transmembrane transport (GO:0098661),-0.45383786266223314,-1.6531843555357595,0.008620689655172414,0.3062424745875621,1.0,26/63,14.00%,SLC12A2;SLC12A7;SLC26A2;GABRG3;ANO1;ANO4;CLCN3;SLC5A6;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC37A3;SLC4A8;SLC25A30;GABRA3;ANO3;ANO2;CFTR;SLC25A11;SLC12A5
prerank,energy reserve metabolic process (GO:0006112),0.6883408523329503,1.648994783501411,0.011164274322169059,0.3226720688016763,1.0,9/19,10.93%,PID1;PHKB;LEPR;PRKAG2;MT3;ADRB3;GFPT1;PYGM;PPP1R3C
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6734548060606457,1.6473607156827088,0.020833333333333332,0.3249490828367493,1.0,7/21,9.62%,IGF1;APOA1;MT3;CTSH;ZFP36L1;MAP2K1;ITGAV
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5686051062131721,1.646658498208754,0.006648936170212766,0.3241430107890285,1.0,14/55,10.16%,GPC6;FMOD;OGN;CEMIP;LUM;DCN;BGN;HSPG2;GALNS;SDC1;OMD;CSPG5;LYVE1;FGF2
prerank,positive regulation of cell differentiation (GO:0045597),0.48230525473807506,1.6462130644428938,0.0,0.3225997045790251,1.0,47/237,8.95%,IGF1;TCF4;NELL1;BMP6;RIN2;COL1A1;GJA1;DDR2;CCN2;GDNF;SMAD3;AR;SOX5;FBN2;FGFR1;IL6R;SP7;BMPR1A;OLFM1;CCN1;ZEB1;MEDAG;WNT4;RIPOR2;ASCL1;YAP1;RUNX2;TGFBR1;CSF1;RAPGEF2;NEUROD4;ACVR1;NEUROD1;AXIN2;SFRP1;PDPN;ZFP36L1;ADRA2C;CDC42;CRB2;AGTR1;WWTR1;PPP1R13L;DAB2;CREBL2;BMP2;CCN4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.7530756589117961,1.6459209278270914,0.017064846416382253,0.32056941025671704,1.0,5/13,10.16%,PDPK1;IGF2;FGFR1;AKT3;FGF2
prerank,negative regulation of cell development (GO:0010721),0.6471051931000956,1.644808699041357,0.01327433628318584,0.32109561082971433,1.0,3/25,4.42%,IGF1;FBN1;APPL2
prerank,activation of adenylate cyclase activity (GO:0007190),0.6201257265759815,1.6433826534897509,0.014771048744460856,0.32287844084405193,1.0,8/35,6.09%,ADCY1;ADCY2;ADCY7;LGR4;ADCY5;ADCY9;LHCGR;ADRB3
prerank,respiratory system development (GO:0060541),0.633738200320121,1.6416797040338915,0.007246376811594203,0.325437178777293,1.0,15/32,16.72%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4;SPEF2;SMCHD1;SHH
prerank,tight junction assembly (GO:0120192),-0.4612595826449164,-1.6410643706292933,0.014652014652014652,0.3319642646234581,1.0,9/49,4.01%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;LSR;CLDN11;RAMP2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6655761350695669,1.6408212086147964,0.01957585644371941,0.3253798064419701,1.0,3/23,4.30%,IGF1;GAS6;APOA1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5154973043855685,1.6405820991303246,0.0011933174224343676,0.32324250749374656,1.0,21/121,7.08%,IGF1;NRP1;BMP6;IGF2;ANGPT1;GHR;IL31RA;LYN;NEDD9;EPHA4;IL6R;IL34;KIT;GAS6;VTN;ACVR1;NTF3;PIBF1;SRC;IL12B;TSLP
prerank,lipid oxidation (GO:0034440),-0.6593035602759888,-1.6405470576069718,0.014285714285714285,0.32726534107413685,1.0,4/12,16.45%,ADIPOR2;PLA2G7;PPARGC1A;ACOX1
prerank,positive regulation of ossification (GO:0045778),0.6062623418411247,1.6404255712179094,0.018387553041018388,0.3208720087632278,1.0,10/39,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,bicellular tight junction assembly (GO:0070830),-0.46804686661297307,-1.640000114940984,0.014084507042253521,0.3227253663715281,1.0,12/46,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;STRN;PAK2
prerank,respiratory tube development (GO:0030323),0.6435192342728431,1.6387376047345041,0.014814814814814815,0.3235820649112989,1.0,12/28,14.89%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4
prerank,activation of protein kinase activity (GO:0032147),0.5221893446000895,1.638360918901223,0.0024390243902439024,0.32188114054357636,1.0,28/106,12.56%,IGF1;PDPK1;ADCY1;NRK;ANGPT1;ADCY2;GHR;ADCY7;ADCY5;GAS6;ADCY9;MT3;NTF3;OSBPL8;ADRA2C;PIBF1;TLR6;NTRK3;STK4;PRRC1;MAP4K4;ITGB3;STK11;TAOK3;ADRA2A;TNFSF15;STRADA;INSR
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6456162864882218,1.637379260074771,0.0273972602739726,0.3222536148185194,1.0,5/26,2.86%,ERRFI1;CBLB;AREG;TGFA;EPGN
prerank,response to iron ion (GO:0010039),0.7661661494645939,1.6316950465311568,0.017513134851138354,0.3374318749044975,1.0,4/12,6.50%,BMP6;BCL2;SLC11A2;ACO1
prerank,rRNA metabolic process (GO:0016072),-0.38265407839659527,-1.630936992397098,0.0,0.34308912928354396,1.0,78/160,28.34%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;NIFK;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;DEDD2;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;WDR46;RPL28;RPL31;NOL8;PDCD11;EXOSC4;NOP56;RPS27;NOLC1;NOC4L;RPS16;PIH1D1;RPL10;RPL15;WDR18;RPL12;RPL9
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5141787464089685,1.629685572246145,0.004711425206124852,0.3408862054927449,1.0,25/108,9.32%,WLS;TRABD2B;DAAM2;CDK14;LRP1;DACT1;SULF2;RUNX1;SALL1;NKD1;KANK1;ITGA3;MACF1;FGFR2;MDFI;TLE1;SULF1;SFRP1;PTK7;SKI;LRRK2;TCF7L1;BMP2;CBY1;PRKN
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5133897355704142,-1.6276300298809183,0.012232415902140673,0.3464274178161228,1.0,13/33,11.17%,GRID2;NRG3;NLGN1;NGF;GRIK1;GRIK2;PXK;LRP8;SLC4A8;LRRC4C;BCR;GRID1;CX3CR1
prerank,cellular response to BMP stimulus (GO:0071773),0.5457148206618281,1.627359490492284,0.005319148936170213,0.3452779160505605,1.0,19/66,15.58%,BMP6;ADAMTS12;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;SFRP1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,bicarbonate transport (GO:0015701),-0.5351393470108752,-1.6256870729515231,0.00821917808219178,0.34599563842247105,1.0,7/25,13.10%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.709878868886387,1.6249539945204594,0.028960817717206135,0.3508643186027858,1.0,4/16,9.32%,PDK1;RORA;GNB3;PRKN
prerank,camera-type eye development (GO:0043010),0.6606187913202767,1.6240680810731043,0.010852713178294573,0.35105572906622984,1.0,7/25,6.66%,LAMA1;FBN1;FBN2;SHROOM2;CYP1B1;SKI;CACNA1C
prerank,regulation of protein autophosphorylation (GO:0031952),0.6120248550583168,1.6229545648568777,0.005571030640668524,0.35186355699859745,1.0,10/36,13.63%,EPHA7;ENPP1;ERRFI1;PDGFD;ENG;DDX3X;IMPACT;PPP2R5D;RAP2A;MVP
prerank,regulation of multicellular organism growth (GO:0040014),0.7287119233399109,1.6199163645407726,0.018456375838926176,0.3593263270226043,1.0,2/15,1.00%,IGF1;GHR
prerank,positive regulation of protein maturation (GO:1903319),0.7636769991317607,1.619659106820626,0.03119584055459272,0.35725334232374595,1.0,1/11,0.21%,CCBE1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5987787283725119,1.6185279742476617,0.01293103448275862,0.35853904560927646,1.0,6/37,5.12%,IGF1;GJA1;TPM1;BMPR1A;MMP2;IGFBP5
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6304578721351272,1.6179089388543881,0.019726858877086494,0.3577860842009419,1.0,13/29,15.87%,LDLRAD4;NKX2-1;SFRP1;SPRY2;USF3;FOXA1;SPRED3;VASN;PTEN;HPN;SPRED1;BMP5;SDHAF2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45708991406655364,-1.617727407499684,0.003745318352059925,0.36429865501229847,1.0,19/54,15.08%,CAV1;DPP10;FHL1;KCNIP4;KCNJ2;KCNAB1;NEDD4L;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;DPP6;KCNJ15;GNB1;KCNJ10;GNG2;CACNA1D
prerank,positive regulation of dendrite development (GO:1900006),-0.6880061078767942,-1.617336257745282,0.01939655172413793,0.3591926277810735,1.0,8/10,20.83%,COBL;LRP8;PTN;ALK;ZDHHC15;PACSIN1;VLDLR;DAB2IP
prerank,neurotransmitter secretion (GO:0007269),-0.4706401265229241,-1.6158865419169002,0.01606425702811245,0.3582859270048308,1.0,21/44,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;RIMS2;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,positive regulation of glycolytic process (GO:0045821),0.6857106144755112,1.615871356559361,0.012944983818770227,0.3593949175075569,1.0,4/20,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6857106144755112,1.615871356559361,0.012944983818770227,0.3593949175075569,1.0,4/20,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of phosphorylation (GO:0042327),0.4794197011072154,1.6149611983362524,0.0,0.3594127414708625,1.0,47/240,10.17%,IGF1;EPHA3;NRP1;EPHA7;ZBTB20;IGF2;DDR2;ROCK2;ANGPT1;AR;LYN;FGFR1;EPHA4;LEPR;IL34;PELI2;EPHA8;CCN1;FGFR2;KIT;FGFR4;PFKFB4;GAS6;PDGFRA;PDGFRB;MT3;AXL;AXIN2;PRKAA2;MUSK;SLCO3A1;ROR1;ENG;LRRK2;NTRK3;STK4;DAB2;DSCAM;ARRB1;EGFR;EPHB2;BMP2;ITGB3;LMO4;ARNT;FGF2;RYK
prerank,determination of bilateral symmetry (GO:0009855),-0.5458210626380546,-1.6147110825888717,0.019553072625698324,0.35590043434233987,1.0,11/24,23.28%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1;ODAD3
prerank,positive regulation of signal transduction (GO:0009967),0.4790473614584534,1.6147057190724297,0.0010660980810234541,0.35747477219317053,1.0,51/238,9.70%,IGF1;NRP1;ROBO1;CCBE1;BMP6;PTGIS;WLS;IGF2;ESM1;MN1;PIK3R1;SASH1;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;YAP1;GAS6;MAML3;TGFBR1;SMO;VTN;SULF1;MT3;AXL;NTF3;PHIP;SFRP1;SMOC2;CUX2;SKI;ENHO;SRC;LRRK2;ING5;TSLP;TRAF7;MYO1C;CD63;RBPJ;NTRK3;DRD3;TEDC1;BMP2;ZMIZ1;KAT2B;ITGB3;ITGAV;ARNT
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5822188376681933,1.614459797609763,0.009708737864077669,0.3553639980040198,1.0,7/43,5.12%,IGF1;GJA1;IL6R;BMPR1A;MMP2;PDGFRB;IGFBP5
prerank,melanocyte differentiation (GO:0030318),0.765787819263076,1.6130847415301568,0.025735294117647058,0.35724504287091535,1.0,5/11,6.52%,ENPP1;LRMDA;MITF;KIT;SLC24A5
prerank,intestinal absorption (GO:0050892),-0.6452028352067115,-1.6096183598029643,0.02364066193853428,0.36538757302459673,1.0,5/13,10.27%,F11R;TJP2;KCNQ1;SLC26A6;UGCG
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6279439076529327,1.608260429200457,0.02304147465437788,0.3711550015503607,1.0,7/26,12.56%,IGF1;PIK3R1;OSBPL8;CREBL2;BRAF;RHOQ;INSR
prerank,lipid phosphorylation (GO:0046834),-0.6941539846323544,-1.6082503723771568,0.017429193899782137,0.3629173814046315,1.0,7/10,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6639897235920977,1.6071184423586535,0.015527950310559006,0.37261480836089284,1.0,4/23,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5260417579337925,1.6071007119055374,0.01256281407035176,0.3698945843651917,1.0,14/86,6.81%,IGF1;NRP1;EPHA7;BMP6;IGF2;ANGPT1;GHR;IL6R;VTN;ACVR1;NTF3;SFRP1;SRC;IL12B
prerank,cAMP metabolic process (GO:0046058),0.7294845448755942,1.606660919127367,0.018211920529801324,0.3686555120619187,1.0,5/13,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6387121694418035,1.6065838275570454,0.03125,0.3661384904809122,1.0,5/27,5.01%,IGF1;DDR2;GAS6;PDGFRA;LIG4
prerank,cardiac conduction system development (GO:0003161),0.6421804190705263,1.6032681527026094,0.015723270440251572,0.3743438212166625,1.0,9/24,14.89%,GJA1;GJB6;BMPR1A;NOTCH2;MSC;SMAD1;CACNA1G;GATA6;BMP4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5872155372413137,1.6026596461309452,0.016973125884016973,0.37363535917141755,1.0,4/39,4.68%,TCF7L2;RBP4;SLC30A8;MCU
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.7793880534176879,1.6023962986226985,0.026041666666666668,0.37185110687897904,1.0,6/10,13.25%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF
prerank,response to organophosphorus (GO:0046683),-0.5930785590141685,-1.6007683275125466,0.03655352480417755,0.37954862717512755,1.0,6/16,13.12%,TRPC3;ABCC9;P2RX7;TRIM16;DGKQ;TYMS
prerank,potassium ion homeostasis (GO:0055075),-0.5359588903463709,-1.6003410619407565,0.008645533141210375,0.3747894921124127,1.0,7/23,6.82%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNMA1;SLC12A6;ATP1B1
prerank,chordate embryonic development (GO:0043009),0.5602076644014378,1.5991816194586712,0.0013568521031207597,0.380389772788269,1.0,12/55,6.06%,RBP4;IGF2;COL1A1;ARNT2;DACT1;SULF2;FGFR1;FGFR2;TGFBR1;SULF1;LIG4;ALDH1A2
prerank,positive regulation of glucose import (GO:0046326),0.645279908654729,1.5967159791100083,0.03354632587859425,0.38605542952256405,1.0,6/21,12.56%,IGF1;PIK3R1;OSBPL8;CREBL2;RHOQ;INSR
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.6020802180974559,-1.5966470642435646,0.02534562211981567,0.38076610987582177,1.0,7/15,18.22%,REEP1;RTN3;TMEM33;ATL2;ARL6IP1;ZFYVE27;REEP2
prerank,protein secretion (GO:0009306),0.5505618052717566,1.5958367943898404,0.012178619756427604,0.38619766414538975,1.0,19/56,16.11%,WLS;STEAP3;ABCA1;SLC30A8;NEUROD1;TVP23B;VIP;FAM3B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;CYB5R4;TVP23A;TANGO2;MAFA;GOLPH3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6345214407664274,-1.5956404984089103,0.027649769585253458,0.3781831169404457,1.0,8/13,20.01%,SEMA7A;PLCG2;TGFB2;TGFB1;GPRC5B;SIRT1;CUEDC2;TGFB3
prerank,acylglycerol metabolic process (GO:0006639),-0.4939638509042446,-1.5954622402249832,0.016722408026755852,0.3731052908770379,1.0,16/37,20.81%,CAV1;MGLL;ABHD2;DGKB;DGKH;DGKK;PGS1;PLAAT3;PNPLA3;DGKG;DGKQ;PNPLA2;ABHD6;DGKZ;LYPLA2;DGKI
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.538397902921326,1.5946388794550004,0.018617021276595744,0.38779733897017615,1.0,13/62,9.89%,IGF1;ROBO1;AUTS2;LYN;NOTCH2;APOA1;LPAR1;ALS2;ARRB1;MAP4K4;RAPGEF1;MAPRE2;SYNPO2L
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6928930669508184,1.5939681505470682,0.026272577996715927,0.38736970408643595,1.0,4/15,12.17%,TCF7L2;GAS6;RBM22;YWHAE
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6860793171132263,1.5932714793675293,0.025889967637540454,0.3870387971909026,1.0,4/18,2.08%,PDPK1;IGF2;COL4A3;FGFR1
prerank,adherens junction organization (GO:0034332),-0.4564915151601494,-1.592952458856046,0.012295081967213115,0.37479128174149884,1.0,18/48,12.65%,CADM2;CDH2;CADM1;CDH1;ACTB;TJP1;NECTIN1;RAMP2;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;PVR;PAK2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.63824722434952,1.591003858868643,0.041666666666666664,0.3924301881467066,1.0,5/23,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,microtubule anchoring at centrosome (GO:0034454),0.761330853595276,1.5907666723931009,0.0313588850174216,0.3905807228867758,1.0,2/10,2.59%,CCDC68;NINL
prerank,mRNA destabilization (GO:0061157),0.5841573539186441,1.5896652607304744,0.023876404494382022,0.39189138145224595,1.0,14/38,20.48%,POLR2D;ROCK2;ZFP36L1;CPEB3;TUT7;METTL14;TUT4;PLEKHN1;RC3H2;RC3H1;METTL3;YTHDF2;FTO;ZFP36L2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6511826948041171,1.5891719152233057,0.017027863777089782,0.3910630585299888,1.0,5/23,6.34%,TGFBR3;TPM1;FGFR2;ADAMTS9;TNNC1
prerank,protein kinase B signaling (GO:0043491),0.6287413372908791,1.5884333274752507,0.04229607250755287,0.39088740935420235,1.0,5/23,7.38%,IGF1;GAS6;MT3;ZFP36L1;SIRT2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6710722029144318,1.5871462308916793,0.03782894736842105,0.3928610516739717,1.0,2/19,4.30%,IGF1;APOA1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7086674434634217,1.5870819531002205,0.03209459459459459,0.3905563747742672,1.0,3/14,4.20%,MOXD1;DAGLA;SLC22A2
prerank,supramolecular fiber organization (GO:0097435),0.4610811634285032,1.5868129080479425,0.0,0.3890035747213938,1.0,51/333,7.67%,COL4A4;COL4A5;MFAP4;COL4A6;COL1A2;COL1A1;DDR2;FBLN5;RHOH;COL4A3;COL22A1;LOXL1;LUM;GSN;COL5A1;COL8A2;CGNL1;FIGN;LOX;COL11A1;HSPG2;BFSP1;DPT;RHOD;ADAMTS2;TPM1;TMOD4;SHROOM2;NCKAP5;RHOBTB1;COL13A1;TGFBR1;COL9A2;MYO1B;APOA1;CLIP4;COL20A1;RHOBTB3;DES;CYP1B1;DYNC1H1;CST3;CDC42;SERPINH1;EMILIN1;RHOBTB2;LTBP2;LTBP3;SNCAIP;CARMIL1;MYO1C
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6646873831499279,1.5815966547226585,0.038834951456310676,0.4042923333865281,1.0,7/18,11.52%,DDR2;SMAD3;RUNX1;PDPN;EMILIN1;BMP2;RGCC
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4786595143430793,1.5810627744920813,0.003464203233256351,0.40361868825930247,1.0,25/150,7.09%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6803579697187916,1.5808042968965959,0.043697478991596636,0.40207695921825437,1.0,4/16,3.56%,NRP1;PDGFD;PDGFRA;PDGFRB
prerank,C4-dicarboxylate transport (GO:0015740),-0.6182440816593457,-1.5806986475679055,0.0332541567695962,0.40628418880704076,1.0,11/14,30.27%,LRRC8D;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC25A11;SLC1A2;SLC25A22;SLC25A10;LRRC8E;SLC25A14
prerank,cardiac muscle tissue development (GO:0048738),0.5509470376293504,1.580196886848417,0.011142061281337047,0.40141310049987255,1.0,17/50,15.58%,RBP4;GJA1;GJB6;BMPR1A;NOTCH2;MSC;ADAMTS9;SIK1;BMP2;CBY1;SMAD1;CSRP3;CACNA1G;AKAP13;GATA6;BMP4;BMP5
prerank,regulation of histone modification (GO:0031056),0.7154223865666856,1.5794282576636838,0.02422145328719723,0.4013283148122513,1.0,6/13,14.64%,IGF2;NNMT;HPF1;MTHFR;SETD5;AKAP8L
prerank,metal ion homeostasis (GO:0055065),-0.4694383995729228,-1.579295016511569,0.03436426116838488,0.40516711641135267,1.0,7/40,6.66%,TMTC2;SLC12A2;SLC12A7;CAV1;ANK3;LETM1;SLC12A6
prerank,regulation of axon guidance (GO:1902667),0.7631167009342965,1.5787145961054667,0.03544776119402985,0.4013465426922344,1.0,2/10,0.51%,NRP1;MYCBP2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4652852591372503,-1.5783449992600855,0.003278688524590164,0.40238121197559246,1.0,11/38,15.08%,CAV1;KCNJ2;CTNNA3;KCNJ3;KCND3;CAMK2D;KCNQ1;JUP;DSG2;CACNA2D1;CACNA1D
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7283143840880943,1.577849309221848,0.04056437389770723,0.3993246582125916,1.0,2/12,6.10%,IGF1;LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7283143840880943,1.577849309221848,0.04056437389770723,0.3993246582125916,1.0,2/12,6.10%,IGF1;LMCD1
prerank,chloride transmembrane transport (GO:1902476),-0.45794555665085507,-1.5740489385280096,0.011673151750972763,0.4106522670654715,1.0,21/48,14.00%,SLC12A2;SLC12A7;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC4A8;GABRA3;ANO3;ANO2;CFTR;SLC12A5
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.7319685262142681,1.572658324214979,0.03819444444444445,0.41483281996802907,1.0,4/12,6.81%,LYN;IL34;CSF1;IL12B
prerank,signal release from synapse (GO:0099643),-0.4583649712222209,-1.5725141024511666,0.026615969581749048,0.4100147123845096,1.0,20/43,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.48133857518071327,1.56975474183572,0.0023584905660377358,0.422443685841653,1.0,32/138,8.62%,EPHA3;EPHA7;MTSS1;DDR2;ANGPTL1;IL31RA;LYN;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CD7;POLR1G;CSF1;AXL;NTF3;FRS2;GUCY2C;MUSK;ROR1;SRC;BDKRB2;GUCY2D;NTRK3;EGFR;EPHB2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5029922355888369,1.5688346565770523,0.009626955475330927,0.4231974464409472,1.0,24/95,10.37%,PDPK1;NREP;TGFBR3;SMAD3;LDLRAD4;ZEB2;ADAMTSL2;ITGA3;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ENG;DKK3;SKI;BCL9;EMILIN1;DAB2;SPRY2;LEMD3;FAM89B;STK11;SPRED3
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5245244187644793,-1.5680873494844831,0.03494623655913978,0.41863003583625275,1.0,5/24,5.29%,MEF2C;CDH2;SPAG9;CDON;TCF3
prerank,chemical synaptic transmission (GO:0007268),-0.3434534896656109,-1.5679975429471154,0.0,0.4132689752222878,1.0,101/284,23.35%,GRM7;DLG2;GRID2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;RIMS1;KCND2;LIN7A;GRIK1;GRIK2;GRIN2A;HSPA8;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;DLGAP2;NRXN1;GABRG2;PRKACB;SLC1A1;CDH8;LRP6;CHRM3;GLRA2;GRM5;CDK5;LIN7C;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;NAAA;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;SYN3;GRID1;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC1A4;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;RAB3A;STX1A;CBLN2;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;DVL1;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;STXBP2;SNPH;GLRA3;SYT5;CHRM1
prerank,T cell differentiation (GO:0030217),0.5731476547815041,1.5646544717169737,0.01928374655647383,0.43571858028527966,1.0,11/40,9.43%,RHOH;LEPR;GLI3;KIT;LIG4;ZFP36L1;TCF7;CD28;NHEJ1;GPR89A;GPR89B
prerank,regulation of extracellular matrix organization (GO:1903053),0.6891939980947936,1.5634915825212163,0.03511705685618729,0.4374757283925358,1.0,6/15,4.03%,DDR2;LRP1;RUNX1;AEBP1;FGFR4;SLC2A10
prerank,phosphate ion homeostasis (GO:0055062),0.7560556062842265,1.5631859298795348,0.04504504504504504,0.4357721489811112,1.0,2/10,3.09%,ENPP1;FGFR4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6894728163888884,1.5627757734376468,0.05102040816326531,0.434607460539299,1.0,2/13,1.04%,ERRFI1;CBLB
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.48762951429065016,1.5621998932610255,0.008353221957040573,0.43412795835784596,1.0,26/112,9.23%,CILP;COL1A2;CLEC3B;TGFBR3;SMAD3;SOX5;BMPR1A;WNT4;TGFBR1;TWSG1;PDCD5;APOA1;APPL2;ACVR1;SFRP1;ITGB5;PDE3A;CDH5;ENG;ZFP36L1;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5637718800153791,-1.5618107288194358,0.03626943005181347,0.42813503848590095,1.0,5/17,10.27%,PDE3B;SORL1;MFSD2A;ALK;GPLD1
prerank,purine nucleotide catabolic process (GO:0006195),-0.6139022542779152,-1.5616602188831281,0.02518891687657431,0.42306794409896875,1.0,7/13,18.50%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,embryonic organ morphogenesis (GO:0048562),0.5631664135064083,1.5609065057961327,0.017266187050359712,0.4362523986436035,1.0,9/42,5.00%,RBP4;FBN1;FBN2;MFAP5;FGFR2;PDGFRA;ACVR1;NEUROD1;RARG
prerank,sphingolipid catabolic process (GO:0030149),-0.5869708896615654,-1.5597069566344006,0.03827751196172249,0.4238847539366423,1.0,4/15,3.32%,ACER3;ENPP2;ACER2;PPT1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3901136836020601,-1.559631825471123,0.016853932584269662,0.41880256514157244,1.0,28/99,13.10%,SLIT2;MEF2C;RAP1A;CDH1;ACTB;DIAPH1;SH3BP4;GABRB3;P2RX7;GLRA1;GABRB1;GABRG2;PDE2A;KCNQ1;GLRA2;AKAP6;SPAAR;RAP1B;TAF1;INPP5K;GABRB2;LARS1;IPO5;SLC26A6;JUP;HRH1;MTOR;CFTR
prerank,renal system development (GO:0072001),0.5475635477318922,1.5591997947681113,0.022191400832177532,0.44014713221541285,1.0,10/52,7.26%,RBP4;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;AGTR1;IFT27
prerank,sensory perception of sound (GO:0007605),0.5108620310146154,1.5590936206124812,0.00865265760197775,0.43801811537433205,1.0,18/88,11.08%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;KIT;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,GPI anchor metabolic process (GO:0006505),-0.5070883850858566,-1.5588639386684604,0.019444444444444445,0.41614746236792155,1.0,11/26,18.79%,DPM1;PIGP;PGAP2;GPLD1;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.5237223656890999,1.5577148275178885,0.015170670037926675,0.44061027498186267,1.0,10/77,6.31%,IGF1;TCF7L2;AR;BCL2;SH3RF1;CFLAR;TGFBR1;ACVR1;PHIP;SRC
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6455910730776792,1.5575167380184933,0.04462809917355372,0.438660272894103,1.0,2/20,4.81%,IGF1;NEUROD1
prerank,anterior/posterior axis specification (GO:0009948),0.694341938964241,1.5567194799301751,0.032467532467532464,0.4389440071887096,1.0,3/15,5.81%,WLS;TBX3;SKI
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6172549413222234,1.5565660071001857,0.03245749613601236,0.4369623129514067,1.0,4/26,7.80%,IGF1;FHL2;LMCD1;RCAN1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6612747462677728,1.5564778563020623,0.04873949579831933,0.4348084041293163,1.0,2/17,1.34%,BMP6;SASH1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3570889592142102,-1.555457886684992,0.0,0.4217550375393084,1.0,71/168,20.52%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;CNOT6L;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;CSDE1;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;PAN3;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;PNLDC1;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;THRAP3;RPL19;RPS20;RPL14;RPL13;DIS3L2;RPL32;RPL5;RPSA;SMG7;RPLP0;NBAS;RPS6;RPL22;AGO1;EXOSC5;CNOT7;RPS21;DDX5;DCP2;RPL37A;RPLP2;TENT2;RPL17;RPL23
prerank,carbohydrate homeostasis (GO:0033500),0.5208415902406915,1.5538837391325744,0.015727391874180863,0.4419445693539125,1.0,14/67,12.78%,TCF7L2;RBP4;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;STK11;ADRA2A;INSR;CYB5R4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5476216339609659,-1.552668770422683,0.04065040650406504,0.4256586512989602,1.0,8/18,11.31%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;RIMS2;SHANK1;PRKCZ
prerank,embryonic digestive tract development (GO:0048566),0.6500996809201023,1.5524143729237305,0.059602649006622516,0.4445014824636653,1.0,6/18,3.68%,GLI2;SALL1;GLI3;FGFR2;PDGFRA;RARB
prerank,regulation of plasminogen activation (GO:0010755),0.7210560517166336,1.552380339198689,0.039792387543252594,0.4421783663224506,1.0,7/12,15.64%,CLEC3B;SERPINE1;RUNX1;PLGRKT;CTSZ;HPN;MELTF
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7246777884045208,1.5518063035531857,0.050359712230215826,0.4418679375782464,1.0,2/11,5.54%,PDK1;CYP1B1
prerank,Rho protein signal transduction (GO:0007266),0.5424904528593113,1.5511180745309474,0.02666666666666667,0.44192830773084485,1.0,15/53,12.41%,COL1A2;ROCK2;ARHGAP6;RHOD;CTNNAL1;ARHGAP29;CDC42EP4;PDPN;CDC42;AGTR1;NTN1;ARHGEF11;TAX1BP3;ADRA2A;ARHGAP5
prerank,epithelial structure maintenance (GO:0010669),0.7132152361436361,1.5493692685323692,0.051418439716312055,0.44507160393769923,1.0,2/11,8.41%,RBP4;PIWIL4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6329421522154104,1.5492949628758617,0.039755351681957186,0.44302714272045046,1.0,7/21,14.94%,ERRFI1;ROCK2;RUNX1;ZFP36L1;CTSL;BMP4;SFRP4
prerank,regulation of biomineral tissue development (GO:0070167),0.619858985610907,1.547587836197845,0.021244309559939303,0.44666718641959735,1.0,6/26,3.44%,DDR2;ENPP1;ROCK2;AHSG;ANKH;GAS6
prerank,wound healing (GO:0042060),0.5259826935336483,1.5466210735110253,0.018666666666666668,0.4475447051404827,1.0,14/62,10.48%,IGF1;SMAD3;TPM1;PPP3CA;MACF1;PPL;PDGFRA;CFLAR;TGFBR1;FUT10;ITGB3;MIA3;FGF2;ANXA6
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6935364150272567,1.5464986792869984,0.053082191780821915,0.4455902469765575,1.0,2/13,0.18%,NRP1;PLXNA2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5087476443333215,-1.5461263814716417,0.025423728813559324,0.44158489658524547,1.0,11/26,18.87%,OCLN;NAV3;MET;RPS3;PAK1;FES;DCTN1;TRPV4;CDK5RAP2;CDK5R1;CLASP1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.6088121500423043,-1.5451807413516931,0.03209876543209877,0.43945722781847174,1.0,5/13,13.49%,ELOVL7;ELOVL5;TECR;TECRL;HACD2
prerank,regulation of acute inflammatory response (GO:0002673),0.6490166010772221,1.5445674669008262,0.0288,0.44975134209873247,1.0,2/18,2.52%,PTGES;OSMR
prerank,regulation of MAPK cascade (GO:0043408),0.4732964977159401,1.5440029778682676,0.003386004514672686,0.44967663986731166,1.0,33/157,11.33%,IGF1;EPHA7;IGF2;ADRA1B;NRK;ROCK2;TGFBR3;KSR1;DAG1;LYN;FGFR1;PELI2;EPHA8;CCN1;FGFR2;KIT;LBH;ROR1;ADRA2C;ADRB3;LPAR1;MAP2K1;TRAF7;NTRK3;STK4;EGFR;BMP2;MAP4K4;FGF2;RYK;TAOK3;GSDME;ADRA2A
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.66697886930775,1.542933027863786,0.054276315789473686,0.45131966037365095,1.0,2/17,3.47%,IGF1;APOE
prerank,negative regulation of proteolysis (GO:0045861),0.5879592560857834,1.542867706847202,0.027314112291350532,0.44926437287846305,1.0,13/34,16.32%,TIMP3;DNAJC1;EPHA4;CST3;LRRK2;TIMP2;SNX12;F2;CLN3;TM4SF20;PTPN3;GAS1;AKT1
prerank,positive regulation of MAPK cascade (GO:0043410),0.4534370080313957,1.5425356211103416,0.0,0.44819082816611705,1.0,48/245,11.33%,IGF1;NRP1;ROBO1;IGF2;ADRA1B;CCN2;ROCK2;ANGPT1;PDGFD;KSR1;FGFR1;IL34;PELI2;EPHA8;EPGN;FGFR2;KIT;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;ADRA2C;ADRB3;CCL4;LRRK2;LPAR1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;RYK;CARD9;BRAF;TAOK3;GSDME;ADRA2A
prerank,dorsal/ventral pattern formation (GO:0009953),0.6620424439494945,1.5410916958505858,0.03685897435897436,0.45087635008095245,1.0,6/20,5.05%,GLI2;BMPR1A;WNT8B;MDFI;ACVR1;SFRP1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4641620697024113,-1.5401357384930001,0.022508038585209004,0.4505741991727045,1.0,16/39,20.17%,RPS24;RPS14;RPS19;RIOK1;RPS15;RPS7;UTP4;RPS5;METTL17;LSM6;SNU13;RPSA;RPS6;RRP36;NPM1;MRPS7
prerank,positive regulation of cell cycle process (GO:0090068),0.5014683799604382,1.5396628119312907,0.013580246913580247,0.45364385157119913,1.0,16/91,8.20%,IGF1;IGF2;SVIL;TGFA;EPGN;PDGFRB;PHIP;MAP3K20;DYNC1H1;CDC42;INO80;CD28;NPM2;SIRT2;UBXN2B;DRD3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.46300133338993615,1.5386195867114254,0.0021953896816684962,0.4551828356304998,1.0,44/186,15.28%,IGFBP2;TCF7L2;BICC1;TRABD2B;RBMS3;MCC;LRP1;IGFBP4;DACT1;NKD1;GLI3;MDFI;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;RNF213;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;CBY1;PRKN;STK11;TAX1BP3;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12;TSC2;MDK;AMFR;CXXC4;SFRP4;GRB10
prerank,axonal fasciculation (GO:0007413),0.7067084633692504,1.538099793031734,0.04727272727272727,0.4547419440131528,1.0,6/12,11.55%,EPHA3;EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,positive regulation of kinase activity (GO:0033674),0.4865764185953913,1.5368747962657172,0.016229712858926344,0.4567585654013864,1.0,31/107,12.56%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;CCN1;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;CCL19;CSF1;RAPGEF2;AXL;MUSK;ROR1;ALS2;NTRK3;EGFR;EPHB2;LMO4;RYK;MRNIP;EPHB3;F2;DUSP19;INSR
prerank,cytoskeleton organization (GO:0007010),0.4856577062499701,1.5357234365154604,0.004667444574095682,0.45851433375284745,1.0,28/114,8.37%,SH3D19;MICAL3;RHOH;RHOD;NEDD9;OBSL1;TPM1;MARK1;ANK1;RHOBTB1;APOE;PALLD;CNN2;WDPCP;FGD1;BRWD1;PHIP;FGD4;RHOBTB3;DES;ARHGAP10;RANBP9;RHOBTB2;CSPG5;WTIP;PLD2;MAST2;CAPZB
prerank,muscle cell differentiation (GO:0042692),-0.4861434996432191,-1.5354445764732287,0.017241379310344827,0.4611835865314523,1.0,8/32,6.41%,NEBL;SYNE1;MRTFB;SGCZ;MEF2C;TBX1;KDM1A;HEY2
prerank,artery development (GO:0060840),0.6160876566405761,1.5342808695827095,0.041990668740279936,0.461204463904298,1.0,5/23,5.69%,NRP1;ROBO1;TGFBR1;SLC2A10;ENG
prerank,detection of mechanical stimulus (GO:0050982),-0.5507085612988343,-1.533902410911337,0.05185185185185185,0.46115326855952893,1.0,3/19,1.56%,PIEZO2;CDH2;PIEZO1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5623510379378038,1.5336262333468322,0.042735042735042736,0.4613906654128836,1.0,6/43,2.39%,IGF2;ENPP1;PID1;AHSG;OGT;KANK1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.44015811506453095,1.5321418575786891,0.0,0.4643421356392798,1.0,68/390,10.17%,IGF1;EPHA3;NRP1;POLR2D;ATP6V0A4;EPHA7;COL4A6;IGF2;MTSS1;COL1A1;DDR2;ROCK2;ANGPT1;GHR;ANGPTL1;PIK3R1;PDGFD;IL31RA;LYN;SULF2;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;MMP2;KL;FGFR2;KIT;FGFR4;RBFOX2;PDGFRA;EFNB2;PDGFRB;ANGPT2;CD7;SULF1;POLR1G;CSF1;RAPGEF2;AXL;NTF3;PHIP;FRS2;MUSK;ROR1;CDC42;SRC;BDKRB2;EFNA2;SIRT2;EIF2AK3;FLRT2;NTRK3;AAMP;FOXC2;ZNF106;EGFR;EPHB2;HNRNPA1;EFNB1;RAPGEF1;ITGB3;POLR2C;ITGAV;ATP6V1E1;FGF2;RYK
prerank,positive regulation of axon extension (GO:0045773),0.6123320368567239,1.5314404573092466,0.03691813804173355,0.464375546301755,1.0,6/22,8.66%,NRP1;MACF1;SEMA5A;GOLGA4;DSCAM;NTN1
prerank,cellular response to ketone (GO:1901655),0.5792313177085661,1.531159769171984,0.02361111111111111,0.4631709500560041,1.0,8/35,7.21%,ADCY1;ROCK2;ADCY2;AR;ADCY5;SFRP1;SRC;SPHK2
prerank,myofibril assembly (GO:0030239),0.5657116921299379,1.53053958049883,0.024079320113314446,0.4630955523094825,1.0,12/42,10.13%,ACTN2;OBSL1;TPM1;TMOD4;TNNT1;PDGFRA;CFLAR;PDGFRB;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6389741972699284,1.5293870581756042,0.03486529318541997,0.464780223251676,1.0,7/21,6.94%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;GUCY2C;GUCY2D
prerank,response to amyloid-beta (GO:1904645),0.5451550072962441,1.5260635911769502,0.036312849162011177,0.474809064859957,1.0,7/44,7.76%,IGF1;GJA1;LRP1;EPHA4;MMP2;CACNB1;TLR6
prerank,negative regulation of cell migration (GO:0030336),0.4785703522114076,1.5258571941431727,0.005847953216374269,0.47322006586481136,1.0,27/137,7.43%,ROBO1;PHLDB2;GJA1;MCC;LDLRAD4;LRP1;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;BMPR1A;KANK1;RECK;NKX2-1;DPYSL3;SULF1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;ATP1B2;DPEP1;AFDN
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5675523370639355,1.5254942125178814,0.04335260115606936,0.47224056730369723,1.0,11/34,14.42%,NRP1;NEDD9;APOA1;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6114948166872476,-1.525354277445594,0.03640776699029126,0.4853519635880615,1.0,8/13,23.02%,KDR;IL33;NAMPT;JAK2;EDN1;NOD2;TLR4;CCL2
prerank,regulation of gastrulation (GO:0010470),0.6867379872557097,1.5252952867445668,0.054982817869415807,0.4707275371445215,1.0,4/14,7.89%,PHLDB2;DAG1;CRB2;OSR1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7354210949370278,1.5223289318174822,0.05922165820642978,0.4788726555350347,1.0,5/10,11.49%,SP7;MLLT3;SFRP1;BATF;UFL1
prerank,odontogenesis (GO:0042476),0.5689555787041953,1.521915015148687,0.029411764705882353,0.47805794642106,1.0,9/35,8.76%,COL1A2;GLI2;FGFR2;WNT6;AXIN2;BCOR;OSR1;AQP6;BMP2
prerank,cell-cell junction organization (GO:0045216),-0.3898509742961754,-1.5217032304085436,0.010752688172043012,0.49229229508164934,1.0,27/79,14.09%,PKP4;CTNND2;OCLN;CADM2;CLDN5;CDH2;CADM1;LIMS2;CDH1;TJP2;TJP1;GJC1;TGFB2;NECTIN1;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;TGFB1;CXADR;PVR;TRPV4;DSG2
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6355664288670904,1.5216864916903887,0.06946688206785137,0.47671092229762185,1.0,2/19,3.47%,IGF1;APOE
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.552444192654711,1.5208174496794191,0.05285118219749652,0.47763104854864474,1.0,11/40,8.76%,TCF7L2;COL1A1;SMAD3;OLFM1;TGFBR1;AXIN2;PDPN;CRB2;WWTR1;DAB2;BMP2
prerank,apical junction assembly (GO:0043297),-0.42138301491385083,-1.5204055430180836,0.031007751937984496,0.4913115658306658,1.0,13/53,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;WDR1;STRN;PAK2
prerank,iron ion transport (GO:0006826),0.5522341848050033,1.5201609306550528,0.0374331550802139,0.47783245928532403,1.0,6/47,6.47%,ATP6V0A4;CP;STEAP3;SCARA5;HEPH;SLC11A2
prerank,catecholamine metabolic process (GO:0006584),0.6715801672951804,1.5197520831169864,0.04770017035775128,0.4769859126942205,1.0,5/14,10.21%,COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6089993680713168,1.51838966267856,0.04754358161648178,0.47988535262869225,1.0,6/24,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5315672981671477,-1.5182241750569272,0.053164556962025315,0.493240970411311,1.0,8/19,12.63%,CSGALNACT1;EXTL3;NDST3;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6213146991044936,1.516924094228428,0.060653188180404355,0.48321092958846984,1.0,2/22,0.75%,IGF1;ROCK2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.6326589920595614,-1.5167833733783478,0.04156479217603912,0.49299083618562967,1.0,3/11,6.57%,SLIT2;CCN3;RIN3
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4114762596267718,-1.5163359410848822,0.01953125,0.4890298105549025,1.0,13/58,11.40%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,embryonic limb morphogenesis (GO:0030326),0.5757822180261634,1.5157726918713108,0.03806734992679356,0.4852419463933148,1.0,11/34,8.18%,CYP26B1;SALL1;GLI3;WDPCP;RARG;TBX3;MAP3K20;SKI;CACNA1C;OSR1;AFF3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5357654295386352,1.515437070293927,0.036241610738255034,0.4841919876313062,1.0,23/50,18.67%,RORA;ZIC1;GLI3;FGFR2;MGRN1;SMO;FBXL17;SFRP1;TULP3;TEDC1;IFT81;GLIS2;TTC23;PTCH2;GLI1;BTRC;SUFU;GAS1;SHH;INTU;HHIP;EVC;PDCL
prerank,regulation of amyloid-beta formation (GO:1902003),0.5701540725400425,1.5154107347248933,0.042735042735042736,0.48207400488801894,1.0,4/34,3.47%,IGF1;ROCK2;EPHA4;APOE
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6792183976680329,1.5152652656146992,0.05203252032520325,0.48042902114057384,1.0,2/15,3.63%,MOXD1;SMOX
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6653301254444832,1.5148327757402789,0.05351170568561873,0.4799808060364987,1.0,2/16,0.75%,IGF1;ROCK2
prerank,axon guidance (GO:0007411),0.4466816002527516,1.5144468552856436,0.004405286343612335,0.47917771021473704,1.0,41/201,10.38%,EPHA3;NRP1;ROBO1;PLXNA2;EPHA7;LAMA1;RHOH;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;NFIB;EFNB2;SMO;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ALCAM;RANBP9;EFNA2;ARHGAP35;SPTAN1;DSCAM;EPHB2;NTN1;EFNB1;GFRA4;SLIT3;SLIT1;RYK;PTPRM;NEXN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.48529816908217965,1.5142303639654846,0.017434620174346202,0.47787975809674144,1.0,23/95,11.93%,GPC6;FMOD;OGN;CEMIP;ANGPT1;LUM;UST;DCN;BGN;HSPG2;PXYLP1;ST3GAL3;DSE;HS6ST1;SDC1;B4GALT1;OMD;CSPG5;EXT1;ABCC5;NDST1;CHST15;GALNT5
prerank,embryonic organ development (GO:0048568),0.5156822584485674,1.5142191242750822,0.022757697456492636,0.47579186936269785,1.0,13/61,4.81%,RBP4;TEAD1;GDNF;PBX1;GLI2;SALL1;BMPR1A;GLI3;FGFR2;KIT;COL13A1;RARB;NEUROD1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5876583174797626,-1.5141905196574357,0.04116222760290557,0.49136726348786103,1.0,3/12,3.55%,PODXL;PROM1;IQGAP1
prerank,aorta development (GO:0035904),0.6654318793370305,1.5134826948461337,0.05752961082910321,0.47629554996800416,1.0,4/14,6.17%,ROBO1;LRP1;PDGFRB;ADAMTS9
prerank,endothelial cell development (GO:0001885),-0.49854079797557393,-1.5132498129109837,0.02702702702702703,0.48927961887309807,1.0,12/25,10.46%,PDE4D;PECAM1;RAP1A;PPP1R16B;MET;RDX;PDE2A;COL15A1;RAP1B;ROBO4;SOX18;MSN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5809806389231765,-1.5129315273003126,0.05236907730673317,0.4853593390291439,1.0,8/15,17.75%,TEC;PTK2B;KDR;BMX;AATK;MAPK3;IGF1R;TXK
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5184850154854009,-1.5128698252436668,0.04392764857881137,0.48052625810914107,1.0,10/21,12.39%,MEF2C;ITGA1;HSP90AB1;PPP1R15B;CALM1;MTMR9;GPLD1;CALM3;PLEK;MTOR
prerank,response to glucose (GO:0009749),0.5318778893474974,1.5126741196185673,0.033738191632928474,0.4769733125269407,1.0,7/46,5.19%,TCF7L2;ZBTB20;NKX6-1;SLC30A8;GAS6;NEUROD1;PRKAA2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7051220911996842,1.5121681479470754,0.06884057971014493,0.4766187004316148,1.0,2/11,4.08%,RUNX1;TWSG1
prerank,regulation of kinase activity (GO:0043549),0.4863665495968109,1.5118653572601914,0.012738853503184714,0.4754752869486329,1.0,22/89,10.59%,EPHA3;EPHA7;LDB2;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;TSPYL2;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;LMO4;RYK;RBL2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5220922802219011,-1.5116095949634833,0.03753351206434316,0.479904598271896,1.0,9/20,14.43%,RPS6KA5;DIP2B;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3;DIP2A
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.45806095825313786,1.511360975870463,0.007803790412486065,0.4751258668126629,1.0,32/161,12.91%,IGFBP2;TCF7L2;BICC1;RBMS3;MCC;IGFBP4;DACT1;NKD1;GLI3;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;PRKN;STK11;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12
prerank,sprouting angiogenesis (GO:0002040),0.5338956856091589,1.5112251952655504,0.02390438247011952,0.47352954447709833,1.0,12/51,6.38%,NRP1;ROBO1;CCBE1;ESM1;ANGPT1;RECK;PARVA;EFNB2;SEMA5A;RNF213;ENG;ADGRA2
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4448099737585866,-1.5109776152431909,0.014545454545454545,0.47719103803040097,1.0,12/41,14.00%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNJ3;ABCC9;SLC12A6;ATP1B1;KCNJ15;ATP1A3;KCNJ10;SLC12A5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5210510279863382,1.5108635259759766,0.027166882276843468,0.47285091249461264,1.0,14/66,6.05%,ROBO1;MTSS1;TGFBR3;SPARC;MCC;NR2F2;FGFR2;NFIB;APOE;NUPR1;SULF1;SFRP1;CASK;ATOH8
prerank,negative regulation of cartilage development (GO:0061037),0.6766417102015642,1.5088505644181744,0.06440071556350627,0.47767840775297504,1.0,3/13,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7027710308631188,1.508776405637982,0.04974271012006861,0.4759054750072839,1.0,6/11,8.34%,NKD1;LBX2;MLLT3;SFRP1;WNT5B;DAB2
prerank,endothelial cell proliferation (GO:0001935),-0.5507875921802617,-1.5061359170669057,0.046703296703296704,0.4884438959986195,1.0,9/17,18.89%,TEK;BMPER;CD34;ACVRL1;THAP1;PRKX;ERN1;BMPR2;ITGB1BP1
prerank,regulation of catabolic process (GO:0009894),-0.5563960683406,-1.5059081494325859,0.029411764705882353,0.48436931385612947,1.0,4/18,4.22%,FAP;ZDHHC2;NEDD4L;FAF1
prerank,negative regulation of cellular protein localization (GO:1903828),0.5677714094155742,1.5045824112473447,0.055800293685756244,0.4890983873835169,1.0,9/34,10.55%,ROCK2;ACTN2;LEPROT;RIPOR2;SNX33;UBXN2B;PICALM;COMMD1;TAX1BP3
prerank,embryonic eye morphogenesis (GO:0048048),0.7050768174446134,1.5033019010289468,0.0506108202443281,0.4918853781173839,1.0,4/11,5.00%,FBN1;FBN2;MFAP5;RARG
prerank,regulation of endopeptidase activity (GO:0052548),0.5184534379336377,1.502604592886021,0.03524804177545692,0.492481587273842,1.0,13/59,10.93%,TIMP3;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2;PICALM;APH1B
prerank,smooth muscle cell differentiation (GO:0051145),-0.619983737789414,-1.5021247294963305,0.052256532066508314,0.49223867323637094,1.0,6/12,14.87%,MRTFB;MEF2C;HEY2;APLNR;HEY1;EDNRB
prerank,ketone body metabolic process (GO:1902224),0.7100916762403426,1.5020428496220404,0.06304728546409807,0.4925108993640298,1.0,4/10,3.16%,SLC27A5;ACSS3;OXCT1;HMGCLL1
prerank,chondrocyte differentiation (GO:0002062),0.5770448567777136,1.5011705846712926,0.04941860465116279,0.49358697654939526,1.0,11/32,8.76%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;CREB3L2;WNT5B;EIF2AK3;OSR1;BMP2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5434533136703652,-1.4996427888643447,0.06419753086419754,0.49572072385342325,1.0,8/17,18.69%,NLGN1;RAB27A;SLC4A8;CACNA1H;RAB15;RAB3A;STX1A;SYT4
prerank,regulation of actin filament-based process (GO:0032970),0.4964706144134707,1.499162430456438,0.023872679045092837,0.4986811554154217,1.0,14/70,7.96%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;CNN2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,sphingolipid metabolic process (GO:0006665),-0.37099582921565977,-1.4989475473201712,0.005988023952095809,0.4931821289802581,1.0,22/108,13.61%,ST6GALNAC3;SGMS1;CERT1;ESYT2;ACER3;ENPP2;SGMS2;ELOVL7;ACER2;DEGS2;PPT1;SPNS2;ELOVL5;HEXB;DEGS1;UGCG;SPTLC2;TECR;SPTSSB;ORMDL3;HACD2;ARV1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6649921979511861,1.4973046572380244,0.06188925081433225,0.5034430015145888,1.0,5/15,5.93%,DDR2;LRP1;FGFR4;PDPN;CST3
prerank,regulation of glucose metabolic process (GO:0010906),0.5573762245527155,1.4954744424533073,0.05065123010130246,0.5081696798737507,1.0,5/34,5.44%,PDK1;RORA;OGT;SLC45A3;GNB3
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5544623458768931,1.494348256418849,0.03982930298719772,0.5101600270168927,1.0,8/35,6.49%,IRAG1;ADCY1;ADCY2;KSR1;APOE;RAPGEF2;PDE3A;PDE7B
prerank,inositol lipid-mediated signaling (GO:0048017),0.5301449689061409,1.4934004368312706,0.032116788321167884,0.5114116039114094,1.0,9/50,6.84%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ADAP2;PLCB4
prerank,cyclooxygenase pathway (GO:0019371),0.7095829634786377,1.490233067267631,0.06294964028776978,0.5210554838760981,1.0,2/10,1.91%,PTGIS;PTGES
prerank,ganglion development (GO:0061548),0.6883941705731589,1.4896931248260585,0.06642728904847396,0.5208482582926269,1.0,2/11,3.20%,NRP1;ASCL1
prerank,myotube cell development (GO:0014904),0.7063945775105848,1.488990729605474,0.09107142857142857,0.5212210384851896,1.0,2/10,5.81%,IGF1;SKI
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.4928314154548783,-1.4888051560996718,0.04748603351955307,0.5237743239067535,1.0,7/25,10.18%,AFAP1L2;CCDC88A;BCAR3;CBL;HIP1R;ARAP1;SHKBP1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6767467786763337,1.488797415297221,0.07042253521126761,0.5197688680059007,1.0,6/13,17.97%,GAS6;AXL;IL12B;ZBTB1;IL23A;IL18
prerank,regulation of protein kinase B signaling (GO:0051896),0.44188772623110134,1.487763683890751,0.011148272017837236,0.5213432468709576,1.0,41/193,13.86%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;DAG1;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28;GRM2;NTRK3;DRD3;EGFR;SPRY2;FGF2;HBEGF;RCN3;PHLPP2;INSR;MUL1;EGF;TSC2;PTEN;FLT3LG
prerank,positive regulation of secretion (GO:0051047),-0.6233938847801306,-1.4873001902101666,0.04608294930875576,0.5244080552027759,1.0,6/11,30.76%,NPR1;GPLD1;ACSL3;XBP1;AQP1;SCIN
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5881715581431998,1.486696338131762,0.03881987577639751,0.523269746387256,1.0,2/25,4.81%,IGF1;NEUROD1
prerank,sarcomere organization (GO:0045214),0.5779591753370129,1.4857802462076455,0.05917159763313609,0.5245996750991822,1.0,7/27,10.13%,ACTN2;TPM1;TNNT1;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6706353168661385,1.4848970698689097,0.07216494845360824,0.5258426643640883,1.0,1/15,0.01%,IGF1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5722623773773784,-1.4847430036791593,0.059850374064837904,0.5289059765955526,1.0,9/14,30.25%,ENTPD1;ENTPD2;ENTPD6;ENTPD3;ADPRM;NUDT16;NUDT9;ENTPD5;NUDT1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6429959554406328,-1.4844033646378383,0.05714285714285714,0.5250724015372535,1.0,7/10,20.74%,GABRG3;GABRA2;GABRG2;GABRB2;GABRA3;GABRA4;GABRG1
prerank,regulation of transmembrane transport (GO:0034762),-0.4604164513215784,-1.4832309937281758,0.025396825396825397,0.524613906227398,1.0,7/31,3.19%,OCLN;SLC2A1;KCNJ2;ACTB;CTTNBP2NL;NEDD4L;KCNJ3
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5161104301631562,1.4822538769344884,0.024128686327077747,0.5334627568435059,1.0,14/56,10.51%,BMP6;LDLRAD4;BMPR1A;INHBE;PMEPA1;TGFBR1;TWSG1;ACVR1;ENG;EMILIN1;DAB2;RBPMS;BMP2;BMP15
prerank,embryonic digit morphogenesis (GO:0042733),0.620249217681651,1.482027005285144,0.07728706624605679,0.5321881456639769,1.0,6/18,7.89%,SALL1;GLI3;WDPCP;TBX3;MAP3K20;OSR1
prerank,regulation of developmental growth (GO:0048638),0.5719596511021279,1.4814180241265915,0.048484848484848485,0.5323220055102681,1.0,5/29,5.36%,IGF1;GHR;OLFM1;APOE;MUSK
prerank,nucleotide catabolic process (GO:0009166),-0.5564700962263784,-1.4806643469197367,0.040106951871657755,0.5287483213727149,1.0,8/16,23.84%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1;VCP
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.44874687324429613,1.4806171840980324,0.00995575221238938,0.5329415820429374,1.0,36/166,12.59%,IGF1;SAMD4A;IGF2;SMAD3;ZEB2;PLD1;GLI2;SLC6A9;NOS1AP;NNMT;FGFR4;PDGFRB;CCL19;APOA1;SLC45A3;SLC25A37;LDLR;STAR;SMOC2;CPEB3;CD28;NPM2;SREBF1;TLR6;NR1D1;LPGAT1;EGFR;METTL14;ARNT;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5341103595739708,1.4804670565047686,0.039780521262002745,0.5314158201566974,1.0,13/41,13.99%,AREG;TGFA;NEDD9;EPHA4;IL34;EPGN;GAS6;SRC;HBEGF;ADRA2A;NOX4;EGF;DLG4
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5880587753724469,1.4796856992361842,0.054773082942097026,0.5322736373034455,1.0,5/24,4.35%,ADAMTS12;TRPS1;SOX5;TGFBR1;CHADL
prerank,regulation of chromatin organization (GO:1902275),0.666137566616887,1.4795465639807655,0.0686106346483705,0.5307622362994909,1.0,7/14,15.19%,IGF2;HPF1;MLLT3;SETD1A;SETD5;TLK1;METTL4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.7002939284987116,1.4790589176739601,0.0920353982300885,0.5302989397846171,1.0,3/10,8.78%,IGF2;DNMT3A;PCGF3
prerank,Golgi ribbon formation (GO:0090161),0.6828955735652873,1.479046605520882,0.06335616438356165,0.5283214855618393,1.0,4/13,8.92%,OPTN;MYO18A;STX16;TRIP11
prerank,autonomic nervous system development (GO:0048483),0.6353340262483955,1.4788785514667313,0.07804878048780488,0.5268695427585462,1.0,3/17,3.20%,NRP1;GDNF;ASCL1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6496561825051894,1.4775959385812416,0.07556270096463022,0.529588896274997,1.0,5/15,14.45%,SH3D19;APOE;SNX33;ADRA2A;SNX9
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6866725780650139,1.476963620470943,0.0967741935483871,0.5298738632319807,1.0,6/11,10.55%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3
prerank,positive regulation of proteolysis (GO:0045862),0.5138784944306909,1.4768949913141485,0.043941411451398134,0.5281419503073248,1.0,8/55,6.72%,CCBE1;SH3D19;OGT;FGFR4;ASPH;APOE;CTSH;SNX33
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5300947711244703,-1.4755150506091583,0.03350515463917526,0.5418860151701489,1.0,7/18,9.66%,GRID2;UNC13B;GRIK1;GRIK2;CDH8;GRIA2;GRID1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4847520388913084,1.474558299467581,0.019925280199252802,0.5348439696149786,1.0,17/85,11.08%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,renal water homeostasis (GO:0003091),0.5877169974192265,1.4742660113277792,0.05614567526555387,0.5338956459630815,1.0,5/23,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5856472918972608,1.473685035307397,0.05196850393700787,0.5341187072939297,1.0,3/25,2.56%,ERRFI1;CBLB;SLC6A9
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6815797265391522,1.4729462450906585,0.0642361111111111,0.5349201000053514,1.0,4/12,3.18%,MYCBP2;GLI2;EPHA4;NFIB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6981647980139426,1.4729286803170383,0.07801418439716312,0.5330364721425355,1.0,5/11,11.10%,GRK3;ADRB3;DRD3;ARRB1;ADM
prerank,glucose homeostasis (GO:0042593),0.4792074388541737,1.472855769495388,0.03333333333333333,0.5313162805173959,1.0,20/83,15.80%,TCF7L2;RBP4;PIK3R1;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;NR1D1;STK11;ADRA2A;INSR;CYB5R4;SLC2A4;FOXK2;PIK3R2;LRRC8A
prerank,keratan sulfate biosynthetic process (GO:0018146),0.583997030773588,1.472785796779549,0.06471494607087827,0.5296422590220515,1.0,6/26,7.98%,FMOD;OGN;LUM;ST3GAL3;B4GALT1;OMD
prerank,positive regulation of transferase activity (GO:0051347),0.44495278785396775,1.4725728924189223,0.013777267508610792,0.5285557042158787,1.0,25/142,10.32%,EPHA3;EPHA7;IGF2;DDR2;ARRDC4;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CHTF8;AXL;MUSK;ROR1;PARM1;NTRK3;EGFR;EPHB2;CD200;LMO4;RYK;PARN
prerank,carbohydrate derivative transport (GO:1901264),-0.5382670617876316,-1.4710690208026012,0.03324808184143223,0.552642063711824,1.0,8/18,14.56%,PLTP;SLC15A2;LBP;NPC2;MFSD2A;ABCG1;SCARB1;VLDLR
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5420006652213617,-1.4707967772326902,0.07425742574257425,0.5488111397976807,1.0,7/18,14.50%,PLCG2;DYSF;LBP;FCER1G;IFI35;SBNO2;KARS1
prerank,ribosomal large subunit assembly (GO:0000027),-0.499456123812449,-1.47073521288453,0.03937007874015748,0.5442532065247734,1.0,11/24,27.97%,RPL3;RPL11;RPL6;PPAN;RPL5;FASTKD2;RPLP0;RRS1;RPF2;DDX28;RPL10
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5949417053626106,1.4702183507631472,0.06466876971608833,0.5352010368741918,1.0,10/23,16.85%,GJA1;GDNF;SMO;LBX2;WNT5B;FGF2;EGF;MDK;BMP4;LIF
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6225792977699218,1.469976067511451,0.05811965811965812,0.5340911185567784,1.0,6/18,9.62%,LTBP1;SMAD3;ITGB8;ITGB6;CD200;ITGAV
prerank,cellular response to glucagon stimulus (GO:0071377),0.6292316445820951,1.4692782161337474,0.05306799336650083,0.5346483764624503,1.0,5/17,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48327320406108404,1.4692283112799862,0.025031289111389236,0.5328791634107921,1.0,18/84,10.16%,NRP1;PDPK1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;PLPP3;FGFR1;SEMA5A;SMOC2;ATOH8;AKT3;AAMP;FOXC2;ANXA3;ITGB3;FGF2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.652249002250815,1.4679854260893226,0.061946902654867256,0.5354192391547596,1.0,3/14,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,regulation of cell migration (GO:0030334),0.4226802295165244,1.4679817949895726,0.0010204081632653062,0.5335219608592326,1.0,83/382,11.33%,IGF1;ROBO1;PLXNA2;LDB2;PHACTR1;COL1A1;CEMIP;ROCK2;AMOTL2;PDGFD;SYNE2;SASH1;LDLRAD4;DAG1;MITF;SEMA3D;SERPINE1;DLC1;RHOD;PODN;NEDD9;TPM1;EPHA4;DOCK10;NKD1;KANK1;RECK;PPP3CA;CCN1;NKX2-1;MACF1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;DPYSL3;SEMA5A;SULF1;CSF1;RFFL;APPL2;ACVR1;NTF3;SFRP1;CTSH;IGFBP5;TBCCD1;PDPN;CXCL16;CYP1B1;CDH5;ENG;SRC;BEX4;WNT5B;VCL;DPEP1;AFDN;CARMIL1;MYO1C;PARD6B;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;ACTN4;CAMK2B;MYADM;LMO4;MIA3;FAM89B;FGF2;NEXN;DNAI3;TRIP6;AMOTL1;HBEGF;ADRA2A
prerank,cellular response to amyloid-beta (GO:1904646),0.5549017353446548,1.4671845496122031,0.06706408345752608,0.5344242571236016,1.0,6/35,7.76%,IGF1;GJA1;LRP1;EPHA4;CACNB1;TLR6
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.48025485187258077,1.466319108907558,0.03841387856257745,0.5355580834563016,1.0,17/88,12.73%,NELL1;SAMD4A;DAPK1;DNAJC1;APOE;CDK5RAP3;IGF2BP2;IGFBP5;CST3;CPEB3;EIF2AK3;RNF139;DDX3X;F2;CLN3;LARP1;TM4SF20
prerank,amide transport (GO:0042886),-0.48812176753115355,-1.4654710047991428,0.03903903903903904,0.5573493840104254,1.0,6/26,6.74%,CERT1;ABCG2;PLTP;SLC5A6;SLC38A5;PLEKHA3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5226960999143502,1.4654253254397513,0.05198358413132695,0.5368203853697995,1.0,6/46,4.26%,TCF7L2;PIK3R1;SMAD3;ZIC1;GAS6;NEDD4
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5595299943491739,1.464627557703217,0.05846153846153846,0.5378840340782296,1.0,6/30,9.62%,IGF1;LYN;NOTCH2;SRC;RAPGEF1;ITGAV
prerank,thyroid hormone generation (GO:0006590),0.6848815659677159,1.464125166849774,0.08407871198568873,0.5378272101741342,1.0,4/10,15.56%,CPQ;SLC5A5;DIO2;TG
prerank,bone development (GO:0060348),0.545645289920067,1.4640384472499317,0.06013986013986014,0.5362422495242423,1.0,8/39,5.81%,GJA1;CYP26B1;SULF2;FGFR2;GNAS;SULF1;SH3PXD2B;SKI
prerank,positive regulation of insulin secretion (GO:0032024),0.5476739180242801,1.4639919946069897,0.059420289855072465,0.5345656456817047,1.0,5/36,5.31%,TCF7L2;RBP4;SLC30A8;MCU;BAIAP3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6501996046716974,1.4633208467579761,0.07705479452054795,0.5350116428138045,1.0,7/15,6.62%,DAAM2;DACT1;LBX2;RNF213;SFRP1;ZNRF3;WNT5B
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6752098618930156,1.4631744759438536,0.07859531772575251,0.5336534776465016,1.0,8/12,28.52%,INSIG2;KDELR3;INSIG1;RER1;HSPA5;OS9;KDELR2;TAPT1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.703438872746336,1.462327004182183,0.09298245614035087,0.5349268504374615,1.0,3/10,3.05%,LYN;PIGR;KIT
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.608934150040705,-1.462025400692041,0.054245283018867926,0.5651757266088432,1.0,4/11,3.18%,SEMA6A;THBS1;EPN2;KLF2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.650075417905231,1.461746609003896,0.08403361344537816,0.5349827092970272,1.0,3/13,6.76%,PTGIS;NNMT;PARP16
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.705271853830499,1.4613025052082216,0.07473309608540925,0.5347213731827895,1.0,3/10,4.42%,ENPP1;PID1;APPL2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5203032184436259,1.460921413112965,0.061711079943899017,0.5342640645430478,1.0,15/43,14.25%,ERRFI1;CBLB;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;GPRC5A
prerank,activation of protein kinase A activity (GO:0034199),0.6348787077483239,1.460739871228905,0.05695142378559464,0.5330388156786046,1.0,5/16,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,integrin-mediated signaling pathway (GO:0007229),0.4859483771807672,1.460556167165702,0.03875968992248062,0.5318425773326362,1.0,16/73,9.62%,ITGBL1;NRP1;FYB1;PLPP3;ITGA11;NEDD9;FBLN1;APOA1;ITGB8;ITGB5;CDC42;SRC;DAB2;ITGB6;ITGB3;ITGAV
prerank,artery morphogenesis (GO:0048844),0.5514817813433934,1.4600378977525081,0.06736526946107785,0.5318014833317828,1.0,7/30,6.17%,NRP1;LRP1;BMPR1A;PDGFRB;TGFBR1;ENG;ADAMTS9
prerank,cellular response to interleukin-6 (GO:0071354),0.584825531987881,1.4596002720049992,0.07244094488188976,0.5315861127533238,1.0,6/26,6.86%,PTGIS;PID1;IL6R;YAP1;SRC;CEBPA
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6773044097942076,1.4595064213387585,0.08188153310104529,0.5301032602542908,1.0,3/11,7.38%,PTGIS;DLC1;SIRT2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6614298456991421,1.4583244886750613,0.07678883071553229,0.5324311813053737,1.0,5/13,8.74%,BMP6;BMPR1A;TGFBR1;DAB2;RBPMS
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5812932658944132,1.4578579010151858,0.07395993836671803,0.5322023124569927,1.0,2/25,0.72%,PDPK1;CEMIP
prerank,regulation of actomyosin structure organization (GO:0110020),0.6709674908626909,1.4569898570056115,0.090311986863711,0.533538519038351,1.0,4/13,6.66%,ROCK2;ASAP3;CDC42;ALMS1
prerank,peptidyl-tyrosine modification (GO:0018212),0.5009212742515486,1.4564089360106707,0.048409405255878286,0.5336844591636607,1.0,11/56,3.56%,EPHA3;DDR2;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;TPST1;PDGFRA;PDGFRB
prerank,cellular response to growth factor stimulus (GO:0071363),0.4494356180488393,1.456387445478326,0.01478953356086462,0.532011221799805,1.0,27/151,9.37%,NRP1;BMP6;ADAMTS12;PDPK1;CILP;CLEC3B;SMAD3;SOX5;BMPR1A;WNT4;RUNX2;TGFBR1;PDCD5;RAPGEF2;APPL2;ACVR1;SFRP1;PDE3A;ZFP36L1;ACAP2;SIRT2;NTRK3;EGFR;BMP2;STAT5B;SPRY2;RAPGEF1
prerank,regulation of fibroblast proliferation (GO:0048145),0.5300052269133656,1.4547033536896041,0.06559571619812583,0.5359695556920581,1.0,7/45,5.81%,IGF1;DDR2;GAS6;PDGFRA;LIG4;SFRP1;SKI
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4356983023642802,1.4541653592575698,0.006507592190889371,0.5360793982845828,1.0,45/199,15.87%,ALDH1A1;ROBO1;GJA1;ROCK2;ADAMTS5;MCC;LDLRAD4;LGR4;WWC2;IL17D;TNNT1;NKX2-1;NFIB;ACOT11;GAS6;NPR3;TWSG1;APOA1;SFRP1;NR1D1;RBPJ;FOXC2;EGFR;BMP2;SPRY2;USF3;STK11;FOXA1;SPRED3;ADM;RGCC;VASN;MAP2K6;SYT11;PTEN;PTPN23;MDK;HPN;NR1H3;BMP4;ASB1;SPRED1;BMP5;CHSY1;SDHAF2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6676710490807404,1.4540676990198333,0.0812274368231047,0.5346605678310133,1.0,5/12,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,C-terminal protein amino acid modification (GO:0018410),-0.6090466136382835,-1.453839192662619,0.05922551252847381,0.5904422596475617,1.0,7/11,30.01%,AGBL4;GPLD1;ATG7;TTL;AGTPBP1;LCMT1;AGBL1
prerank,keratan sulfate metabolic process (GO:0042339),0.5574378263053865,1.4536895452245915,0.06306306306306306,0.5341780295790773,1.0,7/31,7.98%,FMOD;OGN;LUM;ST3GAL3;GALNS;B4GALT1;OMD
prerank,actin filament depolymerization (GO:0030042),0.6861181208267494,1.453288052945299,0.10516605166051661,0.5337646348412984,1.0,2/11,1.20%,MICAL3;GSN
prerank,cardiac muscle contraction (GO:0060048),0.5528876839787384,1.4527348518194292,0.06881405563689605,0.5338111348007752,1.0,8/34,9.66%,SLC8A1;GSN;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,B cell homeostasis (GO:0001782),0.6791437989218556,1.452482588639398,0.1125,0.5330114452064167,1.0,4/10,2.92%,LYN;DOCK10;DOCK11;GAPT
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.5135785626549808,-1.4512275374983084,0.06905370843989769,0.5951245909527116,1.0,5/20,6.07%,ZBTB16;CDK6;PTK2B;HOXA5;MEIS2
prerank,replicative senescence (GO:0090399),0.6690497282610564,1.4512246521074446,0.0831889081455806,0.5356418435279521,1.0,2/12,2.11%,SERPINE1;PLA2R1
prerank,regulation of protein export from nucleus (GO:0046825),0.5933097524616611,1.4509697191658943,0.08461538461538462,0.5348120921278301,1.0,6/23,12.17%,TCF7L2;SP100;GAS6;RBM22;IFI27;YWHAE
prerank,retinoic acid metabolic process (GO:0042573),0.6509735092883631,1.4502924138932156,0.08038585209003216,0.5354196362836333,1.0,3/14,7.28%,CYP26B1;ALDH1A2;ADH1A
prerank,BMP signaling pathway (GO:0030509),0.4925609254836157,1.4495280047604981,0.04054054054054054,0.5363955232833881,1.0,17/62,15.58%,BMP6;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.4535039699640469,-1.4493919824873596,0.034375,0.5971838863761437,1.0,10/34,9.47%,GRID2;MEF2C;GABRG3;GRIN2A;GABRA2;GLRA1;GABRG2;GRIN2B;GSK3A;GABRA3
prerank,positive regulation of DNA binding (GO:0043388),0.5586418204243284,1.449291450948171,0.06402439024390244,0.5355809784813432,1.0,7/31,13.25%,IGF1;NEUROD1;SKI;SIRT2;PRKN;NIBAN2;EGF
prerank,pancreas development (GO:0031016),0.6694755707519537,1.4486955572583575,0.10664335664335664,0.5360066214589078,1.0,3/12,7.53%,TCF7L2;NKX6-1;DNAAF1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5432472794730236,1.447975424998995,0.048209366391184574,0.5367662015293272,1.0,10/36,13.49%,NRP1;AREG;TGFA;EPGN;ADRA2C;EPHB2;HBEGF;ADRA2A;EGF;NCOA3
prerank,regulation of stem cell proliferation (GO:0072091),0.6278853694801584,1.4474191620524182,0.0704,0.5370448007524555,1.0,4/17,5.78%,GJA1;YAP1;FBLN1;ZFP36L1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.47517063643726387,-1.4473846302163174,0.05501618122977346,0.599517153646429,1.0,8/27,14.09%,PDE4D;CAV1;PDE4B;CTNNA3;CAMK2D;JUP;RYR2;DSG2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.48792881568127383,-1.4471405043559826,0.05014749262536873,0.5954072896774658,1.0,10/26,4.62%,SLC39A10;SLC39A8;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5107239953719763,1.4469062690738645,0.05327868852459016,0.5371145677709963,1.0,16/47,15.64%,NRP1;NEDD9;KANK1;FBLN1;APOA1;PDPN;CDC42;DOCK5;CARMIL1;CSPG5;ACTN4;MYADM;P4HB;MDK;FLNA;MELTF
prerank,sensory organ development (GO:0007423),0.5094967001538542,1.4454726884571094,0.051560379918588875,0.5401501499661827,1.0,7/51,6.98%,RBP4;PBX1;SHROOM2;ASCL1;SH3PXD2B;CPAMD8;SMOC1
prerank,histone H3-K4 methylation (GO:0051568),0.562939999987035,1.4454588360806098,0.0803030303030303,0.5385065038339122,1.0,10/26,20.55%,OGT;SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;TET3;CXXC1;RBBP5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6762392391901842,1.4451428716867165,0.0784313725490196,0.5378672611725337,1.0,4/12,9.04%,ROCK2;APOE;RANBP9;PICALM
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6056015987705712,-1.444035221302158,0.0891566265060241,0.6019781811540901,1.0,5/11,10.72%,NOS3;GCH1;DHFR;CALM1;SPR
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5385172730891963,-1.4440202629187386,0.05938242280285035,0.5971552855675192,1.0,2/16,3.00%,CLDN5;CLDN11
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6565803329854006,1.4433950869833496,0.0797872340425532,0.5422030964315501,1.0,5/13,10.86%,PGM3;SLC35A3;GFPT1;UAP1;RENBP
prerank,regulation of cellular catabolic process (GO:0031329),0.4912074651103386,1.4429967246745605,0.043137254901960784,0.5420080276574468,1.0,19/62,20.99%,DAPK2;ITPR1;DAPK1;NUPR1;LRRK2;MTMR3;WDR91;PRKN;LONP2;RRAGD;USP10;PIK3R2;TPCN2;PIP4K2C;ATM;WDR41;PSAP;GPR137B;DDIT3
prerank,regulation of endothelial cell migration (GO:0010594),0.4687914564235848,1.4427084423182588,0.028500619578686492,0.541291979207386,1.0,20/85,10.32%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;GLUL;SASH1;DCN;NR2F2;SP100;APOE;SMOC2;ATOH8;ADAMTS9;AAMP;FOXC2;ANXA3;ITGB3;FGF2;PTPRM
prerank,regulation of focal adhesion assembly (GO:0051893),0.4962535161940893,1.4426842990283013,0.061224489795918366,0.5397199822667894,1.0,10/54,6.79%,EPHA3;NRP1;PHLDB2;ROCK2;ARHGAP6;DLC1;MACF1;SFRP1;SRC;VCL
prerank,protein localization to membrane (GO:0072657),-0.32647009129936894,-1.4413791721280749,0.010638297872340425,0.6020436942603095,1.0,41/187,10.09%,DLG2;CAV1;DPP10;SHANK3;KCNB2;KCNIP4;RAP1A;SMURF1;NLGN1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;NRXN1;RDX;LRRC7;LRP6;EMP2;TTC7A;RAB3C;ITGA4;LIN7C;ATP1B1;EHD4;RAB12;NUP54;GAK;RAB8B;INPP5K;RAB11A;MAP7;PTN;ARL3;JUP;ZDHHC15;SCRIB
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.48574933997457437,1.4411084733882722,0.047872340425531915,0.5437265669573412,1.0,13/72,6.31%,IGF1;PIK3R1;PDGFD;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,dermatan sulfate metabolic process (GO:0030205),0.6512729489732634,1.4408105635091941,0.09171075837742504,0.5430737955360039,1.0,5/13,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,negative regulation of cell differentiation (GO:0045596),0.43066728489221584,1.44057579309953,0.013186813186813187,0.5422767460208283,1.0,50/181,16.01%,ADAMTS12;IGF2;RORA;ENPP1;RUNX1T1;ADGRV1;SMAD3;COL5A1;LDLRAD4;ABCA1;NKX2-1;ASCL1;YAP1;TGFBR1;CHADL;SFRP1;TBX3;SKI;WWTR1;USH2A;SIRT2;OSR1;EGFR;SPRY2;METTL14;TRPM4;ITGB3;ITGAV;USF3;ANKRD26;FOXA1;SPRED3;REST;TMEM64;LRP3;VASN;PDCD4;PAF1;COL5A2;PTEN;HPN;TWIST2;NR1H3;BMP4;SUFU;SPRED1;BMP5;RIOX1;SDHAF2;TRIO
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.4356529221128491,-1.440404476646908,0.04294478527607362,0.600942442884718,1.0,11/34,15.07%,PTPRB;PTPRJ;UBASH3B;PTPN12;DUSP22;PTPN2;PTPRT;DUSP7;PTPN22;DUSP8;PTPN6
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.424063180261503,-1.4402161810456087,0.03787878787878788,0.5967989172749415,1.0,16/42,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;AIMP1;NARS2;MARS2;AIMP2;AARS2;TARS1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.663610771314646,1.4387256182984218,0.11129848229342328,0.546928794797728,1.0,2/11,7.38%,NRP1;SIRT2
prerank,cell chemotaxis (GO:0060326),0.4905762510766037,1.4383987295381913,0.04842931937172775,0.5463766338503473,1.0,12/60,7.51%,NRP1;DOCK4;PARVA;XCR1;KIT;PDGFRA;PDGFRB;SEMA5A;ACKR2;CCR9;AGTR1;LPAR1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5996430949704912,1.4368834029995474,0.10766721044045677,0.5499750880860114,1.0,4/20,10.90%,AKR1B1;STAR;HSD3B2;TSPO
prerank,NAD biosynthetic process (GO:0009435),0.5803316174122589,1.436137062115831,0.08346213292117466,0.5508879024490422,1.0,4/20,6.77%,PTGIS;NNMT;PARP16;KYNU
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6606784708303653,1.4340624468004421,0.1013745704467354,0.5561944576367721,1.0,5/11,8.76%,FGFR4;WNT4;STAR;NR5A1;BMP2
prerank,regulation of cellular component movement (GO:0051270),0.4981602191524281,1.4339427373939653,0.05992010652463382,0.5549356577087986,1.0,16/49,14.04%,MYCBP2;ROCK2;TGFBR3;LYN;ARHGAP18;SP100;TGFBR1;PDPN;MEMO1;EGFR;ZSWIM6;ACTN4;HBEGF;EGF;IGBP1;ETS1
prerank,blood vessel morphogenesis (GO:0048514),0.498969922141438,1.4338219469013145,0.057180851063829786,0.5536964697101517,1.0,10/54,5.69%,NRP1;CCBE1;LAMA1;TGFBR3;LOX;EFNB2;TGFBR1;ITGB8;CYP1B1;ENG
prerank,response to prostaglandin E (GO:0034695),0.6891284121855509,1.4337376239015864,0.11591695501730104,0.5523319900890172,1.0,3/10,5.05%,TGFBR3;CCL19;SFRP1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.647396179288492,1.432579917786689,0.1077943615257048,0.5545139396076117,1.0,3/13,7.99%,GAL3ST3;B3GALT1;B3GALNT1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5971638167736432,1.4325696632411336,0.09344262295081968,0.5529183258417807,1.0,6/19,3.57%,RBP4;TGFBR3;RUNX1;BMPR1A;FGFR2;TGFBR1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.5644836570963764,-1.4319499492453653,0.08851674641148326,0.6225866506221773,1.0,8/13,21.72%,NOTCH1;HEY2;GSK3A;TGFBR2;RYR2;CPE;FOXF1;NPY5R
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.43061097552514194,1.4319202740630101,0.011286681715575621,0.5537169431172206,1.0,46/182,14.20%,IGF1;ROBO1;CILP;SLC24A3;ROCK2;RBMS3;RUNX1;BMPR1A;OLFM1;OPTN;WNT4;YAP1;APOE;SMO;NOTCH2;SLC2A10;ITGB8;LDLR;SFRP1;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CD28;MAP2K1;TET1;TNRC6A;BMP2;PICALM;SNX12;PRKN;MYADM;PARP14;FGF2;TTBK1;RBL2;TCEAL1;REST;TERF2;LRP3;CCDC3;MYCN;DLG4;ZNF148;SETDB1
prerank,hippo signaling (GO:0035329),0.56535740659835,1.4302751015427415,0.07564296520423601,0.5577617189286118,1.0,9/26,12.74%,AMOTL2;TEAD1;YAP1;WWTR1;DCHS1;STK4;AMOTL1;YWHAE;TEAD3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.656936419992609,1.430040863923947,0.08916083916083917,0.5569698081671238,1.0,2/13,3.11%,ENPP1;TPST1
prerank,regulation of glycolytic process (GO:0006110),0.4763772572722112,1.4294375148794112,0.057068741893644616,0.5573763265451708,1.0,17/68,14.43%,IGF1;ZBTB20;OGT;PRKAG2;PFKFB4;NUP107;NUPR1;PRKAA2;NUP42;NCOR1;ARNT;EIF6;NUP98;RAE1;INSR;HDAC4;NUP214
prerank,manganese ion transport (GO:0006828),-0.555767951630109,-1.4288840335247035,0.07862407862407862,0.6296868102624915,1.0,6/14,6.02%,TRPC3;TRPC4;SLC39A8;TRPC5;ATP2C1;TRPC1
prerank,response to interleukin-6 (GO:0070741),0.6880167944623915,1.4287924577561872,0.11808118081180811,0.5579488321328957,1.0,2/10,0.91%,PTGIS;PID1
prerank,actin filament bundle assembly (GO:0051017),0.5434194227874944,1.4287588099440933,0.0734632683658171,0.556421129631776,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5968086631776115,1.4287169480669726,0.07906976744186046,0.5533658642912497,1.0,5/19,18.80%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5968086631776115,1.4287169480669726,0.07906976744186046,0.5533658642912497,1.0,5/19,18.80%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,maturation of LSU-rRNA (GO:0000470),-0.4830504096968228,-1.4285443342005033,0.06629834254143646,0.6260507660494053,1.0,11/26,21.67%,NSA2;RPL7;MAK16;NIFK;RPL7A;SNU13;RPL7L1;RRP15;RPF1;RPF2;ZNHIT3
prerank,positive regulation of response to stimulus (GO:0048584),-0.420324778328676,-1.4285227783455536,0.031545741324921134,0.6213248578388291,1.0,20/40,35.08%,IFIH1;B2M;IL15;TGFB2;HOMER1;CGAS;SIRT1;CD80;ABI3;DHX9;HMGA2;NSMCE1;FMR1;ACOX2;IER5;FCGR2B;ARG2;ANKLE1;GATA3;HMGA1
prerank,regulation of receptor binding (GO:1900120),0.6834178190632325,1.4280768970160134,0.12478336221837089,0.5540893076189137,1.0,1/10,0.07%,GREM2
prerank,ceramide catabolic process (GO:0046514),-0.5512927391565617,-1.427478710261448,0.09425287356321839,0.620409267204797,1.0,7/14,25.08%,ACER3;ACER2;HEXB;HEXA;NEU1;GLA;NEU2
prerank,purine ribonucleotide transport (GO:0015868),-0.532015349100438,-1.427400674674023,0.08641975308641975,0.615974712877666,1.0,5/16,12.87%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,digestive tract development (GO:0048565),0.5459068290225162,1.4272521238558713,0.07456140350877193,0.5553355212153789,1.0,14/32,15.66%,GLI2;SALL1;GLI3;FGFR2;KIT;SMO;RARB;CLMP;DNAAF1;EPHB3;CCDC40;GLI1;GATA6;NPY
prerank,endocrine system development (GO:0035270),0.5865345663990909,1.4269477778738624,0.08647798742138364,0.5548270697811931,1.0,6/21,5.73%,GLI2;SALL1;NKX2-1;WNT4;TGFBR1;DKK3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4732561457264123,-1.4261524277420714,0.06686046511627906,0.6160500754673726,1.0,9/24,17.83%,DACH1;ACVRL1;RPS3;MSH3;SUB1;ZRANB3;DFFA;BMPR2;CDKN1A
prerank,cellular response to cadmium ion (GO:0071276),-0.4779917904158112,-1.425641765955276,0.043835616438356165,0.6135596412074201,1.0,11/24,13.80%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MAPK8;JUN;MAPK3
prerank,response to cadmium ion (GO:0046686),-0.4655544101091873,-1.4251590826232519,0.03409090909090909,0.6109546598796124,1.0,11/26,13.80%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;MAPK8;JUN;MAPK3
prerank,apoptotic cell clearance (GO:0043277),0.540764817966543,1.4251470330144835,0.07782672540381791,0.5595433260902842,1.0,8/30,9.62%,RHOH;LRP1;RHOBTB1;GAS6;TXNDC5;RHOBTB2;ITGB3;ITGAV
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.519876271743289,-1.4250370298155852,0.08051948051948052,0.6068560646029838,1.0,5/17,10.26%,PODXL;PIEZO1;TGFB2;RET;SKAP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.577829511004383,-1.424937526141486,0.08854166666666667,0.6027746652476399,1.0,7/12,23.45%,UBASH3B;PTK2B;DIAPH1;CASQ2;RYR2;MTLN;CASQ1
prerank,central nervous system neuron differentiation (GO:0021953),-0.4446339962165228,-1.4246338839171468,0.05555555555555555,0.5994437840412268,1.0,8/33,11.81%,GRID2;MDGA2;MAP2;SPOCK1;LRP6;OPHN1;ZC4H2;ATP7A
prerank,response to ATP (GO:0033198),-0.5217810574128432,-1.424461434561967,0.08900523560209424,0.5958456484634715,1.0,5/18,12.50%,TRPC3;ABCC9;P2RX7;TAF1;DGKQ
prerank,protein localization to cell periphery (GO:1990778),-0.3356288171021243,-1.424238844527036,0.006944444444444444,0.5923545467209914,1.0,30/133,8.93%,CAV1;DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;LIN7C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7;ARL3
prerank,positive chemotaxis (GO:0050918),0.6081987080902611,1.4237652749528267,0.10277324632952692,0.5627722300749333,1.0,3/17,3.78%,NRP1;ANGPT1;SEMA5A
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5097474532973585,1.4234241001442414,0.062326869806094184,0.5623448411845684,1.0,11/45,10.51%,BMP6;BMPR1A;INHBE;TGFBR1;TWSG1;ACVR1;ENG;DAB2;RBPMS;BMP2;BMP15
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5312491086636227,-1.4233308854150957,0.08088235294117647,0.5914815007401741,1.0,7/15,11.43%,KDM1A;TAFA1;PTN;DISC1;VEGFA;CX3CR1;NF1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.457970294977281,1.42313949751195,0.036773428232502965,0.5618337746858953,1.0,17/102,8.83%,PDPK1;ADCY1;ENPP1;TBC1D4;ADCY2;PIK3R1;ADCY7;ADCY5;ADCY9;INSIG2;CPEB1;ZFP36L1;LHCGR;SRC;TRARG1;SLC30A10;KAT2B
prerank,cellular response to nitrogen compound (GO:1901699),0.5920145602203072,1.4226792267444286,0.07366771159874608,0.5617720460269613,1.0,8/20,19.35%,ROCK2;RIOK3;DDI1;RTF2;TIMELESS;EPG5;ATRX;HSF1
prerank,muscle contraction (GO:0006936),0.4421745816850887,1.4224029950397366,0.03172737955346651,0.5611969810757366,1.0,23/126,7.32%,ROCK2;ACTN2;CALD1;SLC8A1;SNTB1;TPM1;TMOD4;TNNT1;MYL10;MYH13;ASPH;MYLK;LTB4R;MYL12A;TLN1;ITGB5;DES;SMTN;BDKRB2;TNNC1;VCL;MYL4;DTNA
prerank,protein localization to synapse (GO:0035418),-0.5756009268722776,-1.4218554526287661,0.09619686800894854,0.59236218631268,1.0,5/12,10.52%,NLGN1;NRXN1;SHANK1;ZDHHC15;PCLO
prerank,proteoglycan biosynthetic process (GO:0030166),0.5400086129816336,1.4215262244642763,0.08283132530120482,0.562588737811908,1.0,3/31,2.15%,IGF1;GAL3ST3;PXYLP1
prerank,prostanoid biosynthetic process (GO:0046457),0.6259489687574943,1.421156878580492,0.11320754716981132,0.5622132537467215,1.0,3/15,5.18%,PTGIS;PTGES;PLA2G4A
prerank,arachidonic acid metabolic process (GO:0019369),0.5223488168965076,1.421110378027857,0.08620689655172414,0.5607928096111362,1.0,7/35,7.07%,PTGIS;PTGES;DAGLA;EPHX2;PLA2G4A;CYP1B1;ALOXE3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5460755017382807,1.4210799747271283,0.07863501483679525,0.5593407707697892,1.0,8/31,8.13%,TGFBR3;TPM1;BMPR1A;FGFR2;TGFBR1;ENG;TNNC1;RBPJ
prerank,regulation of insulin secretion (GO:0050796),0.4493714040464459,1.4197157084958394,0.041666666666666664,0.5622474966860675,1.0,13/101,7.78%,TCF7L2;RBP4;ITPR1;RAPGEF4;ADCY5;SLC30A8;MCU;CDK16;NEUROD1;SFRP1;ADRA2C;CACNA1C;NR1D1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4761344522368881,-1.4187882571941084,0.05555555555555555,0.5988540447589603,1.0,13/27,27.24%,GPCPD1;ENPP2;PLA2G7;INPP5F;PNPLA8;PLA2G4C;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;LIPC;PLA2G4B;PLA2G5
prerank,adenine nucleotide transport (GO:0051503),-0.5216920309599724,-1.418753871390113,0.0829145728643216,0.5948170308926602,1.0,5/17,12.87%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,cation transport (GO:0006812),-0.3331284914865115,-1.4187092008095485,0.018867924528301886,0.5909028419226453,1.0,29/167,7.91%,TRPM3;PIEZO2;SLC6A6;SLC12A2;SLC47A1;KCNB2;KCNJ2;PIEZO1;ANO1;KCNK5;KCNAB1;NEDD4L;SLC9B2;SLC7A1;KCNJ3;SCN1A;KCNMA1;KCND3;SLC5A6;ABCC9;SLC38A5;KCNN2;SCN3A;SLC1A1;ATP1B1;KCNMB2;NDFIP2;SCN2A;TRPM7
prerank,phospholipid transport (GO:0015914),-0.3996442944135202,-1.4176434223875727,0.043795620437956206,0.5906297673488413,1.0,21/52,17.76%,PITPNC1;ATP8A1;ATP8B1;ATP11C;PLTP;ABCC1;PITPNA;ATP11B;TNFAIP8L3;NPC2;ATP11A;MFSD2A;ABCG1;OSBPL2;SCARB1;PCTP;SCARB2;PITPNB;ATP10A;PRELID2;ABCB4
prerank,cellular amide metabolic process (GO:0043603),0.450295709963258,1.4174761904729045,0.05575326215895611,0.5683486047024816,1.0,21/102,14.88%,CPXM2;PCCA;PLPP3;AEBP1;NNMT;ACOT11;ACOT6;ACOT2;CPXM1;PCCB;SMPD2;MTHFR;ALDH1L1;ABCB9;NSMAF;NAPEPLD;FOLR2;ACSF2;CERK;THOP1;VNN1
prerank,positive regulation of cell migration (GO:0030335),0.4195624481108884,1.4169130795795868,0.009625668449197862,0.5687488068399063,1.0,51/253,9.78%,IGF1;NRP1;COL1A1;DDR2;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;VTN;SEMA5A;CSF1;INSL3;RAPGEF2;SMURF2;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;SRC;WNT5B;DOCK5;RAB25;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;CCN4;SYDE1;ACTN4;MYADM;S100A11;MIA3;FAM89B
prerank,prostaglandin biosynthetic process (GO:0001516),0.5933293986546094,1.4167091582845386,0.10912052117263844,0.5678825232904748,1.0,3/18,5.18%,PTGIS;PTGES;PLA2G4A
prerank,substrate-dependent cell migration (GO:0006929),0.6422322981657751,1.4160776992039272,0.10034013605442177,0.5684988996264495,1.0,3/14,2.61%,NRP1;ITGA11;EPHA8
prerank,ribosome biogenesis (GO:0042254),-0.3269580238694326,-1.4160554485091954,0.0,0.5920624792541289,1.0,69/187,21.54%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;PAK1IP1;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;METTL17;RPL18A;RPL26;RPL6;RPL36A;RPL29;MALSU1;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;NPM1;RRP12;RPL37A;NOP16;RPLP2;URB2;RPL17;RPL23;RPF1;WDR46;RRS1;RPF2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5864557255428656,-1.4154899707685784,0.10297482837528604,0.590107844984264,1.0,7/11,25.88%,UQCRH;CYCS;UQCR10;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,anion transport (GO:0006820),-0.44198727290232503,-1.4153068271040647,0.04375,0.5868138523248613,1.0,6/33,3.99%,ABCG2;SLC26A7;LRRC8C;LRRC8D;SLCO2B1;SLC22A6
prerank,macrophage activation involved in immune response (GO:0002281),-0.5569074723268171,-1.4152171754451197,0.08803611738148984,0.5832652217125689,1.0,6/13,13.00%,PLCG2;DYSF;LBP;IFI35;CX3CR1;SBNO2
prerank,platelet degranulation (GO:0002576),0.44588317557681334,1.4148371787614822,0.03048065650644783,0.571199160300506,1.0,21/118,9.58%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;ACTN4;ISLR;ITGB3
prerank,regulation of tissue remodeling (GO:0034103),0.602343331500215,1.4146141412125879,0.10132890365448505,0.57041355536196,1.0,5/18,6.81%,DDR2;RUNX1;LEPR;CST3;IL12B
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3846585638316262,-1.4145854155395414,0.04417670682730924,0.5817558411141373,1.0,17/56,10.85%,TEK;CNTNAP2;GRID2;CAV1;PTPRJ;CLDN5;NLGN1;IL1RAPL1;KDR;PTPRD;EPHB1;NRXN1;MYOC;CLSTN2;VEGFA;ACE2;CLSTN3
prerank,Golgi organization (GO:0007030),0.4486444539810169,1.4144975075191377,0.04659498207885305,0.5692430028331241,1.0,40/112,19.67%,OBSL1;USP6NL;LMAN2L;OPTN;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;STX16;ZW10;LRRK2;UBXN2B;GOSR2;TRIP11;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;ATP8B2;TBC1D20;BAG5;HACE1;HUWE1;CUL7;GOLPH3;ARFGEF1;TMED10;CSNK1A1;SEC16B;HTT;NSFL1C
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.41699514670156124,1.4140026388989975,0.009708737864077669,0.5693617038195983,1.0,38/214,10.64%,NRP1;EPHA7;CCN2;ANGPT1;TIMP3;TGFBR3;PDGFD;LYN;CCN1;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;FBLN1;RAPGEF2;MT3;ROR1;CCL4;RANBP9;EMILIN1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;EPHB2;BMP2;SPRY2;FGF2;SPRED3;CARD9;BRAF
prerank,actin filament bundle organization (GO:0061572),0.5366446273301612,1.4133235172943797,0.07270029673590504,0.5700700495437613,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,diacylglycerol metabolic process (GO:0046339),-0.4935359220701076,-1.4130082976118368,0.07671232876712329,0.5830396807242695,1.0,10/23,17.45%,PLCE1;DGKB;DGKH;LIPE;DGKK;PGS1;DGKG;DGKQ;PNPLA2;DGKZ
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5023388504223422,1.4129471232321715,0.07320441988950276,0.5697778958893328,1.0,9/46,9.86%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,amino acid import across plasma membrane (GO:0089718),0.5736339176218624,1.4126267554220755,0.0837138508371385,0.5693698959957475,1.0,6/24,4.20%,SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC6A13;SLC22A2
prerank,fatty acid elongation (GO:0030497),-0.5522357904896371,-1.412085404555439,0.08270676691729323,0.5821560016510553,1.0,4/13,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5181727118063706,-1.4112902460908898,0.07268170426065163,0.5812458680895891,1.0,7/16,6.66%,GUCY1B1;NOS3;GUCY1A1;DDAH1;KCNC2;NOS1;DDAH2
prerank,regulation of cellular respiration (GO:0043457),-0.52421349507703,-1.410827395279493,0.057441253263707574,0.5790473068828829,1.0,9/17,28.95%,CBFA2T3;PRDM16;NOA1;PNPT1;IL10RB;IFNAR1;VCP;IFNLR1;NOS2
prerank,visual system development (GO:0150063),0.5314584617925424,1.4104656922568155,0.06789250353606789,0.5751380028179978,1.0,5/37,6.98%,RBP4;PBX1;SH3PXD2B;CPAMD8;SMOC1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.505866977236174,1.4104355506083959,0.05874125874125874,0.5737237337983906,1.0,9/48,6.94%,ADCY1;AMPD3;ADCY2;ADCY7;ADCY5;NUDT2;ADCY9;GUCY2C;GUCY2D
prerank,inner dynein arm assembly (GO:0036159),0.6650660279397996,1.4102241379171345,0.12208258527827648,0.5728858801601568,1.0,5/10,15.91%,CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4758829125847683,1.4093299125665821,0.060810810810810814,0.5745055457369057,1.0,15/67,8.62%,EPHA3;DDR2;GHR;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;PIBF1;SRC;EGFR;EPHB2
prerank,protein autophosphorylation (GO:0046777),0.427364961847211,1.4089239626207326,0.033218785796105384,0.5743328949660887,1.0,35/157,13.77%,STK17B;DAPK2;PDPK1;DDR2;DAPK1;LYN;GRK5;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;MUSK;SRC;ULK2;LRRK2;SIK1;EIF2AK3;OXSR1;STK4;EGFR;CAMK2B;STK11;NEK6;TAOK3;EPHB3;MAP3K13;INSR;ACVR1B;STK16;MARK2;CDK12
prerank,smooth muscle contraction (GO:0006939),0.6233642605794008,1.4087384034451094,0.1094017094017094,0.5734544092715049,1.0,5/14,6.32%,ROCK2;SLC8A1;MYLK;SMTN;BDKRB2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.42321511002143775,-1.4085356659958106,0.0462046204620462,0.58327370914323,1.0,14/36,11.16%,CAV1;NOSTRIN;NOS3;DDAH1;GCH1;NOSIP;DDAH2;ATP2B4;CYGB;DHFR;CALM1;S100A1;SPR;SCARB1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6766492188959714,1.4081827499895938,0.10535405872193437,0.5736767556147251,1.0,2/10,1.78%,ADGRV1;GRXCR1
prerank,gland development (GO:0048732),0.4854246520071566,1.4081559183767531,0.05298913043478261,0.5722673469338619,1.0,18/59,11.64%,TGFBR3;PRKCSH;GLI2;SALL1;ARID5B;NKX2-1;FGFR2;WNT4;TGFBR1;CDK5RAP3;TBX3;DKK3;CEBPA;ARHGAP35;ZBTB1;PHF2;EPHB3;NKX2-8
prerank,response to retinoic acid (GO:0032526),0.4910999706316582,1.4080248923297394,0.07383419689119171,0.5712332711359561,1.0,10/59,6.62%,EPHA3;RBP4;LYN;WNT8B;ASCL1;WNT6;RARG;CTSH;PTK7;WNT5B
prerank,cell projection organization (GO:0030030),0.5428941610936995,1.4074124506814305,0.08456973293768547,0.5718878039803881,1.0,7/30,8.05%,RHOH;GSN;PARVA;CDC42;NPHP1;ATP1B2;CSPG5
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5680135869559404,-1.407190264242028,0.059770114942528735,0.584153536748371,1.0,5/12,17.62%,ACTB;LAMA5;SCRIB;FUZ;ACTG1
prerank,glycoprotein biosynthetic process (GO:0009101),0.46710334720847546,1.4071683192599516,0.04228855721393035,0.5711810388833211,1.0,11/79,8.30%,IGF1;GAL3ST2;GAL3ST3;GALNTL5;B3GALT1;ST3GAL5;ST3GAL3;LARGE1;FUT10;B3GALNT1;ALG5
prerank,positive regulation of wound healing (GO:0090303),0.519422356069551,1.4070431132625512,0.0708215297450425,0.5701235120329916,1.0,11/36,11.76%,PLPP3;SERPINE1;KANK1;MYLK;VTN;INSL3;SMOC2;FOXC2;HBEGF;ADRA2A;F2
prerank,regulation of cell size (GO:0008361),-0.47739808328975786,-1.4064667856474473,0.06775067750677506,0.5832291548720759,1.0,9/23,12.78%,VAV3;RDX;RAP1GAP2;LARS1;EDN1;MSN;PLEK;MTOR;DEPTOR
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5256658081200414,1.4059114891756908,0.0884450784593438,0.5724907026552767,1.0,7/34,7.38%,RORA;ENPP1;RUNX1T1;SMAD3;YAP1;WWTR1;SIRT2
prerank,aorta morphogenesis (GO:0035909),0.5967019872706035,1.4057696217024516,0.1301482701812191,0.5715115790889084,1.0,7/17,8.13%,LRP1;BMPR1A;MYLK;PDGFRB;ENG;ADAMTS9;RBPJ
prerank,axon extension (GO:0048675),0.5633849391020949,1.4057069650997858,0.09145427286356822,0.5702068279535663,1.0,7/23,10.12%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2;SLIT3;SLIT1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.45000136963551307,-1.4055368451897403,0.054140127388535034,0.583020546325235,1.0,12/30,5.15%,SLC12A2;OCLN;PECAM1;CLDN5;JAM2;ESAM;F11R;ACTB;TJP2;LSR;TJP1;SLC1A1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.49093131406862195,1.4054330558633072,0.06590621039290241,0.5696051617469675,1.0,10/57,8.20%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;INSL3;HTR1A;MTNR1A;LPAR1;DRD3
prerank,regulation of interleukin-2 production (GO:0032663),-0.40946381456246594,-1.405000583584239,0.04406779661016949,0.5812142590563789,1.0,20/43,27.14%,PDE4D;PDE4B;CD34;PLCG2;NAV3;SPTBN1;RPS3;TNFAIP3;CD80;PTPRC;HOMER3;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6;PRNP
prerank,regulation of pH (GO:0006885),0.6628052824161136,1.4045290333032765,0.10782608695652174,0.5711424605151489,1.0,1/11,0.20%,ATP6V0A4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4431146388714049,1.4045272992946962,0.031652989449003514,0.5696768323367477,1.0,28/122,14.46%,IGF1;SAMD4A;IGF2;AR;PLD1;GLI2;SLC6A9;FGFR4;PDGFRB;CCL19;SLC25A37;SMOC2;CPEB3;CD28;NPM2;EGFR;METTL14;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3;EGF;MTPN;PLXNB2;NSUN5
prerank,establishment of vesicle localization (GO:0051650),-0.5123596322517945,-1.4044177196470355,0.0633245382585752,0.5794243631932049,1.0,8/18,23.33%,LIMK2;RAB27A;CDK5;RAB11A;TESK1;SYNJ1;KIF5A;TMEM230
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5942801379279405,1.404413182892366,0.11428571428571428,0.5686291552272217,1.0,5/19,9.16%,RHOH;GAS6;AXL;ZMIZ1;ZBTB1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5416078061044876,1.4043548135572699,0.11011904761904762,0.5673847354657363,1.0,5/28,4.42%,ENPP1;PID1;AHSG;KANK1;APPL2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5013704700148216,-1.404351191843869,0.06666666666666667,0.5760760351023164,1.0,12/20,31.68%,DENND1B;B2M;CD55;PRKCZ;CD81;FZD5;TRAF2;MAP3K7;MALT1;TRAF6;NLRP3;IL1R1
prerank,cellular response to glucose starvation (GO:0042149),0.5079614300251359,1.4041986506790114,0.08066759388038942,0.566430952802225,1.0,24/41,26.65%,PRKAG2;PRKAA2;NUAK1;SIK1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;IMPACT;PIK3R4;ITFG2;SESN2;TBL2;FOXO3;BECN1;PRKAG1;SZT2;CPEB4;HSPA5;PMAIP1;PRKAG3;SH3GLB1;RRP8;SESN3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4626764308189222,1.4037025488348684,0.07107231920199501,0.5667090855205829,1.0,9/84,7.87%,IGF1;SAMD4A;DAPK1;APOE;IGF2BP2;IGFBP5;CPEB3;EIF2AK3;RNF139
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6779589342213165,1.4023607115879497,0.13172541743970315,0.5698373975674831,1.0,7/10,22.41%,CPEB1;CPEB3;PAF1;CDC73;HSF1;LEO1;NCBP2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5141044444712836,1.4021688241911967,0.08192090395480225,0.5690359732173862,1.0,5/40,9.32%,IGF1;MOAP1;PDCD5;BCL2L11;PRKN
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4516941731769781,1.4020840194792379,0.04522613065326633,0.5678420551439233,1.0,19/87,9.23%,FMOD;COL1A2;TGFBR3;SMAD3;BMPR1A;TGFBR1;TWSG1;APOA1;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,sodium ion transport (GO:0006814),0.44693812123374127,1.4020703585359588,0.04895960832313342,0.5664602083632717,1.0,9/85,4.52%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC24A1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.6026912624897118,1.401562321124117,0.1118421052631579,0.5667500462965789,1.0,6/17,11.96%,NRP1;ROBO1;EFNB2;MIA3;FGF2;NR4A1
prerank,negative regulation of receptor internalization (GO:0002091),-0.5513822379329212,-1.4015334915227535,0.10046728971962617,0.5821639262799195,1.0,4/12,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5643237385703167,1.4005870927645152,0.09302325581395349,0.5684146211863038,1.0,7/24,6.96%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5490879986360957,1.3997435566852254,0.10130246020260492,0.5697137557627964,1.0,6/26,10.93%,ROCK2;LYN;EPHA4;PICALM;TTBK1;APH1B
prerank,UV protection (GO:0009650),0.6651408355345471,1.3994430101124533,0.1234991423670669,0.5692859108681931,1.0,1/10,0.34%,MFAP4
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6515932341736744,1.399396465054172,0.10350877192982456,0.568005864702661,1.0,4/12,8.91%,ADAMTS12;DCN;IL12B;SPRY2
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4683462488524893,-1.3991704871054678,0.07941176470588235,0.5867291102091282,1.0,5/24,10.46%,PECAM1;F11R;NT5E;ITGA4;MSN
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5924928298050159,1.399105951640222,0.0966183574879227,0.5676145477739504,1.0,7/20,11.33%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5894729449041519,1.3985781356784492,0.10662358642972536,0.5667051328013812,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5894729449041519,1.3985781356784492,0.10662358642972536,0.5667051328013812,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,negative regulation of bone mineralization (GO:0030502),0.6320410088132115,1.398072285073882,0.10714285714285714,0.5669587125639742,1.0,4/13,9.41%,ENPP1;AHSG;BCOR;TRPM4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5292041110313019,1.3977037214146273,0.08702064896755163,0.5668750059866755,1.0,9/32,10.43%,ZBTB20;PRKAG2;APOE;APOA1;PRKAA2;STAR;NR5A1;CREBL2;EIF6
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.40325724240758976,1.3966467728483378,0.0051813471502590676,0.5690140717696074,1.0,82/348,14.99%,IGF1;ROBO1;BMP6;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;GSN;SMAD3;RBMS3;AR;MITF;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;YAP1;GAS6;TGFBR1;SMO;WNT6;RESF1;SLC2A10;TLE1;PDCD5;CSF1;SLC22A2;MT3;NTF3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;NFE2L2;CD28;AFDN;EIF2AK3;MAP2K1;CD63;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;ARRB1;EPHB2;BMP2;SPRY2;SMAD1;PRKN;ITCH;FGF2;PPHLN1;TTBK1;BRAF;DDX3X;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;INSR;TMEM119;MYCN;EGF;MTPN;PDCL3;ETS1;SETDB1;HPN;TADA3;BMP4;SFRP4;FUBP3
prerank,regulation of phospholipase C activity (GO:1900274),0.6160951815742532,1.3960937233643238,0.1085899513776337,0.5694211521785489,1.0,7/15,10.16%,FGFR1;KIT;PDGFRA;PDGFRB;NTF3;NTRK3;FGF2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6641506506372735,1.3957924643699624,0.13523131672597866,0.5690207094826176,1.0,9/11,26.98%,ZFP36L1;PAF1;ZC3H3;CDC73;LEO1;PAPOLA;NCBP2;AHCYL1;NCBP1
prerank,negative regulation of cell junction assembly (GO:1901889),0.5522782689734547,1.3956314702179462,0.11023622047244094,0.5681908471757287,1.0,4/25,1.84%,PHLDB2;ROCK2;ARHGAP6;DLC1
prerank,regulation of hemopoiesis (GO:1903706),0.6446772492068351,1.3954776152352786,0.1358695652173913,0.5673084568225293,1.0,2/10,2.77%,RUNX1;IL17D
prerank,cGMP-mediated signaling (GO:0019934),0.6326159411526024,1.3950306590072574,0.12369337979094076,0.5674336265652309,1.0,3/13,5.63%,IRAG1;APOE;PDE3A
prerank,ncRNA processing (GO:0034470),-0.3227222329516406,-1.394666938030166,0.011494252873563218,0.5984373890719676,1.0,72/200,21.20%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;INTS6;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;LIN28B;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;ADAR;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;HNRNPA2B1;RPL32;RPL5;KARS1;NOL9;RPP21;MRPL44;FARS2;RPLP0;INTS8;MPHOSPH10;SRRT;KRR1;RPS6;RPL22;AGO1;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;INTS1;WDR46
prerank,glycoprotein catabolic process (GO:0006516),0.595657304614193,1.394570819688423,0.11183144246353323,0.5676242633047363,1.0,5/17,16.23%,ADAMTS12;ADAMTS9;NGLY1;CTSL;NEU4
prerank,sodium ion transmembrane transport (GO:0035725),0.4416844737456706,1.3941943748676728,0.05481120584652863,0.5674160652741959,1.0,10/84,4.52%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC9A9;SLC24A1
prerank,B cell receptor signaling pathway (GO:0050853),-0.435573574338493,-1.3939898353152116,0.06172839506172839,0.5970844310509558,1.0,12/32,16.27%,MEF2C;TEC;VAV3;PLCG2;CD38;BMX;NFATC2;PLEKHA1;BCAR1;BLNK;PTPRC;BTK
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5457555787302227,1.3936073688316812,0.10061919504643962,0.5679540805270661,1.0,6/27,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,T cell differentiation in thymus (GO:0033077),0.6196206478688369,1.3933790885246573,0.11993517017828201,0.567320928619651,1.0,3/14,5.78%,GLI3;LIG4;ZFP36L1
prerank,regulation of sodium ion transport (GO:0002028),-0.4299895691740139,-1.3931380369953634,0.059233449477351915,0.5965346842642563,1.0,11/34,9.72%,NKAIN2;ATP1A1;ANK3;YWHAH;NKAIN1;P2RX7;NKAIN3;FGF12;NOS1;ATP2B4;WNK2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4614592400139157,-1.392236849067454,0.08849557522123894,0.5960146620398478,1.0,11/24,13.51%,PDE4D;PDE3B;PDE2A;PRKAR1A;PRKAR2B;PRKAR1B;PRKAR2A;CGAS;PEX5L;UBE2B;APLNR
prerank,zinc ion homeostasis (GO:0055069),-0.4592056956684514,-1.3921780451110097,0.07207207207207207,0.5926780511482207,1.0,10/28,4.62%,SLC39A10;SLC39A8;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4191900575237133,1.39191209207077,0.027777777777777776,0.5707795578471422,1.0,44/173,15.18%,SEC24D;AREG;TGFA;DYNLL1;LMAN2L;ANK1;SEC31A;GAS6;TMED1;GOLGB1;YIF1B;DYNC1H1;LMAN1;ZW10;ARFGAP3;DCTN6;MIA2;TRAPPC4;COPB1;SPTAN1;COG8;CAPZB;COPZ2;GOSR2;TRIP11;BCAP31;MIA3;TMED4;KDELR3;ERGIC2;TRAPPC6B;ERGIC3;GORASP1;F2;COPA;DYNC1I2;CTSZ;KLHL12;USO1;SEC23A;ARF4;BET1L;TBC1D20;ERGIC1
prerank,cell projection assembly (GO:0030031),0.563295620178458,1.3910822806103122,0.11746031746031746,0.5721084355547884,1.0,4/22,6.15%,RHOH;GSN;PARVA;CDC42
prerank,histone H3-K4 trimethylation (GO:0080182),0.6544064751802268,1.390990983272262,0.1306715063520871,0.571096033022472,1.0,6/11,19.26%,OGT;SETD1A;WDR82;KMT2A;SETD1B;TET3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5091975674417691,-1.390485377955934,0.1073170731707317,0.5947982596720232,1.0,8/17,18.91%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD;VPS9D1
prerank,Ras protein signal transduction (GO:0007265),0.4331580188969612,1.390033749655065,0.0340522133938706,0.5728846898230636,1.0,32/137,15.57%,IGF1;COL1A2;RHOH;ROCK2;KSR1;PLD1;ARHGAP6;RHOD;CTNNAL1;CCNA2;RRAS2;ARHGAP29;CDC42EP4;RAPGEF2;MRAS;PDPN;AGTR1;NTN1;ARHGEF11;RAPGEF1;FGF2;TAX1BP3;ADRA2A;ARHGAP5;RAP2A;WASF1;SETDB1;EPS8L1;PLK2;RAPGEF6;HACE1;RASSF1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4951660293769605,-1.3894952455744405,0.10526315789473684,0.5943487550807802,1.0,11/18,34.43%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;GNAQ;HRH3;CHRM5
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5509725556821824,-1.3893428411273137,0.10144927536231885,0.5913177557298201,1.0,4/13,14.06%,TMSB4X;HEY2;TAF1;HEY1
prerank,neuromuscular junction development (GO:0007528),0.5610456071322811,1.3891265895736975,0.10381679389312977,0.5744512064932653,1.0,7/24,6.60%,PDZRN3;PPFIBP2;UNC13C;NEDD4;MUSK;CACNB1;LRRK2
prerank,negative regulation of metabolic process (GO:0009892),0.47935571657500026,1.3883528405460215,0.07898259705488621,0.5755528650908672,1.0,9/54,9.86%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5615150838652501,1.3881898202700471,0.11882716049382716,0.5747187043398241,1.0,6/22,9.04%,ROCK2;LYN;EPHA4;RANBP9;SLC2A13;PICALM
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.47276099099459123,-1.3856157257818273,0.10294117647058823,0.6001339281043891,1.0,12/23,27.54%,MBOAT1;PLAAT3;PNPLA8;PLA2G4C;LPCAT3;PLA2G4F;PLA2G4E;ABHD4;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5821530348349081,1.3851585674120535,0.12214983713355049,0.5835593940350036,1.0,3/18,4.30%,NELL1;DACT1;CDK5RAP3
prerank,cortical cytoskeleton organization (GO:0030865),0.5041878506132892,1.3843707690657787,0.07285714285714286,0.5848721086126388,1.0,13/41,16.62%,RHOH;ROCK2;RHOD;RHOBTB1;RHOBTB3;RHOBTB2;FMNL1;RHOQ;LLGL1;RND3;ARF6;EPB41L3;RHOG
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5277826494843384,-1.3839605228365668,0.09133489461358314,0.6020002866309804,1.0,6/15,16.69%,ENTPD1;AK5;ENTPD2;ENTPD6;AK7;ENTPD3
prerank,entry into host (GO:0044409),-0.5436763286241162,-1.3838684568403978,0.11168831168831168,0.598877386814254,1.0,4/13,5.14%,CDH1;MET;CBL;PPIA
prerank,ribosome assembly (GO:0042255),-0.40087523594836477,-1.3833765215263636,0.05190311418685121,0.5971396802135217,1.0,17/47,21.54%,RPL3;RPS14;RPS19;RPS15;RPL11;RPS5;RPL6;PPAN;RPL5;RPSA;RPLP0;MTERF3;NPM1;C1QBP;MRPS7;RRS1;RPF2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6168555730930374,1.383199844700433,0.13798977853492334,0.5872914228548469,1.0,2/13,2.48%,RUNX1;GLI3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5658712307269643,-1.383095371630256,0.10046728971962617,0.5946625633215167,1.0,5/10,19.80%,SEC14L1;RNF125;TKFC;UFD1;C1QBP
prerank,cholesterol homeostasis (GO:0042632),0.4688576312224261,1.3825826167389645,0.07427055702917772,0.588149011512485,1.0,10/64,7.78%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,synaptic vesicle localization (GO:0097479),-0.5516920089418403,-1.382571260847187,0.11576354679802955,0.5931102654313966,1.0,6/13,23.33%,NLGN1;RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,hepaticobiliary system development (GO:0061008),0.5635173449885453,1.381563005823187,0.12151067323481117,0.5902542163816769,1.0,8/20,11.64%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;PHF2;NKX2-8
prerank,sterol homeostasis (GO:0055092),0.4658695032848272,1.3809310195165183,0.07712418300653595,0.5910726535038556,1.0,10/65,7.78%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.41258386168316025,1.3804449351726047,0.0348314606741573,0.5912549872925106,1.0,15/170,5.78%,IGF1;NELL1;ROCK2;SLC8A1;GDNF;C1D;AFF1;PRDM5;ASCL1;ZNF462;APOE;IGF2BP2;LDLR;GNB3;ZFP36L1
prerank,protein trimerization (GO:0070206),0.628111481542921,1.3803118676674924,0.11298482293423272,0.5890106793058484,1.0,4/14,9.20%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,protein homotrimerization (GO:0070207),0.628111481542921,1.3803118676674924,0.11298482293423272,0.5890106793058484,1.0,4/14,9.20%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,negative regulation of cell motility (GO:2000146),0.4422802201469249,1.3801947402854333,0.0477326968973747,0.588055016561236,1.0,22/108,7.43%,ROBO1;LDLRAD4;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;KANK1;RECK;NKX2-1;DPYSL3;SULF1;FBLN1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;DPEP1;AFDN
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5376833989566935,1.3798608592292958,0.12102874432677761,0.5878280553129742,1.0,4/27,2.39%,ENPP1;PID1;AHSG;KANK1
prerank,gonad development (GO:0008406),0.5011197893449303,1.3785602949476556,0.08936170212765958,0.590678610471958,1.0,8/41,6.58%,AR;NR2F2;SALL1;KIT;WNT4;NUP107;LHCGR;NR5A1
prerank,regulation of signal transduction (GO:0009966),0.4092175127143778,1.3783253590510194,0.025246981339187707,0.590159214528189,1.0,30/190,8.36%,IGFBP2;RORA;GDNF;SLC8A3;GRK3;IGFBP4;GRK5;DHRS3;RUNX1;ZIC1;OGT;ITGA3;FGFR2;SP100;DTNBP1;SEMA5A;IRAK2;FBXL17;SULF1;NCAM1;TSPYL2;ACVR1;IGFBP5;USP20;SRC;LRRK2;WWTR1;CD63;TULP3;TCF7L1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5684761414073959,-1.378294338416648,0.10884353741496598,0.6044164902227743,1.0,6/11,23.78%,NOTCH1;GSK3A;ATP2B4;FOXO1;MLIP;RGS2
prerank,glycerolipid catabolic process (GO:0046503),-0.48524755691437754,-1.376844728567998,0.10204081632653061,0.6059264119470228,1.0,10/19,24.06%,GPCPD1;MGLL;ABHD2;PLA2G4C;ABHD6;PNPLA6;LYPLA2;PLA2G4F;PLA2G4E;GDPD1
prerank,purine-containing compound salvage (GO:0043101),0.6240515330642311,1.3765066680063511,0.1482758620689655,0.5949991253130271,1.0,2/12,2.79%,AMPD3;ADK
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.48329880441064677,1.3764601638750957,0.09128065395095368,0.5937891620307157,1.0,13/48,14.42%,NRP1;NEDD9;OBSL1;APOA1;CUX2;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5328268542312671,1.3763085898560539,0.10946745562130178,0.5929070483005884,1.0,6/29,8.76%,TGFBR3;TPM1;FGFR2;ENG;TNNC1;BMP2
prerank,response to purine-containing compound (GO:0014074),-0.5003627032290636,-1.3759204930193585,0.10743801652892562,0.6057898807155827,1.0,6/17,15.47%,TRPC3;ABCC9;P2RX7;DGKQ;RYR2;P2RY6
prerank,lipid homeostasis (GO:0055088),0.4796354020581447,1.3756489179749696,0.0692410119840213,0.5937656764298727,1.0,14/57,16.30%,ZBTB20;ABCA1;RBP1;APOE;APOA1;PRKAA2;CEBPA;TLCD1;NR1D2;DDX3X;RCN3;DGAT2;NR1H3;THADA
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4630399442026254,1.3751704044215491,0.06447534766118837,0.5938846618603943,1.0,20/75,14.89%,NRP1;PDPK1;IGF2;FGFR1;VASH2;TGFBR1;SEMA5A;VIP;AKT3;AGTR1;BMP2;ITGB3;ARNT;FGF2;FGFBP1;NR4A1;EGF;PDCL3;MDK;BMP4
prerank,negative regulation of inflammatory response (GO:0050728),0.41093968017416815,1.3741297660207408,0.03114571746384872,0.595933258315714,1.0,21/182,7.78%,IGF1;PTGIS;RORA;ADCY1;ADCY2;LYN;ADCY7;ADCY5;APOE;ADCY9;INSL3;APOA1;MVK;VIP;CDH5;LHCGR;ADRB3;SRC;CD247;DPEP1;NR1D1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4222733458955486,1.3740106233787204,0.04285714285714286,0.5949903733769295,1.0,34/128,15.58%,BMP6;COL1A2;TGFBR3;SMAD3;BMPR1A;RUNX2;TGFBR1;TWSG1;APOA1;SMURF2;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;RGMA;BMP2;ZMIZ1;SMAD1;BMP15;USP9Y;PDCD4;ACVR1B;USP9X;HIVEP1;COL3A1;BMP4;PARD3;TGFBRAP1;BMP5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5922257205719313,1.373950290869147,0.1330128205128205,0.5938604894359872,1.0,6/17,18.14%,NKX6-1;ATOH8;FGF2;BMP4;SFRP4;AHI1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4474711220252553,-1.3726205420713817,0.08974358974358974,0.6133095850852254,1.0,14/30,25.99%,ACKR3;RPS3;KDM1A;PTTG1IP;TPT1;SIRT1;BCL2L1;CD44;CLU;SNAI2;TWIST1;CCAR2;MIF;SNAI1
prerank,regulation of embryonic development (GO:0045995),0.5138961270741673,1.3708924751990137,0.09878419452887538,0.6028076038205549,1.0,8/34,12.56%,PHLDB2;DAG1;WDPCP;CRB2;TRIP12;RBM19;NIBAN2;INSR
prerank,response to muramyl dipeptide (GO:0032495),-0.5584899500546049,-1.370630936417939,0.11547344110854503,0.6166985942835718,1.0,7/12,16.10%,NOD1;ARHGEF2;VIM;PTPN22;NOD2;ERBIN;IRF5
prerank,toxin transport (GO:1901998),0.6612580393704024,1.3705851982671078,0.14209591474245115,0.6024653407426562,1.0,3/10,4.20%,ANTXR1;ANTXR2;SLC22A2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4967678708322454,1.370171817097488,0.09970674486803519,0.6025180860855925,1.0,10/40,10.16%,ARHGAP6;FGFR1;KIT;PDGFRA;PDGFRB;NTF3;LPAR1;NTRK3;EGFR;FGF2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6480871591959381,1.3701280320449378,0.1445993031358885,0.6013047866726529,1.0,5/11,14.17%,GAS6;CCL19;AXL;SELENOS;MERTK
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.38774771622568666,1.3696825403542927,0.00408997955010225,0.6014476785243708,1.0,90/509,11.79%,IGF1;TCF7L2;PDPK1;WLS;IGF2;ADRA1B;GJA1;ROCK2;ANGPT1;PIK3R1;PDGFD;ADGRV1;KSR1;SASH1;AREG;TGFA;DCN;LYN;BCL2;FGFR1;PELI2;EPHA8;NOS1AP;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;CFLAR;PDGFRB;TGFBR1;NUPR1;SEMA5A;CCL19;NEDD4;CDK5RAP3;RAPGEF2;EDAR;AXL;NTF3;OSBPL8;FRS2;ROR1;ENG;ADRA2C;ADRB3;CCL4;SRC;RNF31;IL12B;CD28;DDX60;SPHK2;LPAR1;TRAF7;NMI;TLR6;NTRK3;BCL2L11;EGFR;BMP2;RUNDC3A;SPRY2;BCAP31;ACTN4;PRKN;GPR89A;LTBR;ITGAV;SLC38A9;SLC20A1;TMED4;FGF2;RYK;CXXC5;CARD9;NEK6;TRIP6;DDX3X;GSDME;HBEGF;LAMTOR2;ADRA2A;P2RX5;TNIP2;IKBKE;RRAGD;TBK1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4407034645259884,1.3694433764275047,0.06480304955527319,0.6008374129748967,1.0,15/87,7.96%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRA;PDGFRB;NOTCH2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,negative regulation of gene expression (GO:0010629),0.3985131188724364,1.369420188861528,0.01592356687898089,0.5995641609062087,1.0,68/302,15.16%,IGF1;ROBO1;SAMD4A;CILP;SLC24A3;ROCK2;DAPK1;RBMS3;LGR4;RUNX1;BMPR1A;OLFM1;WNT4;YAP1;DNMT3A;APOE;SMO;NOTCH2;SLC2A10;TWSG1;IGF2BP2;ITGB8;SFRP1;IGFBP5;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CPEB3;CD28;EIF2AK3;MAP2K1;DXO;RNF139;NCOR1;TNRC6A;BMP2;KAT2B;PICALM;SNX12;PRKN;MYADM;PARP14;RBBP7;FGF2;PHF1;PPHLN1;TTBK1;RBL2;NCOR2;TCEAL1;DDX3X;RGCC;REST;TERF2;LRP3;LARP1;CCDC3;MYCN;SYT11;ENC1;ZNF148;SETDB1;NUDT16L1;BMP4;ASB1;TMBIM6
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.31502490479807044,-1.3692713319607062,0.0,0.6182676733759097,1.0,37/159,10.61%,ADGRL3;HMCN1;GRID2;PECAM1;CLDN5;CDH2;CADM1;NLGN1;CDH1;IL1RAPL1;TENM2;BSG;KIRREL3;TENM3;CLDN11;LRFN5;TENM4;PTPRD;TGFB2;NECTIN1;CDH12;ATP2C1;CNTN4;CDH6;NTNG1;CDH8;PTPRT;CDH9;CDH13;CNTN6;LRRC4C;ROBO4;TGFBR2;CDH10;FAT2;EMB;UNC5D
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4434421227227758,1.3681234939067362,0.05334987593052109,0.6026105880892989,1.0,21/92,10.75%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;INSL3;CTSH;SMOC2;ATOH8;SRC;DOCK5;RAB25;AAMP;FOXC2;ANXA3;MAP4K4;MAPRE2;ITGB3;FGF2;CAPN7
prerank,presynapse assembly (GO:0099054),-0.5068440266647171,-1.3680832261827671,0.12189054726368159,0.6188778060894407,1.0,7/16,18.25%,NLGN1;IL1RAPL1;PTPRD;LRRTM3;PCLO;NLGN3;DVL1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4803521492689204,-1.367099673046128,0.09116809116809117,0.6190469409646614,1.0,10/21,27.26%,PDE4D;CAV1;INPP5K;DDIT4;NLRP2B;RACK1;NCK2;RASSF2;DMTN;MLXIPL
prerank,response to sterol (GO:0036314),0.6383398782545531,1.3660762335916192,0.15724381625441697,0.6080268324589848,1.0,2/11,3.57%,RORA;TGFBR1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5403356498823092,-1.36605890805524,0.10688836104513064,0.6193444217533657,1.0,5/13,6.82%,SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1
prerank,negative regulation of transposition (GO:0010529),0.6039347322388384,1.3650397806524281,0.14331210191082802,0.6102218838156621,1.0,7/16,17.51%,UBR2;TUT7;PIWIL4;SPOCD1;TUT4;MYBL1;DDX4
prerank,RNA stabilization (GO:0043489),0.5223613128392419,1.3643644381399065,0.10334788937409024,0.6111298253147615,1.0,9/33,12.41%,GDNF;TENT5A;PHAX;AXIN2;VIP;TENT5D;NSUN2;PARN;LARP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5617440655299741,1.3642407459032062,0.1383147853736089,0.6101450396130258,1.0,12/21,24.16%,LRRK2;EIF2AK3;BCL2L11;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;DDIT3;OPA1;TXNDC12;PMAIP1
prerank,embryonic skeletal system development (GO:0048706),0.5180038056097114,1.3639149394245444,0.11747430249632893,0.6098679724498198,1.0,6/35,4.15%,RBP4;COL1A1;SULF2;PDGFRA;SLC2A10;SULF1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5909174887633845,1.3637933283382837,0.14745762711864407,0.6089608568919103,1.0,4/16,3.02%,IGF1;TGFBR3;BMPR1A;FGFR2
prerank,modified amino acid transport (GO:0072337),0.6049389799609287,1.3637724815997565,0.13926174496644295,0.6077008982343113,1.0,5/15,12.64%,SLC16A12;SLC6A13;PDPN;MGST1;FOLR2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4977168438700256,-1.3637468350132584,0.12903225806451613,0.6239110013308705,1.0,5/18,16.80%,CD34;NAV3;TNFAIP3;PTPRC;HOMER3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.49692132188806326,-1.3634100987163866,0.1016949152542373,0.6217791850095041,1.0,8/18,24.57%,JAM2;SLC39A8;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,COPII-coated vesicle budding (GO:0090114),0.457598823065012,1.3625023359410202,0.07351077313054499,0.6107471323956117,1.0,23/68,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;MIA3;SEC23B;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,actin-myosin filament sliding (GO:0033275),0.5098767252011508,1.3625005849323149,0.12091038406827881,0.6081176683171607,1.0,8/38,13.03%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,muscle filament sliding (GO:0030049),0.5098767252011508,1.3625005849323149,0.12091038406827881,0.6081176683171607,1.0,8/38,13.03%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4223650501046201,1.3623653950945804,0.0627177700348432,0.6072437505479932,1.0,20/132,11.49%,IGF1;ZBTB20;SH3D19;DAPK1;DCN;DACT1;OPTN;PFKFB4;APOE;APOA1;PRKAA2;LRRK2;SNX33;DXO;ARNT;STK11;ITCH;RNF152;ADRA2A;UFL1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5502975387768643,-1.362094149211343,0.09669811320754718,0.6231694944716449,1.0,9/13,29.37%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6124178484117448,1.3613592541294328,0.15384615384615385,0.6094150676240582,1.0,7/14,17.54%,SEC24D;SEC31A;MIA3;SEC23B;SEC23A;TBC1D20;SEC24A
prerank,acylglycerol catabolic process (GO:0046464),-0.4234322334300476,-1.361204824356305,0.09451219512195122,0.6228071129760651,1.0,13/30,27.50%,MGLL;ABHD2;LIPE;PNPLA3;PNPLA2;ABHD6;FABP7;LYPLA2;FABP3;LIPH;LIPC;FAAH;LPL
prerank,action potential (GO:0001508),-0.3961138453162629,-1.360974721100279,0.08550185873605948,0.6204608249160276,1.0,11/44,7.82%,KCNJ2;ANK3;KCND2;SCN1A;YWHAH;SCN3A;KCNQ1;GNA14;AKAP6;KCNMB2;SCN2A
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.35778612658787023,-1.360618781175485,0.026785714285714284,0.6183456687899691,1.0,24/75,16.30%,PLCE1;RGS5;MGLL;RGS3;KCTD8;GIT2;NMT2;RGS6;CRY1;FNTA;RGS12;SYP;FNTB;CALM1;EDN1;RGS16;PLEK;RGS4;GIT1;DGKQ;RGS11;PDE6A;METAP2;GPER1
prerank,alcohol catabolic process (GO:0046164),0.6384934078348589,1.3604289625486756,0.14111498257839722,0.6111639995790841,1.0,3/10,7.23%,APOE;MT3;CYP27A1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6443470961778573,1.3596639015475567,0.16753926701570682,0.6110892648912692,1.0,1/10,2.64%,TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6443470961778573,1.3596639015475567,0.16753926701570682,0.6110892648912692,1.0,1/10,2.64%,TULP1
prerank,positive regulation of integrin activation (GO:0033625),-0.5727310702439433,-1.3590625420863658,0.12177985948477751,0.6202268447503495,1.0,5/11,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,regulation of cation channel activity (GO:2001257),-0.33956733997635513,-1.3577512437553065,0.03409090909090909,0.6213148726262868,1.0,29/89,20.30%,DLG2;PDE4D;MEF2C;GRIA4;NLGN1;PTK2B;ANK3;KCNAB1;GRIN2A;CAMK2D;FGF12;LRRC7;NOS1;GRIN2B;STAC;GRIA2;SHANK1;CALM1;HOMER1;APP;GSG1L;CACNG3;CACNG4;HPCA;AHNAK;CTSS;GRIN1;CACNB3;FKBP1A
prerank,cardiac muscle cell development (GO:0055013),0.5611678687849175,1.3575866476115055,0.13157894736842105,0.6166814250553317,1.0,5/20,3.56%,PDLIM5;SLC8A1;OBSL1;PDGFRA;PDGFRB
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5046817162036992,-1.357493237908508,0.12440191387559808,0.6189694429955265,1.0,7/16,17.21%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,epithelial cell migration (GO:0010631),0.5023007410539914,1.357021534878539,0.09742120343839542,0.6171821376775442,1.0,7/37,6.38%,NRP1;ZEB2;KANK1;KIT;FSTL1;CYP1B1;ADGRA2
prerank,negative regulation of signal transduction (GO:0009968),0.39824794885916037,1.3569649172516778,0.023255813953488372,0.616076112791023,1.0,62/249,16.40%,ADAMTS12;CILP;TRABD2B;ENPP1;PID1;CYP26B1;LRP1;AHSG;DCN;LYN;LGR4;BCL2;DACT1;SULF2;NKD1;LEPROT;KANK1;GLI3;MDFI;MGRN1;SLC2A10;TLE1;SULF1;NEDD4;ACVR1;SFRP1;IGFBP5;DKK3;LRRK2;EMILIN1;IL12B;CBLN1;TULP3;IRAK3;ARRB1;EGFR;NTN1;BMP2;CBY1;SPRY2;GLIS2;FGF2;TAX1BP3;IGFBP3;PTCH2;NIBAN2;BTRC;NDRG4;EGF;TSC2;PTEN;FSTL3;CXXC4;SFRP4;SUFU;TMBIM6;GRB10;BMP5;CD47;PIP4K2C;AKT1;KANK2
prerank,liver development (GO:0001889),0.5147276060960473,1.3569475490113718,0.09781021897810219,0.6148352586823842,1.0,11/32,12.43%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;DNAAF1;PHF2;CEBPB;NKX2-8;CCDC40
prerank,regulation of blood circulation (GO:1903522),0.5153914721845864,1.356752654744169,0.11206896551724138,0.6141094136606187,1.0,6/34,6.90%,CELF2;TPM1;DMPK;DES;BDKRB2;AGTR1
prerank,monocarboxylic acid transport (GO:0015718),-0.37798943220953535,-1.355964589273228,0.055970149253731345,0.6209967143566012,1.0,11/51,7.50%,ABCG2;ATP8B1;ABCC4;SLCO2A1;SLCO1C1;SLC16A6;SLCO2B1;SLC5A6;SLC16A9;SLC16A1;SLC16A4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.48103963287876944,1.355388715178943,0.09465020576131687,0.6173727702073473,1.0,10/46,9.62%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;ATRN;ITGB3;ITGAV
prerank,organophosphate catabolic process (GO:0046434),-0.5644161731605981,-1.3547161653865938,0.13646532438478748,0.6221233722600156,1.0,1/11,0.91%,ENPP2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.513219715109386,-1.3546809132713489,0.1038961038961039,0.619104753710484,1.0,9/16,26.94%,ACKR3;RPS3;TPT1;BCL2L1;CLU;SNAI2;CCAR2;SNAI1;NACC2
prerank,multivesicular body organization (GO:0036257),-0.4264659481510385,-1.3542616228223299,0.07051282051282051,0.6173965504095285,1.0,17/31,31.51%,RAB27A;RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,regulation of fat cell differentiation (GO:0045598),0.44374607990494996,1.3540238714696062,0.08396946564885496,0.6206885043531014,1.0,19/74,12.28%,RORA;ENPP1;RUNX1T1;SMAD3;MEDAG;YAP1;SFRP1;GNB3;ZFP36L1;WWTR1;SIRT2;NR1D1;CREBL2;BMP2;TRPM4;ANKRD26;CEBPB;TMEM64;LRP3
prerank,positive regulation of cell motility (GO:2000147),0.40739030625523104,1.3537389970023908,0.031868131868131866,0.6202656777357343,1.0,44/205,11.55%,IGF1;COL1A1;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;SEMA5A;CCL19;CSF1;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;WNT5B;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;NTN1;BMP2;MAP4K4;SPRY2;ACTN4;MYADM;FAM89B;TRIP6;HBEGF;ADRA2A;CCDC25
prerank,acylglycerol homeostasis (GO:0055090),0.5710151187293363,1.3537053242640873,0.13225806451612904,0.6190927642541645,1.0,3/20,4.30%,RORA;APOE;APOA1
prerank,positive regulation of histone modification (GO:0031058),-0.4177750106967665,-1.3536367471858075,0.07547169811320754,0.6163204779588567,1.0,11/33,13.80%,RPS6KA5;KDM1A;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;CHTOP;TADA2A;APLNR;MAPK3
prerank,ion homeostasis (GO:0050801),-0.43021155467695665,-1.3532628970571234,0.0949367088607595,0.6145224812261272,1.0,8/30,9.72%,SLC4A10;FHL1;NEDD4L;CAMK2D;UNC80;KLHL3;SLC4A8;WNK2
prerank,skin development (GO:0043588),0.4573899769961961,1.3532341557185792,0.0881578947368421,0.6193553899588228,1.0,7/65,4.03%,COL1A2;COL1A1;ERRFI1;TXNIP;COL5A1;ITGA3;SLC2A10
prerank,peptide metabolic process (GO:0006518),0.44480588309962454,1.3531324349117635,0.08727272727272728,0.6184071222471968,1.0,12/75,9.74%,CPXM2;CPQ;AEBP1;CPXM1;GSTM4;GSTM2;DPEP1;NAALADL1;SEC11C;APEH;GSTT1;ABCB9
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.5009001278024192,-1.3528663090588813,0.11235955056179775,0.6128381158132152,1.0,8/17,21.88%,CAV1;KLF7;APOLD1;MAFG;PRKX;CEACAM1;DLL1;DSPP
prerank,synaptic vesicle exocytosis (GO:0016079),-0.389719846689351,-1.3527983542473507,0.07692307692307693,0.6100487628927063,1.0,15/40,25.18%,UNC13B;RIMS1;STX3;CDK5;RIMS2;SYT1;PCLO;CPLX1;RAB3A;STX1A;RIMS3;OTOF;SNPH;SYT5;SNAP29
prerank,regulation of trophoblast cell migration (GO:1901163),0.5947712355610555,1.3527053618389084,0.15584415584415584,0.6185160066082054,1.0,4/14,12.87%,GJA1;SMURF2;SYDE1;ACVR1B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5166953954523967,1.352270532684573,0.10977443609022557,0.6186433943441245,1.0,8/29,8.71%,ZBTB20;APOE;APOA1;SLC45A3;LDLR;SREBF1;LPGAT1;CREBL2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6317366785506899,1.351833969574101,0.15245009074410162,0.6189215878081777,1.0,4/11,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,regulation of cardiac conduction (GO:1903779),0.4714601001441718,1.3517292365647011,0.1016949152542373,0.6180009490097013,1.0,7/54,4.12%,ITPR1;SLC8A1;SLC8A3;ATP1A2;DMPK;ASPH;STIM1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4217333342263364,1.351619254623268,0.05909617612977984,0.617054809983864,1.0,32/138,15.03%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;RARG;GTF2E1;GTF2H5;NR5A1;WWTR1;DR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;NR1D2;NCOR2;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,negative regulation of cellular component organization (GO:0051129),0.4491837268073909,1.3514503344066449,0.0728643216080402,0.6163903914954044,1.0,17/74,14.37%,EPHA3;BMP6;AR;APOA1;CDC42;SRC;SNX33;CARMIL1;IRAK3;SPRY2;DDX3X;DNAJA4;IMPACT;TERF2;SYT11;RIOK3;RTEL1
prerank,response to glucagon (GO:0033762),0.5697872477498188,1.3514264864841274,0.12171052631578948,0.6152013120200032,1.0,5/19,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,phospholipid homeostasis (GO:0055091),0.6461681173272311,1.3507639010867514,0.14634146341463414,0.6160391534907791,1.0,4/11,12.19%,ABCA1;APOA1;TLCD1;RCN3
prerank,vesicle coating (GO:0006901),0.4624923038602773,1.3498559181794938,0.08129032258064516,0.6152220130374882,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4624923038602773,1.3498559181794938,0.08129032258064516,0.6152220130374882,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,COPII vesicle coating (GO:0048208),0.4624923038602773,1.3498559181794938,0.08129032258064516,0.6152220130374882,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6404996985276306,1.3496629911210107,0.15726495726495726,0.6145715098382226,1.0,8/10,26.51%,VTN;MT3;ITGB3;ARNT;GRB10;PRKCB;PRKD2;ITGA5
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6525528907159066,1.3490591059799588,0.16036036036036036,0.6152373851818819,1.0,3/10,4.30%,ABCA1;APOE;APOA1
prerank,tRNA modification (GO:0006400),0.45780199176381203,1.3479913568702175,0.09210526315789473,0.6174664446564856,1.0,21/62,19.91%,TRMT44;PUS3;ADAT2;TRMO;NSUN2;BCDIN3D;TRMT9B;TRMT13;URM1;TRMT112;THUMPD3;THUMPD2;OSGEP;ELP5;THADA;DTWD1;ALKBH1;PUSL1;ANKRD16;TRUB1;METTL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.45244837593391907,1.3478817320818743,0.08365508365508366,0.6165548958906308,1.0,12/72,10.91%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1
prerank,lung epithelium development (GO:0060428),0.6493577984426055,1.3476550187153218,0.15742397137745975,0.6160788764404193,1.0,4/10,14.89%,ERRFI1;ASCL1;RCN3;BMP4
prerank,positive regulation of T cell differentiation (GO:0045582),0.5087392343702111,1.3474710188131802,0.11925287356321838,0.6154556711098667,1.0,11/36,16.72%,RHOH;GLI2;GLI3;BCL6;IL12B;ZMIZ1;ZBTB1;MDK;VNN1;IL23A;SHH
prerank,positive regulation of developmental process (GO:0051094),0.4097725146801526,1.347079182234729,0.03810623556581986,0.615434271717128,1.0,40/164,14.21%,PHLDB2;GJA1;CCN2;GDNF;AR;DAG1;SOX5;DCN;FGFR1;BMPR1A;APOE;ADGRL1;SMURF2;NEUROD4;ACVR1;MCU;NEUROD1;SRC;CPEB3;PPP1R13L;KMT5B;BMP2;SYDE1;CAMK2B;PRKN;TRPM4;KRT10;CEBPB;RBM19;REST;NIBAN2;MAP3K13;INSR;ACVR1B;MUL1;TMEM119;NCOA3;DLG4;HMCES;MDK
prerank,positive regulation of gene expression (GO:0010628),0.38540427920626197,1.3470176001175302,0.011213047910295617,0.614438511524563,1.0,97/442,14.99%,IGF1;ROBO1;BMP6;SAMD4A;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;PIK3R1;GSN;SMAD3;RBMS3;AR;MITF;PLD1;PLA2R1;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;HNRNPLL;YAP1;GAS6;TGFBR1;SMO;WNT6;SLC2A10;TLE1;PDCD5;POLR1G;CSF1;SLC22A2;MT3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;CPEB3;BATF;NFE2L2;CD28;SPHK2;AFDN;EIF2AK3;MAP2K1;MYO1C;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;EGFR;EPHB2;RBM22;BMP2;KAT2B;SPRY2;METTL14;SMAD1;PRKN;NFAM1;FGF2;BAZ1B;PHF2;EIF6;TTBK1;CARD9;BRAF;TENT4A;DDX3X;ADRA2A;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;TMEM119;MYCN;EGF;GLMN;PDCL3;ETS1;PLXNB2;HPN;NSUN5;TADA3;BMP4;SFRP4;FUBP3
prerank,negative regulation of protein binding (GO:0032091),-0.3494426695490125,-1.3457708692827446,0.06334841628959276,0.6307375036814548,1.0,26/71,21.95%,CAV1;MAP2;ACTB;B2M;ADAM15;KDM1A;SORL1;CTNNBIP1;ITGA4;ATP2A3;DISC1;GTF2F1;MAPK8;ADRB2;RALB;CARD16;PPP1CA;ZFPM1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;ROCK1;STYX;GSK3B
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6288736282969262,1.3454599738683952,0.1622103386809269,0.6184391486253349,1.0,4/11,8.76%,TGFBR3;TGFBR1;ACVR1;BMP2
prerank,dendritic cell differentiation (GO:0097028),0.5525030317870447,1.345042113782345,0.13731825525040386,0.618484853810354,1.0,5/22,6.84%,LYN;GAS6;CCL19;AXL;BATF
prerank,calcium ion import across plasma membrane (GO:0098703),0.5988234247038257,1.3450288200472689,0.1445578231292517,0.6172988847983789,1.0,3/14,4.52%,SLC8A1;SLC8A3;SLC24A1
prerank,regulation of immunoglobulin production (GO:0002637),0.5445699239515575,1.344793531586191,0.12883435582822086,0.6168239847685049,1.0,1/23,0.15%,RBP4
prerank,response to interleukin-1 (GO:0070555),0.444874302565334,1.344164050896083,0.06873315363881402,0.617680287954052,1.0,17/73,18.49%,ADAMTS12;PTGIS;CCL19;IRAK2;SFRP1;CCL4;SRC;NR1D1;IRAK3;USP10;IGBP1;HDAC4;TAF9;CD47;CX3CL1;RC3H1;PRKCA
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.43146459278198673,1.3440404829159678,0.06424242424242424,0.6168688159901076,1.0,19/101,11.52%,ROBO1;CEMIP;PDGFD;FGFR1;IL34;EPGN;KIT;PDGFRB;RAPGEF2;SRC;LRRK2;PARP16;MAP2K1;EGFR;TELO2;FGF2;DDX3X;ADRA2A;RGCC
prerank,cellular response to fatty acid (GO:0071398),0.6221507062370512,1.3440067059720984,0.16216216216216217,0.6157616433835443,1.0,1/12,0.91%,PID1
prerank,T cell proliferation (GO:0042098),-0.517528104676446,-1.3436604452530685,0.13566739606126915,0.6346985231742258,1.0,8/13,37.51%,CADM1;MSN;PIK3CG;DOCK8;LILRB1;TNFRSF4;CRTAM;LMBR1L
prerank,transferrin transport (GO:0033572),0.5214881835234388,1.3436593800758025,0.13275613275613277,0.6156299004548758,1.0,2/33,0.82%,ATP6V0A4;STEAP3
prerank,negative regulation of vascular permeability (GO:0043116),-0.5432445035990368,-1.3433947277330458,0.12941176470588237,0.6325541699786184,1.0,8/12,9.51%,SLIT2;PTPRJ;CLDN5;RAMP2;SH3GL2;PDE2A;DDAH1;VEGFA
prerank,calcium-mediated signaling (GO:0019722),0.44325143374119846,1.3430601750837317,0.066746126340882,0.6162600002273488,1.0,19/93,9.41%,RCAN2;PDPK1;SLC8A1;DMPK;PPP3CA;XCR1;ADGRL1;MCTP2;MCU;ACKR2;CCR9;LRRK2;CACNA1C;AGTR1;EIF2AK3;RCAN1;EGFR;BCAP31;TRPM4
prerank,sulfur compound biosynthetic process (GO:0044272),0.4269466555444069,1.343005794169228,0.07862407862407862,0.6152164046067339,1.0,20/104,11.74%,FMOD;OGN;ANGPT1;LUM;UST;DCN;BGN;ST3GAL3;DSE;CHAC2;GSTM4;GSTM2;B4GALT1;OMD;CSPG5;MGST1;GSTT1;CDO1;LIAS;CHST15
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5709560985913437,-1.34264842808629,0.13963963963963963,0.6320031065391515,1.0,6/10,26.25%,ATP5F1A;ATP5MG;ATP5F1C;ATP5PD;VPS9D1;ATP5MC2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4514737839685124,1.3422448970304772,0.08376963350785341,0.6164439427496496,1.0,16/66,13.25%,ROBO1;PDGFD;SASH1;FGFR1;IL34;EPGN;KIT;PDGFRB;LRRK2;TLR6;EGFR;FGF2;TAOK3;ADRA2A;DUSP19;EGF
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6422733634183742,1.3414255688612207,0.1853146853146853,0.6165689505469296,1.0,2/10,6.15%,CDC42EP4;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.6422733634183742,1.3414255688612207,0.1853146853146853,0.6165689505469296,1.0,2/10,6.15%,CDC42EP4;CDC42
prerank,cellular response to sterol (GO:0036315),0.6165752005074259,1.341090405636494,0.16393442622950818,0.616470812765526,1.0,3/13,3.86%,RORA;SMO;INSIG2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.40477530013877616,-1.340493544969927,0.11333333333333333,0.6361574133090616,1.0,6/39,5.85%,UTRN;FHL1;NEDD4L;YWHAH;FGF12;CHRM3
prerank,connective tissue development (GO:0061448),0.5051823476382467,1.3402573738935395,0.13,0.6179272661746363,1.0,11/35,10.81%,SOX5;SULF2;ARID5B;SULF1;SH3PXD2B;ITGB8;CREB3L2;TRIP11;PGRMC2;COL11A2;SLC39A13
prerank,cartilage development (GO:0051216),0.476250448581675,1.3400334631719961,0.112,0.6174228105740228,1.0,14/49,10.72%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;ITGB8;CREB3L2;WNT5B;OSR1;BMP2;TRIP11;FGF2;COL11A2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5124565686105138,1.339973638907969,0.12855007473841554,0.6164304855191165,1.0,6/29,8.36%,TCF7L2;TLE1;AXIN2;BCL9;TCF7;TCF7L1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.4302033410720498,-1.339921959373949,0.0932475884244373,0.6350659367559792,1.0,14/29,27.54%,LPCAT1;PLAAT3;PNPLA8;PLA2G4C;MBOAT7;LPCAT3;LPCAT2;PLA2G4F;PLA2G4E;DBI;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,androgen receptor signaling pathway (GO:0030521),0.6435029074187739,1.3398635595422268,0.17043478260869566,0.6155637356490378,1.0,4/11,8.78%,AR;PMEPA1;DDX17;ZMIZ1
prerank,sterol metabolic process (GO:0016125),0.4619610078102221,1.3394541440035364,0.08909574468085106,0.615662489001869,1.0,9/60,7.23%,CYP26B1;CYP7B1;ABCA1;PRKAG2;APOE;INSIG2;APOA1;CYP1B1;CYP27A1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5342334702535297,1.338626145858917,0.14873417721518986,0.6171964107818394,1.0,7/25,13.66%,NRP1;AR;SRC;DSCAM;EGFR;EGF;GLMN
prerank,glycerolipid metabolic process (GO:0046486),-0.5652165374830753,-1.338444220007245,0.12179487179487179,0.6370254451411943,1.0,5/11,17.45%,DGKB;PNPLA3;DGKG;DGKQ;DGKZ
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4271146124767237,1.3382035571265098,0.07203907203907203,0.617367766608137,1.0,14/100,6.31%,IGF1;PIK3R1;PDGFD;PTPN13;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4964573811340747,1.3374590857367006,0.1276595744680851,0.6184560973815681,1.0,10/36,11.71%,VAMP5;MACF1;OPTN;GORASP2;GOLGA4;TRARG1;AFDN;GGA2;GOLPH3L;GORASP1
prerank,dopamine metabolic process (GO:0042417),0.5592640259372152,1.3374209626010463,0.1568627450980392,0.6173973803841557,1.0,6/18,10.21%,MOXD1;COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,sphingoid biosynthetic process (GO:0046520),-0.5609173644086133,-1.3373087111145556,0.1367713004484305,0.6347005422680376,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5609173644086133,-1.3373087111145556,0.1367713004484305,0.6347005422680376,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4504334099859807,-1.3366654329058238,0.1,0.633768205741669,1.0,6/22,16.30%,PDE3B;APOD;PPP2R5A;ALK;CEACAM1;GPER1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5501922019927845,1.3363559165339038,0.14463452566096424,0.619772118509234,1.0,4/20,3.58%,OGT;MLKL;CFLAR;NUPR1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5677343200144197,-1.336087647643455,0.13053097345132744,0.6325185133130012,1.0,4/10,15.58%,FN1;HSP90AB1;TSKU;CDH3
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5892813709895067,1.3352460647146285,0.16803953871499178,0.6221997623618408,1.0,6/15,14.16%,DACT1;ACVR1;SKI;LEMD3;ACVR1B;FSTL3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.39545001903465615,-1.3352373584468826,0.06840390879478828,0.632623541880973,1.0,15/41,13.63%,KCNJ2;ANK3;KCNJ3;KCNMA1;KCNN2;KCNQ1;NOS1;AKAP6;STAC;KCNMB2;ACE2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5471018951251746,1.3351700527501202,0.16586921850079744,0.6212462990618587,1.0,8/22,15.84%,AREG;FGFR2;NOTCH2;ZFP36L1;CASK;KLF9;MDK;EPPK1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.41502432456397015,1.3351164557135193,0.08450704225352113,0.6202636628887507,1.0,27/118,10.41%,PHLDB2;PDLIM5;SH3D19;HECW2;PID1;GDNF;SPARC;DAG1;KIF13B;EPHA4;FGFR2;SP100;VASH2;NEDD4;PHIP;SFRP1;BCL6;ADGRA2;CRB2;LRRK2;BRSK1;ARHGAP35;WTIP;CAPZB;STAT2;FGF2;PDZD8
prerank,positive regulation of protein polymerization (GO:0032273),-0.35252942822638667,-1.3350610477952203,0.04526748971193416,0.6303632467595848,1.0,17/65,19.35%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;FES;DCTN1;TPPP3;CDK5RAP2;CTTN;CDK5R1;PRKCE;NCK2;CLASP1;LMOD1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.40709932251986797,1.334572831336722,0.07126696832579185,0.6208333023097643,1.0,35/150,13.79%,PDPK1;ENPP1;ERRFI1;PID1;PPM1E;LDLRAD4;PTPN13;PLPP3;LYN;DTNBP1;PMEPA1;PRKAG2;FBLN1;CDK5RAP3;NTF3;SFRP1;ENG;LRRK2;EMILIN1;WWTR1;SIRT2;NTRK3;DNAJC3;EPHB2;SPRY2;PRKN;MYADM;SPRED3;IGFBP3;IMPACT;DUSP19;TSC2;MVP;CNKSR3;PTEN
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.4380953096428762,-1.33407887459879,0.1178343949044586,0.630727286657366,1.0,8/26,10.72%,ACER3;ACER2;NOS3;GCH1;NOS1;DDAH2;SPTLC2;SPR
prerank,actin filament network formation (GO:0051639),-0.5588554336492321,-1.3333062847621586,0.140625,0.6302744807351395,1.0,5/11,10.45%,COBL;PLS3;SPIRE1;FHOD3;PLS1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5925129212108534,1.3327693835403973,0.15474209650582363,0.6252820837395384,1.0,5/16,5.68%,ROCK2;GSN;KANK1;RIPOR2;CDH5
prerank,positive regulation of binding (GO:0051099),0.4431215380735555,1.3319264447383143,0.09252217997465145,0.626741872564628,1.0,14/84,9.32%,IGF1;TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;SKI;DERL1;LRRK2;SIRT2;STK4;BMP2;PRKN
prerank,dicarboxylic acid transport (GO:0006835),0.5148502482470104,1.3311274153312684,0.14307692307692307,0.6281655004000691,1.0,4/28,5.39%,SLC1A3;GJA1;SLC13A3;PDPN
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6539416761615212,1.330856264383122,0.16666666666666666,0.6279360363588582,1.0,5/10,13.63%,ENPP1;ERRFI1;ENG;IMPACT;MVP
prerank,prostaglandin metabolic process (GO:0006693),0.5182965106906898,1.330637200070127,0.16030534351145037,0.6274899350836195,1.0,3/26,5.18%,PTGIS;PTGES;PLA2G4A
prerank,negative chemotaxis (GO:0050919),0.49672418771609167,1.3304214902487776,0.1235632183908046,0.6270055201262209,1.0,10/33,10.12%,ROBO1;EPHA7;SEMA3D;APOA1;LRTM1;NTN1;ITGB3;ITGAV;SLIT3;SLIT1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.45531849580599143,1.3300192879138104,0.1167979002624672,0.6270950482535633,1.0,10/63,7.38%,NELL1;TIMP3;BCL2;LEPR;NUPR1;CDK5RAP3;MT3;CST3;TIMP2;SIRT2
prerank,calcium ion import into cytosol (GO:1902656),0.5847639684508941,1.3292462639336011,0.15946843853820597,0.6283946478799053,1.0,3/15,4.52%,SLC8A1;SLC8A3;SLC24A1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.41336304434868787,1.32920937518983,0.07919621749408984,0.6273469525396567,1.0,14/117,7.28%,IGF1;PCCA;CYP26B1;ABAT;ACOT11;ACOT6;PDHA1;CPT1C;ACOT2;PCCB;ALDH1A2;HOGA1;KYNU;ADH1A
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3429216372747557,-1.328863015321389,0.05454545454545454,0.6418934879293884,1.0,21/75,14.78%,SLC12A2;SLC12A7;SLC9A2;KCNJ2;SLC24A2;SLC39A10;ATP1A1;KCNJ3;SLC9A6;ABCC9;SLC39A8;SLC12A6;ATP1B1;ATP2B4;SLC9A7;KCNJ15;ATP1A3;KCNJ10;TRPV4;SLC12A5;CACNA2D1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.41964367049676954,1.328861598941415,0.08536585365853659,0.6272671227598744,1.0,11/108,4.20%,ROBO1;COL4A3;UACA;GSN;DAPK1;SMAD3;DLC1;CASP12;CFLAR;PDCD5;SLC22A2
prerank,regulation of protein secretion (GO:0050708),0.42029939748887957,1.3287837128421907,0.07533414337788578,0.6263442843287111,1.0,12/119,6.81%,IGF1;BMP6;ITPR1;DNAJC1;RAPGEF4;APOE;MYO18A;MYH10;NEUROD1;ADRA2C;CACNA1C;IL12B
prerank,triglyceride biosynthetic process (GO:0019432),0.5816566144500284,1.3286635444557122,0.1632,0.625534095387613,1.0,7/18,21.75%,AGMO;LPGAT1;MOGAT3;DGAT2;GK;LPIN3;LPIN2
prerank,positive regulation of lipid localization (GO:1905954),0.6182623965367757,1.3284298893385416,0.18694885361552027,0.6251648572297624,1.0,2/11,11.60%,LRP1;IKBKE
prerank,MAPK cascade (GO:0000165),0.38351690239200725,1.328296993042833,0.02497398543184183,0.624433021382273,1.0,52/295,11.60%,IGF1;NRK;ANGPT1;ACTN2;GDNF;PIK3R1;KSR1;AREG;TGFA;IL31RA;FGFR1;GFRA2;EPGN;KL;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ABHD17C;APOA1;RAPGEF2;NCAM1;MT3;RASA3;PSME4;FRS2;CTSH;MRAS;MAP3K20;ZFP36L1;RANBP9;LRRK2;MAP2K1;ARAF;SPTAN1;RGL1;EGFR;MAP3K8;ARL2;MAP4K4;CAMK2B;ITGAV;GFRA4;FGF2;FGF13;BRAF;TAOK3;HBEGF;LAMTOR2;KBTBD7;TNIP2
prerank,kidney development (GO:0001822),0.44717952406237194,1.328289823937047,0.1038107752956636,0.6233106362872798,1.0,12/65,7.89%,GDNF;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;CTSH;AGTR1;IFT27;OSR1
prerank,axonogenesis (GO:0007409),0.38672797546126086,1.3278207866839713,0.04017372421281216,0.6237064339506898,1.0,39/237,10.38%,EPHA3;NRP1;ROBO1;EPHA7;LAMA1;AUTS2;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;FGFR2;EFNB2;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ULK2;RANBP9;EFNA2;BRSK1;ARHGAP35;SPTAN1;PARD6B;DSCAM;EPHB2;EFNB1;GFRA4;SLIT3;SLIT1;RYK;NEXN
prerank,Wnt signaling pathway (GO:0016055),0.4303064738090851,1.3275784782738738,0.10661764705882353,0.6233246241959648,1.0,14/92,6.62%,TCF7L2;WLS;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B
prerank,regulation of ion transmembrane transport (GO:0034765),-0.4131118684137399,-1.3272913157523203,0.1118421052631579,0.644248850056915,1.0,16/33,26.26%,KCNJ2;NEDD4L;KCNJ3;P2RX7;KCNQ1;CHRM3;AKAP6;KCNJ15;KCNJ10;CASQ2;ANO6;KCNJ8;KCNJ6;KCNJ13;KCNJ16;WWP2
prerank,positive regulation of cell projection organization (GO:0031346),0.4184967597484804,1.3271738376443307,0.07040572792362769,0.6234526300266852,1.0,29/115,14.30%,EPHA3;ROBO1;PLXNA2;CAMK1D;LYN;OBSL1;TIAM2;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;CARMIL1;ARHGAP35;NTRK3;CAMK2B;RAPGEF1;PLXNC1;MAP3K13;NDRG4;MARK2;PLXNA1;DLG4;MDK;CHODL;PLXNB2
prerank,sensory perception (GO:0007600),0.47505487645572886,1.3269244686010064,0.14344262295081966,0.6231191595405131,1.0,6/45,7.25%,ADGRV1;TRPA1;PTGES;GNAS;ALOXE3;USH2A
prerank,neuron projection extension (GO:1990138),0.5067804305850294,1.326044896702195,0.1378299120234604,0.6247759989344169,1.0,5/32,6.43%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2
prerank,protein prenylation (GO:0018342),-0.5705675337899492,-1.3255083291840657,0.14617169373549885,0.647398676622278,1.0,6/10,22.82%,FNTA;FNTB;PTAR1;CHML;PGGT1B;RCE1
prerank,protein autoubiquitination (GO:0051865),0.453719544352641,1.3254934525424245,0.11780104712041885,0.6254210897005654,1.0,15/61,15.29%,RNF220;SH3RF3;SH3RF1;RNF213;BFAR;RNF10;RNF185;PRKN;ITCH;RNF181;ERCC8;RAD18;RNFT1;AMFR;RNF13
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5411869305385794,1.3253637157280918,0.1358609794628752,0.6246791340793914,1.0,4/21,6.79%,EPHA3;ROCK2;MACF1;VCL
prerank,activin receptor signaling pathway (GO:0032924),0.5855161109783852,1.3246779820802126,0.1582608695652174,0.6257483279045138,1.0,3/15,4.67%,SMAD3;TGFBR1;ACVR1
prerank,positive regulation of cell population proliferation (GO:0008284),0.37713911594539873,1.32415871402467,0.0194672131147541,0.6262260362641627,1.0,54/423,8.95%,IGF1;TCF7L2;BMP6;IGF2;ESM1;GJA1;DDR2;PID1;TGFBR3;GDNF;PDGFD;AREG;AR;TGFA;IL31RA;LYN;BCL2;GRK5;FGFR1;IL6R;BMPR1A;IL34;OSMR;CCN1;LAMC1;EPGN;FGFR2;FGFR4;YAP1;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;CSF1;NTF3;HTR1A;PHIP;LIG4;SFRP1;CTSH;TBX3;VIP;TSLP;WWTR1;RAB25;IL13RA1;OSR1;TET1;RBPJ;NTRK3;EGFR;BMP2;CCN4
prerank,regulation of actin filament depolymerization (GO:0030834),0.5971252547829258,1.3239647351510546,0.19152854511970535,0.625756941787301,1.0,3/12,5.80%,PLEKHH2;SEMA5A;LIMA1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.541528664896243,1.323911163858079,0.13023255813953488,0.6247664794491629,1.0,10/21,23.00%,MT3;SIRT2;SLC30A10;PRKN;SLC18A2;ABCD2;SIRT5;AATF;HDAC6;BRCA1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5032069946700954,-1.3235948856634645,0.12771084337349398,0.6504023788596215,1.0,6/15,16.95%,LEF1;CHD1;SNW1;JUN;EP300;TFAP4
prerank,regulation of MAP kinase activity (GO:0043405),0.42349551981888833,1.3233244518144898,0.08924205378973105,0.6254522203996394,1.0,20/92,13.77%,ROBO1;PDGFD;KSR1;LYN;FGFR1;IL34;EPGN;KIT;APOE;PDGFRB;CDK5RAP3;LRRK2;IRAK3;EGFR;SPRY2;FGF2;ADRA2A;DUSP19;EGF;CDK12
prerank,transition metal ion homeostasis (GO:0055076),0.5162416366784196,1.3229634142457893,0.1426448736998514,0.6254552098095594,1.0,8/28,9.32%,CP;MT3;HEPH;NEO1;CYBRD1;PICALM;COMMD1;PRKN
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.539012512003654,1.3228596960736632,0.16203703703703703,0.6246422329416936,1.0,4/22,8.76%,SASH1;GADD45B;RELL1;BMP2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5451963262617827,1.322621975584329,0.16164817749603805,0.6242312248874686,1.0,6/20,12.17%,ACTN2;HECW2;NEDD4;OSR1;ADRA2A;YWHAE
prerank,female gonad development (GO:0008585),0.5553749753600745,1.3207939225012089,0.15865384615384615,0.6288217096322786,1.0,7/19,11.10%,NR2F2;KIT;NUP107;LHCGR;NR5A1;EIF2B4;CEBPB
prerank,regulation of lipid kinase activity (GO:0043550),0.621481598102245,1.3203409578153382,0.16970802919708028,0.6292362247591599,1.0,6/11,15.74%,PIK3R1;WDR81;WDR91;RBL2;F2;PIK3R2
prerank,myotube differentiation (GO:0014902),0.5653092938591207,1.3202468794394695,0.1634304207119741,0.628413239656833,1.0,2/17,0.94%,IGF1;ADAMTS5
prerank,reverse cholesterol transport (GO:0043691),0.6029935713879032,1.3195250457602958,0.15544041450777202,0.6294710453648131,1.0,3/13,4.30%,ABCA1;APOE;APOA1
prerank,regulation of dendritic spine development (GO:0060998),-0.4930287137010729,-1.3194935329608568,0.12041884816753927,0.6613415777926451,1.0,8/19,10.77%,MEF2C;SHANK3;PPFIA2;NLGN1;GRIN3A;TANC2;SHANK1;KIF1A
prerank,peptide catabolic process (GO:0043171),0.5274375789618136,1.318727241689128,0.15987460815047022,0.6308483325889213,1.0,5/23,7.93%,CPQ;CHAC2;CTSH;DPEP1;NAALADL1
prerank,regulation of actin filament-based movement (GO:1903115),-0.5687458888937971,-1.3185284169411964,0.14516129032258066,0.6616215144149845,1.0,2/10,1.19%,PDE4D;PDE4B
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5297224271625193,1.3182038764120323,0.12883435582822086,0.63139689940205,1.0,6/24,9.90%,PID1;LEPR;MT3;ADRB3;GFPT1;COQ10B
prerank,canonical Wnt signaling pathway (GO:0060070),0.444839373537357,1.3179133327520587,0.13181242078580482,0.6312255307243156,1.0,14/68,8.36%,TCF7L2;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B;TCF7L1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5245072695180528,1.3175075675501033,0.16031746031746033,0.6313134333412981,1.0,10/26,19.26%,OGT;KMT5B;SETD1A;WDR82;SETD5;SETD4;KMT2A;EEF2KMT;SETD1B;TET3
prerank,contractile actin filament bundle assembly (GO:0030038),0.5753201346381492,1.3174349139686654,0.1686143572621035,0.6293260740007421,1.0,5/15,13.29%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,stress fiber assembly (GO:0043149),0.5753201346381492,1.3174349139686654,0.1686143572621035,0.6293260740007421,1.0,5/15,13.29%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4932625231813148,1.3171878310823082,0.140625,0.6290166248481276,1.0,10/37,15.56%,DYNLL1;WDR35;IFT43;IFT27;TRIP11;IFT81;DYNC2I1;DYNLRB2;IFT22;IFT74
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6078202524799936,1.3171665060855355,0.1897810218978102,0.6279769789706668,1.0,6/12,18.68%,DPYSL3;DPYD;CTPS2;CDA;ALDH6A1;DPYSL2
prerank,regulation of neutrophil migration (GO:1902622),0.6193236041768015,1.3164418320114422,0.18571428571428572,0.6290829175038324,1.0,1/10,0.70%,RHOH
prerank,organophosphate ester transport (GO:0015748),-0.4427434590837882,-1.3163843144417888,0.11528150134048257,0.6657759754945929,1.0,10/24,17.09%,PITPNC1;PLTP;PITPNA;TNFAIP8L3;NPC2;OSBPL2;SCARB1;PCTP;PITPNB;PRELID2
prerank,ceramide metabolic process (GO:0006672),-0.37325466008355984,-1.3158343989136785,0.09191176470588236,0.6646486276370414,1.0,6/49,2.87%,ST6GALNAC3;SGMS1;ACER3;SGMS2;ACER2;DEGS2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5981291675030811,1.3156615930286304,0.16970802919708028,0.630373376439363,1.0,3/14,1.77%,GHR;PIK3R1;LYN
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4347860646418195,-1.3154643078785553,0.11731843575418995,0.6629888797856739,1.0,7/23,11.50%,OTUD7B;MINDY2;MINDY1;OTUD7A;OTUD4;YOD1;TNFAIP3
prerank,positive regulation of cellular senescence (GO:2000774),-0.5678410783371565,-1.315009549795732,0.15638766519823788,0.6616752325329395,1.0,5/10,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5257759304255646,1.3143460416891013,0.16615384615384615,0.6333342112920337,1.0,2/23,3.56%,IGF1;EFNB2
prerank,gene expression (GO:0010467),-0.28360236746881873,-1.3139483741745637,0.0,0.6621338788246462,1.0,121/348,20.78%,BICD1;NUP93;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;NUP35;RPL34;WARS1;RPS13;RPL21;RPL7;NUP153;RPL18;RPL27;NUP160;EIF4E;RPL35A;RPL38;RPS15;RPS3;SORL1;RPL39;APOBEC1;RPS7;GALNT2;RPS4X;RNGTT;RPL11;ELAVL4;MRRF;HNRNPK;RPL30;RPS23;NUP54;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;RPS9;RBM8A;ALYREF;HHEX;HNRNPD;CHTOP;RPS5;YARS2;PTMA;RPL4;RPL18A;RPL26;SNRNP40;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;ADAR;MRPS5;RPL7A;RPL19;THAP1;RPS20;RPL14;EEF1A1;RPL13;DEDD2;HNRNPA2B1;DUSP11;RPL32;MRPS12;CLP1;RPL5;YTHDC1;TSPAN17;RPSA;SRSF7;NOL9;FASTKD2;SEC13;ADARB2;MRPL44;MRPS33;SMG7;RPLP0;NUP155;MPHOSPH10;MRPL55;DDX19B;RPS6;RPS6KB2;RPL22;RANBP2;GLE1;DHX38;NUP88;MRPS18B;POLR2E;MRPL42;RPS21;MCM3AP;TASP1;RPL37A;RPLP2;MRPS21;THOC6;SRSF4;MRPS7;RPL17;RPL23;NUP62;MRPL34;SLBP
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.533827779381638,-1.3137035474835395,0.15671641791044777,0.660068260571493,1.0,4/12,6.92%,UNC13B;RIMS1;RIMS2;SYT1
prerank,blood vessel endothelial cell migration (GO:0043534),0.5375955128475741,1.313316450480631,0.16211878009630817,0.6356382229848218,1.0,7/22,11.96%,NRP1;ROBO1;EFNB2;CDH5;MIA3;FGF2;NR4A1
prerank,regulation of GTPase activity (GO:0043087),-0.30511126009959866,-1.3132339451175756,0.021052631578947368,0.6587212434378502,1.0,45/177,11.96%,PKP4;DOCK9;CHN2;EFNA5;FGD5;LRCH1;PLXNA4;RAP1A;ITGA6;ARHGAP44;F11R;VAV3;CAV2;SH3BP4;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;RGS6;RASIP1;PRKG1;RDX;TBC1D15;TGM2;ARHGAP27;ERBB2;EZH2;CCL14;EPHA5;NGEF;CHN1;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;PLXND1;RGS16;ADAP1;AGRN;NF1;EVI5;CD40
prerank,positive regulation of histone methylation (GO:0031062),0.5277386701308113,1.3114905776457624,0.15683229813664595,0.640448375901265,1.0,11/24,23.00%,AUTS2;OGT;TET1;PHF1;PAF1;KMT2A;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,regulation of leukocyte activation (GO:0002694),0.5817954575998249,1.3112456515886823,0.20240137221269297,0.6401056738758223,1.0,7/14,22.37%,LYN;MYO18A;CD200;CD33;PJA2;GPR137B;LCK
prerank,alanine transport (GO:0032328),-0.5592682163472825,-1.3112078151343252,0.18,0.6626839510289836,1.0,3/10,13.96%,SLC6A6;SLC36A4;SLC1A4
prerank,regulation of heart contraction (GO:0008016),0.4237357388278289,1.3110029601031081,0.10179640718562874,0.6396778301935311,1.0,11/90,6.93%,CELF2;ITPR1;SLC8A1;SLC8A3;ATP1A2;TPM1;DMPK;ASPH;STIM1;DES;ATP1B2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4127239734867056,1.3101277719709494,0.09443099273607748,0.6414043077034542,1.0,17/110,8.20%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;ADCY5;GNAS;ADCY9;ADGRL1;RAPGEF2;VIP;ADRA2C;LHCGR;ADRB3;LPAR1;DRD3
prerank,vascular transport (GO:0010232),0.4237076986098328,1.309551135310253,0.11323003575685339,0.6421380388375724,1.0,23/81,12.56%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,negative regulation of immune system process (GO:0002683),0.5769781781852135,1.3094664474791002,0.16908212560386474,0.6413232909343808,1.0,4/16,14.04%,LYN;IL17D;CD200;COL3A1
prerank,sodium-independent organic anion transport (GO:0043252),-0.5605892476290951,-1.3090404181774669,0.16027088036117382,0.6673866432964949,1.0,3/10,2.67%,SLCO2A1;SLCO1C1;SLCO2B1
prerank,cardiocyte differentiation (GO:0035051),0.6369593217769205,1.3090374603229842,0.17896678966789667,0.6415034596032296,1.0,6/10,14.70%,SIK1;BMP2;EEF1AKMT4-ECE2;CBY1;AKAP13;GATA6
prerank,cristae formation (GO:0042407),-0.4319230296004058,-1.3089351420599538,0.1282798833819242,0.6649112666169906,1.0,8/27,17.21%,LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.49061453306676783,1.3088748286236485,0.15129682997118155,0.6409127023272748,1.0,4/33,7.38%,IGF1;PIK3R1;ZFP36L1;SIRT2
prerank,striated muscle contraction (GO:0006941),0.46392264198898003,1.3087929439941475,0.12073490813648294,0.6400519589106689,1.0,11/53,10.13%,SLC8A1;ATP1A2;TPM1;TNNT1;TNNC1;MYL4;DTNA;GAA;ARHGEF11;CSRP3;TNNT3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5688950959018768,-1.308402276869726,0.14908256880733944,0.6636738154845505,1.0,8/10,38.46%,GALNT13;GALNT2;GALNT3;POGLUT3;GALNT4;MGAT5B;GALNT16;POGLUT1
prerank,alpha-amino acid metabolic process (GO:1901605),0.47093474723990747,1.3078237294121855,0.14385474860335196,0.6419305854235142,1.0,9/45,8.64%,ASPG;GLUL;PYCR1;MTHFR;ASPA;PYCR3;DPEP1;MMUT;ALDH18A1
prerank,filopodium assembly (GO:0046847),-0.49249299024434834,-1.3075553349800797,0.13267813267813267,0.6636955905209665,1.0,3/16,3.37%,DNM3;FGD5;SPATA13
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44178558878900215,1.307293135033166,0.11254851228978008,0.6424247439210952,1.0,10/65,7.38%,PTGIS;RORA;SLC8A3;MT3;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,epithelial to mesenchymal transition (GO:0001837),0.465576938466761,1.3064798532401662,0.11543810848400557,0.6438505103091103,1.0,11/47,8.76%,ROCK2;TGFBR3;FGFR1;OLFM1;WNT4;TGFBR1;TBX3;ENG;DDX17;RBPJ;BMP2
prerank,secretory granule organization (GO:0033363),0.617516181236838,1.3060546350081517,0.1736745886654479,0.644062610515034,1.0,3/10,9.55%,ABCA1;DTNBP1;BLOC1S1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5693197647532177,1.3058728654574034,0.18210862619808307,0.6435046538821714,1.0,5/17,6.93%,GJA1;SLC8A1;ATP1A2;CACNA1C;ATP1B2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4783524073798488,1.3057635535828778,0.1447178002894356,0.6427570241850256,1.0,13/39,17.59%,STEAP3;ABCA1;TVP23B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;TVP23A;TANGO2;GOLPH3;COPG1
prerank,bile acid and bile salt transport (GO:0015721),-0.4301626451757047,-1.3055179596241144,0.14634146341463414,0.6676400495307618,1.0,4/24,2.67%,ATP8B1;ABCC4;SLCO1C1;SLCO2B1
prerank,membrane repolarization (GO:0086009),-0.4893686485102311,-1.3053485991208307,0.15326633165829145,0.6654331555331185,1.0,5/15,6.82%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.467915932818522,1.3052568418636614,0.1401098901098901,0.643336891903623,1.0,5/41,4.52%,ITPR1;SLC8A1;SLC8A3;CCL19;SLC24A1
prerank,miRNA metabolic process (GO:0010586),0.5404399735334504,1.3052307251940847,0.19585987261146498,0.642332360771313,1.0,10/20,22.16%,SND1;DDX17;TUT7;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DICER1;DROSHA
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39823645766037613,1.3050406930390859,0.07167235494880546,0.6418549555593167,1.0,27/151,10.64%,NRP1;CCN2;ANGPT1;PDGFD;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;CCL4;MAP2K1;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;CARD9;BRAF
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4727585773573165,-1.3045467404340987,0.13480392156862744,0.6654716667536155,1.0,11/18,31.56%,TMEM14A;HIP1R;GSK3A;BAK1;ZNF205;ACAA2;GSK3B;FZD9;CHCHD10;BID;BAX
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.27897972041938274,-1.3044971081635757,0.03125,0.6629042772430112,1.0,143/306,31.20%,RAD17;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;B4GALT5;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;DBF4;GTPBP1;RPS9;RPS5;ALAS1;RMI1;TOPBP1;ORC4;YARS2;PTMA;RPL4;RPL18A;RAD1;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;MRPS5;RPL7A;RPL19;FAM111A;TYMS;THAP1;RPS20;INHA;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;RPSA;MCM8;HUS1;MRPS33;RPLP0;MRPL55;INHBA;RPS6;RPS6KB2;RPL22;NBN;MRPS18B;POLR2E;MRPL42;MCM3;RPS21;RPL37A;RPLP2;MRPS21;ALAS2;MRPS7;RPL17;RPL23;MRPL34;HELB;DTX1;EIF4EBP2;RPL28;PABPC4;MCM5;RPL31;EEF1A2;ST3GAL4;EXO1;RPS10;HOXD3;E2F1;RPS11;POLR2B;ORC5;RPS27;EEF2K;RHNO1;POLR2J;RPS16;NFKBIB;TOPORS;RPL10;RPL15;SET;RPL12;RPL9;RPS8;DONSON;MRPL28;GRWD1;MEF2A;CDK1;CDC6;PIF1;FEN1;MRPL43;TICRR;MRPS14;POLA1;RPS27A;POLD2;RNPS1;RPL10A;XAB2;TERT;RPS17
prerank,amino sugar biosynthetic process (GO:0046349),0.606730303057897,1.3043632278186845,0.19152854511970535,0.6429202422537704,1.0,4/12,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,transport across blood-brain barrier (GO:0150104),0.4203444934385424,1.304351162790852,0.11492890995260663,0.6418718772847212,1.0,23/83,12.56%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5039764911454621,-1.3037146156001154,0.16169154228855723,0.662812116224039,1.0,8/14,11.74%,PRKAR1A;ATP2B4;PKIB;PRKAR2B;PRKAR1B;PRKAR2A;ADRB2;SIRT1
prerank,regulation of secretion by cell (GO:1903530),-0.35953379182178236,-1.3037057694982772,0.09716599190283401,0.660124558470972,1.0,20/54,19.34%,MEF2C;MCTP1;RIMS1;STXBP5L;RAB21;RAB3C;RIMS2;VAMP8;SYT1;RAB12;RAB8B;LGI3;NSF;CPLX1;RAB15;RAB3A;RIC1;ARFIP1;SYN1;ANXA1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.53969773740648,1.3034750914094266,0.17450682852807284,0.6434358210539102,1.0,5/20,10.19%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,positive regulation of filopodium assembly (GO:0051491),0.5133791137262727,1.3034743553183146,0.17990275526742303,0.6423525957659406,1.0,6/24,6.15%,NRP1;PIK3R1;DOCK11;RIPOR2;DPYSL3;CDC42
prerank,positive regulation of cellular component movement (GO:0051272),0.5265587573179691,1.3034038434893815,0.14923076923076922,0.6414909555831255,1.0,10/24,14.04%,LYN;TGFBR1;CCL19;PDPN;NTN1;ACTN4;STK11;CCDC25;TUBB2B;ETS1
prerank,regulation of cytoskeleton organization (GO:0051493),0.40635660620963443,1.3024350115054038,0.10774818401937046,0.6435372175337299,1.0,13/108,5.50%,EPHA3;PHLDB2;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;IQGAP2;PRKAA2;RHOBTB3
prerank,vasodilation (GO:0042311),-0.5357329777903818,-1.3024149049428417,0.15422885572139303,0.6615886723416007,1.0,6/13,16.30%,NOS3;KLF2;KCNMA1;NOS1;ADRB2;GPER1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.560799291246015,-1.3022393180391636,0.16027088036117382,0.659615498800558,1.0,3/10,7.80%,THBS1;CTTNBP2NL;INPP5K
prerank,ureteric bud morphogenesis (GO:0060675),0.558344906423142,1.3011103953975325,0.18456375838926176,0.6466745726248257,1.0,6/16,16.72%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,positive regulation of axonogenesis (GO:0050772),0.462930200158164,1.3009443137743306,0.14427157001414428,0.6460827851201801,1.0,11/43,14.30%,ROBO1;PLXNA2;MACF1;TIAM2;GOLGA4;NTN1;PLXNC1;MAP3K13;PLXNA1;CHODL;PLXNB2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42251605119752045,1.3008534015169952,0.11928934010152284,0.6453136938903173,1.0,12/78,9.04%,EPHA3;PDPK1;PID1;PIK3R1;AR;LRP1;ITGA3;PTPN9;DAB2;EGFR;EPHB2;PICALM
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4501531140284309,1.3005510307135102,0.125,0.6452039922254847,1.0,12/52,18.31%,POLR2D;SAMD4A;TUT7;EXOSC1;PARN;EXOSC7;TUT4;RC3H2;CNOT3;DCP1A;PATL1;RC3H1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6275158960020588,1.3005118513357812,0.19550173010380623,0.6442652966134115,1.0,4/10,6.60%,DCN;BCL2;SRC;LRRK2
prerank,tRNA wobble base modification (GO:0002097),0.5770163700212291,1.2995487748552699,0.17625231910946196,0.6462882382756159,1.0,6/14,19.90%,ADAT2;TRMT9B;URM1;ALKBH1;DPH3;ELP4
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36312410244851473,-1.2993636616406332,0.07964601769911504,0.6665153726167362,1.0,21/59,15.19%,HMCN1;PECAM1;CDH2;CADM1;CDH1;BSG;KIRREL3;TENM3;NECTIN1;CNTN4;PTPRT;CDH13;CNTN6;ROBO4;FAT2;EMB;PVR;IGSF11;DSG2;CEACAM1;PLXNB3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5405976373904351,1.2993075295412002,0.15396825396825398,0.6460144967206488,1.0,5/21,5.94%,ENPP1;ROCK2;AHSG;GAS6;BCOR
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.477648883084144,-1.2992126642726498,0.16417910447761194,0.6643569195961577,1.0,8/17,26.80%,COX4I1;COX6A1;COX5B;CYCS;COX5A;COX6C;COX8A;AFG1L
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.41384036933970764,1.2982172431032692,0.10538922155688622,0.648338147411388,1.0,20/104,10.37%,PDPK1;CILP;SMAD3;LDLRAD4;ADAMTSL2;BMPR1A;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ACVR1;SKI;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FAM89B;SPRED3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.6338198059850707,1.297788998065967,0.19330855018587362,0.648642989273964,1.0,4/10,12.58%,GHR;LYN;STAT5B;STAT6
prerank,catecholamine biosynthetic process (GO:0042423),0.6078677386234709,1.297633124127774,0.20408163265306123,0.6480975604513579,1.0,1/11,0.53%,MOXD1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.518020418105293,1.2965595062130428,0.1669218989280245,0.6504213163748008,1.0,4/24,5.78%,ERRFI1;ROCK2;RUNX1;ZFP36L1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3775508625441754,1.2956768374217194,0.04288702928870293,0.6520042645295295,1.0,69/308,15.28%,ADRA1B;COL1A1;GJA1;GHR;GDNF;SMAD3;LRP1;SOX5;NKX6-1;ABCA1;SERPINE1;PLA2R1;LEPR;OGT;ACSL1;BMPR1A;OLFM1;GNAS;GAS6;APOE;TGFBR1;SMO;SMURF2;APPL2;ACVR1;AXIN2;PDPN;VIP;EPAS1;DYNC1H1;ADRB3;CRB2;ALMS1;IL12B;BATF;CD28;WWTR1;DAB2;KMT5B;BMP2;SYDE1;TRPM4;NFAM1;FGF2;CARD9;MFAP2;CEBPB;ADRA2A;RBM19;RGCC;REST;NIBAN2;MAP3K13;STAT6;ACVR1B;DECR1;TMEM119;EGF;NCOA3;GLMN;DIO2;G0S2;HMCES;MDK;BMP4;CNOT3;GLIPR2;IL4R;GRB10
prerank,nucleic acid metabolic process (GO:0090304),0.43671635560122624,1.295587981499113,0.12418300653594772,0.651231424590998,1.0,23/69,20.83%,POLR2D;ENPP1;RBFOX2;POLG;DXO;RECQL5;HNRNPR;METTL14;HNRNPA1;POLR2C;DNASE1L1;DNASE2;WTAP;LSM8;HNRNPC;KPNA2;METTL3;DDX1;POLR2L;HNRNPU;HNRNPH1;EXD2;DDX24
prerank,plasma membrane tubulation (GO:0097320),-0.5131893706701086,-1.2952948097903902,0.1388888888888889,0.6746483689864112,1.0,8/13,23.57%,FNBP1L;CAVIN2;BIN3;PACSIN2;PACSIN1;EHD2;CHMP4A;BIN2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4378096822595256,1.2951719145706502,0.116,0.6514194106696034,1.0,10/69,7.38%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ZFP36L1;PLCB4;SIRT2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4801352749191745,-1.2948920016534984,0.15158924205378974,0.6732331055437817,1.0,3/16,1.86%,MEF2C;MCTP1;RIMS1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5232187717902292,-1.2945519882987475,0.16037735849056603,0.6717006545232735,1.0,7/12,22.93%,TAF1B;TAF1;TBP;GTF2A2;BDP1;POLR1E;GTF2B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.4516273830961735,-1.2944026939945454,0.13623188405797101,0.6695132747685284,1.0,6/18,8.29%,RAP1A;NLGN1;RIMS1;RIMS2;RAP1B;SLC4A8
prerank,protein O-linked glycosylation (GO:0006493),0.4158852902053033,1.2940140248473029,0.10869565217391304,0.6539463605486907,1.0,11/96,5.89%,TMTC1;GXYLT2;GALNT14;GALNT15;GALNT18;TMTC4;OGT;PGM3;ST3GAL3;LARGE1;LARGE2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5350495083230732,1.2938335025075525,0.15286624203821655,0.6534389981960009,1.0,6/19,17.31%,AMPD3;ADK;POLL;CDA;AMPD2;DCK
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4632628659970008,1.2938256056318933,0.1416184971098266,0.6524011249281298,1.0,6/43,13.46%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5961403749752564,1.2938036146457264,0.21238938053097345,0.6514194323089288,1.0,2/12,2.08%,LYN;RUNX1
prerank,response to insulin (GO:0032868),0.4321207788551591,1.2933784020719112,0.13043478260869565,0.6516731242829664,1.0,14/80,12.56%,PDPK1;ENPP1;TBC1D4;PIK3R1;OGT;INSIG2;CPEB1;ZFP36L1;TRARG1;KAT2B;EIF6;RHOQ;SELENOS;INSR
prerank,ceramide transport (GO:0035627),-0.5220488339832324,-1.2930754583894408,0.16985645933014354,0.671299301282567,1.0,3/12,6.74%,CERT1;PLTP;PLEKHA3
prerank,membrane assembly (GO:0071709),-0.400930166911718,-1.2930376394108671,0.1440922190201729,0.6687729302156591,1.0,9/34,10.27%,NLGN1;IL1RAPL1;ANK3;PTPRD;SPTBN1;NRXN1;EMP2;GAK;UGCG
prerank,visual perception (GO:0007601),0.42800446738380676,1.2930034304694917,0.11809045226130653,0.6517960659092762,1.0,8/84,4.52%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,negative regulation of blood pressure (GO:0045776),-0.504778002902709,-1.2929907150212023,0.16539440203562342,0.6663086138045995,1.0,3/13,6.37%,NOS3;PRCP;NOS1
prerank,regulation of synapse organization (GO:0050807),0.5133724493947445,1.2918189240889966,0.16614906832298137,0.6545080049820048,1.0,9/26,12.63%,PDLIM5;EPHA4;ABHD17C;NEDD4;CAMK2B;SETD5;MDGA1;CLN3;SLITRK2
prerank,protein O-linked mannosylation (GO:0035269),0.5445908825194686,1.291679447712857,0.18932038834951456,0.6538981039352539,1.0,4/18,5.89%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,sulfur amino acid metabolic process (GO:0000096),0.5128089139912086,1.291366551248273,0.18798151001540833,0.6538319114666278,1.0,7/24,13.13%,MTR;MTHFR;DPEP1;MMUT;CDO1;SMS;NOX4
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4668832809209114,1.2913442025312212,0.13576642335766423,0.6528378030083483,1.0,6/41,13.46%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6168023910587992,1.2899915164659932,0.1948529411764706,0.6558911356583601,1.0,3/10,7.55%,ACTN2;SEMA5A;CARMIL1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.43570723133186623,1.2897282891276018,0.13359273670557717,0.6557194452818631,1.0,8/68,6.60%,ENPP1;AMPD3;TPST1;ACOT11;ACOT6;ACOT2;RAB23;LRRK2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5912491989488157,1.2893353577817648,0.2041522491349481,0.6558832955135186,1.0,4/12,16.19%,IL12B;ZBTB1;CARD9;IL23A
prerank,macrophage activation (GO:0042116),-0.3997181813932347,-1.288511683845882,0.13245033112582782,0.6784135484531428,1.0,16/34,25.49%,CD93;PLCG2;DYSF;LBP;JAK2;FOXP1;IFI35;SBNO2;APP;TLR4;CLU;AGER;AIF1;TREM2;IFNGR1;TMEM106A
prerank,neutrophil migration (GO:1990266),-0.35620425803886,-1.2881482795788493,0.10699588477366255,0.6768625514920402,1.0,10/58,12.13%,PECAM1;PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,acute-phase response (GO:0006953),0.5986539108633611,1.2878724065174858,0.22522522522522523,0.6593310749334177,1.0,2/12,2.21%,AHSG;IL6R
prerank,mononuclear cell differentiation (GO:1903131),0.5180071997469984,1.2873936748088615,0.16436251920122888,0.6597722899896821,1.0,4/24,4.70%,IL31RA;LYN;GAS6;AXL
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.579265732252875,1.2868614313673916,0.2023217247097844,0.6603884976556162,1.0,2/14,6.93%,ACTN2;ATP1B2
prerank,negative regulation of cell activation (GO:0050866),0.5621090426569076,1.286404004585495,0.18512396694214875,0.660729671563776,1.0,8/14,12.06%,PDGFRA;APOE;LDLR;EMILIN1;NR1D1;CD200;F2;C1QTNF1
prerank,lipid transport (GO:0006869),-0.32239371746220913,-1.286309386064437,0.05319148936170213,0.680399764696598,1.0,29/97,17.09%,PITPNC1;CERT1;ATP8A1;ATP8B1;PLTP;ABCC4;SLCO2A1;SLCO1C1;SLCO2B1;PPARD;PITPNA;TNFAIP8L3;SPNS2;LBP;PLEKHA3;NPC2;MFSD2A;ABCG1;OSBPL2;UGCG;SCARB1;PCTP;CEACAM1;ABCD3;ABCC3;MFSD2B;PITPNB;OSBP;PRELID2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4446598428292732,1.2855600711379793,0.14809960681520315,0.6622699910058822,1.0,8/52,8.62%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,focal adhesion assembly (GO:0048041),0.515231134962131,1.285369958817754,0.17665615141955837,0.6619128985219213,1.0,4/21,6.31%,ACTN2;DLC1;RHOD;SRC
prerank,actomyosin structure organization (GO:0031032),0.43188421451523656,1.2853137997851038,0.12390488110137672,0.6610230525111115,1.0,16/75,10.13%,PHACTR1;ROCK2;ACTN2;TPM1;TMOD4;TNNT1;MYO18A;MYH10;FRMD6;CSRP2;ITGB5;SRC;ARRB1;CSRP3;SYNPO2L;TNNT3
prerank,sulfur compound transport (GO:0072348),-0.4145605745120923,-1.2847477070468807,0.13043478260869565,0.6827926071244886,1.0,7/27,9.96%,SLC6A6;ABCG2;SLC26A7;LRRC8D;SLC5A6;SLC25A30;SLC26A6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.53035672883197,1.2846841663220008,0.16531604538087522,0.6621028199876067,1.0,8/20,9.91%,RUNX2;CHD6;MT3;NFE2L2;RBPJ;BMP2;SMAD1;CREB3
prerank,protein depolymerization (GO:0051261),0.5058328766516502,1.2846434076894262,0.17450682852807284,0.6611946503724194,1.0,3/27,2.81%,MICAL3;GSN;NCKAP5
prerank,positive regulation of nervous system process (GO:0031646),-0.4685245646984422,-1.2846086402912276,0.15254237288135594,0.6806825899201566,1.0,5/18,11.80%,UNC13B;RIMS1;TENM4;RIMS2;ATPSCKMT
prerank,T cell mediated immunity (GO:0002456),-0.4941588031914232,-1.284245103878873,0.17391304347826086,0.6791354940040877,1.0,3/13,6.57%,CADM1;EMP2;CD55
prerank,protein kinase A signaling (GO:0010737),-0.5185454051360953,-1.2835755162123388,0.17342342342342343,0.6786707942634873,1.0,3/12,7.60%,RDX;PRKACB;MYOM1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44600732883953925,1.2833886857303243,0.1342281879194631,0.6640184511871092,1.0,8/52,8.62%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,regulation of cholesterol esterification (GO:0010872),0.6029361573722187,1.283360066669405,0.21891418563922943,0.6630510008790157,1.0,3/10,6.90%,APOE;APOA1;AGTR1
prerank,negative regulation of cell projection organization (GO:0031345),0.455024518849166,1.282667984525674,0.15796703296703296,0.6641750177282796,1.0,16/48,15.94%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;PTPRS;DENND5A;LPAR1;PTPN9;SPRY2;GORASP1;PTEN;BAG5;STX1B
prerank,negative regulation of T cell differentiation (GO:0045581),0.608510543116699,1.2825291443066476,0.2144177449168207,0.6635528420180715,1.0,4/10,14.89%,GLI3;IRF1;MDK;BMP4
prerank,neuromuscular process controlling balance (GO:0050885),-0.5218188639383146,-1.2823905801766584,0.20047732696897375,0.6798483409952879,1.0,4/12,9.86%,PCDH15;NRXN1;PAFAH1B1;SHANK1
prerank,nucleosome assembly (GO:0006334),-0.40262213486595677,-1.2822131560069165,0.1402439024390244,0.6778297328854195,1.0,17/31,31.98%,NAP1L4;HIRA;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CABIN1;NASP;ASF1A;HAT1;ASF1B;GRWD1;NAP1L3;NAP1L1
prerank,histone deacetylation (GO:0016575),0.465992566718765,1.2820444789755943,0.16620111731843576,0.6640411442294503,1.0,18/43,23.32%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC8;REST;HDAC4;SUDS3;ELK4;MIER3;BRMS1;SMARCAD1;HDAC6;HDAC5;SFPQ
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.47338234896404496,1.2812511813518874,0.17553956834532375,0.6654346235434166,1.0,2/37,0.40%,EPHA3;PHLDB2
prerank,protein polyglutamylation (GO:0018095),-0.5321338931633612,-1.2812007724353276,0.1961206896551724,0.6785110778152205,1.0,2/11,1.61%,TTLL7;TTLL5
prerank,cAMP-mediated signaling (GO:0019933),0.5082645000307683,1.28084800640114,0.17851739788199697,0.665612461724198,1.0,6/24,6.49%,ADCY1;ADCY2;KSR1;RAPGEF2;PDE3A;PDE7B
prerank,inorganic anion transport (GO:0015698),-0.3560158635843272,-1.2807861493714796,0.09125475285171103,0.677144645153406,1.0,10/53,9.96%,SLC4A10;SLC26A7;CLIC4;ANO1;ANO4;CLIC5;GLRA1;CLIC1;SLC25A30;SLC26A6
prerank,positive regulation of phagocytosis (GO:0050766),0.45791489205825386,1.2805770786210904,0.15881561238223418,0.6654177468285982,1.0,8/47,4.49%,CAMK1D;AHSG;TULP1;GAS6;MYO18A;APOA1;APPL2;C4B
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5137597053432424,-1.279678026575551,0.170316301703163,0.6782480019318006,1.0,4/13,10.72%,NOS3;GCH1;CALM1;SPR
prerank,response to hexose (GO:0009746),0.500000070407457,1.2795986519481795,0.18662519440124417,0.6674884928762425,1.0,7/25,16.07%,TCF7L2;SLC30A8;NEUROD1;EIF2B4;SELENOS;EIF2B3;MAFA
prerank,extracellular matrix assembly (GO:0085029),0.5091705938053611,1.279542887769371,0.18322981366459629,0.6666302653148597,1.0,5/23,6.87%,MFAP4;FBLN5;GAS6;EMILIN1;LTBP3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.47804357764963534,-1.2795413084997291,0.18932038834951456,0.6761890569261366,1.0,4/16,7.65%,PRCP;KLK2;DDAH1;GSK3A
prerank,protein localization to cell-cell junction (GO:0150105),-0.4788809390882204,-1.2784643697394995,0.15656565656565657,0.6770625191703977,1.0,6/15,2.91%,MPP7;F11R;ACTB;TJP2;LSR;TJP1
prerank,limb development (GO:0060173),0.4971222297113386,1.2784451534684498,0.18181818181818182,0.6691133651007443,1.0,6/28,8.83%,SALL1;GLI3;MAP3K20;ZNRF3;SMOC1;KAT2B
prerank,excitatory postsynaptic potential (GO:0060079),-0.45930742316946005,-1.2784419836147178,0.17232375979112272,0.6746505142235315,1.0,5/19,7.65%,GRID2;MEF2C;GRIN2A;GRIN2B;GSK3A
prerank,positive regulation of hydrolase activity (GO:0051345),-0.30364667799161527,-1.278148421925657,0.08661417322834646,0.6731830591773046,1.0,32/137,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RAP1GDS1;BCAR3;NET1;SNX13;RGS6;TGM2;ARHGAP27;RPS3;ERBB2;EZH2;FNTA;CCL14;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;MAPK8;CALM1;MTMR9;RGS16;CALM3;AGRN;NF1;EVI5;CD40
prerank,negative regulation of macrophage activation (GO:0043031),0.5536793814878578,1.2781448573475958,0.21694915254237288,0.6690229697630435,1.0,7/16,17.52%,IL31RA;LDLR;NR1D1;CD200;SYT11;NR1H3;CX3CL1
prerank,protein ADP-ribosylation (GO:0006471),0.5029524691204565,1.2781263727416707,0.17304747320061256,0.6680406992193784,1.0,10/28,19.03%,ART4;PARP11;HPF1;PARP16;SIRT2;PARP14;TNKS2;ARF4;PARP12;SIRT5
prerank,positive regulation of translational initiation (GO:0045948),0.5433509886355637,1.2773962821387674,0.20195439739413681,0.6693464317016057,1.0,4/18,12.41%,POLR2D;CDC123;DDX3X;LARP1
prerank,acidic amino acid transport (GO:0015800),0.54678721504178,1.2772691979142925,0.18688524590163935,0.6686782999577164,1.0,3/17,3.80%,SLC1A3;GJA1;SLC6A13
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5817467155854009,1.2768424947214696,0.2065972222222222,0.6689065091991336,1.0,7/14,23.00%,AUTS2;KMT2E;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,negative regulation of wound healing (GO:0061045),0.5004100187626012,1.2767442900217412,0.1689497716894977,0.6681693075424602,1.0,6/28,5.86%,PHLDB2;SERPINE1;APOE;VTN;TFPI;CASK
prerank,synaptic vesicle transport (GO:0048489),-0.5305996186434608,-1.276719745090853,0.1721698113207547,0.6755595950310779,1.0,5/11,23.33%,RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,regulation of nervous system process (GO:0031644),0.5433116736569494,1.2764822943693912,0.2113323124042879,0.6679845649498719,1.0,2/18,1.31%,ROCK2;SLC8A3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.5068488924043244,-1.2751977545264535,0.18382352941176472,0.6781906799776121,1.0,8/13,16.79%,PTPRT;JAK2;MGAT5;HES1;CRLF2;PTPRC;PIGU;JAK3
prerank,negative regulation of response to wounding (GO:1903035),0.5405910111557355,1.2747565899864481,0.2012987012987013,0.6722947528264362,1.0,8/19,15.84%,SERPINE1;EPHA4;PTPRS;CASK;FGF2;MDK;CERS2;EPPK1
prerank,lipid translocation (GO:0034204),-0.4453415681199908,-1.2741987702156208,0.14447592067988668,0.6788660715728123,1.0,6/21,7.23%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;ATP11A
prerank,receptor signaling pathway via STAT (GO:0097696),0.5187156735871127,1.2741761342089741,0.2033898305084746,0.6730272263618672,1.0,7/25,13.57%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,L-glutamate transmembrane transport (GO:0015813),0.6004087449083806,1.27411326804667,0.21379310344827587,0.6721951428406255,1.0,1/10,0.18%,SLC1A3
prerank,positive regulation of protein localization to membrane (GO:1905477),0.40611923594450655,1.2739989525121715,0.11344019728729964,0.6715638863133184,1.0,14/98,9.32%,EPHA3;PDPK1;CEMIP;PIK3R1;LRP1;BCL2;ITGA3;PDCD5;MYO1C;PTPN9;EGFR;EPHB2;SLC5A3;PRKN
prerank,protein localization to plasma membrane (GO:0072659),-0.3025698881326026,-1.2737222287542087,0.05806451612903226,0.6779056456224284,1.0,27/129,8.24%,DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;ZDHHC2;CCDC88A;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4889499254899968,1.2735178907362876,0.1676470588235294,0.6719693104309058,1.0,1/33,0.01%,IGF1
prerank,inhibitory synapse assembly (GO:1904862),-0.5353342390746942,-1.272677177191015,0.17142857142857143,0.6787293908712592,1.0,4/11,8.12%,GABRA2;GABRB3;GABRG2;GABRB2
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4481685151194969,-1.2725658003075113,0.1620879120879121,0.6765912184343401,1.0,9/20,26.46%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;LY6G6D
prerank,skeletal system morphogenesis (GO:0048705),0.4614847875791169,1.2721456484438987,0.15439093484419264,0.6750668595668106,1.0,14/42,18.20%,CYP26B1;FBN2;FGFR1;FGFR2;PDGFRA;TGFBR1;SKI;DYNC2I1;SFRP4;HOXC4;SPEF2;ANKRD11;HHIP;SOX11
prerank,cGMP metabolic process (GO:0046068),-0.5204190177889676,-1.271644758492648,0.18137254901960784,0.676928739502426,1.0,5/12,8.35%,GUCY1B1;GUCY1A1;PDE2A;NPR1;PDE9A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4296405717445337,1.2714965276826868,0.14720812182741116,0.676042428658999,1.0,11/68,8.24%,ENPP1;MMAB;PCCA;NNMT;MTR;PCCB;MTHFR;PDXK;MMUT;CYB5A;ALDH1L1
prerank,ephrin receptor signaling pathway (GO:0048013),0.4128948726759109,1.2709235562375851,0.12285012285012285,0.676777924191582,1.0,13/82,9.03%,EPHA3;EPHA7;ROCK2;LYN;EPHA4;EPHA8;MMP2;EFNB2;CDC42;SRC;EFNA2;EPHB2;EFNB1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.49061620914053816,-1.2703590911368885,0.1748768472906404,0.6787766998156407,1.0,5/15,4.18%,TMSB4X;THBS1;NOTCH1;MET;FGF1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5397352418693339,-1.2698905913277156,0.18937644341801385,0.6779245319846255,1.0,4/10,11.17%,KDM1A;DISC1;VEGFA;CX3CR1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.552984825428567,1.2694112491441283,0.22019867549668873,0.6804367226510362,1.0,5/15,11.59%,GGACT;CHAC2;HOGA1;DPEP1;SARDH
prerank,peptidyl-amino acid modification (GO:0018193),0.6062495214451444,1.2692871650126578,0.22359154929577466,0.6798048575719443,1.0,3/10,6.62%,FKBP7;APOA1;TTLL4
prerank,cellular iron ion homeostasis (GO:0006879),0.43936171387747724,1.2692532207978826,0.14915693904020752,0.6788760324358484,1.0,7/55,6.50%,BMP6;CP;SCARA5;HEPH;CYBRD1;SLC11A2;ACO1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5110231352830694,-1.2691440184155527,0.16926503340757237,0.6780520092895639,1.0,5/11,10.23%,TBX1;LRP5;CTNNBIP1;TGFBR2;PDGFA
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3569866159710326,1.26911674771456,0.009018036072144289,0.6782928143277077,1.0,157/834,15.85%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FGFR2;THRB;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;RUNX2;MLXIP;RARB;NFIX;MEOX2;CRTC3;RLF;IRF1;RFX5;ACVR1;NEUROD1;NCOA2;KLF15;PHIP;RARG;BRD8;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;MED14;NR5A1;CEBPA;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;MED16;NR1D1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;BMP2;ZMIZ1;KAT2B;STAT5B;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;FGF2;ZSCAN21;NR1D2;DDX3X;CEBPB;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;GLI1;STAT6;ZNF513;RIPK2;MYCN;SMARCD2;NPAS2;HELZ2;NCOA3;KMT2A;CDK12;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;TCERG1;AKAP8L;GATA6;NR1H3;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;PIK3R2;POGZ;ZBTB17
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.43698577810172795,1.26878434236681,0.14884979702300405,0.6783072962073374,1.0,14/55,15.38%,PID1;PDGFRB;MT3;CYP1B1;AGTR1;SPHK2;SIRT2;PRKN;DCXR;EIF6;F2;NOXO1;ARF4;PIKFYVE
prerank,positive regulation of protein kinase activity (GO:0045860),0.3888596441119081,1.2684923337633405,0.09464082098061574,0.6781813653120666,1.0,35/148,14.45%,DDR2;NRK;NEDD9;EPHA4;IL6R;IL34;CCN1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;NAB2;SRC;PARP16;IL12B;MAP2K1;ALS2;STK4;MAP4K4;ITGB3;TELO2;STK11;TTBK1;MRNIP;TAOK3;DDX3X;ADRA2A;STRADA;DUSP19;INSR;NOX4;MARK2;DLG4;SNX9
prerank,anion transmembrane transport (GO:0098656),0.42881775691985546,1.2680770870526263,0.14786967418546365,0.6783970675957803,1.0,9/67,6.08%,SLC1A3;SLC7A2;SLC16A12;SLC13A3;SLC13A4;SLC6A9;SLC6A13;SFXN2;SLC35A3
prerank,regulation of microtubule-based process (GO:0032886),0.47340204346700515,1.2677043628160618,0.1627565982404692,0.6785999527661241,1.0,5/36,7.72%,EPHA3;PHLDB2;MACF1;PRKAA2;MEMO1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.36775319777308646,1.2676009441350728,0.04512820512820513,0.6778650749295687,1.0,46/348,8.91%,IGF1;NRP1;BMP6;IGF2;DDR2;CEMIP;ROCK2;ANGPT1;GHR;PDGFD;LYN;IL6R;LEPR;BMPR1A;IL34;PELI2;CCN1;INHBE;PRKAG2;GAS6;TGFBR1;VTN;CCL19;TWSG1;CSF1;RAPGEF2;MT3;ACVR1;NTF3;AXIN2;MUSK;SLCO3A1;ENG;SRC;LRRK2;ARAF;ALS2;NTRK3;STK4;DAB2;ARRB1;EGFR;CREBL2;RBPMS;BMP2;SPRY2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.45724008125595234,1.2675295292109854,0.17453505007153075,0.6770520167074834,1.0,13/39,13.63%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP
prerank,ventricular septum development (GO:0003281),0.4677157376019761,1.2674514433688273,0.1744186046511628,0.6762580469857453,1.0,6/37,4.67%,ROBO1;TGFBR3;SALL1;BMPR1A;TGFBR1;ACVR1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.585308613367302,1.2672237649451976,0.21180555555555555,0.674903682334964,1.0,2/12,7.80%,FHL2;RCAN1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.585308613367302,1.2672237649451976,0.21180555555555555,0.674903682334964,1.0,2/12,7.80%,FHL2;RCAN1
prerank,regulation of membrane depolarization (GO:0003254),-0.447204614103435,-1.2670362612606931,0.16201117318435754,0.6827206961161367,1.0,3/18,4.03%,FHL1;NEDD4L;CAMK2D
prerank,receptor clustering (GO:0043113),-0.39630557295275687,-1.2669108757949115,0.15835777126099707,0.680648386486329,1.0,11/27,18.89%,DLG2;NLGN1;NRXN1;LRRC7;ITGA4;PTN;SCRIB;AGRN;SYNJ2BP;DVL1;ITGB1BP1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4132879066404327,1.2666908598141944,0.1295843520782396,0.6756285647828775,1.0,19/87,15.81%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;SFRP1;ZFP36L1;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1;NR4A1;TIAL1;DSTYK;SPRED1;FIBP
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5429045964628432,1.265963247247555,0.19861830742659758,0.6758062543800403,1.0,4/16,6.31%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5429045964628432,1.265963247247555,0.19861830742659758,0.6758062543800403,1.0,4/16,6.31%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.48709724955169,-1.2659058919930137,0.20243902439024392,0.6814632349319992,1.0,5/14,11.74%,SEMA7A;PLCG2;CAMK4;GPRC5B;SIRT1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.44461888410809,1.2656773071040464,0.15654520917678813,0.6756440560868376,1.0,9/51,9.23%,GREM2;FBN1;BMPR1A;FSTL1;SMURF2;SKI;BMP2;LEMD3;SMAD1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3985492780228848,1.2655453535982293,0.12454212454212454,0.6750402308070033,1.0,25/105,15.04%,PTGIS;RORA;SERPINE1;EPHA4;APOE;APOA1;MVK;PTPRS;CDH5;CASK;MAPKBP1;SIRT2;NMI;NR1D1;DRD3;IRAK3;ITCH;FGF2;TNFAIP6;SELENOS;MUL1;PTEN;NR1H3;CERS2;TNFRSF1A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.49820604839510363,-1.2647009619758665,0.18138424821002386,0.6826254312652215,1.0,3/13,6.96%,SLC4A10;GRIK2;SYP
prerank,ribosomal small subunit assembly (GO:0000028),-0.48304154694735113,-1.2646133912460857,0.1658291457286432,0.6805035338145717,1.0,7/16,20.17%,RPS14;RPS19;RPS15;RPS5;RPSA;PRKDC;MRPS7
prerank,apical protein localization (GO:0045176),-0.5367269679577958,-1.2643466253838331,0.18040089086859687,0.6789751632617891,1.0,3/10,2.24%,ATP8B1;ACTB;MAL
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.41744832266868576,-1.263787908476133,0.1620879120879121,0.6782308624508917,1.0,6/25,7.65%,GRID2;MEF2C;GRIN2A;GLRA1;GRIN2B;GSK3A
prerank,regulation of cellular pH (GO:0030641),-0.4001803074500153,-1.2631215922615373,0.15015015015015015,0.6778635755501959,1.0,6/29,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,cholesterol efflux (GO:0033344),0.5215268474765326,1.2626556733782437,0.20352564102564102,0.6829589964037159,1.0,3/20,4.30%,ABCA1;APOE;APOA1
prerank,iron ion homeostasis (GO:0055072),0.4313152266895199,1.262168899278551,0.14490861618798956,0.6834533999675781,1.0,8/58,6.50%,BMP6;CP;SCARA5;HEPH;NEO1;CYBRD1;SLC11A2;ACO1
prerank,intestinal lipid absorption (GO:0098856),0.5782555119803798,1.2613783431901298,0.23783783783783785,0.684853511125077,1.0,2/11,5.80%,LDLR;LIMA1
prerank,muscle organ development (GO:0007517),0.4325056617525779,1.2613636124672196,0.17107093184979139,0.6838895793063582,1.0,13/54,14.36%,IGF1;LAMA2;ITGA11;VAMP5;LARGE1;MRAS;SMTN;CHD2;HBEGF;SGCE;COL6A3;CHODL;TCF12
prerank,fat cell differentiation (GO:0045444),0.4332276031963906,1.2610927462579236,0.16298342541436464,0.6837035513109219,1.0,8/57,8.89%,TCF7L2;PID1;OSBPL8;FAM120B;WNT5B;CEBPA;ALOXE3;CBY1
prerank,SNARE complex assembly (GO:0035493),-0.539119990677491,-1.2610276078912042,0.20608899297423888,0.681979219480729,1.0,2/10,6.64%,STXBP6;VAMP8
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6020207663827069,1.261022702520637,0.22791519434628976,0.682891195204881,1.0,4/10,7.89%,HECW2;ATP1A2;NEDD4;OSR1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5851597221651524,1.2607903045883544,0.21951219512195122,0.6826003755603375,1.0,3/11,11.60%,COLEC12;RFTN1;TNIP2
prerank,homeostasis of number of cells (GO:0048872),-0.5122655608521899,-1.2601792068644795,0.2111650485436893,0.68247102843002,1.0,5/12,14.21%,NOTCH1;NOS3;CCN3;CX3CR1;LPCAT3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.44450755946085535,1.2598409956920615,0.16690042075736325,0.6845646999151228,1.0,15/45,15.61%,PIK3R1;HNRNPLL;BUD23;MAP2K1;DXO;EGFR;RBM22;DIMT1;WDR43;NMD3;MYCN;TRMT112;BMP4;DYRK1A;SLC38A2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4832855804476803,-1.259298200490904,0.1932367149758454,0.683069860758886,1.0,6/14,16.55%,THBS1;ECSCR;ITGA4;CD40;GPER1;ANO6
prerank,T cell activation (GO:0042110),0.4268898560255454,1.258578086350094,0.15384615384615385,0.6874343387333158,1.0,14/69,14.21%,RHOH;KIF13B;LEPR;PPP3CA;KIT;CCL19;CD7;CD28;NHEJ1;GPR89A;GPR89B;IFNK;DDOST;MDK
prerank,negative regulation of hemostasis (GO:1900047),0.5783310635006307,1.2584270991040971,0.20833333333333334,0.6869018768973244,1.0,4/12,5.43%,SERPINE1;APOE;VTN;TFPI
prerank,cellular response to peptide (GO:1901653),0.4429004407359277,1.2580870022682509,0.1545827633378933,0.6869637829925597,1.0,8/56,7.76%,IGF1;GJA1;LRP1;EPHA4;CACNB1;ZFP36L1;SRC;TLR6
prerank,regulation of gene expression (GO:0010468),0.3528050703927258,1.257833294220656,0.009009009009009009,0.6867678167655773,1.0,175/903,15.64%,IGF1;NELL1;ROBO1;BMP6;CILP;NFIA;IGF2;RORA;SLC24A3;GJA1;RHOH;ROCK2;ANGPT1;PID1;SLC8A1;GDNF;ATXN1;GSN;SMAD3;ARNT2;RBMS3;AR;C1D;MITF;LYN;RUNX1;WWC2;AFF1;BMPR1A;OLFM1;NOS1AP;SON;NKX2-1;EPHX2;FGFR4;PRDM5;DTNBP1;WNT4;ASCL1;HNRNPLL;ZNF462;YAP1;NUP107;GAS6;APOE;TGFBR1;SMO;WNT6;NOTCH2;SLC2A10;TLE1;PDCD5;OGG1;CSF1;SLC22A2;ZC3H7B;MSC;MT3;IGF2BP2;ITGB8;NCOA2;SFRP1;CTSH;PRKAA2;DENND4A;MUSK;GNB3;SNRNP70;BCL6;CDH5;ENG;CUX2;ZFP36L1;TNRC6B;TCF7;ATOH8;APBB2;NAB2;PML;NR5A1;EMILIN1;IL12B;CEBPA;NFE2L2;CD28;WWTR1;SAP30;REXO4;AFDN;ZBTB38;EIF2AK3;MAP2K1;TLR6;OSR1;WTIP;RBPJ;NTRK3;AFF3;TULP3;TCF7L1;TNRC6A;EPHB2;CREBL2;BMP2;ZBTB4;SPRY2;CCN4;PICALM;NONO;SNX12;MZF1;SMAD1;PRKN;GTF2IRD1;MYADM;NSD1;PARP14;FGF2;ACTR8;ZSCAN21;PHF1;RNF6;TTBK1;NR1D2;RBL2;BRAF;TCEAL1;DDX3X;CEBPB;IFNK;RGCC;DNAJA4;REST;C1QTNF1;TERF2;LRP3;LARP1;HMGN5;INSR;ZNF513;ACVR1B;TRIP4;CCDC3;TMEM119;MYCN;EGF;TAF5L;GLMN;HDAC4;PDCL3;ETS1;ZNF148;SETDB1;ZNF219;HPN;YAF2;TADA3;CLK4;AFF4;BMP4;SFRP4;ERMAP;FUBP3;SUFU;MYCBP;FOXK2;METTL4;CLK3;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;SLC38A2;MYT1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5791965825362165,1.2578066829848737,0.20701754385964913,0.6858445760385674,1.0,6/13,18.64%,APOE;DKK3;BMP2;REST;BMP5;ERLIN1
prerank,smoothened signaling pathway (GO:0007224),0.4741473458600036,1.2575832222357266,0.19096209912536444,0.6855450851782162,1.0,8/32,12.49%,GLI2;GLI3;SMO;B9D1;IFT27;EVC2;PTCH2;GLI1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.511650140994446,1.257438061490132,0.2199367088607595,0.684995752107581,1.0,5/22,11.76%,ZBTB20;APOE;APOA1;CREBL2;F2
prerank,protein deacetylation (GO:0006476),0.45369168927128134,1.2573904419624486,0.1790633608815427,0.684159595539936,1.0,10/41,14.90%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC4;FLNA;SUDS3
prerank,proteolysis (GO:0006508),0.36764377632203815,1.25715798218155,0.09381663113006397,0.6838989182898164,1.0,49/252,18.26%,CPXM2;ADAMTS12;TRABD2B;ADAM33;ADGRV1;CPQ;OGT;AEBP1;MMP2;MMP19;VASH2;ENDOU;CPXM1;CTSH;CTSF;MMEL1;ADAMTS9;SPRTN;PRSS48;CLPX;EEF1AKMT4-ECE2;ECE2;APEH;ATG4A;HTRA1;LONP2;CAPN7;CLPP;APH1B;CASP7;RSPRY1;CPA2;CLN3;CTSZ;CTSL;SENP6;HPN;THOP1;SUFU;DPP3;CUL7;LONP1;PSEN2;UBE3A;PSMB5;MMP14;ST14;YME1L1;CASP1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5381688550299806,1.2571371604576178,0.20621931260229132,0.6829762444335429,1.0,4/18,8.69%,ADCY1;CAMK1D;CRTC3;CD200
prerank,negative regulation of cell division (GO:0051782),0.582361975347747,1.2571173050406026,0.22202797202797203,0.6820460218778345,1.0,1/11,1.01%,TXNIP
prerank,heart trabecula morphogenesis (GO:0061384),0.5370541708140895,1.2568105165878407,0.218213058419244,0.6820573357813956,1.0,6/18,8.13%,RBP4;TGFBR3;BMPR1A;TGFBR1;ENG;RBPJ
prerank,regulation of DNA binding (GO:0051101),0.45507067820582264,1.2557206813836366,0.16951566951566951,0.6843942392969794,1.0,7/44,9.32%,IGF1;SP100;MDFI;SMO;SKI;SIRT2;PRKN
prerank,positive regulation of cell aging (GO:0090343),-0.5317888980248245,-1.2556961771783384,0.18058690744920994,0.6921698895326026,1.0,5/11,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,small GTPase mediated signal transduction (GO:0007264),0.40050294695933264,1.2556020252973978,0.14081145584725538,0.6837707839151939,1.0,17/103,9.06%,IGF1;RIN2;KSR1;PLD1;CCNA2;ARHGAP18;TIAM2;RRAS2;RAPGEF2;MRAS;ARHGAP32;ARHGEF18;PLD2;RGL1;NTN1;RUNDC3A;ARFIP2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46875909715520603,1.2548063885051688,0.1990811638591118,0.6852274873956531,1.0,4/38,7.68%,BMP6;SASH1;DDX60;NMI
prerank,response to UV-B (GO:0010224),0.5790262396105462,1.254319854824805,0.2097053726169844,0.6857450831095144,1.0,3/12,9.86%,MFAP4;IL12B;STK11
prerank,regulation of cell morphogenesis (GO:0022604),0.4925993082745429,1.2542791684165848,0.18825301204819278,0.6849084763054745,1.0,8/30,10.41%,SH3D19;SPARC;MACF1;PHIP;PDPN;WTIP;CAPZB;PDZD8
prerank,regulation of angiogenesis (GO:0045765),0.3784924135113966,1.2541430524975978,0.09922822491730982,0.6843628852237014,1.0,28/192,6.63%,PDPK1;PTGIS;COL4A3;ROCK2;SPARC;GLUL;SASH1;DCN;SERPINE1;HSPG2;RUNX1;SP100;VASH2;ISM1;THBS2;SEMA5A;STIM1;SULF1;ITGB8;SFRP1;CTSH;SMOC2;CYP1B1;CDH5;SERPINF1;ADGRA2;PML;EMILIN1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5143169335087939,1.2539561474612388,0.20933734939759036,0.683978809339885,1.0,5/21,10.19%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5551348223315532,1.253796914054406,0.22711267605633803,0.6834864559260497,1.0,5/15,8.05%,UST;DCN;BGN;DSE;CSPG5
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.40743377047808704,1.2536385455459764,0.1515527950310559,0.682971069919075,1.0,19/86,10.51%,BMP6;ZEB2;BMPR1A;CCN1;INHBE;TGFBR1;SLC2A10;TWSG1;SULF1;ACVR1;CDH5;ENG;CRB2;RBPJ;DAB2;RBPMS;BMP2;STK11;BMP15
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33991871219605196,-1.2532051639806077,0.11538461538461539,0.6976059689167495,1.0,23/57,21.54%,RPS24;RPS19;RPL7;RIOK1;RPL35A;RPL38;RPS15;RPS7;PAK1IP1;RPL11;METTL17;RPL26;MALSU1;NVL;RPL14;RPL5;RPS6;RRP36;NPM1;NOP16;URB2;RRS1;RPF2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.324545280350453,-1.2530134653451215,0.11818181818181818,0.695855706933701,1.0,24/75,18.55%,MEF2C;MAP2;ACTB;ANK3;NRCAM;KLF7;CNTN4;NTNG1;BTBD3;OPHN1;CDK5;DCDC2;MFSD2A;NEFH;DCC;APBB1;LMTK2;APP;MAP1B;RAB3A;SHTN1;UNK;DVL1;BRSK2
prerank,positive regulation of receptor internalization (GO:0002092),0.5147229914085413,1.2521259492093535,0.2218798151001541,0.6865511549505535,1.0,8/22,18.14%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;SFRP4;AHI1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.44560977598068835,1.2518795735911545,0.18044077134986225,0.6863223489925845,1.0,12/48,14.80%,ROBO1;DCST1;GAS6;RFFL;APOA1;IRAK3;STAT2;PARP14;SLIT3;MUL1;CCDC3;NR1H3
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.46876439463194886,1.251620517761836,0.18567251461988304,0.6860856037933912,1.0,4/35,3.78%,NRP1;PLXNA2;SEMA3D;SEMA5A
prerank,regulation of response to interferon-gamma (GO:0060330),-0.4744794963621795,-1.251044197784801,0.18203309692671396,0.6996913444842187,1.0,4/14,14.62%,PTPN2;HSP90AB1;JAK2;CDC37
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.38387746235138487,1.2505826185441298,0.1172566371681416,0.6883801308464012,1.0,36/166,15.03%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;POLR1G;RARG;GTF2E1;BRF1;GTF3C1;GTF2H5;NR5A1;WWTR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;TFAM;NR1D2;NCOR2;POLRMT;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,pinocytosis (GO:0006907),0.5928183485423223,1.2495959873894402,0.23603603603603604,0.6904798436211501,1.0,3/10,7.55%,AHSG;SNX33;CARMIL1
prerank,aortic valve morphogenesis (GO:0003180),0.4821001733836785,1.2494093573428082,0.19850746268656716,0.6900259408586917,1.0,3/30,0.85%,ROBO1;ROCK2;ELN
prerank,response to progesterone (GO:0032570),-0.44430423434564575,-1.2493857684625769,0.18421052631578946,0.7026492021197847,1.0,4/18,3.96%,CAV1;THBS1;ABHD2;TGFB2
prerank,regulation of lymphocyte migration (GO:2000401),-0.5274500886100957,-1.2490686710854462,0.2219730941704036,0.7013519993539177,1.0,3/10,10.46%,JAM2;STK10;MSN
prerank,positive regulation of lipid transport (GO:0032370),0.5581305780637353,1.2487071805547623,0.2459546925566343,0.6912366738735292,1.0,2/12,3.47%,LRP1;APOE
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4157333502631031,1.2484244499591903,0.1673052362707535,0.6910842128896142,1.0,13/72,8.59%,NRP1;ROBO1;ABCA1;DLC1;KANK1;ITGA3;RIPOR2;APOE;APOA1;ARHGEF18;LPAR1;ARHGAP35;ARRB1
prerank,transcription by RNA polymerase II (GO:0006366),0.36326913905107144,1.2484081355698577,0.0741901776384535,0.6901546183003598,1.0,92/305,21.90%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;SOX5;GLIS3;PRRX1;MAF;THRB;YAP1;MAML3;HSF2BP;RARB;NOTCH2;NFIX;PHAX;RARG;MLLT3;GTF2E1;GTF2H5;NR5A1;WWTR1;PMF1;SNAPC1;MED16;NR1D1;RBPJ;NCOR1;KAT2B;TRIP11;ZBTB1;CCNK;POLR2C;RPAP2;WDR33;NR1D2;MBD1;NCOR2;INTS4;NKX2-8;TTF2;NR4A1;MNAT1;PAF1;TEAD3;TAF5L;GTF2E2;CDK12;TAF9;NELFE;ELL2;ADRM1;NRBF2;SNAPC5;AFF4;SNAPC4;PCF11;NR1H3;RXRA;TFCP2;COPS2;TFDP1;SP1;GTF2I;TSC22D1;ELOF1;CCNT2;LSM10;CPSF2;CDC73;POLR2L;FIP1L1;TAF2;PAX1;MAML2;GTF2A1;ELP4;DEAF1;NFE2L3;LEO1;TAF8;MLLT1;IRF9;SCAF8;NOCT;ERCC3;MED23;CCNT1;PAPOLA;RPAP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3979435651620988,-1.2481916848839012,0.15568862275449102,0.701778663945571,1.0,11/31,15.04%,PPP1R13B;YWHAH;YWHAQ;HIP1R;GSK3A;MAPK8;CASP8;YWHAG;BBC3;BAK1;ZNF205
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4192150591566378,-1.248155868449158,0.1676829268292683,0.6994999551119082,1.0,7/24,13.91%,PDE4D;CAMK2D;NOS1;AKAP6;CALM1;CALM3;CASQ2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.49068766783587625,-1.2478942934656556,0.21588089330024815,0.6980866785184471,1.0,7/13,13.91%,PDE4D;CAV1;ANK3;CAMK2D;CALM1;CALM3;CASQ2
prerank,RNA modification (GO:0009451),0.4347908155340218,1.2477723912118368,0.1783783783783784,0.6911574715246604,1.0,17/54,19.91%,PUS3;ADAT2;NSUN2;FTSJ3;PARN;BCDIN3D;TRMT9B;URM1;NSUN5;NSUN4;ELP5;DTWD1;ALKBH1;METTL3;ANKRD16;TRUB1;METTL1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5144569730787086,1.247414951551702,0.20065789473684212,0.6912745991127464,1.0,9/20,14.89%,TGFBR3;OLFM1;TGFBR1;TBX3;ENG;RBPJ;BMP2;PDCD4;BMP4
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5317661206254278,-1.247270266903037,0.20919540229885059,0.6978730563409494,1.0,3/10,9.89%,PRKCH;MED1;TRIM16
prerank,GPI anchor biosynthetic process (GO:0006506),-0.39249133660778074,-1.2468211797250852,0.1642651296829971,0.6969935424158353,1.0,10/30,18.79%,DPM1;PIGP;PGAP2;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5801452564948345,1.2466541690871948,0.21541155866900175,0.6927421988079279,1.0,7/11,29.34%,PARP11;PARP16;PARP14;PARP12;PARP10;PARP9;PARP6
prerank,engulfment of apoptotic cell (GO:0043652),0.548242689831834,1.2466030419379392,0.2252836304700162,0.6919297649720514,1.0,3/15,6.75%,RHOH;RHOBTB1;RHOBTB2
prerank,leukocyte tethering or rolling (GO:0050901),-0.45989228521722664,-1.2454386698882354,0.17344173441734417,0.6991947355769973,1.0,7/17,24.57%,JAM2;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.38378151703693986,-1.2447211217269196,0.17971014492753623,0.6992517885916651,1.0,10/32,21.81%,PPP1R13B;HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;FHIT;DDX5;MSH2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4407967025071901,-1.2434799220975716,0.18527918781725888,0.7007576328429096,1.0,7/19,21.81%,HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;MSH2
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.35345204855301054,1.2434597993987204,0.03939393939393939,0.7006573767431775,1.0,109/572,15.03%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;YAP1;DNMT3A;JDP2;RARB;NFIX;MXI1;NEDD4;SMURF2;ZHX2;RARG;ETV6;TBX3;BCL6;CUX2;SKI;BCOR;CPEB3;MBD2;SAP30;SIRT2;DR1;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;MTA3;BMP2;JAZF1;ZBTB4;BRMS1L;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;IFI27;ZKSCAN3;CXXC5;NR1D2;NCOR2;ZNF177;CEBPB;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;TCF25;PHF21A;PEX2;PAF1;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA
prerank,purine-containing compound catabolic process (GO:0072523),-0.4913604610515827,-1.2426786200609665,0.18604651162790697,0.7012132639327731,1.0,7/13,18.50%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,multivesicular body assembly (GO:0036258),-0.39406556373782115,-1.2422212704980615,0.134185303514377,0.7003054821894342,1.0,16/30,31.51%,RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4059835462382653,1.2420640598011463,0.15201005025125627,0.7039040807369134,1.0,15/80,12.17%,EPHA7;UACA;DAPK1;SH3RF1;GAS6;PDCD5;MT3;USP47;SRC;DPEP1;BCAP31;CARD9;DDX3X;REST;YWHAE
prerank,positive regulation of B cell proliferation (GO:0030890),-0.39380854291429035,-1.2420030136814457,0.1712538226299694,0.6987619317585729,1.0,10/29,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;CD40;CD81;GPR183;PTPRC;CD320
prerank,DNA biosynthetic process (GO:0071897),-0.4539437350869143,-1.241850290539706,0.178117048346056,0.6969448112979476,1.0,9/16,31.18%,PPIA;POLH;SIRT1;TYMS;POLD4;WRNIP1;POLA1;POLD2;TERT
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5141022460700758,1.2418358372479907,0.1921182266009852,0.7036233317524972,1.0,6/20,15.26%,TGFBR1;EPAS1;ZMIZ1;PRKN;ITCH;DCUN1D2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4693252230248155,1.2416563591783591,0.2145985401459854,0.7031918165538429,1.0,3/32,5.72%,PDPK1;CEMIP;GSTM2
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3625013611282098,-1.2415636619336017,0.1232876712328767,0.6956575984105341,1.0,11/46,14.60%,PIEZO2;F11R;PIEZO1;CRADD;MAP3K1;PDE2A;MAPK8;CASP8;CD40;MAPK3;BAK1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.4447524940897783,1.2413943582419682,0.1917241379310345,0.7030137188814382,1.0,12/45,11.26%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5256757620437166,1.241171382996956,0.2303839732888147,0.7027367623112841,1.0,9/18,24.16%,PIK3R1;RNF185;BCL2L11;TMEM259;RNFT1;DDIT3;BAG6;ATXN3;PMAIP1
prerank,RNA metabolic process (GO:0016070),0.3855848211762945,1.2410437328117034,0.1352601156069364,0.702153146578888,1.0,41/127,22.41%,POLR2D;CELF2;RBMS1;ATXN1;RBFOX2;SND1;DDX17;RBMS2;HNRNPR;RBPMS;METTL14;HNRNPA1;POLR2C;RNASEL;PARN;DDX3X;WTAP;EXOSC7;MTREX;RBM39;RBM5;RBM6;RNASEH2C;LSM8;SYNCRIP;HNRNPC;PAPOLG;ALKBH1;METTL3;POLR2L;DICER1;FTO;HNRNPU;AGO4;HNRNPH1;DDX24;PAPOLA;RBM4;SIDT2;DROSHA;NCBP2
prerank,presynaptic endocytosis (GO:0140238),-0.42757886765530073,-1.2409447625712087,0.2155688622754491,0.6953835257652996,1.0,11/24,24.83%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;STX1A;SYNJ1;SYT5;SNCG
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4320335174033043,-1.2408084498410001,0.20855614973262032,0.6935229371259855,1.0,6/21,15.93%,PRKCH;SLC39A10;RPS3;FOXP1;CD81;PTPRC
prerank,regulation of cell adhesion (GO:0030155),0.381112042307921,1.2402274121879548,0.12967289719626168,0.7037689775970758,1.0,30/129,14.30%,PLXNA2;EPHA7;ROCK2;ANGPT1;LYN;RHOD;TPM1;EPHA4;EPHA8;PPP3CA;RIPOR2;SEMA5A;FBLN1;NUAK1;SRC;IL12B;DSCAM;EPHB2;RSU1;MYADM;ITGAV;MIA3;EPHB3;PLXNC1;SIPA1;DACT2;P4HB;PLXNA1;MDK;PLXNB2
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5924569050549852,1.239298734922242,0.2517482517482518,0.7056911214640674,1.0,2/10,4.33%,ZEB2;RAPGEF2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.48819627195987925,-1.2392740617767761,0.20493827160493827,0.696028810752817,1.0,8/15,19.53%,GRM7;GRM3;GRM5;GRM8;HOMER1;HOMER3;GRM1;DAGLB
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5268383804542632,-1.2392452371715672,0.21585903083700442,0.6939082741100027,1.0,3/10,10.26%,PODXL;PIEZO1;SKAP1
prerank,cellular amino acid catabolic process (GO:0009063),0.40648268759791745,1.2387238683060506,0.16523867809057527,0.7065392208122686,1.0,14/87,8.29%,GLUL;IVD;ABAT;HMGCLL1;BCKDHB;PHYKPL;TDO2;DDO;HOGA1;ASPA;HNMT;KYNU;DBT;ALDH7A1
prerank,protein destabilization (GO:0031648),0.4629939669501554,1.2383562927579386,0.1915204678362573,0.7066943071839216,1.0,10/32,13.02%,GSN;CTSH;DERL1;FBXL3;NR1D1;RNF139;PRKN;BTRC;PEX2;MUL1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.42009492528324965,1.2382215875275715,0.17757009345794392,0.7061536773495217,1.0,25/62,23.91%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3913380316411252,-1.2379216326842408,0.18991097922848665,0.6958005165582546,1.0,14/26,19.52%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;MTMR2;RIMS2;TMEM108;SHANK1;PRKCZ;APP;NLGN3;TMEM25;GRIN1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3531425508756034,1.2375295485211173,0.047715736040609136,0.7073081068595615,1.0,102/476,16.78%,IGF1;TCF4;COL1A1;RORA;TBL1XR1;TEAD1;SMAD3;ARNT2;AR;MITF;IL31RA;NR2F2;GLI2;RUNX1;SALL1;ZIC1;GLI3;NKX2-1;FZD2;SP100;WNT4;NFIB;YAP1;APOE;RUNX2;TGFBR1;LBH;RLF;IRF1;ZIC2;MT3;ACVR1;NEUROD1;CREB3L2;FZD1;PHIP;MLLT3;SFRP1;ARID1B;ATXN7L3;ATOH8;SMARCA1;PML;MED14;ING5;RNF10;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;FOXC2;EGFR;ARHGEF11;CREBL2;BMP2;ZMIZ1;PICALM;BICRAL;GLIS2;NSD1;ZKSCAN3;FGF2;TFAM;RNF6;NR1D2;CEBPB;NFE2;REST;NIBAN2;GLI1;HMGN5;BTRC;ZNF318;TRIP4;MYCN;NPAS2;EGF;KMT2E;KMT2A;HDAC4;ETS1;YAF2;TADA3;GATA6;NR1H3;PHF8;BMP4;FUBP3;RXRA;FOXK2;CDKN1C;DYRK1A;DYRK1B;AKT1;CREB5;ZNF423;PCBD2;RHOG;ATF5;SHH;SP1
prerank,regulation of potassium ion transport (GO:0043266),-0.38806418103722506,-1.2375186647588128,0.1744186046511628,0.6948525345334189,1.0,8/31,6.37%,DPP10;FHL1;KCNIP4;PTK2B;ANK3;KCNAB1;KCNN2;NOS1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.5037934066529891,-1.2374471955808437,0.21749408983451538,0.6928878366594735,1.0,5/13,21.43%,PRR5L;GTPBP1;PNPT1;CNOT7;CNOT8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5664901242668193,1.237226583606194,0.2491349480968858,0.7072317607194611,1.0,3/12,10.90%,AKR1B1;STAR;TSPO
prerank,negative regulation of RNA splicing (GO:0033119),-0.448004744671966,-1.2367421011137527,0.18803418803418803,0.6929897644562735,1.0,11/19,30.81%,RPS13;PTBP2;PTBP3;SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,regulation of endocytic recycling (GO:2001135),0.5796637968278713,1.2363345977246818,0.23859649122807017,0.7090491369296062,1.0,2/11,3.62%,ACTN2;ATP9A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3388266363235353,-1.2361510775003477,0.11155378486055777,0.6926546305556919,1.0,21/57,22.69%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;DLGAP2;LRRC7;GRIN2B;GRIA2;SHANK1;LYNX1;APP;GSG1L;CACNG3;CACNG4;GRIN1;SHISA9;BEGAIN;MINK1;RELN
prerank,regulation of lipid metabolic process (GO:0019216),0.40190350262406854,1.2360746390499517,0.16296296296296298,0.7088395036588302,1.0,27/88,20.05%,RORA;TBL1XR1;FGFR4;PRKAG2;C1QTNF2;CHD9;NCOA2;MVK;GNB3;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;CCDC3;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;CARM1;NCOA6;SCD;ABCA7;PSAP
prerank,blood circulation (GO:0008015),0.43612611681148983,1.235640636892935,0.16823687752355315,0.709301705131697,1.0,7/49,6.90%,COL4A3;ROCK2;ELN;SERPING1;MEOX2;BDKRB2;AGTR1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3977210454522503,-1.2349288217883618,0.17699115044247787,0.6945090548740114,1.0,8/29,11.81%,DPP10;KCNIP4;KCNAB1;KCNN2;FGF12;ATP2B4;HOMER1;DPP6
prerank,regulation of cellular response to heat (GO:1900034),-0.316960644130892,-1.2348335722387414,0.11627906976744186,0.6926366328631763,1.0,30/77,25.02%,CD34;NUP93;HSPA8;NUP35;CAMK2D;NUP153;NUP160;HSP90AB1;NUP54;BAG4;CAMK2G;SIRT1;MTOR;DNAJB6;MAPK3;SEC13;NUP155;EP300;HIKESHI;RANBP2;NUP88;HSPH1;NUP62;AKT1S1;GSK3B;NUP85;MAPK1;DNAJB1;CCAR2;NUP43
prerank,sensory perception of light stimulus (GO:0050953),0.4059702134747443,1.2341981056829645,0.16625,0.7128859140689551,1.0,8/87,4.52%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,lipoprotein localization (GO:0044872),0.5707488358719026,1.2339245124284524,0.2517482517482518,0.7127379102151323,1.0,2/11,9.69%,LRP1;MIA3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5257231128889699,1.2338860267354341,0.23247863247863249,0.7118956893619145,1.0,2/17,6.87%,GJA1;LTBP3
prerank,steroid catabolic process (GO:0006706),-0.5215191040166934,-1.2333820902415795,0.2164009111617312,0.6950359138959828,1.0,5/10,28.48%,YWHAH;SPP1;HSD11B1;HSD17B11;HSD17B14
prerank,cellular response to insulin stimulus (GO:0032869),0.3859483385763184,1.2332371983205705,0.15940366972477063,0.7130038044858679,1.0,14/124,8.83%,ATP6V0A4;PDPK1;IGF2;ENPP1;TBC1D4;PIK3R1;INSIG2;PHIP;CPEB1;ZFP36L1;TRARG1;FOXC2;ZNF106;KAT2B
prerank,T cell migration (GO:0072678),-0.4838079071765252,-1.2326179083850437,0.2169811320754717,0.695229079169979,1.0,4/13,14.25%,SLC12A2;S1PR1;MSN;GPR183
prerank,epithelial tube morphogenesis (GO:0060562),-0.3811626596945536,-1.2324141719597508,0.17834394904458598,0.6937774213623068,1.0,13/32,13.99%,SLIT2;PODXL;MEF2C;ACVRL1;MET;SOX17;RASIP1;PAK1;RHOB;SCRIB;HES1;PRKX;RYR2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5706666924159872,1.2320104315340286,0.226890756302521,0.7158695266832862,1.0,2/12,2.59%,CCDC68;NINL
prerank,triglyceride homeostasis (GO:0070328),0.4885235633677656,1.231917769783602,0.20625,0.7151727803936624,1.0,3/26,4.30%,RORA;APOE;APOA1
prerank,positive regulation of chemotaxis (GO:0050921),0.44797171078461423,1.2318431719962557,0.1934156378600823,0.7144014518156566,1.0,9/43,10.16%,NRP1;IL6R;PDGFRB;SEMA5A;CCL19;SMOC2;NTRK3;DSCAM;FGF2
prerank,response to muscle stretch (GO:0035994),0.5329017770092909,1.2310167522095716,0.23170731707317074,0.7159392838881457,1.0,2/15,1.20%,SLC8A1;GSN
prerank,regulation of histone methylation (GO:0031060),0.5723488921956809,1.230852435587705,0.24787775891341257,0.71552848531092,1.0,5/13,12.72%,NNMT;MTHFR;TET1;NSD1;PAF1
prerank,cellular response to metal ion (GO:0071248),-0.3002868855285589,-1.2307273770018863,0.060810810810810814,0.6971066299074197,1.0,22/123,4.62%,DLG2;SLC12A2;MEF2C;CPNE8;CLIC4;NLGN1;CDH1;ANK3;PLCG2;B2M;IQGAP1;CAMK2D;CPNE3;GLRA1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,negative regulation of ossification (GO:0030279),0.5018005299392746,1.2307230468663057,0.23137876386687797,0.714974643902473,1.0,6/23,9.41%,ENPP1;AHSG;SFRP1;BCOR;RBPJ;TRPM4
prerank,phospholipid catabolic process (GO:0009395),-0.41922798782221715,-1.2307212638824843,0.19825072886297376,0.694983197886582,1.0,9/24,26.89%,GPCPD1;ENPP2;PLA2G4C;SMPDL3A;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;PLA2G4B
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4949351044412832,1.2301159230926397,0.2234375,0.7158495891628016,1.0,4/26,3.68%,GDNF;NOS1AP;APOE;NPR3
prerank,positive regulation of vasculature development (GO:1904018),0.3946743600389595,1.2298538283501013,0.16967509025270758,0.715683324497786,1.0,13/94,5.68%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,lipoprotein transport (GO:0042953),0.5835873793334951,1.2294695892504093,0.25087719298245614,0.7159427893141939,1.0,2/10,9.69%,LRP1;MIA3
prerank,positive regulation of cellular process (GO:0048522),0.34657047864799806,1.2291632922600422,0.03535353535353535,0.7159391564558973,1.0,70/565,8.16%,IGF1;BMP6;IGF2;ESM1;CCN2;CAMK1D;GDNF;COLEC12;PDGFD;AREG;AR;LRP1;AHSG;TGFA;IL31RA;LYN;BCL2;GRK5;RHOD;TPM1;FGFR1;EPHA4;IL6R;IL34;OSMR;TULP1;PPP3CA;EPGN;FGFR2;FGFR4;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;NUPR1;CSF1;APOA1;MT3;NEUROD4;NTF3;NEUROD1;HTR1A;AXIN2;PHIP;SFRP1;CTSH;SLC30A2;PRKAA2;PDPN;CXCL16;TBX3;VIP;DYNC1H1;USP47;ZFP36L1;CDC42;INO80;SMC5;IL12B;TSLP;WWTR1;RNF10;RAB25;IL13RA1;SIRT2;IL15RA;PPP1R13L;TET1;NTRK3
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5009978927186387,-1.2289221661327092,0.21678321678321677,0.6986783756475425,1.0,4/12,26.01%,JAM2;APP;AIF1;DOCK8
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.530860709513044,1.227938015987472,0.25162337662337664,0.7186871104873122,1.0,5/17,11.33%,SLC8A1;ATP1A2;CACNA1C;TRPM4;CACNA1G
prerank,regulation of chemotaxis (GO:0050920),0.47665713471207116,1.2278984491086933,0.21100917431192662,0.7178555939858533,1.0,7/30,9.24%,MYCBP2;PDGFRA;EFNB2;PDGFRB;CCL19;ADGRA2;ZSWIM6
prerank,histone H3-K36 demethylation (GO:0070544),0.5859367568230429,1.2269908892143218,0.2333931777378815,0.7196317858959728,1.0,5/10,21.12%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,ventricular septum morphogenesis (GO:0060412),0.48058053793581185,1.2268235213780494,0.21319018404907975,0.7191012514140509,1.0,5/27,4.67%,ROBO1;TGFBR3;BMPR1A;TGFBR1;ACVR1
prerank,neuron projection fasciculation (GO:0106030),0.5892575956939764,1.2262413858591272,0.23563218390804597,0.719849918960434,1.0,5/10,11.55%,EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5470162703506862,1.2260711205436678,0.2372322899505766,0.7193875936066648,1.0,5/14,5.12%,LRP1;SERPINE1;TPM1;BMPR1A;IGFBP5
prerank,meiosis I (GO:0007127),0.4976039391112098,1.2257008040524433,0.2278688524590164,0.7196152915292259,1.0,8/23,17.51%,HSF2BP;BCL2L11;ZSCAN21;SYCP3;SGO1;MYBL1;FOXJ3;DDX4
prerank,positive regulation of biosynthetic process (GO:0009891),0.4474519623002846,1.2256081105692453,0.20373027259684362,0.7190005921723792,1.0,13/40,16.32%,ZBTB20;RUNX1;WNT4;APOE;APOA1;TLR6;CREBL2;SLC5A3;RGCC;F2;MTPN;BMP4;AKT1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3728235232412212,-1.2254984979656665,0.18095238095238095,0.7073820620434151,1.0,13/39,16.19%,EFNA5;ACER2;THBS1;NOTCH1;SPOCK1;ADAM15;FZD4;MYOC;NEXMIF;SPRY4;HOXA7;CORO1C;RASA1
prerank,neuron development (GO:0048666),-0.2926505912492166,-1.2251285983557845,0.07575757575757576,0.706439295152502,1.0,33/141,9.28%,FRY;CNTNAP2;MEF2C;GPM6A;MAP2;PBX3;NLGN1;PPP1R9A;TENM2;ETV1;TENM3;GPM6B;PPT1;TENM4;STX3;TGFB2;SH3GL2;MYT1L;CNTN4;B4GALT5;MYOC;OPHN1;VSX1;CDK5;EPHA5;TMEM108;RP1;RAB11A;RASGRF1;ULK1;ALK;ARL3;BTG2
prerank,cellular response to hexose stimulus (GO:0071331),0.4936394862397363,1.224979986114341,0.24613003095975233,0.7198430093554451,1.0,3/23,5.19%,ZBTB20;GAS6;PRKAA2
prerank,negative regulation of hormone secretion (GO:0046888),0.5774150985757913,1.2248884870318633,0.25133689839572193,0.7192296297362631,1.0,1/10,0.60%,GJA1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.5050171257152485,-1.2241786436456477,0.22877358490566038,0.7072192446843013,1.0,7/11,27.59%,HIRA;H3-3A;CABIN1;NASP;ASF1A;HAT1;ASF1B
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4955344106298511,-1.223404391793029,0.2222222222222222,0.707373874928819,1.0,5/12,14.09%,CAV1;CTNNA3;JUP;RYR2;DSG2
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.45538920434234575,-1.2223338263709775,0.23645320197044334,0.708518726314429,1.0,9/16,29.91%,PPT1;ACSS1;HSD17B8;DIP2A;PPT2;ACACA;SCD5;CBR4;MLYCD
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3430494097495747,1.2222997264512472,0.007,0.7261761168977261,1.0,235/1082,18.30%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;COL1A1;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;IL31RA;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;ZIC1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FZD2;FGFR2;THRB;SP100;WNT4;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;APOE;RUNX2;TGFBR1;MLXIP;RARB;LBH;NFIX;MEOX2;CRTC3;RLF;IRF1;ZIC2;MT3;RFX5;ACVR1;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;RARG;MLLT3;SFRP1;ARID1B;BRD8;ATXN7L3;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;PML;MED14;NR5A1;CEBPA;ING5;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;EIF2AK3;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;ARHGEF11;CREBL2;BMP2;ZMIZ1;KAT2B;STAT5B;PICALM;BICRAL;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;NSD1;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;ZKSCAN3;FGF2;ZSCAN21;TFAM;RNF6;NR1D2;DDX3X;CEBPB;NFE2;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;WDR43;NIBAN2;GLI1;HMGN5;STAT6;ZNF513;BTRC;RIPK2;ZNF318;TRIP4;MYCN;SMARCD2;NPAS2;EGF;KMT2E;HELZ2;NCOA3;KMT2A;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;YAF2;TCERG1;TADA3;AKAP8L;GATA6;NR1H3;PHF8;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;CDKN1C;DYRK1A;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;DYRK1B;PIK3R2;POGZ;ZBTB17;NCOA7;AKT1;CREB5;PLAG1;ZNF423;PCBD2;RHOG;ATF5;SHH;TFDP1;SP1;LIF;MYBL1;PRPF6;EFCAB7;IRF2;ABHD14B;FOXJ3;ATM;CX3CL1;TNIP1;ELOF1;ELF1;CCNT2;KAT5;FOXO3;IL18;AHI1;NFIL3;RFXANK;SOX11;WAC;TRIM45
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.49460243408690907,1.2219924826600879,0.24307692307692308,0.7261923759509198,1.0,2/24,3.58%,EPHA7;NUPR1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.31716525311330257,-1.2219847014825203,0.095,0.7073733714692987,1.0,25/72,17.32%,SHANK3;SLC24A2;NLGN1;PTK2B;RIMS1;ZDHHC2;GRIK2;TSHZ3;GRIN2A;NRXN1;RIMS2;GRIN2B;SYT1;CLSTN2;CLSTN3;ADCY8;PRKCZ;LGMN;APP;NLGN3;GPER1;LGI1;CACNG3;CACNG4;MPP2
prerank,positive regulation of vascular permeability (GO:0043117),0.5596440671819626,1.2217946879442545,0.2542955326460481,0.7258283477789141,1.0,4/12,7.30%,BMP6;ANGPT1;PDE3A;TJP3
prerank,regulation of mitochondrial fusion (GO:0010635),0.5657501044634002,1.2215186122130766,0.2643478260869565,0.7256498357715526,1.0,4/11,15.21%,PID1;PRKN;MUL1;HUWE1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5661169857060455,1.2202113807724135,0.2607204116638079,0.7286622576644494,1.0,1/12,0.46%,IGF2
prerank,regulation of dopamine secretion (GO:0014059),0.48702589497412413,1.219844414127856,0.2345679012345679,0.728818207603485,1.0,7/25,13.47%,GDNF;DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12
prerank,in utero embryonic development (GO:0001701),0.48987122513748926,1.219638087607796,0.23197492163009403,0.7284989428128561,1.0,5/25,5.01%,IGF2;ARNT2;FGFR2;TGFBR1;LIG4
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5786474840956376,1.219430028151464,0.2688356164383562,0.7281765479469078,1.0,5/10,14.80%,APOA1;SLC45A3;LPGAT1;ABCD2;NR1H3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.38313398421503303,-1.2184714480265508,0.2108626198083067,0.7164718106014955,1.0,7/30,5.44%,KCNJ2;ATP1A1;NEDD4L;GJC1;SCN1A;FGF12;KCNQ1
prerank,negative regulation of defense response (GO:0031348),0.39886947720795146,1.218095419750609,0.18619791666666666,0.731316414634405,1.0,17/77,15.04%,PTGIS;RORA;APOE;APOA1;MVK;CDH5;MAPKBP1;SIRT2;NMI;NR1D1;IRAK3;ITCH;TNFAIP6;SELENOS;MUL1;NR1H3;TNFRSF1A
prerank,epithelial cell-cell adhesion (GO:0090136),0.5723725805381745,1.217844918678957,0.28191489361702127,0.7311598247163126,1.0,4/11,6.79%,PLEKHA7;KIT;ITGB5;VCL
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4100427086669423,-1.2174708765732078,0.1804733727810651,0.7174600996678,1.0,15/25,27.10%,PDE4D;PDE4B;PLCG2;SPTBN1;RPS3;CD80;PTPRC;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6
prerank,positive regulation of DNA metabolic process (GO:0051054),0.42205709519773554,1.2174538655812266,0.21296296296296297,0.7313167812523891,1.0,14/61,14.37%,EYA2;EYA1;FGFR4;PDGFRB;SMOC2;PML;EGFR;FGF2;PPP1R10;RGCC;ERCC8;USP9X;NPAS2;RTEL1
prerank,smooth muscle tissue development (GO:0048745),0.5879188933810477,1.217054885115159,0.2687074829931973,0.7315968472617946,1.0,6/10,18.98%,MYLK;SMO;ENG;BMP4;SHH;EFEMP2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5731292031639126,1.2168787589138672,0.2508591065292096,0.7311832909061012,1.0,6/10,24.20%,IVD;ETFDH;ETFA;ETFB;ACADM;ACADVL
prerank,phasic smooth muscle contraction (GO:0014821),0.5874494636264275,1.2164899996735383,0.27181208053691275,0.7314772216614522,1.0,1/10,1.17%,GDNF
prerank,cellular response to lipid (GO:0071396),0.369143859547513,1.2164086400050904,0.13842746400885936,0.7307703829245709,1.0,20/191,7.78%,EPHA3;RORA;ADCY1;ROCK2;PID1;ADCY2;AR;SERPINE1;LYN;ATP1A2;ADCY5;WNT8B;WNT6;AXL;SFRP1;PTK7;TFPI;WNT5B;SPHK2;NR1D1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.49693719515503965,1.2154502204668716,0.24918032786885247,0.7327634800008541,1.0,5/21,14.97%,SAMD4A;TUT7;PARN;TUT4;CNOT3
prerank,ncRNA transcription (GO:0098781),0.5470259773252889,1.2152205185549951,0.24297520661157024,0.7325502996214528,1.0,5/13,9.77%,POLR1G;BRF1;GTF3C1;USPL1;RPAP2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.35755376716176335,-1.2133456500944322,0.16339869281045752,0.7281578058268643,1.0,14/38,23.23%,SNRPB;PRMT7;SNRPD1;SRSF12;LSM2;SNUPN;PRPF31;USP4;SNRPD3;COIL;GEMIN8;STRAP;CD2BP2;GEMIN7
prerank,purine nucleotide metabolic process (GO:0006163),-0.40764215947666116,-1.2131775904249988,0.1873015873015873,0.7264968793186461,1.0,9/24,19.04%,NT5E;NT5C2;PRPS2;NT5C1A;GDA;NT5C;PNP;GPX1;FHIT
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3817968055483115,-1.2131410853706688,0.19596541786743515,0.7244943781057703,1.0,13/31,12.38%,SHANK3;PPFIA2;NLGN1;ARHGAP44;SIPA1L1;SRCIN1;CDK5;NGEF;TANC2;LRP8;ZDHHC15;KIF1A;ABI3
prerank,post-translational protein modification (GO:0043687),0.35043505422400634,1.2131143191112534,0.08368200836820083,0.7380394471698637,1.0,83/332,20.64%,LTBP1;CP;FBN1;SPSB1;MATN3;AHSG;PRKCSH;IGFBP4;OBSL1;CCN1;LAMC1;GAS6;APOE;FSTL1;FBXL19;CSF1;APOA1;APLP2;PSME4;SERPIND1;IGFBP5;EPAS1;CST3;TNC;CUL4B;STT3A;CUL5;FBXL3;RCN1;DNAJC3;COMMD1;FN3KRP;MIA3;RBBP7;ASB12;BMP15;IGFBP3;PDIA6;FBXO9;FBXO11;KBTBD7;DCAF8;ERCC8;FBXO4;FBXL12;FEM1C;ITIH2;GPS1;BTRC;COPS3;P4HB;FSTL3;ASB6;WDR5;BMP4;ASB1;SENP8;MELTF;CUL7;KTN1;COPS2;HRC;KCTD7;PSMB5;LAMB2;PSMC2;CALU;CKAP4;FN3K;PSMD1;RABGGTA;ASB13;PSMD4;MXRA8;PRSS23;PSME3;FBXL18;FEM1B;HIF3A;DCAF11;DCAF6;RBBP5;PSMA3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5139508138821134,1.2130940697371475,0.2268370607028754,0.737157221730022,1.0,3/18,2.21%,CAMK1D;LYN;IL6R
prerank,regulation of axonogenesis (GO:0050770),0.4239738890649664,1.2129801034390402,0.21610169491525424,0.7365581719771853,1.0,14/51,14.30%,ROBO1;PLXNA2;KIF13B;EPHA4;TIAM2;BRSK1;ARHGAP35;EPHB3;PLXNC1;MARK2;PLXNA1;PTEN;CHODL;PLXNB2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.40277627384514253,1.2128327793037001,0.1961038961038961,0.736046382020804,1.0,7/73,4.20%,ROBO1;COL4A3;SMAD3;DLC1;CASP12;CFLAR;SLC22A2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42434402723119974,1.2124995630704385,0.20810055865921787,0.7361481725550655,1.0,9/59,8.47%,TCF7L2;CDK8;MITF;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5813208309875781,1.2124711020665633,0.2849264705882353,0.7343428895457202,1.0,4/10,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5813208309875781,1.2124711020665633,0.2849264705882353,0.7343428895457202,1.0,4/10,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5320274935259477,1.2124034688298986,0.2564102564102564,0.733610398182147,1.0,3/16,6.87%,SOX5;SP7;LTBP3
prerank,secretion (GO:0046903),0.5342250378429884,1.212339498027814,0.2436548223350254,0.7328952599040933,1.0,5/14,8.20%,FBLN5;SLC22A2;VIP;SLC22A4;DRD3
prerank,negative regulation of cellular component movement (GO:0051271),0.5372768013633207,1.2119981876825485,0.24957841483979765,0.7330004119770892,1.0,3/15,4.29%,TGFBR3;SP100;FBLN1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3603253570298105,1.2116723943772245,0.14912280701754385,0.733071827225192,1.0,38/208,15.04%,PDPK1;WLS;RORA;GJA1;RHOH;PELI2;OPTN;CFLAR;CCL19;TLE1;EDAR;ROR1;RNF31;MAPKBP1;SPHK2;LPAR1;TLR6;NR1D1;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;UFL1;TNIP2;IKBKE;TBK1;RIPK2;USP10;MUL1;RIOK3;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.34186026442654144,-1.211163137492356,0.18081180811808117,0.7286839190700414,1.0,11/48,19.92%,PDE4D;PDE4B;SLC7A5;CYRIB;SCRIB;PTPN22;ZFPM1;TLR4;TXK;CD276;FZD5
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4778269705415075,-1.2107940110303845,0.2430379746835443,0.7277061375336887,1.0,4/13,4.38%,NR3C2;ESR1;ABHD2;MED1
prerank,second-messenger-mediated signaling (GO:0019932),0.40282736529991414,1.2105171558670462,0.20314389359129384,0.7355279582496338,1.0,14/82,7.80%,RCAN2;PDPK1;XCR1;APOE;MCTP2;INPP5A;MCU;NEUROD1;ACKR2;CCR9;LRRK2;AGTR1;EIF2AK3;RCAN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4346602765695466,1.2103543730688051,0.21153846153846154,0.7351093418853716,1.0,5/47,6.82%,PTGIS;ROCK2;WNT4;RAPGEF2;SIK1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5064940001269349,-1.2099453787923335,0.24228028503562946,0.7281216253797113,1.0,4/11,21.84%,CAV1;FOXO1;ATP6V0A2;ATG7
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4033153002812326,1.2097378415800295,0.2010178117048346,0.7360960176299338,1.0,14/70,13.27%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;RAB25;ATRN;ITGB3;ITGAV;EPHB3;DACT2;NTNG2
prerank,lipid biosynthetic process (GO:0008610),0.3980277038602507,1.2097275181494185,0.18663303909205547,0.7352025711783111,1.0,10/77,7.90%,PAM;ACSL1;MVK;PRKAA2;STAR;HSD3B2;AGPAT3;SREBF1;SRD5A1;DOLPP1
prerank,aerobic electron transport chain (GO:0019646),-0.3167069837056399,-1.2095406560861817,0.12875536480686695,0.7273049257170378,1.0,31/68,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,amino sugar metabolic process (GO:0006040),-0.5165561368118031,-1.2091815508185657,0.23648648648648649,0.7264220290973774,1.0,2/10,0.97%,CSGALNACT1;ST6GAL1
prerank,cellular response to purine-containing compound (GO:0071415),0.5682957926530807,1.2088841368509868,0.26773049645390073,0.7368888994917054,1.0,2/10,5.72%,SLC8A1;GSTM2
prerank,positive regulation of calcium ion import (GO:0090280),0.5567470140880435,1.208681876508071,0.2620320855614973,0.7365754377955623,1.0,2/12,7.21%,PDGFRB;SPHK2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4678958607888197,1.2086371071324278,0.2280966767371601,0.7357906665906776,1.0,7/31,12.81%,PYCR1;STAR;HSD3B2;PYCR3;SRD5A1;LIAS;MOCS1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.36755126147227596,-1.2075792753952304,0.1919191919191919,0.7294271780446466,1.0,8/35,7.10%,SGIP1;BICD1;B2M;PPT1;CBL;RAB21;HIP1R;HNRNPK
prerank,positive regulation of potassium ion transport (GO:0043268),-0.36501450251645035,-1.2070146322309634,0.16613418530351437,0.7290568354466527,1.0,12/38,13.63%,FHL1;KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,negative regulation of cell population proliferation (GO:0008285),0.3472236278406208,1.2063891464803216,0.10721649484536082,0.7418676338635904,1.0,81/351,16.99%,NELL1;RBP4;MTSS1;OGN;COL4A3;MN1;TGFBR3;AR;MCC;LYN;DLC1;PODN;PDS5B;NUPR1;PDCD5;FBLN1;RAPGEF2;APPL2;IRF1;AXIN2;RARG;SFRP1;IGFBP5;PDPN;TBX3;CYP1B1;VIP;SKI;ALDH1A2;PML;IL12B;CEBPA;ING5;P3H3;SIRT2;MAP2K1;NMI;RNF139;CD200;BMP2;KAT2B;S100A11;STK11;INCA1;FGFBP1;IGFBP3;GSDME;IFNK;CGRRF1;RGCC;REST;CD33;NIBAN2;PEX2;NDRG4;NOX4;TSC2;GLMN;PTEN;CLMN;ETS1;FRK;HPN;GATA6;BMP4;SFRP4;RBM5;CDKN1C;PRKRA;BMP5;EPPK1;ZBTB17;SST;SPEG;KANK2;ADAMTS1;SLC16A2;ATF5;TFDP1;TNS2;CDKN2C
prerank,response to molecule of bacterial origin (GO:0002237),-0.3157747991473852,-1.206182276645926,0.16593886462882096,0.7296734467885497,1.0,19/69,19.92%,NOS3;TNFRSF11A;CYRIB;GGT5;LBP;GCH1;NOS1;JAK2;FOXP1;TNFAIP3;PTPN22;ERBIN;IRF5;TRIM6;TLR4;HMGB2;IFNAR1;GGT1;FZD5
prerank,protein phosphorylation (GO:0006468),0.3415535620444603,1.2059221601833225,0.0782520325203252,0.7423941966203144,1.0,77/479,12.87%,EPHA3;STK17B;DAPK2;PDPK1;PDK1;DDR2;NRK;ROCK2;CDK14;CAMK1D;TGFBR3;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;EPHA4;BMPR1A;DMPK;MARK1;EPHA8;CCNA2;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;TGFBR1;ACVR1;CDK16;PRKAA2;MUSK;MAP3K20;NUAK1;SRC;ULK2;GTF2H5;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EGFR;EPHB2;BMP2;MAP4K4;CAMK2B;VRK3;STK11;RNASEL;RYK;BAZ1B;TTBK1;NEK6;BRAF;TAOK3;IGFBP3;EPHB3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;MAP2K6;ACVR1B
prerank,cellular copper ion homeostasis (GO:0006878),-0.47400002514300654,-1.2053565034110871,0.2529832935560859,0.7302303913087139,1.0,8/14,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;MT2A;SLC31A2;PRNP
prerank,respiratory electron transport chain (GO:0022904),-0.47170979726543116,-1.2050910912210107,0.22871046228710462,0.7289824927697635,1.0,9/14,26.93%,SLC25A13;SLC25A12;PPARGC1A;NDUFA5;SDHB;SLC25A22;ETFRF1;UQCRFS1;GPD2
prerank,positive regulation of heart rate (GO:0010460),0.5128755565580788,1.2047752772671199,0.2708018154311649,0.7448248778852495,1.0,4/17,11.10%,ADRA1B;TPM1;TRPM4;ADM
prerank,regulation of monooxygenase activity (GO:0032768),-0.41086700273343035,-1.204563526166292,0.23423423423423423,0.7286790393883028,1.0,9/23,10.72%,CAV1;NOSTRIN;NOS3;DDAH1;NOSIP;DDAH2;CYGB;CALM1;SPR
prerank,relaxation of muscle (GO:0090075),0.5540027764338189,1.204270348433019,0.2846975088967972,0.7453933883835752,1.0,4/13,5.72%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5575812608041304,1.2042501403698387,0.25671140939597314,0.7445251464143504,1.0,4/12,6.85%,DOCK4;TPM1;IGFBP5;DOCK5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5212426066658512,1.204210630842818,0.24783362218370883,0.7437223937448684,1.0,5/17,5.86%,ITGA3;FSTL1;TWSG1;SULF1;CASK
prerank,regulation of cell-cell adhesion (GO:0022407),-0.35735178184824307,-1.204162951259803,0.16964285714285715,0.7280073679014724,1.0,6/39,2.61%,PTPRG;EFNA5;PODXL;CDH1;ZDHHC2;TENM3
prerank,response to axon injury (GO:0048678),0.5192547835697896,1.2032559059843329,0.25368248772504093,0.7456523333340556,1.0,3/18,4.34%,NREP;DPYSL3;MTR
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5594830882861476,1.2032106256638262,0.27364864864864863,0.7448703885252882,1.0,7/10,30.77%,SPHK2;KMT2A;SMARCB1;BRCA1;HDAC5;RAPGEF3;SMAD4
prerank,microtubule-based transport (GO:0099111),0.5613161796996587,1.2031285901620343,0.2773851590106007,0.744185014480408,1.0,6/12,19.55%,CCDC40;DYNC1I2;CABYR;SPEF2;HTT;ROPN1L
prerank,fibrinolysis (GO:0042730),0.5473970222249682,1.202515240482072,0.2552083333333333,0.7451659024775686,1.0,2/13,11.76%,SERPINE1;F2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.47481475526327066,1.2022326569323067,0.23100303951367782,0.7451878872387008,1.0,4/27,4.20%,SLC1A3;SLC7A2;SLC6A9;SLC22A2
prerank,regulation of cell death (GO:0010941),0.3814781998180207,1.2022277822620875,0.18401937046004843,0.7442821907120482,1.0,19/94,13.23%,CCN2;LRP1;CCN1;RRAS2;MT3;SLC25A24;AXIN2;CCN5;LRRK2;PARP16;CCN4;PRKN;FGF2;TBK1;RAD18;IMPACT;RIPK2;CTSZ;NPAS2
prerank,regulation of ossification (GO:0030278),0.4516214741015645,1.2019780300042429,0.21502209131075112,0.7441407600554615,1.0,8/36,8.76%,DDR2;ENPP1;AHSG;ANKH;ACVR1;SFRP1;RBPJ;BMP2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3568988479800819,-1.2019675459114525,0.16878980891719744,0.7329728476785531,1.0,16/34,27.83%,PDE4D;PDE4B;KCNQ1;NOS1;ATP1B1;CALM1;CALM3;RYR2;CHGA;GJA5;PIK3CG;RGS2;PLN;CALM2;HCN4;SRI
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.44207219752251603,1.201919908466662,0.23636363636363636,0.7433853000596742,1.0,4/38,2.69%,PTGIS;ROCK2;SMAD3;NOS1AP
prerank,glucan catabolic process (GO:0009251),0.5284894301467506,1.2012199888561745,0.24958402662229617,0.7445364342259713,1.0,7/15,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,negative regulation of GTPase activity (GO:0034260),-0.41074647163997136,-1.2011379239309103,0.21220159151193635,0.7333493261230342,1.0,4/22,4.83%,LRCH1;F11R;SH3BP4;RDX
prerank,amino acid transport (GO:0006865),0.42414360196122436,1.2011314521139573,0.2119205298013245,0.7438586461955733,1.0,8/49,9.72%,SLC7A11;SLC7A2;SLC1A5;SLC7A13;PDPN;SLC38A6;SLC38A9;SLC43A1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5524473945846852,1.2005664938012237,0.28169014084507044,0.7446241034884963,1.0,5/12,17.97%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5542031638196683,1.2002768388532001,0.26573426573426573,0.7445679634482526,1.0,1/13,0.46%,IGF2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.543101992401804,1.1994336347779369,0.26897689768976896,0.7462851964999369,1.0,3/13,6.15%,GLUL;DDO;ASPA
prerank,regulation of NMDA receptor activity (GO:2000310),-0.36670876633315863,-1.1991896191667468,0.19444444444444445,0.7374496691630255,1.0,9/32,8.47%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;LRRC7;GRIN2B;GRIA2
prerank,regulation of filopodium assembly (GO:0051489),0.44273632560955173,1.1991748623557617,0.2257100149476831,0.7461699024396461,1.0,8/38,8.37%,NRP1;PIK3R1;MYO10;DOCK11;RIPOR2;DPYSL3;CDC42;CAPZB
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.40399328618735797,1.1988432490212753,0.21400264200792601,0.746284858593818,1.0,25/64,23.91%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,response to cytokine (GO:0034097),0.3684226549521636,1.1987266645959298,0.16996507566938301,0.7457365490116558,1.0,28/141,14.08%,PID1;TIMP3;SMAD3;PTPN13;BCL2;IL6R;OSMR;PTPN20;SP100;DPYSL3;IRAK2;CXCL16;ALDH1A2;SRC;PML;KYNU;TIMP2;PTPN9;AFF3;IRAK3;IKBKE;TBK1;DDOST;IGBP1;HDAC4;TAF9;COL3A1;PTPN23
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.37966274231370484,-1.198407440987615,0.23745819397993312,0.7378141243867422,1.0,10/33,11.49%,MEF2C;THBS1;NOTCH1;ACVRL1;MECP2;ATP2B4;JUP;VASH1;KLF4;TGFB1
prerank,mesenchymal cell differentiation (GO:0048762),0.4198854870978514,1.1977407948619525,0.212707182320442,0.7477985909124529,1.0,11/51,8.76%,ROCK2;TGFBR3;FGFR1;FGFR2;WNT4;TGFBR1;FBXL17;ENG;DDX17;RBPJ;BMP2
prerank,cellular response to cytokine stimulus (GO:0071345),0.34260411271701996,1.1969774353418692,0.09834368530020704,0.749225190839639,1.0,48/416,8.87%,GREM2;ADAMTS12;PTGIS;COL1A2;RORA;PID1;GHR;PIK3R1;DAPK1;SMAD3;PTPN13;IL31RA;BCL2;IL6R;LEPR;IL34;OSMR;ZEB1;MMP2;PTPN20;KIT;RIPOR2;GAS6;NUMBL;DPYSL3;CCL19;IRAK2;CSF1;IRF1;AXL;SFRP1;BCL6;ZFP36L1;TCF7;CCL4;SDC1;IL12B;BATF;CEBPA;NFE2L2;IL13RA1;NR1D1;OXSR1;PTPN9;IRAK3;BCL2L11;STAT5B;CNTFR
prerank,glycogen catabolic process (GO:0005980),0.5248725023638172,1.1960748163766113,0.2621359223300971,0.7509971396693556,1.0,7/15,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,regulation of water loss via skin (GO:0033561),-0.4543824453312608,-1.195798732906057,0.24120603015075376,0.7415997721327086,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,establishment of skin barrier (GO:0061436),-0.4543824453312608,-1.195798732906057,0.24120603015075376,0.7415997721327086,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,regulation of postsynapse organization (GO:0099175),-0.394307559564122,-1.1957161910592842,0.1936416184971098,0.739784259015799,1.0,13/28,12.38%,SHANK3;PPFIA2;ARHGAP44;IL1RAPL1;SIPA1L1;SRCIN1;CDK5;TANC2;ABHD17B;ZDHHC15;KIF1A;HOMER1;ABI3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.46914741181017733,1.1951688678125243,0.24849397590361447,0.752847544283447,1.0,5/29,7.56%,GDNF;TENT5A;AXIN2;VIP;TENT5D
prerank,response to peptide hormone (GO:0043434),0.4333971387003292,1.1945193371575795,0.25616438356164384,0.7538728432676837,1.0,14/43,16.32%,ROCK2;TGFBR3;OGT;IGFBP5;ZFP36L1;SRC;STAT5B;STAT2;EIF6;EIF2B4;STAT6;STAT4;EIF2B3;AKT1
prerank,protein neddylation (GO:0045116),-0.47911347167055873,-1.1943012135722675,0.21809744779582366,0.7419547044130713,1.0,3/13,10.96%,RBX1;UBA3;DCUN1D4
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4764069509841973,1.1942633637686002,0.2267080745341615,0.7537420456928087,1.0,13/25,23.18%,FBXL17;DERL1;RNF185;NGLY1;UGGT2;CLPP;AUP1;LONP1;YME1L1;ZER1;BAG6;HDAC6;ATXN3
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.49730851988948205,-1.1940597457346993,0.21923937360178972,0.740628316364135,1.0,5/11,10.46%,RDX;MTMR2;SORL1;RAB21;MSN
prerank,modulation by symbiont of host process (GO:0044003),-0.5148396869386103,-1.1938269156193217,0.2511737089201878,0.7393687923624237,1.0,6/10,33.34%,B2M;HGS;UBC;RPS27A;TLR2;PGK1
prerank,regulation of phosphorylation (GO:0042325),0.3742384353279866,1.1932462993190205,0.1923536439665472,0.7559147354123142,1.0,36/120,19.55%,NRP1;LDB2;SRPX2;AR;LYN;DYNLL1;OGT;PRKAG2;NUP107;PHIP;CDH5;PML;NUP42;SIRT2;DSCAM;EGFR;STAT2;EIF6;NUP98;RAE1;EGF;GLMN;PLXNB2;NUP214;BMP4;SESN2;CDKN1C;FNIP1;CDKN2C;KCTD20;GCK;SEH1L;TPR;CDKN1B;PRKAG1;ROPN1L
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4127678002602791,-1.1931328888336525,0.20728291316526612,0.7395078143191804,1.0,13/21,33.67%,KDM1A;DISC1;VEGFA;CX3CR1;DLL4;TOX;LRP2;FZD3;FZD9;DISP3;CTNNB1;NAP1L1;RASSF10
prerank,heart morphogenesis (GO:0003007),0.41850502542851314,1.192991339329663,0.2326241134751773,0.7557879247289329,1.0,11/50,9.89%,TGFBR3;DLC1;BMPR1A;OLFM1;TGFBR1;ACVR1;TBX3;ENG;FLRT2;BMP2;SYNPO2L
prerank,protein stabilization (GO:0050821),0.3602342059886697,1.1927665334787085,0.16666666666666666,0.7555730055424417,1.0,29/168,15.66%,IGF1;PIK3R1;PLPP3;A1CF;EPHA4;PARVA;ZSWIM7;APOA1;MT3;ATP1B2;STK4;CREBL2;WDR81;PRKN;TELO2;PEX6;TNIP2;PER3;SUGT1;MUL1;USP9X;HYPK;PTEN;TAF9;PDCL3;FLNA;BAG5;PRKRA;LAMP2
prerank,pseudouridine synthesis (GO:0001522),0.5450536169299515,1.192719726699514,0.2614601018675722,0.7547821459846769,1.0,5/13,18.89%,PUS3;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,regulation of mRNA stability (GO:0043488),0.36371624376044054,1.1922994827330053,0.17803468208092485,0.7551569767296648,1.0,36/145,20.64%,SAMD4A;ROCK2;GDNF;TENT5A;CSDC2;IGF2BP2;PSME4;AXIN2;VIP;ZFP36L1;TENT5D;EXOSC1;METTL14;PARN;SERBP1;EXOSC7;LARP1;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;METTL3;PSMD1;PRKCA;PSMD4;FASTKD3;PSME3;YTHDF2;FTO;HNRNPU;ZFP36L2;PSMA3
prerank,protein mannosylation (GO:0035268),0.47940720641175555,1.1914030912342146,0.27035330261136714,0.757019962020596,1.0,4/22,5.89%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,transport along microtubule (GO:0010970),0.543157399667823,1.1911154957743317,0.2898032200357782,0.7569769060608451,1.0,5/13,17.59%,ARHGAP21;CDC42;APBA1;DYNC1I2;COPG1
prerank,regulation of T cell differentiation (GO:0045580),0.4577919546587227,1.190872925216158,0.27031019202363366,0.7568021289050351,1.0,5/33,9.16%,RHOH;RUNX1;TCF7;ZMIZ1;ZBTB1
prerank,ion transport (GO:0006811),-0.2946844815930231,-1.1908522731290405,0.15217391304347827,0.7444788972775751,1.0,17/111,5.15%,TRPM3;PIEZO2;SLC12A2;SLC26A7;SLC12A7;SLC9A2;SLC24A2;SLC26A2;PIEZO1;ANO1;SLC9A6;ATP11B;GLRA1;GABRB1;KCNN2;SLC15A2;SLC1A1
prerank,steroid biosynthetic process (GO:0006694),0.41371569062363817,1.1906912758037387,0.22985468956406868,0.7564692851656949,1.0,8/56,7.55%,CYP7B1;SLC27A5;PRKAG2;INSIG2;STAR;HSD3B2;CYP27A1;SRD5A1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4752931722150219,1.1905344916675928,0.2608695652173913,0.7560191278123143,1.0,7/26,9.89%,ROCK2;ASAP3;SYNPO2;CDC42;ALMS1;PRKN;SYNPO2L
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5353837913306272,1.1904813377446255,0.2905405405405405,0.7552732971457646,1.0,5/14,17.97%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3547295072867878,-1.1903361834364048,0.2168284789644013,0.7440559522197446,1.0,7/39,5.00%,UTRN;ANK3;NEDD4L;HECW1;YWHAH;CAMK2D;FGF12
prerank,bone morphogenesis (GO:0060349),0.532623471160832,1.1901108567695815,0.26143790849673204,0.7555010527562254,1.0,3/14,5.81%,CYP26B1;FGFR2;SKI
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5026828619966883,1.1890579230379679,0.26916802610114193,0.7577156357231125,1.0,4/18,9.04%,ROCK2;EPHA4;SLC2A13;PICALM
prerank,proton transmembrane transport (GO:1902600),0.4420235013103887,1.188724221149467,0.2396576319543509,0.757851460609473,1.0,2/36,1.81%,ATP6V0A4;ATP1A2
prerank,response to fatty acid (GO:0070542),0.5076385870244012,1.188636629558833,0.28187919463087246,0.757237727546887,1.0,1/17,0.91%,PID1
prerank,histone modification (GO:0016570),0.37800042760669694,1.1883565998085044,0.1943127962085308,0.7572021278315445,1.0,16/109,10.20%,TBL1XR1;EYA2;EYA1;CCNA2;PRDM5;MIDEAS;MT3;BRD8;ATXN7L3;SIRT2;UBE2U;MTA2;MTA3;BRMS1L;NSD1;BAZ1B
prerank,positive regulation of protein transport (GO:0051222),0.40371076763171393,1.1881297131126904,0.22506738544474394,0.7569565066061332,1.0,4/67,3.85%,IGF1;BMP6;MYO18A;MYH10
prerank,aortic valve development (GO:0003176),0.45123287613798235,1.1879583843298513,0.2485294117647059,0.7565968935072991,1.0,3/34,0.85%,ROBO1;ROCK2;ELN
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4473405657456433,-1.1876269204272794,0.24274406332453827,0.7506588582151709,1.0,8/16,19.53%,THBS1;PPP1R16B;JCAD;GATA2;VEGFA;APLNR;DLL4;PDCD10
prerank,response to calcium ion (GO:0051592),-0.2967488009450008,-1.1874947965386815,0.16184971098265896,0.7489783454787605,1.0,27/102,13.99%,CAV1;MEF2C;CPNE8;CLIC4;NLGN1;TRPC3;THBS1;PLCG2;IQGAP1;KCNMA1;CAMK2D;SLC25A13;CPNE3;SLC25A12;TRPC1;SYT1;KCNMB2;ITPR3;CALM1;GPLD1;CALM3;ADCY8;LGMN;HOMER1;SYT6;CASQ2;RYR2
prerank,L-amino acid transport (GO:0015807),0.470856163602984,1.187367684925054,0.2594752186588921,0.757421088445571,1.0,2/28,0.60%,SLC1A3;SLC7A2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.36110254396603875,1.1868210044914669,0.1842696629213483,0.7582132455360943,1.0,17/152,7.51%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;GRK5;ADCY5;GNAS;ADCY9;ADGRL1;INSL3;VIP;LHCGR;ADRB3;MTNR1A;LPAR1
prerank,regulation of integrin activation (GO:0033623),-0.44650603649416726,-1.1867606524776573,0.2575,0.749320632196419,1.0,5/15,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4806660680131498,1.186646229141507,0.2708018154311649,0.7578438071791694,1.0,11/23,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3738790404160013,1.1866357133451122,0.21780986762936222,0.7569734961276463,1.0,25/107,16.00%,ITPR1;PIK3R1;BCL2;GORASP2;CDK5RAP3;CREB3L2;ERLEC1;DERL1;ATG10;EIF2AK3;RNF185;RNF139;BCL2L11;AIFM1;BCAP31;PRKN;TMEM259;CEBPB;UFL1;RCN3;SELENOS;P4HB;UFC1;PIK3R2;ERP44
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5226565902417256,1.1865770199531978,0.281505728314239,0.7562539127833725,1.0,4/16,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4857437917430971,-1.1855960336344684,0.27007299270072993,0.7509900799392139,1.0,2/12,2.63%,SLIT2;CCN3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.4268299472985871,-1.1853689505124851,0.24331550802139038,0.7496451226910533,1.0,6/19,14.93%,SLCO1C1;KLF2;MAPK8;KLF4;PAX8;APP
prerank,positive regulation of vasoconstriction (GO:0045907),0.5450904257025111,1.1848484900000567,0.30427350427350425,0.7605620081166722,1.0,2/13,9.41%,ADRA1B;TRPM4
prerank,striated muscle tissue development (GO:0014706),0.45817571818910374,1.1847924575646684,0.2488619119878604,0.7598303183518111,1.0,4/29,4.38%,RBP4;SVIL;CFLAR;MSC
prerank,regulation of cilium assembly (GO:1902017),-0.32459753873722547,-1.1846673158964036,0.18359375,0.7498667313621757,1.0,17/62,14.22%,LIMK2;RABGAP1;CCDC88A;TBC1D1;TBC1D8;TBC1D14;TBC1D15;DCDC2;KCTD17;TBC1D30;CEP97;TESK1;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8
prerank,establishment of spindle orientation (GO:0051294),0.4663627029387061,1.1842218604375243,0.25522388059701495,0.7606020825607063,1.0,13/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;LLGL1;CENPA;HTT;NUMA1;NSFL1C;NDE1;LLGL2;FBXW11;ITGB1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5449964922856655,1.1837809955277838,0.2842465753424658,0.7610307491536848,1.0,6/12,23.92%,PARP11;PARP16;TNKS2;PARP12;PARP10;TNKS
prerank,regulated exocytosis (GO:0045055),0.3613619047386135,1.1831584550804017,0.17361894024802707,0.7619268164758881,1.0,22/173,9.58%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;SYT9;ACTN4;ISLR;ITGB3
prerank,icosanoid metabolic process (GO:0006690),0.4258695798570338,1.1830083186993907,0.2383638928067701,0.7615183919428974,1.0,7/40,7.16%,PTGIS;DAGLA;PLA2G4A;CYP1B1;DPEP1;ALOXE3;DPEP2
prerank,negative regulation of blood coagulation (GO:0030195),0.43808259334747535,1.1826451627954806,0.2776998597475456,0.7617922709817069,1.0,6/38,5.43%,SERPINE1;SERPING1;PDGFRA;APOE;VTN;TFPI
prerank,ncRNA metabolic process (GO:0034660),0.4395828308406366,1.1825833467037687,0.24850299401197604,0.7610500333696225,1.0,11/37,18.90%,TDRD1;DDX17;TUT7;PIWIL4;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DDX4;DICER1
prerank,regulation of histone acetylation (GO:0035065),-0.3728981129318858,-1.1825624956441323,0.2012987012987013,0.7545155164434506,1.0,8/33,13.80%,RPS6KA5;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5532205288423048,1.182328792443705,0.30825688073394497,0.7609228504633623,1.0,2/10,9.32%,MT3;PRKN
prerank,limb morphogenesis (GO:0035108),0.4992167806025116,1.1820461991168785,0.2895148669796557,0.760863505002117,1.0,4/20,5.81%,CYP26B1;GLI3;TBX3;SKI
prerank,regulation of cytoplasmic transport (GO:1903649),0.5501362680604939,1.181962548044573,0.28862478777589134,0.7602220029115508,1.0,4/11,7.60%,ATP9A;SRC;LRRK2;MAP2K1
prerank,membrane depolarization during action potential (GO:0086010),0.460074655317084,1.181960420287668,0.2692889561270802,0.7593432044178614,1.0,3/26,1.81%,SCN7A;SLC8A1;ATP1A2
prerank,sensory perception of pain (GO:0019233),0.4853479118588822,1.1818739037727675,0.2852760736196319,0.7587522003103372,1.0,4/21,11.72%,TRPA1;PTGES;ALOXE3;NIPSNAP1
prerank,positive regulation of viral transcription (GO:0050434),0.47482484166989813,1.181647150765098,0.27301092043681746,0.7584975200182684,1.0,1/25,0.14%,POLR2D
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5032520702381001,1.181418112329402,0.28858024691358025,0.7582870188284292,1.0,4/17,6.31%,AR;ATP1A2;TFPI;SRC
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5052668142266639,1.1812779611189055,0.3,0.7577781364848525,1.0,6/18,17.47%,SETD7;ASH1L;SETD1A;SETD4;KMT2A;SETD1B
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4974844240995612,-1.1812243923005863,0.26066350710900477,0.756774885004583,1.0,3/10,8.02%,HK2;PFKL;PFKP
prerank,cellular response to acid chemical (GO:0071229),-0.38626802421813833,-1.181175654492536,0.20588235294117646,0.7549158890796583,1.0,9/27,12.39%,SH3BP4;KLF2;GLRA1;GLRA2;SPAAR;LARS1;VEGFA;IPO5;MTOR
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.45723499676488555,-1.18099557839591,0.2425,0.7534296614786733,1.0,4/14,10.01%,YBX3;ANGEL2;ELAVL4;ELAVL1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5066374479506338,1.1807394945125493,0.27980922098569155,0.7585268187826736,1.0,2/16,3.47%,LRP1;APOE
prerank,positive regulation of protein binding (GO:0032092),0.41128571163521904,1.1806675219718046,0.23684210526315788,0.7578380531258836,1.0,11/56,9.32%,TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;DERL1;LRRK2;STK4;BMP2;PRKN
prerank,negative regulation of translation (GO:0017148),0.3881952668771258,1.179367151797254,0.2390488110137672,0.7607588748703455,1.0,10/87,8.96%,SAMD4A;ROCK2;DAPK1;IGF2BP2;IGFBP5;CPEB1;CPEB3;EIF2AK3;RNF139;METTL14
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.507433500598655,1.179255415871015,0.27986348122866894,0.760221378994424,1.0,4/18,6.86%,IL6R;YAP1;SRC;CEBPA
prerank,"wound healing, spreading of cells (GO:0044319)",0.47332013333243395,1.1788968490629996,0.26403641881638845,0.7604162872062041,1.0,4/24,7.96%,COL5A1;CCN1;PDPN;ARHGAP35
prerank,B cell activation involved in immune response (GO:0002312),0.5298210060887323,1.1788262185185314,0.296551724137931,0.7597448790832587,1.0,3/13,6.84%,GAPT;LIG4;BATF
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4122290509826598,-1.178294583960669,0.24396782841823056,0.7599793323123099,1.0,6/22,6.50%,SLIT2;TMSB4X;KANK3;CYRIB;TMSB10;HIP1R
prerank,regulation of transposition (GO:0010528),0.5454422842425329,1.1781438519473901,0.29081632653061223,0.7609179713314804,1.0,5/13,17.51%,UBR2;PIWIL4;SPOCD1;MYBL1;DDX4
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5005343413847081,1.1781116198520607,0.27929373996789725,0.7601262856756704,1.0,3/19,4.18%,CAMK1D;IL34;CSF1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.44530406059691174,1.1776542132095658,0.2832618025751073,0.7606161854233346,1.0,9/34,10.16%,PIK3R1;EPHA8;KIT;PDGFRA;PDGFRB;CCL19;WDR81;WDR91;FGF2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.4199142086451218,-1.1774320213412988,0.215633423180593,0.7608084915465771,1.0,6/20,6.82%,SLC12A2;KCNJ2;ATP1A1;NEDD4L;KCNMA1;ATP1B1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4997673753289862,1.1772356651036258,0.2755775577557756,0.7609118782215885,1.0,4/17,8.16%,NRP1;NTF3;CDC42;NTRK3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.45701543593097005,1.1769983973112133,0.2458521870286576,0.7608281424673461,1.0,5/28,5.19%,MITF;NOS1AP;FGFR4;PRKAG2;PRKAA2
prerank,regulation of protein localization to membrane (GO:1905475),0.4551989158802859,1.1767211981554162,0.27769110764430577,0.7608293135940407,1.0,3/28,1.40%,GPC6;GSN;AR
prerank,regulation of primary metabolic process (GO:0080090),0.361848492922363,1.1766107300106157,0.2037914691943128,0.7602949536745552,1.0,40/126,23.43%,ROCK2;TBL1XR1;FGFR4;C1QTNF2;CHD9;APOE;PSME4;NCOA2;LDLR;MVK;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;PSMB5;PSMC2;OAZ3;PSMD1;CARM1;NCOA6;SCD;PSMD4;ABCA7;PSME3;PSAP;PSMA3;RUBCNL;NFYC;CYP51A1;PSMA2;PSMC5;SREBF2
prerank,cell junction organization (GO:0034330),-0.3097149883405652,-1.1762559332648646,0.17272727272727273,0.7624592112984735,1.0,27/71,20.01%,CTNND2;OCLN;PPFIA2;LIMS2;ACTB;TJP2;TJP1;MYO9A;TGFB2;PPFIA1;GRM5;OPHN1;RAB8B;AGRN;TGFB1;CXADR;APP;NLGN3;LIMS1;ELFN1;CBLN2;MARVELD2;ACTG1;DVL1;PPFIA4;SH3BP1;TGFB3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.3125545080921128,-1.1759854516753252,0.18614718614718614,0.7613406069661334,1.0,23/63,24.61%,MEF2C;VAV3;CD38;SLC7A1;IL15;TFRC;NFATC2;CD40;CD80;CD81;GPR183;PTPRC;JAK3;CD320;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1;IRS2;MIF
prerank,cellular metal ion homeostasis (GO:0006875),0.37827744511714406,1.1758817645868196,0.20095124851367419,0.7615460274228595,1.0,16/102,8.20%,SLC24A3;SLC8A1;SLC8A3;ATP1A2;SLC41A1;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;ATP1B2;TMEM203;DRD3
prerank,regulation of wound healing (GO:0061041),0.42670053266968966,1.1758787908719461,0.2564102564102564,0.7606836216777453,1.0,11/42,11.76%,SERPINE1;KANK1;MYLK;VTN;INSL3;CASK;EPHB2;FGF2;HBEGF;ADRA2A;F2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.329378114833929,1.1754047822131173,0.015,0.7612937358728586,1.0,334/1668,17.26%,IGF1;TCF7L2;TCF4;BMP6;ZBTB20;LDB2;AUTS2;NFIA;IGF2;FHL2;RORA;TBL1XR1;ZFHX4;PID1;TRPS1;TEAD1;CDK8;GDNF;ATXN1;PIK3R1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;DACT1;GLI2;RUNX1;PRRX1;WWC2;SALL1;KCNIP3;ZIC1;SP7;OGT;IKZF2;BMPR1A;VGLL3;CBX7;MAF;GLI3;AEBP1;PPP3CA;CCN1;ARID5B;ZEB1;NKX2-1;FGFR2;KIT;ARID4A;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;SSBP3;ZNF462;YAP1;DNMT3A;JDP2;MAML3;APOE;RUNX2;SIX5;MLXIP;RARB;MIDEAS;ZIC4;NFIX;MXI1;LBX2;FBXL19;MEOX2;CRTC3;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;NEUROD1;CREB3L2;NCOA2;KLF15;PHIP;RARG;ETV6;ARID1B;BRD8;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;SKI;BCL9;TNRC6B;BCOR;TCF7;ATOH8;HES7;INO80;SMARCA1;ZNF483;ZNF23;MED14;GTF2H5;NR5A1;CPEB3;BATF;CEBPA;ATAD2B;NFE2L2;ZNF697;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;TET1;MTA2;RBPJ;LIN9;DAB2;TCF7L1;FOXC2;SAFB2;NCOR1;CHD2;MTA3;TNRC6A;KDM5B;HIVEP2;ARRB1;EGFR;RGMA;BMP2;PCGF3;ZMIZ1;JAZF1;KAT2B;STAT5B;ZBTB4;BRMS1L;HOXC5;ZBTB1;MZF1;CCNK;SMAD1;GMEB1;PRKN;GTF2IRD1;HEXIM2;STAT2;GLIS2;CSRP3;NSD1;ARNT;RPAP2;CREB3L4;CREB3;RNASEL;FOXA1;IFI27;ZKSCAN3;FGF2;SP140;BAZ1B;ZSCAN21;PHF2;CXXC5;NR1D2;MED13L;NCOR2;SP5;ZBTB8A;DDX3X;ZNF177;CEBPB;KLF9;CCNL2;MED29;BHLHE41;NFE2;RGCC;TNIP2;SPDEF;NKX2-8;ZBTB37;TBK1;HDAC8;ZFP30;REST;NR4A1;PER3;RHOQ;IMPACT;CCNL1;MNAT1;TCF25;GLI1;CAMTA1;PHF21A;STAT6;ZNF513;RIPK2;PEX2;PAF1;TEAD3;MYCN;SMARCD2;USP9X;NPAS2;HELZ2;IGBP1;NCOA3;KMT2A;HOXC8;EBF1;STAT4;TIAL1;ZNF182;CDK12;HDAC4;PTEN;TAF9;MED19;ARF4;HIVEP1;ETS1;FRK;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;TCERG1;HSBP1;TADA3;AKAP8L;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;UBE2D1;ZNF25;FUBP3;HOXC4;SUFU;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;TSHZ1;HDGFL3;BMP5;CAMTA2;MYT1;MTF1;TFCP2;RNF2;PIK3R2;POGZ;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;MXD4;NCOA7;EBF4;KANK2;CREB5;FNIP1;PLAG1;CCNQ;ATF5;SHH;TFDP1;FOXO6;SP1;LIF;MYBL1;BAZ2B;PRPF6;EFCAB7;IRF2;ZSCAN20;CBX6;ABHD14B;KDM3B;FOXJ3
prerank,"phagocytosis, engulfment (GO:0006911)",0.44550644353401014,1.1752194406569045,0.2696793002915452,0.7609989789551106,1.0,6/36,7.40%,RHOH;GSN;RHOBTB1;CDC42;RHOBTB2;GULP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43507486759457054,1.1749998043489664,0.2679083094555874,0.7607406220219654,1.0,10/39,12.62%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2;RGCC;TNIP2;PDCD4
prerank,positive regulation of B cell activation (GO:0050871),-0.33146297727948515,-1.1744697435463956,0.19172932330827067,0.7639727721171925,1.0,15/50,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;SH3KBP1;SHLD1;CD40;CD81;GPR183;NOD2;PTPRC;BTK;CD27;CD320
prerank,positive regulation of exocytosis (GO:0045921),-0.35645496376777386,-1.1744680278961093,0.21630094043887146,0.7619647190896238,1.0,14/35,26.47%,RAB27A;SDCBP;CADPS;RAB27B;PDCD6IP;CFTR;RAB15;RAB3A;CLASP1;VPS4A;SNF8;EXPH5;STXBP5;HGS
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5216166218216082,1.1738716764227148,0.29194630872483224,0.7631733211690112,1.0,8/14,23.52%,LRRK2;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;OPA1;TXNDC12
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.49766684964608465,-1.172407132631786,0.296551724137931,0.7627267988243915,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.49766684964608465,-1.172407132631786,0.296551724137931,0.7627267988243915,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.49766684964608465,-1.172407132631786,0.296551724137931,0.7627267988243915,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,relaxation of cardiac muscle (GO:0055119),0.5441241466873312,1.1723945216745484,0.295169946332737,0.7666848932662804,1.0,4/13,5.72%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.48430301374837,1.1715015750802398,0.2818471337579618,0.768532165963236,1.0,10/21,23.49%,SMO;SFRP1;TEDC1;TTC23;GLI1;SHH;EVC;PDCL;TXNDC15;STK36
prerank,barbed-end actin filament capping (GO:0051016),0.49636600893210264,1.1713675319233539,0.27450980392156865,0.7671612841585618,1.0,2/18,1.20%,SVIL;GSN
prerank,actin filament capping (GO:0051693),0.49636600893210264,1.1713675319233539,0.27450980392156865,0.7671612841585618,1.0,2/18,1.20%,SVIL;GSN
prerank,tRNA methylation (GO:0030488),0.43717193200709414,1.1708424460111406,0.25958702064896755,0.7677929061474287,1.0,10/34,16.30%,TRMT44;TRMO;NSUN2;BCDIN3D;TRMT13;TRMT112;PRORP;THUMPD3;THUMPD2;THADA
prerank,stem cell differentiation (GO:0048863),0.4304689837729828,1.1704132094263553,0.26170798898071623,0.768208133240138,1.0,10/39,11.49%,SP7;FGFR2;KIT;FBXL17;MLLT3;SFRP1;BATF;OSR1;EEF1AKMT4-ECE2;UFL1
prerank,metal ion export (GO:0070839),-0.3772418360336662,-1.1700979189438983,0.22922636103151864,0.7680408446043351,1.0,9/31,11.87%,KCNK5;ATP1A1;KCND3;KCNQ1;ATP1B1;ATP2B4;SLC40A1;ATP7A;ATP1A3
prerank,cellular protein metabolic process (GO:0044267),0.3356221451054477,1.170095433753052,0.128099173553719,0.768304902600329,1.0,36/396,8.44%,LTBP1;IGF1;IGFBP2;PAPPA;CP;FBN1;IGF2;MATN3;LOX;AHSG;PRKCSH;IGFBP4;MSRB3;RRBP1;CCN1;LAMC1;MMP2;GAS6;APOE;FSTL1;CSF1;TGM5;APOA1;APLP2;SERPIND1;CTSH;IGFBP5;CST3;LMCD1;TNC;ADPRH;ARAF;RCN1;UBA7;SEC11C;DNAJC3
prerank,positive regulation of secretion by cell (GO:1903532),0.395527406988143,1.169309796494593,0.2557544757033248,0.7697180265128083,1.0,6/70,5.31%,IGF1;BMP6;DTNBP1;MYO18A;MYH10;BAIAP3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3763976797412596,-1.169068272614792,0.22535211267605634,0.7693797387056946,1.0,5/29,6.96%,SLC4A10;MCTP1;ZDHHC2;GRIK2;SYP
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4521870259961229,-1.1690485593460527,0.2813953488372093,0.767457211453696,1.0,7/14,30.03%,DENND1B;PRKCZ;CD81;NOD2;CD86;RARA;NLRP3
prerank,regulation of cartilage development (GO:0061035),0.4942822895095453,1.1688072015663729,0.27903225806451615,0.7703199991071094,1.0,5/18,14.89%,TRPS1;SOX5;BMP2;MDK;BMP4
prerank,negative regulation of protein processing (GO:0010955),0.5386376576817204,1.168569855464767,0.3103448275862069,0.7701420124415265,1.0,5/12,15.10%,SERPINE1;LRRK2;SNX12;CTSZ;GAS1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5625703907903811,1.168293321652478,0.31534569983136596,0.770159995497016,1.0,4/10,13.10%,ATP1A2;ADRA2A;YWHAE;VDAC1
prerank,regulation of lamellipodium organization (GO:1902743),0.5189176241118628,1.1682551426390488,0.2934609250398724,0.7694124350872054,1.0,4/14,8.37%,PDPN;CDC42;CARMIL1;CAPZB
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.42445756270762536,-1.1679125549116107,0.26108374384236455,0.7691463064731211,1.0,3/17,2.87%,CAV1;ADIPOR2;PPARD
prerank,synaptic vesicle recycling (GO:0036465),-0.3656264045647545,-1.1676009952769724,0.2417910447761194,0.7681449848113482,1.0,10/31,18.60%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;RAB3A;STX1A;SYNJ1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.445511066086424,1.1668739659138276,0.27219796215429404,0.7727200799027897,1.0,9/33,13.79%,OGN;TPM1;IGFBP5;VIP;IL12B;IGFBP3;PDCD4;NDRG4;PTEN
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3126807918028094,-1.1668007538093284,0.1872146118721461,0.7687722580297909,1.0,17/67,14.82%,ATP8B1;PODXL;CAV1;PPP1R16B;RABGAP1;TBC1D1;TBC1D8;TBC1D14;RDX;TBC1D15;DCDC2;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8;GAP43
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4422711953707101,1.1664689889437867,0.26595744680851063,0.773068285691841,1.0,7/32,8.81%,PHLDB2;SERPINE1;ARHGAP6;DLC1;CASK;SRC;MAP4K4
prerank,Golgi localization (GO:0051645),0.5392699255819341,1.166101395090267,0.304421768707483,0.7732855386205055,1.0,5/11,17.59%,ARHGAP21;TBCCD1;CDC42;UVRAG;COPG1
prerank,regulation of T cell cytokine production (GO:0002724),-0.45004215245895063,-1.165649054834332,0.26216216216216215,0.7705450548417111,1.0,7/15,27.10%,B2M;CD55;FZD5;TRAF2;MAP3K7;MALT1;TRAF6
prerank,cellular response to pH (GO:0071467),-0.43077756088749336,-1.1653801997184512,0.2868020304568528,0.7694405080851512,1.0,7/17,26.50%,HYAL1;GPLD1;GPR68;RAB11FIP5;HVCN1;PKD2L1;KCNK4
prerank,neural crest cell differentiation (GO:0014033),-0.42198783756778163,-1.1649319719847384,0.24685138539042822,0.7689840102160975,1.0,3/18,5.51%,MEF2C;CDH2;LRP6
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.4563880329155845,1.1648997242430823,0.28043143297380585,0.776119856225808,1.0,10/26,22.09%,LGR4;APPL2;IRF1;IRAK3;GPR108;APPL1;TLR5;SMPDL3B;BIRC2;BIRC3
prerank,calcium ion transport (GO:0006816),0.3648668738534068,1.1646301405894883,0.2350835322195704,0.7760655477641181,1.0,15/113,9.62%,ITPR1;SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;STIM1;SLC24A1;SLC24A5;CACNA1C;PANX1;ORAI2;TRPM4;ITGAV
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3776929388281523,1.1644424391619397,0.2471626733921816,0.7756808056449761,1.0,12/80,9.59%,NRP1;AUTS2;PIK3R1;DOCK11;RIPOR2;DPYSL3;CCL19;CDC42EP4;CDC42;ARHGAP35;CROCC;PLEKHM1
prerank,response to chemokine (GO:1990868),-0.465552453415805,-1.1643329845903767,0.2857142857142857,0.7688676065155364,1.0,2/13,0.68%,SLC12A2;LRCH1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5050583003885906,1.162980133354063,0.3088235294117647,0.77907322106276,1.0,6/16,14.41%,ADCY7;APPL2;F2;PDCD4;ABCD2;CHID1
prerank,macrophage chemotaxis (GO:0048246),-0.48386190811183494,-1.1628191343747072,0.31277533039647576,0.7717046740848688,1.0,7/10,47.64%,CKLF;EDNRB;CCL2;CXCL17;CCL3;CCL5;LGALS3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2828357008844109,-1.1627213406385521,0.12883435582822086,0.7700351350949993,1.0,40/119,19.28%,PIP5K1B;EFR3B;PLCG2;INPP5D;BMX;PIK3R6;DPM1;MTMR2;SOCS2;TTC7A;INPP4B;PLEKHA3;PIGP;INPP5K;PLEKHA1;INPP5F;PGAP2;MTMR9;IP6K1;PIK3R3;ARF1;PIGB;SACM1L;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PIGL;PIK3CA;RAB4A;DPM3;PIGU;DPM2;PITPNM3;INPP5E;PIGO;SYNJ1;PIGV;RUFY1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4340143273397629,1.1627092191094524,0.2600896860986547,0.7790473307519894,1.0,4/35,3.16%,PAM;SLC27A5;ACSS3;HMGCLL1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.304476638625644,-1.1625832711728317,0.17105263157894737,0.7685096082069983,1.0,31/69,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4621641581210126,1.1623184797938317,0.2878338278931751,0.7793217170726188,1.0,8/23,15.02%,ENPP1;GLI3;MGRN1;TULP3;GLIS2;PTCH2;BTRC;SUFU
prerank,positive regulation of GTPase activity (GO:0043547),-0.26602631432828727,-1.1622355111075002,0.08045977011494253,0.76761132305117,1.0,44/188,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;TBC1D1;RGS6;ARHGEF15;SIPA1L2;TBC1D8;TBC1D14;TBC1D15;TGM2;ARHGAP27;RAP1GAP2;ERBB2;EZH2;TBC1D9;CCL14;NGEF;TBC1D30;ARAP1;RASGRF1;RGS7;CCDC125;LARS1;BCR;RUNDC1;RALGAPA2;SCRIB;RGS16;ARHGAP25;AGRN;RANGAP1;NF1;EVI5;CD40
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4477142919852565,1.162213129667167,0.2770167427701674,0.7787755810782414,1.0,2/28,1.86%,ITPR1;BCL2
prerank,positive regulation of cellular component organization (GO:0051130),0.37147845111964056,1.16203209243928,0.2308598351001178,0.7784326013552587,1.0,16/107,10.14%,ASAP1;TRABD2B;FRMPD4;AR;LRP1;RUNX1;APOE;TGFBR1;ADGRL1;CCL19;CDH5;LMAN1;DAB2;BCL2L11;CAMK2B;PLEKHM2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3845951206997231,1.16168867899932,0.24537607891491986,0.7786014127349878,1.0,19/88,11.96%,NRP1;ANGPT1;SPARC;NR2F2;VASH2;APOE;TGFBR1;SEMA5A;SULF1;VIP;ATOH8;AKT3;BMP2;ITGB3;ARNT;FGF2;PTPRM;RGCC;NR4A1
prerank,cellular response to alcohol (GO:0097306),0.4236064496376807,1.1614797550662856,0.2803738317757009,0.778357894724818,1.0,7/42,7.21%,ADCY1;ADCY2;ADCY7;ADCY5;SMO;SFRP1;SPHK2
prerank,positive regulation of synapse assembly (GO:0051965),-0.39024067102337445,-1.1611206481221816,0.2361963190184049,0.7693292496778946,1.0,12/27,17.60%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;CLSTN2;CLSTN3;AGRN;NLGN3;LRRC4B;VSTM5
prerank,regulation of interleukin-4 production (GO:0032673),-0.4124424566831527,-1.1605343260462238,0.261455525606469,0.769262655894919,1.0,6/21,18.96%,LEF1;SLC7A5;FCER1G;PRKCZ;ZFPM1;CD86
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.46134713160851176,1.160038783276285,0.28362573099415206,0.7818128378805702,1.0,8/26,17.55%,GAL3ST2;LARGE1;GBGT1;ALG11;ALG6;GOLPH3;GK;TNIP1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4849305120975497,1.1597565699754746,0.3058637083993661,0.7817751910344309,1.0,4/19,8.29%,PHYKPL;DDO;ASPA;ALDH7A1
prerank,phagosome acidification (GO:0090383),0.4613204988150994,1.1594635417658143,0.2873900293255132,0.7817800255320609,1.0,1/26,0.20%,ATP6V0A4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.39087509351671335,1.1589112869301812,0.26181353767560667,0.7825616701679036,1.0,12/75,6.63%,COL4A3;ROCK2;SPARC;DCN;HSPG2;WNT4;ISM1;THBS2;SULF1;SERPINF1;PML;EMILIN1
prerank,positive regulation of protein modification process (GO:0031401),0.35068875846461944,1.1588189739079129,0.1962719298245614,0.7819778096304056,1.0,37/203,13.68%,IGF2;TRABD2B;ROCK2;ANGPT1;LYN;DLC1;LEPR;IL34;PELI2;CCN1;NOS1AP;NNMT;GAS6;MT3;AXIN2;MUSK;SLCO3A1;CDH5;ENG;LRRK2;ATG10;NTRK3;STK4;DAB2;ARRB1;EGFR;BMP2;ITGB3;FGF2;DDX3X;F2;CAMTA1;INSR;RAP2A;TMEM119;RAB3GAP1;ALG10B
prerank,negative regulation of protein depolymerization (GO:1901880),0.457359882295046,1.1587974603234328,0.27439024390243905,0.781172816159485,1.0,8/24,21.34%,PLEKHH2;LIMA1;KATNB1;FGF13;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,oxoacid metabolic process (GO:0043436),0.461273428084784,1.158679114816748,0.2944693572496263,0.780683959790632,1.0,3/27,5.85%,ENPP1;TPST1;DDO
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3926933708254934,-1.1577337028826389,0.23333333333333334,0.7762187030969065,1.0,11/22,31.32%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ;CD300A;DUSP3;PRNP;GPS2;FCGR2B;PHPT1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4949993936603792,1.1576174187580057,0.30130293159609123,0.7828914840003272,1.0,3/19,6.86%,AR;NAB2;CEBPA
prerank,membrane organization (GO:0061024),-0.26063874729747966,-1.1574943556764363,0.038461538461538464,0.7750643046041359,1.0,36/227,8.99%,DNM3;CERT1;SGCZ;FNBP1L;SGIP1;ACTB;ANK3;RIMS1;EPN2;NUP93;REEP1;REPS2;CCDC88A;TFRC;PPT1;HSPA8;CBL;DYSF;FZD4;SH3GL2;TMEM33;SPTBN1;AMPH;ATP2C1;HIP1R;VAMP8;SUN2;PLEKHA3;SYT1;SYP;ARPC3;GAK;SH3KBP1;PACSIN2;RTP4;OSBPL2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.42210768097221335,1.1569548090474124,0.2849083215796897,0.7839569351875043,1.0,6/39,5.69%,NRP1;GDNF;GLI2;SALL1;NKX2-1;ENG
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.3343047995323066,-1.156604904740797,0.23985239852398524,0.7760157331930918,1.0,12/42,10.26%,UTRN;TEK;PTPRJ;CDK6;PTK2B;KDR;MYOC;EMP2;CDH13;VEGFA;JUP;SKAP1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5097691054914926,1.1565487959482146,0.2881646655231561,0.7842904047128738,1.0,3/14,4.30%,GAS6;RFFL;APOA1
prerank,endomembrane system organization (GO:0010256),0.3503484349011463,1.1565285256070985,0.21316964285714285,0.7834950226678176,1.0,48/178,16.38%,OBSL1;USP6NL;DMPK;LMAN2L;OPTN;SEC31A;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;ARFGEF2;ZW10;LRRK2;SNX33;UBXN2B;EIF2AK3;RAB22A;ALS2;TLCD1;TRIP11;LEMD3;MIA3;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;HOOK2;ATP8B2;TOR1B;FER1L5;TBC1D20;BAG5;HACE1;HUWE1;LAPTM4B;CUL7;GOLPH3;TOR1AIP2;ARFGEF1
prerank,negative regulation of locomotion (GO:0040013),-0.4681208513149179,-1.156381550074257,0.28841607565011823,0.7748312560773019,1.0,3/12,8.56%,FRMD5;PTPN2;CCDC125
prerank,stress granule assembly (GO:0034063),-0.40749243382925976,-1.1562919064328359,0.2607449856733524,0.7731791649231696,1.0,6/20,12.90%,BICD1;CSDE1;RPS23;LSM14A;YTHDF3;G3BP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3819166068359967,-1.1553454252955648,0.24024024024024024,0.7741932591703725,1.0,14/27,23.96%,IL1RAPL1;CCDC88A;MBOAT1;NTNG1;GSK3A;EFHC2;DISC1;CAMK2G;HOMER1;BRSK2;FBXO7;GSK3B;TREM2;CTNNA2
prerank,aspartate family amino acid metabolic process (GO:0009066),0.49198886242745216,1.1549093244625586,0.304552590266876,0.7874321173769423,1.0,3/18,6.15%,ASPG;MTHFR;ASPA
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.39688101199132697,-1.154718785912468,0.25,0.7741470565081023,1.0,4/21,4.35%,MTUS1;PTK2B;THBS1;CMKLR1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45402944448713123,-1.1545226542968583,0.2927400468384075,0.7728205886101409,1.0,6/14,21.67%,RPL7;NIFK;NOL9;RPL7L1;RPF2;ZNHIT3
prerank,myoblast fusion (GO:0007520),-0.46668839148899366,-1.1539581832900756,0.31295843520782396,0.7726559918606919,1.0,6/12,13.74%,ADGRB3;JAM2;ADAM12;NOS1;CD81;CACNA1H
prerank,actin nucleation (GO:0045010),-0.4029507078670396,-1.1539470640261673,0.2798913043478261,0.7707884750680226,1.0,6/21,19.35%,ARPC1B;SPIRE1;ARPC3;ARPC5L;ARPC4;LMOD1
prerank,regulation of cellular localization (GO:0060341),0.41048836924233895,1.1538814716140247,0.27019498607242337,0.7895739161601082,1.0,11/46,9.32%,GSN;LYN;ADCY5;CDK16;DYNC1H1;LRRK2;BRSK1;NR1D1;PARD6G;PARD6B;PRKN
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5229133303728632,1.1538436089024084,0.3121869782971619,0.7888327058112197,1.0,2/13,5.69%,NRP1;ENG
prerank,cellular response to retinoic acid (GO:0071300),0.43052238192413605,1.1536198788730552,0.2812939521800281,0.7886437041354356,1.0,6/42,6.62%,EPHA3;LYN;WNT8B;WNT6;PTK7;WNT5B
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5015946334330531,1.153453006783682,0.31518151815181517,0.7882912130295767,1.0,5/15,16.72%,GLI3;IL12B;EBI3;IL23A;SHH
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3901789406463123,-1.1533850258925606,0.26136363636363635,0.7706296516854221,1.0,9/24,27.96%,TTLL7;TTLL5;AGBL4;TTLL3;TTLL8;PARP1;TTLL6;TTLL2;AGTPBP1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4836623678380456,1.1532215032669981,0.3125,0.7881021098321181,1.0,6/20,14.18%,SULF2;SULF1;SMOC2;SPRY2;FGF2;DSTYK
prerank,carboxylic acid transmembrane transport (GO:1905039),0.41969130526603093,1.1532010373718378,0.28493894165535955,0.7873042397835166,1.0,10/40,15.61%,SLC7A11;SLC13A3;SLC7A13;SLC38A6;SLC38A9;ABCC5;SLC38A3;SLC7A6;SLC38A10;SLC38A2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.35872814555191385,1.151719903678662,0.24444444444444444,0.7907863572837103,1.0,13/116,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4106450489297082,1.1516212662104401,0.2787794729542302,0.7902479781351297,1.0,13/46,17.55%,TIMP3;LYN;FBLN1;RANBP9;EMILIN1;EPHB2;SPRY2;SPRED3;CNKSR3;PTEN;SPRED1;DUSP4;TNIP1
prerank,negative regulation of neurogenesis (GO:0050768),-0.3537631048580538,-1.1512359529732312,0.2508361204013378,0.7751375589240764,1.0,12/34,18.53%,NOTCH1;B2M;YWHAH;SORL1;GDI1;ARHGDIA;PTN;NF1;LINGO1;MAG;MCF2;RTN4R
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5036947111003308,1.150713508122666,0.2926829268292683,0.7920717422403667,1.0,7/16,23.00%,AUTS2;BCOR;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.43367686493289,1.1503398830197904,0.2834067547723935,0.7922905033954565,1.0,7/34,9.48%,LYN;LGR4;PTPRS;TLR6;NR1D1;IRAK3;RAB7B
prerank,protein heterooligomerization (GO:0051291),-0.42203362111843706,-1.1502900511162288,0.29292929292929293,0.7762148917170025,1.0,10/17,27.86%,KCNC2;GRIN2B;CPSF7;MAT2A;HSD17B8;TMEM120A;GRIN1;CBR4;CPSF6;PKD1
prerank,positive regulation of nervous system development (GO:0051962),-0.34060579685832654,-1.1500067365971398,0.22419928825622776,0.7752051869858053,1.0,17/42,16.30%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;TGM2;SNW1;CLSTN2;CLSTN3;CX3CR1;FAIM;MME;NUMB;NLGN3;LRRC4B;GPER1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5130984603122098,1.1499966978199097,0.3223570190641248,0.7924345573713717,1.0,4/13,11.82%,PGM3;LARGE1;RENBP;MGAT3
prerank,cellular response to glucose stimulus (GO:0071333),0.44500253334355877,1.14979169998754,0.29246676514032494,0.7921715348363758,1.0,3/30,5.19%,ZBTB20;GAS6;PRKAA2
prerank,peptide hormone secretion (GO:0030072),0.4575887637257412,1.1497677589327575,0.2993920972644377,0.791394902905456,1.0,5/26,5.61%,SLC30A8;CDK16;NEUROD1;VIP;FAM3B
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.468612698028951,1.1497323477026367,0.2942989214175655,0.7906634667087432,1.0,4/24,10.48%,ITPR1;CCL19;FGF2;ANXA6
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.49189892899396,-1.1494838403094272,0.3157894736842105,0.7750207066396513,1.0,7/10,31.21%,NOTCH1;LRP6;LIN7C;DLL4;ARHGAP12;TBX20;PHACTR4
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.55499645430653,1.1491425796156707,0.3177737881508079,0.7914912943609804,1.0,1/10,0.24%,BMP6
prerank,male meiosis I (GO:0007141),0.5045734098025781,1.148945428928382,0.30155979202772965,0.7911924056781297,1.0,6/16,17.51%,HSF2BP;ZSCAN21;SYCP3;MYBL1;FOXJ3;DDX4
prerank,regulation of protein ubiquitination (GO:0031396),0.3644540516198547,1.1487919135165254,0.25961538461538464,0.7907976197318336,1.0,22/108,15.21%,MYCBP2;ANGPT1;SASH1;OGT;TGFBR1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;ARRB1;SPRY2;COMMD1;PRKN;UFL1;FBXO4;HDAC8;RIPK2;FANCI;UBE2D1;BAG5;HUWE1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5379564007845172,1.1486090639250368,0.3125,0.7904611052562326,1.0,4/12,14.80%,ABCA1;ITGB3;ITGAV;NR1H3
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.3034237715018738,-1.1483887830319988,0.189873417721519,0.7765138011089617,1.0,17/64,11.43%,UTRN;EFNA5;CDK6;ACER2;PTK2B;THBS1;LIMCH1;GPM6B;ADAM15;MYOC;EMP2;CDH13;NEXMIF;JUP;SKAP1;PEAK1;NF1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5102114478227162,1.1481843589637097,0.3122866894197952,0.7908656514911646,1.0,3/16,9.29%,SLC2A10;SLC45A3;SLC5A3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.49417660168662236,-1.1480347159794007,0.31019522776572667,0.7757405756805197,1.0,3/10,12.70%,CD55;TGFBR2;CD81
prerank,heart contraction (GO:0060047),0.4192804764742262,1.1480103457712645,0.2833333333333333,0.7905243766117284,1.0,7/41,9.66%,SLC8A1;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,regulation of Rac protein signal transduction (GO:0035020),0.49213816780223335,1.1479600693529348,0.30971993410214166,0.7898198481579748,1.0,4/16,11.51%,AUTS2;OGT;ALS2;KBTBD7
prerank,positive regulation of apoptotic process (GO:0043065),0.3311284210632288,1.1477171389212737,0.19351464435146443,0.7897015910337045,1.0,59/293,16.01%,STK17B;EPHA7;DAPK2;PTGIS;DAPK1;DLC1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;TGFBR1;NUPR1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;ARHGEF17;SIK1;ING5;SPHK2;SIRT2;ARHGEF18;TRAF7;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,negative regulation of cellular process (GO:0048523),0.32448566383415717,1.1475322616030788,0.1317907444668008,0.7894607203082611,1.0,127/521,17.57%,PLXNA2;GJA1;ENPP1;COL4A3;CCN2;ANGPT1;TGFBR3;TXNIP;SMAD3;AR;LYN;DLC1;BCL2;PODN;CCN1;SP100;RIPOR2;PDS5B;NUPR1;SEMA5A;UBR2;PDCD5;FBLN1;APOA1;RAPGEF2;TSPYL2;APPL2;IRF1;MT3;AXIN2;RARG;SFRP1;CCN5;PDPN;CYP1B1;BCL6;SKI;CASK;ALDH1A2;APBB2;PML;EMILIN1;PARP16;CEBPA;ING5;P3H3;SPHK2;SIRT2;EIF2AK3;MAP2K1;NMI;RNF139;PIWIL4;DSCAM;EPHB2;CD200;BMP2;KAT2B;CCN4;PRKN;S100A11;MIA3;STK11;INCA1;RBBP7;SLIT3;FGF2;ANXA6;FGFBP1;DDX3X;IGFBP3;GSDME;IFNK;JADE1;CGRRF1;RGCC;ST7L;SPOCD1;NME6;RAD18;REST;NR4A1;IMPACT;CD33;PLXNC1;NIBAN2;CDA;PDCD4;SIPA1;ACVR1B;DACT2;MUL1;NOX4;NPAS2;SYT11;TSC2;GLMN;PLXNA1;PTEN;CLMN;ETS1;FRK;MDK;PLXNB2;NR1H3;FER1L5;BMP4;SFRP4;RBM5;TMBIM6;SESN2;PRKRA;BMP5;ZBTB17;SST;SPEG;KANK2;ADAMTS1;ATF5;SHH;TNS2;CDKN2C;MYBL1;VPS13C;DDX4;DCBLD2;CDK10
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5010985383907366,1.1474624134305342,0.31155778894472363,0.7888327784449737,1.0,7/16,16.46%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,negative regulation of coagulation (GO:0050819),0.5173130702340796,1.147430386742647,0.3157894736842105,0.7880878673469134,1.0,4/14,5.43%,SERPINE1;APOE;VTN;TFPI
prerank,response to interleukin-4 (GO:0070670),-0.4952222099586176,-1.147419948890754,0.29718004338394793,0.7759142022104323,1.0,1/10,0.16%,LEF1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5082439602612399,1.1473088145496926,0.3141891891891892,0.7876217148855573,1.0,4/15,20.47%,HECW2;NEK6;TPR;CDC23
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4851711806689318,1.146986938911471,0.3279742765273312,0.7876813439636003,1.0,2/19,3.11%,ENPP1;TPST1
prerank,neuron projection regeneration (GO:0031102),0.5482971819268084,1.1469829152269762,0.3368421052631579,0.7868596114200286,1.0,2/10,4.34%,NREP;MTR
prerank,establishment of melanosome localization (GO:0032401),-0.41279673106948006,-1.1468729776746733,0.2884097035040431,0.7756877670876553,1.0,8/19,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,positive regulation of immunoglobulin production (GO:0002639),0.43519430759501143,1.146796278282651,0.29461756373937675,0.7865900738143905,1.0,3/31,8.62%,RBP4;KMT5B;EPHB2
prerank,mesenchymal cell development (GO:0014031),-0.4166671502359284,-1.1466234876626846,0.29581151832460734,0.774584349716605,1.0,8/18,28.16%,CDH2;NOTCH1;HEY2;SOX8;HEYL;SNAI2;NOLC1;TBX20
prerank,polyamine metabolic process (GO:0006595),0.5320336022903276,1.146322140664274,0.3315972222222222,0.7870902905280955,1.0,5/13,22.74%,SMOX;SMS;SAT2;SAT1;HDAC6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.47642835542134576,1.1456199945797911,0.31993817619783615,0.7881975251365392,1.0,2/21,4.57%,EPHA7;MT3
prerank,retrograde axonal transport (GO:0008090),-0.4327669028906936,-1.145215249041362,0.2706766917293233,0.777052814700818,1.0,8/16,27.71%,DLG2;TMEM108;PAFAH1B1;KIF1A;KIF5A;HAP1;SOD1;ACTR10
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4771388072534093,1.1449960635502057,0.29936305732484075,0.7891849964445614,1.0,4/18,8.20%,DAAM2;IL34;SLC45A3;DRD3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.35674282429618925,1.1447759937184498,0.24882629107981222,0.789028252913586,1.0,13/117,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4798761325556743,1.144730851709182,0.3011647254575707,0.7883274713576002,1.0,8/20,21.45%,SLC8A3;MCU;PMPCB;MICU2;YME1L1;PHB2;AFG3L2;STOML2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.384177993058427,-1.1441757127000975,0.27624309392265195,0.7785266948839177,1.0,8/25,15.19%,SLIT2;ARHGAP44;LIMK2;TBC1D30;CEP97;TESK1;ABI3;PLXNB3
prerank,regulation of cell population proliferation (GO:0042127),0.3215068476525821,1.1435472816816252,0.1214859437751004,0.7909696864306673,1.0,118/691,14.09%,IGF1;TCF7L2;BMP6;IGF2;ESM1;COL4A3;ELN;GDNF;PDGFD;KSR1;AREG;AR;TGFA;IL31RA;LYN;DLC1;BCL2;GRK5;PODN;RUNX1;FGFR1;IL6R;BMPR1A;IL34;OSMR;EPGN;FGFR2;KIT;FGFR4;RBFOX2;YAP1;PDGFRA;PDS5B;EFNB2;PDGFRB;TGFBR1;NUPR1;NPR3;PDCD5;CSF1;RAPGEF2;IRF1;NTF3;HTR1A;AXIN2;PHIP;RARG;SFRP1;CTSH;PDPN;TBX3;CYP1B1;VIP;BCL6;ENG;ZFP36L1;SKI;ALDH1A2;NUAK1;PML;BEX4;CEBPA;AGTR1;ING5;P3H3;TSLP;WWTR1;RAB25;IL13RA1;SIRT2;MAP2K1;NMI;RNF139;TET1;NTRK3;EGFR;CD200;BMP2;KAT2B;STAT5B;TRPM4;S100A11;ITGAV;STAT2;STK11;INCA1;FGF2;CDC123;TSPO;FGFBP1;SETD4;IGFBP3;GSDME;IFNK;HBEGF;ADRA2A;CGRRF1;UFL1;RGCC;REST;CD33;NIBAN2;GLI1;HMGN5;INSR;STAT6;FOLR2;NOX4;EGF;STAT4;TSC2;GLMN;HDAC4;PTEN;FLT3LG;CLMN;ETS1;FRK
prerank,protein glycosylation (GO:0006486),0.36087472693460015,1.143434224153619,0.25406032482598606,0.7904756356799627,1.0,26/125,13.98%,GALNT18;GALNTL5;B3GALT1;OGT;ST3GAL5;PGM3;MAN1C1;ST3GAL3;LARGE1;MOGS;LARGE2;FUT10;B4GALT1;STT3A;DOLPP1;TET1;B3GALNT1;GFPT1;ALG5;ALG11;MGAT3;POMT1;DDOST;GALNT6;ALG10B;ALG6
prerank,negative regulation of phosphorylation (GO:0042326),0.3703740544759596,1.1432502364405226,0.23786407766990292,0.7901259837576771,1.0,23/85,15.47%,PID1;PTPN13;PLPP3;LYN;DYNLL1;NUPR1;FBLN1;CDK5RAP3;LRRK2;WWTR1;NTRK3;NCOR1;EPHB2;PRKN;MYADM;IGFBP3;IMPACT;HDAC4;PTEN;IBTK;BMP4;CDKN1C;NPRL2
prerank,lamellipodium organization (GO:0097581),-0.36468515185883676,-1.1429280593339732,0.22875816993464052,0.7805624457616993,1.0,9/29,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;SNX1;ABLIM3;ABLIM2
prerank,pyruvate metabolic process (GO:0006090),-0.32171502730835255,-1.1426644822058578,0.19391634980988592,0.7796332687123284,1.0,13/52,12.09%,BSG;GPI;HK2;DLAT;SLC16A1;ME1;PDHX;PFKL;TPI1;PFKFB1;ALDOA;LDHB;ME2
prerank,regulation of cell motility (GO:2000145),0.3570311283069095,1.142663242469516,0.2613240418118467,0.7909970263783538,1.0,27/121,14.42%,PLXNA2;LDB2;ROCK2;AMOTL2;DOCK10;ARHGAP18;MACF1;CCL19;FBLN1;TBCCD1;BEX4;MEMO1;PARD6B;EGFR;NTN1;LMO4;FGF2;NEXN;AMOTL1;HBEGF;CCDC25;MGAT3;PLXNC1;EGF;PLXNA1;PLXNB2;FLNA
prerank,cardiac muscle cell contraction (GO:0086003),-0.40290081948210765,-1.142342030202879,0.23848238482384823,0.7787361036080479,1.0,8/19,15.08%,KCNJ2;ATP1A1;SCN1A;CAMK2D;FGF12;PIK3CA;CACNA2D1;CACNA1D
prerank,tRNA aminoacylation (GO:0043039),-0.33790316054017916,-1.1420615409749508,0.24482758620689654,0.7777582136829233,1.0,12/37,22.19%,WARS1;WARS2;LARS1;YARS1;YARS2;QARS1;KARS1;FARS2;AIMP1;MARS2;AIMP2;TARS1
prerank,neuron migration (GO:0001764),0.4058313761225445,1.1417044294805934,0.2886178861788618,0.7928761666699204,1.0,7/48,5.49%,NRP1;AUTS2;FGFR1;MARK1;SH3RF1;RAPGEF2;LRP12
prerank,AMP metabolic process (GO:0046033),0.5289181905027883,1.1409630041330296,0.3409490333919156,0.794198780295115,1.0,2/13,3.28%,AMPD3;NUDT2
prerank,generation of neurons (GO:0048699),0.3418181899434098,1.1406589429205771,0.24,0.7942993182321196,1.0,25/190,7.60%,NRP1;AUTS2;RUNX1;FGFR1;MARK1;SH3RF1;WNT8B;FZD2;WNT4;ASCL1;YAP1;RUNX2;WNT6;RAPGEF2;NEUROD4;NEUROD1;FZD1;LRP12;THOC2;ATOH8;HES7;SMARCA1;WNT5B;BRSK1;MAP2K1
prerank,myelination (GO:0042552),-0.3310483791962084,-1.140584211463241,0.22887323943661972,0.7804157250827567,1.0,15/46,14.74%,ADGRG6;ACER3;MAL;CMTM8;B4GALT5;MYOC;SCN2A;EIF2B5;DEGS1;TNFRSF21;NF1;MAL2;MALL;PLP1;NFASC
prerank,regulation of hydrolase activity (GO:0051336),-0.2992829111766115,-1.1401678640367239,0.21008403361344538,0.7798224218708213,1.0,18/71,7.22%,CHN2;EFNA5;FGD5;CAV1;PLXNA4;ARHGAP44;VAV3;RABGAP1;SIPA1L1;RASIP1;PRKG1;RDX;TBC1D15;ARHGAP27;EPHA5;NOS1;NGEF;CHN1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.4076450298352069,-1.1400614769306328,0.30193905817174516,0.7783107792780483,1.0,11/20,27.21%,GATM;GCLM;PTDSS1;OPLAH;GAMT;GCLC;GGT1;GGCT;PLSCR1;GSS;PLOD2
prerank,positive regulation of protein import (GO:1904591),0.4409787672988647,1.139703729640637,0.2950075642965204,0.7963550651262767,1.0,10/30,18.63%,PIK3R1;SMAD3;ZIC1;PDCD5;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3522580350618741,-1.1396509764674605,0.24761904761904763,0.7777774839898387,1.0,16/36,24.79%,SDCBP;RYBP;OPHN1;RPL11;HSP90AB1;AQP11;PSMF1;GIPC1;N4BP1;FHIT;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;PRKCG
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3771460096442901,1.1394205014576084,0.28,0.7963096251042886,1.0,14/80,10.99%,SAMD4A;ROCK2;PLD1;EPHA4;SMPD2;CPEB3;CD28;SPHK2;SLC2A13;METTL14;PICALM;EIF6;NSMAF;DDX3X
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5088976194709092,1.1385913354478199,0.33276740237691,0.7979552380103955,1.0,1/14,0.63%,ENPP1
prerank,negative regulation of mRNA processing (GO:0050686),-0.4365512764330963,-1.1385568563512032,0.289002557544757,0.7794729234503863,1.0,9/15,32.67%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1;BARD1
prerank,B cell differentiation (GO:0030183),-0.3257674785320646,-1.138454552543528,0.2326388888888889,0.7780632035439243,1.0,28/46,36.43%,PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;BLNK;PTPRC;JAK3;ADGRG3;MSH2;KLF6;VCAM1;DCAF1;CEBPG;IRF2BP2;GPS2;FLT3;CR2;LYL1;IL11;MS4A1;ZBTB7A;CLCF1;SYVN1;IL4;CD79A
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.3624490339223391,-1.1382175245074935,0.267515923566879,0.7770214389865876,1.0,9/33,4.18%,BMPER;SEMA6A;THBS1;PPP1R16B;EPN2;CEMIP2;TJP1;KLF2;FGF1
prerank,regulation of cell communication (GO:0010646),0.42248371564653586,1.1381302640560886,0.3031161473087819,0.7984790188081966,1.0,4/35,4.40%,SLC8A1;GRK3;GRK5;TSPYL2
prerank,cellular response to organic substance (GO:0071310),0.35941992428116304,1.1375462774561356,0.27014218009478674,0.799444613901647,1.0,17/116,8.85%,CLEC3B;PID1;GHR;SMAD3;PTPN13;BMPR1A;PTPN20;TGFBR1;DPYSL3;ACVR1;NCOA2;SFRP1;IGFBP5;CYP1B1;LRRK2;PTPN9;STAT5B
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4178942569895108,-1.1372801389446383,0.2532981530343008,0.7780488014229271,1.0,5/19,2.91%,PRKCH;OCLN;CLDN5;F11R;TJP1
prerank,regulation of transferase activity (GO:0051338),0.483983169228815,1.13699252693672,0.3176470588235294,0.8002841956278709,1.0,1/17,0.36%,LDB2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38534518893348607,-1.1365690474745638,0.29444444444444445,0.7766168159185818,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38534518893348607,-1.1365690474745638,0.29444444444444445,0.7766168159185818,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5023097932051833,1.1363845874720153,0.30756302521008405,0.8012102241544939,1.0,10/16,25.66%,LRRK2;BCAP31;MIA3;UBAC2;SEC16B;SEC16A;HSPA5;PPP1R15A;ANK2;VAPA
prerank,circulatory system development (GO:0072359),0.35697815195259985,1.1359648756216119,0.2654970760233918,0.801539690303831,1.0,21/118,8.83%,RBP4;FBN1;PDLIM5;HSPG2;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;CDH5;ADAP2;BCOR;CRB2;CACNA1C;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4190953842106958,1.1349963242323318,0.2784992784992785,0.8034787473639328,1.0,5/38,7.78%,RORA;RHOH;TLE1;MAPKBP1;NR1D1
prerank,organelle organization (GO:0006996),0.32695190848164285,1.1348632862129537,0.19285714285714287,0.8030453649445354,1.0,109/388,19.67%,SH3D19;MICAL3;NEDD9;OBSL1;TPM1;PYROXD2;USP6NL;LMAN2L;MARK1;ANK1;OPTN;SEC31A;APOE;RAB30;MYO18A;PALLD;CNN2;WDPCP;FGD1;GORASP2;BRWD1;ARHGAP21;TMED1;GOLGB1;PHIP;LIG4;FGD4;FAF2;DES;LMAN1;ARHGAP10;CDC42;ZW10;RANBP9;LRRK2;UBXN2B;EPS15;EIF2AK3;CSPG5;WTIP;PLD2;MAST2;CAPZB;TRIP11;WDR81;PRKN;MIA3;RHOT1;ARL1;TMED4;PLEKHM2;LONP2;TJAP1;TFAM;PDZD8;POLRMT;PEX6;GOLPH3L;CFAP410;GORASP1;FGD3;SLC25A36;PEX2;SIPA1;GOLGA8B;GOLGA5;CHMP5;RAB3GAP1;ABCA3;TANGO2;CECR2;MDK;ABCD2;ATP8B2;TOR1B;PEX11B;TBC1D20;BAG5;HACE1;HUWE1;PIKFYVE;AUP1;CUL7;GOLPH3;VPS13D;TOR1AIP2;ARFGEF1;LONP1;RHOU;VPS13C;CAMSAP1;RAB32;TMED10;DYRK3;PRKCI;YME1L1;CSNK1A1;PHB2;ODF2;SEC16B;DPYSL2;CDCA8;SIRT5;HTT;NUMA1;SMPD4;ZFYVE16;PEX7;NSFL1C
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3283674591130504,1.1348380076805444,0.2027168234064786,0.8022866779227626,1.0,79/327,18.97%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZMIZ1;ZBTB4;NONO;MZF1;ACTN4;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;COPS2;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,glycolipid biosynthetic process (GO:0009247),0.41694198986866005,1.1347861472213556,0.3025936599423631,0.801600576585534,1.0,4/38,4.33%,ST6GALNAC5;ST3GAL5;LARGE1;GBGT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.46597905388822214,1.1346207001387187,0.3069306930693069,0.8012810631923474,1.0,4/20,7.37%,EPHX2;APOE;GNB3;SREBF1
prerank,negative regulation of endocytosis (GO:0045806),0.45420693622994807,1.1340445188087964,0.32533733133433285,0.8021118454297849,1.0,6/24,15.37%,EPHA3;SNX33;PICALM;SYT11;NR1H3;ARF6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47054260299628325,1.1338806042513212,0.2985553772070626,0.8017862160687048,1.0,8/19,20.89%,RUNX1;WNT4;EMILIN1;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.40657574865008633,1.1335758791801298,0.3163841807909605,0.8018565096267485,1.0,9/42,16.19%,SERPINE1;IL6R;OPTN;IL12B;CAMP;RNASE7;F2;GSDMD;IL23A
prerank,homocysteine metabolic process (GO:0050667),0.5297056451349988,1.1335602502457776,0.3321976149914821,0.8010829292666231,1.0,4/11,13.13%,MTHFR;DPEP1;MMUT;NOX4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.4747852153370518,-1.1335553880886047,0.3225058004640371,0.7844036933974733,1.0,5/10,13.51%,PDE4D;PDE3B;PDE2A;UBE2B;APLNR
prerank,positive regulation of signaling (GO:0023056),-0.33090575783644527,-1.1335265418796636,0.26031746031746034,0.7826760561720939,1.0,12/37,12.19%,RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;INPP5F;EDN1;SCRIB;CLSTN3;NSF;HOMER1;CD80
prerank,extracellular matrix disassembly (GO:0022617),0.39042594153496474,1.1330040392453102,0.30277777777777776,0.8018980535282104,1.0,13/53,14.33%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1;NOXO1;CTSL;HPN
prerank,positive regulation of tissue remodeling (GO:0034105),0.5426550703750261,1.1329814790864094,0.34205933682373474,0.8011405315145114,1.0,2/10,6.81%,ROCK2;IL12B
prerank,regulation of cell junction assembly (GO:1901888),-0.368385905873876,-1.13295619331495,0.28059701492537314,0.7828232406062566,1.0,7/27,2.91%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;F11R;TJP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4414014788994695,-1.1327912521689771,0.30445544554455445,0.7815449794017637,1.0,8/14,30.81%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.46485082868586164,1.1326489822172876,0.3333333333333333,0.8012464179972011,1.0,7/20,19.02%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C;CDKN1B
prerank,regulation of protein localization to cell surface (GO:2000008),0.422594832819463,1.1320820718715596,0.31958762886597936,0.802042320147053,1.0,10/33,19.68%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3;EGF;BDNF;TM9SF4;ABCA7
prerank,regulation of protein kinase activity (GO:0045859),0.35706265746379756,1.1318725329263424,0.267538644470868,0.8018431406072629,1.0,11/106,4.40%,PDPK1;DDR2;PPM1E;CCN1;DTNBP1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;TSPYL2
prerank,neutrophil chemotaxis (GO:0030593),-0.3210133116411159,-1.1317173325068821,0.264,0.7830867680998617,1.0,9/53,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4584995215598039,-1.1313868773555569,0.2967289719626168,0.7823513879023553,1.0,4/12,9.72%,ANK3;NOS1;ATP1B1;WNK2
prerank,positive regulation of neurogenesis (GO:0050769),0.37780026170144876,1.1313834307240054,0.28005115089514065,0.8024395621676357,1.0,8/68,5.78%,ROBO1;PLXNA2;OBSL1;TIAM2;NUMBL;LIG4;CUX2;SERPINF1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.47657684382359117,1.1310670257884683,0.32298136645962733,0.8025674228897448,1.0,4/20,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,RNA destabilization (GO:0050779),0.4660978831129614,1.130952034798537,0.319935691318328,0.8020962334506243,1.0,10/18,27.73%,ROCK2;DXO;METTL14;METTL3;YTHDF2;FTO;METTL16;GIGYF2;ZC3H18;PUM1
prerank,regulation of JNK cascade (GO:0046328),0.3619957182432091,1.1307539608874184,0.2709599027946537,0.8018442710355961,1.0,19/101,12.75%,CCN2;TGFBR3;SH3RF3;DACT1;SH3RF1;GADD45B;CCL19;EDAR;MTURN;NCOR1;EGFR;MAP4K4;PRKN;LTBR;ITCH;CARD9;TAOK3;DUSP19;RAP2A
prerank,endothelial cell differentiation (GO:0045446),-0.45575215324956886,-1.1307362830065066,0.32516703786191536,0.782634845670648,1.0,6/12,19.43%,TIE1;KDR;ACVRL1;SOX18;BMPR2;ACVR2B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2761712548996019,-1.1307195128626455,0.19375,0.7809104336276838,1.0,33/114,23.95%,TMSB4X;PTK2B;TNFRSF11A;ST18;NFKBIA;TNFRSF11B;AIM2;JAK2;BAG4;TRAF5;EIF5A;CARD14;CD40;PSMF1;TRAF1;TXNDC17;PSMB8;PSMA4;PSMB10;PSMB2;LIMS1;CD27;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;COMMD7;CHUK;TNFRSF12A;PSMA8;PSMB1
prerank,regulation of myoblast fusion (GO:1901739),0.5321689559868211,1.1306697937436274,0.32967032967032966,0.8012678056802848,1.0,3/11,11.17%,RIPOR2;CFLAR;CD53
prerank,regulation of phosphate metabolic process (GO:0019220),0.48884006262623375,1.1302843110942553,0.3333333333333333,0.8015196341586343,1.0,3/16,7.38%,SRPX2;GNB3;SIRT2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3780355948995536,-1.129877369611007,0.27070063694267515,0.7818441706611825,1.0,9/25,14.09%,CAV1;CTNNA3;CAMK2D;CALM1;JUP;CALM3;CXADR;RYR2;DSG2
prerank,sulfate transport (GO:0008272),-0.44399149484076367,-1.129274034753906,0.3015075376884422,0.7819645958516453,1.0,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,chromosome organization (GO:0051276),0.35807169639209935,1.129009700623232,0.2811004784688995,0.8043113984605978,1.0,17/99,12.96%,TCF7L2;SETD7;BRWD1;AXIN2;LIG4;MTHFR;CUL4B;TOP2B;TCF7L1;POLE3;PHF1;CENPH;L3MBTL1;RAE1;HDAC8;GPS1;COPS3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4909040892964832,1.1287738592944205,0.31711409395973156,0.8042274057206451,1.0,3/15,3.57%,FGFR2;PDGFRA;TGFBR1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.48589200035487845,-1.1283827296088864,0.3274336283185841,0.7830470991717355,1.0,3/10,10.51%,ENPP2;PLA2G7;PNPLA8
prerank,positive regulation of protein ubiquitination (GO:0031398),0.37041591122142986,1.1280538738476416,0.2672634271099744,0.8054148224749507,1.0,15/80,15.26%,MYCBP2;ANGPT1;ARRDC4;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;FANCI;UBE2D1;HUWE1;DCUN1D2
prerank,synaptic membrane adhesion (GO:0099560),0.5067181862857781,1.1280474681393493,0.3333333333333333,0.8046166221358414,1.0,2/14,5.18%,GPC6;PTPRS
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5250048300391881,1.1278430499058574,0.346483704974271,0.8044231895866182,1.0,3/12,3.81%,DOCK10;DOCK11;NOTCH2
prerank,regulation of transport (GO:0051049),0.4197555245789116,1.1272256852364622,0.3236994219653179,0.8053954152609116,1.0,6/36,9.32%,NRP1;LEPR;SLC30A8;LRRK2;RAB25;PRKN
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.4774138674548311,1.127152732453841,0.34,0.8047945119405341,1.0,1/18,0.43%,FBN1
prerank,muscle cell development (GO:0055001),0.4320148066798526,1.1270670848482294,0.3288888888888889,0.8042182596124449,1.0,4/30,6.56%,IGF1;SLC8A1;ENG;SDC1
prerank,steroid hormone biosynthetic process (GO:0120178),0.4303456965603863,1.1267880062243854,0.3180473372781065,0.8042286248692785,1.0,5/29,10.90%,AKR1B1;STAR;HSD3B2;SRD5A1;TSPO
prerank,phospholipid biosynthetic process (GO:0008654),-0.3520347703980147,-1.1267691558353718,0.25573770491803277,0.7862683225999493,1.0,5/36,4.46%,SGMS1;SGMS2;CPNE3;LPCAT1;MBOAT1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4545982155989302,-1.1266384084418855,0.31965442764578833,0.7849231497582183,1.0,5/11,33.80%,ITM2A;BACE2;NECAB2;ITM2C;NECAB3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37792618236778036,1.1265700074198404,0.2964376590330789,0.8039999348820998,1.0,17/66,17.14%,PIK3R1;SMAD3;ZIC1;YAP1;CDK5RAP3;WWTR1;EIF2AK3;RBM22;F2;NMD3;FLNA;SESN2;PIK3R2;UBR5;AKT1;LIF;EFCAB7
prerank,negative regulation of nuclear division (GO:0051784),0.5423662106136901,1.1262998992269964,0.36313868613138683,0.8039495294741287,1.0,3/11,14.89%,TOM1L2;NME6;BMP4
prerank,potassium ion export across plasma membrane (GO:0097623),-0.45400377529673785,-1.1260144492855142,0.29906542056074764,0.7850356270025678,1.0,3/13,5.44%,KCNK5;KCND3;KCNQ1
prerank,regulation of ion transport (GO:0043269),-0.2884292125090117,-1.1256471110121962,0.2132701421800948,0.7843518440636569,1.0,14/76,6.92%,NKAIN2;KCNJ2;ATP1A1;ANK3;NEDD4L;B2M;KCNJ3;PXK;YWHAH;NKAIN1;P2RX7;NKAIN3;NOS1;SYT1
prerank,vacuolar acidification (GO:0007035),0.46879037201413926,1.1250402438921292,0.31875,0.80671722422641,1.0,1/21,0.20%,ATP6V0A4
prerank,inorganic cation transmembrane transport (GO:0098662),0.3315224935601752,1.124807606144138,0.24309978768577495,0.8065009274907269,1.0,30/268,9.62%,SLC1A3;ATP6V0A4;KCNK2;SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;TRPA1;ATP1A2;SLC41A1;SCARA5;SLC6A9;SLC30A8;GAS6;SLC6A13;SLC9A9;SLC24A1;SLC30A2;KCNK7;SLC11A2;SLC24A5;CACNA1C;SLC30A10;NNT;KCNQ4;SLC9A5;KCNJ14;TRPM4;ITGAV
prerank,vasculature development (GO:0001944),0.4941801115801306,1.124474310392466,0.3497536945812808,0.8066801720041907,1.0,5/16,9.86%,ERRFI1;PDGFRA;PDGFRB;CDH5;STK11
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5404795393492583,1.123892831330301,0.36229205175600737,0.8076069907019926,1.0,4/10,9.06%,HECW2;NEDD4;OSR1;COMMD1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3512352763314416,-1.1237447148892394,0.2990353697749196,0.7884653335420103,1.0,13/33,18.60%,DNM3;NLGN1;AMPH;OPHN1;CDK5;SYT1;GAK;ITSN2;PACSIN1;NLGN3;DNM1;STX1A;SYNJ1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3689480254899201,1.1237323370089713,0.28716645489199494,0.807241825257243,1.0,18/76,17.55%,MYCBP2;ANGPT1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;MUL1;HDAC4;FANCI;UBE2D1;HUWE1;DCUN1D2;UBE3A;TNIP1
prerank,cellular component disassembly (GO:0022411),0.38956114294354527,1.1236583193165313,0.3009845288326301,0.8066228505935265,1.0,10/53,9.84%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.42034994465704834,-1.1234529881870103,0.3325301204819277,0.7875762223206405,1.0,4/15,15.96%,ARPC1B;ARPC3;ARPC5L;ARPC4
prerank,positive regulation of protein metabolic process (GO:0051247),0.3549859643708289,1.1233987661558549,0.2779783393501805,0.806554039145984,1.0,15/110,6.90%,ROCK2;HECW2;DACT1;NKD1;SLC6A9;IL17D;APOE;CSF1;NEDD4;SLC25A37;SMURF2;VIP;RANBP9;IL12B;AGTR1
prerank,heart process (GO:0003015),-0.43771597399300366,-1.1232097652825201,0.31840796019900497,0.7866242746336372,1.0,1/14,0.35%,SGCZ
prerank,positive regulation of neuron death (GO:1901216),0.3979858434134729,1.1226540270963796,0.3,0.807873461635919,1.0,5/46,9.04%,EPHA7;EFNB2;NUPR1;TLR6;PICALM
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4215539432187185,1.1223959669661492,0.3142437591776799,0.8078035438383296,1.0,3/34,8.62%,RBP4;SPHK2;EPHB2
prerank,aminoglycan catabolic process (GO:0006026),0.4334222864144917,1.1222275064293685,0.31341107871720114,0.8075084081989935,1.0,3/28,6.56%,GPC6;HSPG2;SDC1
prerank,protein localization to cell junction (GO:1902414),-0.38370352993249085,-1.1221310059340703,0.3044776119402985,0.7881781231205863,1.0,8/22,12.65%,NLGN1;TJP2;TJP1;NECTIN1;HEG1;SHANK1;PCLO;PAK2
prerank,negative regulation of secretion by cell (GO:1903531),-0.3446257904323464,-1.122073491614216,0.29573170731707316,0.78658572285145,1.0,4/38,2.20%,GRM7;STXBP6;IL1RAPL1;NOTCH1
prerank,microglial cell activation (GO:0001774),-0.38796218751012623,-1.1220643225924591,0.2864721485411141,0.7848847789702322,1.0,8/21,24.16%,JAK2;CX3CR1;APP;CLU;AGER;AIF1;TREM2;IFNGR1
prerank,positive regulation of metabolic process (GO:0009893),0.3583968685702438,1.1219573461484733,0.27751196172248804,0.807475173394706,1.0,22/103,15.28%,GJA1;CAMK1D;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;INSR;STAT6;DECR1;DIO2;G0S2;FASN;CNOT3;IL4R;GRB10
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.4440874567642271,1.1219166206986415,0.3402985074626866,0.806794384119723,1.0,7/29,13.57%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,cellular response to chemokine (GO:1990869),-0.31958359209677906,-1.1216751169626282,0.25704225352112675,0.7842865483699296,1.0,5/46,6.29%,SLC12A2;LRCH1;PTK2B;ACKR3;CCL14
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4322996843763304,1.1216316768968795,0.3362193362193362,0.8067799773132532,1.0,2/32,0.72%,PDPK1;CEMIP
prerank,gliogenesis (GO:0042063),-0.42910936486043577,-1.1215050391086048,0.315,0.7831221392481674,1.0,3/15,3.96%,CDH2;CDK6;TGFB2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.4353932606416965,-1.1213986491659378,0.3154034229828851,0.7817396192199462,1.0,6/14,19.53%,THBS1;NOTCH1;KLF4;DLL4;ITGB1BP1;PDCD10
prerank,phosphorylation (GO:0016310),0.32010071684941627,1.1212598897105415,0.21721311475409835,0.8070722343479809,1.0,66/385,14.17%,STK17B;EPHA7;DAPK2;PDPK1;PDK1;NRK;ROCK2;CDK14;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;BMPR1A;DMPK;MARK1;PRKAG2;GAS6;TGFBR1;ACVR1;CDK16;PRKAA2;MAP3K20;NUAK1;LRRK2;AKT3;SIK1;SPHK2;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EPHB2;BMP2;MAP4K4;CAMK2B;XYLB;STK11;RNASEL;RYK;TTBK1;NEK6;BRAF;TAOK3;PI4KA;IGFBP3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;ACVR1B;MARK2;PIK3R4;CDK12;CERK;FRK;MERTK
prerank,regulation of DNA repair (GO:0006282),0.4085822323441719,1.1208250261930641,0.314404432132964,0.8074920528184019,1.0,11/44,16.60%,EYA2;EYA1;AXIN2;PML;TRIP12;UBE2V2;EGFR;ERCC8;NPAS2;UBR5;SMCHD1
prerank,protein transport (GO:0015031),0.3238622318710639,1.120786238331239,0.22750775594622544,0.8068019339168353,1.0,59/332,16.17%,ATP6V0A4;WLS;RABGAP1L;TBC1D4;STEAP3;TXNIP;LRP1;ARRDC4;ABCA1;VAMP5;USP6NL;LMAN2L;MACF1;OPTN;SEC31A;APOE;TMED1;VPS26C;GOLGA4;RAB23;STXBP3;TVP23B;TOM1;STX16;ARFGAP3;ADPRH;SNX33;LTBP2;MIA2;IFT27;RAB22A;COPZ2;ARFIP2;MIA3;TBC1D2B;ARL1;GGA2;ATP6V1E1;TMED4;ARRDC2;GOLPH3L;STXBP1;RCN3;TLK1;MTTP;COPA;USO1;TVP23A;ARF4;TANGO2;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;GOLPH3;RAB19
prerank,regulation of mast cell activation (GO:0033003),0.5401875548614996,1.1203265865390248,0.3628620102214651,0.807325098513164,1.0,2/10,7.08%,LYN;TSLP
prerank,regulation of synapse assembly (GO:0051963),0.4020766704192661,1.1202007323043537,0.300561797752809,0.8068980132675512,1.0,11/46,12.63%,GPC6;PDLIM5;SRPX2;MUSK;CUX2;EPHB2;SLIT1;SETD5;MDGA1;EPHB3;SLITRK2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5121476997361382,1.1201344574574583,0.34519572953736655,0.8062952741112704,1.0,2/12,3.64%,GDNF;SMO
prerank,RNA methylation (GO:0001510),0.38070709419732607,1.120126488525721,0.31382978723404253,0.8055283570050106,1.0,18/60,19.91%,TRMT44;BUD23;TRMO;NSUN2;METTL14;DIMT1;FTSJ3;WTAP;BCDIN3D;TRMT13;TRMT112;NSUN5;THUMPD3;THUMPD2;NSUN4;THADA;METTL3;METTL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5082397841090615,1.1194119436474976,0.3507853403141361,0.8068080533760468,1.0,2/12,2.01%,CYP26B1;DHRS3
prerank,positive regulation of neuron projection development (GO:0010976),0.36429823236785636,1.118969202775021,0.30512820512820515,0.8073037896893835,1.0,15/85,9.37%,EPHA3;CAMK1D;LYN;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,protein localization to condensed chromosome (GO:1903083),0.5103044853678477,1.1186629886628365,0.3516666666666667,0.8074131790124576,1.0,4/12,9.45%,SPDL1;ZW10;CHAMP1;MTBP
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3476894308510096,-1.1183557054137778,0.2692307692307692,0.7891908995482871,1.0,10/29,22.16%,CAV1;THBS1;TNFSF10;RET;PAK2;DEDD2;GPER1;INHBA;TRAF2;TNFRSF12A
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.4525307223853046,1.1182409567610778,0.32643312101910826,0.8078914753805084,1.0,10/23,26.88%,EPHX2;GSTM4;GSTM2;ALOXE3;FADS1;CYP1A1;ALOX12;HPGD;LTA4H;ACOT7
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.44825377992770216,1.1172888447372595,0.33586626139817627,0.8098369373060089,1.0,2/23,1.04%,ERRFI1;CBLB
prerank,regulation of inflammatory response (GO:0050727),0.332713361406713,1.117143510670683,0.27048260381593714,0.8094414365333215,1.0,40/190,18.26%,ADAMTS12;PTGIS;RORA;AHSG;SERPINE1;PTGES;DAGLA;CASP12;APOE;APOA1;MVK;BCL6;CDH5;IL12B;CEBPA;AGTR1;TSLP;NMI;NR1D1;CD200;CCN4;NR1D2;SETD4;TNFAIP6;UFL1;NAPEPLD;SELENOS;PDCD4;ETS1;MDK;NR1H3;TNFRSF1A;CD47;IL23A;FNDC4;LACC1;CX3CL1;TNIP1;IL18;CASP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.38935374609034745,1.1169596240680488,0.31911966987620355,0.8091832391587858,1.0,18/59,18.49%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.313834177892522,1.1165428613377661,0.066,0.8095551496206914,1.0,325/1646,17.26%,IGF1;TCF7L2;TCF4;ZBTB20;NFIA;IGF2;COL1A1;RORA;RHOH;CDK14;TBL1XR1;ZFHX4;TRPS1;RUNX1T1;TEAD1;ATXN1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;GLIS3;NKX6-1;IL31RA;NR2F2;GLI2;RUNX1;PRRX1;WWC2;SALL1;ZIC1;SP7;OGT;IKZF2;VGLL3;MAF;GLI3;ARID5B;ZEB1;NKX2-1;FZD2;KIT;ARID4A;PRDM5;SP100;WNT4;FOXP2;NFIB;ASCL1;RBFOX2;YAP1;NUP107;GAS6;JDP2;APOE;RUNX2;SIX5;TGFBR1;MLXIP;LBH;MIDEAS;ZIC4;NFIX;MXI1;LBX2;TLE1;FBXL19;OGG1;MEOX2;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;PRICKLE1;MT3;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;CDK16;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;MLLT3;SFRP1;ETV6;DENND4A;ARID1B;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;DKK3;USP47;BCOR;TCF7;CBX3;ATOH8;HES7;APBB2;NAB2;SMARCA1;ZNF483;PML;ZNF23;MED14;NR5A1;BATF;CEBPA;ING5;NFE2L2;ZNF697;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;REXO4;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MAP2K1;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;WTIP;RBPJ;LIN9;TULP3;TCF7L1;FOXC2;SAFB2;NCOR1;ZMYND15;CHD2;MTA3;KDM5B;HIVEP2;ARRB1;EGFR;ARHGEF11;CREBL2;SCML2;BMP2;PCGF3;ZMIZ1;STAT5B;ZBTB4;CBY1;HOXC5;PICALM;NONO;ZBTB1;BICRAL;MZF1;CCNK;SMAD1;GMEB1;GTF2IRD1;HEXIM2;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;PBXIP1;ZKSCAN3;FGF2;SP140;BAZ1B;ACTR8;ZSCAN21;PHF1;PHF2;TFAM;RNF6;NR1D2;MBD1;KDM5C;MED13L;NCOR2;SETD5;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;IFNK;CCNL2;MED29;L3MBTL1;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;CCNL1;MNAT1;NIBAN2;GLI1;CAMTA1;HMGN5;INSR;STAT6;PDCD4;BTRC;TEAD3;ZNF318;ACVR1B;TRIP4;L3MBTL2;MYCN;SMARCD2;NPAS2;EGF;KMT2E;KMT2A;HOXC8;EBF1;TAF5L;STAT4;TIAL1;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;YAF2;TADA3;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;ZNF25;FUBP3;HOXC4;SUFU;RXRA;MYCBP;FOXK2;METTL4;CDKN1C;DYRK1A;SAP30L;SMARCB1;GPBP1;TSHZ1;FADS1;TGFBRAP1;HDGFL3;PSPC1;CAMTA2;MYT1;MTF1;TFCP2;DYRK1B;RIOX1;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;SCMH1;MXD4;NCOA7;EBF4;AKT1;CREB5;PLAG1;ZNF423;CCNQ;PCBD2;RHOG;ATF5;SHH;TFDP1;FOXO6;SP1;ZFAT;MYBL1;BAZ2B;SPIN4;TIMELESS;IRF2;ZSCAN20;KDM3B;FOXJ3
prerank,cellular protein modification process (GO:0006464),0.3134029819103343,1.1164273379319714,0.13113113113113112,0.8090899852549933,1.0,157/983,14.17%,LTBP1;STK17B;DAPK2;PDPK1;PDK1;CP;FBN1;SPSB1;NRK;PPM1H;ROCK2;CDK14;LOXL1;PPM1E;MATN3;CDK8;DAPK1;UST;LOX;PTPN13;AHSG;GRK3;PRKCSH;GALNTL5;IGFBP4;LYN;GRK5;OBSL1;ART4;FGFR1;B3GALT1;BMPR1A;DMPK;ST3GAL5;MARK1;PPP3CA;CCN1;LAMC1;PRKAG2;GAS6;APOE;PTPN21;TGFBR1;ST3GAL3;FSTL1;FBXL19;CSF1;LARGE1;TGM5;APOA1;APLP2;MT3;ACVR1;PSME4;CDK16;SERPIND1;IGFBP5;PTPRS;PRKAA2;MAP3K20;EPAS1;CST3;NUAK1;FUT10;TNC;CD247;CUL4B;LRRK2;ADPRH;AKT3;PARP16;ATG10;SIK1;STT3A;CUL5;SIRT2;EIF2AK3;BRSK1;MAP2K1;FBXL3;ARAF;RCN1;OXSR1;PTPN9;B3GALNT1;UBA7;MAST2;ALG5;STK4;IRAK3;DNAJC3;MTMR3;BMP2;MAP4K4;COMMD1;MTMR7;FN3KRP;CAMK2B;KRT10;MIA3;NGLY1;STK11;CTDSP2;RNASEL;PARP14;RBBP7;RYK;ASB12;PTPRM;TTBK1;BMP15;NEK6;BRAF;TAOK3;IGFBP3;PDIA6;FBXO9;FBXO11;UFL1;KBTBD7;DCAF8;IKBKE;ERCC8;FBXO4;TBK1;FBXL12;TLK1;STRADA;WNK1;PPP2R5D;FEM1C;MAP3K13;INSR;ITIH2;GPS1;BTRC;WIPI1;MAP4K5;GRK4;ACVR1B;PTPN3;COPS3;DDOST;TNKS2;P4HB;ENGASE;MARK2;ALG10B;PIK3R4;CDK12;PTEN;JMJD7;ARF4;COL3A1;FRK;FSTL3;MERTK
prerank,negative regulation of chemokine production (GO:0032682),-0.43513767573557927,-1.116403300310858,0.33488372093023255,0.7935705882055301,1.0,4/14,14.23%,APOD;SIRPA;KLF4;SIGIRR
prerank,neuropeptide signaling pathway (GO:0007218),-0.3067578020639489,-1.116399401561983,0.24778761061946902,0.7918618479910652,1.0,17/58,24.42%,SORCS2;GLRA1;SORL1;GLRA2;HCRTR2;CYSLTR1;CYSLTR2;SORCS1;GPR37;NXPH2;PPY;CPE;SORCS3;PNOC;NMUR2;GLRA3;NXPH4
prerank,aminoglycan biosynthetic process (GO:0006023),0.3888390504288384,1.116349318290559,0.31593038821954483,0.8085182021210046,1.0,10/49,11.93%,GPC6;HSPG2;PXYLP1;B3GALT1;HS6ST1;SDC1;B3GALNT1;EXT1;NDST1;GALNT5
prerank,regulation of microglial cell activation (GO:1903978),0.49385414725428545,1.1158940968972015,0.338409475465313,0.809029615871123,1.0,5/15,17.52%,LDLR;NR1D1;TTBK1;SYT11;CX3CL1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4266219095745852,1.115395407465913,0.33186490455212925,0.8096571967421711,1.0,11/30,16.72%,SP7;KIT;MLLT3;SFRP1;BATF;UFL1;FSTL3;BMP4;PRRC2C;PLD4;SHH
prerank,cellular response to drug (GO:0035690),-0.36126887206119584,-1.1153692680159413,0.2966666666666667,0.7931170031599826,1.0,7/25,10.27%,MEF2C;PDE4B;ACER2;TFRC;KCNQ1;AIM2;GPLD1
prerank,establishment of mitotic spindle localization (GO:0040001),0.43654199751531464,1.1151093048663276,0.33382137628111275,0.8096983221409604,1.0,12/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;KPNB1;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4158719107621974,-1.1148550057445132,0.31989247311827956,0.7929747374781848,1.0,6/15,14.14%,MVB12B;PTPN12;ERBB2;CDH13;LGMN;CEACAM1
prerank,positive regulation of catalytic activity (GO:0043085),0.4134304263349995,1.1147738505601845,0.3231441048034934,0.8099103466625244,1.0,6/37,9.29%,IGF2;FGFR4;APOA1;MT3;NHEJ1;SLC5A3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.466992363011284,1.1145979268705437,0.3630573248407643,0.8095820334288003,1.0,9/20,23.17%,ROCK2;FMNL1;RHOQ;LLGL1;ARF6;FHOD1;LLGL2;NCKAP1L;DLG1
prerank,regulation of sensory perception of pain (GO:0051930),-0.47183613080596565,-1.1145760449642532,0.3443396226415094,0.7921155054583274,1.0,5/11,19.08%,MGLL;CCN3;ATPSCKMT;ZFHX2;ACP3
prerank,positive regulation of cell communication (GO:0010647),-0.34590139305212575,-1.1142213675511508,0.3123209169054441,0.7914735237670142,1.0,10/28,12.19%,ANK3;RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;EDN1;CLSTN3;HOMER1;CD80
prerank,embryonic heart tube development (GO:0035050),-0.4270042935223289,-1.1138752884730703,0.3325062034739454,0.7908530999885518,1.0,6/14,16.88%,SOX17;TBX2;SOX18;HES1;RYR2;CITED2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.42328463400913047,1.1137374376374913,0.31888111888111886,0.8110657731435582,1.0,7/35,6.81%,COL4A3;SPARC;NR2F2;APOE;SULF1;ATOH8;IL12B
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3155862615595661,1.1129821733992842,0.1715145436308927,0.8124378866673788,1.0,148/807,15.07%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;RUNX1T1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;ARID4A;THRB;PRDM5;SP100;MDFI;WNT4;FOXP2;ASCL1;RBFOX2;YAP1;DNMT3A;GAS6;JDP2;RUNX2;RARB;LBH;MIDEAS;NFIX;MXI1;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;RARG;SFRP1;ETV6;TBX3;BCL6;CUX2;DKK3;USP47;SKI;BCOR;CBX3;ATOH8;NAB2;PML;CPEB3;CEBPA;MBD2;SAP30;SIRT2;DR1;ZBTB38;SMARCC2;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;ZMYND15;MTA3;SCML2;BMP2;JAZF1;ZBTB4;BRMS1L;CBY1;NONO;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;PBXIP1;IFI27;ZKSCAN3;CXXC5;NR1D2;MBD1;KDM5C;NCOR2;ZNF177;CEBPB;L3MBTL1;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;NIBAN2;TCF25;PHF21A;PDCD4;BTRC;PEX2;PAF1;ZNF318;L3MBTL2;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TWIST2;FLNA;YAF2;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA;FOXK2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.45091452042381136,1.1129687490561306,0.3412698412698413,0.8117028433517319,1.0,3/24,6.15%,AUTS2;PIK3R1;CDC42
prerank,histone lysine demethylation (GO:0070076),0.43797370588267065,1.1128712986011058,0.34235668789808915,0.8112322727669112,1.0,11/25,23.23%,KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;KDM3A
prerank,epithelial cell development (GO:0002064),0.46741314343362494,1.1124143985677453,0.34833333333333333,0.8117952478985436,1.0,5/20,12.99%,BFSP1;WNT5B;RAB25;LRTOMT;DACT2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.49008737583365614,1.1121825723384666,0.3505654281098546,0.8116836909096811,1.0,5/16,20.48%,ZFP36L1;CPEB3;PLEKHN1;RC3H1;ZFP36L2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4887910247608982,1.1121662675173467,0.3305921052631579,0.8109434276488622,1.0,1/14,2.52%,OSMR
prerank,regulation of cell growth (GO:0001558),-0.24968064260615622,-1.112142812136761,0.15476190476190477,0.7946257264561956,1.0,49/204,14.57%,PLCE1;SLIT2;PTPRJ;FHL1;ADAM10;NRG3;SPOCK1;SH3BP4;CCN3;ACVRL1;NET1;PAK5;TFRC;PPT1;ADAM15;OSGIN2;SDCBP;SOX17;TGFB2;CAMK2D;ERBB2;SOCS2;NPR1;AKAP6;NDRG3;MFSD2A;EGLN2;SERTAD3;HYAL1;WFDC1;SGK1;RPS6KA1;CCDC85B;LTBP4;OGFR;MINAR1;BCAR1;TGFB1;SLC25A33;SIRT1;MTOR;ATAD3A;FAM107A;SERTAD2;SUPV3L1;APBB1;CEACAM1;H3-3A;DERL2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3855092033948294,-1.1120760630710564,0.3254437869822485,0.7931503952668612,1.0,11/23,22.34%,PDE4B;TGM2;KCNQ1;ATP2B4;GNB1;GNG2;MAPK3;RYR2;GABPA;ATF4;MAPK1
prerank,positive regulation of actin nucleation (GO:0051127),0.5291201626639859,1.1116252390554904,0.35239852398523985,0.8117076763728825,1.0,3/11,16.32%,GSN;WASF1;FCHSD2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.49596223202786655,1.1115975866465326,0.33828382838283827,0.8110135793949126,1.0,3/15,3.05%,ADGRV1;COL11A1;KIT
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4390686922197465,-1.1112627043449732,0.30855855855855857,0.7938734183328243,1.0,8/12,29.93%,SGTB;CHMP4B;CHMP4A;SGTA;SEC61G;GET3;SEC61A2;SEC63
prerank,regulation of intracellular protein transport (GO:0033157),-0.34511653191493236,-1.1109716781896295,0.290519877675841,0.7931040277639386,1.0,12/32,27.49%,PRR5L;PTPN14;KIF20B;TGFB1;UHMK1;PDCD10;PLK3;TENM1;CEP131;GCC2;RAB29;LCP1
prerank,protein lipidation (GO:0006497),-0.3031413508490635,-1.1108698754495065,0.27756653992395436,0.7917178034673994,1.0,19/59,18.79%,ZDHHC2;DPM1;PIGP;ZDHHC16;PGAP2;ZDHHC15;GPLD1;UGCG;ZDHHC14;PIGB;WDR45B;ZDHHC5;PIGL;DPM3;WIPI2;PIGU;DPM2;PIGO;PIGV
prerank,nuclear pore organization (GO:0006999),-0.42995349194665067,-1.1108511587284282,0.3586698337292161,0.7900899382001995,1.0,4/14,7.43%,NUP93;NUP35;NUP153;NUP54
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.27975194933985226,-1.1107420753642407,0.22105263157894736,0.7887674041652432,1.0,24/86,19.40%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;CFL2;EDN1;PLEK;WDR1;FES;DCTN1;TRPV4;CDK5RAP2;APP;CTTN;CDK5R1;PRKCE;NCK2;GPX1;CLASP1;LMOD1;CLU
prerank,neuron apoptotic process (GO:0051402),-0.3964064562532659,-1.1103699838186383,0.31362467866323906,0.7881220823812363,1.0,8/19,14.93%,TRPC5;SIAH1;CIT;CDK5;SCN2A;TNFRSF21;ERBB3;APP
prerank,regulation of protein phosphorylation (GO:0001932),0.3312488809097692,1.1103568823998458,0.25643776824034337,0.8137149883783732,1.0,55/256,14.89%,EPHA7;IGF2;ROCK2;ANGPT1;PID1;PTPN13;PLPP3;LYN;LEPR;IL34;PELI2;CCN1;GAS6;FBLN1;CDK5RAP3;TSPYL2;MT3;AXIN2;PHIP;MUSK;SLCO3A1;CDH5;ENG;PML;LRRK2;WWTR1;EIF2AK3;NTRK3;STK4;DAB2;ARRB1;EGFR;EPHB2;BMP2;PRKN;MYADM;ITGB3;STAT2;NSD1;FGF2;IGFBP3;CEBPB;F2;IMPACT;PPP2R5D;INSR;RAP2A;TMEM119;PTEN;PDCL3;PLXNB2;IBTK;AKAP8L;RSPO1;BMP4
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3696088311633806,-1.1096809349050916,0.31547619047619047,0.7884366391943887,1.0,3/25,1.79%,TMTC2;CAV1;ANK3
prerank,calcium ion homeostasis (GO:0055074),0.3578339615896175,1.109548606405652,0.30154946364719903,0.8151844251634777,1.0,13/95,9.66%,SLC24A3;SLC8A1;SLC8A3;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;CDH5;SLC24A5;TMEM203;DRD3;CSRP3
prerank,regulation of viral life cycle (GO:1903900),-0.3793001312359826,-1.109540790006475,0.31868131868131866,0.7872220424232682,1.0,10/21,21.76%,TRIM14;PPIA;HS3ST5;TRIM25;TRIM68;TYRO3;TRIM6;TRIM62;VPS4A;NECTIN2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.40279214575127753,-1.1092431401391085,0.3282828282828283,0.7863921647779274,1.0,6/19,11.62%,PLCE1;NFATC2;NFATC3;NFATC1;EDN1;HRH1
prerank,cellular glucan metabolic process (GO:0006073),0.5104601345181948,1.1092143392684146,0.3711864406779661,0.8152643432589939,1.0,5/11,16.24%,PHKB;PRKAG2;PYGM;PPP1R3C;PHKA1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.40894182428119313,-1.1090100464211754,0.3168044077134986,0.785474106453217,1.0,4/17,21.48%,NEDD4L;KCNQ1;RYR2;KCNJ8
prerank,positive regulation of innate immune response (GO:0045089),-0.352733015107845,-1.1087800488780688,0.2844574780058651,0.7845151667835092,1.0,13/30,27.24%,RPS19;GBP5;LBP;NLRC5;IFI35;UBE2K;TRIM6;TRIM62;DHX9;PLSCR1;POLR3C;SLC15A4;PLA2G5
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4176127470401396,1.1085933909965247,0.3353028064992615,0.8162428097232913,1.0,8/30,10.77%,AR;NCOA2;SFRP1;DAB2;SAFB2;NCOR1;RNF6;NCOR2
prerank,stabilization of membrane potential (GO:0030322),0.4844129142634975,1.1084031553596976,0.3599320882852292,0.8159845091634468,1.0,2/16,6.18%,KCNK2;KCNK7
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4197441251086333,1.1073519168421384,0.3445255474452555,0.8181602686615471,1.0,11/33,15.84%,MCC;DCN;NR2F2;SP100;APOE;ADAMTS9;PTPRM;DNAJA4;PTEN;PTPN23;EPPK1
prerank,blood vessel diameter maintenance (GO:0097746),-0.34161593894377745,-1.107169052979339,0.27522935779816515,0.7877424665615255,1.0,14/34,20.25%,EDNRA;NOS3;KLF2;NOS1;NPR1;KCNMB2;GCLM;ACE2;EDN1;EDNRB;GPER1;GCLC;ITGB1BP1;ROCK1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.42620206952630163,1.1063140454932563,0.3404255319148936,0.8203231756681872,1.0,11/29,22.16%,SMAD3;ZC3H7B;TUT7;SMAD1;TUT4;PRKRA;METTL3;DICER1;AGO4;SMAD2;DROSHA
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5099688518319825,1.1062269779299811,0.3528428093645485,0.8197594361303419,1.0,4/13,14.78%,OGG1;NEIL1;MBD4;UPP2
prerank,nervous system development (GO:0007399),0.3142629494993231,1.1059784608316694,0.23955147808358818,0.8196830579583084,1.0,65/429,10.50%,NELL1;ROBO1;LDB2;TEAD1;FARP1;GDNF;ATXN1;GSN;ADGRV1;ARNT2;ZEB2;DACT1;RBFOX1;OBSL1;ZIC1;DAGLA;GFRA2;WNT8B;ASCL1;RBFOX2;YAP1;TGFBR1;NUMBL;SMO;SEMA5A;NOTCH2;ZIC4;FBXL17;WDPCP;MTR;ZIC2;IGF2BP2;AXL;NTF3;NEUROD1;LIG4;NAV2;TBX3;ALDH1A2;FUT10;ATXN10;NAB2;ADGRA2;PMP22;FGF11;WWTR1;DCHS1;LPAR1;APBA1;CSPG5;CBLN1;SH3GL1;DSCAM;NHEJ1;EPHB2;CNTFR;PRKN;MARCKSL1;GLIS2;GFRA4;FGF2;FGF13;RYK;NRSN1;PCDHB3
prerank,phospholipid translocation (GO:0045332),-0.357643175662286,-1.1054256079538023,0.32919254658385094,0.7914785468425476,1.0,8/28,7.78%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;P2RX7;ATP11A;MFSD2A
prerank,membrane lipid metabolic process (GO:0006643),0.4480296914274286,1.1049993463035392,0.338301043219076,0.821698571166377,1.0,4/22,7.21%,AGMO;CYP1B1;ALOXE3;SPHK2
prerank,melanosome localization (GO:0032400),-0.38670793961577765,-1.1049454197899915,0.3136729222520107,0.7913654867344021,1.0,8/21,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,mRNA splice site selection (GO:0006376),0.42342191534383306,1.1048834881073837,0.34615384615384615,0.8212285449721397,1.0,6/30,17.99%,CELF2;SF1;NOL3;SRSF5;SRSF10;KHDC4
prerank,regulation of protein import into nucleus (GO:0042306),0.4111087920676515,1.104763962303818,0.3281027104136947,0.8207719189117211,1.0,12/36,18.63%,PIK3R1;SMAD3;ZIC1;RAB23;RBM22;FLNA;BMP4;SUFU;PIK3R2;UBR5;EFCAB7;TPR
prerank,regulation of vacuole organization (GO:0044088),0.45776576568579014,1.1047350969463108,0.3471337579617834,0.8200797054407807,1.0,8/20,18.11%,NPRL3;ADPRH;ENO2;MTMR3;PIKFYVE;NPRL2;LAPTM4B;ENO3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37846910192248673,1.1045755284938281,0.33819628647214856,0.8197681162145822,1.0,8/60,8.47%,TCF7L2;CDK8;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4797515470932282,1.1043938948005378,0.36683417085427134,0.8194935733377239,1.0,8/16,22.94%,AMPD3;NUDT2;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.37122812113364667,1.104381237637729,0.31859557867360205,0.8187671537366219,1.0,10/67,9.62%,NRP1;ROCK2;PIK3R1;SULF1;AXL;CDC42;SRC;AAMP;ITGB3;ITGAV
prerank,negative regulation of angiogenesis (GO:0016525),0.36528345916835697,1.1042092915851196,0.3172839506172839,0.8184615188732319,1.0,13/84,6.63%,COL4A3;ROCK2;SPARC;DCN;SERPINE1;HSPG2;ISM1;THBS2;SULF1;SERPINF1;ADAMTS9;PML;EMILIN1
prerank,covalent chromatin modification (GO:0016569),0.49704137291629324,1.1041615591142528,0.37043478260869567,0.8178216314874021,1.0,4/14,11.49%,MT3;MBD2;SETD5;UFL1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.34129787344417173,1.1036039756808043,0.30103806228373703,0.8186490778944292,1.0,26/136,16.11%,TCF7L2;PTGIS;SP100;MDFI;GAS6;NUPR1;IRAK2;CDK5RAP3;CYP1B1;SIK1;MTURN;IRAK3;ARRB1;CD200;COMMD1;GLIS2;ITCH;UFL1;BTRC;HDAC4;FLNA;SFRP4;SUFU;EGLN1;RNF2;NWD1
prerank,granulocyte chemotaxis (GO:0071621),-0.3075830866718951,-1.1032152589327755,0.2857142857142857,0.7949899070929781,1.0,9/55,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,somite development (GO:0061053),0.5269071867067546,1.1029488125814733,0.37735849056603776,0.8196888516430401,1.0,5/11,21.15%,SMO;MEOX2;SHH;SOX11;PPP2R3A
prerank,canonical glycolysis (GO:0061621),-0.3729464255133602,-1.1028594869140118,0.31750741839762614,0.7927373471707165,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3729464255133602,-1.1028594869140118,0.31750741839762614,0.7927373471707165,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.46345702849784737,-1.1027707034304872,0.335632183908046,0.7913726267930864,1.0,4/10,5.72%,PTPRJ;APOD;PTPN12;PTPN2
prerank,lymphocyte chemotaxis (GO:0048247),0.41483736954290357,1.1027218224210467,0.33925925925925926,0.8196029094712545,1.0,5/34,6.11%,CYP7B1;GAS6;CCL19;CXCL16;CCL4
prerank,"phototransduction, visible light (GO:0007603)",-0.4397033626805662,-1.102681754328274,0.36253041362530414,0.7900155101094563,1.0,7/14,33.84%,RP1;GNB1;PDE6A;GNA11;GNAQ;PDE6B;SAG
prerank,response to organic cyclic compound (GO:0014070),0.3862909557387261,1.1025809310865786,0.3383356070941337,0.8192426487092658,1.0,11/52,10.01%,WNT8B;FGFR4;SFRP1;IGFBP5;CYP1B1;STRN3;LRRK2;KYNU;DRD3;STAT5B;FOXA1
prerank,mesonephros development (GO:0001823),-0.45999662213770576,-1.1025308148283475,0.3579418344519016,0.788847495044416,1.0,3/11,11.76%,ZBTB16;FGF1;PAX8
prerank,snRNA transcription (GO:0009301),0.3703532327640886,1.1024539246264602,0.31565656565656564,0.818846883017835,1.0,25/70,24.69%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;USPL1;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4794709642580563,1.1023584937663329,0.35852090032154343,0.8183529288035899,1.0,4/17,12.18%,OGG1;NEIL1;MBD4;TERF2
prerank,spliceosomal complex assembly (GO:0000245),0.39417104944830733,1.1023554074296473,0.3236914600550964,0.8175918957501341,1.0,12/46,18.51%,CELF2;SF1;DDX23;NOL3;SNRPD2;SRSF5;RBM5;PRPF6;SF3B1;SRSF10;KHDC4;DDX1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4966728929778622,1.1020936813867515,0.36752136752136755,0.8175244628114723,1.0,3/13,9.87%,MOAP1;BCL2L11;RHOT1
prerank,positive regulation of cell development (GO:0010720),0.42590637910978796,1.1018875210837857,0.3462109955423477,0.8173196099232741,1.0,5/31,5.78%,NKX6-1;NUMBL;LIG4;PDE3A;SERPINF1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.4093256477238842,1.1018674128745776,0.3603851444291609,0.8166090645909566,1.0,8/39,8.83%,ROBO1;YAP1;MAML3;ENHO;SRC;RBPJ;ZMIZ1;KAT2B
prerank,cellular glucose homeostasis (GO:0001678),0.39761389353059107,1.1011145611231736,0.3376251788268956,0.8179411947606653,1.0,5/41,7.78%,ZBTB20;PIK3R1;GAS6;PRKAA2;NR1D1
prerank,T-helper cell differentiation (GO:0042093),-0.43149689911922534,-1.1008406017511732,0.3582089552238806,0.792392774922585,1.0,5/14,17.09%,LEF1;FOXP1;ATP7A;GPR183;ZFPM1
prerank,long-chain fatty acid import into cell (GO:0044539),0.5262566041983383,1.1007113130664496,0.37213403880070545,0.8182974675523604,1.0,2/10,2.35%,SLC27A5;ACSL1
prerank,import into cell (GO:0098657),0.40098089846874274,1.1006885155533856,0.34978843441466856,0.8176040644433253,1.0,9/41,9.98%,SLC1A3;GLUL;ATP1A2;SLC6A13;SLC22A2;SLC11A2;SLC22A4;SLC5A3;SLC29A1
prerank,regulation of coagulation (GO:0050818),-0.45948022071869876,-1.100400865489009,0.3225058004640371,0.7921604837112,1.0,2/11,5.27%,CAV1;HS3ST5
prerank,calcium ion transmembrane transport (GO:0070588),0.3569019783591269,1.1000678199862162,0.314214463840399,0.8185897516766335,1.0,14/86,9.92%,SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;SLC24A1;MCU;SLC24A5;CACNA1C;PMPCB;TRPM4;ITGAV;MICU2
prerank,cardiac ventricle morphogenesis (GO:0003208),0.39959814652040515,1.0998715537152624,0.3319209039548023,0.8183878812147068,1.0,7/41,8.13%,TGFBR3;TPM1;BMPR1A;FGFR2;ENG;TNNC1;RBPJ
prerank,epithelium development (GO:0060429),0.3490501317001611,1.0997305028309419,0.32608695652173914,0.8180148662891601,1.0,24/107,18.30%,ERRFI1;DAG1;DACT1;SALL1;FGFR2;WNT4;SMO;CNN3;MEOX2;ALDH1A2;VCL;OSR1;BMP2;RCN3;NDRG4;VDAC1;GSTK1;GATA6;KANK2;SHH;TIMELESS;AHI1;SOX11;FN3K
prerank,negative regulation of histone methylation (GO:0031061),0.5250611235552858,1.0996674569233453,0.35951134380453753,0.8174448208945211,1.0,7/10,23.00%,BCOR;PHF1;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,vesicle organization (GO:0016050),-0.3197211015653967,-1.0994568852348279,0.26881720430107525,0.7935015046243824,1.0,11/46,16.17%,CAV1;FNBP1L;CD34;CAV2;DNAJC13;ALS2CL;WASHC5;EXOC8;AKTIP;SRGN;DNM1
prerank,lamellipodium assembly (GO:0030032),-0.36643240236364893,-1.0991859705297244,0.32802547770700635,0.7926485470084467,1.0,8/26,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;ABLIM3;ABLIM2
prerank,nucleic acid-templated transcription (GO:0097659),0.40419500058834523,1.099172529030157,0.33,0.8180300333527061,1.0,6/42,11.64%,POLR2D;THRB;CREBL2;POLR3A;POLR2C;NKX2-8
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.39641322154523395,1.0986972400119936,0.34210526315789475,0.8186263774097837,1.0,4/40,6.60%,PID1;BCL2;PYCR1;LRRK2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.42775743442882885,1.098388787003579,0.351270553064275,0.818734314488272,1.0,9/28,18.63%,PIK3R1;SMAD3;ZIC1;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4833810184523498,1.098387262920611,0.34983498349834985,0.8179827935432087,1.0,6/16,24.20%,APPL2;NCOR1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,actin polymerization or depolymerization (GO:0008154),0.390551915217196,1.0983498737800714,0.34573002754820936,0.8173282560873554,1.0,4/50,1.79%,MICAL3;SVIL;GSN;ARHGAP6
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.39990865766543693,-1.0981729523456318,0.33985330073349634,0.7940838506077204,1.0,5/17,17.45%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.43718068050491554,1.0981090897125778,0.36555891238670696,0.8172311030589318,1.0,5/24,9.51%,NRP1;PIK3R1;SFRP1;MAP4K4;MAPRE2
prerank,cell part morphogenesis (GO:0032990),0.49393280717145294,1.0979839263998692,0.36395759717314485,0.8168244934268991,1.0,4/13,13.22%,PID1;CSPG5;NUBPL;WASF1
prerank,protein-containing complex assembly (GO:0065003),0.320987337123011,1.0978083036999104,0.2929399367755532,0.8165653651423306,1.0,79/259,22.80%,TCF7L2;TEAD1;SEC24D;AREG;TGFA;MITF;PLEKHA7;LAMC1;SEC31A;YAP1;TLE1;SH3PXD2B;MCU;AXIN2;LMAN1;BCL9;TCF7;PML;CD247;ZW10;RANBP9;LRRK2;TRAPPC4;AFDN;PARD6B;TCF7L1;GOSR2;PICALM;TSPAN4;CDC123;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;FANCC;MNAT1;CTSZ;KLHL12;NOL3;USO1;WASF1;KMT2A;SEC23A;LLGL1;DLG4;SNX9;COL16A1;TBC1D20;TNFRSF1A;PARD3;GSDMD;TAPBP;CX3CL1;SEC24A;KAT5;DARS1;TMED10;CDC73;CSNK1A1;SEC16B;HSF1;MDM4;TRAPPC1;TRAPPC3;AFG3L2;RBBP5;HGSNAT;LEO1;TLE3;CAPZA1;OPA1;STOML2;TLE4;IL1RAP;SEC16A;SLC9A1;FANCA;NAPA;NCKAP1L
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5292392249985556,1.0975592585221103,0.3786764705882353,0.8164747862565181,1.0,3/10,15.29%,LYN;MAP2K1;RNF13
prerank,positive regulation of angiogenesis (GO:0045766),0.3455815432627232,1.0971586946085754,0.31641086186540734,0.8168666690662129,1.0,13/108,5.68%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.49310815844185724,1.0970442031500427,0.3688663282571912,0.8164451147133087,1.0,1/14,0.14%,NRP1
prerank,regulation of defense response (GO:0031347),0.36398657517463334,1.096958478944148,0.3307593307593308,0.8159526361661837,1.0,9/76,6.90%,ADAMTS12;AHSG;PTGES;CASP12;APOE;APPL2;IRF1;BCL6;AGTR1
prerank,regulation of epithelial cell migration (GO:0010632),0.3806144299433375,1.0969125850638906,0.330188679245283,0.8153326803728991,1.0,9/51,7.29%,GLUL;SASH1;MCC;MACF1;INSL3;CTSH;SRC;DOCK5;RAB25
prerank,protein localization to vacuole (GO:0072665),-0.4313816613645971,-1.0968599529966403,0.3470873786407767,0.7962760295613546,1.0,4/13,19.76%,SH3BP4;KPTN;CD81;LMBRD1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3447783486077505,-1.096694812889319,0.2839506172839506,0.7951040172298736,1.0,11/32,12.39%,PPP1R16B;ITGA1;PPIA;HSP90AB1;PPP1R15B;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1;MTOR
prerank,basement membrane organization (GO:0071711),0.4876465857269541,1.0966459438343799,0.380718954248366,0.8152659546595721,1.0,8/14,23.24%,NID1;NID2;FLRT2;NTNG2;HPN;LAMB2;COL4A1;PXDN
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4382496102767815,1.0963274574244477,0.3535660091047041,0.8154092141450491,1.0,3/24,3.78%,NRP1;SEMA3D;SEMA5A
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.37865175318191435,-1.0960925076365269,0.3316582914572864,0.7953087412339824,1.0,9/20,30.27%,ADAM10;TGFB1;MBTPS2;ADAM9;RHBDD1;APH1A;MBTPS1;TRAF6;NCSTN
prerank,sulfation (GO:0051923),0.5130915875786027,1.0958810746679737,0.3885017421602787,0.8159502144750977,1.0,1/11,1.33%,UST
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4136134942731675,1.0955305280082694,0.3386627906976744,0.8162084479869727,1.0,8/35,8.78%,AR;PMEPA1;RBFOX2;YAP1;NEDD4;SRC;DDX17;ZMIZ1
prerank,sphingoid metabolic process (GO:0046519),0.5157828959962751,1.0954438177967556,0.3806343906510851,0.8157031438941604,1.0,3/12,10.90%,PLPP3;SPHK2;KDSR
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2561952996676416,-1.0952639779548277,0.26277372262773724,0.7961512329094173,1.0,42/149,21.79%,PRKCH;CAV1;NOD1;RPS6KA5;TNFRSF11A;TFRC;TRIM14;PPIA;NFKBIA;RPS3;ARHGEF2;RBCK1;AIM2;TRIM25;ALK;RPS6KA4;TRAF5;CX3CR1;PRKCZ;RTKN2;CARD14;CD40;TRAF1;TRIM68;APP;NOD2;CARD16;TAB1;TRIM6;BTK;EP300;TLR4;TRIM62;NPM1;CLU;DHX9;PSMA6;AGER;TRAF2;UBE2V1;DDRGK1;CHUK
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4409530900396284,1.0950899452508178,0.3617693522906793,0.815907469510843,1.0,8/24,15.28%,VTN;NEDD4;MT3;EMILIN1;ITGB3;ARNT;NIBAN2;GRB10
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4715202467392208,1.0950324711402952,0.3652597402597403,0.8153035311862911,1.0,5/18,7.96%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35
prerank,heart development (GO:0007507),0.3326744789905776,1.0946493027223665,0.322435174746336,0.8156343705135659,1.0,24/150,9.89%,RBP4;FBN1;PDLIM5;TGFBR3;DLC1;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;ADAP2;BCOR;CACNA1C;SCUBE1;FLRT2;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B;CSRP3;SYNPO2L
prerank,epithelial cell morphogenesis (GO:0003382),0.46837343438416457,1.0945659267139725,0.3637846655791191,0.8151240486620174,1.0,3/17,12.99%,COL22A1;RAB25;DACT2
prerank,neuron projection organization (GO:0106027),-0.4153837015329409,-1.0945119613271501,0.3325301204819277,0.7969590621050995,1.0,9/15,27.14%,PLS1;ARF1;LGMN;ATP1A3;DCTN1;APP;GSK3B;PICK1;PRNP
prerank,regulation of adaptive immune response (GO:0002819),0.4586387883648357,1.0942481498473593,0.3564189189189189,0.815209240526796,1.0,2/18,4.43%,ADCY7;IRF1
prerank,response to laminar fluid shear stress (GO:0034616),0.5124880043699529,1.0938957180621924,0.3754646840148699,0.8154075603985527,1.0,2/10,6.96%,ABCA1;NFE2L2
prerank,response to metal ion (GO:0010038),0.3729087398675977,1.0935104112956142,0.33118556701030927,0.8157472250698482,1.0,10/67,6.47%,PAM;BCL2;PPP3CA;SLC30A8;SEC31A;NEDD4;MT3;SLC30A2;NDRG1;SLC11A2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3487354208750078,1.0933024615117546,0.33455433455433453,0.8156054649066661,1.0,13/94,11.60%,ITPR1;PDK1;BCL2;MOAP1;CYP1B1;PML;CUL5;BCL2L11;AIFM1;STK11;DDX3X;CEBPB;IKBKE
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.349748036017478,1.093258406411501,0.3282172373081464,0.8149946112452786,1.0,16/107,8.27%,SLC24A3;SLC8A1;SLC8A3;SLC41A1;DMPK;SLC30A8;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;TMEM203;DRD3;SLC30A10
prerank,secondary alcohol metabolic process (GO:1902652),0.3947673168767922,1.0932493561672285,0.3446808510638298,0.8142839213560288,1.0,8/42,15.42%,ABCA1;APOE;APOA1;CYP27A1;IDH2;LCAT;RXRA;OSBPL5
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.44882517136922273,-1.0931290763060058,0.3764988009592326,0.7994942069025828,1.0,3/11,2.91%,F11R;TJP2;TJP1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4350702153170942,-1.0929408776412812,0.3568181818181818,0.7984267812784673,1.0,6/12,20.96%,PLCG2;RAB27A;ZNF205;TLR4;GRIN1;ADGRB1
prerank,regulation of proteolysis (GO:0030162),0.3849597747462101,1.0928517016082753,0.3267882187938289,0.8146783832466767,1.0,14/48,16.72%,DNAJC1;OGT;FGFR4;ASPH;CST3;RNF139;ITCH;F2;CLN3;BTRC;TM4SF20;SPOP;AKT1;SHH
prerank,regulation of ruffle assembly (GO:1900027),-0.37026805802878926,-1.092683261204529,0.29737609329446063,0.7975773721329238,1.0,4/23,7.19%,CAV1;NLGN1;RDX;EPS8L2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4539303351511304,1.0926021133280035,0.3684210526315789,0.8146242064465007,1.0,9/20,24.20%,WNT4;SIK1;BMP2;BMP5;ERLIN1;SLC27A1;BRCA1;ERLIN2;ACADVL
prerank,cobalamin metabolic process (GO:0009235),0.45988160162856695,1.0925699599844783,0.37936507936507935,0.8139752635464823,1.0,3/17,8.03%,MMAB;MTR;MMUT
prerank,intraciliary retrograde transport (GO:0035721),0.5016681777796606,1.091941714788716,0.3913793103448276,0.8149760639623136,1.0,3/12,10.60%,WDR35;IFT43;DYNC2I1
prerank,cell differentiation in hindbrain (GO:0021533),-0.4617100409138558,-1.0915884622918395,0.3501199040767386,0.7992020904659337,1.0,3/11,11.81%,GRID2;OPHN1;ATP7A
prerank,rRNA 3'-end processing (GO:0031125),0.5245140006614335,1.0913961892498398,0.37628865979381443,0.8157101372863544,1.0,7/10,27.35%,ERI3;ERI1;EXOSC7;EXOSC2;ERI2;EXOSC8;EXOSC9
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4523649575362704,1.0913385527134092,0.36245954692556637,0.8151468512473738,1.0,6/21,10.48%,SLC8A3;MCU;BCAP31;MICU2;PDZD8;ANXA6
prerank,positive regulation of neuron differentiation (GO:0045666),0.3997365661537024,1.0912136588059784,0.352773826458037,0.8147350394895835,1.0,9/40,12.08%,TCF4;FGFR1;ZEB1;ASCL1;NEUROD1;ADRA2C;BMP2;REST;IMPACT
prerank,cellular response to hormone stimulus (GO:0032870),0.3668156730192272,1.0907751806072712,0.340153452685422,0.8152177186107562,1.0,19/69,13.49%,GHR;AR;ATP1A2;THRB;NCOA2;SFRP1;CTSH;BRD8;TFPI;ZFP36L1;LHCGR;SRC;STAT5B;SLIT3;KLF9;ADRA2A;SLC5A5;CTSL;NCOA3
prerank,telomere maintenance via recombination (GO:0000722),0.5010938936964717,1.0905973140304963,0.3936348408710218,0.8149522218708373,1.0,5/11,20.24%,SMC5;SMC6;TEP1;RAD51D;NSMCE2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5153252304743713,1.0895078471973627,0.3867403314917127,0.8164170539896635,1.0,3/10,12.38%,APOA1;MYADM;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5153252304743713,1.0895078471973627,0.3867403314917127,0.8164170539896635,1.0,3/10,12.38%,APOA1;MYADM;WNK1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.40018637516988104,1.088751744049919,0.3446808510638298,0.8176926320308422,1.0,8/37,9.62%,OPTN;APOE;MT3;SIRT2;NCOR1;PRKN;ITGB3;ITGAV
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4028242020562737,-1.0885935225158319,0.32460732984293195,0.8064313731159388,1.0,3/17,6.48%,ANK3;KCNAB1;AKAP6
prerank,mitochondrion morphogenesis (GO:0070584),0.5077498170008756,1.0884578498858448,0.3779816513761468,0.8177759654903382,1.0,3/11,13.22%,PID1;NUBPL;WASF1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3539634219181323,-1.0884108156413719,0.33236994219653176,0.8053625182313647,1.0,16/30,25.67%,SDCBP;RYBP;RPL11;HSP90AB1;USP14;GIPC1;N4BP1;SVIP;FHIT;DDRGK1;STYX;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3409527700111511,-1.0883729907715523,0.32653061224489793,0.8038525658424046,1.0,13/32,27.54%,SERINC5;MBOAT1;PLA1A;PLAAT3;PTDSS1;LPCAT3;PLA2G4F;PLA2G4E;PLSCR1;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4568142093306977,-1.0879816626124992,0.36323851203501095,0.8034298854416535,1.0,4/11,16.30%,MEF2C;TGFB2;TGFB1;GPER1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.36717046797721753,-1.087874513788777,0.32919254658385094,0.8021985340167369,1.0,6/25,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,positive regulation of lamellipodium organization (GO:1902745),0.41495283376045755,1.0877777832037892,0.367624810892587,0.8189719277950046,1.0,5/32,7.55%,AUTS2;PIK3R1;CDC42;SRC;CARMIL1
prerank,regulation of endocytosis (GO:0030100),0.37598100806214063,1.0865106701826615,0.3439153439153439,0.8217148254569339,1.0,10/61,9.18%,EPHA3;LRP1;APOE;CCL19;SRC;SNX33;STON1;DAB2;PICALM;SNX12
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4361926908198228,1.0865058362600746,0.36577708006279436,0.820993815244597,1.0,2/23,3.24%,CEMIP;PRKAG2
prerank,cell differentiation in spinal cord (GO:0021515),-0.46644590922306745,-1.0862508808889333,0.3886255924170616,0.8053760398733492,1.0,2/10,9.30%,MDGA2;ZC4H2
prerank,cellular response to oxidative stress (GO:0034599),0.3379900971848985,1.0862155650436647,0.33136094674556216,0.8210576390688032,1.0,21/118,13.13%,DAPK1;TPM1;PLA2R1;PYCR1;NUDT2;PDGFRA;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;ERCC6L2;SIRT2;EGFR;ARNT;MGAT3;FANCC;SELENOS;GPX3;NOX4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.41708514878518016,-1.0861608504783729,0.3625866050808314,0.8040443308111159,1.0,9/15,35.38%,RAD17;MDC1;HUS1;FANCD2;ATF2;HUS1B;NEK11;RAD9A;EME1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.4960232566166954,1.0858702611006412,0.3825136612021858,0.8212938107394631,1.0,5/12,16.83%,MYCBP2;ARHGAP35;EPHB2;PTEN;B4GALT6
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4451772660208718,1.0855872586186333,0.38102893890675243,0.8213626665775247,1.0,3/22,5.68%,RUNX1;IRF1;BCL6
prerank,ERBB signaling pathway (GO:0038127),0.3685354215667573,1.0845672574000755,0.33509234828496043,0.8233936034354143,1.0,13/64,11.26%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;CUL5;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,negative regulation of type I interferon production (GO:0032480),-0.3237101156736823,-1.0843475337284214,0.32867132867132864,0.8079082457216702,1.0,12/40,19.26%,IFIH1;RNF125;SIRPA;TRIM25;NLRC5;YY1;REL;TNFAIP3;RELB;PCBP2;UFD1;TAX1BP1
prerank,positive regulation of response to external stimulus (GO:0032103),0.3368331697610557,1.0841130573796125,0.3598531211750306,0.8238990297318438,1.0,29/128,18.49%,BMP6;SASH1;SERPINE1;OPTN;PDGFRB;CCL19;IL12B;CEBPA;AGTR1;TSLP;DDX60;NMI;CCN4;SETD4;IFNK;F2;NAPEPLD;PDCD4;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18;DHX58;PRKCA
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4212574865431608,-1.0838932083226787,0.36666666666666664,0.8077084834239454,1.0,2/12,6.37%,ANK3;NOS1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.45884519994222367,1.0835647908237553,0.3768352365415987,0.8247220636968934,1.0,8/18,26.76%,DNAAF1;CCDC40;CABYR;CFAP53;SPEF2;ROPN1L;ODAD4;NPHP3
prerank,organelle fission (GO:0048285),-0.36193422935791647,-1.0832633122212634,0.340625,0.8079373346511082,1.0,6/24,16.18%,DNM3;WASHC5;MTFR1;CORO1C;DNM1;MTFR2
prerank,macromolecule catabolic process (GO:0009057),-0.36694811866936106,-1.0831435215627092,0.35446685878962536,0.8066983141263474,1.0,8/26,12.39%,SMURF1;PPT1;SIAH1;TRIM24;KIF16B;TGFB1;LGMN;MTOR
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4438257782239023,-1.082945216929528,0.36941176470588233,0.8057406506863909,1.0,5/11,16.32%,NOVA2;PCBP3;PCBP1;RASA1;PCBP2
prerank,B cell activation (GO:0042113),-0.2933649714736441,-1.0828445298139908,0.2744186046511628,0.8044615567853572,1.0,23/68,23.49%,MEF2C;PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;CASP8;CD40;BLNK;GPR183;PTPRC;BTK;JAK3;ADGRG3;CD86;MSH2;KLF6;VCAM1;DCAF1;MALT1;CEBPG
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3660655434085526,1.082822169488327,0.3474358974358974,0.8260272638172923,1.0,9/64,7.07%,DAGLA;ACSL1;EPHX2;ACOT2;GSTM4;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2866872127391718,-1.08270410155019,0.3008474576271186,0.8033025117978847,1.0,9/71,5.34%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5
prerank,negative regulation of programmed cell death (GO:0043069),0.3117899641435268,1.082264285848796,0.302158273381295,0.8267957579315517,1.0,71/355,17.06%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;GAS6;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;FSTL1;MT3;AXL;PHIP;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;ITCH;BRAF;DDX3X;CLN3;ANXA5;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;HYPK;TAF9;HSPA9;ARF4;TM7SF3;DSTYK;HPN;FLNA;PLK2;GATA6;BMP4;TMBIM6;GOLPH3;AKT1;KANK2;ATF5;SHH;PIM1;PSEN2;GLO1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.47451408033747833,1.0819334034255872,0.3730834752981261,0.8269203938030443,1.0,2/15,3.64%,GDNF;SMO
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5234617988942851,1.0817135595338576,0.3811252268602541,0.8267812240000452,1.0,3/10,8.91%,DCN;IL12B;SPRY2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5143635221953572,1.0814075240388688,0.40476190476190477,0.8268975905259448,1.0,3/10,17.56%,RPUSD4;RPUSD2;NAF1
prerank,"transcription, DNA-templated (GO:0006351)",0.3208715261497069,1.0812296442174492,0.32786885245901637,0.826681719856171,1.0,66/207,23.84%,POLR2D;SOX5;GLIS3;MAF;THRB;HSF2BP;NFIX;MLLT3;GTF2E1;BRF1;GTF3C1;GTF2H5;PMF1;MED16;CREBL2;POLR3A;TRIP11;CCNK;POLR2C;TFAM;MBD1;POLRMT;NKX2-8;TTF2;MNAT1;PAF1;TEFM;TAF5L;GTF2E2;TAF9;NELFE;AFF4;FUBP3;TTF1;COPS2;TFDP1;TSC22D1;CCNT2;FOXO3;CDC73;NCOA6;POLR2L;TAF2;PAX1;HSF1;GTF2A1;DEAF1;BRF2;NFE2L3;LEO1;MLLT1;IRF9;GTF3C3;NOCT;ERCC3;CCNT1;RPAP1;NCBP2;POLR1C;CDK7;ERCC2;KLF13;TAF4B;NAT14;ELOC;SETX
prerank,JNK cascade (GO:0007254),-0.327455719679868,-1.0809876520096995,0.33766233766233766,0.8068029523363733,1.0,20/40,30.87%,NOD1;TNFRSF19;MAPK10;MAPK8;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MINK1;MAP3K7;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.33760055364488134,-1.0809348831085872,0.3136094674556213,0.8054108098098803,1.0,17/33,34.42%,PTPRJ;RPS3;PTPN2;CD81;PTPN22;CEACAM1;DGKZ;CD300A;NECTIN2;CARD11;DUSP3;RAB29;PRNP;IKBKG;PHPT1;TRAT1;CD226
prerank,chromatin assembly or disassembly (GO:0006333),0.5076882542563901,1.0807395753831284,0.3828264758497317,0.8272960236983337,1.0,3/11,11.81%,CHAF1B;MTA2;HDAC8
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.49543263499532986,1.0805141903170339,0.40134907251264756,0.8271882820420858,1.0,2/12,7.99%,B3GALT1;B3GALNT1
prerank,glycine metabolic process (GO:0006544),-0.4374452226803198,-1.0799450796379022,0.37844036697247707,0.8068396599184325,1.0,6/12,33.60%,GCSH;GCAT;SHMT1;AMT;GLYAT;GLDC
prerank,protein localization to cell surface (GO:0034394),0.42760205844138205,1.0798619249314938,0.361890694239291,0.8281848743868827,1.0,6/26,15.37%,FBLN5;ANGPT1;VCL;GGA2;FLNA;ARF6
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3186959661948403,1.0798448634154956,0.32708333333333334,0.8275191571007282,1.0,33/259,9.22%,NRP1;ASAP1;MTSS1;ACTN2;GSN;DYNLL1;RHOD;PARVA;KIT;MYLK;WDPCP;FGD1;RAPGEF2;DZIP1L;RAB23;FGD4;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;VCL;PMP22;IFT43;DNAAF1;CARMIL1;FBF1;EMP3;NTN1;MAP4K4;ARFIP2;IFT81
prerank,negative regulation of cyclase activity (GO:0031280),0.4765661142099274,1.0794639256558611,0.3762541806020067,0.8277884084243454,1.0,3/14,8.20%,ADGRV1;GRM2;DRD3
prerank,brain development (GO:0007420),0.3369119904559727,1.079405976825261,0.35368663594470046,0.8272372706534885,1.0,14/136,4.48%,EPHA7;ATXN1;PBX1;ARNT2;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;CDK5RAP3;SYNJ2;RAPGEF2;ZIC2
prerank,negative regulation of viral transcription (GO:0032897),-0.4238285281019486,-1.0791614347553573,0.37623762376237624,0.807583395920983,1.0,7/13,27.84%,TRIM14;TRIM11;TRIM62;IFITM3;TRIM13;MID2;UBP1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.38344037466737796,-1.0788693963024054,0.37755102040816324,0.8069134583529468,1.0,3/18,7.80%,OCLN;SLC2A1;INPP5K
prerank,vasculogenesis (GO:0001570),-0.34090654790799346,-1.078024020853407,0.32894736842105265,0.8078593593633071,1.0,12/32,13.51%,CAV1;KDR;NOTCH1;SOX17;RASIP1;RAMP2;HEY2;SOX18;VEGFA;TGFBR2;TGFB1;APLNR
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3257865188248599,1.0779227165316605,0.3373231773667029,0.8305233574372111,1.0,22/190,8.20%,ITPR1;RORA;RHOH;UACA;CGNL1;DAG1;LYN;BCL2;WWC2;MGRN1;NPRL3;TLE1;UBR2;RFFL;PRKAA2;PDE3A;SRC;MAPKBP1;NMI;NR1D1;WTIP;DRD3
prerank,regulation of protein kinase C signaling (GO:0090036),0.484326428568913,1.0775534974659071,0.3869346733668342,0.8308692464505066,1.0,3/14,9.40%,ADGRV1;SPHK2;MYADM
prerank,regulation of leukocyte migration (GO:0002685),0.4634478647954059,1.0775290761740208,0.3817891373801917,0.8302014300556892,1.0,1/16,0.70%,RHOH
prerank,cell-substrate junction assembly (GO:0007044),0.3981765215574677,1.0771143024400327,0.36046511627906974,0.8306028842123591,1.0,5/33,6.31%,ACTN2;DLC1;RHOD;LAMC1;SRC
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4927140885624708,1.0768884149914837,0.37785588752196836,0.8304886660196339,1.0,4/14,10.16%,SULF2;SULF1;SPRY2;FGF2
prerank,chromatin remodeling (GO:0006338),0.3456408442095757,1.076816298302838,0.3545568039950062,0.8299584267179408,1.0,36/100,23.33%,ARID1B;NPM3;CBX3;INO80;SMARCA1;NPM2;MBD2;DR1;SMARCC2;MTA2;KDM5B;KAT2B;ZBTB1;POLE3;FOXA1;BAZ1B;ACTR8;KDM5C;SMARCD2;HDAC4;CECR2;SMARCB1;HNRNPC;BAZ2B;ATRX;KDM4A;SRCAP;KDM5A;TAF6L;KDM4C;JARID2;NUDT5;SMARCAD1;PBRM1;HDAC5;SMARCE1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3579440403420514,-1.0766573749076414,0.3620689655172414,0.8103541241515967,1.0,7/23,13.80%,RPS6KA5;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,embryonic hemopoiesis (GO:0035162),-0.4397739151553465,-1.0764979274658681,0.3791469194312796,0.8092516934094508,1.0,4/12,9.69%,KITLG;KDR;TAL1;TGFBR2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.36843966940688333,-1.076053024938039,0.3402061855670103,0.8090194656226704,1.0,11/22,25.45%,AKAP6;STAC;ATP1B1;CALM1;CALM3;RYR2;P2RY6;HAP1;CASQ1;VMP1;CALM2
prerank,translational elongation (GO:0006414),-0.26738735819417553,-1.075853377789017,0.2751322751322751,0.8080366671459401,1.0,40/101,32.17%,EEF2;GTPBP1;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;EEF1A1;EEF1B2;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;RACK1;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;EEF1A2;LTN1;MRPS22;MRPL38;MRPS31;EEF2K;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,renal filtration (GO:0097205),0.518934863953073,1.0758007293024485,0.40747330960854095,0.8320366272212666,1.0,3/10,4.15%,SULF2;ITGA3;SULF1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4175059185318953,1.074878917234512,0.37254901960784315,0.8338512958385197,1.0,3/28,3.47%,ADCY1;EPHA4;APOE
prerank,positive regulation of response to wounding (GO:1903036),0.42643968688023354,1.0748512672280797,0.3644578313253012,0.833195855326443,1.0,8/24,16.38%,KANK1;MYLK;VTN;INSL3;HBEGF;ADRA2A;MDK;ARFGEF1
prerank,neuron projection morphogenesis (GO:0048812),-0.25235042367571986,-1.0746208673479472,0.2459016393442623,0.8102091930054113,1.0,33/137,15.06%,CNTNAP2;SHANK3;CTNND2;GPM6A;MAP2;NLGN1;ACTB;ANK3;NGF;NRCAM;IQGAP1;SLC9A6;KLF7;EPHB1;CNTN4;NTNG1;BTBD3;CDK5;DCDC2;PAK1;SGK1;SHANK1;NEFH;DCC;KIF20B;ATP7A;PACSIN1;NYAP2;APBB1;DIP2A;LMTK2;APP;MAP1B
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4651552843823071,1.0744667925970934,0.3996569468267582,0.8335352410224651,1.0,6/16,19.20%,PDS5B;POGZ;SGO1;NIPBL;BOD1;NAA50
prerank,lipid modification (GO:0030258),-0.31911444546532186,-1.0742941225424587,0.3303030303030303,0.8096611711422157,1.0,15/37,20.81%,DGKB;DGKH;PLA2G7;MBOAT1;PLPPR5;DGKK;PLPPR1;DGKG;DGKQ;PLPP4;MBOAT7;LPCAT3;DGKZ;PLPP6;DGKI
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3843817729115925,1.0740671304034315,0.3743169398907104,0.833986014722388,1.0,9/49,11.08%,DAPK2;BCL2;NUPR1;SRC;EIF2AK3;BCL2L11;BCAP31;DDX3X;GSDME
prerank,regulation of autophagosome assembly (GO:2000785),0.4053275271340307,1.073982693519545,0.3815028901734104,0.8334625483598639,1.0,9/33,16.29%,NUPR1;NPRL3;LRRK2;ADPRH;MTMR3;RAB3GAP1;PIKFYVE;NPRL2;PIP4K2C
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4831975966742549,1.0731016511433775,0.3979933110367893,0.8351087806570276,1.0,3/13,8.20%,ADGRV1;GRM2;DRD3
prerank,histone H2A acetylation (GO:0043968),0.4617657768934199,1.0726049591854452,0.40202702702702703,0.8357223466948701,1.0,3/16,7.21%,ING3;BRD8;SPHK2
prerank,skeletal muscle organ development (GO:0060538),0.422265108196215,1.0724620298789531,0.3826219512195122,0.8353858917625812,1.0,4/26,4.38%,SVIL;CFLAR;LARGE1;MSC
prerank,positive regulation of cation channel activity (GO:2001259),-0.3226046562634867,-1.0720241809500608,0.3470790378006873,0.8147688523119093,1.0,17/40,23.45%,SHANK3;TMSB4X;ANK3;AKAP6;STAC;CALM1;CALM3;ADRB2;ATPSCKMT;P2RY6;NLGN3;CTSS;KCNIP2;HAP1;RELN;CCL2;CASQ1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.32683458363666623,-1.071762541768653,0.32903225806451614,0.8140122360711733,1.0,18/37,25.67%,SDCBP;HIPK2;RYBP;RPS7;RPL11;HSP90AB1;TAF1;RPL5;GIPC1;N4BP1;FHIT;RPL23;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,cell-cell junction assembly (GO:0007043),0.3668130957950212,1.0715194393951217,0.36964980544747084,0.8372430195897567,1.0,12/63,8.02%,GJA1;CDH11;GJB6;GJB2;TLN2;ARVCF;TLN1;CDH5;VCL;DCHS1;FBF1;PARD6B
prerank,negative regulation of immune response (GO:0050777),0.32696848983607846,1.0714971630059558,0.3344788087056128,0.836586550941744,1.0,17/154,8.40%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;MAPKBP1;DPEP1;SIRT2;NMI;IRAK3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4407944087743786,-1.07135498267525,0.3607305936073059,0.8136453260780986,1.0,6/12,30.28%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3610471748744584,1.0711475262623766,0.361323155216285,0.8368058486053045,1.0,24/69,24.69%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,intracellular pH reduction (GO:0051452),0.41115781809452956,1.071065953249752,0.3904494382022472,0.8363277690065035,1.0,4/33,10.05%,ATP6V0A4;GPR89A;GPR89B;ATP6V1E1
prerank,proteasomal protein catabolic process (GO:0010498),0.3198257094813778,1.070884138143641,0.33150384193194293,0.8361068519297344,1.0,65/201,23.51%,SPSB1;TBL1XR1;HECW2;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;ERLEC1;BFAR;DERL1;PML;CUL4B;NFE2L2;UBE4B;SIRT2;UBXN2B;UBE2U;RNF185;NR1D1;RNF139;ARRB1;UBXN11;PRKN;ITCH;IFI27;KBTBD7;ERCC8;RCN3;FEM1C;BTRC;TNFAIP1;ENC1;APPBP2;HACE1;HUWE1;DDI1;NHLRC3;SPOP;PSMB5;PSMC2;KAT5;RNF34;PSMD1;PSMD4;NSFL1C;PSME3;CCDC47;FEM1B;KCTD13;DCAF11;PSMA3;ZSWIM8;DDIT3;UCHL1;BIRC2;RNF216;BAG6;KLHL20;PSMA2;FBXW11;ATXN3;PSMC5;ARMC8
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.43139104808025897,1.0708197269700617,0.38023952095808383,0.8355576488875793,1.0,11/24,24.02%,SEC24D;SEC31A;BCAP31;ABCB9;SEC23A;TAPBP;SEC24A;IDE;TAP1;PDIA3;CANX
prerank,response to X-ray (GO:0010165),0.46741163269933306,1.0706061363607697,0.3879598662207358,0.8353840647482926,1.0,5/14,20.17%,LIG4;IKBIP;ATM;NIPBL;BRCC3
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3459404100822419,-1.0702527196876337,0.34593023255813954,0.8151866519651403,1.0,9/27,23.10%,RIMS1;ARHGAP17;RIMS2;SYT1;SYT6;SYT4;RIMS3;SYT15;SYT5
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.46036546004529877,1.070018589251161,0.39166666666666666,0.836266636595216,1.0,7/16,20.89%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,regulation of cellular component organization (GO:0051128),-0.2535342295998204,-1.0691057095633625,0.2764227642276423,0.8170327100212526,1.0,31/135,14.30%,PLCE1;RAP1A;NRG3;RIT2;SPOCK1;TJP1;NET1;PAK5;TFRC;HSPA8;CAMK2D;SOCS2;OPHN1;HIP1R;RAP1B;RAB5B;CDH13;EGLN2;PACSIN2;WFDC1;SGK1;LTBP4;SSRP1;OGFR;BCAR1;MTOR;ATAD3A;FAM107A;PACSIN1;CEACAM1;RAB4A
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.377953566064301,1.069025153967525,0.3748271092669433,0.8382218185700172,1.0,4/48,2.08%,PDPK1;ANGPT1;SRPX2;FGFR1
prerank,regulation of neuron projection development (GO:0010975),0.32183104193767215,1.0688274652695124,0.37175141242937854,0.8380315825801238,1.0,27/163,9.37%,EPHA3;PDLIM5;CAMK1D;LYN;KIF13B;EPHA4;KANK1;MARK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;FZD1;PTK7;PTPRS;ROR1;LRRK2;ATP1B2;DENND5A;LPAR1;BRSK1;PTPN9;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,primary miRNA processing (GO:0031053),0.5086071954737539,1.0686662233967872,0.4052044609665427,0.8377433227687061,1.0,5/10,22.16%,SMAD3;SMAD1;METTL3;SMAD2;DROSHA
prerank,mesenchymal to epithelial transition (GO:0060231),0.510775535538994,1.0686412722230003,0.4101123595505618,0.8370894507609937,1.0,1/10,2.13%,SALL1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.4290721290318692,1.0683812507478587,0.38284839203675347,0.8370770554199455,1.0,2/26,3.80%,ITPR1;CCL19
prerank,long-chain fatty acid transport (GO:0015909),0.4113716886103265,1.068196629649434,0.3965014577259475,0.8368198707384134,1.0,4/30,5.19%,ACSL1;PRKAG2;APOE;PRKAA2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3033267013853428,-1.068074173922945,0.2972972972972973,0.8184889940269605,1.0,13/47,14.63%,STXBP6;EXOC4;EXOC6;ANK3;EXOC5;SPTBN1;KIF13A;STEAP2;ARL3;NSF;EXOC8;EXOC2;CCDC93
prerank,response to gamma radiation (GO:0010332),0.4255993835453721,1.0679968063851244,0.4028436018957346,0.8366767531405329,1.0,3/24,5.51%,YAP1;LIG4;MAP3K20
prerank,natural killer cell activation (GO:0030101),0.42271564713716003,1.06799624468798,0.40222575516693165,0.8359644996275543,1.0,4/23,11.12%,PBX1;AXL;IL12B;IFNK
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3074412246758785,1.0677000033189292,0.3419421487603306,0.8360561498655098,1.0,81/366,18.97%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;CCNA2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZBTB4;NONO;MZF1;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;EIF2B4;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;MTPN;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;RBM4B;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;FOXO3;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48519447696612056,1.0675679502581876,0.38831615120274915,0.8357012224391546,1.0,5/12,22.37%,MIA3;WNK1;MDK;AKT1;LCK
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41488619258858844,1.0667693613782105,0.37329286798179057,0.836387166000412,1.0,6/29,17.19%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41488619258858844,1.0667693613782105,0.37329286798179057,0.836387166000412,1.0,6/29,17.19%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,steroid metabolic process (GO:0008202),0.35374661138836533,1.0665252951232609,0.37128072445019406,0.8362926104653653,1.0,7/72,7.55%,CYP26B1;CYP7B1;STAR;HSD3B2;CYP1B1;CYP27A1;SRD5A1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5014043464679654,1.0664204888698632,0.41729323308270677,0.8358602287661997,1.0,1/11,1.20%,GSN
prerank,histone ubiquitination (GO:0016574),0.4360004958080297,1.0663085778054546,0.38591117917304746,0.8354587341694979,1.0,12/21,27.36%,UBR2;ATXN7L3;UBE2U;PAF1;HUWE1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40;UBE2N
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41497638002622717,-1.0653444431404613,0.3901869158878505,0.825084224814082,1.0,5/14,11.19%,MYO9A;OPHN1;SCRIB;MSN;PATJ
prerank,iron ion transmembrane transport (GO:0034755),0.5202374355538694,1.0648223948036235,0.41471571906354515,0.8387126532010638,1.0,4/10,10.70%,SCARA5;SLC25A37;SLC11A2;ABCC5
prerank,hexose biosynthetic process (GO:0019319),0.38564937367950763,1.064716677085162,0.3699731903485255,0.8382896384728382,1.0,4/42,8.02%,RBP4;AKR1B1;MDH2;ENO2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3577497385491214,-1.0645473493482496,0.3435754189944134,0.8260078455704334,1.0,10/25,23.25%,SLC7A5;PLCG2;B2M;CD55;NOD2;TRIM6;FZD5;TRAF2;MAP3K7;MALT1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.38398842474434575,1.0644757317667484,0.3804347826086957,0.838233397496392,1.0,5/44,7.23%,CYP7B1;SLC27A5;PRKAG2;INSIG2;CYP27A1
prerank,regulation of Golgi organization (GO:1903358),0.4543887674341926,1.0642264295224464,0.3944353518821604,0.8381703833750443,1.0,3/17,7.60%,USP6NL;RBSN;MAP2K1
prerank,heterocycle biosynthetic process (GO:0018130),0.48078612872865717,1.0640064740347537,0.38971807628524047,0.8380843145137138,1.0,4/14,12.81%,PYCR1;PYCR3;LIAS;MOCS1
prerank,regulation of protein modification process (GO:0031399),0.3799005068773734,1.0637183790244198,0.40405405405405403,0.8381175289984087,1.0,11/50,10.37%,IGF2;LYN;MT3;HPF1;PHIP;CDH5;PML;ATG10;KAT2B;STAT2;SPRED3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.37281478517204736,-1.0624554226545984,0.3763440860215054,0.8307588057744986,1.0,7/20,12.61%,SEMA6D;SEMA6A;SEMA7A;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4113357412816142,1.0612794440168247,0.38074074074074077,0.8439603782942199,1.0,4/28,7.96%,ARHGAP28;PLEKHG2;ARHGAP18;ARHGAP35
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2994197467166896,-1.0611169555080884,0.33941605839416056,0.8332988840333359,1.0,25/54,30.50%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;RPL11;MINAR1;COPS9;TNFAIP3;RPL5;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;CAPN3;ISG15;BAG2;U2AF2;CTNNB1;SQSTM1
prerank,cellular response to interferon-beta (GO:0035458),-0.4100068925721194,-1.060142281565995,0.37616822429906543,0.8347187054024033,1.0,5/14,16.14%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3706904452830407,-1.05994214623664,0.3707865168539326,0.8338129544092889,1.0,10/22,24.22%,B2M;MED1;CNTN4;HES1;HEY1;DLL1;DTX1;GSK3B;NEPRO;EIF2AK4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3095115163977914,-1.0597785802466633,0.38028169014084506,0.8328169750878874,1.0,13/44,13.63%,KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;ATP1B1;KCNMB2;WNK2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,response to organonitrogen compound (GO:0010243),0.3904060287685059,1.0593650858565806,0.3868312757201646,0.8483370279313112,1.0,9/38,12.19%,ERLEC1;DERL1;KYNU;RNF185;RNF139;DRD3;IRAK3;PRKN;RCN3
prerank,regulation of vasoconstriction (GO:0019229),0.42152504291780346,1.0591440805730692,0.4107946026986507,0.8482110375202387,1.0,5/27,11.10%,ADRA1B;BDKRB2;AGTR1;TRPM4;ADM
prerank,negative regulation of histone acetylation (GO:0035067),-0.4404222513864121,-1.0585820173620126,0.39172749391727496,0.83487287817029,1.0,4/11,28.28%,CTBP1;SIRT1;THAP7;SET
prerank,neural crest cell migration (GO:0001755),0.3888329588326818,1.0581806921561943,0.3929577464788732,0.8500986445795427,1.0,4/36,3.78%,NRP1;GDNF;SEMA3D;SEMA5A
prerank,muscle tissue development (GO:0060537),0.479998509182564,1.0578897962413574,0.4158415841584158,0.850180488749656,1.0,6/13,16.72%,SMO;CSRP2;ENG;CSRP3;BMP4;SHH
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.41846974814832383,1.057659062299408,0.4023494860499266,0.8500941980591531,1.0,13/26,25.71%,PRKAG2;APOA1;SLC45A3;PRKAA2;LPGAT1;EIF6;NR1H3;ERLIN1;BRCA1;ERLIN2;PRKAB2;ACADVL;PDK4
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4313104288726023,1.0575870058612213,0.3839869281045752,0.8495683896537206,1.0,4/22,7.08%,GHR;KIT;CYP1B1;TSLP
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4400915661261651,1.0574752700720946,0.4142857142857143,0.8491430721840137,1.0,5/22,8.20%,ADGRV1;STIM1;CACNA1C;GRM2;DRD3
prerank,synaptic vesicle cycle (GO:0099504),-0.3435108888242437,-1.0574294853104422,0.3712374581939799,0.8367957041223683,1.0,7/30,16.85%,NLGN1;RIMS1;CDK5;PCLO;CPLX1;RAB3A;STX1A
prerank,negative regulation of autophagosome assembly (GO:1902902),0.485195339428989,1.0569591998481773,0.42504409171075835,0.8497485806301489,1.0,2/13,6.60%,NUPR1;LRRK2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.37622324605076196,-1.056830653044746,0.3961218836565097,0.8371151117165261,1.0,8/21,12.63%,EXTL3;NDST3;HS3ST4;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,nuclear migration (GO:0007097),0.4776162256994972,1.0557563523576885,0.40414507772020725,0.8521650926843382,1.0,6/13,23.44%,SYNE2;DYNC1H1;CLMN;CEP120;FBXW11;TMEM201
prerank,lipid catabolic process (GO:0016042),-0.378992601063307,-1.0557505210041285,0.3778337531486146,0.8389249455508899,1.0,9/18,28.48%,PPT1;LIPE;PLA1A;PLAAT3;HSD11B1;LIPH;LIPC;LPL;HSD17B14
prerank,histone H4-K16 acetylation (GO:0043984),0.44780834738745934,1.0556485380875567,0.4185667752442997,0.8517148904485787,1.0,9/19,24.63%,OGT;JADE1;KMT2A;WDR5;MSL2;KANSL1;MEAF6;KANSL3;JADE2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.4102884651157717,-1.0552488881357998,0.3786407766990291,0.8389860869833903,1.0,3/14,9.98%,NOS3;ACE2;EDN1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3469388590012079,-1.0550332159670577,0.3923705722070845,0.8381197218034903,1.0,15/23,43.71%,CADM1;PIK3R6;PVR;RAET1E;NECTIN2;LILRB1;SLAMF6;CD226;CRTAM;ARRB2;NCR1;CD160;KLRK1;LAMP1;AP1G1
prerank,negative regulation of protein modification process (GO:0031400),0.349053087902193,1.0549276278029682,0.38633540372670805,0.852972607666848,1.0,14/79,9.40%,PID1;PTPN13;PLPP3;LYN;FBLN1;CDK5RAP3;PRKAA2;LRRK2;BEX4;WWTR1;NTRK3;EPHB2;PRKN;MYADM
prerank,regulation of humoral immune response (GO:0002920),0.3733983232200688,1.0547516916990933,0.401894451962111,0.8527149296060462,1.0,12/44,20.23%,SERPING1;VTN;CFH;C4B;C8G;F2;CFHR2;CXCL13;GATA6;PROS1;PHB2;SUSD4
prerank,glycogen metabolic process (GO:0005977),0.41330347395597056,1.0545650952423975,0.40181268882175225,0.8524737768289794,1.0,10/27,16.46%,PHKB;PRKAG2;NR1D1;GAA;AGL;PYGM;PPP1R3C;PYGB;PHKA1;PHKA2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3419003504934485,1.0544599927123008,0.3877038895859473,0.8520637539450877,1.0,13/93,10.83%,CCN2;SH3RF3;SASH1;SH3RF1;GADD45B;CCL19;EDAR;RELL1;MTURN;BMP2;LTBR;CARD9;TAOK3
prerank,apoptotic process (GO:0006915),-0.24142853701126094,-1.0544097052912706,0.2976190476190476,0.8384201693358949,1.0,50/203,15.78%,EFNA5;ZBTB16;SEMA6A;ELMO1;PTK2B;MAL;FAP;EGLN3;PLAGL1;PPARD;TNFRSF19;PAK5;TBX1;ADAM15;TRPC5;SIAH1;BCL2L13;CIT;PPIA;NFKBIA;DPF2;PRUNE2;HK2;MAGI3;CDK5;RHOB;SCN2A;JAK2;RFK;TGFBR2;YARS1;DDIT4;CASP8;DCC;CYFIP2;TNFRSF21;BBC3;MTOR;ERBB3;BCL2L1;PAEP;BNIP1;PIK3CA;BAK1;APP;ARHGEF6;FASTKD2;FOXO1;DAP;IAPP
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4873569965527136,1.054282978217369,0.3978685612788632,0.8518353865343435,1.0,4/11,14.89%,MAP2K1;EGFR;MYCN;BMP4
prerank,regulation of cholesterol transport (GO:0032374),0.43867361433192636,1.05410994289453,0.4133545310015898,0.8515685321973561,1.0,5/20,18.08%,LRP1;APOA1;TSPO;NR1H3;YJEFN3
prerank,negative regulation of neuron projection development (GO:0010977),0.3638492422332719,1.0540762322874255,0.3880794701986755,0.850944160929549,1.0,10/56,7.92%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;MT3;PTPRS;DENND5A;LPAR1;PTPN9
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.27527787726694664,-1.0536246578043706,0.34977578475336324,0.8393667878269236,1.0,22/71,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34411104391997915,1.0531331456035447,0.3672955974842767,0.8526861332645151,1.0,12/75,9.97%,SLC8A1;SLC8A3;LYN;NR2F2;APOE;CDK5RAP3;PKIA;CEBPA;IRAK3;SPRY2;HEXIM2;INCA1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.28754804317742666,-1.0529840910585275,0.3218390804597701,0.8397275992410288,1.0,7/62,2.31%,MEF2C;ZBTB16;CDK6;PTK2B;TNRC6C;THBS1;HOXA5
prerank,regulation of osteoclast differentiation (GO:0045670),0.3918315743920133,1.0529224381967035,0.37648809523809523,0.8525633635908453,1.0,10/33,21.05%,FBN1;CSF1;IL12B;TCTA;CEBPB;FSTL3;IL23A;CARTPT;GPR137B;PRXL2A
prerank,regulation of acrosome reaction (GO:0060046),-0.45518230278805427,-1.052698585615543,0.4031890660592255,0.839028731892284,1.0,2/10,13.74%,GLRA1;CACNA1H
prerank,protein localization to kinetochore (GO:0034501),0.46590510346578456,1.05246382504059,0.4184514003294893,0.8530479837781799,1.0,4/14,9.45%,SPDL1;ZW10;CHAMP1;MTBP
prerank,negative regulation of TORC1 signaling (GO:1904262),0.47315366951698007,1.052214077249637,0.407871198568873,0.8530117862788428,1.0,7/13,20.42%,STK11;RNF152;CASTOR2;ITFG2;SESN2;ATM;SZT2
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.36272119617775134,-1.0521653904571031,0.38858695652173914,0.8390837296479635,1.0,7/21,11.07%,PDE4D;NT5E;NT5C2;PDE2A;NUDT4;PDE9A;NT5C1A
prerank,inositol phosphate metabolic process (GO:0043647),-0.30367337476036727,-1.052065418395046,0.325,0.83786568474424,1.0,20/46,25.99%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,neuromuscular synaptic transmission (GO:0007274),0.4516994092981611,1.051747041659059,0.44212218649517687,0.8534960707284632,1.0,6/18,24.26%,ERC2;DTNA;FCHSD2;STAC3;CHRNB2;RIMBP2
prerank,macrophage differentiation (GO:0030225),0.4776553429839311,1.0515451638318492,0.4213197969543147,0.8533184334748747,1.0,3/13,6.15%,IL31RA;CSF1;CDC42
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4508349162250779,-1.051451448091172,0.40835266821345706,0.8382336298953806,1.0,6/10,19.88%,PDE4B;NIPSNAP2;CALM1;CALM3;CACNA2D1;CACNB3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.4105459078776935,-1.0512313396626027,0.40425531914893614,0.837407421025157,1.0,2/14,1.66%,ADAM10;PTK2B
prerank,protein ubiquitination (GO:0016567),0.29983805586330914,1.0506518584788338,0.34822335025380713,0.8550539761404379,1.0,120/471,20.85%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;SH3RF3;SASH1;ARRDC4;BCL2;PELI2;SH3RF1;MGRN1;FBXL17;UBR2;FBXL19;NEDD4;SMURF2;PSME4;RNF213;EPAS1;BFAR;DERL1;ZNRF3;CUL4B;RNF31;NFE2L2;UBE4B;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;UBE2V2;ARRB1;UBOX5;COMMD1;FBXO28;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;FBXO11;ERCC8;FBXO4;FBXL12;RAD18;SELENOS;BTRC;PEX2;PAF1;RNFT1;RNF217;KLHL12;MUL1;USP9X;TNFAIP1;TNKS2;RNF19A;ENC1;RC3H2;UBE2E2;AMFR;UBA6;THOP1;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;CUL7;NHLRC3;SPOP;UBR5;UBE2R2;MSL2;UBR3;UBE3B;RNF138;UBE3A;PSMB5;RNF135;PJA2;PSMC2;DTX3;HERC6;UNKL;KLHL18;WAC;RC3H1;CDC73;RNF34;PSMD1;TRIM47;TRIM41;TRIM32;PSMD4;TRIM26;PSME3;TRIM21;FBXL18;HIF3A;RNF11;KCTD13;ARIH2;CDC23;UBE2T;PSMA3;LEO1;ZSWIM8
prerank,Golgi inheritance (GO:0048313),-0.43310840681695617,-1.0505105669797763,0.4068965517241379,0.8380024973676478,1.0,4/11,29.32%,VRK1;PDCD10;PLK3;CDK1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.37713009883852394,-1.0504003827865618,0.3684210526315789,0.8353216788667456,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.37713009883852394,-1.0504003827865618,0.3684210526315789,0.8353216788667456,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,axonal transport of mitochondrion (GO:0019896),-0.44303794682595127,-1.0503135371226953,0.40563991323210413,0.8340938304396134,1.0,7/11,39.31%,SYBU;HIF1A;TRAK2;HAP1;ACTR10;MAPT;NEFL
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3762034154883908,-1.049361862480009,0.3860103626943005,0.8355372213173822,1.0,7/18,24.85%,SEC14L1;RNF125;USP15;UFD1;C1QBP;OASL;PUM2
prerank,cellular response to radiation (GO:0071478),-0.30727722066078816,-1.0493571631499121,0.34615384615384615,0.8340599979417008,1.0,22/40,35.90%,NET1;RHOB;RAD1;SIRT1;KDM4D;HUS1;RAD51;ECT2;CDKN1A;TANK;RAD51AP1;RHNO1;RRH;OPN1MW3;OPN1MW;FIGNL1;OPN3;GRB2;RAD9A;MAPK14;NSMCE3;EEF1D
prerank,gastrulation (GO:0007369),-0.4102504651377471,-1.049345596369698,0.4166666666666667,0.8326157485487905,1.0,4/15,12.63%,GPC3;LRP5;TASOR;UGDH
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.4240328082448376,-1.0492752687468019,0.4173027989821883,0.8313495530121383,1.0,2/11,1.68%,MECOM;CD34
prerank,actin filament organization (GO:0007015),0.3193077287230819,1.0484200974380673,0.3837471783295711,0.8601806951649749,1.0,23/151,10.61%,RHOH;SVIL;GSN;CGNL1;RHOD;NEDD9;TPM1;TMOD4;SHROOM2;RHOBTB1;DPYSL3;MYO1B;MCU;RHOBTB3;CDC42;RHOBTB2;CARMIL1;MYO1C;FAT1;MARCKSL1;MPRIP;SHROOM3;EFS
prerank,camera-type eye morphogenesis (GO:0048593),-0.4464739727199322,-1.0484026063345981,0.39952718676122934,0.8324941244147789,1.0,5/10,11.43%,TENM3;LRP6;TBX2;VEGFA;NF1
prerank,photoreceptor cell development (GO:0042461),-0.4089268559099757,-1.0483961442354812,0.3756345177664975,0.831041360829398,1.0,5/14,9.51%,RORB;RP1;MFSD2A;ARL3;VEGFA
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4053251171436627,1.048302082936296,0.40119760479041916,0.8597918303716952,1.0,6/30,11.52%,VAMP5;MACF1;OPTN;GOLGA4;GGA2;GOLPH3L
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.40015315327914036,-1.0481522114157888,0.39371980676328505,0.8302387560085909,1.0,3/15,9.89%,PRKCH;MED1;TRIM16
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5094128649973846,1.0478522549017442,0.43286219081272087,0.8602551139517166,1.0,3/10,6.96%,PYCR1;LRRK2;NFE2L2
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4185511248146398,1.0469038249370217,0.41930379746835444,0.8621205780868535,1.0,6/22,15.25%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C
prerank,cellular response to alkaloid (GO:0071312),0.4489840635728703,1.046584297032671,0.4388609715242881,0.8622301018120364,1.0,3/17,10.96%,SLC8A1;GSTM2;CASP7
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3427285553852044,-1.0463066449838567,0.3935309973045822,0.8344097953938945,1.0,8/26,13.10%,EFNA5;ANO1;LRP5;KLF7;EPHA5;GPLD1;ADCY8;CFTR
prerank,regulation of immune response (GO:0050776),0.3219425053136227,1.0458392582631413,0.3901345291479821,0.8634260417811753,1.0,10/135,6.92%,COL1A2;COL1A1;COLEC12;LYN;ADCY7;APPL2;IRF1;BCL6;CD247;KLRD1
prerank,nucleus organization (GO:0006997),-0.29404110547963846,-1.0456848983840767,0.37857142857142856,0.8347661857318663,1.0,12/47,19.82%,SYNE1;NUP93;RPS19;NUP35;SUN2;NUP54;PDCD6IP;PITPNB;NUP155;IRAG2;VPS4A;CHMP2B
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.45875651039681353,1.0455637681827874,0.40476190476190477,0.8634525274300633,1.0,3/14,16.19%,CSF1;IL12B;IL23A
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.36313236135114685,1.044296774667167,0.4032258064516129,0.8661989113083645,1.0,25/52,27.13%,SEC31A;TSPYL2;TLN1;PARP16;GFPT1;DNAJC3;GOSR2;CTDSP2;KDELR3;PDIA6;WIPI1;ZBTB17;CUL7;YIF1A;SRPRB;CXXC1;WFS1;ATP6V0D1;HSPA5;EXTL2;ACADVL;SSR1;LMNA;FKBP14;DNAJB9
prerank,ceramide biosynthetic process (GO:0046513),-0.3133814416835523,-1.0442605677877848,0.37543859649122807,0.8376467573638409,1.0,9/40,11.40%,ST6GALNAC3;SGMS1;ST8SIA4;SGMS2;DEGS2;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.37558929545242264,1.0440308133017,0.40298507462686567,0.8661889143054211,1.0,17/45,21.05%,SMAD3;TOM1L2;BCL6;ZFP36L1;ZW10;ZWINT;RGCC;NME6;PTPN3;PLK2;BMP4;GAS1;CDKN1C;CDKN1B;FOXC1;ZFP36L2;PRCC
prerank,metal ion transport (GO:0030001),0.33535989106467484,1.0438788744205567,0.39622641509433965,0.8658717574173422,1.0,9/86,7.00%,ITPR1;SLC8A1;SLC8A3;SLC41A1;SLC30A8;SLC24A1;MT3;CACNA1C;PANX1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.43952321937077765,-1.0436892090082492,0.3995381062355658,0.8379278984534603,1.0,4/11,14.21%,ATL2;BNIP1;ARL6IP1;LPCAT3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2995619782373643,-1.043540154608887,0.381294964028777,0.8368798554138346,1.0,13/47,21.51%,TOMM70;LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;MTX3;MTX2;ATP5PD;MTX1;TIMM10
prerank,cholesterol transport (GO:0030301),0.3672956596429395,1.043483651907211,0.3968926553672316,0.8661939227260792,1.0,6/45,5.80%,ABCA1;APOE;APOA1;LDLR;STAR;LIMA1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3437091593584629,1.0431279294606772,0.41379310344827586,0.8663443548529101,1.0,13/72,10.17%,PLEKHH2;EML2;KANK1;APOE;CHADL;LDLR;CDH5;LIMA1;EMILIN1;PRKN;MYADM;KATNB1;FGF13
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3026075629078127,-1.043075319388963,0.3594306049822064,0.8368788181027084,1.0,12/43,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;HES1;STIL;APLNR;RYR2;MICAL2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37203457071612217,1.042825058059324,0.4057971014492754,0.8664198035495817,1.0,5/51,4.18%,SERPINE1;IL6R;IL34;GAS6;CSF1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3527455411783764,1.0427079831735853,0.4015748031496063,0.8660089074632693,1.0,14/67,9.40%,NRP1;NEDD9;CSF1;APOA1;SFRP1;ECM2;CDC42;PLEKHA2;DOCK5;CARMIL1;CSPG5;ARL2;RSU1;MYADM
prerank,tetrapyrrole metabolic process (GO:0033013),0.43772801756550983,1.0426527265354641,0.42276422764227645,0.8654461386720659,1.0,3/18,8.03%,MMAB;MTR;MMUT
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.43090103102836474,1.0425211827400125,0.4169230769230769,0.8650839278733459,1.0,9/22,25.91%,ROCK2;PPP4R4;BOD1L1;PTPA;BOD1;NCKAP1L;PPP1R15A;MASTL;STYXL1
prerank,mitotic cytokinesis (GO:0000281),0.3777305767157926,1.0425106372597417,0.41112618724559025,0.8644086123819873,1.0,8/47,9.02%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18;KLHDC8B
prerank,ruffle organization (GO:0031529),0.44862291559211853,1.0424464971731988,0.41444270015698587,0.8638352958484009,1.0,4/16,9.06%,TPM1;LIMA1;CARMIL1;ARFIP2
prerank,motor neuron axon guidance (GO:0008045),0.47163721285692517,1.0424271810382613,0.44407345575959933,0.863192675243128,1.0,4/15,10.12%,RHOH;EPHA4;NTN1;SLIT1
prerank,regulation of blood coagulation (GO:0030193),-0.3414710268318404,-1.0420890786078418,0.37058823529411766,0.8382608147672236,1.0,5/27,2.59%,CAV1;CD34;THBS1;FAP;THBD
prerank,alpha-amino acid catabolic process (GO:1901606),0.4063777918879948,1.042077650802864,0.4250386398763524,0.8634609922648095,1.0,10/29,22.54%,TDO2;DDO;HOGA1;KYNU;SARDH;ACADSB;PRODH;CBS;KYAT1;FAH
prerank,cellular component assembly (GO:0022607),0.30230930192031236,1.0420366347998375,0.39850427350427353,0.86286839803796,1.0,45/253,14.45%,RHOH;TEAD1;CALD1;GSN;MITF;RHOD;NEDD9;PARVA;LAMC1;SHROOM2;YAP1;GAS6;DPYSL3;MYO1B;GORASP2;FZD1;FSCN3;CHAF1B;LIMA1;CDC42;PML;CD247;ZW10;RANBP9;PARD6B;SYCE2;TLCD1;CFAP46;PICALM;TEX12;TSPAN4;FLNC;STAG3;FANCC;RHOQ;MNAT1;CCDC40;PAWR;WASF1;KMT2A;ABCA3;LLGL1;DLG4;FLNA;SNX9
prerank,mesenchyme development (GO:0060485),0.456016769008767,1.0419071670594988,0.4391080617495712,0.8624886204600549,1.0,4/15,14.89%,FGFR2;TGFBR1;BMP2;BMP4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3886412965928246,1.0416120104653734,0.4178470254957507,0.8625995368088493,1.0,9/37,15.34%,CEMIP;PRKAG2;SIRT2;SPRY2;SPRED3;RIPK2;EGF;PARD3;SPRED1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.34016854754582765,1.0415164221835467,0.403530895334174,0.8621473486663315,1.0,11/86,9.37%,IGF1;LYN;DLC1;OGT;KANK1;NOTCH2;DENND4A;ARHGEF18;EPHB2;SPRY2;RAPGEF1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.399497628322922,1.0412102391566929,0.40683229813664595,0.862227936096102,1.0,7/30,14.66%,ROBO1;APOA1;LPAR1;ARRB1;SYNPO2L;COL3A1;AKAP13
prerank,epiboly involved in wound healing (GO:0090505),0.45379348493564714,1.041202880973884,0.413961038961039,0.861547541403156,1.0,4/16,14.42%,CCN1;PDPN;ARHGAP35;FLNA
prerank,regulation of cytokinesis (GO:0032465),-0.26422126567697046,-1.040862002462748,0.3624454148471616,0.8404080229994324,1.0,24/78,21.15%,PKP4;CIT;KIF13A;RAB11A;RAB11FIP3;CALM1;CALM3;KIF20B;CDC14A;CSPP1;GIT1;BCL2L1;CETN2;GIPC1;PRPF40A;PRC1;KIF23;PRKCE;ECT2;CUL3;VPS4A;E2F7;FLCN;PLK3
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.48383471468491107,1.0407541049495992,0.43252595155709345,0.8620250214633731,1.0,1/12,1.40%,AR
prerank,organic acid transport (GO:0015849),0.33408912578645905,1.0405620503023187,0.39615846338535415,0.8618454697391257,1.0,9/94,5.39%,SLC7A11;SLC7A2;SLC1A5;SLC13A3;SLC27A5;ACSL1;SLC6A13;NCOA2;PDPN
prerank,polyol metabolic process (GO:0019751),-0.3024739926109376,-1.040399640576327,0.3548387096774194,0.8402891076041985,1.0,20/46,25.99%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3967205765732905,-1.0398525076966396,0.3848101265822785,0.8404393477440818,1.0,3/14,9.72%,ANK3;ATP1B1;WNK2
prerank,heart looping (GO:0001947),-0.30728069809524383,-1.039405679513138,0.38461538461538464,0.8403326011765877,1.0,10/39,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,xenobiotic transport (GO:0042908),-0.37940185234509893,-1.039338283350196,0.391644908616188,0.8390539116506404,1.0,5/17,5.07%,SLC47A1;ABCG2;SLC7A5;ABCC1;SLC15A2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3618416631744751,1.0393201964856762,0.41231593038821956,0.8644399362315219,1.0,13/53,21.26%,EYA2;EYA1;PLA2R1;EGFR;SPRED3;ERCC8;NPAS2;SPRED1;SMCHD1;ATM;UIMC1;BRCC3;NSMCE4A
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4897132879603122,1.0392291525091812,0.4239864864864865,0.8639827206319406,1.0,2/11,7.76%,LYN;TLR6
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3459527377784523,1.0388218310886324,0.4103896103896104,0.8643625823577973,1.0,14/71,13.35%,ADAMTS12;FBXL17;CTSH;CTSF;CUL4B;NR1D1;CLPX;PRKN;NGLY1;CLPP;RSPRY1;CTSZ;USP9X;CTSL
prerank,regulation of macrophage migration (GO:1905521),-0.44733829004725245,-1.0386429991146837,0.4255813953488372,0.8396864007150076,1.0,4/10,12.70%,MTUS1;PTK2B;CX3CR1;CD81
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2697188297160502,-1.0385910489050931,0.3761467889908257,0.8383746279828315,1.0,22/73,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,positive regulation of cell growth (GO:0030307),0.3341265765058982,1.0385191372375546,0.42560975609756097,0.8644139433012367,1.0,12/96,8.66%,IGF1;BCL2;MACF1;TGFBR1;GOLGA4;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;NTN1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.3961687178165668,-1.0383149094159658,0.43498817966903075,0.8377527155925147,1.0,3/14,5.21%,TMSB4X;FAF1;NFKBIA
prerank,regulation of mRNA polyadenylation (GO:1900363),0.44612512225513673,1.0379518012747206,0.42394822006472493,0.8652005352797709,1.0,10/17,27.03%,CPEB1;CPEB3;NELFE;ZC3H3;HSF1;CCNT1;RNF20;NCBP2;NCBP1;RNF40
prerank,7-methylguanosine mRNA capping (GO:0006370),0.39504582380836634,1.0375156632457145,0.4235294117647059,0.8649558029821388,1.0,10/31,23.01%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),0.39504582380836634,1.0375156632457145,0.4235294117647059,0.8649558029821388,1.0,10/31,23.01%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3227100615815449,1.0373264099460922,0.4099099099099099,0.864724516331917,1.0,29/140,9.87%,RHOH;CGNL1;ARHGAP6;SYDE2;DLC1;RHOD;ARHGAP28;PLEKHG2;ARHGAP18;TIAM2;SOS2;ARHGAP29;FGD1;ARHGAP21;FGD4;ARHGAP19;ARHGAP32;ARHGAP10;CDC42;SRC;FAM13A;ARHGEF17;ARHGEF18;ARHGAP35;ARHGAP9;ARHGEF11;SYDE1;ITGAV;RHOT1
prerank,cellular response to interleukin-4 (GO:0071353),-0.45380789378909775,-1.0371282084977445,0.43231441048034935,0.839802697959052,1.0,1/10,0.16%,LEF1
prerank,response to ketone (GO:1901654),-0.3424434026585733,-1.0371215910022231,0.40869565217391307,0.8383772422575886,1.0,5/24,3.96%,SLIT2;CAV1;THBS1;ABHD2;TGFB2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.38481435129782876,1.0369184483397278,0.4025974025974026,0.8651467409881489,1.0,7/35,8.16%,NRP1;PDGFRA;NOTCH2;NTF3;IQGAP2;CDC42;NTRK3
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4117043927083678,1.0365532132727557,0.41784037558685444,0.865393334512258,1.0,7/25,8.13%,BMPR1A;CCN1;SULF1;CDH5;ENG;CRB2;RBPJ
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.43430135642089196,-1.0364814757275116,0.42824074074074076,0.8388220991636595,1.0,5/11,35.96%,JAK2;SIRT1;TMEM106A;XBP1;IL4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.43899198474079126,1.0362019587156297,0.4327390599675851,0.8649437297097281,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,glutathione derivative metabolic process (GO:1901685),0.43899198474079126,1.0362019587156297,0.4327390599675851,0.8649437297097281,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,modulation by host of viral genome replication (GO:0044827),0.4737877745602781,1.0357898614975956,0.4206896551724138,0.8653692960988926,1.0,4/13,15.02%,CCNK;PRKN;IFI27;TBC1D20
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4440880346478553,1.0355139579147445,0.44788273615635177,0.8654007838614916,1.0,8/17,23.12%,SPDL1;ZW10;CHAMP1;MTBP;CENPA;BOD1;IK;CTCF
prerank,regulation of fibrinolysis (GO:0051917),-0.4197180842854634,-1.0354799479555898,0.4339622641509434,0.8402489786268365,1.0,3/13,2.59%,THBS1;FAP;THBD
prerank,negative regulation of ATP metabolic process (GO:1903579),0.4379283920607598,1.035443439883406,0.41116751269035534,0.8649029782648888,1.0,3/17,8.39%,PID1;NUPR1;NCOR1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3893525641586354,1.0348843009050646,0.40976331360946744,0.8656320533033843,1.0,5/33,8.64%,GLUL;ART4;PYCR1;PYCR3;ALDH18A1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.43596489503590774,1.0343303772863397,0.43929712460063897,0.8664457372526925,1.0,4/19,11.52%,BMP6;AFDN;FOXA1;RGCC
prerank,response to nitric oxide (GO:0071731),0.47153769582425387,1.034131561926151,0.4422735346358792,0.866279790476055,1.0,4/13,6.97%,CCL19;MTR;MT3;DPEP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3479461602639621,1.033749148571832,0.42327365728900257,0.8665649132376186,1.0,17/72,23.01%,POLR2D;GTF2H5;CUL4B;POLR2C;ERCC8;MNAT1;GPS1;COPS3;COPS2;PPIE;XPA;POLR2L;RFC5;ERCC3;CDK7;LIG1;ERCC2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3564055528638557,1.0335691857648348,0.4376657824933687,0.8663143746763367,1.0,5/66,7.76%,IGF1;CCL19;APOA1;PANX1;TLR6
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27772578245394114,-1.03331457201053,0.3541666666666667,0.8451017010444681,1.0,28/70,27.54%,ENPP2;PLA2G7;LPCAT1;MBOAT1;SLC44A5;MFSD2A;PLAAT3;GPLD1;PNPLA8;PLA2G4C;PCTP;MBOAT7;LPCAT3;STARD7;LPCAT2;PCYT1B;PLA2G4F;PLA2G4E;CHKA;DBI;ABHD4;PLAAT1;CHPT1;LIPC;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.29530051792707535,-1.0331328191347011,0.39622641509433965,0.8442673689325514,1.0,6/49,6.37%,LRCH1;MAP2;F11R;SH3BP4;RDX;NOS1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.368256471956054,1.0331221029096833,0.4397163120567376,0.8668232527920684,1.0,17/42,25.04%,ARID1B;INO80;SMARCA1;MBD2;SMARCC2;MTA2;ACTR8;SMARCD2;CECR2;SMARCB1;HNRNPC;SRCAP;SMARCAD1;PBRM1;SMARCE1;DMAP1;HDAC1
prerank,regulation of presynapse assembly (GO:1905606),0.43513920330632694,1.0330623729116892,0.42197452229299365,0.8656062204533077,1.0,1/18,0.24%,GPC6
prerank,regulation of presynapse organization (GO:0099174),0.43513920330632694,1.0330623729116892,0.42197452229299365,0.8656062204533077,1.0,1/18,0.24%,GPC6
prerank,regulation of fatty acid oxidation (GO:0046320),0.4436981118996217,1.0330121448251268,0.4425956738768719,0.8650434119884148,1.0,3/16,10.19%,PRKAG2;APPL2;LONP2
prerank,acute inflammatory response (GO:0002526),0.4233792998500181,1.032533927199597,0.4592833876221498,0.865626459682017,1.0,2/23,2.21%,AHSG;IL6R
prerank,triglyceride metabolic process (GO:0006641),0.36870004050351013,1.0323004651124474,0.4178082191780822,0.8655650517941779,1.0,3/48,3.47%,AGMO;SLC27A5;APOE
prerank,negative regulation of axon extension (GO:0030517),-0.3285574749267458,-1.032271355678371,0.4024390243902439,0.8454210724897689,1.0,9/30,12.61%,SEMA6D;SEMA6A;MAP2;SEMA7A;DIP2B;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,regulation of mitochondrial fission (GO:0090140),0.4108066374709384,1.0321976425322357,0.4216300940438871,0.8651481129292333,1.0,6/24,13.02%,DCN;MCU;LRRK2;PRKN;STAT2;MUL1
prerank,axonemal dynein complex assembly (GO:0070286),0.39995430019142775,1.0321634630467877,0.4416403785488959,0.8645425299519295,1.0,9/27,18.77%,SPAG1;CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5;DNAL1;DNAH8;TTC12
prerank,negative regulation of complement activation (GO:0045916),0.4901248471577144,1.0320922211064885,0.4413793103448276,0.8640461080084592,1.0,1/10,2.27%,SERPING1
prerank,cellular protein-containing complex assembly (GO:0034622),0.3118405156445587,1.0314362213955772,0.42367256637168144,0.8650721217696596,1.0,23/159,14.45%,TCF4;FMOD;ANGPT1;SMAD3;NUP107;COX7A2;SPAG1;SRC;EPS15;DNAAF1;ARL2;AIFM1;PICALM;SMAD1;CENPC;NUP98;STXBP1;UVRAG;CCDC40;RAB5IF;NSG2;ADRM1;SNX9
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3471827753220802,1.0313369332113624,0.39841688654353563,0.8646560893710399,1.0,13/70,16.00%,PDPK1;SMAD3;BCL2;IL6R;MOAP1;ITGAV;IFI27;DDX3X;ACVR1B;G0S2;CASP8AP2;TNFRSF1A;CASP9
prerank,electron transport chain (GO:0022900),-0.39691044660953095,-1.0308600877533902,0.4261501210653753,0.8479940056272599,1.0,7/15,25.88%,PDIA5;PPARGC1A;CYB561;NDUFA5;SDHB;ETFRF1;UQCRFS1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3204821224890875,-1.0307091889670286,0.39,0.8470171051841326,1.0,9/32,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.43643369217762545,1.0303850819867604,0.43137254901960786,0.8664476225825537,1.0,7/17,20.89%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,receptor metabolic process (GO:0043112),-0.28330840511905797,-1.0302943032561431,0.39215686274509803,0.8468622220636027,1.0,12/53,12.70%,DNM3;CAV1;SMURF1;ACKR3;TFRC;RAMP2;SNX1;FCER1G;KIF16B;TGFB1;LGMN;CD81
prerank,regulation of phagocytosis (GO:0050764),0.35922387908200915,1.0300077128071181,0.42780026990553305,0.8667837951778679,1.0,11/53,16.04%,CAMK1D;AHSG;TULP1;GAS6;APOA1;IL15RA;ITGAV;SYT11;MERTK;FER1L5;CD47
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.43969713016085427,1.029526273803618,0.4297253634894992,0.867354151220969,1.0,5/16,14.62%,AR;RBFOX2;DDX17;TRIP4;TADA3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.28707101563943377,-1.0294869133497992,0.4064748201438849,0.8478508063943215,1.0,17/55,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,carnitine shuttle (GO:0006853),0.488947061930993,1.0292937864109988,0.4635416666666667,0.8672495391805665,1.0,2/11,5.19%,PRKAG2;PRKAA2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3780502961141568,1.0292881696344522,0.43383356070941337,0.8665847387410668,1.0,8/40,8.59%,ANGPT1;SERPINE1;VTN;CCL19;NTF3;CD63;DAB2;ARRB1
prerank,regulation of vasculature development (GO:1901342),-0.33290936760087797,-1.0289445288254966,0.3911764705882353,0.8480365239068253,1.0,9/26,11.43%,BMPER;WARS1;ERBB2;EMP2;HTATIP2;TSPAN12;PLXND1;VASH1;NF1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4321153946009666,1.0287335282185188,0.4326923076923077,0.8673601896423762,1.0,2/18,6.90%,GDNF;AGTR1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3446479120306954,-1.028692351652775,0.42696629213483145,0.8473332852041383,1.0,6/23,17.75%,PTPN2;HSP90AB1;JAK2;NLRC5;CDC37;TXK
prerank,icosanoid biosynthetic process (GO:0046456),0.5037045391965184,1.0286832081274728,0.44190140845070425,0.8668013970849476,1.0,6/10,27.00%,PLA2G4A;FADS1;ALOX5AP;LTA4H;MGST3;MGST2
prerank,protein localization to lysosome (GO:0061462),-0.3369726188644176,-1.0286028902650597,0.4276315789473684,0.8461562667275836,1.0,9/28,19.76%,SH3BP4;SORL1;KPTN;NCOA4;CD81;SCARB2;GGA3;VPS4A;LMBRD1
prerank,protein modification by small protein conjugation (GO:0032446),0.2957044799856824,1.0283525581642587,0.42455775234131116,0.866936110741117,1.0,95/361,20.85%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;ARRDC4;EYA1;MGRN1;NUP107;FBXL17;UBR2;NEDD4;CDK5RAP3;SMURF2;RNF213;EPAS1;DERL1;ZNRF3;CUL4B;ATG10;NFE2L2;NUP42;CUL5;DTX4;FBXL3;TRAF7;RNF139;UBA7;UBE2V2;ARRB1;COMMD1;PRKN;TRPM4;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;NUP98;FBXO9;FBXO11;UFL1;RAE1;FBXO4;RAD18;SELENOS;BTRC;PEX2;PAF1;URM1;MUL1;USP9X;TNFAIP1;ENC1;AMFR;NUP214;UBA6;UFC1;UBE2D1;ASB1;HACE1;HUWE1;DCUN1D2;HLTF;CUL7;UBE2R2;MSL2;UBR3;RNF138;RNF135;PJA2;DTX3;SEH1L;KLHL18;WAC;CDC73;RNF34;TRIM47;TRIM41;TPR;TRIM32;SUMO1;TRIM26;TRIM21;HIF3A;AAAS;NSMCE2;KCTD13;ARIH2;CDC23;UBE2T;LEO1;ZSWIM8
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4460344891433575,-1.0282525562887903,0.4444444444444444,0.8457558373053461,1.0,3/10,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,defense response to protozoan (GO:0042832),-0.40358277271023707,-1.0278906015793277,0.44419642857142855,0.8452947808251107,1.0,5/12,21.28%,GBP4;GBP7;CD40;LYST;GBP6
prerank,negative regulation of developmental growth (GO:0048640),0.40415370511616144,1.0276288195682244,0.4556213017751479,0.8681766789413757,1.0,7/30,10.41%,WWC2;NKD1;MT3;PTPRS;ULK2;FGF13;RNF6
prerank,cGMP biosynthetic process (GO:0006182),-0.4397424767812431,-1.0275968075120367,0.45537757437070936,0.8448075899354631,1.0,3/10,6.46%,GUCY1B1;GUCY1A1;NPR1
prerank,granulocyte differentiation (GO:0030851),-0.37282080500246695,-1.0274045965070489,0.42777777777777776,0.8439433294562485,1.0,3/18,8.31%,LEF1;CBFA2T3;TAL1
prerank,amino acid import (GO:0043090),0.43022720780467233,1.0273256261847572,0.4283464566929134,0.8682497623137916,1.0,5/21,7.63%,SLC1A3;SLC6A13;SLC22A2;SFXN2;SLC22A4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.33465557706358146,1.027174693156436,0.4345679012345679,0.8679554133776952,1.0,19/90,15.28%,GJA1;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;STAT6;DECR1;DIO2;G0S2;CNOT3;IL4R;GRB10
prerank,glycolytic process (GO:0006096),-0.33571252424338016,-1.0268597305813987,0.40773809523809523,0.8441885610252994,1.0,10/28,23.32%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;PKM;PGAM1;PGAM4;ALDOC
prerank,regulation of microtubule polymerization (GO:0031113),-0.30608739647141003,-1.0268163183828458,0.37966101694915255,0.8429410511860208,1.0,11/40,18.87%,OCLN;MAP2;NAV3;MET;RPS3;PAK1;FES;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.48152556553085424,1.026688053332634,0.426056338028169,0.8684740654532708,1.0,4/10,14.37%,DCLRE1C;DCLRE1A;TERF2;RTEL1
prerank,mitochondrial fission (GO:0000266),-0.38709526453077625,-1.0265950832214052,0.44054054054054054,0.8421699101519882,1.0,4/16,16.18%,DNM3;MTFR1;DNM1;MTFR2
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4155979969993936,1.0265066593403616,0.42812006319115326,0.8682394091117923,1.0,5/23,13.93%,MOAP1;COX18;BCL2L11;TIMM9;TOMM22
prerank,regulation of protein neddylation (GO:2000434),-0.4470695896856312,-1.0263661969862372,0.451685393258427,0.8414481480077258,1.0,5/10,15.15%,RPL11;DCUN1D4;COPS9;RPL5;HIF1A
prerank,positive regulation of phospholipid transport (GO:2001140),0.4932508376180298,1.0258894493603383,0.4416058394160584,0.8691052817433417,1.0,5/10,22.48%,APOE;APOA1;ABCA3;ABCA7;PRELID1
prerank,calcium ion import (GO:0070509),0.396722728257912,1.0250745624886495,0.42433234421364985,0.8705748148583655,1.0,5/28,11.33%,SLC8A1;MCU;CACNA1C;MICU2;CACNA1G
prerank,detection of calcium ion (GO:0005513),-0.3986599707262996,-1.0249898655145497,0.458128078817734,0.8440201762863098,1.0,7/13,19.41%,SYT1;KCNMB2;CALM1;CALM3;CASQ2;RYR2;KCNIP2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3121943459364652,1.024909431390974,0.42775881683731515,0.8703090395255992,1.0,8/144,3.44%,TCF7L2;CEMIP;PIK3R1;SMAD3;BCL2;ZIC1;LEPROT;GAS6
prerank,ncRNA 3'-end processing (GO:0043628),-0.40174048246637595,-1.0248500829540055,0.41728395061728396,0.8430273984010743,1.0,4/14,17.97%,INTS6;PTCD1;INTS8;ELAC2
prerank,nitrogen compound transport (GO:0071705),0.31601868812810174,1.0248016762494587,0.44040862656072643,0.8698991756598892,1.0,12/141,5.62%,SLC7A11;SLC7A2;TXNIP;SLC1A5;ARRDC4;LMAN2L;SLC6A13;SLC44A1;SLC22A2;SLC35F3;PDPN;TOM1
prerank,regulation of peptide hormone secretion (GO:0090276),0.3450189447749079,1.0245394787969042,0.4308300395256917,0.8699128638615516,1.0,5/67,6.66%,ITPR1;RAPGEF4;NEUROD1;ADRA2C;CACNA1C
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.36177136558833106,-1.0244577268869215,0.3901734104046243,0.8427672624118052,1.0,9/20,18.59%,ENTPD1;NT5E;P2RX7;HSP90AB1;APP;TXN;ANO6;C3AR1;PSTPIP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.34353235173502294,1.0240875515111976,0.4491094147582697,0.8703278283855556,1.0,10/65,6.86%,IL31RA;RUNX1;KIT;CCL19;CSF1;CDC42;PML;EFNA2;BATF;CEBPA
prerank,negative regulation of protein polymerization (GO:0032272),-0.3339873179742735,-1.0232494768924405,0.4090909090909091,0.8448336168593521,1.0,5/27,6.50%,SLIT2;MAP2;KANK3;CYRIB;HIP1R
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2939649173679882,1.022948210526138,0.43724696356275305,0.872526493975828,1.0,92/497,15.25%,TCF7L2;SAMD4A;ENPP1;RUNX1T1;ATXN1;DAPK1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;TSPYL2;IRF1;ZIC2;PRICKLE1;MT3;IGF2BP2;ZHX2;SFRP1;IGFBP5;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CPEB3;CEBPA;MBD2;SIRT2;ZBTB38;EIF2AK3;SMARCC2;NR1D1;RNF139;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;HEXIM2;S100A11;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;DDX3X;L3MBTL1;BHLHE41;REST;NIBAN2;SELENOS;LARP1;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ENC1;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;WAPL;CDKN1C
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4715323483687678,1.0229400410346834,0.41824440619621345,0.8718753042912952,1.0,5/11,19.35%,IL34;CSF1;LIF;PRKCA;HSF1
prerank,histone H3 acetylation (GO:0043966),-0.2992194564399897,-1.0226963581723005,0.4583333333333333,0.8450293224905806,1.0,13/40,18.28%,LEF1;JADE3;TRIM16;KAT2A;TAF10;TADA2A;LDB1;PER1;KAT6A;NAA60;BRCA2;SGF29;YEATS2
prerank,bile acid biosynthetic process (GO:0006699),0.4188300076199597,1.0226249736982542,0.459375,0.8720250650582195,1.0,3/24,7.23%,CYP7B1;SLC27A5;CYP27A1
prerank,rRNA methylation (GO:0031167),0.4191474579574812,1.0219889038299195,0.44254658385093165,0.8729746981134996,1.0,6/22,15.17%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN5;NSUN4
prerank,histone H2B ubiquitination (GO:0033523),0.49811109474361004,1.0217681326199313,0.4363957597173145,0.8728571414261148,1.0,7/10,27.03%,PAF1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4072412873011805,-1.021706855965751,0.4302600472813239,0.84649528653876,1.0,5/12,23.35%,PRKDC;CCND1;FBXO31;PLK3;SDE2
prerank,negative regulation of transport (GO:0051051),0.35804337640910655,1.0210325096866342,0.4340369393139842,0.8739592525476954,1.0,11/51,14.84%,EPHA3;SNX33;SNX12;PRKN;ITGB3;ITGAV;EGF;SYT11;PTEN;NR1H3;FER1L5
prerank,lytic vacuole organization (GO:0080171),0.3916268792654951,1.0209508874348463,0.4333821376281113,0.8734600274299869,1.0,10/32,19.33%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,regulation of microtubule-based movement (GO:0060632),-0.4291258092303895,-1.0208276328012165,0.4331065759637188,0.8477170445844352,1.0,5/11,25.37%,MAP2;NEFH;DYNLT2B;HAP1;CCDC65
prerank,pentose-phosphate shunt (GO:0006098),0.4960143410869834,1.020799702369336,0.43508771929824563,0.8731699924247212,1.0,6/11,31.06%,H6PD;PGD;TALDO1;PGLS;TKT;DERA
prerank,phagosome maturation (GO:0090382),0.38736130422620924,1.0207363496801876,0.44635193133047213,0.8726635367197406,1.0,1/35,0.20%,ATP6V0A4
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.38016647264715886,-1.0204935890785565,0.43373493975903615,0.8472840565826638,1.0,5/14,16.67%,PPP2R2B;PPP1R15B;PPP2R2A;PPP2R2C;PPP1CA
prerank,aminoglycan metabolic process (GO:0006022),0.48914627292190765,1.0204246526844065,0.4561717352415027,0.87278919213362,1.0,1/10,1.37%,GAL3ST3
prerank,regulation of translational initiation (GO:0006446),0.34899012747601194,1.0201698329023263,0.4174252275682705,0.8727551843293514,1.0,19/63,22.41%,POLR2D;EIF2AK3;DNAJC3;EIF4A2;CDC123;DDX3X;CEBPB;EIF5B;IMPACT;LARP1;ALKBH1;DDX1;TPR;CTIF;YTHDF2;MIF4GD;EIF4G2;RBM4;NCBP2
prerank,regulation of apoptotic process (GO:0042981),0.28810974134914985,1.0200975652607245,0.4310171198388721,0.872271309851335,1.0,114/676,15.16%,IGF1;STK17B;DAPK2;FHL2;ANGPT1;STEAP3;ACTN2;GDNF;PIK3R1;DAPK1;IL31RA;BCL2;GRK5;OLFM1;SON;SH3RF1;PLEKHG2;ASCL1;GADD45B;TIAM2;GAS6;PHLDA1;CFLAR;NUPR1;MYO18A;MOAP1;NOTCH2;SOS2;TXNDC5;FSTL1;FGD1;PDCD5;MT3;AXL;NTF3;NEUROD1;ING3;PHIP;RARG;SFRP1;CTSH;FGD4;PRKAA2;PDPN;TBX3;MAP3K20;CYP1B1;VIP;BCL6;USP47;BFAR;ARHGAP10;NDRG1;SRC;ARHGEF17;ING5;DPEP1;TSLP;CD28;SPHK2;ARHGEF18;ARAF;OSR1;STK4;DAB2;DNAJC3;BCL2L11;EGFR;ARHGEF11;BMP2;MAP4K4;SPRY2;AIFM1;ACTN4;PRKN;FOXA1;ITCH;BRAF;APH1B;DDX3X;IGFBP3;FBXO11;SPDEF;ADAMTSL4;FGD3;CLN3;ANXA5;REST;NIBAN2;HMGN5;RIPK2;PLEKHN1;NOL3;PAWR;IFIT2;VDAC1;HYPK;TAF9;HSPA9;ARF4;DSTYK;HPN;FLNA;AKAP13;PLK2;GATA6;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;GAS1;TMBIM6
prerank,long-term synaptic potentiation (GO:0060291),-0.3573054846688261,-1.0199741861485818,0.42151162790697677,0.8474585712915442,1.0,5/21,6.70%,SLC24A2;PTK2B;TSHZ3;GRIN2A;GRIN2B
prerank,regulation of neuron differentiation (GO:0045664),0.33771987454939695,1.018688124458097,0.4475703324808184,0.8751685602001206,1.0,10/76,6.60%,TCF4;NREP;FGFR1;ZEB1;ASCL1;CDK5RAP3;NTF3;NEUROD1;ADRA2C;LRRK2
prerank,regulation of mast cell degranulation (GO:0043304),0.44616550342125294,1.0185130810786376,0.4288107202680067,0.8749814972970263,1.0,2/14,7.21%,LYN;SPHK2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.357502829248194,1.0175060800867504,0.4718019257221458,0.8768240376453,1.0,8/52,11.94%,CELF2;RBFOX1;RBFOX2;DDX17;HNRNPA1;SMU1;WTAP;REST
prerank,response to lipopolysaccharide (GO:0032496),-0.2374342680796392,-1.0172006277953272,0.42962962962962964,0.8540186138711632,1.0,30/138,19.51%,MEF2C;PDE4B;NOS3;TNFRSF11A;GGT5;LBP;GCH1;VIM;NOS1;SIRPA;JAK2;FOXP1;MAPK8;SCARB1;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;PTPN22;NOD2;CARD16;ERBIN;TRIM6;ADAM9;TLR4;HMGB2;IFNAR1;CD86;GGT1
prerank,protein targeting to lysosome (GO:0006622),-0.35333638585752836,-1.0169495755857918,0.44077134986225897,0.8533713503412887,1.0,10/20,26.51%,HSPA8;SORL1;NCOA4;SCARB2;GGA3;CLU;VPS4A;GNPTAB;HGS;GCC2
prerank,melanosome organization (GO:0032438),0.40328607392379656,1.0167983799509408,0.45975232198142413,0.8779699166607161,1.0,9/26,19.33%,SHROOM2;DTNBP1;BLOC1S1;AP1M1;PIKFYVE;ABCB6;RAB32;HPS4;SNAPIN
prerank,cardiac muscle cell differentiation (GO:0055007),0.4298313480584058,1.016794423789575,0.4439102564102564,0.8773103766964802,1.0,5/21,8.89%,SLC8A1;ACVR1;SIK1;BMP2;CBY1
prerank,regulation of fibroblast migration (GO:0010762),0.42592660164442775,1.0166359215642853,0.45454545454545453,0.8770429379876838,1.0,5/20,11.91%,DDR2;RFFL;APPL2;FGF2;CLN3
prerank,cell cycle G2/M phase transition (GO:0044839),0.319326141044872,1.0165145703053668,0.46072684642438455,0.8766718026498413,1.0,23/129,14.92%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;AKAP8L;CEP192
prerank,ameboidal-type cell migration (GO:0001667),-0.2847523701807424,-1.0163989004183673,0.4201388888888889,0.8535446138492784,1.0,18/51,16.21%,GPC3;SEMA6D;SEMA6A;SEMA7A;CCN3;ERBB4;TBX1;ITGA4;PKN1;SEMA5B;SEMA3G;FAT2;PKN3;SEMA3C;SEMA4B;PDLIM1;CORO1C;SOX8
prerank,prostanoid metabolic process (GO:0006692),0.4612494353017906,1.0158674330637527,0.45863309352517984,0.8775891529104453,1.0,1/13,1.91%,PTGES
prerank,response to estrogen (GO:0043627),-0.3174633468356652,-1.0153709856746058,0.45045045045045046,0.85501328517503,1.0,10/31,17.81%,CAV1;ESR1;TRIM24;TRIM25;NCOA4;ARID5A;EP300;SERPINB9;CITED2;KRT19
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4174896790424957,1.0151210186143813,0.4533762057877814,0.8787804813380135,1.0,4/19,10.86%,PGM3;GFPT1;UAP1;RENBP
prerank,glycolipid metabolic process (GO:0006664),-0.2983288827776238,-1.0148964975133852,0.4398496240601504,0.8549718886121684,1.0,3/47,0.81%,ST6GALNAC3;ST3GAL6;ESYT2
prerank,negative regulation of viral entry into host cell (GO:0046597),0.46908772657974246,1.0148579064591652,0.4583333333333333,0.8787855832102568,1.0,1/12,1.20%,GSN
prerank,cardiac muscle cell action potential (GO:0086001),-0.3149482000906081,-1.014414590031506,0.44807121661721067,0.8549605574204402,1.0,7/30,6.82%,KCNJ2;ATP1A1;SCN1A;KCND3;FGF12;KCNQ1;ATP1B1
prerank,cellular response to estrogen stimulus (GO:0071391),0.4530993396077001,1.014036621096937,0.45293072824156305,0.8802034393530477,1.0,2/14,5.05%,AR;SFRP1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.36038696788378505,-1.0140084054119916,0.42118863049095606,0.8547762557244587,1.0,5/18,11.49%,ESR1;RPS13;PTBP2;PTBP3;TGFB1
prerank,negative regulation of lyase activity (GO:0051350),0.4408691709215321,1.0137965090418588,0.4593698175787728,0.880105285117408,1.0,3/16,8.20%,ADGRV1;GRM2;DRD3
prerank,positive regulation of transport (GO:0051050),0.3299838087136921,1.0137357476202398,0.4422360248447205,0.8795958542238791,1.0,11/85,8.34%,CAMK1D;LRP1;AHSG;TULP1;GAS6;APOE;CCL19;APOA1;DYNC1H1;IL15RA;DAB2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3140480079851257,1.0134390710034784,0.45894263217097864,0.8797023239855842,1.0,15/141,6.60%,RORA;ADCY1;ROCK2;ADCY2;AR;ATP1A2;ADCY5;RAPGEF2;SFRP1;IGFBP5;TFPI;CYP1B1;PDE3A;ZFP36L1;LRRK2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35812290258711926,-1.0132890611248717,0.43490304709141275,0.855489164268241,1.0,10/19,27.14%,PTPRJ;KDR;GRM5;RYR2;PTPRC;FIS1;VCAM1;SELP;DMTN;PRNP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.42017401067376287,-1.0131984076879745,0.45132743362831856,0.8543953234857484,1.0,4/10,10.23%,TBX1;LRP5;TGFBR2;PDGFA
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3752958105459009,-1.013055784009296,0.43765281173594134,0.8534255207494398,1.0,5/16,18.99%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,ether lipid metabolic process (GO:0046485),0.4682269476145823,1.012808081857084,0.46296296296296297,0.8805985707726607,1.0,1/14,0.62%,AGMO
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3347811338875619,-1.0126938394658125,0.4386503067484663,0.8530917223241056,1.0,8/23,14.78%,UBASH3B;PTK2B;DIAPH1;CAMK2D;NOS1;CASQ2;CBARP;CACNA2D1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.43884648023563216,-1.0124166372517074,0.4806763285024155,0.8525280857254781,1.0,6/10,28.85%,DGKH;GAP43;CHRM1;PICK1;PLPP1;F2R
prerank,maturation of 5.8S rRNA (GO:0000460),0.4385271223923796,1.0124164801313158,0.4634974533106961,0.8809371351857728,1.0,5/17,12.90%,C1D;MPHOSPH6;FTSJ3;EIF6;MTREX
prerank,positive regulation of ion transport (GO:0043270),0.3552243788872866,1.0121614957910046,0.470189701897019,0.8809166674692914,1.0,4/48,6.11%,ACTN2;GDNF;MYLK;CCL4
prerank,negative regulation of potassium ion transport (GO:0043267),-0.40781443903410625,-1.0115188577211283,0.47044334975369456,0.8538012153024411,1.0,4/13,6.37%,CAV1;PTK2B;NEDD4L;NOS1
prerank,regulation of autophagy (GO:0010506),0.3045462914071878,1.0110142827106197,0.45384615384615384,0.8832252032254161,1.0,51/216,21.23%,DAPK2;ITPR1;DAPK1;DCN;BCL2;LEPR;OPTN;PRKAG2;NUPR1;NEDD4;MT3;PRKAA2;LRRK2;SREBF1;SIRT2;MTMR3;PRKN;SLC38A9;STK11;ATP6V1E1;ZKSCAN3;RNF152;LAMTOR2;UFL1;RRAGD;USP10;VDAC1;PLK2;FOXK2;NPRL2;PIK3R2;TPCN2;PIP4K2C;AKT1;ATM;KAT5;FOXO3;PRKACA;KDM4A;PRKAG1;RHEB;TRIM21;WDR41;PSAP;GPR137B;MLST8;ATP13A2;SNX6;DDIT3;UCHL1;EIF4G2
prerank,retina homeostasis (GO:0001895),0.405715124560664,1.0110093842462649,0.45220030349013657,0.882565606936306,1.0,4/23,6.93%,TULP1;PIGR;CRB2;ATP1B2
prerank,error-prone translesion synthesis (GO:0042276),-0.34944149172350275,-1.01093194207702,0.4492753623188406,0.8541900314396259,1.0,2/21,8.38%,REV3L;POLH
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.32958588914108344,-1.0107779779332318,0.45614035087719296,0.8532500279391194,1.0,12/29,30.46%,RPS14;RPS19;UTP4;RRP36;RPS21;HELB;WDR46;RRS1;RPS16;RPS8;TSR1;RPP40
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4539526336493557,1.0107730339212828,0.4595070422535211,0.8824931789993763,1.0,2/13,5.01%,ABCA1;LDLR
prerank,mitochondrial translational termination (GO:0070126),-0.2582465737351996,-1.0102674599739585,0.4292929292929293,0.8532958778148927,1.0,34/88,32.17%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,positive regulation of JNK cascade (GO:0046330),0.3426515075864134,1.0098820723289446,0.4442970822281167,0.8841080783901741,1.0,11/70,12.36%,CCN2;SH3RF3;SH3RF1;GADD45B;CCL19;EDAR;MTURN;LTBR;CARD9;TAOK3;DUSP19
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.25077134010910196,-1.009753287514884,0.4437869822485207,0.8534065889714436,1.0,38/100,24.70%,RNF144B;CBFA2T3;RNF144A;SDCBP;RBX1;RYBP;TRIB2;RPL11;HSP90AB1;TAF1;GSK3A;FOXF2;HSPBP1;ZYG11B;GIPC1;RAD23A;COP1;GNA12;N4BP1;RACK1;BBS7;DVL1;RNF14;FHIT;CLU;DDRGK1;GSK3B;GABARAP;UBXN1;RCHY1;CAMLG;USP5;NUB1;CSNK1D;VCP;CCAR2;USP7;DDA1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4004701506188836,1.0091982540506308,0.45,0.8852074508598078,1.0,7/25,19.43%,AMPD3;ADK;GART;AMPD2;DCK;PRPSAP2;PPAT
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.26608641799375266,-1.0091582962107357,0.4398148148148148,0.8537070243170432,1.0,21/70,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,linoleic acid metabolic process (GO:0043651),0.43789702755285687,1.0089356211874092,0.47068403908794787,0.8851431636262188,1.0,3/17,7.07%,ACSL1;GSTM2;ALOXE3
prerank,regulation of B cell apoptotic process (GO:0002902),0.47168392438748286,1.0088004684479286,0.4784172661870504,0.8848235899190999,1.0,2/12,5.68%,LYN;BCL6
prerank,regulation of striated muscle contraction (GO:0006942),0.38948191032674445,1.008261719203681,0.4727540500736377,0.8854731511828206,1.0,2/27,1.81%,SLC8A3;ATP1A2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2617562033883139,-1.006925025134291,0.45147679324894513,0.8589036132739171,1.0,20/75,18.84%,GPCPD1;SERINC5;DGKH;CPNE3;PLA2G7;PLA1A;PIGP;PAFAH1B1;GPLD1;PLEK;PNPLA3;PIGB;PLA2G4C;CRLS1;PIGL;ABHD6;DPM2;SYNJ1;PIGV;PNPLA6
prerank,protein processing (GO:0016485),0.31903103624110574,1.0067297619553803,0.451145958986731,0.8888371118016194,1.0,13/102,11.91%,CPXM2;OGT;AEBP1;CPXM1;CTSH;MMEL1;SPRTN;SEC11C;EEF1AKMT4-ECE2;ECE2;LONP2;APH1B;CLN3
prerank,negative regulation of cell death (GO:0060548),0.326135076270568,1.0066608018017256,0.47619047619047616,0.8883632012732318,1.0,21/88,18.20%,CCN2;CCN1;INPP5A;CSF1;MT3;CCN5;LRRK2;PARP16;CD200;CCN4;PRKN;FGF2;RAD18;IMPACT;NPAS2;TM7SF3;BMP4;AKT1;KANK2;BECN1;SOX11
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.40844774187226623,1.0051500389210366,0.4699367088607595,0.8915937435330478,1.0,4/23,6.20%,GHR;KIT;CYP1B1;PIBF1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3665358033928385,-1.0050281232752445,0.4637305699481865,0.8628098132620703,1.0,4/18,8.82%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,tRNA wobble uridine modification (GO:0002098),0.446999427921408,1.0047552124607293,0.478584729981378,0.8919275729400685,1.0,5/14,20.94%,TRMT9B;URM1;DPH3;ELP4;TRMU
prerank,positive regulation of hormone secretion (GO:0046887),-0.36762814887789264,-1.004496758848137,0.45,0.862914022948264,1.0,10/17,45.90%,VAMP8;EDN1;SPP1;GRP;C1QTNF3;PLA2G3;RASL10B;TFR2;CYP19A1;HCAR2
prerank,zinc ion transport (GO:0006829),0.42481172895104996,1.0041392679391872,0.46865203761755486,0.8928579176830135,1.0,5/21,10.81%,SLC30A8;MT3;SLC30A2;SLC30A10;SLC39A13
prerank,regulation of p38MAPK cascade (GO:1900744),0.3774869098371438,1.0040020283080011,0.4574314574314574,0.8925349820489447,1.0,4/35,8.76%,SASH1;GADD45B;RELL1;BMP2
prerank,anterograde axonal transport (GO:0008089),-0.30850579214074186,-1.00366384027023,0.44983818770226536,0.8639054695957344,1.0,14/37,27.59%,DLG2;RAB21;AP3B1;RAB27B;KIF1A;TRAK2;AP3S1;BLOC1S5;KIF5A;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,negative regulation of axonogenesis (GO:0050771),-0.32866487351031687,-1.002991249283642,0.4604519774011299,0.8645059034500044,1.0,11/27,18.53%,MAP2;DIP2B;GDI1;ULK1;ARHGDIA;SEMA3G;DCC;LINGO1;MAG;MCF2;RTN4R
prerank,positive regulation of ATPase activity (GO:0032781),0.36743204169963706,1.0029167161044104,0.4563106796116505,0.8945726188286165,1.0,6/41,11.53%,DYNLL1;TPM1;ATP1B2;MYL4;TNNT3;TOR1AIP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.33960647890045037,1.0028865677107184,0.43386243386243384,0.8939754189743051,1.0,11/60,13.39%,FGFR4;PDGFRB;CHTF8;SMOC2;PARM1;HNRNPA1;FGF2;PARN;RGCC;FBXO4;TNKS2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.44243062547674744,1.0028506805699393,0.47386172006745364,0.8933928173046797,1.0,3/16,3.68%,NOS1AP;APOE;NPR3
prerank,cranial nerve development (GO:0021545),0.46180803021704725,1.0027468183173593,0.4631956912028725,0.8929571227175057,1.0,4/11,21.16%,SALL1;CHD7;CHRNB2;TIFAB
prerank,mRNA modification (GO:0016556),0.4105447507492008,1.0025293523298697,0.46275752773375595,0.8928146873570867,1.0,8/22,18.89%,PUS3;NSUN2;METTL14;RPUSD2;WTAP;TRUB2;METTL3;TRUB1
prerank,negative regulation of B cell proliferation (GO:0030889),0.45561301154069833,1.002193152241981,0.4785046728971963,0.8929967483937664,1.0,1/11,1.77%,LYN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4467101532246389,1.001819998691871,0.4684838160136286,0.8932741550234674,1.0,4/13,17.38%,PLA2R1;SPRED3;SPRED1;ATM
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.37326939407714477,1.001772808798552,0.4462686567164179,0.8927238326486521,1.0,5/36,8.47%,TCF7L2;PPP3CA;FZD2;TNRC6B;TNRC6A
prerank,membrane fusion (GO:0061025),-0.3191897002829201,-1.0015917903987424,0.4444444444444444,0.8669995200278761,1.0,5/33,11.54%,DNM3;RIMS1;DYSF;GCA;NSF
prerank,protein import into nucleus (GO:0006606),0.33078048937013577,1.0015826707339635,0.45977011494252873,0.8925433531420383,1.0,19/66,18.84%,CBLB;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;KPNA6;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;AKT1;KPNA2;KPNA1;PHB2;TPR;APPL1;KPNB1
prerank,regulation of Notch signaling pathway (GO:0008593),-0.26193357196529954,-1.0009037612073381,0.42783505154639173,0.8677001958875785,1.0,23/76,19.60%,NOTCH3;EPN2;NOTCH1;NOS3;CCN3;BEND6;TGFB2;JAG2;GATA2;NOTCH4;SNW1;MFNG;LFNG;GALNT11;HEY1;NOD2;EP300;DLL4;SYNJ2BP;ITGB1BP1;PDCD10;DLL1;EGFL7
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4265082460652726,-1.000781879186795,0.4674698795180723,0.8666529846646973,1.0,4/10,23.25%,ESR1;ATF7IP;PSMC4;THRA
prerank,positive regulation of vasculogenesis (GO:2001214),0.4697988164619653,1.0006965552225573,0.4696969696969697,0.894038012802895,1.0,2/10,4.33%,RIN2;RAPGEF2
prerank,regulation of feeding behavior (GO:0060259),0.46543106690644326,1.0004696644436586,0.45518453427065025,0.893924159584767,1.0,2/11,5.44%,LEPR;GNB3
prerank,central nervous system neuron development (GO:0021954),-0.38493166998624856,-1.0004215688892202,0.45083932853717024,0.8663266503517066,1.0,5/15,11.81%,MAP2;LHX6;B4GALT5;HSP90AB1;ATP7A
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42933288291237404,1.0000705529659408,0.4764227642276423,0.8942928324436215,1.0,6/18,20.48%,ZFP36L1;BCL2L11;KLF9;REST;HNRNPU;ZFP36L2
prerank,positive regulation of immune system process (GO:0002684),-0.3743982362999858,-1.0000074767222316,0.4358974358974359,0.8661960474780187,1.0,3/16,9.51%,IL15;TGFB2;VEGFA
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4033942783401556,0.9993052002097438,0.4462025316455696,0.8955705537672716,1.0,3/22,6.06%,RBP1;UBIAD1;ALDH1A2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3922079725046592,-0.9991617151782005,0.46380697050938335,0.8673583607563028,1.0,6/14,35.14%,ECI2;AMACR;ACOX1;ACOX2;ACOXL;ACOT8
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3042934500765107,0.998999332557338,0.4664391353811149,0.8956475620949244,1.0,43/153,21.36%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,positive regulation of rRNA processing (GO:2000234),0.47336865165654385,0.9988901218677272,0.47377938517179025,0.8952695795184246,1.0,4/10,13.24%,BUD23;DIMT1;WDR43;TRMT112
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3762481004791677,0.9982339606647141,0.49646393210749645,0.8963138148734985,1.0,5/36,7.65%,DAPK2;BCL2;TGFBR1;ING5;TRAF7
prerank,negative regulation of cilium assembly (GO:1902018),-0.4026376326639748,-0.998230824624808,0.4589041095890411,0.8686414016790093,1.0,4/12,10.94%,LIMK2;TBC1D30;CEP97;TESK1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31388311229763655,0.998130147765411,0.49122807017543857,0.8959133019913189,1.0,22/128,14.92%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192
prerank,presynapse organization (GO:0099172),-0.4343747557257872,-0.9978849025003701,0.5,0.8683579135692859,1.0,4/10,18.25%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,cellular response to light stimulus (GO:0071482),-0.26667829141414323,-0.9973541208758651,0.45491803278688525,0.8685061507231321,1.0,26/66,30.06%,PTPRK;KDM1A;TAF1;YY1;RPL26;COPS9;GNB1;BAK1;PDE6A;EP300;N4BP1;RHBDD1;NPM1;PARP1;POLK;TRIAP1;ATF4;SDE2;EIF2AK4;FMR1;RUVBL2;RHNO1;AQP1;RRH;OPN1MW3;OPN1MW
prerank,indolalkylamine catabolic process (GO:0046218),0.4780538659792511,0.9967090985921409,0.46946564885496184,0.8988228915190406,1.0,2/10,6.77%,TDO2;KYNU
prerank,negative regulation of chemotaxis (GO:0050922),0.3804906047784237,0.9966624613925706,0.4552129221732746,0.8982563973766312,1.0,4/31,3.78%,ROBO1;SEMA3D;ANGPT2;SEMA5A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.32900812599623463,-0.996569556737959,0.46458923512747874,0.8693391924643854,1.0,12/25,25.67%,HIPK2;RPS7;OPHN1;RPL11;HSP90AB1;TAF1;PSMF1;RPL5;RPL23;EFNA1;PRKCG;SGTA
prerank,isotype switching (GO:0045190),0.4732266448442743,0.9965269832050886,0.4869109947643979,0.8979380060515928,1.0,2/10,6.84%,LIG4;BATF
prerank,response to hydrogen peroxide (GO:0042542),-0.2920522170868528,-0.996242827272617,0.4722222222222222,0.8689549679345555,1.0,14/45,19.53%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;APTX;ADAM9;ECT2;GPX1;ANXA1;CAT;PDCD10
prerank,bile acid metabolic process (GO:0008206),0.39364695627264845,0.9961490098404282,0.4686064318529862,0.8982193848363464,1.0,3/27,7.23%,CYP7B1;SLC27A5;CYP27A1
prerank,methylguanosine-cap decapping (GO:0110156),-0.42137032808042585,-0.9960910178051576,0.48372093023255813,0.8680452767448391,1.0,4/10,21.58%,EDC3;PNRC2;DCP2;DCPS
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.47082087762226454,0.9960030680590382,0.4965156794425087,0.8979270077077323,1.0,3/11,6.31%,KANK1;PDPN;SRC
prerank,positive regulation of telomere capping (GO:1904355),-0.3709395604692881,-0.9958618547574308,0.4920212765957447,0.8673352082550857,1.0,6/17,22.34%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;MAPK1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3739304364498444,-0.9956595358042254,0.45588235294117646,0.8665973261636712,1.0,7/17,15.93%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;PTPRC
prerank,O-glycan processing (GO:0016266),0.3488382474839488,0.9955408536320284,0.48412698412698413,0.8984081982652796,1.0,4/54,3.69%,GXYLT2;GALNT14;GALNT15;ST3GAL3
prerank,cellular calcium ion homeostasis (GO:0006874),0.3089360044226614,0.9953666400364934,0.476905311778291,0.8981685673489629,1.0,22/133,12.17%,SLC24A3;SLC8A1;SLC8A3;BCL2;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MCU;CDH5;PML;SLC24A5;TMEM203;DRD3;CSRP3;MICU2;PDZD8;ANXA6;F2;CLN3;YWHAE
prerank,endothelial cell migration (GO:0043542),0.3702340303538547,0.9952419672155504,0.4664764621968616,0.8978132297797857,1.0,5/37,6.38%,NRP1;FSTL1;CYP1B1;CDH5;ADGRA2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.4245928661251096,0.9946023338654385,0.47587354409317806,0.8987521012568663,1.0,4/18,13.02%,DCN;MCU;PRKN;MUL1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3668948873288983,-0.9941355606258706,0.46835443037974683,0.8696660804573112,1.0,6/17,11.49%,NOTCH1;TENM4;PTN;ID2;HES1;TGFB1
prerank,regulation of complement activation (GO:0030449),0.36135238800392316,0.9939213109185208,0.48599439775910364,0.8997979997664397,1.0,5/40,6.12%,SERPING1;VTN;CFH;C4B;C8G
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.40048958899768683,0.9937952308429863,0.4712121212121212,0.8994370168333023,1.0,5/27,3.80%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.38651902364772095,0.9937126249240692,0.45987654320987653,0.8989556211580085,1.0,9/26,21.29%,MAPKBP1;SIRT2;NMI;IRAK3;ITCH;MUL1;DHX58;TRIM21;TRIB1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.35852470966838873,0.9936845693971158,0.4843304843304843,0.8983697452292808,1.0,12/44,16.41%,SH3RF1;GAS6;CAST;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;IGBP1;AKT1;FNIP1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3754971848091432,0.9936524938564044,0.4899425287356322,0.8977690765635392,1.0,7/35,8.91%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35;EPHB2;SPRY2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3088122651121662,-0.9936356517384844,0.47003154574132494,0.8696895802178889,1.0,14/31,19.80%,DLG2;LIN7A;MYO9A;LRRC7;OPHN1;LIN7C;SCRIB;MSN;PDCD6IP;WDR1;ERBIN;SYNJ2BP;MTCL1;SH3BP1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.44310257744745607,0.9936229220860676,0.478476821192053,0.8971946187119986,1.0,3/16,4.22%,ST6GALNAC5;ST3GAL5;LARGE1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3210223093488854,0.9935791348164841,0.48271604938271606,0.8966463138991688,1.0,19/98,14.94%,ANGPT1;PID1;APOE;PDGFRB;CSF1;APOA1;MT3;NTF3;AGTR1;CD63;ARRB1;DCXR;F2;INSR;EGF;HPN;FASN;NR1H3;SFRP4
prerank,regulation of axon extension (GO:0030516),0.3691001226609426,0.9935547465155294,0.475,0.8960556719797549,1.0,9/37,12.45%,OLFM1;MACF1;APOE;MT3;GOLGA4;PTPRS;NTN1;RNF6;MAP3K13
prerank,organic hydroxy compound transport (GO:0015850),0.3667936072993984,0.9931134749112013,0.4730290456431535,0.8964693331358704,1.0,3/36,4.89%,RBP4;SLC27A5;NCOA2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.43215521137974666,-0.992908727623023,0.5091324200913242,0.8704088332489245,1.0,4/10,14.18%,SIRPA;YY1;REL;RELB
prerank,regulation of viral transcription (GO:0046782),0.3617305572528288,0.9925016016808558,0.4765957446808511,0.8973109494739979,1.0,1/39,0.14%,POLR2D
prerank,negative regulation of apoptotic process (GO:0043066),0.28232506402496743,0.9924563964004139,0.5227502527805864,0.8967597130082643,1.0,73/444,14.89%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;YAP1;GAS6;APOE;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;TLE1;FSTL1;MT3;AXL;NTF3;RNF213;PHIP;LIG4;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;SLC30A10;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;PRKN;ITCH;BRAF;DDX3X;CLN3;ANXA5;YWHAE;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;IGBP1;HYPK;TAF9;HSPA9;ARF4;MERTK;DSTYK;MDK;HPN;FLNA;PLK2;GATA6;BMP4
prerank,amyloid fibril formation (GO:1990000),0.34771112623731054,0.9923526649228194,0.46502057613168724,0.8963605810028697,1.0,9/51,13.18%,GSN;HSPG2;APOA1;CST3;SNCAIP;PRKN;GGA2;APH1B;USP9X
prerank,positive regulation of viral process (GO:0048524),0.3356966995841024,0.9922998388077536,0.4705111402359109,0.8958390084785064,1.0,13/60,18.80%,POLR2D;AXL;KPNA6;CD28;POLR2C;DDX3X;LARP1;STAU1;NELFE;TBC1D20;KPNA2;PPIE;POLR2L
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.44327523108333416,0.9922738285549518,0.4745762711864407,0.8952419198254776,1.0,5/13,21.73%,IRAK2;TNIP2;PIK3R4;EPG5;MYD88
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.31578987758901095,0.9921974798137172,0.49458483754512633,0.8947892690146889,1.0,30/104,22.91%,SLC8A1;KSR1;SLC8A3;CCNA2;CDK5RAP3;SRC;PARP16;MAP2K1;CCNK;TELO2;DDX3X;UVRAG;MNAT1;DUSP19;CNPPD1;CDK12;AKT1;CDKN2C;CCNT2;CDKN1B;HTT;ETAA1;SERTAD1;CCND2;TRIB1;CCNT1;TSG101;CCNG2;CDK7;SLC27A1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3646212066237865,-0.9920803292152035,0.47494033412887826,0.871355482084341,1.0,5/18,6.64%,ACTB;ZDHHC2;SPTBN1;CDK5;VAMP8
prerank,body fluid secretion (GO:0007589),0.44142800822737105,0.992070343334012,0.47704918032786886,0.8944674289675747,1.0,3/15,7.63%,SLC22A2;VIP;SLC22A4
prerank,I-kappaB phosphorylation (GO:0007252),-0.42695656410162064,-0.99205184150176,0.4758771929824561,0.8700975653092025,1.0,7/10,38.76%,TLR4;DAB2IP;CHUK;MAP3K7;ERC1;TLR2;TLR3
prerank,insulin secretion (GO:0030073),0.4162151677734197,0.9920334709848702,0.47596153846153844,0.8939088557793226,1.0,5/19,16.07%,SLC30A8;NEUROD1;FAM3B;CYB5R4;MAFA
prerank,protein localization to nucleus (GO:0034504),0.3151152614911332,0.9916077701630459,0.4610705596107056,0.8943228449704451,1.0,29/102,20.15%,COL1A1;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;PML;ARL2;HEATR3;CSE1L;PPP1R10;TOR1AIP1;YWHAE;PAF1;BANP;TSC2;NUP214;TOR1B;BMP4;PIKFYVE;AKT1;TOR1AIP2;PHB2;XPA;TPR;APPL1;KPNB1;ABCA7;HNRNPU
prerank,B cell proliferation (GO:0042100),0.4302422008518524,0.9915347502261678,0.49409780775716694,0.8938537354562116,1.0,2/17,2.92%,BCL2;GAPT
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3168415988651301,-0.9914981539928279,0.434375,0.8703848328251659,1.0,10/27,25.45%,PDE4D;CAMK2D;NOS1;CALM1;HPCA;AHNAK;CACNB3;FKBP1A;PLN;CALM2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.4405262715412811,0.9911304012096539,0.5061946902654867,0.894163935175387,1.0,3/13,8.05%,DCN;BGN;CSPG5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.45558971018097677,0.9906853882543906,0.4919786096256685,0.894578309203793,1.0,4/12,10.77%,SFRP1;DAB2;NCOR1;NCOR2
prerank,regulation of protein localization to nucleus (GO:1900180),0.35737725231644624,0.9904457330936833,0.46573426573426574,0.8945282346916174,1.0,13/43,18.63%,GLUL;YAP1;CDK5RAP3;WWTR1;EIF2AK3;BYSL;F2;BMP4;SESN2;AKT1;SHH;LIF;TPR
prerank,neuron differentiation (GO:0030182),0.29907132632453987,0.9902612980404364,0.49330357142857145,0.8943406515477231,1.0,21/165,7.60%,PBX1;GLI2;RUNX1;WNT8B;FZD2;WNT4;ASCL1;RUNX2;TGFBR1;WNT6;NEUROD4;HS6ST1;NEUROD1;FZD1;THOC2;ATOH8;SMARCA1;WNT5B;USH2A;BRSK1;MAP2K1
prerank,protein modification process (GO:0036211),-0.25775123075717665,-0.9901003261396002,0.4880382775119617,0.8729255460812436,1.0,17/76,19.36%,ST3GAL6;ST8SIA4;YES1;STK38;UBA3;CHRM3;B4GALT7;MMP15;MAN2B1;UBE2D3;ATG3;UBE2S;PRKDC;RPN1;QPCT;CPE;PARP1
prerank,mitochondrial translation (GO:0032543),-0.24210548720760727,-0.9899455572794824,0.4946808510638298,0.8720621849486736,1.0,39/104,32.17%,MRRF;NOA1;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;NDUFA7;MRPL48;MRPL4;MRPL21;FASTKD2;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;GATC;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MTIF3;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,polarized epithelial cell differentiation (GO:0030859),-0.39662379628845235,-0.9899066978275785,0.46635730858468677,0.8708537486487625,1.0,4/13,10.46%,MYO9A;OPHN1;SCRIB;MSN
prerank,negative regulation of cytokine production (GO:0001818),-0.2284218641604977,-0.9896885405598592,0.42016806722689076,0.8701217243426599,1.0,41/163,19.80%,LEF1;FN1;TMSB4X;IFIH1;CD34;THBS1;RPS6KA5;NAV3;OTUD7B;APOD;RNF125;CMKLR1;TRIB2;SIRPA;TRIM25;NLRC5;RPS6KA4;TNFRSF21;KLF4;TNFAIP3;PTPN22;INHBB;INHA;CEACAM1;SIGIRR;CUEDC2;PTPN6;SRGN;PTPRC;PCBP2;JAK3;HOMER3;N4BP1;INHBA;ZFPM1;TLR4;UFD1;TAX1BP1;ANXA1;DLL1;C1QBP
prerank,cellular response to interleukin-12 (GO:0071349),-0.280433336859122,-0.9895919556245518,0.4981949458483754,0.8690924753840854,1.0,14/48,15.70%,PITPNA;PPIA;RAP1B;SIRPA;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4673985523578559,0.9895504468613275,0.49263502454991814,0.8955090407828208,1.0,6/11,28.84%,SLC30A10;SLC18A2;ABCD2;ABCD1;FYN;PPARA
prerank,positive regulation of DNA replication (GO:0045740),0.44125173858742317,0.9895482560027385,0.4878048780487805,0.8948647932505781,1.0,5/16,13.25%,GLI2;NPM2;EGFR;GLI1;EGF
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3690155854869907,0.9895031965335508,0.4828080229226361,0.8943257258413025,1.0,6/36,9.95%,GAS6;CSF1;AXL;TSLP;PRKN;PARP14
prerank,peptide cross-linking (GO:0018149),-0.3309061085275204,-0.9892994025275477,0.48760330578512395,0.8686039333079111,1.0,3/25,4.94%,FN1;THBS1;TGM2
prerank,regulation of cellular metabolic process (GO:0031323),0.3577884682572658,0.9892866818817787,0.49358059914407987,0.8942195284644674,1.0,9/45,14.75%,PID1;GNB3;CYP1B1;PRKN;EIF6;NCOR2;ARF4;RSPO1;FASN
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4478046609726342,0.989093061781413,0.48507462686567165,0.8940445764405593,1.0,2/12,8.52%,PIK3R1;BCL2L11
prerank,negative regulation of hippo signaling (GO:0035331),0.4521930492809192,0.9888432248718667,0.47304347826086957,0.8939885484665575,1.0,2/12,8.07%,WWC2;WTIP
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.40074888000293285,0.9882053788078815,0.4775888717156105,0.8948732317797254,1.0,9/23,24.33%,FAF2;LMAN1;DERL1;SELENOS;AUP1;TECPR2;SEC16A;RANGRF;OS9
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3561526731924418,0.9881125939531005,0.46262341325811,0.8944699651191499,1.0,8/43,14.89%,TEAD1;SMAD3;NFIB;ATOH8;FGF2;REST;ETS1;BMP4
prerank,plasma membrane organization (GO:0007009),-0.264891281203909,-0.9879785422796229,0.4933920704845815,0.8709331270035767,1.0,15/61,13.61%,FNBP1L;CAVIN2;ANK3;AHNAK2;DYSF;SPTBN1;P2RX7;BIN3;PACSIN2;OSBPL2;DEGS1;UGCG;NSF;PACSIN1;ARV1
prerank,positive regulation of chromosome organization (GO:2001252),0.4371020054166076,0.9878514657581947,0.4900990099009901,0.8944824609635121,1.0,7/15,26.06%,LIG4;PML;PPP1R10;RTEL1;ATRX;MRE11;RAD50
prerank,receptor-mediated endocytosis (GO:0006898),0.30727859684510445,0.9877252879371727,0.5023310023310024,0.8941406827894962,1.0,26/132,13.35%,DNAJC6;COLEC12;SPARC;LRP1;GRK3;HSPG2;APOE;NEDD4;APOA1;LDLR;CXCL16;COLEC11;ADRB3;EPS15;DAB2;AP1G2;PICALM;IGF2R;MASP1;ADM;CLN3;LRP3;INSR;GRK4;WASF1;CTSL
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3986574197912502,0.9877156826903489,0.4946727549467275,0.893519845965979,1.0,3/25,6.60%,ITPR1;CCL4;LRRK2
prerank,nucleoside phosphate catabolic process (GO:1901292),0.44761481227127986,0.9871175729356464,0.5051020408163265,0.8943054048748816,1.0,1/13,0.63%,ENPP1
prerank,mitochondrial protein processing (GO:0034982),0.45845686767211263,0.9867003312503024,0.4516728624535316,0.8946590841463499,1.0,6/11,24.92%,PMPCB;IMMP1L;YME1L1;AFG3L2;STOML2;MIPEP
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34744156538472054,0.9865992721048853,0.49445983379501385,0.894239502798261,1.0,13/49,14.61%,RUNX1;TNRC6B;MTURN;TNRC6A;SETD1A;KAT2B;RAB7B;EIF6;L3MBTL1;NFE2;KMT2E;KMT2A;WDR5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.38675532375085186,-0.9864517443040026,0.47560975609756095,0.8739733487287967,1.0,4/13,6.98%,TMSB4X;NOS3;NOS1;PPARGC1A
prerank,synaptonemal complex assembly (GO:0007130),0.4412201371130573,0.9864319420610047,0.4793103448275862,0.8933585106268944,1.0,3/15,11.79%,SYCE2;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.4412201371130573,0.9864319420610047,0.4793103448275862,0.8933585106268944,1.0,3/15,11.79%,SYCE2;TEX12;STAG3
prerank,nuclear export (GO:0051168),0.32616825525881316,0.9858055299052271,0.49748743718592964,0.8942133165611836,1.0,15/80,14.58%,ATXN1;RANBP17;PHAX;U2AF1L4;THOC2;NUP42;HNRNPA1;XPO7;DDX39A;CSE1L;RAE1;MAGOHB;STRADA;NUP214;SRSF5
prerank,copper ion homeostasis (GO:0055070),-0.36827139212950305,-0.985442968783586,0.4813895781637717,0.8755499406339226,1.0,9/17,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;CUTC;MT2A;SLC31A2;PRNP
prerank,muscle tissue morphogenesis (GO:0060415),0.4270929650156053,0.9854061792108741,0.4875207986688852,0.894588307491854,1.0,3/16,8.76%,TGFBR3;MYLK;BMP2
prerank,regulation of immune effector process (GO:0002697),0.3549159812758801,0.9853786727749516,0.49226441631504925,0.8939975593053132,1.0,5/41,6.12%,SERPING1;VTN;CFH;C4B;C8G
prerank,diol metabolic process (GO:0034311),-0.35200166415338285,-0.9852226151066446,0.49591280653950953,0.8748438110674638,1.0,6/19,10.72%,NOS3;DEGS2;GCH1;NAAA;CALM1;SPR
prerank,negative regulation of DNA binding (GO:0043392),-0.315798055753012,-0.984976095271496,0.5028571428571429,0.8743122943079603,1.0,9/28,17.16%,LEF1;NFKBIA;KDM1A;HEY2;JAK2;JUN;HEY1;TFAP4;RSF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3120667062094113,0.9842234465348979,0.5173237753882916,0.8961365702269211,1.0,18/101,14.80%,SAMD4A;PLD1;DACT1;OGT;FGFR4;ASPH;CSF1;CPEB3;ATG10;AGTR1;CD28;METTL14;EIF6;DDX3X;BTRC;PLXNB2;NSUN5;NR1H3
prerank,DNA catabolic process (GO:0006308),0.45844989894976285,0.9842079813288347,0.49480968858131485,0.8955339648499397,1.0,2/11,10.45%,REXO4;DNASE1L1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3788524747727441,-0.9840008866700322,0.45384615384615384,0.8756521285484896,1.0,6/14,15.08%,NOS3;NOS1;MAPK8;NF1;MAPK3;CACNA1D
prerank,postsynaptic membrane organization (GO:0001941),-0.3733513833855346,-0.9837713204606806,0.4753246753246753,0.8749737934289974,1.0,3/17,4.75%,SHANK3;NLGN1;NRXN1
prerank,male gonad development (GO:0008584),0.37004561022603183,0.9834191481735711,0.4888888888888889,0.8967665169242884,1.0,5/34,6.58%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,mRNA stabilization (GO:0048255),0.36159414003305806,0.9832143731288987,0.4979253112033195,0.8966137042728687,1.0,14/40,22.88%,GDNF;TENT5A;AXIN2;VIP;TENT5D;LARP1;MAPKAPK2;SYNCRIP;HNRNPC;HNRNPU;TIRAP;NOCT;MYD88;IGF2BP1
prerank,extracellular transport (GO:0006858),0.4624161134068618,0.982571548420411,0.4855595667870036,0.8975067495434003,1.0,5/12,21.87%,CCDC40;CABYR;SPEF2;ROPN1L;TSG101
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.44330043959093024,0.9822501219048078,0.47775947281713343,0.8976426708716742,1.0,2/15,2.08%,RAI2;FGFR1
prerank,negative regulation of protein kinase activity (GO:0006469),0.3191086269294704,0.9816700475194677,0.48451053283767037,0.8984326164034057,1.0,7/88,4.30%,PDPK1;PPM1E;SLC8A1;SLC8A3;DTNBP1;PRKAG2;CDK5RAP3
prerank,regulation of interleukin-13 production (GO:0032656),-0.392039984996575,-0.9815213775773387,0.49047619047619045,0.8800107740841634,1.0,3/13,11.31%,LEF1;TNFRSF21;PRKCZ
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.42569494789141443,0.98144412420932,0.4909983633387889,0.8983620342004155,1.0,4/18,5.68%,ROCK2;KANK1;RIPOR2;CDH5
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.42475832925669127,-0.981319327826772,0.49445676274944567,0.879307615396885,1.0,3/10,13.19%,LBP;IFI35;PTPN22
prerank,positive regulation of programmed cell death (GO:0043068),0.2845088227864044,0.9812358240746809,0.5205479452054794,0.8982100719007503,1.0,52/272,16.01%,STK17B;DAPK2;DAPK1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;LRRK2;ARHGEF17;ING5;SPHK2;ARHGEF18;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,regulation of intracellular pH (GO:0051453),-0.3018899140794856,-0.9811072054251418,0.47854785478547857,0.8786036507497387,1.0,6/34,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,cellular response to hydroxyurea (GO:0072711),0.4801733618385005,0.9810384512688998,0.4864864864864865,0.8980467968974759,1.0,4/10,18.74%,DDI1;RTF2;TIMELESS;ATRX
prerank,cognition (GO:0050890),-0.2920231883989665,-0.9805908507184156,0.46996466431095407,0.8787536446804864,1.0,15/42,23.27%,SHROOM4;GRM5;MFSD2A;DOP1B;GPR155;STRA6;NF1;FAM107A;SLC1A4;CBR3;APP;CHMP2B;JAKMIP1;PTCHD1;ST3GAL4
prerank,regulation of dendrite morphogenesis (GO:0048814),0.37086602065567426,0.9801870871846037,0.4805755395683453,0.899454165621592,1.0,5/32,5.70%,HECW2;OBSL1;NEDD4;RAPGEF2;CUX2
prerank,negative regulation of cell growth (GO:0030308),0.30575835661480705,0.9801400443848409,0.5046620046620046,0.8989290345810259,1.0,26/121,13.02%,GJA1;ENPP1;SMAD3;TSPYL2;MT3;SFRP1;PTPRS;BCL6;APBB2;PML;ULK2;SPHK2;STK11;RBBP7;SLIT3;FGF13;RNF6;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4438705624067313,0.9800698018014921,0.48911222780569513,0.8984758319114147,1.0,2/13,4.87%,CBLB;KPNA6
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28801283098792585,-0.9797211589573488,0.4831081081081081,0.8799404012530467,1.0,10/42,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,cellular response to fluid shear stress (GO:0071498),0.4493981679018109,0.9796137936982239,0.5112781954887218,0.8989745793385424,1.0,2/12,6.96%,MTSS1;NFE2L2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.4076117462462535,0.979490980346459,0.48171701112877585,0.8986347128999512,1.0,6/20,18.03%,GSN;PLA2R1;RGCC;PDCD4;SFRP4;PRKCI
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.37378797894425425,0.9788176979779288,0.4933530280649926,0.8996076212617026,1.0,4/33,10.16%,TEAD1;SMAD3;ATOH8;FGF2
prerank,protein localization to chromatin (GO:0071168),-0.35555309962008125,-0.978194640153992,0.48418491484184917,0.8828901966882644,1.0,10/18,28.23%,ESR1;TASOR;MCM8;LRWD1;SGF29;MSH2;RAD21;RUVBL2;PIH1D1;PLK1
prerank,transition metal ion transport (GO:0000041),0.3634744342889059,0.9781434873230478,0.48826979472140764,0.9006271905039375,1.0,6/35,8.27%,CP;SLC30A8;MT3;HEPH;SLC11A2;SLC30A10
prerank,regulation of monocyte differentiation (GO:0045655),0.43320118836141835,0.9780450339907606,0.48833333333333334,0.9002395888789393,1.0,3/14,5.78%,IL34;CSF1;ZFP36L1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4086890113548158,0.9776842075932213,0.4959871589085072,0.9004697021954287,1.0,5/19,10.12%,BMPR1A;OLFM1;ACVR1;BMP2;SLIT3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3936303401722818,-0.9774792372365824,0.49528301886792453,0.8836288469424443,1.0,4/12,13.10%,ANO1;GPLD1;ADCY8;CFTR
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.44698074050088554,0.9773640940886313,0.4950166112956811,0.9006508388405925,1.0,3/12,17.97%,IL12B;IL23A;IL18
prerank,mesoderm development (GO:0007498),-0.3541771601496412,-0.9773137380074214,0.4754521963824289,0.8828358461120063,1.0,12/18,30.61%,TIE1;TBX1;BMX;JAK2;VEGFA;BTK;HCK;MEST;MESD;TCF15;IKZF1;IKZF3
prerank,adipose tissue development (GO:0060612),0.45895601771283556,0.9771492199220904,0.49097472924187724,0.9005414458351988,1.0,5/11,15.71%,ARID5B;SH3PXD2B;PGRMC2;DGAT2;DYRK1B
prerank,carbohydrate catabolic process (GO:0016052),-0.30345648377827394,-0.9770526324643447,0.4899328859060403,0.8822925321589618,1.0,13/38,25.08%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;MAN2B1;NEU1;PKM;PGAM1;PGAM4;ALDOC;NEU2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.42181463156420007,0.9770468510908463,0.499151103565365,0.9001507113163121,1.0,3/17,6.79%,ROCK2;CDH5;VCL
prerank,ureteric bud development (GO:0001657),-0.3555325968808303,-0.9766952047879496,0.4754521963824289,0.8819791332285475,1.0,3/17,2.74%,SLIT2;GPC3;SIX1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.32322706753633657,0.9763668360907338,0.5,0.9011498797931597,1.0,10/76,9.89%,NRP1;SEMA5A;CDC42EP4;SYNPO2;NTF3;DYNC1H1;CDC42;CARMIL1;NTRK3;SYNPO2L
prerank,regulation of neuron migration (GO:2001222),0.3889236830328906,0.9755972139277114,0.49848024316109424,0.9023217228105868,1.0,9/26,17.75%,PHACTR1;RAPGEF2;CAMK2B;NTNG2;COL3A1;MDK;PLXNB2;CX3CL1;NIPBL
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2966640367669736,0.9755277786166343,0.5175936435868331,0.9018471454555836,1.0,27/158,15.04%,WLS;GJA1;PELI2;CFLAR;CCL19;EDAR;ROR1;RNF31;LPAR1;TLR6;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;TNIP2;IKBKE;TBK1;RIPK2;MUL1;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,copper ion transport (GO:0006825),0.46128023054687595,0.9751184194123117,0.5064935064935064,0.9021783002785355,1.0,2/11,6.47%,STEAP3;SLC11A2
prerank,urogenital system development (GO:0001655),0.454209671292439,0.9748803717682883,0.4875886524822695,0.9021551525218298,1.0,4/11,16.72%,OSR1;EPHB2;EPHB3;SHH
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.420619356116392,0.9747764868133841,0.48322147651006714,0.9017507022150809,1.0,5/17,8.76%,BMPR1A;NOTCH2;ACVR1;RBPJ;BMP2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3227686924924839,0.9745640510477784,0.47547169811320755,0.9016368858314179,1.0,14/79,10.16%,ADAMTS12;SULF2;BMPR1A;SULF1;NEDD4;SMURF2;SKI;CASK;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FGF2
prerank,cellular response to hypoxia (GO:0071456),0.3024796763952387,0.9744714115371802,0.5088967971530249,0.9012177363568763,1.0,11/126,7.38%,PTGIS;RORA;SLC8A3;MT3;PSME4;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,cholesterol metabolic process (GO:0008203),0.33022261371454276,0.9744595979263322,0.5067204301075269,0.9006174270540005,1.0,12/68,15.73%,ABCA1;APOE;INSIG2;APOA1;MT3;MVK;CYP27A1;IDI1;LCAT;RXRA;OSBPL5;HMGCS1
prerank,positive regulation of translation (GO:0045727),0.3134026407628808,0.9741982735727985,0.5221556886227545,0.9005919061295232,1.0,10/94,10.99%,POLR2D;SAMD4A;PLD1;RPUSD4;CPEB3;CD28;METTL14;EIF6;CDC123;DDX3X
prerank,response to alcohol (GO:0097305),0.38161205036132867,0.9740568949182788,0.5015060240963856,0.9002750397219906,1.0,6/27,10.12%,TGFBR3;TGFBR1;CCL19;HSD3B2;DRD3;SLIT3
prerank,insulin receptor signaling pathway (GO:0008286),0.327053998661283,0.9739618881218705,0.5156657963446475,0.8998806857829424,1.0,9/69,12.56%,ATP6V0A4;IGF2;PIK3R1;PHIP;FOXC2;ZNF106;ATP6V1E1;RHOQ;INSR
prerank,transcription by RNA polymerase I (GO:0006360),-0.29997934058099923,-0.9738509001820875,0.4965034965034965,0.8886564900188643,1.0,9/34,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,protein localization to mitochondrion (GO:0070585),0.46010854070875834,0.9738294158306409,0.5217391304347826,0.8995555556889244,1.0,4/11,16.32%,COX18;LRRK2;MTCH2;AKT1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.26320234065930503,-0.9738095119320319,0.525,0.8874713370172841,1.0,20/65,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;CHFR;PSMC4;VPS4A;PSMA6;PSMD9;PSMD11;PSMD5;NABP1;PSMA8;PSMB1
prerank,ear morphogenesis (GO:0042471),0.39869374215469583,0.9737191624910101,0.4935897435897436,0.8991834791000328,1.0,4/20,8.62%,ZIC1;FGFR2;OSR1;EPHB2
prerank,dendrite morphogenesis (GO:0048813),0.36083005028502935,0.9732008779124923,0.49556213017751477,0.8997712906165879,1.0,8/35,13.99%,PHACTR1;FARP1;DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.3218965237946095,0.9729780726583181,0.4986979166666667,0.8996821764161881,1.0,26/73,23.94%,IGF2;DNMT3A;POLR1G;SPHK2;MYO1C;KAT2B;RBBP7;BAZ1B;PHF1;PHF2;PPHLN1;GLMN;HDAC4;SF3B1;DNMT3B;POLR2L;POLR1F;JARID2;DNMT1;POLR1H;POLR1C;HDAC6;CTCF;HDAC5;PPM1D;TDG
prerank,regulation of gene silencing by RNA (GO:0060966),0.33666206337191396,0.972875215222081,0.5183673469387755,0.8986718294408785,1.0,7/50,11.57%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.33666206337191396,0.972875215222081,0.5183673469387755,0.8986718294408785,1.0,7/50,11.57%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.36466929245593094,0.9728608947724824,0.5043859649122807,0.8980873394752223,1.0,5/33,6.81%,RUNX1;IL34;CSF1;ZFP36L1;IL12B
prerank,hemidesmosome assembly (GO:0031581),-0.40509159109137727,-0.9727767304299042,0.49160671462829736,0.8891016896403711,1.0,2/11,3.29%,ITGA6;ITGB4
prerank,regulation of metal ion transport (GO:0010959),0.424113091398855,0.9727714857888765,0.4960380348652932,0.8976952917486392,1.0,4/16,9.32%,BCL2;STIM1;SLC30A10;CAMK2B
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3060143012655408,-0.9722681726079261,0.4937888198757764,0.8892740613600373,1.0,4/31,3.78%,CDK6;NOTCH1;RORB;LRP5
prerank,positive regulation of endocytosis (GO:0045807),0.34946676610732935,0.9721248951242675,0.5142083897158322,0.89867453524963,1.0,9/45,8.34%,LRP1;SERPINE1;APOE;VTN;CCL19;APPL2;AXL;CDC42;DAB2
prerank,regulation of rRNA processing (GO:2000232),0.4207968872398512,0.9719628209015788,0.5016393442622951,0.8984359962086095,1.0,5/16,13.24%,BUD23;KAT2B;DIMT1;WDR43;TRMT112
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4091108944797609,-0.971645985847159,0.4768211920529801,0.8895941714570675,1.0,3/11,6.41%,ZFPM2;TGFB2;HEY2
prerank,erythrocyte development (GO:0048821),-0.41045967195802524,-0.9710487269409224,0.514218009478673,0.8899973220730387,1.0,4/10,24.34%,MED1;ALAS1;ALAS2;DMTN
prerank,response to ethanol (GO:0045471),-0.3786414026336976,-0.9709057922403157,0.49029126213592233,0.8891045342331397,1.0,5/14,7.48%,GRIN2A;GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3386382582331987,-0.9709047115716699,0.5068493150684932,0.8878084634835289,1.0,4/22,8.16%,ESR1;MED1;MED4;SUB1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3004871507619362,-0.9707236458177245,0.49504950495049505,0.8869795625743537,1.0,19/34,22.00%,SEMA6A;KDR;NOTCH1;RAMP2;MT1G;FLT4;GAB1;VEGFA;PIK3CA;ERN1;DLL4;FLT1;VEGFC;ITGB1BP1;ANXA1;EGR3;DAB2IP;MAP2K3;VEGFD
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.24991698425466435,-0.9704485032007347,0.5247524752475248,0.8864417425943715,1.0,28/78,24.70%,CAV1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;UBQLN2;CLU;PLK3;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.47353974872991283,0.9702394019882501,0.5271739130434783,0.9019021735632657,1.0,2/10,11.01%,SETD7;SETD4
prerank,striated muscle cell differentiation (GO:0051146),0.4253434843598102,0.970227239203992,0.5119453924914675,0.9013104444259967,1.0,5/16,8.89%,SKI;SDC1;SIK1;BMP2;CBY1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.37768173986228853,0.9699640448965327,0.48847926267281105,0.9012833043734951,1.0,7/27,12.33%,FGFR4;PDGFRB;SMOC2;FGF2;RGCC;TERF2;NIBAN2
prerank,peptidyl-threonine modification (GO:0018210),0.3312339135007227,0.9698759344853787,0.5086782376502003,0.900858399141423,1.0,18/66,18.49%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,regulation of response to cytokine stimulus (GO:0060759),0.41092145799680513,0.9697958159434096,0.5016611295681063,0.9004221632003357,1.0,3/19,4.30%,RUNX1;IRAK2;APOA1
prerank,brain morphogenesis (GO:0048854),-0.39684121272851713,-0.9697186186892484,0.5119047619047619,0.8872322924420231,1.0,2/12,8.63%,SHANK3;PAFAH1B1
prerank,nuclear body organization (GO:0030575),0.44283760793717586,0.9696637530796414,0.5113438045375218,0.9001007319812206,1.0,5/12,17.95%,PML;USPL1;SERBP1;ETS1;DYRK3
prerank,response to tumor necrosis factor (GO:0034612),0.3132203239151142,0.9694796732862528,0.5433673469387755,0.8999379761338449,1.0,10/91,8.18%,ADAMTS12;PID1;CCL19;SFRP1;CXCL16;ZFP36L1;CCL4;NFE2L2;NR1D1;AFF3
prerank,sodium ion homeostasis (GO:0055078),0.3962811123837256,0.9692257725997871,0.5104669887278583,0.899920973137336,1.0,3/21,6.93%,SLC8A1;ATP1A2;ATP1B2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2868495601764862,0.9691916252060586,0.5434083601286174,0.8993915010953795,1.0,35/234,13.79%,ADCY1;DDR2;CAMK1D;SMAD3;AR;PLPP3;NKX6-1;ARID5B;FZD2;KIT;CFLAR;SMO;IRAK2;CRTC3;ZIC2;NEUROD1;FZD1;SLCO3A1;ROR1;RNF31;TLR6;IRAK3;ANXA3;CD200;RAB7B;FOXA1;NFAM1;CARD9;RGCC;IKBKE;MAP3K13;RIPK2;MTPN;HDAC4;PTEN
prerank,neuron projection development (GO:0031175),0.2934929501331185,0.9691618181959547,0.5375854214123007,0.8988431960663916,1.0,33/168,13.99%,NRK;GDNF;ADGRV1;LYN;GRXCR1;EPHA4;DOCK10;EPHA8;DTNBP1;VASH2;APOE;NEDD4;RAPGEF2;NTF3;CDK16;LRP12;CDC42;ATXN10;LRRK2;ALS2;EPHB2;MAP4K4;BLOC1S1;RYK;PTPRM;MANF;TAOK3;EPHB3;NRTN;GAS7;MARK2;PTEN;DLG4
prerank,protein localization to organelle (GO:0033365),0.3031257077341472,0.9690872194867007,0.5310668229777257,0.8983940940598513,1.0,34/133,19.92%,COL1A1;OBSL1;TULP1;OPTN;TRAM2;LRRK2;WDR35;CYB5A;TULP3;CROCC;CSRP3;ARL1;DDX3X;TRAM1;TOR1AIP1;YWHAE;UBAC2;PAF1;BANP;TOR1B;MTCH2;BMP4;ARF6;PIKFYVE;LAMP2;AUP1;ZNF423;DCP1A;MICALL1;DDX1;XPA;ABCA7;CCDC47;EHD1
prerank,intracellular cholesterol transport (GO:0032367),0.42666323768872627,0.9683444866426276,0.5016778523489933,0.8995043320200137,1.0,3/15,5.21%,ABCA1;LDLR;STAR
prerank,rRNA modification (GO:0000154),0.3950682099868895,0.9682906837776621,0.48031496062992124,0.8990093749042715,1.0,5/21,15.17%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN4
prerank,regulation of BMP signaling pathway (GO:0030510),0.3243928707942443,0.9680222261598194,0.5202086049543677,0.8990132869652624,1.0,22/73,16.77%,BMPR1A;CCN1;ITGA3;FSTL1;TWSG1;SULF1;SMURF2;CDH5;ENG;SKI;CRB2;RBPJ;BMP2;LEMD3;SMAD1;FSTL3;BMP4;UBE2D1;SFRP4;SPART;ZNF423;DAND5
prerank,potassium ion transport (GO:0006813),0.305729466432228,0.9679330696653602,0.5376593279258401,0.8985938505126252,1.0,11/120,9.27%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;SLC9A9;SLC24A1;KCNK7;KCNQ4;SLC9A5;KCNJ14
prerank,protein heterotetramerization (GO:0051290),-0.3869434075613296,-0.9679130850083554,0.4987951807228916,0.8910696223185696,1.0,7/13,27.86%,GRIN2B;CPSF7;HSD17B8;GRIN1;CBR4;CPSF6;PKD1
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2852677702627517,-0.967650428154344,0.5032894736842105,0.8905239915216947,1.0,12/40,27.07%,PGLYRP1;RPL39;LBP;GBP4;GBP7;HMGB2;FGR;CHGA;GBP6;PPP1R11;MPEG1;STAB2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2876209128561276,-0.967646379370369,0.4862068965517241,0.8892441415211059,1.0,11/39,21.94%,FNBP1L;PPFIA2;MYO1D;TANC2;PAFAH1B1;KIF1A;BICDL1;TRAK2;SYT4;MYO15A;HAP1
prerank,oligosaccharide metabolic process (GO:0009311),0.3467933999845751,0.9674604662011903,0.5137741046831956,0.8991512114049196,1.0,5/46,6.86%,ST6GALNAC5;GAL3ST3;B3GALT1;ST3GAL3;B4GALT1
prerank,protein complex oligomerization (GO:0051259),-0.2538781963901181,-0.9672654221465943,0.5321100917431193,0.8890314535330969,1.0,22/85,17.78%,LRRC8C;LRRC8D;LETM1;KCNC2;EHD4;CPSF7;ATL2;MAT2A;ELAVL1;PNPT1;AQP11;PDCD6IP;ADCY8;HOMER1;TMEM120A;UGDH;UPB1;CUTC;RBMX;MPP2;VSTM5;ECT2
prerank,Notch signaling pathway (GO:0007219),0.33206257467559464,0.9672462180972744,0.5183727034120735,0.8990528042188964,1.0,13/59,10.93%,PBX1;GMDS;ASCL1;MAML3;NOTCH2;DTX4;TRAF7;RBPJ;BMP2;KAT2B;ITCH;MIB1;APH1B
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4445334355776707,0.9667533739015199,0.525305410122164,0.8995757327153658,1.0,2/13,6.66%,GJA1;CACNA1C
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.39054495138919587,-0.9665926900701789,0.5138248847926268,0.8895839162762736,1.0,3/12,11.49%,ESR1;ELAVL1;TGFB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3611712856668661,0.9665654548467361,0.49714285714285716,0.8993987046196973,1.0,10/36,11.89%,DCN;NR2F2;SP100;APOE;ANGPT2;ADAMTS9;FGF2;PTPRM;RGCC;DNAJA4
prerank,membrane depolarization (GO:0051899),-0.30174104144267466,-0.9664642005369971,0.542319749216301,0.8886429337923302,1.0,6/32,7.82%,CAV1;SCN1A;YWHAH;P2RX7;SCN3A;SCN2A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4285674461933002,0.9662842149905039,0.5081699346405228,0.899416905913139,1.0,3/15,8.76%,GLI2;WNT6;BMP2
prerank,inner ear morphogenesis (GO:0042472),0.39036720606476893,0.9662417338998177,0.5123076923076924,0.8989025291610417,1.0,4/22,8.62%,ZIC1;FGFR2;TTC39C;EPHB2
prerank,central nervous system myelination (GO:0022010),-0.4024066643709069,-0.9657356332875425,0.5150812064965197,0.8893818051506214,1.0,4/11,19.40%,TENM4;B4GALT5;PLP1;CLU
prerank,response to cAMP (GO:0051591),-0.29243710537975565,-0.9656078666496117,0.5071428571428571,0.8884340352470702,1.0,9/37,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;DGKQ;CFTR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.443413207566441,0.9651953645155263,0.5135135135135135,0.9006735262411182,1.0,4/12,18.52%,CHAMP1;CENPC;SEH1L;BOD1
prerank,negative regulation of ion transport (GO:0043271),0.38938169274848305,0.9651737151854903,0.5184,0.9001091351327283,1.0,7/24,13.46%,ACTN2;NEDD4;VIP;ADRA2A;CD33;WNK1;SYT11
prerank,protein tetramerization (GO:0051262),-0.25402223598488394,-0.9648572581638766,0.5304347826086957,0.8891892209502411,1.0,26/67,26.42%,KCNJ2;B2M;GBP5;GRIN2B;CPSF7;OSBPL2;ACOT13;ALDOA;HSD17B8;HOMER1;AQP4;APIP;ALDH9A1;UPB1;CUTC;ACACB;GRIN1;HCN1;KCNC1;SOD2;ALDH1A3;ACACA;SHMT1;PKD2L1;CBR4;CPSF6
prerank,positive regulation of macroautophagy (GO:0016239),0.3436513818669231,0.9648205671818406,0.5149456521739131,0.9003288676464647,1.0,15/48,19.60%,DCN;OPTN;PRKAA2;TBK1;UVRAG;LARP1;VDAC1;RAB3GAP1;TSC2;SESN2;PIP4K2C;VPS13D;WAC;HTT;GPSM1
prerank,carnitine metabolic process (GO:0009437),0.44246352985635884,0.9647803378620051,0.5072992700729927,0.8998042082727982,1.0,7/12,30.21%,CPT1C;BBOX1;CPT1A;ACADM;CPT2;CPT1B;CRAT
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3796066536968327,-0.9643291390268469,0.5111111111111111,0.8894338785808,1.0,4/13,18.69%,SYT1;CACNA1H;STX1A;SYT4
prerank,negative regulation of synaptic transmission (GO:0050805),0.38118467132937905,0.9640409336125909,0.4961948249619482,0.9009436545564629,1.0,8/23,14.70%,SLC24A1;LRRK2;CBLN1;DRD3;STXBP1;SYT11;PTEN;PLK2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.31103728687100446,0.9639200195369854,0.5124378109452736,0.900591939498486,1.0,13/91,9.62%,NRP1;PLD1;SLC30A8;ATP9A;SRC;LRRK2;RAB25;MAP2K1;STON1;RNF139;PICALM;SNX12;ITGAV
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3979155941291623,0.9636168672194094,0.49842271293375395,0.9007113668301479,1.0,4/21,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,lipoprotein catabolic process (GO:0042159),0.4651384444035759,0.9633060529738242,0.5302491103202847,0.9008333901739299,1.0,3/11,6.13%,APOE;ABHD17C;LYPLAL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.3885467921620768,-0.9629909204711564,0.4878640776699029,0.8918210560773434,1.0,6/13,14.60%,GRIN2A;PERP;CASP8;CYFIP2;LGMN;BAK1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4157281368595815,-0.9628014260543869,0.5080459770114942,0.8911099240744392,1.0,3/10,14.93%,SHANK3;SYP;APP
prerank,positive regulation of developmental growth (GO:0048639),-0.27033840259282543,-0.9623458186719221,0.5333333333333333,0.8911344538434821,1.0,8/49,7.82%,SMURF1;SEMA7A;RIMS1;NGF;NEDD4L;RIMS2;SYT1;ITSN2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.45669334500969117,0.9621431227829371,0.5391156462585034,0.902977999818427,1.0,3/12,8.45%,NKD1;TULP1;DSCAM
prerank,histone H4 deacetylation (GO:0070933),0.46138750766702236,0.9617270527199331,0.5392670157068062,0.9033152614641914,1.0,6/10,25.04%,SIRT2;HDAC8;REST;HDAC4;SMARCAD1;HDAC1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.43366878912485163,0.9616994261674965,0.503584229390681,0.9027614736664502,1.0,6/13,12.49%,TGFBR3;BMPR1A;FGFR2;RBPJ;FGF2;GLI1
prerank,negative regulation of binding (GO:0051100),-0.249103803834648,-0.9614025275687186,0.5488372093023256,0.8923803624077419,1.0,28/81,21.95%,LEF1;CAV1;ACTB;NFKBIA;KDM1A;SORL1;BTAF1;CTNNBIP1;JAK2;DISC1;GTF2F1;MAPK8;RALB;JUN;CARD16;PPP1CA;TFAP4;ZFPM1;RSF1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;HMGA2;ROCK1;STYX;GSK3B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4422663322687103,0.9613003389845813,0.5106761565836299,0.9030819176774895,1.0,2/11,4.33%,LYN;RAPGEF2
prerank,positive regulation of protein catabolic process (GO:0045732),0.31393722424901077,0.9612985227174551,0.5118306351183064,0.9024719926291795,1.0,16/84,15.21%,SH3D19;HECW2;DACT1;NKD1;APOE;NEDD4;SMURF2;VIP;SNX33;PRKN;ITCH;ADRA2A;SNX9;PLK2;HACE1;HUWE1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3366096415637788,0.9611370787164937,0.5157750342935528,0.9022214286583145,1.0,13/50,16.41%,SH3RF1;GAS6;RFFL;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;NOL3;IGBP1;AKT1;FNIP1
prerank,transepithelial transport (GO:0070633),0.4292971420837157,0.960857515058919,0.5105348460291734,0.9022519342449309,1.0,1/15,0.18%,SLC1A3
prerank,histone monoubiquitination (GO:0010390),0.38583714140616493,0.9607078575341352,0.5390505359877489,0.9019929416334455,1.0,9/24,22.32%,ATXN7L3;BCOR;CUL4B;PAF1;RNF2;WAC;CDC73;LEO1;RNF20
prerank,regulation of stem cell differentiation (GO:2000736),0.30571014390824636,0.9606730401983227,0.5315985130111525,0.9014662874728602,1.0,22/89,20.64%,GDNF;RUNX1;SP7;BMPR1A;YAP1;PDGFRA;PSME4;SETD1A;NSUN2;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;HNRNPU;ZFP36L2;PSMA3
prerank,protein polymerization (GO:0051258),-0.26500534617359356,-0.9603377476944475,0.5313653136531366,0.8939407973557129,1.0,25/55,24.60%,COBL;DIAPH1;SPIRE1;DIAPH3;GPX4;JAK2;WASHC5;UBE2K;MSRB2;FAM107A;TPPP3;TTC17;TRPV4;CASQ2;ARL6;UBE2S;TRIM6;CORO7;PSTPIP1;PREX1;AIF1;CASQ1;CHMP4B;CHMP4A;MID1IP1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4262383919045257,0.9602053750133843,0.5033333333333333,0.9019513896376198,1.0,3/15,6.93%,SLC8A1;ATP1A2;ATP1B2
prerank,regulation of macrophage activation (GO:0043030),0.36545847338514553,0.9595639888817623,0.5156017830609212,0.9028198555864153,1.0,8/30,17.41%,IL31RA;MYO18A;CEBPA;TLR6;CD200;TNIP2;NR1H3;PJA2
prerank,regulation of interferon-gamma production (GO:0032649),-0.25121129610102066,-0.9595205053950385,0.5694444444444444,0.8949637651491793,1.0,15/71,19.92%,PDE4D;PDE4B;SLC7A5;CYRIB;SIRPA;SCRIB;PTPN22;INHA;INHBA;ZFPM1;TLR4;TXK;CD276;C1QBP;FZD5
prerank,regulation of neuron death (GO:1901214),-0.24705868844797207,-0.9594118274114181,0.5544554455445545,0.8940243077722603,1.0,12/82,10.38%,GRID2;MEF2C;CD34;EGLN3;EPHB1;SORL1;CDK5;GRIN2B;PPARGC1A;EGLN2;DDIT4;DCC
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.34193104965464155,-0.9588744558310466,0.5194444444444445,0.8942827675837559,1.0,8/20,26.09%,FAR2;PPT1;HSD17B8;PPT2;ACSL3;ACACA;SCD5;CBR4
prerank,integrated stress response signaling (GO:0140467),0.44315562680478054,0.9583884286602425,0.5217391304347826,0.904901362724262,1.0,5/14,23.10%,NFE2L2;EIF2AK3;IMPACT;DDIT3;HSPA5
prerank,negative regulation of DNA recombination (GO:0045910),0.3480598042660462,0.958090868851868,0.5220994475138122,0.9050133360063591,1.0,8/43,18.80%,POLR2D;POLR2C;TERF2;RTEL1;SHLD3;SMCHD1;ATRX;POLR2L
prerank,sphingosine metabolic process (GO:0006670),-0.36234170489215933,-0.9577729798385685,0.49743589743589745,0.8960695887288872,1.0,4/17,10.37%,ACER3;ACER2;NAAA;SPTLC2
prerank,chromatin disassembly (GO:0031498),0.4268437542001005,0.9573128109244736,0.5313531353135313,0.9055665649383937,1.0,6/14,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.4268437542001005,0.9573128109244736,0.5313531353135313,0.9055665649383937,1.0,6/14,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2310843464300536,-0.9572634795804194,0.5594405594405595,0.8961843741548923,1.0,21/113,11.49%,MPP7;UNC13B;FNIP2;PIEZO1;ESR1;TFRC;WARS1;RASIP1;FAF1;RBX1;GBP5;RPS3;MMP1;RAP1B;TAL1;VEGFA;GTF2H1;DDB2;SKAP1;PLEK;TGFB1
prerank,cellular response to cAMP (GO:0071320),-0.3055820491606283,-0.9570893809430696,0.5225806451612903,0.8953609294466744,1.0,8/30,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;CFTR
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4012651530272412,0.9569025996157321,0.5219594594594594,0.9058913994336878,1.0,6/18,14.89%,MAP2K1;NCOR1;EGFR;NCOR2;MYCN;BMP4
prerank,regulation of response to oxidative stress (GO:1902882),-0.4007979780848219,-0.9564790075497418,0.5236907730673317,0.8957872153016848,1.0,1/11,0.90%,MCTP1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3631994083764307,0.9561650296116193,0.5240174672489083,0.9070332300073345,1.0,5/33,8.37%,SERPINE1;LYN;EPHA8;CYP1B1;FOXC2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3764132845771648,0.9560460933482657,0.5197472353870458,0.9067168967790024,1.0,13/26,20.58%,EGFR;MTBP;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;CDK10;LSM10;PLCB1;CCND2
prerank,cellular response to interleukin-2 (GO:0071352),-0.4022972631865885,-0.9559128345493946,0.5625,0.8947669133479668,1.0,5/11,28.73%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4022972631865885,-0.9559128345493946,0.5625,0.8947669133479668,1.0,5/11,28.73%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4440805552196367,0.9549661562093985,0.5278745644599303,0.9086430152033058,1.0,3/11,13.51%,PRKN;REST;P4HB
prerank,positive regulation of leukocyte migration (GO:0002687),0.3763094489940635,0.9548689937911821,0.5377503852080123,0.9082790789139795,1.0,4/27,14.21%,IL6R;CSF1;MIA3;MDK
prerank,neuron maturation (GO:0042551),-0.35856783004890525,-0.954825278153985,0.48166259168704156,0.8963935072602413,1.0,8/18,22.38%,ADGRB3;B4GALT5;SCARF1;APP;ANKS1A;SRRM4;LGI4;RND1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3721667517300293,0.9547614585092021,0.5389507154213037,0.90792786991102,1.0,7/27,17.52%,GAS6;IRAK3;ARRB1;CD200;SELENOS;SYT11;CX3CL1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3416642182335513,-0.9545826236662318,0.5294117647058824,0.8957702400573474,1.0,6/18,27.26%,PPP1R16B;INPP5K;URI1;PPP1R35;MFHAS1;GPATCH2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.470317094769235,0.9544700449418486,0.5363790186125211,0.9079725872019355,1.0,4/10,23.10%,NFE2L2;EIF2AK3;DDIT3;HSPA5
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2604471670146137,-0.9542494027134566,0.5753968253968254,0.8941908236511712,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2604471670146137,-0.9542494027134566,0.5753968253968254,0.8941908236511712,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,plasma membrane repair (GO:0001778),-0.3816727039249628,-0.9541052329233675,0.5439814814814815,0.8932857711306844,1.0,2/13,4.08%,AHNAK2;DYSF
prerank,regulation of TOR signaling (GO:0032006),0.3216951955441384,0.9538735941333535,0.5436507936507936,0.9087770688879397,1.0,21/67,20.59%,GAS6;NPRL3;UBR2;RFFL;PRKAA2;ARAF;SLC38A9;TELO2;FBXO9;LAMTOR2;RRAGD;TSC2;ITFG2;NPRL2;GOLPH3;FNIP1;SEH1L;DYRK3;RICTOR;RHEB;MLST8
prerank,chromatin assembly (GO:0031497),-0.2855735107183814,-0.9537858829122294,0.5154320987654321,0.8929424566506544,1.0,16/38,29.47%,NAP1L4;SIRT1;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CDAN1;HMGA2;LIN54;ASF1A;GRWD1;H1-0;NAP1L3
prerank,neural tube development (GO:0021915),0.41636467738317606,0.9534230845508664,0.5356550580431177,0.9092079401394701,1.0,2/15,6.06%,DACT1;ALDH1A2
prerank,digestive tract morphogenesis (GO:0048546),0.4205915532770346,0.9530585921684784,0.4974271012006861,0.9093961486551814,1.0,6/14,18.20%,FGFR2;PDGFRA;EPHB3;GLI1;NIPBL;SOX11
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.35606257804495006,0.952873202479271,0.5234493192133132,0.9091849646645292,1.0,8/31,18.59%,LYN;CEBPB;GLMN;SDC4;ATM;SOX11;RC3H1;VTCN1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3317204537025299,-0.9528244446032309,0.5154929577464789,0.8942875967416076,1.0,9/21,20.83%,SLIT2;CYRIB;TGFB2;ARHGAP25;SPRY4;CD2AP;SH3BP1;ARHGAP12;DAB2IP
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.31532870321556006,0.9527497714297242,0.5383663366336634,0.908854197668698,1.0,11/76,11.49%,PTGIS;IRAK2;CDK5RAP3;CYP1B1;MTURN;IRAK3;ARRB1;CD200;COMMD1;ITCH;UFL1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3890248749877597,-0.9526033292812112,0.5166666666666667,0.8936427306938216,1.0,3/12,3.67%,PTPRJ;APOD;CBL
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.27350308173521803,-0.9524286649569192,0.5393258426966292,0.8928621122822714,1.0,20/50,28.69%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;TAF1;MINAR1;TNFAIP3;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;ISG15;BAG2;U2AF2
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.40828090853775933,-0.952097123213529,0.5173913043478261,0.8924741537897487,1.0,1/10,0.97%,ST6GAL1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3623440477462201,0.951938465029951,0.530758226037196,0.9101460493219784,1.0,9/31,13.49%,STXBP3;SYT9;ADRA2A;CACNA1G;REST;STXBP1;SYT11;SYT12;RAB3GAP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2750497921244956,0.9517096078398203,0.6248715313463515,0.9100423195442279,1.0,85/417,16.67%,TCF7L2;RUNX1T1;ATXN1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;SFRP1;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CEBPA;MBD2;SIRT2;ZBTB38;SMARCC2;NR1D1;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;EIF4A2;HEXIM2;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;L3MBTL1;BHLHE41;REST;NIBAN2;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;CDKN1C;PSPC1;RIOX1;CBX5;SCMH1;COPS2;ZNF423;ATF5
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.23998152153847516,-0.95075756455622,0.5494505494505495,0.894736313551437,1.0,23/93,20.20%,PDE4D;CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;INPP5K;ATP2B4;VEGFA;DDIT4;TGFB1;NLRP2B;APP;TRIM6;TXN;RACK1;NCK2;CD44;PDCD10;HCLS1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.29929889846467406,-0.9499173495142698,0.5315315315315315,0.8957903920317509,1.0,13/32,23.99%,ERBB4;HK2;BBC3;BCL2L1;ATG3;BAK1;BIK;CLU;NDUFS1;FIS1;GGCT;SOD2;CCAR2
prerank,nitric oxide metabolic process (GO:0046209),-0.3679705715673441,-0.9497919787021517,0.5115681233933161,0.8948890863116978,1.0,5/14,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,regulation of lipid catabolic process (GO:0050994),-0.344419965885151,-0.9494751872835021,0.5258855585831063,0.8944937785328289,1.0,2/19,8.61%,PDE3B;ALK
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3967865526566149,0.949185526186677,0.5351437699680511,0.9152326610432827,1.0,5/18,10.91%,SRPX2;AKT3;FOXC2;FGF2;FGFBP1
prerank,regulation of cell cycle (GO:0051726),0.27853666581041037,0.9487356642533948,0.5817409766454352,0.915661270230671,1.0,41/271,12.85%,TCF7L2;SMAD3;GRK5;SON;FGFR2;GADD45B;TGFBR1;NUPR1;SND1;NOTCH2;FBXL17;CDK5RAP3;TSPYL2;IRF1;LIN52;SFRP1;PCLAF;TBX3;MAP3K20;APBB2;PML;IL12B;SIK1;SIRT2;MAP2K1;FBXL3;CKS1B;LIN9;TTC28;BMP2;KAT2B;STK11;CDC123;NEK6;L3MBTL1;RGCC;FBXL12;NR4A1;PDCD4;MAP2K6;SIPA1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.36992106854546425,0.9485246311600692,0.5116959064327485,0.9155405744209967,1.0,5/29,3.80%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,negative regulation of autophagy (GO:0010507),0.32966315666981233,0.9483932833929982,0.5248990578734859,0.9152568103059143,1.0,8/54,10.16%,BCL2;LEPR;NUPR1;MT3;SNRNP70;LRRK2;SIRT2;ZKSCAN3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3897965011741069,0.9481603072067724,0.5344,0.9151668765134154,1.0,7/21,23.13%,CYP26B1;HOGA1;NUDT19;LPIN3;LPIN2;FAH;LDHD
prerank,maturation of SSU-rRNA (GO:0030490),-0.2998374002529159,-0.9481108112556936,0.5632530120481928,0.8969319692863871,1.0,9/34,21.20%,RPS14;RPS19;RIOK1;UTP4;LSM6;SNU13;RRP36;HELB;WDR46
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.34727614903365617,0.9480235335573914,0.5480631276901005,0.9148628565163565,1.0,10/37,16.56%,ADCY7;IL17D;APPL2;TLR6;CARD9;F2;PDCD4;ABCD2;CHID1;PLD4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4145660428524656,0.9478521462965562,0.5100334448160535,0.9146555017775976,1.0,2/15,6.77%,TDO2;KYNU
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.29734780837345004,-0.9477519717283838,0.5333333333333333,0.8966578070343872,1.0,13/32,19.53%,KDR;THBS1;NOTCH1;JCAD;GATA2;VEGFA;KLF4;PTGS2;MAP3K3;DLL4;ITGB1BP1;ANXA1;PDCD10
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3466368757462124,-0.9475438585217765,0.5620437956204379,0.8960056417539044,1.0,11/16,43.71%,CADM1;PVR;RAET1E;NECTIN2;SLAMF6;CD226;CRTAM;CD160;KLRK1;LAMP1;AP1G1
prerank,regulation of cell development (GO:0060284),0.3558477249494871,0.9469430767499274,0.5428571428571428,0.9161523932361391,1.0,11/36,19.98%,ASCL1;YAP1;NOTCH2;HES7;ADGRA2;BHLHE41;AKT1;CX3CL1;WNT3;RHEB;YTHDF2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3873252250327272,0.9467940624313839,0.5467511885895404,0.9158678200988445,1.0,4/22,9.48%,LYN;APPL2;NR1D1;RAB7B
prerank,hyaluronan metabolic process (GO:0030212),0.39005700731350507,0.9464703203965251,0.5335365853658537,0.9159914169286352,1.0,4/23,10.70%,CEMIP;LYVE1;FGF2;ABCC5
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.39485803553714094,0.9464494289468673,0.5157728706624606,0.9154293799663541,1.0,3/19,8.81%,NRP1;SFRP1;MAP4K4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.45364351911019835,0.9459907905352105,0.5281306715063521,0.9159046689708745,1.0,2/10,4.44%,PXYLP1;DSE
prerank,dendrite self-avoidance (GO:0070593),-0.350521803456736,-0.9459732796015593,0.5326370757180157,0.8990150938838479,1.0,5/16,10.50%,BSG;CNTN4;CNTN6;ROBO4;EMB
prerank,lysosome organization (GO:0007040),0.3534115579451038,0.9450475793293637,0.5361702127659574,0.917509762431682,1.0,10/36,19.33%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,neurotransmitter transport (GO:0006836),0.3168873611659846,0.9449501184050294,0.5658227848101266,0.9171207065127875,1.0,12/73,13.19%,SLC1A3;GLUL;ATP1A2;SLC22A2;STXBP3;CASK;BRSK1;APBA1;SLC29A1;PPFIA3;STXBP1;SLC18A2
prerank,negative regulation of protein secretion (GO:0050709),0.3503453715836622,0.9444098759796834,0.5564738292011019,0.9177372288401783,1.0,12/38,18.60%,APOE;SFRP1;IL12B;DRD3;CD200;PRKN;ADRA2A;REST;SERGEF;NR1H3;RHBDF2;DPH3
prerank,peptidyl-lysine modification (GO:0018205),0.30132012999553803,0.944308801041099,0.5548780487804879,0.9173478674697064,1.0,24/99,20.24%,LOXL1;LOX;EYA1;NUP107;P3H3;NUP42;SIRT2;KAT2B;USPL1;TRPM4;BLOC1S1;NUP98;RAE1;HDAC4;SENP6;NUP214;SENP7;SEH1L;KAT5;TPR;SIRT5;SUMO1;AAAS;NSMCE2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.26947899721309204,-0.9441013054888489,0.6142857142857143,0.9029366817869737,1.0,13/46,15.70%,PITPNA;PPIA;RAP1B;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,protein import (GO:0017038),0.3054005863483445,0.9440387650315162,0.562807881773399,0.9173655971790683,1.0,23/84,18.84%,RANBP17;NUP107;APOE;APPL2;FAM53C;PRICKLE1;SNX33;PXMP2;HEATR3;CSE1L;PPP1R10;PEX2;TSC2;TOMM22;ABCD2;NUP214;PEX11B;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,fatty acid transmembrane transport (GO:1902001),0.39550832729776386,0.9438116325860206,0.5248796147672552,0.9172823945493116,1.0,3/19,5.19%,SLC27A5;PRKAG2;PRKAA2
prerank,amino acid transmembrane transport (GO:0003333),0.3367565382001156,0.9437859259151901,0.5401360544217687,0.9167298166564876,1.0,13/45,16.48%,SLC7A11;SLC6A13;SLC22A2;SLC7A13;SFXN2;SLC38A6;SLC22A4;SLC38A9;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,genitalia development (GO:0048806),0.43406504937460183,0.9436782195090566,0.5338983050847458,0.9163621666372536,1.0,5/12,21.16%,TBX3;LHCGR;SHH;CHD7;TIFAB
prerank,synapse organization (GO:0050808),0.29362919747872257,0.9436514053524825,0.569620253164557,0.9158369332139918,1.0,17/125,8.45%,GPC6;PDZRN3;FARP1;PPFIBP2;SLC8A3;OBSL1;UNC13C;CAST;NEDD4;PTPRS;MUSK;CACNB1;CDC42;APBB2;LRRK2;CBLN1;DSCAM
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3981097875966716,-0.9434912837803947,0.5444191343963554,0.9033119461360757,1.0,5/10,25.87%,CALM1;CALM3;CBARP;FMR1;CRHR1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.3252216159522549,-0.9434340811333652,0.5258620689655172,0.9022152396433979,1.0,6/23,15.95%,NMT2;FNTA;FNTB;CALM1;PDE6A;METAP2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4262717706096802,0.943156395311625,0.5104895104895105,0.9163121597529154,1.0,4/13,13.84%,GAS6;AXL;TSLP;TAF9
prerank,lipoprotein biosynthetic process (GO:0042158),0.44105812413968004,0.9425080492583435,0.5422535211267606,0.917177747060195,1.0,3/11,12.69%,APOE;ATG10;WIPI1
prerank,nucleotide-excision repair (GO:0006289),0.30122349264459425,0.9424432336505123,0.5813679245283019,0.9167122547284381,1.0,13/101,12.96%,POLR2D;OGG1;LIG4;GTF2H5;CUL4B;POLL;COMMD1;POLR2C;ERCC8;FANCC;MNAT1;GPS1;COPS3
prerank,protein N-linked glycosylation (GO:0006487),0.3197484423341239,0.9424410812016017,0.5694444444444444,0.9161149989432057,1.0,16/66,13.98%,PGM3;MAN1C1;MOGS;LMAN1;B4GALT1;STT3A;DERL3;DOLPP1;GFPT1;ALG5;UGGT2;ALG11;MGAT3;DDOST;ALG10B;ALG6
prerank,regulation of DNA replication (GO:0006275),0.33705330286972596,0.9423781816266058,0.5479632063074902,0.9156694282046639,1.0,10/49,15.19%,GLI2;CCNA2;TSPYL2;NPM2;ZBTB38;EGFR;S100A11;GLI1;EGF;WAPL
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3835019069975734,0.9419959642169418,0.5185758513931888,0.9159160065299881,1.0,1/23,0.20%,ATP6V0A4
prerank,pulmonary valve morphogenesis (GO:0003184),0.40705506605984465,0.9419904702871639,0.5286415711947627,0.9153250939356954,1.0,2/17,3.81%,ROBO1;NOTCH2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.45461167653214496,0.9419457464694989,0.5549645390070922,0.9148291662135831,1.0,1/11,0.87%,ACTN2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3736627241711096,-0.9417930096054948,0.5270935960591133,0.905399875290681,1.0,5/13,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,regulation of T cell migration (GO:2000404),-0.34030032596870313,-0.9412105388113318,0.5253807106598984,0.9057332257582729,1.0,2/18,3.35%,LRCH1;APOD
prerank,regulation of necroptotic process (GO:0060544),0.38152309191344486,0.940407957998167,0.549618320610687,0.9177371845802169,1.0,3/23,3.51%,OGT;MLKL;CFLAR
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21677197549716418,-0.940250799756547,0.6292134831460674,0.9068926016622073,1.0,48/172,18.60%,PIP5K1B;PLCG2;DGKB;INPP5D;BMX;DGKH;PIK3R6;CPNE3;LPCAT1;SLC44A5;MTMR2;INPP4B;PLEKHA3;MFSD2A;INPP5K;PLEKHA1;INPP5F;AGPAT1;PGS1;MTMR9;PIK3R3;PNPLA3;ARF1;PLA2G4C;ETNK1;SACM1L;DGKG;PCTP;DGKQ;CRLS1;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PTDSS1;LPCAT3;PIK3CA;RAB4A;AGPAT5;STARD7;PITPNM3;LPCAT2;DGKZ;PCYT1B;INPP5E;SELENOI;SYNJ1
prerank,negative regulation of lipid storage (GO:0010888),0.3852568409166314,0.9398985036545482,0.5282392026578073,0.9183660672994266,1.0,4/19,9.62%,ABCA1;OSBPL8;ITGB3;ITGAV
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38997213087163873,0.9382969882324391,0.5387045813586098,0.9213851742973747,1.0,2/20,3.23%,GRK3;MGRN1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.30102049970779143,0.9379720529903004,0.5764139590854392,0.9214927230101453,1.0,9/91,6.50%,BMP6;CP;SCARA5;SLC30A8;MT3;HEPH;CYBRD1;SLC11A2;ACO1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.38463527949547155,0.9378232531840305,0.5358778625954198,0.9212172433376442,1.0,6/22,16.48%,MAN1C1;RNF185;RNF139;UGGT2;AMFR;MAN1A2
prerank,vesicle transport along microtubule (GO:0047496),-0.3209498761531754,-0.9373447537047406,0.551829268292683,0.9133282123305564,1.0,8/23,21.94%,KIFAP3;KIF13A;PAFAH1B1;KIF1A;BICDL1;TRAK2;KIF5A;HAP1
prerank,negative regulation of developmental process (GO:0051093),0.31710209799031974,0.9369298994638757,0.5857687420584498,0.9226762209662909,1.0,10/69,9.32%,ROCK2;KANK1;IL17D;NFIB;GAS6;SFRP1;PTPRS;CST3;BMP2;PRKN
prerank,macrophage migration (GO:1905517),-0.36524625124228466,-0.9368114778903801,0.5349397590361445,0.9135282803286663,1.0,3/13,23.02%,CKLF;EDNRB;CCL2
prerank,negative regulation of kinase activity (GO:0033673),0.31757548387004836,0.9367427372703132,0.5740987983978638,0.9224960912503548,1.0,4/62,3.24%,PDPK1;PPM1E;DTNBP1;PRKAG2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.30748736780801655,0.9363825012001284,0.5598455598455598,0.9227227558768134,1.0,26/78,24.29%,NR2F2;CCNA2;CDK5RAP3;CEBPA;EGFR;CCNK;HEXIM2;INCA1;RGCC;MNAT1;CNPPD1;PTEN;CDKN1C;AKT1;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;HEXIM1;CCNY;CCNE2;PKD2
prerank,intermediate filament organization (GO:0045109),0.40034900197028783,0.9362510413486661,0.5472312703583062,0.9224537884940225,1.0,4/17,15.84%,BFSP1;DES;KRT9;EPPK1
prerank,regulation of actin nucleation (GO:0051125),0.4277973044344227,0.9361254344799588,0.5418118466898955,0.922125848446446,1.0,2/12,9.06%,GSN;ARFIP2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.33042626525330326,-0.9360609884224556,0.5418848167539267,0.9142895770094402,1.0,8/20,23.37%,PPIA;FKBP5;PPIG;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4429128058101747,0.9358369040863631,0.5314091680814941,0.922179070407835,1.0,4/10,15.03%,RARB;RARG;ACTN4;RXRA
prerank,peptidyl-serine modification (GO:0018209),0.28281187538675506,0.9356866463777578,0.6015801354401806,0.9219109805998439,1.0,43/166,21.36%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;HPF1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3439973127610749,0.9356104327202339,0.5578512396694215,0.9214827219574631,1.0,6/41,7.07%,DAGLA;ACSL1;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,cellular response to gamma radiation (GO:0071480),0.3966267954845214,0.9355509433512668,0.5428571428571428,0.9210168882135195,1.0,2/17,5.51%,YAP1;MAP3K20
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3062657048596761,-0.9354870917268889,0.5857988165680473,0.914632330437835,1.0,9/30,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,histone methylation (GO:0016571),-0.3045198684497496,-0.9349438633203053,0.5769230769230769,0.9148757545217928,1.0,6/26,14.46%,EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.24000873874306283,-0.9347939478332259,0.6009174311926605,0.914041450870392,1.0,26/76,24.70%,SMURF1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3251334678201054,0.9343660186354894,0.5751014884979703,0.9230463002641156,1.0,11/54,15.96%,GPC6;HSPG2;PXYLP1;HS6ST1;SDC1;EXT1;NDST1;GALNT5;SDC4;GNS;EXT2
prerank,regulation of tube diameter (GO:0035296),0.42504587813413086,0.9343467397649524,0.5507487520798668,0.9218978873987687,1.0,2/13,6.90%,ROCK2;AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.42504587813413086,0.9343467397649524,0.5507487520798668,0.9218978873987687,1.0,2/13,6.90%,ROCK2;AGTR1
prerank,negative regulation of viral life cycle (GO:1903901),0.410844197480524,0.9342992828879941,0.5356550580431177,0.9214120076986999,1.0,1/15,1.20%,GSN
prerank,neutrophil activation (GO:0042119),-0.3857427995905111,-0.9342954544934855,0.5368171021377672,0.914122755077687,1.0,3/12,19.48%,IL15;FCER1G;PREX1
prerank,regulation of intracellular signal transduction (GO:1902531),0.26794030570960736,0.9341172532718186,0.6535353535353535,0.9212046052205314,1.0,65/420,12.50%,DAPK2;PDPK1;NRK;RHOH;PTPN13;LYN;ARHGAP6;SYDE2;DLC1;RHOD;WWC2;ARHGAP28;PLEKHG2;ARHGAP18;OPTN;PRKAG2;TIAM2;LBH;AKAP7;SOS2;ARHGAP29;FGD1;RFFL;ARHGAP21;FGD4;ARHGAP19;PRKAA2;ARHGAP32;ARHGAP10;CDC42;NUAK1;PML;LRRK2;FAM13A;ARHGEF17;ING5;SPHK2;GRM2;ARHGEF18;PPP1R13L;ARAF;ARHGAP35;MTA2;NTRK3;STK4;ARHGAP9;EGFR;ARHGEF11;MAP4K4;SYDE1;ITGAV;TELO2;STK11;RHOT1;RBBP7;TAOK3;CASTOR2;L3MBTL1;FBXO9;UFL1;FGD3;RHOQ;RCN3;ARHGAP5;FAM13B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.38507222326414403,0.9340209490013011,0.5324881141045958,0.9208160691609247,1.0,4/20,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.44610785987407275,0.9338446221610678,0.5606837606837607,0.9206289533216501,1.0,2/11,5.49%,NOS1AP;CACNB1
prerank,homotypic cell-cell adhesion (GO:0034109),0.3454366967304737,0.9334657414779213,0.5678321678321678,0.9208796280188697,1.0,11/39,15.81%,PLPP3;GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,regulation of muscle contraction (GO:0006937),0.3703918967136507,0.9329512343143926,0.538235294117647,0.9214901196606935,1.0,6/26,10.48%,ATP1A2;TPM1;TNNT1;TNNC1;TNNT3;ANXA6
prerank,regulation of anoikis (GO:2000209),0.3943650004074602,0.9328131799099669,0.5657894736842105,0.9212088716642,1.0,4/19,6.82%,BCL2;TLE1;SRC;SIK1
prerank,carboxylic acid transport (GO:0046942),0.328019916712456,0.9324989495109555,0.5693135935397039,0.9213235647508027,1.0,16/55,20.05%,SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC38A6;CLN3;SLC16A3;SLC38A3;SLC7A6;SLC38A2;SLC16A2;SLC38A1;SLC25A29;SLC6A12;PSAP
prerank,glycerol metabolic process (GO:0006071),-0.40121130108875624,-0.9323462731181449,0.5654205607476636,0.9180366548007913,1.0,6/10,37.71%,TPI1;TKFC;GOT1;COQ2;PDXP;PGP
prerank,mitotic chromosome condensation (GO:0007076),-0.301181767320858,-0.9322016004841245,0.5348189415041783,0.917181893558683,1.0,17/26,40.08%,MCPH1;NCAPD3;SMC4;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;NCAPG2;NUSAP1;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.40206637257241185,0.9316491265528162,0.5477386934673367,0.9226325624718338,1.0,6/16,16.72%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.43313943142711386,0.9313252932337497,0.5441941074523396,0.9227820479486943,1.0,1/11,2.89%,PIGR
prerank,pulmonary valve development (GO:0003177),0.39541648631944426,0.9312235994285555,0.567699836867863,0.9224094811015909,1.0,2/18,3.81%,ROBO1;NOTCH2
prerank,RNA processing (GO:0006396),0.280043513865252,0.9311375191482356,0.608548931383577,0.9220054896252812,1.0,37/176,18.90%,CELF2;RBMS1;ATXN1;SON;DDX17;TUT7;RBMS2;HNRNPR;RBPMS;NONO;RNASEL;TENT4A;SMU1;DDX23;PRMT9;MAGOHB;TUT4;NOL3;SNRPD2;CDK12;TCERG1;SRSF5;AKAP8L;RBM39;RBM5;RNPC3;RBM6;GEMIN2;TENT4B;SYNCRIP;HNRNPC;PRPF6;SF3B2;SF3B1;METTL3;PRKACA;DICER1
prerank,antibacterial humoral response (GO:0019731),0.414513607980429,0.9310145881603173,0.5546218487394958,0.9216937620914674,1.0,3/16,11.57%,WFDC3;CAMP;RNASE7
prerank,vesicle transport along actin filament (GO:0030050),-0.3292744187629525,-0.9307695766003484,0.5316455696202531,0.9198092072530679,1.0,2/19,1.46%,FNBP1L;MYO1D
prerank,regulation of actin filament polymerization (GO:0030833),-0.24739654255631646,-0.930558508542662,0.6067961165048543,0.9191131506543054,1.0,6/69,3.00%,SLIT2;BAIAP2L1;KANK3;ESAM;PTK2B;CYRIB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3625075459600554,0.9302864990576476,0.5497630331753555,0.9227512239649698,1.0,3/27,2.15%,DCN;BGN;PXYLP1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3540977366293829,-0.9298787392371141,0.5606060606060606,0.9197525584745914,1.0,4/15,20.52%,RPS7;RPL11;RPL5;RPL23
prerank,acylglycerol biosynthetic process (GO:0046463),0.3887861171099425,0.9297364279714351,0.5383411580594679,0.9234050788614083,1.0,7/23,19.50%,AGMO;PLA2G4A;LPGAT1;MOGAT3;DGAT2;GK;LPIN3
prerank,activation of GTPase activity (GO:0090630),0.3006345207664318,0.9293747065465577,0.5831325301204819,0.9236807810034638,1.0,15/89,13.54%,RABGAP1L;TBC1D4;SYDE2;USP6NL;TIAM2;ARHGAP29;NTF3;ADPRH;NTRK3;SYDE1;TBC1D2B;TAX1BP3;ARHGEF10;SIPA1;CXCL13
prerank,positive regulation of cell death (GO:0010942),0.31498423149098626,0.929121525622387,0.5621693121693122,0.9236355207059678,1.0,8/59,9.04%,LRP1;EFNB2;SLC6A13;MT3;AXIN2;RARG;LRRK2;PICALM
prerank,microtubule anchoring (GO:0034453),0.42137866259556217,0.9290703042808723,0.5472027972027972,0.9231674370385838,1.0,2/12,9.49%,DAG1;SAXO2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2713337144550623,0.927960188853079,0.633788037775446,0.925031441465636,1.0,41/291,13.54%,EPHA3;RORA;ROCK2;PID1;DAPK1;SERPINE1;LYN;TPM1;WNT8B;PDGFRA;WNT6;RAPGEF2;MTR;MT3;AXL;SFRP1;PTK7;IGFBP5;CPEB1;PDE3A;ZFP36L1;WNT5B;CPEB3;DPEP1;ERCC6L2;NR1D1;EGFR;RAPGEF1;SLC38A9;LAMTOR2;TNIP2;RRAGD;SLC5A5;IMPACT;SELENOS;PDCD4;PAF1;CD14;CHMP5;NCOA3;CXCL13
prerank,response to reactive oxygen species (GO:0000302),-0.2607408297155275,-0.9277367292173502,0.5753968253968254,0.9243558883685342,1.0,21/54,22.43%,APOD;PTPRK;PXN;RPS3;HYAL1;MAPK8;SIRT1;JUN;APTX;MAPK3;HIF1A;PTPRN;ADAM9;GPX1;CAT;PDCD10;PLK3;CHUK;PRDX5;MAPK1;SOD2
prerank,ERAD pathway (GO:0036503),0.30685999276560455,0.9276473904035568,0.5712484237074401,0.9251227298466943,1.0,33/83,27.22%,ERLEC1;FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;RNF139;ECPAS;PRKN;UGGT2;FOXRED2;RCN3;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;CCDC47;JKAMP;BAG6;WFS1;HSPA5;ATXN3;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,regulation of cell projection organization (GO:0031344),0.4284853743964272,0.9275281308171798,0.5644891122278057,0.9247957149648649,1.0,4/13,13.27%,MACF1;CCL19;SPRY2;NTNG2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3635863011544906,-0.9270849070926853,0.5390428211586902,0.9247986417338645,1.0,5/13,21.57%,SRSF12;LSM2;PRPF31;USP4;CD2BP2
prerank,neutral amino acid transport (GO:0015804),-0.29491171828611706,-0.9266420073576979,0.5779816513761468,0.9247301351968765,1.0,8/28,13.96%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC43A2;SLC36A4;SLC3A2;SLC1A4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.30717310931920994,-0.9263674634427032,0.5914634146341463,0.9242687671901939,1.0,12/24,25.99%,ACKR3;KDM1A;TPT1;SIRT1;BCL2L1;CD44;CLU;TRIAP1;SNAI2;CCAR2;MIF;SNAI1
prerank,regulation of lamellipodium assembly (GO:0010591),0.3461147433788882,0.9261179204093136,0.5705967976710334,0.927321451064601,1.0,4/34,8.37%,AUTS2;PIK3R1;CDC42;CAPZB
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.26337546353966457,-0.9261027052042622,0.5899280575539568,0.9237221131557669,1.0,6/47,4.35%,ZBTB16;CREB1;SIX1;PPARD;LRP5;CMKLR1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2741483037371094,-0.9260628094344135,0.5699300699300699,0.9226043776075815,1.0,4/41,2.91%,PODXL;PIEZO1;ANK3;TJP1
prerank,regulation of dendrite development (GO:0050773),0.34484289472966073,0.9260333258070571,0.5409356725146199,0.9269210400164848,1.0,4/37,4.26%,CAMK1D;HECW2;MARK1;NEDD4
prerank,negative regulation of microtubule polymerization (GO:0031115),0.43619395122172333,0.9259033614733625,0.5595854922279793,0.9266044877746212,1.0,2/12,5.68%,EML2;CDH5
prerank,glycogen biosynthetic process (GO:0005978),-0.3707065043113781,-0.9256056232621114,0.5586206896551724,0.9213088834816869,1.0,3/12,6.98%,GBE1;GYS1;UGP2
prerank,glucan biosynthetic process (GO:0009250),-0.3707065043113781,-0.9256056232621114,0.5586206896551724,0.9213088834816869,1.0,3/12,6.98%,GBE1;GYS1;UGP2
prerank,positive regulation of telomerase activity (GO:0051973),-0.2847556628260756,-0.9255707118829946,0.5870967741935483,0.9201974709916755,1.0,7/33,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,peptidyl-asparagine modification (GO:0018196),-0.299626745557725,-0.9252901943950104,0.6036585365853658,0.9197251990860195,1.0,9/31,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,potassium ion transmembrane transport (GO:0071805),0.2900901786049573,0.9251870232773329,0.6129779837775203,0.9276468862318639,1.0,13/135,9.27%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;KCNT2;SLC9A9;SLC24A1;KCNK7;ATP1B2;KCNQ4;SLC9A5;KCNJ14
prerank,early endosome to Golgi transport (GO:0034498),0.43730228842325714,0.9251846355057579,0.5537037037037037,0.9270644170613483,1.0,3/11,11.28%,LMAN1;RBSN;TRAPPC10
prerank,oligodendrocyte differentiation (GO:0048709),0.3832855136156539,0.9251715859819308,0.5647249190938511,0.9265078395546829,1.0,5/19,16.72%,SLC8A3;EIF2B4;NSUN5;EIF2B3;SHH
prerank,negative regulation of nervous system development (GO:0051961),-0.3369586682062857,-0.9251324234343222,0.5733333333333334,0.918940325574057,1.0,3/17,5.60%,NOTCH1;B2M;SORL1
prerank,fatty acid transport (GO:0015908),0.3945823001054506,0.9248662491879,0.5659163987138264,0.9265945018538563,1.0,2/17,3.47%,ACSL1;APOE
prerank,cytosolic calcium ion transport (GO:0060401),0.36548926160636447,0.9248268988318119,0.5745937961595273,0.9260820824597581,1.0,4/28,9.92%,SLC8A1;MCU;CACNA1C;MICU2
prerank,neural crest cell development (GO:0014032),-0.2738164496622372,-0.9248034477181417,0.5950704225352113,0.9185899230559915,1.0,6/44,3.34%,SEMA6D;CDH2;SEMA6A;SEMA7A;ERBB4;TBX1
prerank,histone lysine methylation (GO:0034968),0.3534706467569682,0.9247176206901514,0.5757575757575758,0.9257357312434785,1.0,11/33,20.88%,PRDM5;WDR82;SMYD3;TRMT112;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3405922639897997,0.9245988973278393,0.5806451612903226,0.9253923927884059,1.0,4/38,3.44%,NEDD9;EPHA4;IL34;GAS6
prerank,Notch signaling involved in heart development (GO:0061314),-0.3855155776058056,-0.9245621648316599,0.5665137614678899,0.9179759696887148,1.0,8/11,25.99%,NOTCH1;HEY2;GALNT11;HEY1;DLL4;HEYL;SNAI2;SNAI1
prerank,protein homooligomerization (GO:0051260),0.288138813543952,0.924162233162443,0.6045949214026602,0.9258073858917033,1.0,15/114,10.54%,SLC1A5;TRPA1;SCARA5;MLKL;IKZF4;TDO2;APPL2;RNF213;ALDH1A2;ALS2;CBY1;ZBTB1;CLYBL;TRPM4;CARD9
prerank,chromosome condensation (GO:0030261),-0.2796781361979038,-0.9235613646401015,0.5683890577507599,0.9193643324422801,1.0,23/36,40.08%,MCPH1;NCAPD3;SMC4;TOP2A;GPER1;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;H1-0;BANF2;NCAPG2;ERN2;NUSAP1;DFFB;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,regulation of cellular senescence (GO:2000772),-0.29235343208805464,-0.923397853914602,0.5640326975476839,0.918592960590333,1.0,8/28,15.46%,CDK6;B2M;PNPT1;VASH1;CGAS;SIRT1;ABI3;MAP3K3
prerank,cellular senescence (GO:0090398),0.35868529038845764,0.9232532991456921,0.5639097744360902,0.9272150367304831,1.0,6/27,12.18%,TBX3;PML;SMC5;MAP2K1;SMC6;TERF2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.27287103489820635,-0.9231019955005816,0.6115107913669064,0.9182130286859722,1.0,14/42,24.34%,NOTCH1;SPOCK1;FZD4;VIT;EMP2;JAK2;NF1;CORO1C;LIMS1;NDNF;CORO2B;MINK1;TBCD;DMTN
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.36641020920764966,0.9229725297672196,0.5574803149606299,0.9272399299630553,1.0,5/25,13.61%,ACTN2;SLC6A9;ATP1B2;WNK1;PIRT
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3598738711287877,0.922642295493007,0.5776119402985075,0.9273507671444737,1.0,5/27,9.62%,ABCA1;CSF1;AGTR1;ITGB3;ITGAV
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.28526911366723995,0.9226260816664958,0.6241457858769932,0.9267991023876997,1.0,23/142,13.99%,ADRA1B;SLC8A1;SMAD3;ATP1A2;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;F2;CLN3;C1QTNF1;YWHAE;CXCR6;CXCL13;DLG4
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.34891614953941286,-0.9226096395741346,0.5643564356435643,0.9184111063077135,1.0,5/16,18.79%,PIGP;PIGB;PIGL;DPM2;PIGV
prerank,cellular response to inorganic substance (GO:0071241),0.3768092803735344,0.9219960691322064,0.5517241379310345,0.9275521561842754,1.0,7/21,18.74%,MTR;MT3;DPEP1;DDI1;RTF2;TIMELESS;ATRX
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2875026106682314,0.9217966370966996,0.6244239631336406,0.9274301237593231,1.0,21/124,10.76%,GDNF;LYN;TPM1;EPHA8;DTNBP1;APOE;WDPCP;NEDD4;RAPGEF2;CDK16;LRP12;LIMA1;ATXN10;ATP1B2;RAB25;CARMIL1;ARFIP2;BLOC1S1;RYK;PTPRM;MANF
prerank,aggrephagy (GO:0035973),0.36379153056330915,0.9217636515718716,0.5569044006069803,0.9269012139031412,1.0,5/27,12.46%,DYNLL1;DYNC1H1;WDR81;PRKN;DYNC1I2
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.28727025977397574,0.9212862505109388,0.6168674698795181,0.9273201939536274,1.0,11/124,6.15%,TCF7L2;PPP3CA;FZD2;WNT4;SMURF2;PRICKLE1;PSME4;FZD1;SFRP1;TNRC6B;CDC42
prerank,response to interferon-alpha (GO:0035455),0.4002852325349875,0.9209906453690421,0.5602605863192183,0.927366003817754,1.0,2/16,4.70%,GAS6;AXL
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.30006996656600415,0.9208947283665809,0.6024844720496895,0.926986330938042,1.0,11/84,11.94%,CELF2;RBFOX1;SON;RBFOX2;SF1;DDX17;HNRNPA1;NUP98;SMU1;WTAP;REST
prerank,coenzyme A metabolic process (GO:0015936),0.41130559143035983,0.9208160889463615,0.5492227979274611,0.9265847934563515,1.0,8/14,30.12%,NUDT7;PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2;ACLY
prerank,Rac protein signal transduction (GO:0016601),0.40097231070715256,0.9204903737422401,0.5953177257525084,0.9267521945063453,1.0,1/18,0.70%,RHOH
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3886532403343479,0.9203197455471502,0.5685950413223141,0.926528554297124,1.0,4/19,20.07%,APOE;COLQ;RAPSN;CHRNB2
prerank,peptidyl-arginine modification (GO:0018195),0.4040412880951149,0.9201627779827547,0.5424528301886793,0.9262828944723804,1.0,1/15,2.07%,ART4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.39799309486116957,-0.9200959296000676,0.5642201834862385,0.9236173515855449,1.0,3/10,14.14%,PRKG1;RDX;CEACAM1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40944314584148545,0.919670357380804,0.5684931506849316,0.9267876570735407,1.0,2/16,5.33%,NUPR1;COX7A2
prerank,cellular protein localization (GO:0034613),0.26744869705106006,0.9195807252989293,0.6552083333333333,0.9264046874545606,1.0,52/285,16.17%,WLS;GJA1;FBLN5;RABGAP1L;TBC1D4;ANGPT1;USP6NL;SEC31A;SH3PXD2B;TMED1;VPS26C;AXIN2;RAB23;STXBP3;STX16;NPHP1;COX18;ARFGAP3;LRRK2;ADPRH;VCL;IFT27;CD63;RAB22A;CROCC;COPZ2;EGFR;ARFIP2;CSRP3;TBC1D2B;ARL1;GGA2;TMED4;LAMTOR2;TM9SF2;RRAGD;STXBP1;TLK1;COPA;WIPI1;RAP2A;USO1;ARF4;FLNA;SNX9;IFT22;ARF6;EPB41L3;STX1B;ARL5A;SNX31;RAB19
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.27926952166240826,-0.9195203770233806,0.5709876543209876,0.9238953446229569,1.0,12/35,17.76%,CDK6;HOXA5;MED1;TAL1;ACVR2A;LDB1;HIF1A;PRKDC;INHBA;ZFPM1;FAM210B;HMGB2
prerank,positive regulation of growth (GO:0045927),0.31280778616383315,0.9188437738382297,0.5955204216073782,0.9274022520624365,1.0,23/64,23.38%,BCL2;TGFBR1;RFTN1;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;DDX3X;INSR;MTPN;HPN;AKT1;MMP14;TRIM32;PLCB1;DDX49;N6AMT1;EIF4G2;WFS1;EXOSC2;BRAT1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3359742230032194,0.9185020771080847,0.6036161335187761,0.9275672390201214,1.0,6/46,8.12%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.38130508497338983,0.918115230395332,0.5819032761310452,0.9278501610636173,1.0,1/22,1.07%,PPM1E
prerank,regulation of protein kinase A signaling (GO:0010738),0.377463405082122,0.917908445067282,0.557427258805513,0.9277252037353863,1.0,3/20,6.60%,ADGRV1;AKAP7;LRRK2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.37993643592098403,0.9178975906663072,0.5472,0.927165220684121,1.0,8/19,23.43%,SREBF1;PRKN;VDAC1;HTT;ATP13A2;HAX1;HDAC6;SREBF2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.42155627316272376,0.9175563776089085,0.5643564356435643,0.9273134595232219,1.0,7/12,21.84%,NEDD4;IFI27;NUP214;BMP4;TPR;AAAS;RBM4
prerank,regulation of protein polymerization (GO:0032271),0.34306303358256685,0.9172909289770881,0.588150289017341,0.9273138881234443,1.0,5/35,10.44%,ARHGAP28;PLEKHG2;ARHGAP18;ARL2;TTBK1
prerank,glucose transmembrane transport (GO:1904659),-0.31929799997876906,-0.9169214975561683,0.5751295336787565,0.9293366510609312,1.0,2/18,2.87%,SLC2A1;PPARD
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2649573049689536,0.9167902544755131,0.6929460580912863,0.927825298055112,1.0,106/336,24.39%,LYN;BCL2;SETD7;YAP1;PDS5B;MOAP1;OGG1;PSME4;HPF1;PCLAF;BCL6;USP47;CBX3;INO80;PML;RAD51B;CUL4B;SPRTN;SMC5;BATF;TRIP12;REXO4;UBE2U;ZBTB38;BRSK1;UBA7;RECQL5;KMT5B;BCL2L11;ZBTB4;ZBTB1;CCNK;SMC6;POLE3;STK11;BAZ1B;PHF1;MRNIP;TAOK3;UFL1;IKBKE;ERCC8;RAD18;FANCC;MBD4;UVRAG;MNAT1;BOD1L1;MAP2K6;MTREX;USP10;TAF9;HMCES;RAD51D;UBE2E2;RTEL1;UBA6;MAPKAPK2;CASP9;CBX5;UBR5;XRCC2;TIMELESS;ATM;NIPBL;ALKBH1;ZBTB40;WAC;METTL3;XPA;ENDOV;RAD54L;NCOA6;SUMO1;RFC5;NRDE2;AATF;ETAA1;STK33;RBBP5;FAN1;USP3;UBE2T;MUTYH;DDIT3;RMI2;NSMCE4A;TAOK1;ERCC3;APLF;FANCA;XIAP;LIG1;BRCA1;MACROD1;BRAT1;VCPIP1;PPP1R15A;PSEN1;SETX;POLI;MSH6;NABP2;MAPK12;MASTL;MRE11
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2651057009322288,0.9166630953050788,0.6735966735966736,0.9275431814323699,1.0,90/314,23.51%,SPSB1;TBL1XR1;HECW2;FBXO48;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;CDC20B;PSME4;FAF2;BFAR;DERL1;PML;CUL4B;UBXN4;NFE2L2;DERL3;UBE4B;CUL5;SIRT2;UBXN2B;UBE2U;FBXL3;RNF185;ARRB1;UBXN11;ECPAS;ANAPC5;PRKN;ITCH;IFI27;FOXRED2;FBXO9;KBTBD7;ERCC8;FBXO4;FBXL12;SELENOS;FEM1C;BTRC;TNFAIP1;APPBP2;AMFR;FBXO38;UBE2D1;HACE1;HUWE1;TMUB1;AUP1;NHLRC3;SPOP;UBR3;AMN1;PSMB5;PSMC2;KAT5;TMEM67;RNF34;PSMD1;ERLIN1;PSMD4;NSFL1C;PSME3;FBXL18;FEM1B;KCTD13;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;JKAMP;BIRC2;RNF216;BAG6;ANAPC4;KLHL20;WFS1;PSMA2;HSPA5;FBXW11;ATXN3;PSMC5;ERLIN2;ARMC8
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3088461556354202,0.9166445874354608,0.6069057104913679,0.9269996048837597,1.0,8/62,11.57%,POLR2D;NUP107;NUP42;WTIP;TNRC6A;POLR2C;NUP98;RAE1
prerank,positive regulation of cytokine production (GO:0001819),0.26723992294695,0.9153357460511303,0.6740976645435244,0.9293032432924735,1.0,37/292,12.97%,CCBE1;RORA;ROCK2;SERPINE1;SULF2;RUNX1;PLA2R1;IL6R;IL17D;RFTN1;CCL19;SULF1;IRF1;CYP1B1;PIBF1;IL12B;BATF;TSLP;CD28;SPHK2;EIF2AK3;TLR6;CD200;POLR3A;RAB7B;ARNT;NFAM1;CARD9;SETD4;CEBPB;ADRA2A;RGCC;TBK1;EBI3;STAT6;RIPK2;CD14
prerank,positive regulation of autophagy (GO:0010508),0.30271192768131183,0.9151866031669083,0.6050314465408805,0.9290441024003824,1.0,22/81,19.78%,DAPK1;DCN;OPTN;PRKAA2;LRRK2;PRKN;STK11;RNF152;UFL1;TBK1;LARP1;TSC2;PLK2;SESN2;NPRL2;KAT5;FOXO3;WAC;PHB2;HTT;GPSM1;TRIM21
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.31437904953155,-0.915183629881429,0.5905044510385756,0.9325777434986108,1.0,10/21,27.54%,MBOAT1;PLA1A;PLAAT3;LPCAT3;PLA2G4F;PLA2G4E;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,membrane lipid catabolic process (GO:0046466),-0.39219443665296333,-0.9150371181239384,0.566350710900474,0.931736889098586,1.0,2/10,3.32%,ENPP2;PPT1
prerank,DNA modification (GO:0006304),0.37710572217919913,0.9147029947022195,0.5799373040752351,0.9295124434177631,1.0,4/22,12.18%,OGG1;NEIL1;MBD4;TERF2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.36935760794077155,0.9146954394401823,0.568503937007874,0.9289437616882839,1.0,2/24,7.67%,CEMIP;MYO1C
prerank,lymphocyte differentiation (GO:0030098),0.309740247281014,0.9145556661345927,0.5943877551020408,0.9286708284032782,1.0,10/68,11.12%,RHOH;PBX1;LEPR;KIT;AXL;NHEJ1;GPR89A;GPR89B;NFAM1;IFNK
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.29916986784780264,-0.9140560273507518,0.5926966292134831,0.933117724052266,1.0,4/25,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,regulation of platelet activation (GO:0010543),0.37212031246484356,0.9139644227774079,0.5537190082644629,0.929340139550275,1.0,6/21,12.06%,LYN;PDGFRA;APOE;PLA2G4A;F2;C1QTNF1
prerank,defense response to bacterium (GO:0042742),0.29153115161677423,0.9138607771411894,0.6174016686531585,0.928985445297888,1.0,16/105,16.19%,COLEC12;SERPINE1;IL6R;OPTN;OAS2;WFDC3;IL12B;TLR6;CAMP;ANXA3;CEBPB;RNASE7;CXCL13;NLRC4;GSDMD;IL23A
prerank,positive regulation of inflammatory response (GO:0050729),0.2944526949769533,0.913358203678744,0.6012658227848101,0.9295096303970533,1.0,20/86,17.97%,SERPINE1;OSMR;NUPR1;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;NAPEPLD;PDCD4;ETS1;MDK;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,muscle cell migration (GO:0014812),-0.3909287132123643,-0.9132142220060612,0.572429906542056,0.9340453611334056,1.0,5/10,21.47%,CCN3;SIX1;ITGB1BP1;ROCK1;MEGF10
prerank,histone H4-K5 acetylation (GO:0043981),0.4095576862577516,0.9129978193900722,0.5675213675213675,0.9291231301874305,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),0.4095576862577516,0.9129978193900722,0.5675213675213675,0.9291231301874305,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.34258064284257284,-0.9128343424373616,0.56575682382134,0.9338951589965601,1.0,7/15,25.82%,FAM98B;CLP1;ERN1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.35767016508108074,-0.9127931176748069,0.6035353535353535,0.9328107285841722,1.0,6/15,28.81%,SCYL2;HIP1R;UBQLN2;SNAP91;UNC119;BMP2K
prerank,fatty acid oxidation (GO:0019395),-0.25002125129673924,-0.9127891107295433,0.6473029045643154,0.9316136712443621,1.0,11/57,21.04%,ADIPOR2;PPARD;ECI2;ECHDC1;PPARGC1A;ACAD11;ABCD3;ACOX1;ABCD4;MTLN;ACAA2
prerank,mesenchyme morphogenesis (GO:0072132),-0.33818195918247496,-0.9127236090878773,0.5895522388059702,0.9306038818240401,1.0,5/17,6.42%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.36267891208822833,0.9125088561176775,0.594311377245509,0.9295803062057009,1.0,4/26,8.85%,PDPK1;ZFP36L1;EGFR;STAT5B
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3401956181935249,0.9124720632721578,0.5807407407407408,0.9290821921935054,1.0,6/33,11.49%,AR;RUNX1;NCOA2;SAFB2;RNF6;UFL1
prerank,gluconeogenesis (GO:0006094),0.33625567502904546,0.9122979737387266,0.5899182561307902,0.9289071303015716,1.0,3/39,8.02%,RBP4;MDH2;ENO2
prerank,sensory perception of chemical stimulus (GO:0007606),0.40510143227144363,0.9121957694469067,0.5685950413223141,0.9285454635747882,1.0,1/15,3.29%,GNAS
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.277080892247931,-0.9121290347436707,0.577922077922078,0.9309669276645005,1.0,17/37,31.14%,ENTPD1;HNRNPD;PNPT1;ENTPD2;SUPV3L1;ENTPD6;ENTPD3;ADPRM;RNASEH1;DNASE1L2;NUDT16;PABPC4;NUDT9;ISG20;ENTPD5;NUDT1;RNASEH2B
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2998761516325793,0.9116168600567756,0.6046228710462287,0.9291873188145836,1.0,15/88,10.09%,SH3D19;DNAJC6;DTNBP1;TXNDC5;MYO1B;GOLGB1;MON2;ARFGEF2;EPS15;ARRB1;AP1G2;COMMD1;BLOC1S1;AP1M1;VPS35L
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38387170088995937,0.911530589575536,0.5697865353037767,0.9288040109727455,1.0,6/20,20.33%,WNT4;SIK1;NCOR1;CDA;GCK;BCKDK
prerank,regulation of neuron apoptotic process (GO:0043523),0.295589519460856,0.9113132491662245,0.6123936816524909,0.9287127789828282,1.0,8/96,5.01%,EPHA7;GDNF;BCL2;APOE;NUPR1;MT3;NTF3;LIG4
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.359937391223774,0.9112650230132735,0.583710407239819,0.9282258005255317,1.0,9/26,16.32%,PYCR1;LRRK2;NFE2L2;PRKN;REST;NOL3;VNN1;BAG5;AKT1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31862815851225057,0.9111332021377888,0.5948158253751705,0.9279650421411488,1.0,5/54,3.73%,PDPK1;ANGPT1;FGFR1;APOE;ANGPT2
prerank,regulation of receptor internalization (GO:0002090),0.341472453684519,0.9106780564222339,0.5756302521008403,0.9283772981007263,1.0,9/35,14.94%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;DLG4;RSPO1;SFRP4
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4283556823691478,0.910671601250986,0.5654648956356736,0.9278227629665172,1.0,4/10,21.58%,TSLP;SPHK2;IL18;LGALS9
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.2779974599906567,-0.9105808107162968,0.620253164556962,0.9336723298287217,1.0,8/35,10.07%,NLGN1;CDH12;ATP2C1;CDH6;CDH8;CDH9;CDH13;CDH10
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3962760140783581,0.9104207130307272,0.5840266222961731,0.9278203760403129,1.0,5/15,20.48%,ZFP36L1;BCL2L11;REST;HNRNPU;ZFP36L2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3221573409295301,0.9095799906930877,0.5776315789473684,0.9290287234275195,1.0,5/49,6.31%,LDLRAD4;DACT1;PMEPA1;CDC42;SRC
prerank,cellular response to ATP (GO:0071318),-0.3538590637670173,-0.9093104643698922,0.5910165484633569,0.9355869558797456,1.0,2/14,6.97%,P2RX7;TAF1
prerank,plasma membrane invagination (GO:0099024),0.3526968363154476,0.9092635430655164,0.5760709010339734,0.9291284030251253,1.0,5/29,8.98%,GSN;CDC42;SNX33;GULP1;SNX18
prerank,cytoplasmic sequestering of protein (GO:0051220),0.40755958065091225,0.9091449714178692,0.5528052805280528,0.9288313134175693,1.0,3/13,15.02%,MDFI;FLNA;SUFU
prerank,positive regulation of neuron migration (GO:2001224),-0.37721183747938325,-0.9090254664395309,0.56,0.935099556687888,1.0,5/11,20.83%,SEMA6A;ARHGEF2;KIF20B;SHTN1;DAB2IP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.34282930446460524,0.9088324165762846,0.5895953757225434,0.928930991817887,1.0,11/33,19.70%,MN1;APPL2;INO80;GLI1;PAF1;PTEN;CDC73;PHB2;APPL1;CDKN1B;PSME3
prerank,central nervous system development (GO:0007417),0.26615903918794365,0.9082710867902812,0.6734042553191489,0.9296045751465645,1.0,28/250,9.65%,EPHA7;ATXN1;GSN;PBX1;ARNT2;SLC8A3;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;SMO;ZIC4;CDK5RAP3;SYNJ2;ZIC2;LIG4;TBX3;SMARCA1;ADGRA2;SH3GL1;NHEJ1;SETD1A;EEF1AKMT4-ECE2;PRKN;MARCKSL1;GLIS2
prerank,acetyl-CoA metabolic process (GO:0006084),0.3998445782474386,0.9081086240148887,0.5738539898132428,0.9293723796524324,1.0,3/15,5.14%,TDO2;MVK;NUDT7
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36101790550526003,0.9079979240990074,0.583203732503888,0.9290472960672036,1.0,5/26,12.17%,ATP1A2;GSTM2;DRD3;ADRA2A;YWHAE
prerank,negative regulation of catalytic activity (GO:0043086),-0.30703228431407076,-0.9079797501821989,0.6166666666666667,0.9365044973156347,1.0,5/24,11.74%,NOTCH1;NOSIP;NOS1;TMBIM1;SIRT1
prerank,regulation of T cell mediated immunity (GO:0002709),0.44779829362021617,0.9075950104203028,0.6026936026936027,0.9293322084992411,1.0,2/10,9.41%,ZBTB1;TRPM4
prerank,neuronal action potential (GO:0019228),-0.31099007108860965,-0.907382275302692,0.5983606557377049,0.9368377950382664,1.0,10/22,20.84%,ANK3;SCN1A;SCN3A;KCNMB2;SCN2A;KCNA2;CACNA1H;GPER1;MYH14;SCN8A
prerank,hyaluronan catabolic process (GO:0030214),0.3920547174484862,0.9073033894735334,0.5857142857142857,0.9293506240873673,1.0,3/18,10.16%,CEMIP;LYVE1;FGF2
prerank,ovarian follicle development (GO:0001541),0.4048967037561139,0.9072308783222465,0.5726351351351351,0.9289294288399906,1.0,4/13,11.10%,KIT;LHCGR;EIF2B4;CEBPB
prerank,cardiac myofibril assembly (GO:0055003),0.400909232579224,0.9071020705578969,0.5644067796610169,0.9286568409806787,1.0,3/15,3.56%,OBSL1;PDGFRA;PDGFRB
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.26715362644515217,-0.9068830148320242,0.6006825938566553,0.9369417543572574,1.0,16/38,29.15%,HIRA;MIS18BP1;KNL1;H3-3A;RUVBL1;RSF1;NPM1;CENPI;CENPN;CABIN1;NASP;ASF1A;HAT1;ASF1B;HJURP;ITGB3BP
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4181002852464409,0.9068804301046524,0.5594795539033457,0.9285821283011212,1.0,3/11,8.76%,EFNB2;FRS2;BMP2
prerank,protein methylation (GO:0006479),-0.2701180371425246,-0.9067341101040466,0.6543624161073825,0.9360842926044445,1.0,9/40,19.14%,RAB6A;EZH2;SNRPB;PRMT7;ATPSCKMT;FAM98B;PRMT6;SNRPD3;PRMT3
prerank,Fc receptor signaling pathway (GO:0038093),0.2857772225929739,0.9064098543075532,0.6439854191980559,0.9290007506378749,1.0,7/110,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PIGR;KIT;PSME4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.37411880128631825,0.9061262572454695,0.6018808777429467,0.9290174568747005,1.0,9/22,23.91%,CCNK;CDK12;TCERG1;CCNT2;CDC73;LEO1;SCAF8;CCNT1;CDK13
prerank,negative regulation of growth (GO:0045926),0.2805891808174489,0.9060562029096798,0.6360465116279069,0.9285921867349477,1.0,24/121,13.02%,GJA1;ENPP1;SMAD3;NOTCH2;TSPYL2;MT3;SFRP1;BCL6;APBB2;PML;ING5;SPHK2;STK11;RBBP7;SLIT3;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,negative regulation of MAPK cascade (GO:0043409),0.29593933835887487,0.9060125347612553,0.6366995073891626,0.9281112205711838,1.0,18/87,15.74%,TIMP3;DAG1;LYN;APOE;FBLN1;CDK5RAP3;RANBP9;EMILIN1;IRAK3;EPHB2;SPRY2;SPRED3;IGBP1;CNKSR3;PTEN;BMP4;SPRED1;PIK3R2
prerank,regulation of cellular component biogenesis (GO:0044087),0.33673650386133924,0.9058908610742797,0.5892857142857143,0.9278030859650085,1.0,6/39,9.37%,ROCK2;APOE;CCL19;RAPGEF2;SNCAIP;RAPGEF1
prerank,hemopoiesis (GO:0030097),0.2931128898785041,0.905878677422798,0.6140776699029126,0.9272621041011856,1.0,12/87,6.86%,TGFBR3;RUNX1;PGM3;MFAP5;FGFR2;KIT;RUNX2;NOTCH2;SFRP1;ETV6;FUT10;CEBPA
prerank,response to hydroxyurea (GO:0072710),0.43095788561153225,0.9058640184496171,0.5734024179620034,0.9267285635362157,1.0,4/11,18.74%,DDI1;RTF2;TIMELESS;ATRX
prerank,sterol biosynthetic process (GO:0016126),0.3420749815151214,0.9057914224668473,0.5741839762611276,0.9263176876344571,1.0,5/33,9.33%,PRKAG2;INSIG2;APOA1;MVK;IDI1
prerank,negative regulation by host of viral process (GO:0044793),0.443165319091108,0.9057506276418437,0.6022727272727273,0.9258297121965564,1.0,2/10,9.32%,CCNK;PRKN
prerank,phosphatidic acid metabolic process (GO:0046473),0.32687274444727177,0.9055514731781903,0.605191256830601,0.9257091626545719,1.0,6/48,8.12%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,cellular response to heat (GO:0034605),0.34375615884948124,0.9053268775507918,0.5901639344262295,0.9255906048529852,1.0,1/35,0.14%,POLR2D
prerank,mammary gland development (GO:0030879),0.3801246337069561,0.9050309927038317,0.567651632970451,0.9256775156319325,1.0,4/21,7.96%,GLI2;WNT4;TBX3;ARHGAP35
prerank,phosphate ion transmembrane transport (GO:0035435),-0.36667865815288,-0.9049143596050065,0.5778781038374717,0.9393635385761384,1.0,4/12,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.33988713268871795,-0.9046744384536671,0.6068796068796068,0.9387760925667771,1.0,7/16,26.03%,SHLD1;CGAS;PARPBP;POLQ;HELB;SHLD2;KLHL15
prerank,regulation of hippo signaling (GO:0035330),-0.3280223780414955,-0.9046071104139324,0.5943396226415094,0.9377466002249367,1.0,3/17,5.06%,MOB3B;SCHIP1;CIT
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2569598887412099,0.9045134706890907,0.7610887096774194,0.9261679632807328,1.0,55/532,10.16%,GREM2;COL1A2;RORA;GHR;PIK3R1;IL31RA;BCL2;IL6R;LEPR;IL34;PELI2;OSMR;ZEB1;MMP2;KIT;SP100;YAP1;NUMBL;CCL19;IRAK2;CNN2;CSF1;NCAM1;APPL2;BRWD1;IRF1;EDAR;MT3;PSME4;OAS2;BCL6;CCL4;CDC42;SRC;PML;SDC1;IL12B;BATF;CEBPA;TSLP;IL13RA1;IL15RA;IRAK3;BCL2L11;MAP3K8;STAT5B;CNTFR;ACTN4;CAMK2B;RAPGEF1;LTBR;STAT2;RNASEL;IFI27;FGF2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3037138422839401,0.9044601203637088,0.6085825747724317,0.9257239232613927,1.0,14/65,14.14%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;PDE6G
prerank,tryptophan catabolic process (GO:0006569),0.42036185985429836,0.9044425207909597,0.5698324022346368,0.9251994223072124,1.0,2/11,6.77%,TDO2;KYNU
prerank,response to zinc ion (GO:0010043),0.3642537902327202,0.9043980252790703,0.5786163522012578,0.9247387217228696,1.0,4/25,5.15%,PAM;SLC30A8;MT3;SLC30A2
prerank,amyloid-beta metabolic process (GO:0050435),0.4007197325618215,0.9043443885076367,0.5690515806988353,0.9242914491376969,1.0,7/16,19.72%,APEH;APH1B;MGAT3;DYRK1A;PSEN2;ABCA7;IDE
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4036538012485523,0.9043008243509675,0.5833333333333334,0.9238336921275315,1.0,9/14,26.43%,CHKB;ETNK2;LPIN3;CEPT1;LPIN2;PCYT2;SLC27A1;PISD;LPIN1
prerank,polyol biosynthetic process (GO:0046173),-0.3317299009716898,-0.904224719037662,0.5558194774346793,0.9374514285559085,1.0,4/16,11.02%,ACER3;IP6K1;ISYNA1;IPMK
prerank,glycosphingolipid metabolic process (GO:0006687),0.32671660542091313,0.9040052633191094,0.6005398110661269,0.9238925260960671,1.0,6/42,10.19%,ST6GALNAC5;ST3GAL5;LARGE1;SMPD2;B3GALNT1;ST6GALNAC6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3215668076866982,-0.9036719893029258,0.5771428571428572,0.937658571494536,1.0,8/19,18.32%,DLG2;CLIC4;LRRC7;SCRIB;PATJ;ERBIN;SYNJ2BP;MTCL1
prerank,negative regulation of catabolic process (GO:0009895),0.32526905774337556,0.9035099077581243,0.6057298772169167,0.9244015552833589,1.0,12/47,16.25%,NUPR1;CST3;SIRT2;NCOR1;IRAK3;EGFR;SNX12;ADRA2A;BANP;HDAC4;FLNA;AGAP2
prerank,negative regulation of cell adhesion (GO:0007162),0.3020274157317052,0.9034648234947941,0.6084724005134788,0.9239360009148625,1.0,16/72,14.30%,PLXNA2;ANGPT1;SERPINE1;RIPOR2;SEMA5A;FBLN1;CYP1B1;DSCAM;EPHB2;MIA3;PLXNC1;SIPA1;DACT2;PLXNA1;MDK;PLXNB2
prerank,negative regulation of protein transport (GO:0051224),0.3615941765489835,0.9033956657540015,0.5913312693498453,0.9235125586384655,1.0,9/25,22.56%,APOE;IL12B;DRD3;SNX12;SERGEF;RHBDF2;DPH3;RSAD2;CYP51A1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.33770650128153745,0.9033739017702429,0.5847953216374269,0.9229998585648028,1.0,5/31,15.26%,ARRDC4;GORASP1;BTRC;PTEN;DCUN1D2
prerank,response to UV (GO:0009411),0.29188348448507245,0.9032281035512456,0.6316440049443758,0.9227306758699114,1.0,11/95,9.16%,MFAP4;NEDD4;PCLAF;USP47;INO80;SPRTN;IL12B;UBE4B;BRSK1;EGFR;ZBTB1
prerank,regulation of response to external stimulus (GO:0032101),0.2823607728686361,0.9028190745053472,0.6396713615023474,0.9230778498719963,1.0,12/121,6.94%,ADAMTS12;AHSG;PTGES;CASP12;PDGFRA;EFNB2;APPL2;IRF1;BCL6;ADGRA2;AGTR1;GUCY2D
prerank,negative regulation of innate immune response (GO:0045824),0.34129211592966696,0.9022197387298577,0.5811209439528023,0.9237287796571358,1.0,11/34,20.23%,SERPING1;DCST1;NMI;IRAK3;STAT2;MUL1;DHX58;METTL3;TRIM21;YTHDF2;SUSD4
prerank,monocyte differentiation (GO:0030224),0.4328383719899398,0.9019188240410798,0.5993031358885017,0.9238141984734615,1.0,1/10,1.75%,IL31RA
prerank,regulation of defense response to virus by host (GO:0050691),-0.2804293511456524,-0.9017839697468802,0.6180758017492711,0.9410627940502961,1.0,12/30,27.98%,TOMM70;AIM2;TNFAIP3;CGAS;PTPN22;TRIM6;DHX9;EIF2AK4;TRIM44;IFNLR1;LILRB1;TRAF3IP2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3268039646035093,0.9014852966754311,0.5924855491329479,0.9241491364005957,1.0,7/39,12.38%,BMP6;APOA1;BMP2;MYADM;MIA3;RGCC;WNK1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3271560994569309,-0.9008768638135667,0.6408268733850129,0.9421449900649425,1.0,6/18,9.69%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;TGFBR2
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2540801653944081,-0.9005715144816338,0.667910447761194,0.9405859884022963,1.0,22/51,33.50%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2540801653944081,-0.9005715144816338,0.667910447761194,0.9405859884022963,1.0,22/51,33.50%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.3900466130864113,-0.9002120176493451,0.5838926174496645,0.940337232346512,1.0,4/10,23.23%,SORL1;DNAJB6;SACS;DNAJB1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3652635444685079,0.9001414239314446,0.5579119086460033,0.9264332032739087,1.0,5/20,10.43%,TNRC6B;WTIP;HELZ;TNRC6A;EIF6
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.37955355053164996,-0.9000571009614093,0.6096385542168675,0.9395521766076489,1.0,2/11,5.92%,CAV1;PTPRT
prerank,negative regulation of myotube differentiation (GO:0010832),-0.36966271436718035,-0.8998629613084553,0.5788177339901478,0.9388387180208331,1.0,2/12,2.63%,NOTCH1;CCN3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.35348539989281874,-0.8998497973463219,0.6105769230769231,0.9376915083458057,1.0,2/13,7.19%,NLGN1;EPS8L2
prerank,regulation of neuron projection arborization (GO:0150011),-0.3379848060524604,-0.8996489152541782,0.6146341463414634,0.936965105791925,1.0,4/15,7.78%,MYO9A;FZD4;NTNG1;MFSD2A
prerank,positive regulation of cytokinesis (GO:0032467),-0.28097775894773563,-0.8995553674904652,0.6398809523809523,0.9360312042265108,1.0,10/32,18.72%,PKP4;CIT;KIF20B;CDC14A;CSPP1;GIPC1;KIF23;PRKCE;ECT2;CUL3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2833170757458424,0.8989842157325951,0.6391625615763546,0.9282730456017393,1.0,14/112,13.46%,IGF1;GAS6;CCL19;OAS2;ARFGEF2;IL12B;SPHK2;IRAK3;EPHB2;SETD4;CD33;SELENOS;CD14;SYT11
prerank,heterochromatin organization (GO:0070828),-0.3541965766271494,-0.8987064686419873,0.5766233766233766,0.9370309503755525,1.0,2/14,3.93%,MECOM;PRDM16
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4252886095681154,0.8985594850786562,0.5843270868824532,0.9280534549003456,1.0,2/11,4.32%,INPP5A;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4252886095681154,0.8985594850786562,0.5843270868824532,0.9280534549003456,1.0,2/11,4.32%,INPP5A;SYNJ2
prerank,DNA double-strand break processing (GO:0000729),0.3858508280893733,0.8985358621742073,0.5756578947368421,0.9275514251618932,1.0,12/18,30.65%,UBE2V2;RNF138;ATM;KAT5;EXD2;SMARCAD1;BRCA1;MRE11;RAD50;UBE2N;RBBP8;DNA2
prerank,cellular protein catabolic process (GO:0044257),0.30681680317188365,0.8984274237985671,0.6155913978494624,0.9272489766030163,1.0,10/59,13.35%,ADAMTS12;CTSH;CTSF;CLPX;PRKN;CLPP;RSPRY1;CPA2;CTSZ;CTSL
prerank,skeletal muscle tissue development (GO:0007519),0.3397861150556421,0.8977314777630554,0.6100719424460431,0.9281200479057427,1.0,5/32,9.66%,SVIL;CFLAR;MSC;SKI;CSRP3
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.32266175060568275,-0.8976288943935918,0.6195652173913043,0.9384737094616232,1.0,8/18,31.61%,OTUD7B;APOD;CABP1;FLCN;GSK3B;MFHAS1;LATS1;MDFIC
prerank,acyl-CoA metabolic process (GO:0006637),0.3357212497070233,0.8973726917366938,0.6111929307805597,0.9283235646800994,1.0,8/35,17.19%,ACOT11;ACOT6;ACOT2;SUCLG2;ACSF2;HMGCS1;ACOT9;OXSM
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38950796077662897,0.8966229839158364,0.5823817292006526,0.9293255696205817,1.0,4/17,8.83%,PBX1;MAML3;RBPJ;KAT2B
prerank,establishment of epithelial cell polarity (GO:0090162),-0.32413941918352007,-0.8963751621354694,0.5822454308093995,0.9403117551443982,1.0,7/19,19.80%,CYTH3;MYO9A;OPHN1;MSN;CYTH1;CLASP1;SH3BP1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2872610107274972,-0.8962547396963032,0.6101190476190477,0.9394376711285239,1.0,8/27,11.49%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;MTMR9;CALM3;TGFB1
prerank,negative regulation of calcium ion transport (GO:0051926),0.3954171254460486,0.8962442563426926,0.6,0.9295250971172507,1.0,4/15,15.16%,ATP1A2;ADRA2A;CD33;TMBIM6
prerank,histone mRNA catabolic process (GO:0071044),0.3928728631353572,0.896070728652204,0.5898778359511344,0.9293221709017551,1.0,5/15,17.38%,TUT7;ERI1;TUT4;TENT4B;ATM
prerank,sodium ion export across plasma membrane (GO:0036376),0.40381453893047603,0.8960177923015699,0.6003344481605352,0.9288849507691886,1.0,2/13,6.93%,ATP1A2;ATP1B2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3983796653915933,0.8960078940670376,0.5716753022452504,0.9283491773778615,1.0,3/15,10.16%,PDPK1;SMAD1;FGF2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.260350300573095,-0.8956261604988498,0.6688524590163935,0.9398924585890791,1.0,16/38,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAB1;NDUFB4;NDUFV2;NDUFV3
prerank,determination of left/right symmetry (GO:0007368),-0.2756579617085505,-0.8953795319622623,0.6274509803921569,0.9393653119902104,1.0,10/36,19.58%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1
prerank,neuromuscular process (GO:0050905),0.3956680635915741,0.8950642082136693,0.5799319727891157,0.9297351876202936,1.0,1/16,0.51%,MYCBP2
prerank,vasoconstriction (GO:0042310),0.4217246284585541,0.8950497178253345,0.5749128919860628,0.9292182512644412,1.0,1/11,1.14%,SLC8A1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3721921520296379,0.8948464610681033,0.5845410628019324,0.9290860637242525,1.0,3/21,7.70%,MITF;MED14;MED16
prerank,response to thyroid hormone (GO:0097066),0.41266344364107344,0.894351715710084,0.6062717770034843,0.9295826249968141,1.0,6/13,14.33%,THRB;CTSH;BRD8;KLF9;CTSL;HPN
prerank,negative regulation of protein metabolic process (GO:0051248),0.3197274196770635,0.8942642048421756,0.6372155287817939,0.9292112577014843,1.0,12/48,16.75%,APOE;LDLR;SIRT2;IRAK3;EGFR;SNX12;ITGB3;ITGAV;BANP;FLNA;AGAP2;VBP1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3401190867013924,0.8941645273526472,0.6020710059171598,0.928865614052922,1.0,4/35,5.54%,GHR;LEPROT;KIT;CYP1B1
prerank,mitotic recombination (GO:0006312),0.38585712759831026,0.8940406116647436,0.5866013071895425,0.9285540706643689,1.0,5/15,14.12%,DMC1;SMC5;SMC6;TEP1;RAD51D
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3141454161541656,0.8937365457396116,0.6098829648894668,0.9286018407830536,1.0,7/56,8.98%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2735811762955398,-0.8935789918834814,0.6168831168831169,0.9425973824389915,1.0,11/31,25.12%,EDC3;LSM2;LSM6;DIS3L2;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,base conversion or substitution editing (GO:0016553),0.4114300783373637,0.8933610254284894,0.6060100166944908,0.9288370316516218,1.0,1/11,1.90%,A1CF
prerank,neuron fate commitment (GO:0048663),0.3981682818409176,0.8931855152223913,0.5784148397976391,0.9286533722141034,1.0,2/14,3.57%,ASCL1;TGFBR1
prerank,neuron remodeling (GO:0016322),-0.3850255116555284,-0.8931446390895376,0.6291390728476821,0.9425188251281216,1.0,5/10,22.38%,ADGRB3;SCARF1;APP;ANKS1A;RND1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2759389647508147,-0.8927333630085243,0.6447368421052632,0.9423044767609314,1.0,10/31,27.61%,OTUD7B;OTUD7A;OTUD4;YOD1;TNFAIP3;BABAM1;BABAM2;USP7;OTUB2;USP33
prerank,inflammatory response (GO:0006954),0.26666422714806637,0.8921443210870662,0.7066521264994547,0.9302752634064205,1.0,34/195,16.06%,ADCY1;HSPG2;IL17D;XCR1;KIT;TPST1;CCL19;LTB4R;CCL4;BDKRB2;AGTR1;SCUBE1;TLR6;BMP2;ITCH;NFAM1;CDO1;LIAS;CEBPB;ADM;TNFAIP6;TBK1;FOLR2;RIPK2;CD14;NOX4;CXCL13;HDAC4;ADORA2A;VNN1;TNFRSF1A;NLRC4;MAPKAPK2;KLRG1
prerank,negative regulation of cholesterol transport (GO:0032375),0.42850866181270414,0.8921435486195984,0.6032608695652174,0.9297256784063186,1.0,10/10,57.18%,SHH;SREBF2;NFKB1;APOC1;APOC3;ABCG8;PLA2G10;APOA2;ABCG5;ABCA2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3189660834041359,0.8913564232725683,0.6089466089466089,0.9308432618769769,1.0,6/44,8.96%,ROCK2;ZFP36L1;TNRC6B;CPEB3;TNRC6A;METTL14
prerank,mRNA 3'-end processing (GO:0031124),0.2950046579981072,0.8913352388607511,0.6389937106918239,0.9303371270885615,1.0,28/78,27.30%,POLR2D;U2AF1L4;THOC2;DDX39A;WDR33;MAGOHB;PAF1;SRSF5;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;SRSF3;PAPOLA;NCBP2;CASC3;PAPOLB;SLU7;GRSF1;SSU72;AHCYL1;CDC40;NCBP1;PABPN1
prerank,outer dynein arm assembly (GO:0036158),0.38138564459099916,0.8912922693861537,0.5976027397260274,0.9298890713691886,1.0,6/14,24.56%,DNAAF1;DNAAF5;DNAL1;DNAH8;ODAD4;ODAD1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3427078375406339,-0.8911451965893147,0.6120092378752887,0.9449007553342549,1.0,6/15,21.94%,NGF;DDIT4;BCAR1;ZFYVE27;NTRK2;HAP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.28089486294372035,-0.8909637817482982,0.6269113149847095,0.9441762116998047,1.0,4/32,7.25%,RPS19;PGLYRP1;RPL39;RPL30
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2920835859494294,0.8909522245938042,0.6427672955974842,0.9300483272955308,1.0,16/80,15.38%,DENND2A;BAIAP3;RHOBTB3;LMAN1;STX16;RBSN;DENND5A;GOSR2;HEATR5A;SNX12;RAB7B;ARL1;TRAPPC10;TMEM87B;BET1L;PIKFYVE
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3793126380233908,0.8908013050162568,0.610410094637224,0.9298102890509058,1.0,7/18,16.32%,NFE2L2;NONO;PRKN;NOL3;VNN1;BAG5;AKT1
prerank,protein maturation (GO:0051604),0.28562671524800654,0.8900502273897013,0.6442542787286064,0.9308037907813542,1.0,10/95,11.91%,CPXM2;OGT;AEBP1;CPXM1;MMEL1;EEF1AKMT4-ECE2;ECE2;LONP2;APH1B;CLN3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.34734294943071364,0.8897299086367573,0.5972644376899696,0.9308917388167699,1.0,3/26,10.63%,HECW2;ANAPC5;NEK6
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3116957029838141,0.8891951296242456,0.6580381471389646,0.9314273288331915,1.0,10/57,12.68%,UACA;DAPK1;ASPH;PDCD5;BCAP31;TTBK1;CARD9;DDX3X;REST;RIPK2
prerank,negative regulation of TOR signaling (GO:0032007),0.3312933573980652,0.8890384617373713,0.6347305389221557,0.9311979888442776,1.0,12/36,17.38%,NPRL3;UBR2;PRKAA2;STK11;RNF152;CASTOR2;TSC2;ITFG2;SESN2;NPRL2;FNIP1;ATM
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2921989681524776,0.8889907676473359,0.6462324393358876,0.9307637945785476,1.0,8/76,8.20%,ADRA1B;ACTN2;LTB4R;VIP;LHCGR;AGTR1;LPAR1;DRD3
prerank,positive regulation of defense response (GO:0031349),0.28581288167277646,0.8887333266666567,0.6343001261034048,0.9307585924620756,1.0,22/89,17.97%,SERPINE1;OPTN;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;IFNK;NAPEPLD;PDCD4;NPAS2;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34831966621160576,0.8885063894440312,0.5925925925925926,0.9306866903474356,1.0,6/27,14.89%,TNRC6B;MAP2K1;WTIP;EGFR;MYCN;BMP4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3159664817926817,0.8883901039722267,0.5988779803646563,0.9303886813818699,1.0,14/41,20.10%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;LACC1;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,piRNA metabolic process (GO:0034587),0.38556517215417374,0.8881911692011334,0.6033333333333334,0.9302617560713505,1.0,4/19,17.51%,TDRD1;PIWIL4;MYBL1;DDX4
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.39881802722803916,0.8881650172439908,0.6046128500823723,0.9297645802330478,1.0,3/13,6.96%,PYCR1;LRRK2;NFE2L2
prerank,negative regulation of bone remodeling (GO:0046851),-0.3702998393007533,-0.8876957822161942,0.5829493087557603,0.9508870252933026,1.0,3/11,11.50%,UBASH3B;P2RX7;TNFAIP3
prerank,negative regulation of cell cycle (GO:0045786),0.2944577693307856,0.8875495060070107,0.6602809706257982,0.9304759820233521,1.0,17/73,15.85%,SMAD3;NR2F2;NUPR1;TSPYL2;CEBPA;BMP2;HEXIM2;INCA1;NR4A1;PDCD4;SIPA1;PTPN3;PTEN;BMP4;GAS1;CDKN1C;ZBTB17
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.30384590439780446,-0.8873565509467097,0.6190476190476191,0.9505568620570692,1.0,11/22,28.24%,MVB12B;VPS37B;VPS37A;RNF126;VPS28;VPS36;VPS4A;VPS37C;SNF8;MVB12A;UBAP1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3007922307542801,-0.8872257273290448,0.6214511041009464,0.9497000663272047,1.0,11/26,23.11%,FNBP1L;SGIP1;GAK;ITSN2;INPP5F;AP2A1;CLTB;DLL1;LMBRD1;SNAP91;AP2M1
prerank,anterior/posterior pattern specification (GO:0009952),0.30881888448455064,0.8869546064676578,0.635752688172043,0.9311734852297425,1.0,9/53,15.00%,WLS;TGFBR1;SKI;HES7;BMP2;HOXC5;BHLHE41;ATP6AP2;HOXC4
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2627828840674318,-0.8862713044601918,0.64,0.9508868590566695,1.0,13/34,23.10%,RIMS1;RAB27A;RIMS2;SYT1;SYT6;RAB15;RAB3A;SYT4;SYN1;RIMS3;SYT15;GSK3B;SYT5
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.22102792511802352,-0.8857898288253084,0.7213114754098361,0.9508430574273138,1.0,28/96,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.423296939105822,0.8855335729367633,0.6149914821124361,0.9335551087566258,1.0,4/11,15.92%,DERL1;RNF185;UGGT2;AUP1
prerank,renal absorption (GO:0070293),0.4205025382483153,0.8854906414017797,0.5982142857142857,0.9330927580340698,1.0,1/10,1.20%,GSN
prerank,immunoglobulin mediated immune response (GO:0016064),0.4219767152534364,0.8851705177735237,0.5948616600790514,0.9331982601825057,1.0,2/10,10.54%,GAPT;CARD9
prerank,cellular response to interleukin-1 (GO:0071347),0.2713017272228956,0.8851193137138802,0.6773049645390071,0.9327514702950062,1.0,11/143,8.61%,ADAMTS12;PTGIS;PELI2;CCL19;IRAK2;PSME4;SFRP1;CCL4;NR1D1;IRAK3;MAP3K8
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3592779071887102,-0.8847507526306877,0.639618138424821,0.952187607001028,1.0,8/12,39.65%,ABCC9;CACNA1H;KCNJ8;ABCC8;PKD2L1;P2RX3;KCNJ11;RHAG
prerank,organic substance transport (GO:0071702),0.27659348507151715,0.8846359004027531,0.6587112171837709,0.9332490249852152,1.0,20/121,14.22%,TXNIP;ARRDC4;ABCA1;ABCA9;LMAN2L;SLC22A2;APOA1;SLC35F3;TOM1;PLEKHA8;SLC22A4;MIA3;ABCB9;ARRDC2;SLC22A18;RCN3;SLC48A1;SLC18A2;ABCA3;ABCD2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29859155986732594,0.8845763750313845,0.6326259946949602,0.9328447426048931,1.0,24/66,20.58%,DACT1;APPL2;INO80;EGFR;RBL2;DDX3X;JADE1;RGCC;KMT2E;PTEN;UBE2E2;AKT1;KANK2;ADAMTS1;CDK2AP2;TFDP1;CDKN2C;LSM10;MYO16;CDC73;APPL1;PSME3;PLCB1;CCND2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.40320483276348057,0.8844050984708306,0.601010101010101,0.9326461543041976,1.0,2/12,5.01%,APOE;LDLR
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3941352298816137,0.8841747498133773,0.6040268456375839,0.9325843355908153,1.0,4/15,15.92%,FAF2;DERL1;SELENOS;AUP1
prerank,regulation of establishment of protein localization (GO:0070201),-0.35172361946609115,-0.8840236216975454,0.6227390180878553,0.9527338362910897,1.0,5/13,28.82%,GAPVD1;CEP135;CORO2B;TREM2;PTP4A3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.277638449169285,-0.8839937991203655,0.6216216216216216,0.9504789566622415,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,tRNA export from nucleus (GO:0006409),-0.277638449169285,-0.8839937991203655,0.6216216216216216,0.9504789566622415,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.36837213926321055,-0.883229005279148,0.6073903002309469,0.9500293814447939,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.36837213926321055,-0.883229005279148,0.6073903002309469,0.9500293814447939,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.22947150467363148,-0.8828278893239464,0.7107438016528925,0.9498332122820768,1.0,24/74,23.95%,NOTCH1;EGLN3;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;CITED2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;VHL;PSMA8;PSMB1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.37171191647508184,0.8825534283487384,0.6122754491017964,0.9353899843712591,1.0,3/21,4.91%,WNT8B;FZD2;FZD1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.35047279329536685,0.8825297071408365,0.630057803468208,0.934889754504435,1.0,7/27,15.42%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2955325175324192,0.8818705966752092,0.6458072590738423,0.935661054024916,1.0,18/72,24.39%,ENPP1;OGG1;GTF2H5;CUL4B;REXO4;DXO;DNASE1L1;DCP1A;DDX1;XPA;DICER1;RFC5;FAN1;EXD2;ERCC3;ERCC2;SPO11;MRE11
prerank,cytoplasmic translational initiation (GO:0002183),0.3772886605586855,0.8815835390775408,0.6029411764705882,0.9356843097849615,1.0,8/17,23.86%,EIF4A2;EIF3A;EIF2S2;EIF2B3;EIF3I;RBM4;MCTS1;EIF2D
prerank,negative regulation of anoikis (GO:2000811),0.39105407501107625,0.8815738071993434,0.5927209705372617,0.9351559033663328,1.0,3/14,6.31%,BCL2;TLE1;SRC
prerank,regulation of B cell proliferation (GO:0030888),-0.2606492323091807,-0.8812326956245189,0.6702127659574468,0.9524565846947303,1.0,11/44,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;TNFRSF21;CD40;CD81;GPR183;PTPRC;CD320
prerank,intracellular protein transport (GO:0006886),0.25449002022865896,0.8811687501665622,0.7567849686847599,0.9354474258341847,1.0,56/304,16.32%,WLS;RABGAP1L;TBC1D4;KIF13B;USP6NL;RANBP17;SEC31A;NUP107;APPL2;FAM53C;PRICKLE1;TMED1;VPS26C;RAB23;STXBP3;LMAN1;FUT10;STX16;COX18;ARFGAP3;ADPRH;TRARG1;LTBP2;NUP42;IFT27;MYO1C;RAB22A;COPZ2;ARFIP2;XPO7;KATNB1;HEATR3;TBC1D2B;ARL1;GGA2;TMED4;CSE1L;PPP1R10;STXBP1;TLK1;STRADA;COPA;USO1;TSC2;ARF4;NUP214;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;RAB19;TECPR2;AKT1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.30780641163224165,0.8811682321685333,0.6203576341127923,0.9349068204127735,1.0,10/50,12.97%,SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3826211243987,0.8811248154621767,0.6114754098360655,0.9344486203270893,1.0,2/16,7.21%,PID1;SPHK2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3007771364948486,-0.8804992793316764,0.6302521008403361,0.9530615770894113,1.0,5/23,13.49%,ELOVL7;FAR2;ELOVL5;TECR;HACD2
prerank,kinetochore organization (GO:0051383),0.4055291217584648,0.8792264225933352,0.6132404181184669,0.9377522957215954,1.0,4/13,18.44%,CENPC;CENPH;POGZ;CENPA
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.37433779282503155,-0.8791503860167318,0.5953389830508474,0.9551643371290169,1.0,3/10,10.46%,MYO9A;OPHN1;MSN
prerank,dendritic cell chemotaxis (GO:0002407),0.3933703341008643,0.8791494240940722,0.6085578446909667,0.9373511534882645,1.0,2/14,9.41%,CCL19;TRPM4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.24736446939875892,-0.8788724665637515,0.7344398340248963,0.9546368186231685,1.0,11/52,12.06%,PPP1R13B;YWHAH;YWHAQ;SAE1;GSK3A;ABLIM3;MAPK8;CASP8;YWHAG;BBC3;UBE2D3
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.31731198228411955,-0.8783324474046136,0.649616368286445,0.9546878896395947,1.0,9/18,45.62%,CCT8;CEP135;CORO2B;TREM2;PTP4A3;CCT6A;TNF;CCT7;CCT2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.34687104325282975,-0.8780825211936881,0.6082725060827251,0.9541340334825426,1.0,8/14,34.42%,RPS3;CD81;NECTIN2;CARD11;RAB29;IKBKG;TRAT1;CD226
prerank,tryptophan metabolic process (GO:0006568),0.4142764492302846,0.8777511465331279,0.6285178236397748,0.9395692641521454,1.0,2/11,6.77%,TDO2;KYNU
prerank,ganglioside biosynthetic process (GO:0001574),0.3914586447467091,0.8775354864777754,0.610223642172524,0.9394809725819527,1.0,2/15,2.42%,ST6GALNAC5;ST3GAL5
prerank,protein monoubiquitination (GO:0006513),0.3240584734463941,0.8773203427056399,0.6367583212735166,0.9393552393439228,1.0,14/36,22.32%,MGRN1;ATXN7L3;PRKN;RAD18;PAF1;KLHL12;HUWE1;UBE2R2;WAC;CDC73;TRIM21;UBE2T;LEO1;RNF20
prerank,skeletal muscle contraction (GO:0003009),0.36900439848856587,0.8773008086820453,0.624420401854714,0.9388432903352308,1.0,3/19,10.13%,TNNT1;TNNC1;TNNT3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3366887536747211,0.8772951741464711,0.6433770014556041,0.9383102535478716,1.0,8/33,16.32%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF;PDE6G;AKT1
prerank,regulation of type I interferon production (GO:0032479),-0.22144490878609793,-0.8772367112329766,0.7476190476190476,0.9550078333632376,1.0,20/84,19.40%,IFIH1;RNF125;LRRFIP1;POLR3H;TRIM25;NLRC5;TNFAIP3;CGAS;G3BP1;PTPN22;PRKDC;IRF5;PCBP2;EP300;DDX41;IRF8;POLR2E;UFD1;TAX1BP1;DHX9
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.37332638151948433,-0.8772275136078836,0.6164079822616408,0.9538750078298526,1.0,1/10,1.02%,ADAM10
prerank,regulation of muscle cell differentiation (GO:0051147),0.34017300948414436,0.877185100895002,0.6229007633587786,0.9379827952371399,1.0,3/31,6.15%,IGF2;FGFR2;CDC42
prerank,inositol phosphate catabolic process (GO:0071545),0.40520041445236665,0.8769041418144472,0.6258389261744967,0.9379957560504208,1.0,2/12,4.32%,INPP5A;SYNJ2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3827642459307062,0.8763959552118804,0.6,0.93847430634153,1.0,2/14,4.37%,NNMT;SLC45A3
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3516332438320192,-0.8760983849491399,0.5975903614457831,0.9554385725370023,1.0,3/12,13.55%,MAOA;ATP7A;DDC
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.33368596073649787,-0.8758721613233864,0.6327944572748267,0.9548163505316409,1.0,9/15,45.62%,CCT8;RUVBL1;RUVBL2;SHQ1;NHP2;CCT6A;NOP10;CCT7;CCT2
prerank,organelle disassembly (GO:1903008),-0.27605877437894866,-0.875483574817957,0.6878980891719745,0.9545948495769196,1.0,6/33,11.06%,VRK1;MRRF;TEX264;ULK1;GFM2;UBA5
prerank,icosanoid secretion (GO:0032309),-0.3546199941614756,-0.8752095169468457,0.6674937965260546,0.9541255343712247,1.0,7/12,31.30%,ABCC4;PNPLA8;ANXA1;NMUR2;PLA2G5;NOS2;ACE
prerank,RNA transport (GO:0050658),0.29181232102313837,0.8750979412033182,0.6568123393316195,0.9404815988079392,1.0,12/71,14.58%,RBFOX1;RFTN1;U2AF1L4;SIDT1;ZFP36L1;THOC2;HNRNPA1;DDX39A;RAE1;MAGOHB;NUP214;SRSF5
prerank,regulation of TORC1 signaling (GO:1903432),0.3279232527960394,0.8749959209936207,0.6330827067669172,0.940153059406588,1.0,12/33,20.42%,TELO2;STK11;RNF152;CASTOR2;RRAGD;ITFG2;SESN2;ATM;SEH1L;DYRK3;GPR137B;SZT2
prerank,response to unfolded protein (GO:0006986),0.31704181718064484,0.874938206477604,0.6538461538461539,0.9397232968538963,1.0,18/48,24.70%,OPTN;DERL1;SERPINH1;PRKN;HSPB7;HSPA9;TM7SF3;TOR1B;TMBIM6;ERP44;HSPB2;HSF1;DDIT3;HSPA14;HSPA5;DNAJA1;HSPA4;BAG3
prerank,mesonephric tubule development (GO:0072164),0.38051162001816907,0.8747437446194625,0.6171617161716172,0.9395537236054801,1.0,3/15,7.89%,SALL1;FGFR2;OSR1
prerank,photoperiodism (GO:0009648),0.34213957656986854,0.8746651921431183,0.6237482117310443,0.9391691276583193,1.0,7/28,15.42%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,mesoderm formation (GO:0001707),0.3817720765761611,0.8746228027839106,0.6262458471760798,0.9387022009385831,1.0,3/17,9.58%,ITGA3;CRB2;ITGB3
prerank,embryonic appendage morphogenesis (GO:0035113),0.4059553098281282,0.874280213354639,0.6065857885615251,0.9388131437291988,1.0,2/12,5.81%,CYP26B1;SKI
prerank,histone H2A ubiquitination (GO:0033522),0.3741399292125247,0.8742294619123704,0.618066561014263,0.9383929553241871,1.0,3/17,6.57%,UBR2;BCOR;CUL4B
prerank,negative regulation of viral process (GO:0048525),-0.2443043153994944,-0.8741828891265577,0.7257383966244726,0.9554449159388846,1.0,21/57,29.88%,IFIH1;TRIM14;PPIA;SRPK1;FAM111A;TRIM11;TRIM6;N4BP1;TRIM62;OASL;PLSCR1;IFITM3;TRIM28;TRIM13;MID2;UBP1;ISG15;ISG20;TRIM35;IFIT1;ZC3HAV1
prerank,response to interferon-gamma (GO:0034341),0.2943683230082179,0.8737100426692648,0.66005291005291,0.9388525102521872,1.0,6/67,6.77%,DAPK1;SP100;CCL19;CXCL16;CCL4;KYNU
prerank,positive regulation of protein deacetylation (GO:0090312),0.39532527751754915,0.8736666980323562,0.6030405405405406,0.9384042846218875,1.0,6/14,20.82%,NNMT;AKAP8L;DYRK1A;SAP30BP;NIPBL;BRMS1
prerank,platelet aggregation (GO:0070527),0.33095029723031844,0.873637948296195,0.648068669527897,0.937916467833917,1.0,10/33,15.81%,GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3140669360178193,0.8732863136158069,0.6535326086956522,0.9380908617844623,1.0,2/48,0.72%,PDPK1;CEMIP
prerank,positive regulation of cell adhesion (GO:0045785),0.28520563669945986,0.8731918669909706,0.6826196473551638,0.9377390571172377,1.0,11/74,9.62%,RHOD;TPM1;EPHA4;PPP3CA;ECM2;IL12B;AFDN;FOXC2;ARL2;RSU1;ITGAV
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3253375208127341,-0.8729259565992405,0.631979695431472,0.9572857264138103,1.0,9/16,40.75%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR;RAD9A;RAD9B;CDT1
prerank,detection of visible light (GO:0009584),0.3808916965511625,0.8727052419070583,0.6055646481178396,0.9381471896514106,1.0,1/16,2.64%,TULP1
prerank,regulation of protein localization (GO:0032880),0.30221238559177427,0.871957234482926,0.6558704453441295,0.9391028679214776,1.0,9/58,11.49%,RABGAP1L;WDPCP;DZIP1L;VIP;AFDN;PICALM;ITGB3;PLEKHM2;UFL1
prerank,positive regulation of isotype switching (GO:0045830),-0.32999419346506575,-0.8718474273772439,0.625,0.9586469820747671,1.0,4/15,11.96%,TFRC;SHLD1;TGFB1;CD40
prerank,glycoprotein metabolic process (GO:0009100),0.30723622907151693,0.8718157663440509,0.6520547945205479,0.9388496160333,1.0,15/53,17.55%,GAL3ST2;PRKCSH;MAN1C1;LARGE1;ADAMTS9;NGLY1;ST6GALNAC6;GANAB;ENGASE;AGA;ERP44;GOLPH3;NEU4;MAN1A2;TNIP1
prerank,morphogenesis of an epithelium (GO:0002009),0.34740378235814956,0.8717696119271138,0.6550151975683891,0.9383968142928477,1.0,3/25,6.79%,DAG1;FGFR2;VCL
prerank,axonal transport (GO:0098930),-0.2661840427739995,-0.871766333473889,0.6602564102564102,0.9577051210383936,1.0,15/36,27.59%,RAB21;AP3B1;TMEM108;SYBU;PAFAH1B1;KIF1A;DCTN1;HIF1A;AP3S1;BLOC1S5;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.31604096952358796,-0.8714389949957684,0.6230769230769231,0.9573102315339533,1.0,7/18,21.76%,THBS1;IL33;LBP;KARS1;CRLF2;TLR4;NECTIN2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.34945246019568044,-0.8713380291627664,0.6013667425968109,0.9552537095420679,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.34945246019568044,-0.8713380291627664,0.6013667425968109,0.9552537095420679,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,protein polyubiquitination (GO:0000209),0.25214457702576776,0.8712131121863933,0.7767295597484277,0.9389692074328394,1.0,71/297,20.64%,SPSB1;HECW2;SASH1;BCL2;PELI2;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;RNF31;UBE4B;TRIP12;UBE2U;FBXL3;UBE2V2;UBOX5;ANAPC5;FBXO28;PRKN;ITCH;IFI27;RNF6;RNF152;FBXO9;FBXO11;KBTBD7;ERCC8;FBXO4;FBXL12;BTRC;RNF217;MUL1;TNKS2;RNF19A;RC3H2;UBE2E2;AMFR;FBXO38;THOP1;UBE2D1;HACE1;HUWE1;DZIP3;NHLRC3;SPOP;UBR5;UBE2R2;UBE3B;UBE3A;PSMB5;RNF135;PSMC2;HERC6;UNKL;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;PSME3;TRIM21;FBXL18;ARIH2;CDC23;UBE2T;PSMA3
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.27058486860105646,-0.8709125764341505,0.6699029126213593,0.9550883336004632,1.0,4/30,10.70%,HSPA8;UGGT1;GAK;DNAJB14
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.31909339733044584,-0.8708967858597094,0.6381418092909535,0.9539970850272406,1.0,8/16,31.19%,TRIB2;TNFRSF21;JAK3;DLL1;AGER;VSIR;LILRB1;FCGR2B
prerank,actin filament-based transport (GO:0099515),0.3644569481868285,0.8708428963982049,0.6532905296950241,0.93914230298404,1.0,4/21,9.28%,SYNE2;MYO1B;MYO1C;ACTN4
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3092648812325063,-0.8707967396705901,0.6332518337408313,0.9531123480547227,1.0,6/18,13.80%,RDX;MTMR2;DNAJC13;RAB21;MSN;MAPK3
prerank,regulation of mitotic cell cycle (GO:0007346),-0.20055014641195096,-0.8698217896249543,0.8349514563106796,0.9542470165652365,1.0,34/171,15.71%,AFAP1L2;CAV2;NEK7;IQGAP1;SDCBP;CUL1;BRINP3;EIF4E;MEIS2;ANGEL2;BRINP1;ANAPC16;ANAPC15;ANAPC7;TAL1;BORA;BTG2;SCRIB;KIF20B;TGFB1;BRINP2;LGMN;SIRT1;DYNLT3;PSMF1;USP22;THAP1;PSMB8;PSMA4;APP;PSMB10;PSMB2;UBE2S;BUB1B
prerank,negative regulation of JNK cascade (GO:0046329),0.3348113110117247,0.8698179502798278,0.6400602409638554,0.9406214742855058,1.0,7/31,12.62%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;PDCD4
prerank,modulation by host of symbiont process (GO:0051851),-0.26854620123095835,-0.8698053057509213,0.6703601108033241,0.9531606263895993,1.0,8/31,16.95%,LEF1;CHD1;SNW1;INPP5K;CX3CR1;JUN;EP300;TFAP4
prerank,regulation of monocyte chemotaxis (GO:0090025),0.35955011394322034,0.8690680862124384,0.6270190895741556,0.9415620674794959,1.0,2/24,1.77%,SERPINE1;LYN
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.35218918122284226,-0.869061976722487,0.6359550561797753,0.9536576825031724,1.0,3/12,11.49%,ESR1;LIN28B;TGFB1
prerank,primary neural tube formation (GO:0014020),0.3356274173538646,0.8689167740262238,0.6231671554252199,0.9413192541289445,1.0,7/30,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,regulation of vasculogenesis (GO:2001212),0.3847778175490424,0.8687909145537636,0.6128500823723229,0.9410466997371457,1.0,2/14,4.33%,RIN2;RAPGEF2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2727061109325835,-0.8677056016928051,0.6786786786786787,0.9555640230712908,1.0,12/29,28.15%,ELOVL7;PPT1;ELOVL5;TECR;HSD17B8;HACD2;PPT2;ACSL3;ACACA;SCD5;CBR4;ELOVL2
prerank,regulation of aerobic respiration (GO:1903715),-0.33087986951079784,-0.867582573164697,0.6240786240786241,0.9547616769978279,1.0,3/15,11.81%,CBFA2T3;SLC25A33;ATP7A
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.34792431701829507,-0.8672043193369806,0.6240963855421687,0.9544886082838154,1.0,7/14,28.82%,CPSF7;ERN1;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1
prerank,regulation of protein binding (GO:0043393),0.2746356659704552,0.8670707639410559,0.6933962264150944,0.9438870239590309,1.0,22/114,15.16%,TCF7L2;LRP1;DACT1;VTN;RAPGEF2;DERL1;LRRK2;STK4;DAB2;BMP2;PRKN;TTBK1;NMD3;RIPK2;CTSZ;IFIT2;CFHR2;MARK2;HDAC4;AMFR;BMP4;TMBIM6
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.23268160089123513,-0.866688801254905,0.757847533632287,0.9545132758085068,1.0,26/73,30.05%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CD86;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,oogenesis (GO:0048477),-0.3299391551884559,-0.8665762902764507,0.649164677804296,0.9536624820295704,1.0,7/15,34.14%,FMN2;PTN;MEI4;TRIP13;KMT2D;PIWIL2;IHO1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.32125955040745696,0.8660434544935849,0.6492220650636492,0.9453915754386842,1.0,5/38,5.05%,SERPINE1;SP100;CFLAR;RFFL;SFRP1
prerank,regulation of telomere capping (GO:1904353),-0.29144292238503655,-0.865970618121074,0.6703910614525139,0.9539627986443292,1.0,8/23,24.24%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;NBN;MAPK1;USP7
prerank,DNA metabolic process (GO:0006259),0.2520046668581286,0.8655479721162742,0.7589098532494759,0.9457925691169234,1.0,79/270,26.39%,TCF7L2;SP100;PDS5B;OGG1;PSME4;AXIN2;LIG4;NEIL1;INO80;RAD51B;DMC1;POLG;REXO4;UBE2U;TOP3B;TOP2B;POLL;RECQL5;KMT5B;UBE2V2;ZBTB1;POLE3;DNASE1L1;DNASE2;DDX23;RAD18;FANCC;MBD4;UVRAG;TERF2;MCM2;MNAT1;RAD51D;RTEL1;SMARCB1;XRCC2;LONP1;PRIMPOL;KPNA2;TIMELESS;ATM;CDC7;KAT5;ALKBH1;XPA;ENDOV;RAD54L;SUMO1;RFC5;FAN1;USP3;UBE2T;EXD2;MUTYH;CBS;RMI2;DNMT1;NSMCE4A;ERCC3;SMARCAD1;NOC3L;FANCA;LIG1;BRCA1;POLI;TDG;MSH6;NABP2;MRE11;POLE2;MCM6;HMGB3;MPG;ATRIP;RAD50;RPAIN;MMS19;UPF1;HMGB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3560822666659054,-0.8654427667165088,0.6553398058252428,0.9541189410259748,1.0,7/12,40.04%,FOXP1;KLF4;TLR4;LPL;OAS3;MBP;TNF
prerank,negative regulation of biosynthetic process (GO:0009890),0.37731847417393705,0.8652113973611542,0.6142857142857143,0.9459045550378959,1.0,4/16,14.22%,EMILIN1;SLC30A10;SLC18A2;ABCD2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.3432800284802182,-0.8650758484331473,0.6464646464646465,0.9538277461805724,1.0,3/14,9.59%,ADAM10;ABCG1;ADAM19
prerank,tube closure (GO:0060606),0.33068527096830186,0.8649600791284768,0.6399416909620991,0.9458834444430188,1.0,7/31,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,ganglioside metabolic process (GO:0001573),0.3649854159082102,0.8646563973033227,0.6486068111455109,0.9459394477055424,1.0,2/20,2.42%,ST6GALNAC5;ST3GAL5
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.30579204175445496,0.8646187979365475,0.6512261580381471,0.945476188476987,1.0,7/47,11.76%,PID1;PDGFRB;AGTR1;TLR6;SLC5A3;DCXR;F2
prerank,histone acetylation (GO:0016573),-0.22547620342825395,-0.8644311929048074,0.7478260869565218,0.9541200026280822,1.0,18/69,18.75%,LEF1;JADE3;PHF20L1;TRIM16;KAT2A;TAF10;TADA2A;APBB1;PER1;RUVBL1;KAT6A;NAA60;EP300;MRGBP;BRCA2;SGF29;YEATS2;ZZZ3
prerank,positive regulation of RNA splicing (GO:0033120),0.33561108206873447,0.8642323043907474,0.65284178187404,0.9456990062564734,1.0,6/29,15.61%,PIK3R1;HNRNPLL;RBM22;NUP98;DYRK1A;SLC38A2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3641121644732219,-0.8637910606629764,0.625560538116592,0.9544626385710863,1.0,7/10,55.04%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,response to acidic pH (GO:0010447),-0.3451858254682819,-0.8635867758500073,0.6506849315068494,0.9537719836957843,1.0,5/13,26.08%,LGMN;GPR4;CTSS;RAB11FIP5;PKD2L1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3303880623946559,0.8634702488573095,0.6228070175438597,0.946734233114849,1.0,3/30,4.50%,SLC27A5;ACSL1;ACOT2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3482329962874978,-0.8628978341500037,0.665871121718377,0.9542376203287183,1.0,4/12,11.84%,CAV1;IFIH1;CGAS;RALB
prerank,regulation of keratinocyte migration (GO:0051547),0.395567502690652,0.8627597384509329,0.647985989492119,0.9475679630635417,1.0,5/12,15.84%,MAP4K4;MAPRE2;PTEN;ARF6;EPPK1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.36180727624615727,-0.8625651609301328,0.6329411764705882,0.9538473437331284,1.0,4/11,19.01%,EGLN3;EGLN2;P4HA3;P3H2
prerank,regulation of microtubule nucleation (GO:0010968),0.4060052264702165,0.861940027505963,0.643979057591623,0.9486491474051079,1.0,1/10,1.79%,EML2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.3338171989893497,-0.8613730737273504,0.6361386138613861,0.9553621712175365,1.0,5/13,29.56%,ANAPC15;CDK5RAP2;GEN1;LCMT1;DYNC1LI1
prerank,toll-like receptor signaling pathway (GO:0002224),0.27800500116022886,0.8613033251460891,0.6878901373283396,0.9493220336471628,1.0,24/84,22.12%,COLEC12;RFTN1;IRAK2;NMI;TLR6;IRAK3;TNIP2;RIPK2;CD14;CTSL;PIK3R4;UBE2D1;MAPKAPK2;TNIP1;EPG5;TLR5;SFTPA1;SFTPA2;TIRAP;LGALS9;MYD88;BIRC2;BIRC3;CNPY3
prerank,embryonic axis specification (GO:0000578),-0.3327967240139219,-0.8609097749143797,0.6304909560723514,0.9552839822581441,1.0,5/15,19.92%,COBL;TASOR;STIL;PTCH1;FZD5
prerank,regulation of cellular component size (GO:0032535),-0.277592925111053,-0.860750632929491,0.6627565982404692,0.9545152437470116,1.0,7/30,12.39%,VAV3;RDX;RAP1GAP2;RIN3;LARS1;MSN;MTOR
prerank,cardiac ventricle development (GO:0003231),-0.3099349723767449,-0.8603459546527622,0.6339522546419099,0.9543245390938376,1.0,9/20,21.70%,NOTCH1;PDE2A;HEY2;HES1;STRA6;HEY1;DLL4;HEYL;GJA5
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.37711712649217544,0.8602782987502854,0.6328671328671329,0.9501586879650203,1.0,3/15,6.70%,ZFP36L1;TNRC6B;CPEB3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.37711712649217544,0.8602782987502854,0.6328671328671329,0.9501586879650203,1.0,3/15,6.70%,ZFP36L1;TNRC6B;CPEB3
prerank,lysine metabolic process (GO:0006553),0.3910619702277364,0.86005938296009,0.624561403508772,0.9495084129066462,1.0,2/12,8.29%,PHYKPL;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.3910619702277364,0.86005938296009,0.624561403508772,0.9495084129066462,1.0,2/12,8.29%,PHYKPL;ALDH7A1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3573102601841836,-0.8596013411930744,0.634703196347032,0.9548638814336803,1.0,1/11,1.02%,ADAM10
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.20132882186415801,-0.8594594274266666,0.8832116788321168,0.9540870584175063,1.0,44/145,23.95%,FHL1;CUL1;RBX1;FBXL7;KCNH5;AVEN;MECP2;RAB11A;TUBB4B;PRKAR2B;PAFAH1B1;YWHAG;RAD51C;ACTR1A;PSMF1;CEP70;CEP135;DCTN1;PSMB8;SDCCAG8;CETN2;CDK5RAP2;PSMA4;PSMB10;CEP57;PSMB2;CCND1;CEP43;CEP63;PSMC4;CLASP1;PSMA6;HAUS2;PSMD9;PSMD11;PSMD5;CENPF;DTL;HMMR;KIF14;CEP131;PSMA8;CSNK1D;PSMB1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.23180173448738167,-0.8592896762395117,0.7835497835497836,0.9533479168635033,1.0,25/69,30.05%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.38456932415913825,0.8590215825698727,0.655536028119508,0.9509941973678302,1.0,4/15,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of transporter activity (GO:0032411),0.39143217987626594,0.8588340140722015,0.6238859180035651,0.9508120920408388,1.0,6/13,20.47%,SYNGR3;KMT2A;NR1H3;RXRA;KCTD7;SGK2
prerank,regulation of DNA metabolic process (GO:0051052),-0.24578519394948273,-0.8581113871832844,0.7028985507246377,0.9547973414017444,1.0,12/44,20.88%,SUB1;POLH;ALYREF;HNRNPD;PDGFA;MPHOSPH8;NBN;YLPM1;PARG;WRNIP1;UBE2V1;HELB
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3322036085899625,0.8579856547648181,0.6513056835637481,0.951874008183822,1.0,5/29,9.40%,PLEKHH2;KANK1;LIMA1;PRKN;MYADM
prerank,carboxylic acid metabolic process (GO:0019752),0.32901162855369104,0.8571622719201072,0.6671469740634006,0.9529375816019032,1.0,5/33,11.07%,PTGIS;PLA2G4A;DDO;CYB5A;LIAS
prerank,regulation of mitochondrion organization (GO:0010821),0.3030730243266704,0.8564544204642514,0.6794520547945205,0.9537717818253433,1.0,8/47,13.10%,PID1;LRRK2;SREBF1;PRKN;STAT2;RHOT1;MUL1;VDAC1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2710754475931699,-0.8563774070195124,0.7041420118343196,0.9573870850833207,1.0,12/33,24.26%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;SIGMAR1;ECT2;ANXA1;RNF112;MAPK7
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30092540723449207,-0.8562960520975165,0.6596858638743456,0.9564622722218801,1.0,4/20,9.86%,SHANK3;NLGN1;LRP8;SHANK1
prerank,dephosphorylation (GO:0016311),0.26259916638037284,0.856030634461905,0.7318757192174914,0.954044047365784,1.0,28/147,17.53%,PPM1H;PPM1E;PTPN13;PLPP3;PXYLP1;PPP3CA;EPHX2;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;STK11;CTDSP2;PTPRM;PLPP5;PPP2R5D;BTRC;PTPN3;PTEN;PSPH;SDHAF2;PTPRA;ACP6;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,endocardial cushion development (GO:0003197),-0.2954405929295766,-0.8559455345224549,0.6794871794871795,0.9561290744606696,1.0,10/21,21.06%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;HEY1;BMPR2;HEYL;CRELD1;FOXF1
prerank,protein localization to cilium (GO:0061512),0.32306228183324837,0.8554032553833946,0.6408045977011494,0.9546943518728642,1.0,11/32,25.67%,TULP1;WDR35;TULP3;INVS;ZNF423;EHD1;ODAD4;IFT140;TULP2;TTC21B;TCTN2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.3401576223252491,-0.8553432330660663,0.6766743648960739,0.9563397360924291,1.0,7/12,37.23%,PPARGC1A;MTLN;TWIST1;IRS2;MLYCD;NR4A3;PLIN5
prerank,DNA methylation (GO:0006306),0.3477388733346722,0.8552604334346451,0.6692913385826772,0.9544213729742425,1.0,10/23,24.64%,DNMT3A;SPOCD1;KMT2E;METTL4;DNMT3B;ATRX;N6AMT1;DNMT1;PPM1D;DMAP1
prerank,tRNA transport (GO:0051031),-0.26436258083850334,-0.8552160035320743,0.693069306930693,0.9554961558453519,1.0,11/35,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,development of primary male sexual characteristics (GO:0046546),0.3221523681499185,0.8550122076477364,0.661849710982659,0.9543780709868542,1.0,5/34,6.58%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,DNA strand elongation (GO:0022616),-0.3071317329711893,-0.8544999205249075,0.6945169712793734,0.9559574028433954,1.0,9/18,34.69%,DCLRE1B;GINS3;NBN;MCM3;GINS2;POLA1;POLD2;TERT;MCM7
prerank,metanephric mesenchyme development (GO:0072075),0.42159215410596595,0.8543956028535272,0.6268656716417911,0.9550316432400289,1.0,5/10,24.85%,WNT4;OSR1;SHH;PKD2;STAT1
prerank,response to exogenous dsRNA (GO:0043330),0.3660467779190604,0.8541270094400558,0.6512738853503185,0.955012493663272,1.0,5/18,13.02%,COLEC12;RFTN1;IRAK3;IFNK;MUL1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.22396980971557037,-0.8538240383557196,0.755,0.9563464692247036,1.0,10/73,9.51%,CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;ATP2B4;VEGFA
prerank,mitochondrion localization (GO:0051646),0.35683050447919035,0.853809664370057,0.6348684210526315,0.9551160965870482,1.0,4/19,13.60%,MARK1;LRRK2;MUL1;MARK2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.36293168636623385,-0.85373444656246,0.6768149882903981,0.9554757942633635,1.0,5/11,30.83%,PWP1;MTOR;SMARCA4;PIH1D1;IPPK
prerank,fatty acid catabolic process (GO:0009062),0.28784021359941697,0.8535939721409039,0.6893453145057766,0.9550037887090577,1.0,11/67,14.22%,PCCA;PCCB;NUDT7;ECHDC2;ECI1;MMUT;ABHD3;ECHS1;PEX2;DECR1;ABCD2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38290936610645604,0.8535701765591229,0.6406779661016949,0.9545096370831325,1.0,1/13,0.57%,ADCY1
prerank,positive regulation of lyase activity (GO:0051349),-0.33662713888965934,-0.8534357304673881,0.6758241758241759,0.955041766424221,1.0,5/14,15.08%,NOS3;NOS1;NF1;ISCU;CACNA1D
prerank,endodermal cell differentiation (GO:0035987),0.3251605488369912,0.8532748669372406,0.6476761619190404,0.9545571903065807,1.0,9/31,18.32%,COL11A1;MMP2;VTN;ITGB5;ITGAV;PAF1;COL4A2;MMP14;CDC73
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2843817159185384,0.8532506597943392,0.6754716981132075,0.9540655424293994,1.0,10/72,11.36%,RUNX1;GAS6;CFLAR;IRAK2;AXL;RNF31;TSLP;IRAK3;RNASEL;ABCE1
prerank,phagosome-lysosome fusion (GO:0090385),0.4118138738344609,0.8529815486374278,0.6618181818181819,0.9540651289656285,1.0,3/10,15.38%,RAB7B;CLN3;PIKFYVE
prerank,positive regulation of TOR signaling (GO:0032008),0.3068606130778022,0.8529167871619258,0.6620305980528511,0.9536524542775235,1.0,12/40,20.59%,GAS6;SLC38A9;TELO2;LAMTOR2;RRAGD;GOLPH3;FNIP1;SEH1L;RICTOR;RHEB;GPR137B;MLST8
prerank,eye photoreceptor cell development (GO:0042462),0.3838810863628729,0.8526290819581668,0.641156462585034,0.9536828348178886,1.0,2/15,6.57%,TULP1;CRB2
prerank,protein-DNA complex disassembly (GO:0032986),0.37126524951005435,0.8526248168032372,0.65,0.9531599648291523,1.0,6/16,23.33%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,cellular response to starvation (GO:0009267),0.2592981500254707,0.8524918493354586,0.7448512585812357,0.9528875611070134,1.0,40/147,20.59%,PRKAG2;NPRL3;SFRP1;PRKAA2;NUAK1;LRRK2;SIK1;SREBF1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;WIPI1;PIK3R4;ITFG2;SESN2;NPRL2;FADS1;LAMP2;TBL2;FNIP1;MAP1LC3A;SEH1L;FOXO3;BECN1;PRKAG1;RHEB;CARTPT;WDR45;SZT2;GCGR;MLST8
prerank,cellular response to UV (GO:0034644),0.28192943876828974,0.8521457483549763,0.7047738693467337,0.9530222829686833,1.0,8/76,9.86%,MFAP4;MMP2;NEDD4;USP47;INO80;CUL4B;ZBTB1;STK11
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.28864106611317203,-0.8518549787910322,0.6828571428571428,0.9572801964795641,1.0,7/22,23.25%,B2M;CYRIB;CD55;FZD5;TRAF2;MAP3K7;MALT1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.30094171111679596,0.8517877275411474,0.6730506155950753,0.9531935611285074,1.0,15/51,18.90%,NRK;DTNBP1;NTF3;LRRK2;ALS2;MAP4K4;TAOK3;WASF1;GAS7;EPB41L3;TRIO;MYO16;BDNF;NYAP1;DICER1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.29878740268033926,0.8514031393637749,0.6564245810055865,0.9534018988902312,1.0,9/48,10.34%,POLR1G;ARID1B;ATAD2B;SPHK2;MYO1C;ZMIZ1;KAT2B;BAZ1B;PHF2
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3105566108658476,0.8512430350317264,0.6703755215577191,0.9531717095419757,1.0,16/38,26.31%,LEPROT;LMAN1;LRRK2;RNF31;SREBF1;PRKN;HUWE1;RHOU;HPS4;ARIH2;HAX1;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,positive regulation of organelle assembly (GO:1902117),0.30684120407423865,0.8510601928363083,0.6661786237188873,0.953019013214166,1.0,12/44,20.67%,ASAP1;DYNC1H1;SDC1;ARHGAP35;CROCC;RAB3GAP1;SDC4;PIP4K2C;HTT;NUMA1;FSCN1;CEP120
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.21570571773911026,-0.8510371913825034,0.8423645320197044,0.9579624839342463,1.0,30/85,25.42%,RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;ECSCR;TAF1;GSK3A;HSPBP1;TMTC3;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DAB2IP;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;TREM2;DDA1;FMR1
prerank,DNA repair (GO:0006281),0.2491161848935634,0.8509639249670302,0.8119747899159664,0.9526827991335621,1.0,94/284,26.37%,EYA1;PDS5B;OGG1;PSME4;HPF1;LIG4;USP47;NEIL1;INO80;RAD51B;GTF2H5;CUL4B;SPRTN;ERCC6L2;REXO4;UBE2U;DCLRE1C;POLL;RECQL5;KMT5B;UBE2V2;MLH1;COMMD1;ZBTB1;ASCC3;WDR33;EXO5;BAZ1B;ACTR8;TENT4A;TDP2;ERCC8;DCLRE1A;RAD18;FANCC;MBD4;UVRAG;MNAT1;RAD51D;FANCE;FANCI;HUWE1;XRCC2;PRIMPOL;KPNA2;TIMELESS;ATM;KAT5;ALKBH1;DDX1;XPA;ENDOV;RAD54L;KDM4A;SUMO1;RFC5;UIMC1;FTO;BRCC3;FAN1;USP3;UBE2T;EXD2;MUTYH;RMI2;NSMCE4A;ERCC3;EME2;APLF;FANCA;CENPX;LIG1;BRCA1;ERCC2;ATXN3;VCPIP1;SETX;POLI;TDG;MSH6;NABP2;RAD51AP2;MRE11;POLE2;MPG;XRCC4;ATRIP;ABL1;RAD23B;RAD50;RPAIN;BAP1;MMS19;UPF1
prerank,regulation of axon regeneration (GO:0048679),0.3855788151657666,0.8508322558784328,0.6447602131438721,0.9523942630707452,1.0,2/12,5.18%,EPHA4;PTPRS
prerank,negative regulation of B cell activation (GO:0050869),0.3451648034984728,0.8498340858778075,0.6666666666666666,0.9537619018271967,1.0,2/21,5.05%,LYN;SFRP1
prerank,response to steroid hormone (GO:0048545),0.3285840116832107,0.8497691416876684,0.6598240469208211,0.9533465199387722,1.0,4/31,5.43%,AR;ATP1A2;YAP1;TFPI
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.27009561097616896,0.8492776569605295,0.7260765550239234,0.9537557962465018,1.0,26/94,23.16%,DYNLL1;NINL;CEP152;DYNC1H1;NPHP1;B9D1;ALMS1;FBF1;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;TMEM67;AHI1;ODF2;PRKACA;CEP250;KIF24;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.39892068340122044,0.8481597320232019,0.6519434628975265,0.9553193155564831,1.0,5/12,13.35%,THRB;CTSH;BRD8;KLF9;CTSL
prerank,lymphocyte migration (GO:0072676),-0.26721971292871827,-0.8475776252742234,0.684971098265896,0.964188415642592,1.0,5/32,10.46%,S1PR1;CCL14;RET;CKLF;MSN
prerank,carbohydrate transport (GO:0008643),-0.35776187826912315,-0.8472134447044846,0.6932084309133489,0.9638104987636582,1.0,2/11,10.71%,SLC26A6;AQP11
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2989782031796743,-0.8470709914814726,0.6728723404255319,0.9630310044016084,1.0,6/18,24.52%,NUP93;HHEX;DDX19B;MCM3AP;DDX25;POLDIP3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3514494850540456,-0.8470044058868618,0.6188235294117647,0.9620583416948474,1.0,2/11,11.53%,MSH3;ZRANB3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2768168503513829,-0.8469936312117579,0.7110481586402266,0.9609943715038705,1.0,13/27,25.99%,KDM1A;PTTG1IP;SMYD2;SIRT1;KMT5A;SPRED2;CD44;DDX5;MSX1;SNAI2;TWIST1;MIF;SNAI1
prerank,mitochondrial translational elongation (GO:0070125),-0.21379295110298077,-0.8467132448871031,0.7906976744186046,0.9604756221960564,1.0,32/88,32.17%,GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,regulation of ATP metabolic process (GO:1903578),0.2933390881719081,0.8465555074923982,0.6975476839237057,0.9577470653542549,1.0,15/54,20.10%,OGT;PRKAG2;NUP107;COX7A2;NUP42;SPHK2;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,negative regulation of leukocyte migration (GO:0002686),-0.35722746705583563,-0.8463043754734023,0.6635730858468677,0.960285122999891,1.0,1/10,0.43%,SLIT2
prerank,phospholipid dephosphorylation (GO:0046839),0.31455028851290967,0.8457565459922833,0.6652421652421653,0.9586780144044585,1.0,6/37,10.53%,PLPP3;EPHX2;SYNJ2;MTMR3;MTMR7;PLPP5
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3948174044178337,0.8455651764650712,0.6376306620209059,0.9585325664969583,1.0,4/11,20.22%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3849097650871799,0.8454507057012709,0.6560283687943262,0.9582274936018749,1.0,3/12,15.19%,AXIN2;HDAC8;WAPL
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3297511529377758,-0.8454110706817651,0.6425233644859814,0.9612341598307069,1.0,11/14,35.65%,PRKCZ;CD80;NFKBIZ;CD86;ANXA1;MALT1;RARA;NFKBID;NLRP3;SOCS5;MYB
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3619603787349287,-0.8447581248304049,0.6520787746170679,0.9615250870449159,1.0,6/10,38.16%,CRY1;WDR76;CCAR2;RPA2;THOC5;RFWD3
prerank,negative regulation of leukocyte activation (GO:0002695),0.38008026353410235,0.8447326088783724,0.6655791190864601,0.9590832273535496,1.0,3/15,14.80%,IL31RA;CD200;NR1H3
prerank,calcium import into the mitochondrion (GO:0036444),0.4106210421089211,0.8447020977564287,0.6282051282051282,0.958601777047212,1.0,2/10,9.92%,MCU;MICU2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2797328096823787,0.8446879025586156,0.7279411764705882,0.9575677476750745,1.0,11/78,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2797328096823787,0.8446879025586156,0.7279411764705882,0.9575677476750745,1.0,11/78,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.32264433481117544,0.8445367457099537,0.687211093990755,0.9573249915498931,1.0,5/29,11.49%,RUNX1;YAP1;STRN3;FOXA1;UFL1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.3472307879965467,-0.8441949965805645,0.6941176470588235,0.9615779873054255,1.0,3/12,20.57%,SKAP1;CD44;AGER
prerank,mitochondrial transport (GO:0006839),0.2978535439188152,0.8431386629181686,0.7054973821989529,0.9594551556472866,1.0,8/53,10.90%,BCL2;SLC25A24;TIMM17B;COX18;BCAP31;TIMM44;TIMM9;TSPO
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2624785804630269,-0.8427290599882945,0.7220447284345048,0.9635440128720328,1.0,10/33,17.76%,HOXA5;MED1;TAL1;FES;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,membrane raft organization (GO:0031579),0.36380090011915145,0.8426834000582485,0.6566666666666666,0.959763413872706,1.0,6/15,19.68%,RFTN1;MYADM;CLN3;NPC1;YJEFN3;ABCA7
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3474123011054157,-0.8423105616557394,0.6745843230403801,0.9632856556174958,1.0,4/11,12.87%,YBX3;ARHGEF2;CASP8;SLC25A4
prerank,cellular response to type I interferon (GO:0071357),0.30955210997858057,0.8418912379921593,0.6742532005689901,0.9601797508443799,1.0,11/41,21.73%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,type I interferon signaling pathway (GO:0060337),0.30955210997858057,0.8418912379921593,0.6742532005689901,0.9601797508443799,1.0,11/41,21.73%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.40804452910147454,0.8418417074118211,0.6490566037735849,0.959739404069289,1.0,3/10,10.79%,KLF15;PRKAA2;SETD5
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3850282811703759,0.841499686384027,0.6564748201438849,0.9598774205934284,1.0,1/11,1.77%,LYN
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35447292195598723,-0.8410386918907408,0.6627634660421545,0.9637801699855271,1.0,4/10,32.08%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35447292195598723,-0.8410386918907408,0.6627634660421545,0.9637801699855271,1.0,4/10,32.08%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,regulation of DNA recombination (GO:0000018),-0.2576547350475442,-0.8410055496705279,0.7121212121212122,0.9627729382048326,1.0,14/32,35.96%,KDM1A;MSH3;ALYREF;ZRANB3;RAD51;SHLD2;MSH2;RAD51AP1;H1-0;FIGNL1;IL7R;RPA2;SIRT6;IL4
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.30853860200561833,-0.8408747174429028,0.6890547263681592,0.9619700549654507,1.0,8/17,30.72%,EMC3;EMC9;CAMLG;MMGT1;EMC4;SGTA;GET3;GET1
prerank,fatty acid biosynthetic process (GO:0006633),-0.2289383300373089,-0.8407717552538481,0.7709251101321586,0.9611179504663183,1.0,22/63,28.26%,ELOVL7;ABHD2;ELOVL5;GPX4;DEGS1;TECR;HSD17B8;TECRL;HACD2;PTGS2;ABCD3;ACACA;LIPH;SCD5;NDUFAB1;HACD3;CBR4;LIPC;LPL;XBP1;ELOVL2;ALOX5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3744886526747568,0.8407223070047556,0.6421052631578947,0.9608401340716092,1.0,4/13,14.80%,NUPR1;EIF2AK3;MANF;NR1H3
prerank,positive regulation of macrophage activation (GO:0043032),-0.31485668016022084,-0.8406853794557693,0.6624685138539043,0.9602243781276348,1.0,3/17,5.63%,THBS1;IL33;LBP
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.3621519278101893,-0.8400821811972181,0.6954545454545454,0.9604254747450786,1.0,2/10,3.35%,LRCH1;APOD
prerank,cell proliferation in forebrain (GO:0021846),0.4000144761304948,0.8398609453179178,0.657608695652174,0.9619448481245937,1.0,3/10,20.67%,NUMBL;AKNA;CEP120
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.27900880390698546,-0.8387766342064042,0.7291666666666666,0.961942591544749,1.0,4/26,13.19%,CAV1;LBP;IFI35;PTPN22
prerank,myeloid cell differentiation (GO:0030099),-0.2463504687849342,-0.8386337831808613,0.7491039426523297,0.9611775013237281,1.0,16/47,20.20%,ZBTB16;RPS14;RPS19;HIPK2;PTPN2;TAL1;JAK2;UBA5;INHA;PRKX;KAT6A;JAK3;INHBA;ZFPM1;ALAS2;HCLS1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.20902373435820354,-0.8384522807857497,0.8473684210526315,0.9604713121739429,1.0,38/94,31.88%,NOD1;RPS6KA5;CUL1;RBX1;ST18;NFKBIA;RPS6KA4;PSMF1;PSMB8;MAPK3;PSMA4;NOD2;PSMB10;PSMB2;MAP3K3;TAB1;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;UBE2V1;CHUK;PELI1;MAP3K7;PSMA8;PSMB1;EGR1;TRAF6;PSMD10;IL1A;IL1R2;SQSTM1;UBC;RPS27A;IKBKG;IL1R1;PSMC3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3802743777568644,0.837192806994457,0.6777003484320557,0.9663146338351764,1.0,3/12,8.22%,GMDS;SLC35A3;GFPT1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.37794588686501696,0.8370252909282084,0.6490299823633157,0.966082866322584,1.0,5/12,23.03%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,neural tube closure (GO:0001843),0.3158082084714304,0.836998053095725,0.6913229018492176,0.9656001622955035,1.0,7/34,14.30%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,regulation of viral release from host cell (GO:1902186),-0.2917610424579498,-0.8368642106961234,0.7116402116402116,0.9624587966241779,1.0,10/21,29.21%,TRIM25;VPS37B;TRIM11;TRIM62;VPS4A;CHMP2B;TRIM28;TRIM13;MID2;TRIM35
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.361293576544944,0.8361792107918585,0.6905158069883528,0.9665887586358457,1.0,5/16,17.56%,TERF2;TNKS2;RTEL1;ATM;NAF1
prerank,intracellular sterol transport (GO:0032366),0.3790313035255006,0.8361668945686357,0.6615646258503401,0.9660835463632527,1.0,2/13,5.21%,ABCA1;STAR
prerank,protein dephosphorylation (GO:0006470),0.2579645568826419,0.8360768546632891,0.7581018518518519,0.965741449351262,1.0,26/135,17.53%,PPM1H;EYA2;PPM1E;PTPN13;EYA1;PPP3CA;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;RPAP2;STK11;CTDSP2;PTPRM;PPP2R5D;BTRC;PTPN3;PTEN;SDHAF2;PTPRA;TNS2;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,positive regulation of ERAD pathway (GO:1904294),0.3898145590339169,0.8355021290959128,0.6407599309153713,0.9662431443212955,1.0,5/13,12.77%,NFE2L2;RNF185;BCAP31;TMEM259;RNFT1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.33395628937482297,-0.8350878434482149,0.6946564885496184,0.9650902048368802,1.0,6/13,28.47%,SORL1;CD81;BRSK2;TMEM30A;GCC2;TMEM30B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.34962458890082615,0.8349546092351295,0.6537842190016103,0.9667481698733204,1.0,7/20,24.47%,ZC3H7B;PRKRA;TSNAX;DICER1;AGO4;DROSHA;AGO3
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.294804813360066,0.8344117647290263,0.718421052631579,0.9672133156613107,1.0,5/53,6.55%,XCR1;HTR1A;LHCGR;ADRB3;MTNR1A
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3192661795924261,-0.8340858077071777,0.6848341232227488,0.9660214837485288,1.0,2/14,4.35%,THBS1;CMKLR1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24923813532762473,0.8331513471096667,0.7802441731409545,0.9690580930380419,1.0,49/184,23.33%,HECW2;DYNLL1;NINL;CEP152;APPL2;PSME4;DYNC1H1;ZFP36L1;INO80;ZW10;ALMS1;NPM2;SIRT2;ANAPC5;NEK6;RGCC;YWHAE;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192;UBE2D1;PSMB5;PSMC2;KLHL18;PSMD1;ODF2;PRKACA;APPL1;PSMD4;PSME3;CDC23;ZFP36L2;PSMA3;CEP250;AURKA;ERCC3;NDE1;ANAPC4;HAUS5;HAUS6;TUBG1;PSMA2;ERCC2;SFI1;PSMC5
prerank,cellular response to nutrient levels (GO:0031669),-0.22732558886836238,-0.8320422392538904,0.8072289156626506,0.9690385916549046,1.0,20/62,22.27%,HSPA8;MFSD2A;ULK1;CLEC16A;WDR45B;SIRT1;RALB;MTOR;FAM107A;ATG14;GAS2L1;INHBB;FOXO1;WIPI2;BMPR2;FLCN;VPS41;ATG7;NUPR2;ZFYVE1
prerank,mitochondrial gene expression (GO:0140053),-0.24739201010525366,-0.831760808033421,0.7609427609427609,0.9685594790559007,1.0,12/42,20.17%,TFB2M;NOA1;GFM2;SLC25A33;MRPS18A;MRPS12;NDUFA7;FASTKD2;MRPL57;MRPS18B;MRPS21;MRPS7
prerank,atrial septum morphogenesis (GO:0060413),0.3959173584093054,0.8315476599927819,0.6415770609318996,0.9714674383782761,1.0,2/10,4.67%,NOTCH2;ACVR1
prerank,sodium ion import across plasma membrane (GO:0098719),0.35586270971869505,0.8314307652918504,0.6589403973509934,0.9711721871153919,1.0,4/17,9.41%,SLC8A1;SLC9A9;SLC9A5;TRPM4
prerank,positive regulation of catabolic process (GO:0009896),0.2808699391546315,0.8311902338777083,0.7152061855670103,0.9710662814065613,1.0,6/65,5.56%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP
prerank,protein modification by small protein removal (GO:0070646),0.24342569299358852,0.8309164840083151,0.8115015974440895,0.971049427371271,1.0,70/252,23.50%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;USPL1;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;GPS1;COPS3;USP32;USP10;USP9X;USP38;PTEN;SENP6;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;SENP7;COPS2;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3325266219654873,0.8305565051522327,0.6651162790697674,0.9711717203036014,1.0,7/23,18.90%,REXO4;DNASE1L1;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,nuclear pore complex assembly (GO:0051292),-0.3524788685734972,-0.8298925609350801,0.6808988764044944,0.9713505616625621,1.0,2/10,4.51%,NUP93;NUP153
prerank,establishment of protein localization to membrane (GO:0090150),0.27991036502256395,0.8293773156213825,0.7473958333333334,0.9727991819753817,1.0,17/66,18.03%,RFTN1;GORASP2;YIF1B;COX18;AFDN;MYO1C;EGFR;BRAF;VPS37D;GORASP1;RAB3GAP1;PARD3;PIKFYVE;NPC1;ZDHHC20;MICALL1;PRKCI
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2710089522516485,-0.8293150325850559,0.7361111111111112,0.9714161805804521,1.0,12/26,29.19%,EIF4E;MEIS2;TAL1;HES1;LGMN;USP22;APP;CUL3;RPS6KB1;DUSP3;TTL;USP2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.21390437061093948,-0.8292185644518706,0.8356807511737089,0.9705519606703047,1.0,27/86,24.26%,EGLN3;KLF2;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;ATF3;ATF4;VHL;DNAJB1;PSMA8;PSMB1;MAPK7
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33123076835865567,0.8292071578313678,0.6947852760736196,0.9725586075362929,1.0,10/25,23.91%,RECQL5;WDR43;CDK12;NELFE;TCERG1;CDC73;HNRNPU;LEO1;HEXIM1;CDK13
prerank,cardiac cell development (GO:0055006),0.3847265761693256,0.8289936808628251,0.6486486486486487,0.9724643619410093,1.0,1/11,1.14%,SLC8A1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2686973368841814,-0.8284132661476343,0.74,0.9711056255956453,1.0,8/28,19.60%,NOTCH3;BEND6;GATA2;LFNG;HEY1;DLL4;DLL1;EGFL7
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.35747831552109494,0.8282700449498671,0.6638513513513513,0.9732836056482652,1.0,3/16,7.37%,APOA1;LDLR;SREBF1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.33836886130925525,0.8272184500567868,0.6896,0.9746806366841491,1.0,4/20,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.36489250358560854,0.8270283816417653,0.675,0.9745011963809452,1.0,2/17,9.91%,SERPINE1;CREB3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.367377338196497,0.8267729419223591,0.6552315608919382,0.9744435008038486,1.0,5/13,23.03%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,protein K48-linked ubiquitination (GO:0070936),0.28532601354040066,0.8263953049769329,0.7302631578947368,0.9746051985739488,1.0,20/54,20.63%,RFFL;BFAR;PRKN;ITCH;IFI27;RNF6;RNF152;KBTBD7;UBE2E2;AMFR;FBXO38;UBE2D1;HACE1;UBR5;UBE2R2;UBE3A;RNF34;TRIM32;ARIH2;UBE2T
prerank,RNA export from nucleus (GO:0006405),-0.2059373028946939,-0.8260809483678415,0.8944444444444445,0.9748691104821233,1.0,28/100,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,regulation of histone deacetylation (GO:0031063),-0.32266152577199986,-0.825919014246512,0.7023809523809523,0.9741063158942374,1.0,4/13,14.46%,CAMK2D;CTBP1;APLNR;PRMT6
prerank,production of siRNA involved in RNA interference (GO:0030422),0.39865398692891957,0.8257893486245355,0.6613756613756614,0.975169433359942,1.0,4/10,22.16%,PRKRA;TSNAX;DICER1;DROSHA
prerank,response to amino acid (GO:0043200),-0.2636028529383807,-0.825562743006336,0.7380191693290735,0.9737552778763542,1.0,7/31,12.39%,SH3BP4;GLRA1;GLRA2;SPAAR;LARS1;IPO5;MTOR
prerank,positive regulation of cholesterol efflux (GO:0010875),0.33834260022460094,0.824971792213763,0.6762820512820513,0.976130608683182,1.0,3/21,4.30%,LRP1;APOE;APOA1
prerank,regulation of astrocyte differentiation (GO:0048710),0.38488853057534317,0.8245774997445616,0.6702317290552585,0.9763284486736367,1.0,3/12,11.76%,EPHA4;BMP2;F2
prerank,sterol transport (GO:0015918),-0.29950508505190065,-0.8245747660992271,0.7255936675461742,0.9746041329658109,1.0,6/19,18.10%,CAV1;NPC2;OSBPL2;ARV1;OSBP;MSR1
prerank,selective autophagy (GO:0061912),0.2859693151490276,0.8243304300517686,0.7269129287598944,0.9762320727427295,1.0,14/56,18.44%,DYNLL1;DYNC1H1;ULK2;WDR81;PRKN;UFL1;USP30;DYNC1I2;UFC1;AUP1;ATM;BECN1;ATG2B;PHB2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.31552961701301296,0.824232329066273,0.6833578792341679,0.9758693692041075,1.0,1/29,1.53%,ARRDC4
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.369482406497505,0.824040062358844,0.6763110307414105,0.9756840352825248,1.0,5/13,28.02%,ETS1;MDK;NFAT5;RELA;IL6
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2946883947842464,0.8239524673749901,0.7038081805359662,0.9753121629117024,1.0,13/41,20.10%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.3769639720109913,0.8235060644083871,0.6847133757961783,0.9755903674705177,1.0,5/14,15.34%,ZEB1;OSR1;SPRY2;SPRED3;SPRED1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2891260324827872,-0.8233059276137842,0.7241379310344828,0.976087773716101,1.0,7/21,19.78%,ADAM10;SPPL3;BACE2;ADAM19;RBMX;ADAM9;APH1A
prerank,protein targeting to membrane (GO:0006612),-0.21574002285542324,-0.8228111985823096,0.8489583333333334,0.975971415721893,1.0,34/83,31.63%,ZDHHC2;SDCBP;RAB8B;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;PEX26;VPS37A;ARL6IP1;ATG3;ABCD3;ARL6;SGTB;PEX12;FIS1;VPS37C;ZDHHC18;CHMP4B;CHMP4A;PEX16;SGTA;PEX5;PXMP4;ZDHHC24;NACAD;SRPRA;GET3;ZDHHC22;SEC63;NCF1;ZDHHC6;ZDHHC12
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.37605440878816426,0.8225557917058853,0.6533333333333333,0.9768589424893658,1.0,4/11,24.24%,NOS1AP;ALG10B;LRRC38;LRRC55
prerank,amide biosynthetic process (GO:0043604),0.294878709226926,0.8224069640223137,0.7323943661971831,0.9765985719694864,1.0,6/47,9.70%,PAM;SMPD2;ALOXE3;CERS6;CERS5;NMRAL1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.28392447707679075,0.8223850860053018,0.7317397078353254,0.9761155349454301,1.0,5/59,7.23%,CYP7B1;SLC27A5;ALDH1A2;HOGA1;CYP27A1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.24837400676748164,-0.8220576575333601,0.8082191780821918,0.9763378482586181,1.0,7/37,11.49%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3266956671626976,0.8219747076443155,0.697289156626506,0.976392160372501,1.0,3/25,7.76%,SMAD3;NOS1AP;TLR6
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2796370023287275,0.8219526154046496,0.7197368421052631,0.9758955629543716,1.0,10/55,11.08%,BCL2;TGFBR1;NUPR1;PML;ING5;TRAF7;BCL2L11;BCAP31;LTBR;GSDME
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.33732490537223203,0.821911501100266,0.6925566343042071,0.9754425993677383,1.0,10/22,27.45%,ERI3;FTSJ3;ERI1;EXOSC7;EXOSC2;NOP14;ERI2;EXOSC8;EXOSC9;KRI1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2725392753751407,0.821744410372927,0.7706535141800247,0.9752414897209137,1.0,11/79,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,substantia nigra development (GO:0021762),0.30001137517969423,0.821721162310884,0.710334788937409,0.9747615718284351,1.0,10/37,14.90%,DYNLL1;CDC42;SIRT2;CKB;TTBK1;YWHAE;SYNGR3;ZNF148;MAOB;SUDS3
prerank,clathrin coat assembly (GO:0048268),-0.3105855993178507,-0.8215246670257431,0.7331670822942643,0.9763719014821405,1.0,2/15,6.50%,SGIP1;HIP1R
prerank,endoderm formation (GO:0001706),0.3049932766607801,0.8214695637227551,0.7035971223021583,0.9747168221785611,1.0,4/35,5.48%,COL11A1;MMP2;VTN;ITGB5
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2451620776992922,-0.8209235270011861,0.7653061224489796,0.976501120068284,1.0,14/40,26.22%,CRY1;POLH;SMYD2;MCL1;WDR76;KMT5A;PARG;HMGA2;WRNIP1;UBE2V1;IER3;NSMCE1;FMR1;USP1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.31592308992135776,-0.8207552841028992,0.7035175879396985,0.9757685488728692,1.0,1/15,0.27%,PRKCH
prerank,protein export from nucleus (GO:0006611),0.32065542569686145,0.8207431933550521,0.6903323262839879,0.9755246263796836,1.0,8/27,20.52%,RANBP17;NUP42;XPO7;CSE1L;STRADA;NUP214;TPR;CCHCR1
prerank,regulation of catecholamine secretion (GO:0050433),0.3198290123345988,0.8206734432522896,0.6923076923076923,0.9751323843603296,1.0,8/29,20.07%,DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12;SYT13;CHRNB2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3294270450817179,0.8205032492155657,0.6965944272445821,0.974917298378067,1.0,3/26,6.93%,ACTN2;NEDD4;ATP1B2
prerank,response to leucine (GO:0043201),0.39002569001750415,0.8203667754103802,0.6775956284153005,0.9741048506163976,1.0,3/10,15.23%,UBR2;RRAGD;SESN2
prerank,cellular response to leucine (GO:0071233),0.39002569001750415,0.8203667754103802,0.6775956284153005,0.9741048506163976,1.0,3/10,15.23%,UBR2;RRAGD;SESN2
prerank,erythrocyte differentiation (GO:0030218),0.2970501960451717,0.8202151459734975,0.7157001414427157,0.9738662294419703,1.0,4/44,4.30%,TGFBR3;LYN;KIT;CDK5RAP3
prerank,cation transmembrane transport (GO:0098655),0.30001617933217156,0.8198934679756472,0.7287671232876712,0.9739328246286403,1.0,4/44,5.38%,SLC7A2;ATP1A2;SLC6A9;SFXN2
prerank,positive regulation of cartilage development (GO:0061036),-0.3113343184724814,-0.8197478887705427,0.7233502538071066,0.9766277822610127,1.0,3/17,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,negative regulation of neuron death (GO:1901215),0.26569026809709956,0.8196864792631322,0.7551766138855055,0.9738008505073668,1.0,14/93,11.94%,GDNF;BCL2;APOE;INPP5A;CSF1;MT3;NTF3;LIG4;LRRK2;SLC30A10;CD200;PRKN;CLN3;REST
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23300032996235343,-0.8195781937459355,0.7545126353790613,0.9759019350865213,1.0,12/48,16.61%,FNIP2;HIPK2;SNW1;CRIP1;DDIT4;SIRT1;BCL2L1;MCL1;BAK1;DYRK2;PRKDC;EP300
prerank,placenta development (GO:0001890),-0.33356991871543973,-0.819540609912559,0.7113163972286374,0.9749226794752481,1.0,6/12,30.93%,ADAM19;E2F7;PLAC1;SOD1;E2F8;PTK2
prerank,non-motile cilium assembly (GO:1905515),-0.2624538363742742,-0.819260538235986,0.7545454545454545,0.9743486469024435,1.0,9/30,26.41%,DISC1;TMEM216;DCTN1;FUZ;CCDC13;CSNK1D;VANGL2;GORAB;BBS10
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.3996409718085576,0.8191978462159913,0.658493870402802,0.9741465672744948,1.0,5/10,25.74%,TLR6;MIA3;AKT1;MYD88;TICAM1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.3170325764583647,-0.8190893826973006,0.6953316953316954,0.9736234071188707,1.0,6/15,24.39%,CEP83;STIL;SPAG5;CEP131;CSNK1D;CCDC14
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3393050128853685,0.8190150618483621,0.6754658385093167,0.9739561094638888,1.0,4/22,6.60%,SP100;RAB23;LMAN1;LRRK2
prerank,chromatin organization (GO:0006325),0.2540192994794001,0.8188743134032612,0.790080738177624,0.9737209128445711,1.0,24/132,14.20%,SETD7;BRWD1;NPM3;CBX3;INO80;SMARCA1;NPM2;DR1;SMARCC2;MTA2;TCF7L1;KDM5B;KAT2B;ZBTB1;FOXA1;BAZ1B;PHF1;KDM5C;SETD5;L3MBTL1;HDAC8;SMARCD2;HDAC4;SETDB1
prerank,negative regulation of DNA replication (GO:0008156),0.3711925408132817,0.8188682853704328,0.680064308681672,0.9732132100490843,1.0,3/13,15.19%,TSPYL2;S100A11;WAPL
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.20502626162667606,-0.8187779054917678,0.8615384615384616,0.9731643886424518,1.0,31/87,29.24%,SDHAF3;NDUFC1;COX17;SLC25A33;NDUFAF2;NDUFA6;DMAC2;NDUFA5;SURF1;TMEM126B;NDUFA7;NDUFA8;COA3;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;UQCRFS1;SDHAF1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3;COA5
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3258681549243002,0.8184089423710277,0.6626323751891074,0.9735406526584575,1.0,10/24,23.52%,LRRK2;PRKN;CREB3;SELENOS;NR1H3;TMBIM6;CREB3L1;OPA1;WFS1;TXNDC12
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24448735809090888,-0.8180762530906838,0.7620689655172413,0.9734365280971472,1.0,10/40,16.03%,SMURF1;PTK2B;HIPK2;RPS7;RPL11;TAF1;FOXF2;RPL5;RAD23A;GNA12
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.37717758634194337,0.8178281824385117,0.689908256880734,0.9740699331464767,1.0,3/11,16.19%,IL12B;CARD9;IL23A
prerank,phosphate ion transport (GO:0006817),-0.3060145726746731,-0.8171104622711373,0.7173396674584323,0.9741859530962144,1.0,4/16,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.33634484673641646,0.8166152167148184,0.710077519379845,0.975697118671361,1.0,9/22,19.92%,RAPGEF2;NTF3;ACAP2;NTRK3;RAPGEF1;WASF1;AKT1;BDNF;EHD1
prerank,glycine transport (GO:0015816),0.4007547579185721,0.816463325522281,0.6910112359550562,0.975449740172146,1.0,3/10,18.99%,SLC6A9;SLC6A5;SLC25A38
prerank,arachidonic acid secretion (GO:0050482),0.39296071795302495,0.8163371856244421,0.676320272572402,0.9746461255473956,1.0,2/10,8.20%,BDKRB2;DRD3
prerank,arachidonate transport (GO:1903963),0.39296071795302495,0.8163371856244421,0.676320272572402,0.9746461255473956,1.0,2/10,8.20%,BDKRB2;DRD3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.27010304732008916,-0.8158388618063894,0.7492957746478873,0.9755597748342936,1.0,8/25,17.76%,MED1;TAL1;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.34082016661978976,-0.8157200342674885,0.6757425742574258,0.9747377864361267,1.0,2/11,8.30%,PLA2G7;ABCG1
prerank,B cell mediated immunity (GO:0019724),-0.347819685431308,-0.8153187187850823,0.7089715536105032,0.9744973096157412,1.0,5/10,32.15%,FCER1G;CD27;MSH2;FCGR2B;TLR8
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3722593211193482,0.8152565629744616,0.6763698630136986,0.9760856837527285,1.0,4/13,16.72%,GLI2;VNN1;BMP4;SHH
prerank,stress-activated MAPK cascade (GO:0051403),-0.22441530326428266,-0.8149536057044934,0.8266129032258065,0.9741269144414233,1.0,26/61,30.87%,NOD1;TNFRSF19;CUL1;MAPK10;MAPK8;MAPK3;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MAP2K3;CHUK;MAPK1;MINK1;MAP3K7;MAPK11;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,protein targeting (GO:0006605),-0.1962735607297631,-0.8147285746213505,0.9290322580645162,0.9735019357828918,1.0,46/118,29.93%,NLGN1;RASSF9;ZDHHC2;SDCBP;TOMM70;SORL1;AP4E1;RPL11;AKAP6;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;VPS37A;ATG3;CDC37;GIPC1;ARL6;TOMM7;TRAK2;HOMER3;CACNG3;ZFAND2B;TOMM40;SPCS1;PEX12;FBXO7;FIS1;TIMM10;VPS37C;HAP1;GABARAP;ZDHHC18;PEX16;EDEM1;AIP;HACL1;ZDHHC24;NACAD;SRPRA;TIMM17A;TIMM22;SEC61G;ZDHHC22;SEC63
prerank,regulation of protein catabolic process (GO:0042176),0.26047122046725935,0.8142713371737431,0.7699642431466031,0.9773464181676668,1.0,24/99,19.72%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP;SIRT2;IRAK3;EGFR;SNX12;WDR91;PRKN;ITCH;BANP;FLNA;PLK2;HACE1;HUWE1;AGAP2;OAZ3;TRIM32;CDKN1B;MDM4;IDE
prerank,serine family amino acid catabolic process (GO:0009071),-0.3397427799394068,-0.813512484375892,0.7051546391752578,0.9747566886659468,1.0,6/10,38.33%,GCSH;SHMT1;AMT;GLDC;DAO;THNSL2
prerank,mitotic cell cycle phase transition (GO:0044772),0.24647969584228235,0.8131022922163175,0.8153503893214683,0.9788950381525474,1.0,52/203,23.16%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;ACVR1;DYNC1H1;CUL4B;ALMS1;CUL5;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;ACVR1B;HAUS7;HAUS3;CEP164;PLK2;PHF8;CEP192;CDKN2C;CDC7;ODF2;PRKACA;CDKN1B;CACUL1;TAF2;CDC23;PLCB1;GSPT1;USP37;CCND2;CEP250;AURKA;NES;NDE1;EPS8;CCNG2;HAUS5;HAUS6;TUBG1;CDK7;FBXW11;SFI1
prerank,protein-containing complex subunit organization (GO:0043933),0.2553978475008988,0.8128498312035969,0.7698795180722892,0.978819008255347,1.0,20/109,15.12%,TEAD1;MITF;LAMC1;YAP1;PML;CD247;ZW10;RANBP9;PARD6B;PICALM;TSPAN4;NUP98;FANCC;MNAT1;WASF1;KMT2A;LLGL1;DLG4;SNX9;PARD3
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.27063802008387045,-0.8126733858757235,0.7391304347826086,0.975296273933152,1.0,9/24,27.98%,TOMM70;AIM2;CGAS;PTPN22;TRIM6;EIF2AK4;TRIM44;LILRB1;TRAF3IP2
prerank,neurogenesis (GO:0022008),0.29589217210850793,0.8125590588029347,0.7195994277539342,0.9788043938436195,1.0,8/43,10.17%,DAGLA;ASCL1;NEUROD1;THOC2;DCHS1;LPAR1;METTL14;RYK
prerank,regulation of mononuclear cell migration (GO:0071675),0.32848747695254943,0.812288105016512,0.7050473186119873,0.9787849553006656,1.0,3/23,4.18%,LYN;IL34;CSF1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3818579606598343,0.8121748261492696,0.674074074074074,0.9784779999669577,1.0,3/11,11.94%,NONO;PRKN;REST
prerank,negative regulation of defense response to virus (GO:0050687),0.3788898937428613,0.812129753558921,0.7063063063063063,0.9780467471335127,1.0,2/10,13.02%,ITCH;MUL1
prerank,mammary gland epithelium development (GO:0061180),-0.3194976359823346,-0.812097464439164,0.6989795918367347,0.9753380577050864,1.0,4/14,10.09%,ERBB4;JAK2;ID2;SCRIB
prerank,translational termination (GO:0006415),-0.2049279686970916,-0.8115624215560566,0.8648648648648649,0.975309174604207,1.0,24/95,21.01%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15
prerank,regulation of ERAD pathway (GO:1904292),0.3844544314678228,0.811517720172281,0.6880570409982175,0.9786145546410875,1.0,5/11,23.18%,RNF185;TMEM259;RNFT1;BAG6;ATXN3
prerank,nucleoside catabolic process (GO:0009164),-0.33552756369543096,-0.81126412223239,0.7214285714285714,0.9748003131316669,1.0,4/11,17.65%,NT5E;NT5C1A;UPB1;NT5C
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2745513750043818,0.8099653464745262,0.7526041666666666,0.9809165855758992,1.0,26/69,27.22%,FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;ECPAS;FOXRED2;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;JKAMP;BAG6;WFS1;HSPA5;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.31592386003014455,0.8099611290969067,0.7020280811232449,0.9804026704915134,1.0,1/26,0.43%,FBN1
prerank,cellular response to osmotic stress (GO:0071470),-0.28105551467682766,-0.8097430478713709,0.75,0.9765586464618884,1.0,6/21,13.90%,LRRC8D;YBX3;ARHGEF2;SCN2A;RCSD1;TRPV4
prerank,protein localization to Golgi apparatus (GO:0034067),0.3201003084135624,0.8097100056380837,0.7327327327327328,0.9803336691628199,1.0,8/27,17.91%,OBSL1;OPTN;ARL1;ARL5A;GOLPH3;VPS13D;VPS13C;TMED10
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3457271470362521,-0.8095992173519911,0.7223529411764706,0.97578261201335,1.0,4/10,17.65%,NT5E;NT5C1A;UPB1;NT5C
prerank,female gamete generation (GO:0007292),0.3121874826567795,0.808680050756219,0.7054380664652568,0.9816721503213414,1.0,11/29,24.42%,DMC1;DIAPH2;PARN;BMP15;USP9X;MDK;METTL3;GDF9;TOB2;SPO11;NANOS3
prerank,monocyte chemotaxis (GO:0002548),0.31223358097888887,0.808573718317307,0.7078825347758887,0.9813364250294453,1.0,3/32,6.11%,IL6R;CCL19;CCL4
prerank,megakaryocyte differentiation (GO:0030219),-0.3338088435732621,-0.8080570397812249,0.7293577981651376,0.9774700252885754,1.0,4/11,17.09%,MED1;TAL1;UBA5;ZFPM1
prerank,axon development (GO:0061564),0.2636563497470474,0.8075971117633122,0.7753530166880617,0.9825241817966606,1.0,16/78,15.12%,NREP;FGFR2;VASH2;SEMA5A;MTR;BRSK1;ARHGAP35;PARD6B;EPHB2;RYK;EPHB3;SLITRK2;NTNG2;MARK2;LLGL1;PARD3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.36994616626177224,0.8075128547950914,0.690846286701209,0.9821653604947709,1.0,4/13,20.22%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,protein autoprocessing (GO:0016540),0.3528441258525019,0.8074480416590721,0.6834415584415584,0.9817475754148361,1.0,4/17,20.01%,SPRTN;CTSL;CASP1;AFG3L2
prerank,mRNA transport (GO:0051028),-0.20021030732645032,-0.8072890248860548,0.8888888888888888,0.9778984548675479,1.0,28/101,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.37600525205095897,0.807177862308548,0.7067137809187279,0.9817128148802678,1.0,4/12,14.20%,RESF1;TET1;PPHLN1;SETDB1
prerank,regulation of neurogenesis (GO:0050767),0.2864311136804997,0.8070053567464494,0.7563587684069611,0.9814943766571287,1.0,7/55,6.12%,ASCL1;YAP1;NUMBL;APPL2;LIG4;SERPINF1;HES7
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.376627009281314,0.8069526870108106,0.6798561151079137,0.98107653791062,1.0,1/11,1.86%,BCL2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.33466277298791325,0.806880327598209,0.6927899686520376,0.9806778114056027,1.0,6/19,20.15%,SRC;HNRNPA1;TERF2;TENT4B;HNRNPC;HNRNPU
prerank,positive regulation of interferon-beta production (GO:0032728),0.302868319341283,0.8068304952575482,0.7112375533428165,0.9802507112693675,1.0,9/33,18.23%,IRF1;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3229357077519955,0.8066311669911996,0.6857142857142857,0.9800777349521853,1.0,2/23,4.70%,GAS6;AXL
prerank,receptor catabolic process (GO:0032801),-0.2721801501208838,-0.8060133329793833,0.7718309859154929,0.9792036229936694,1.0,7/24,15.09%,SMURF1;KIF16B;RNF43;TGFB1;LGMN;VLDLR;AP2A1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.31350460620575116,0.805013439878194,0.7309486780715396,0.9824632554868149,1.0,5/26,10.77%,SFRP1;STRN3;DAB2;NCOR1;NCOR2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.34222489550253476,0.804690011395392,0.7045075125208681,0.9824947929203547,1.0,2/18,3.47%,DACT1;APOE
prerank,long-term memory (GO:0007616),0.33461866931338674,0.8046297130404975,0.71900826446281,0.9820841305423446,1.0,3/19,6.70%,APOE;LDLR;CPEB3
prerank,cardiac atrium morphogenesis (GO:0003209),-0.30301702371256845,-0.8044072798085604,0.7587822014051522,0.9810705896064399,1.0,6/16,17.36%,NOTCH1;TGFB2;HEY2;ZFPM1;DLL4;BMPR2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2467845176257041,0.8040546573729158,0.8089244851258581,0.9825774454476611,1.0,20/151,11.50%,PAM;GAL3ST2;PLPP3;APOE;SLC44A1;LARGE1;APOA1;GSTM4;PLA2G4A;GSTM2;SPHK2;CERS6;CERS5;MGST1;GSTT1;NMRAL1;CHKB;CDO1;KDSR;ABHD3
prerank,regulation of cytokine production (GO:0001817),0.2473336896810437,0.8039803421993464,0.8197879858657244,0.9821900264769253,1.0,24/126,16.56%,LYN;LGR4;PLA2R1;TWSG1;IGF2BP2;BCL6;IL12B;BATF;CD28;DTX4;MAST2;CCN4;NFAM1;CARD9;ADRA2A;RGCC;TBK1;SYT11;GLMN;ERMAP;ASB1;MAPKAPK2;CD47;PLD4
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3008303825663765,-0.803474772476858,0.727735368956743,0.9816708650218602,1.0,6/15,23.54%,KDR;CDH13;VEGFA;VEGFC;VEGFD;F3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2500126908439271,0.8034583874203445,0.8068181818181818,0.9825951117650057,1.0,19/140,13.99%,ADRA1B;SLC8A1;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;P2RX5;C1QTNF1;CXCR6;CXCL13;DLG4
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.38214960809220255,0.8033353841838635,0.6917562724014337,0.9822988862537305,1.0,3/10,6.63%,CHADL;CST3;EMILIN1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.33466355833901695,0.8032228670953422,0.7030995106035889,0.9819939492526867,1.0,3/20,9.62%,BCL2;MOAP1;ITGAV
prerank,pharyngeal system development (GO:0060037),0.3502819762721294,0.8029255019553382,0.7142857142857143,0.9819879571086789,1.0,2/15,3.57%,BMPR1A;TGFBR1
prerank,stem cell development (GO:0048864),-0.2986842503159547,-0.8026812057338987,0.7111111111111111,0.9821064136070082,1.0,6/16,29.10%,CDH2;PTPRC;SOX8;SNAI2;NOLC1;WNT7A
prerank,negative regulation of cation channel activity (GO:2001258),0.31953570698465494,0.8022787121956225,0.7255813953488373,0.9826223813528266,1.0,4/26,8.62%,SLC6A9;GSTM2;DRD3;EPHB2
prerank,regulation of programmed cell death (GO:0043067),0.24179055982971898,0.8018188042943325,0.8227990970654627,0.9829143799803275,1.0,13/161,9.32%,DAPK2;STEAP3;ACTN2;DAPK1;MOAP1;NTF3;RARG;BCL6;NDRG1;LRRK2;BCL2L11;ACTN4;PRKN
prerank,regulation of cellular protein localization (GO:1903827),0.28511502241142034,0.8018136309401009,0.744475138121547,0.9824069271886,1.0,2/45,5.19%,GPC6;PRKAA2
prerank,mitochondrial transcription (GO:0006390),0.38333551142766836,0.8017927649791677,0.6964285714285714,0.9819238235953329,1.0,4/10,17.93%,TFAM;POLRMT;TEFM;FOXO3
prerank,response to lipid (GO:0033993),0.2539585461685717,0.8015045791614812,0.7797408716136631,0.9819247611510118,1.0,16/105,15.91%,RBP4;WNT8B;FGFR4;ASCL1;RARG;CTSH;STRN3;IRAK3;STAT5B;FOXA1;LIAS;GPX3;PAQR7;GATA6;RXRA;MAPKAPK2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.31768381464104106,0.8008574957688771,0.7356495468277946,0.9825686666875374,1.0,3/26,7.76%,SMAD3;NOS1AP;TLR6
prerank,negative regulation of MAP kinase activity (GO:0043407),0.28754883975380324,0.8006256597584416,0.7602256699576869,0.9824635705751794,1.0,8/44,14.89%,LYN;APOE;CDK5RAP3;IRAK3;SPRY2;DUSP19;PDCD4;BMP4
prerank,positive regulation of cell division (GO:0051781),0.29757028051585993,0.8004975561234909,0.7457142857142857,0.9821832196585156,1.0,5/38,8.20%,SVIL;FGFR2;CDC42;SIRT2;DRD3
prerank,endodermal cell fate commitment (GO:0001711),-0.34450352985827815,-0.8003122574043501,0.7331838565022422,0.9853292401224679,1.0,2/10,9.50%,SOX17;RTF1
prerank,cellular response to dsRNA (GO:0071359),-0.3018549525642868,-0.8002163157135503,0.7279596977329975,0.9844899788528317,1.0,6/15,19.40%,CAV1;IFIH1;CGAS;RALB;NPM1;DHX9
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3324691887618295,-0.8001210997820016,0.7023255813953488,0.9836248148995341,1.0,8/11,38.65%,IP6K1;IPMK;PPIP5K1;ITPKB;ITPKC;IPPK;IP6K3;PPIP5K2
prerank,endosome organization (GO:0007032),-0.23433610621523854,-0.8000679770604565,0.839041095890411,0.9827061895202337,1.0,9/41,16.17%,RAB27A;CLCN3;DNAJC13;ALS2CL;WASHC5;EXOC8;CORO1C;AKTIP;DNM1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.33597691666791585,0.8000157819860697,0.7045454545454546,0.9825039461244013,1.0,4/18,16.23%,ADAMTS9;NGLY1;BPGM;NEU4
prerank,protein sumoylation (GO:0016925),-0.23274158429501196,-0.8000064394314162,0.8152173913043478,0.98176801847715,1.0,13/49,17.88%,IFIH1;NUP93;NUP35;NUP153;NUP160;SAE1;NUP54;BCL11A;RANGAP1;NUP155;STX1A;RANBP2;NUP88
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.38870032194193727,0.7998443417518143,0.6927272727272727,0.9822819083479287,1.0,2/10,7.38%,CDC42;SIRT2
prerank,regulation of chromatin binding (GO:0035561),-0.3392542139051622,-0.7996818533155751,0.7423167848699763,0.9812649628890349,1.0,3/10,24.44%,BTAF1;KDM4D;HMBOX1
prerank,atrioventricular valve development (GO:0003171),0.36033113076060613,0.7995631035194413,0.6845637583892618,0.9822568148953695,1.0,4/14,10.12%,BMPR1A;ACVR1;BMP2;SLIT3
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3739011846158127,0.7995471277021932,0.6878216123499142,0.9817726376009249,1.0,5/11,21.25%,RESF1;PPHLN1;SETDB1;TPR;DNMT1
prerank,RNA polyadenylation (GO:0043631),0.31623799485646703,0.7993502200525254,0.7136150234741784,0.9811059314322663,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.31623799485646703,0.7993502200525254,0.7136150234741784,0.9811059314322663,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.23848044866105983,0.7992074537512832,0.8536853685368537,0.9808257263848016,1.0,19/198,9.79%,EPHA7;ENPP1;PLPP3;PXYLP1;ACYP2;PPP3CA;EPHX2;PFKFB4;PLCD1;INPP5A;PLA2G4A;LRRK2;PLCB4;SPHK2;GFPT1;EPHB2;INPP4A;XYLB;SLC20A1
prerank,regulation of myotube differentiation (GO:0010830),-0.26937786025256455,-0.7991979165316324,0.7890173410404624,0.9810609482990914,1.0,5/24,11.40%,PIEZO1;NOTCH1;CCN3;ATP11A;SMYD1
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24949161356248545,-0.7981526472241467,0.7928802588996764,0.9818849491204966,1.0,6/33,15.44%,ANKRD28;HSP90AB1;DCLRE1B;CTC1;ZBTB48;RAD51
prerank,dendritic spine organization (GO:0097061),0.30978377363122767,0.7979161038166953,0.721183800623053,0.9825557041704617,1.0,8/26,13.99%,DOCK10;ITGA3;CDC42;EPHB2;EPHB3;INSR;PTEN;DLG4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3287154266167704,-0.7977256146249753,0.7186761229314421,0.9816450699961891,1.0,7/11,55.04%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,TOR signaling (GO:0031929),-0.2666238073357258,-0.7972843669196017,0.7787356321839081,0.9814321420443405,1.0,11/26,28.50%,PRR5L;CCDC88A;MTOR;RPS6;RPS6KB2;FLCN;EIF4EBP2;PRR5;RPS6KB1;CARD11;RHEBL1
prerank,pore complex assembly (GO:0046931),0.3376395336165717,0.7968782200615239,0.7030995106035889,0.9838380597418578,1.0,4/19,10.96%,PLEKHA7;NUP107;AFDN;NUP98
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.32626433333179317,-0.7963050075736894,0.7281323877068558,0.9821606971512455,1.0,6/12,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,positive regulation of DNA repair (GO:0045739),0.29229924212425185,0.7959925317329632,0.7613168724279835,0.9848531990972769,1.0,2/46,1.57%,EYA2;EYA1
prerank,DNA methylation or demethylation (GO:0044728),0.33403164957760184,0.7959525308030114,0.7101449275362319,0.9838929918435326,1.0,8/19,24.64%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,DNA alkylation (GO:0006305),0.33403164957760184,0.7959525308030114,0.7101449275362319,0.9838929918435326,1.0,8/19,24.64%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.34669608312821665,0.7958207421954693,0.6981450252951096,0.9836032950741015,1.0,3/16,17.69%,LEPROT;CHMP5;TMEM50B
prerank,regulation of exosomal secretion (GO:1903541),0.33613215109515815,0.7955986047831081,0.740506329113924,0.9834733092390091,1.0,4/19,13.91%,ATP9A;SDC1;PRKN;SDC4
prerank,positive regulation of locomotion (GO:0040017),-0.2612195041757184,-0.7955098947064747,0.7751479289940828,0.9825547536060997,1.0,5/27,11.49%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.34522688916254596,0.7954856157007233,0.6983870967741935,0.9831694543220684,1.0,4/17,15.92%,FAF2;DERL1;SELENOS;AUP1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3429612121198794,0.7954572993050416,0.7233333333333334,0.9827087627839791,1.0,4/15,16.32%,SLC45A3;PPM1K;ADM;AKT1
prerank,water transport (GO:0006833),0.37180699471330997,0.7954379264556194,0.7094594594594594,0.9822385996695857,1.0,2/12,8.38%,PDPN;AQP6
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.27066347488608794,-0.7953809758689994,0.7564766839378239,0.9817462531786448,1.0,6/23,12.41%,CBFA2T3;CRY1;GSK3A;PFKFB1;PLEK;GIT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3631900092631471,0.795127300131651,0.7258620689655172,0.982243550824538,1.0,2/14,4.18%,IL34;CSF1
prerank,regulation of secretion (GO:0051046),-0.3135375361635364,-0.7949629567998456,0.7330097087378641,0.981409498865934,1.0,4/13,12.77%,KCNQ1;SGK1;GPLD1;ERBB3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.36600945834887,0.794665265730555,0.7103825136612022,0.9825398217037671,1.0,4/11,14.76%,BMPR1A;CD200;GATA6;ATP6AP2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2646362677425867,0.7943429552966116,0.7667934093789607,0.9825942740412694,1.0,9/69,9.32%,GDNF;BCL2;APOE;MT3;NTF3;LIG4;SLC30A10;NONO;PRKN
prerank,regulation of amyloid fibril formation (GO:1905906),0.34335378801973754,0.794266083789721,0.7333333333333333,0.9822170973042934,1.0,2/15,5.01%,APOE;LDLR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.25129552070692096,-0.7941658668735477,0.8104575163398693,0.9818091794146114,1.0,10/29,25.12%,EDC3;LSM2;LSM6;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3459087048617231,0.7938978370468447,0.7387687188019967,0.9823405923753957,1.0,2/15,4.30%,APOE;APOA1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3016509406136697,0.7938197847938324,0.7176820208023774,0.9819592374535079,1.0,2/32,4.79%,CDK14;CDK16
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.29663019045497047,0.7935580538589457,0.7419354838709677,0.981891803890647,1.0,15/33,20.58%,EGFR;DDX3X;RGCC;GLI1;PAF1;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC73;PHB2;PLCB1;CCND2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.25036761588801965,-0.7934882262326437,0.8083067092651757,0.9819522560261292,1.0,7/30,15.93%,CAV1;SRCIN1;PTPN2;INPP5F;PRKCZ;PTPN6;PTPRC
prerank,positive regulation of intracellular transport (GO:0032388),0.2906474719501426,0.7933892517403445,0.7582089552238805,0.9816643669506228,1.0,4/38,9.86%,ACTN2;NEDD4;DYNC1H1;STK11
prerank,regulation of viral entry into host cell (GO:0046596),-0.2516413989229365,-0.7926991804886809,0.8,0.9822465230735477,1.0,8/30,18.25%,LY6E;TRIM14;HS3ST5;TRIM25;TRIM68;TRIM11;TRIM6;TRIM62
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.2593316453585097,0.7921652322917456,0.80440097799511,0.9832095663126529,1.0,23/82,23.16%,DYNLL1;NINL;CEP152;DYNC1H1;ALMS1;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;ATF5;DYRK3;ODF2;PRKACA;CEP250;AURKA;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,regulation of chemokine production (GO:0032642),-0.2437003094594516,-0.7920193620806558,0.8323353293413174,0.9823606016258712,1.0,13/36,27.50%,IL33;FOXP1;SIGIRR;APP;HIF1A;TLR4;ACKR1;AGER;AIF1;SNAI2;TREM2;EGR1;LPL
prerank,glutathione biosynthetic process (GO:0006750),-0.33008885660276066,-0.7918994760970348,0.7327188940092166,0.9815764725863871,1.0,6/11,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,regulation of RNA metabolic process (GO:0051252),0.27079917487112226,0.7916884752373059,0.7651715039577837,0.9835332908515408,1.0,6/59,5.58%,MITF;SON;HNRNPLL;IGF2BP2;OAS2;SNRNP70
prerank,regulation of calcium ion import (GO:0090279),0.323053294347636,0.7915783802476106,0.7110016420361248,0.983208528314433,1.0,4/21,17.02%,PDGFRB;SPHK2;EGF;PSEN2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.27480051429845126,-0.7914871838542177,0.7645502645502645,0.9812943359924537,1.0,4/20,12.60%,SYNE1;SUN2;RANGAP1;MORC3
prerank,negative regulation of immune effector process (GO:0002698),-0.32186708062730274,-0.7912366506611381,0.7688564476885644,0.9807392205106755,1.0,2/13,6.57%,RPS19;CD55
prerank,negative regulation of JUN kinase activity (GO:0043508),0.37190153705457696,0.7910742695082992,0.7135416666666666,0.9835516937138093,1.0,5/10,26.75%,DUSP19;PDCD4;AIDA;DNAJA1;HIPK3
prerank,regulation of protein targeting to membrane (GO:0090313),0.3111347219851181,0.7909943303491735,0.7503852080123267,0.9831851293767658,1.0,1/28,0.72%,CEMIP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.35074389453970656,0.7908783687907445,0.6955782312925171,0.982881837549648,1.0,3/15,7.37%,LDLR;SIK1;SREBF1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3020728863560604,0.7904506254537904,0.766566265060241,0.98309787526184,1.0,14/32,24.99%,CDK5RAP3;BRSK1;MRNIP;TAOK3;ATM;UIMC1;CLSPN;BRCC3;TAOK1;TRIM39;BRCA1;MRE11;RINT1;CDC14B
prerank,rRNA transcription (GO:0009303),0.33758642678087025,0.7903204083166361,0.7236842105263158,0.98280168959889,1.0,3/17,5.98%,POLR1G;BRF1;GTF3C1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2443714749144125,0.7902354666662358,0.8417945690672963,0.9824471597612945,1.0,23/132,18.90%,POLR2D;CELF2;SF1;TRAF7;ERAL1;EIF6;EIF3A;EIF2S2;DDX23;NOL3;SNRPD2;SRSF5;RBM5;RRP7A;GEMIN2;PRPF6;NAF1;SF3B1;SRSF10;KHDC4;CDC73;DDX1;DICER1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.26061511738054116,0.7900636179933003,0.7777777777777778,0.9822512086694214,1.0,20/80,19.23%,PLPP3;ATP9A;ZW10;ARFGAP3;COPB1;COPZ2;KDELR3;ERGIC2;GOLPH3L;ERGIC3;UVRAG;COPA;ARF4;ERGIC1;GOLPH3;TAPBP;COPG1;TMED10;RER1;HTT
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3542715782024268,0.7896446118501594,0.7325383304940375,0.9824266858631365,1.0,4/15,10.16%,FGFR1;SEMA5A;SMOC2;FGF2
prerank,glucose metabolic process (GO:0006006),0.268760756749122,0.7894886529699147,0.7789072426937739,0.9821900071732222,1.0,6/58,11.22%,RBP4;MDH2;ENO2;GAA;DCXR;GALM
prerank,regulation of macrophage differentiation (GO:0045649),0.34843333950935573,0.7894603924186234,0.718801996672213,0.9817324082554814,1.0,2/15,4.18%,IL34;CSF1
prerank,response to interferon-beta (GO:0035456),-0.2707982281134946,-0.788501470161475,0.8089005235602095,0.9844331394946133,1.0,8/22,28.44%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6;PLSCR1;IFITM3;IFNAR2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.30937627794267436,0.7883547186867447,0.7361319340329835,0.9831032039112586,1.0,3/25,8.52%,MOAP1;PDCD5;BCL2L11
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24632761943035789,0.7876418224417161,0.8401880141010576,0.9838025465803257,1.0,20/109,16.29%,PIK3R1;PTPN13;PDGFRB;PLCD1;SYNJ2;PLA2G4A;PLEKHA8;PLEKHA2;LPGAT1;MTMR3;INPP4A;MTMR7;FGF2;PI4KA;PIK3R4;PTEN;PGAP3;PIKFYVE;PIK3R2;PIP4K2C
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3140117919811975,0.7874190233878785,0.7511380880121397,0.9831527342344402,1.0,4/23,9.86%,ZEB2;SLC2A10;DAB2;STK11
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3140117919811975,0.7874190233878785,0.7511380880121397,0.9831527342344402,1.0,4/23,9.86%,ZEB2;SLC2A10;DAB2;STK11
prerank,positive regulation of embryonic development (GO:0040019),0.3346826953061042,0.7871815752442335,0.7254237288135593,0.9830641638419578,1.0,4/19,12.33%,WNT4;OSR1;RBM19;NIBAN2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3172319246260039,0.7868566623000471,0.73125,0.9831393699840884,1.0,10/24,20.99%,CHD6;MT3;NFE2L2;RBPJ;CEBPB;SESN2;HSF1;MUC1;CREB3L1;DDIT3
prerank,negative regulation of viral genome replication (GO:0045071),-0.2363826687294553,-0.786773232640001,0.818815331010453,0.9863268906187341,1.0,16/40,29.88%,IFIH1;INPP5K;SRPK1;TASOR;MPHOSPH8;FAM111A;TRIM6;N4BP1;HMGA2;OASL;PLSCR1;IFITM3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3187932086297543,0.7866812909965274,0.7546583850931677,0.9829208401048619,1.0,9/24,24.11%,SRC;HNRNPA1;TERF2;TNKS2;TENT4B;HNRNPC;HNRNPU;TNKS;XRN1
prerank,regulation of urine volume (GO:0035809),0.3714066886049364,0.7866669639829055,0.7161904761904762,0.9824508054856181,1.0,2/10,11.10%,NPR3;ADM
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.29959664324718566,0.7863094774997783,0.7697841726618705,0.9825509564102178,1.0,12/30,26.31%,LEPROT;PDCD5;RNF31;HUWE1;RHOU;HPS4;ARIH2;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.3083365377626009,-0.7861821559446766,0.7570093457943925,0.9863418143700181,1.0,6/14,28.89%,ME1;AK5;AK7;PNP;AK3;NME2
prerank,N-glycan processing (GO:0006491),0.3358550990924536,0.7858114886639342,0.7119741100323624,0.9828808336340976,1.0,2/18,2.63%,PRKCSH;MAN1C1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3011259201572488,-0.7858114207272171,0.7549019607843137,0.9859360341078145,1.0,6/14,25.82%,FAM98B;CLP1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,regulation of cholesterol efflux (GO:0010874),0.30116014034700433,0.7855606140016316,0.7522658610271903,0.9828163638427043,1.0,9/30,19.68%,LRP1;APOE;APOA1;ABCA3;NR1H3;RXRA;SHH;YJEFN3;ABCA7
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3165625338978887,0.7847258317574893,0.7471819645732689,0.9836960773441845,1.0,2/21,1.65%,DCN;BGN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.34219757303098663,0.7840821194093202,0.7201309328968903,0.9842805891585171,1.0,3/15,8.32%,APOA1;SLC45A3;LPGAT1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.36345626111548346,0.783458716622226,0.7145242070116862,0.9848115384181837,1.0,3/12,17.97%,NUPR1;TTBK1;IL18
prerank,T cell receptor signaling pathway (GO:0050852),0.23993572315102296,0.7831499261360395,0.8409356725146199,0.9848197222788094,1.0,9/138,7.09%,PDPK1;THEMIS;PIK3R1;FYB1;RFTN1;PSME4;CD247;RNF31;CD28
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2050052964957039,-0.7829779483863362,0.8934426229508197,0.9895754068747836,1.0,20/70,24.94%,B2M;VAMP8;NCF2;FCER1G;MFSD6;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1;LNPEP
prerank,gas transport (GO:0015669),-0.33901987970438163,-0.7828195748440833,0.7530266343825666,0.9888362900584198,1.0,2/10,8.56%,IPCEF1;CYGB
prerank,ncRNA catabolic process (GO:0034661),0.31059685996790065,0.782575702062731,0.7619760479041916,0.9852645784933033,1.0,11/28,25.25%,SND1;PARN;EXOSC7;TUT4;MTREX;NUDT16L1;TENT4B;DIS3L;EXOSC2;XRN1;EXOSC8
prerank,positive regulation of lipid storage (GO:0010884),-0.272561195848459,-0.7824246910176282,0.7936507936507936,0.9884601540731467,1.0,7/21,27.50%,SCARB1;PLIN2;MSR1;OSBPL11;HILPDA;PLIN3;LPL
prerank,positive regulation of hemostasis (GO:1900048),0.376010026480618,0.7824174206474516,0.7206132879045997,0.9845414234628006,1.0,2/10,11.76%,SERPINE1;F2
prerank,positive regulation of coagulation (GO:0050820),0.376010026480618,0.7824174206474516,0.7206132879045997,0.9845414234628006,1.0,2/10,11.76%,SERPINE1;F2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.2979969627832057,0.782379110762571,0.75,0.9841019120577401,1.0,5/31,10.60%,FGFR2;PDGFRA;TGFBR1;OSR1;DYNC2I1
prerank,sister chromatid segregation (GO:0000819),0.2999618655779411,0.7819139168241147,0.7655786350148368,0.9843724250458475,1.0,10/31,22.74%,INO80;ZW10;TOP2B;CHAMP1;ZWINT;SGO1;CDCA8;DSN1;TUBG2;TUBG1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3265842012038289,0.7819003228951817,0.7495961227786753,0.983899622532794,1.0,7/20,22.94%,AMPD3;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2979969045502648,0.781678681552387,0.7525325615050651,0.9837509981021688,1.0,5/35,12.08%,OGG1;NEIL1;POLG;POLL;MBD4
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2981123850430061,-0.7816607571780732,0.7587064676616916,0.9886723152858693,1.0,5/16,27.63%,TUBB4B;LYST;RAET1E;CEBPG;CORO1A
prerank,epithelial cell differentiation (GO:0030855),0.25294885839048326,0.7813522375005092,0.7974842767295598,0.9838011506833189,1.0,12/88,14.89%,MAF;FGFR2;ASCL1;CNN3;FSTL1;SCUBE1;DAB2;GLI1;VDAC1;GSTK1;GATA6;BMP4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37708133396436305,0.7812570595248332,0.7460869565217392,0.9834572696153059,1.0,2/10,10.17%,FZD1;RYK
prerank,Rap protein signal transduction (GO:0032486),0.3863140949050542,0.781191402573481,0.7278582930756844,0.9830671976045765,1.0,4/10,14.70%,RAPGEF2;RAPGEF1;RAP2A;PLK2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3178981384018493,0.7808993008396916,0.7380239520958084,0.9830680377378926,1.0,3/23,10.99%,UACA;NMI;DDX3X
prerank,tricarboxylic acid metabolic process (GO:0072350),0.35334785166534466,0.7804436495290438,0.7206896551724138,0.9833493568097015,1.0,2/12,9.52%,ACO1;IDH2
prerank,DNA replication initiation (GO:0006270),-0.23626077719448874,-0.7803691024317425,0.8316151202749141,0.9896772380369575,1.0,15/37,34.69%,DBF4;TOPBP1;ORC4;POLE4;MCM8;LRWD1;MCM3;MCM5;ORC5;PRIM1;CDC6;POLA1;RPA2;CDC34;MCM7
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3114628250730902,0.7799800500556822,0.7617554858934169,0.9836150732546669,1.0,4/24,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,cellular response to UV-A (GO:0071492),0.3627919764993434,0.7797984723658681,0.7026022304832714,0.9834201615703984,1.0,1/11,2.80%,MMP2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.33944124827298283,0.7797757351853414,0.714527027027027,0.982964774646715,1.0,3/15,13.84%,BCL2;PRKN;TAF9
prerank,positive regulation of T cell activation (GO:0050870),0.26362594317215976,0.7789621373017029,0.8218997361477572,0.9837727784059432,1.0,6/62,9.16%,RHOH;CCL19;IL12B;CD28;ZMIZ1;ZBTB1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.28629939645756325,-0.7785458951393731,0.7908847184986595,0.9916795458701155,1.0,9/17,25.45%,INPP5K;CALM1;DDIT4;CALM3;DGKQ;SPRED2;PPEF2;DMTN;CALM2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.26952068837471777,-0.7782680642232234,0.7838541666666666,0.9910584042908944,1.0,10/21,32.44%,RPS7;RPL11;RPL5;UBE2S;RPL23;FZR1;PLK1;BAG2;CDC20;UBE2C
prerank,positive regulation of vacuole organization (GO:0044090),0.37398570790699526,0.7779734442821673,0.734375,0.9848791087115643,1.0,7/10,29.35%,RAB3GAP1;PIP4K2C;ANXA2;PIP4K2A;SH3GLB1;PIP4K2B;GRN
prerank,regulation of cell division (GO:0051302),0.2604134579795542,0.7779218320975054,0.8155216284987278,0.984465951270209,1.0,13/72,18.01%,TXNIP;FGFR2;KIF20A;EFHC1;MLLT3;SIRT2;UVRAG;NCOA3;PIK3R4;PLK2;CDK2AP2;SHH;BECN1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3613276615710201,0.7775096573757463,0.7167235494880546,0.9846727777185088,1.0,2/11,10.17%,FZD1;RYK
prerank,secondary alcohol biosynthetic process (GO:1902653),0.30003435365378694,0.7772341364304075,0.7300613496932515,0.9846122557542608,1.0,4/30,9.33%,INSIG2;APOA1;MVK;IDI1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.33227917175734833,-0.7772314393798894,0.75,0.9917419062540924,1.0,2/10,10.09%,PRKAR1A;SCRIB
prerank,positive regulation of cholesterol transport (GO:0032376),0.30378406128096325,0.7770193109740968,0.7269938650306749,0.9844866958165877,1.0,3/27,4.30%,LRP1;APOE;APOA1
prerank,regulation of centrosome cycle (GO:0046605),-0.2686954607667975,-0.7767074289938067,0.764367816091954,0.9915655765488771,1.0,8/21,29.11%,PDCD6IP;SIRT1;NPM1;CHMP2B;CEP131;CHMP4B;GEN1;CHMP4C
prerank,striated muscle cell development (GO:0055002),-0.3047306785252325,-0.77663734182897,0.7439353099730458,0.9906946321238809,1.0,3/14,6.03%,TMOD2;PGM5;TMOD3
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3592839468479803,0.7765874797089095,0.7540394973070018,0.9841587265399501,1.0,3/12,9.28%,KANK1;FBLN1;ACTN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3592839468479803,0.7765874797089095,0.7540394973070018,0.9841587265399501,1.0,3/12,9.28%,KANK1;FBLN1;ACTN4
prerank,nerve growth factor signaling pathway (GO:0038180),0.3745449245298701,0.7764496932137275,0.726643598615917,0.9839015497795085,1.0,3/10,9.37%,RAPGEF2;NTF3;RAPGEF1
prerank,response to nutrient levels (GO:0031667),-0.28158967090702475,-0.7762202651696521,0.7574931880108992,0.990350369028461,1.0,9/17,40.62%,ULK1;MTOR;FAM107A;ATF4;RPS6KB1;RPTOR;SCTR;CD68;UCN2
prerank,autophagosome organization (GO:1905037),0.2757914230365852,0.7761948632424809,0.7910863509749304,0.9837943622941524,1.0,15/50,22.93%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;ATP13A2;ATG9A;STX12;AMBRA1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.20285622801994846,-0.7761497832748426,0.9017857142857143,0.9894567056833179,1.0,21/87,20.61%,FHL1;CDK6;CUL1;RBX1;FBXL7;AVEN;BRD7;KLF4;PSMF1;FAM107A;PSMB8;PSMA4;PSMB10;PSMB2;CDKN1A;PSMC4;PSMA6;E2F7;PSMD9;PSMD11;PSMD5
prerank,protein deneddylation (GO:0000338),0.36538819987849547,0.7760614337628727,0.726775956284153,0.9834929822264803,1.0,3/10,16.49%,GPS1;COPS3;COPS2
prerank,positive regulation of peptidase activity (GO:0010952),0.32292980705425633,0.7757355283138344,0.7488653555219364,0.9835138847911928,1.0,6/20,24.23%,CTSH;APH1B;RCN3;PSME3;PRELID1;MAPK12
prerank,dendritic spine morphogenesis (GO:0060997),0.33932799438703887,0.77544609155071,0.7184300341296929,0.9835251371866434,1.0,6/15,13.99%,DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,cellular defense response (GO:0006968),0.2769593117718103,0.7752692603231438,0.7799442896935933,0.9833038720823203,1.0,3/40,5.27%,LSP1;RAB23;CCR9
prerank,histone exchange (GO:0043486),-0.23072252126717005,-0.7749526451774356,0.8595317725752508,0.9903548202755524,1.0,14/37,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;VPS72;NPM1;CENPI;RNF8;CENPN;ANP32E;ZNHIT1;NASP;HJURP;ITGB3BP
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2590756735554702,0.7748617811014563,0.8036410923276983,0.9834822960002928,1.0,11/76,12.97%,UACA;SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.36064046019786195,0.7747535534898001,0.731418918918919,0.9831691734194861,1.0,1/12,2.35%,ACSL1
prerank,positive regulation of cellular protein localization (GO:1903829),0.25645721165808094,0.7746937025908325,0.7862595419847328,0.9827845411884201,1.0,23/69,23.49%,YAP1;CDK5RAP3;PRKAA2;SNX33;WWTR1;EIF2AK3;CROCC;SLC5A3;PRKN;F2;SYT11;SESN2;AKT1;LIF;TM9SF4;NUMA1;ABCA7;GPR137B;CEP250;GPD1L;CARD10;PARD6A;RANGRF
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.34633121440546216,0.7743993783285584,0.7429577464788732,0.982767819297976,1.0,4/13,12.68%,ERLEC1;DERL3;BCAP31;UBAC2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.33910836265806854,0.7739952910846463,0.734860883797054,0.9829309960257236,1.0,3/16,9.95%,LEPROT;PIBF1;PARP14
prerank,response to glucocorticoid (GO:0051384),0.3044765430783385,0.7739860605861657,0.7782874617737003,0.9824566565823561,1.0,5/26,11.94%,HSD3B2;ZFP36L1;BCL2L11;SLIT3;REST
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.35732559022360466,0.7739848402937335,0.7314974182444062,0.9819696654707484,1.0,5/12,24.20%,PIBF1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3294009626043675,-0.773895303082452,0.7885985748218527,0.9910269775191288,1.0,2/10,6.87%,SORL1;HSP90AB1
prerank,nuclear membrane reassembly (GO:0031468),-0.21698304678860758,-0.7738650569473928,0.8695652173913043,0.9900702437979322,1.0,16/54,25.02%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43
prerank,ncRNA export from nucleus (GO:0097064),-0.2355866637099698,-0.7738042160235906,0.8044871794871795,0.9891804820505737,1.0,12/36,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NPM1;NUP62;NUP85
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.31733328704137975,0.7737368000590235,0.7435064935064936,0.9818782075219521,1.0,2/21,2.08%,LYN;RUNX1
prerank,protein deubiquitination (GO:0016579),0.2277303158655495,0.773449973558209,0.8848614072494669,0.9818443285752709,1.0,65/242,23.50%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;ATXN7L3;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;USP32;USP10;USP9X;USP38;PTEN;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,cellular respiration (GO:0045333),-0.23232600126632474,-0.7733836813413575,0.8520900321543409,0.9888742920253728,1.0,17/41,25.88%,SLC25A13;PPARGC1A;MTFR1;UQCRH;NDUFA5;CYCS;SURF1;SDHB;MTFR2;MTLN;NDUFS7;NDUFS1;UQCR10;COQ10A;UQCRC1;ETFRF1;UQCRFS1
prerank,dendritic cell migration (GO:0036336),0.3370115741668899,0.773151984591546,0.7308917197452229,0.9818286283977985,1.0,2/16,9.41%,CCL19;TRPM4
prerank,negative regulation of heart contraction (GO:0045822),0.3658104204955738,0.7730847745839785,0.7235188509874326,0.9814477042225364,1.0,1/11,1.81%,ATP1A2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2647460899138335,0.7729919510231318,0.8026666666666666,0.9811094550841474,1.0,15/58,20.24%,LIG4;SMC5;DCLRE1C;POLL;UBE2V2;NHEJ1;ERCC8;DCLRE1A;UVRAG;ATM;KAT5;SUMO1;UIMC1;BRCC3;NSMCE2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3335563616813912,0.7728653316784708,0.7289879931389366,0.9808057649314714,1.0,5/15,19.98%,DCST1;STAT2;MUL1;METTL3;YTHDF2
prerank,cilium assembly (GO:0060271),0.22579830297938527,0.7722451571519647,0.9247648902821317,0.9812911248264342,1.0,42/296,14.92%,ASAP1;GSN;DYNLL1;PARVA;NINL;CEP152;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;NPHP1;TTC39C;B9D1;ALMS1;WDR35;IFT43;IFT27;DNAAF1;FBF1;CFAP46;TRIP11;IFT81;DYNC2I1;CFAP44;CFAP410;YWHAE;CCDC40;DYNC1I2;HAUS1;DYNLRB2;PTPDC1;ARF4;PTPN23;HAUS7;FLNA;HAUS3;CEP164;IFT22;CEP192
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.36131963123081684,0.7721666148532482,0.7098540145985401,0.9804502894679353,1.0,3/10,13.78%,NUPR1;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.36131963123081684,0.7721666148532482,0.7098540145985401,0.9804502894679353,1.0,3/10,13.78%,NUPR1;NCOR1;HDAC4
prerank,RNA splicing (GO:0008380),-0.19482705677781642,-0.7719498619219979,0.9415204678362573,0.9901952511725817,1.0,20/95,19.90%,MBNL1;IVNS1ABP;SNRPB;PPARGC1A;ZCRB1;SRPK1;RBM8A;SNRPD1;SNRNP40;LSM6;SNRPA1;SRSF7;MPHOSPH10;PPIG;SNRPD3;SNRPN;SF3B4;USB1;WDR83;SRSF4
prerank,regulation of interleukin-10 production (GO:0032653),-0.2250211298858205,-0.7719417563047103,0.8585858585858586,0.9892058872281378,1.0,10/44,20.57%,CD34;PLCG2;TRIB2;TNFRSF21;PRKCZ;NOD2;JAK3;TLR4;DLL1;AGER
prerank,histone H3 deacetylation (GO:0070932),0.34172356282907224,0.7717753487435676,0.7274193548387097,0.9806151512261482,1.0,7/15,25.04%,SIRT2;HDAC8;HDAC4;ELK4;SMARCAD1;SFPQ;HDAC1
prerank,regulation of establishment of planar polarity (GO:0090175),0.2512290562393933,0.7717187514185752,0.8291457286432161,0.9802266111257985,1.0,7/88,6.15%,DACT1;FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,gene silencing by miRNA (GO:0035195),0.2889076939367178,0.7715673564090302,0.7496296296296296,0.9799694211739225,1.0,11/32,24.63%,ZC3H7B;TNRC6B;WTIP;TNRC6A;EIF6;PRKRA;DICER1;AGO4;RBM4;AGO3;AJUBA
prerank,zymogen activation (GO:0031638),-0.23228315261771665,-0.771558564337721,0.8380952380952381,0.9887916611164036,1.0,8/39,14.60%,GRIN2A;PERP;KLK2;PRSS12;CASP8;CYFIP2;LGMN;BAK1
prerank,regulation of platelet aggregation (GO:0090330),0.32099811860222316,0.7715151661901622,0.736318407960199,0.9795735608876219,1.0,5/17,19.61%,LYN;PDPN;C1QTNF1;PRKCA;ALOX12
prerank,cellular response to amino acid stimulus (GO:0071230),0.29081731155827123,0.7710490873847988,0.7522255192878339,0.9798362809384549,1.0,7/33,11.70%,UBR2;CPEB1;CPEB3;SLC38A9;CASTOR2;LAMTOR2;RRAGD
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3320000323657728,0.7706283279225682,0.7628318584070797,0.98000805322455,1.0,4/15,10.80%,TNRC6B;CPEB3;TNRC6A;TENT4A
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3214435171147103,0.7703211180189629,0.7197986577181208,0.9800028766560163,1.0,1/17,1.86%,BCL2
prerank,organonitrogen compound catabolic process (GO:1901565),0.26645585312799713,0.7700675023539924,0.8108843537414966,0.979925126461571,1.0,7/57,10.86%,CPQ;GGACT;PLA2G4A;SMPD2;NAALADL1;CLPX;RENBP
prerank,histone mRNA metabolic process (GO:0008334),0.2984682669757214,0.769976620833536,0.7588424437299035,0.9795903009852446,1.0,12/27,26.98%,TUT7;ERI1;TUT4;TENT4B;ATM;LSM10;CPSF2;NCBP2;XRN1;SNRPE;UPF1;NCBP1
prerank,positive regulation of viral life cycle (GO:1903902),0.31548282862679794,0.7697613840010891,0.7455138662316476,0.9794328233561108,1.0,6/22,21.87%,AXL;KPNA6;P4HB;KPNA2;LGALS9;TSG101
prerank,protein homotetramerization (GO:0051289),0.2680819976684898,0.7695809443023739,0.8066759388038943,0.9792220222685295,1.0,6/49,9.41%,TRPA1;TDO2;APPL2;ALDH1A2;CBY1;TRPM4
prerank,protein targeting to mitochondrion (GO:0006626),0.2737157395298344,0.7694693409710844,0.8002680965147453,0.978908021025589,1.0,9/52,13.93%,TIMM17B;PMPCB;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;IMMP1L;TOMM22
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3511160310300271,0.7693560541864903,0.7303754266211604,0.9785933306768092,1.0,1/13,1.26%,GLUL
prerank,regulation of telomere maintenance (GO:0032204),0.3047036305500712,0.7693473813533432,0.7544378698224852,0.9781282331592256,1.0,10/26,27.29%,PML;PPP1R10;HDAC8;TERF2;RTEL1;ATRX;MRE11;RAD50;UPF1;SMG1
prerank,endocytic recycling (GO:0032456),0.2693869696345544,0.7687593034347605,0.8052126200274349,0.9785484965617799,1.0,12/50,17.24%,VPS26C;ACAP2;TRARG1;EPS15;SNX12;VPS35L;DENND1A;PTPN23;ARF6;SNX31;ANKRD50;MICALL1
prerank,chemical homeostasis (GO:0048878),0.26423581333057,0.7678495972577807,0.814621409921671,0.9794609358506069,1.0,10/61,16.58%,ZBTB20;RBP1;CEBPA;TLCD1;NR1D2;DDX3X;WNK1;NR1H3;THADA;TENT4B
prerank,secondary palate development (GO:0062009),0.3393687975309678,0.767839097635464,0.7261904761904762,0.9790005828384009,1.0,1/14,1.00%,TGFBR3
prerank,mucosal immune response (GO:0002385),0.3450309159641384,0.7677034387572582,0.7467532467532467,0.9787284594590258,1.0,2/15,7.86%,PIGR;CAMP
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.37557849965859,0.7676128367930455,0.7246891651865008,0.9783824257495808,1.0,2/10,12.33%,OGT;SELENOS
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.29763736088186626,-0.7668510877119943,0.7619047619047619,0.9950519962084292,1.0,4/14,13.19%,CD55;TGFBR2;CD81;PTPN22
prerank,regulation of cytoplasmic translation (GO:2000765),-0.2941360174398219,-0.7667302532600456,0.7852028639618138,0.9942282155667108,1.0,7/14,25.42%,YBX3;UNK;DHX9;RBM24;CPEB2;PKM;FMR1
prerank,pre-miRNA processing (GO:0031054),0.34170983220870443,0.766551761726139,0.7344827586206897,0.979538964880015,1.0,7/14,24.47%,TUT7;TUT4;PRKRA;DICER1;AGO4;DROSHA;AGO3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2897801502005628,0.7664991905902176,0.7694566813509545,0.9791411487718552,1.0,9/32,21.34%,EML2;CDH5;KATNB1;FGF13;DYRK1A;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.353750427413919,0.7662391231895418,0.7102177554438861,0.9790802628572698,1.0,7/12,28.50%,PCGF3;SMCHD1;METTL3;HNRNPU;BRCA1;LRIF1;RBM15
prerank,regulation of chromosome segregation (GO:0051983),0.329137329059693,0.7660912082515324,0.7615780445969125,0.978818208050775,1.0,5/16,21.24%,SMC5;SMC6;RAD18;NUMA1;RMI2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2440556462993255,-0.7660768439903206,0.832807570977918,0.9942309245161152,1.0,3/29,6.87%,ANKRD28;PPIA;HSP90AB1
prerank,cellular response to interferon-gamma (GO:0071346),0.24672181014836272,0.7658511395303902,0.8283582089552238,0.9787123479660387,1.0,8/88,6.42%,DAPK1;SP100;CCL19;NCAM1;IRF1;OAS2;CCL4;PML
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.2611283007644815,-0.7657793201916717,0.8393351800554016,0.993695043105376,1.0,9/23,22.07%,MTMR2;INPP5K;INPP5F;MTMR9;SACM1L;MTMR6;INPP5B;SYNJ1;TPTE
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2779149768966792,-0.7657077094848979,0.773936170212766,0.9928135835539155,1.0,8/18,32.98%,MECP2;RAB11A;RAD51C;CCND1;DTL;RCC2;CDK1;BRD4
prerank,regulation of defense response to virus (GO:0050688),-0.2969475857373659,-0.765197105273989,0.7971360381861575,0.9926030897940333,1.0,5/14,25.30%,TNFAIP3;PCBP2;DHX9;C1QBP;IFNLR1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29244969761317396,0.7647802299079919,0.8011695906432749,0.9799190041898895,1.0,15/32,27.02%,SLC44A1;APOA1;CHKB;ABHD3;LCAT;SLC44A3;PCYT1A;PEMT;LPIN3;CEPT1;LPIN2;SLC27A1;SLC44A2;LPIN1;CSNK2B
prerank,endothelial tube morphogenesis (GO:0061154),-0.3279601307243836,-0.764730522826771,0.7843601895734598,0.9922828952416936,1.0,2/10,7.70%,ACVRL1;RHOB
prerank,heme biosynthetic process (GO:0006783),-0.2604465468578258,-0.7646668979270912,0.8,0.9913743383536191,1.0,1/22,0.42%,ABCG2
prerank,regulation of interleukin-1 production (GO:0032652),-0.28707210189360505,-0.7644964325954458,0.7711442786069652,0.9906864285324009,1.0,5/15,19.34%,SIRPA;FOXP1;CEACAM1;TLR4;ANXA1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.32213434773811056,0.7643750346627736,0.7720465890183028,0.9800637509010844,1.0,5/17,13.00%,MAPKBP1;TLR6;ARRB1;CD33;SSC5D
prerank,UV-damage excision repair (GO:0070914),0.35578272693036617,0.7638520390025106,0.7394957983193278,0.9804027439952883,1.0,2/12,6.57%,INO80;CUL4B
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21090747202798396,-0.7632988972929712,0.9054545454545454,0.991535043473443,1.0,24/57,30.28%,RAD17;FOXN3;TOPBP1;MDC1;HUS1;PRKDC;BABAM1;CCND1;FBXO31;NBN;CDKN1A;HMGA2;BABAM2;DTL;FANCD2;SDE2;ATF2;HUS1B;FZR1;PLK1;DONSON;CDK1;NEK11;TICRR
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.29291446020103146,0.7631583015827971,0.7671232876712328,0.9810075669523608,1.0,11/29,22.71%,COPB1;COG8;COPZ2;GOSR2;TRAPPC10;COPA;GOLGA5;COPG1;TRAPPC3;COG2;NAPA
prerank,positive regulation of viral genome replication (GO:0045070),-0.23928739383858022,-0.7630142355105491,0.8407079646017699,0.9909463804069936,1.0,9/29,20.11%,PPIA;PABPC1;SRPK1;ADAR;NR5A2;TOP2A;RAD23A;CNOT7;PPID
prerank,regulation of organelle assembly (GO:1902115),0.25503193164300025,0.7629505539743474,0.8414154652686763,0.9808533364159273,1.0,13/72,15.47%,GSN;USP6NL;NPRL3;TBC1D19;ALMS1;ADPRH;MTMR3;TBC1D2B;SENP6;PLK2;TBC1D20;PIKFYVE;NPRL2
prerank,positive regulation of immune effector process (GO:0002699),0.29807284322590794,0.762384061717374,0.763744427934621,0.9812275932788271,1.0,4/27,7.14%,MYO18A;APPL2;IL12B;DDX60
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3021664348185135,-0.7622355020447933,0.757847533632287,0.9911094219128926,1.0,11/13,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,glutamate metabolic process (GO:0006536),0.32100253560330233,0.7620798946328616,0.7541254125412541,0.9812001051990269,1.0,2/19,8.64%,GLUL;ALDH18A1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.2868036082612239,0.7619592869050316,0.7900302114803626,0.9809000767689474,1.0,4/30,8.05%,DCN;BGN;DSE;CSPG5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.27457695528034587,-0.7613903107022875,0.7984293193717278,0.9913719165669951,1.0,4/18,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.31777981363695534,0.761237674134987,0.7573770491803279,0.9815061477236499,1.0,3/19,9.32%,OBSL1;CUX2;CAMK2B
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.19940331601681635,-0.7610147991075483,0.93048128342246,0.9909487211504179,1.0,26/83,24.43%,CDK6;CDK17;CUL1;USP29;EIF4E;CDK5;DBF4;DHFR;BCAT1;TYMS;NPAT;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;CDK18;HINFP;PLK3;BACH1;CDKN3;MAX;PIM2;NASP;RPS6KB1
prerank,positive regulation of cell killing (GO:0031343),-0.2988134132306111,-0.7608051420542903,0.7935034802784223,0.9902498641043382,1.0,4/13,28.95%,MAPK8;DVL2;NOX1;NOS2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.29831100825225954,0.7603059922552758,0.7496087636932708,0.9824377958858583,1.0,4/25,9.62%,PARVA;CD200;ITGB3;ITGAV
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2640852198765037,0.7598478918586392,0.8284182305630027,0.9827066375569596,1.0,6/54,9.32%,GAS6;CFLAR;RFFL;APOA1;RNF31;PRKN
prerank,regulation of mRNA catabolic process (GO:0061013),0.23618825533604515,0.7595492906349626,0.8797083839611178,0.9826938007777206,1.0,24/121,20.64%,SAMD4A;CSDC2;IGF2BP2;PSME4;ZFP36L1;EXOSC1;PARN;SERBP1;EXOSC7;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;PSMD1;PRKCA;PSMD4;PSME3;YTHDF2;ZFP36L2;PSMA3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3587950222967467,0.7594718939477467,0.7594254937163375,0.9823325848932081,1.0,2/10,8.40%,APOA1;IRAK3
prerank,positive regulation of double-strand break repair (GO:2000781),-0.23060926447059477,-0.7593138245203649,0.8472727272727273,0.9914531502097567,1.0,9/39,21.30%,SPIRE1;FMN2;SHLD1;KDM4D;PRKDC;SLF1;PNKP;PARP1;SHLD2
prerank,regulation of calcium ion transport (GO:0051924),0.26448134396506395,0.7592751138779263,0.813858695652174,0.9821611219262915,1.0,10/54,16.90%,BCL2;MYLK;STIM1;CCL4;CAMK2B;ADRA2A;CD33;EGF;CASR;HRC
prerank,ATP transport (GO:0015867),0.36920204693103353,0.7591918774323674,0.7313974591651543,0.9818187575152358,1.0,2/10,16.04%,SLC25A24;CD47
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.20526003788537525,-0.7591853199768035,0.9068825910931174,0.9906702695377302,1.0,15/63,21.43%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;PRKDC;CCND1;EP300;FBXO31;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2660467732533962,-0.7589792153874515,0.8197674418604651,0.9899872588657804,1.0,8/21,29.32%,MECP2;RAB11A;RAD51C;CCND1;NPM1;DTL;RCC2;CDK1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.239156817848064,-0.7584309514885491,0.8642384105960265,0.9897996007058769,1.0,6/30,10.92%,TAF1B;TBP;CAVIN1;GTF2H1;TAF1C;UBTF
prerank,cellular response to calcium ion (GO:0071277),0.25802891050809307,0.7579279552099303,0.8220779220779221,0.983211707656802,1.0,7/67,7.85%,ADCY1;ADGRV1;SLC25A24;PRKAA2;DPEP1;CPNE2;SYT9
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.21825133581930722,0.75770579044681,0.951092611862643,0.9830577978422206,1.0,95/341,23.63%,SPSB1;TBL1XR1;HECW2;DCST1;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;ZNRF3;PML;NFE2L2;UBE4B;TRIP12;SIRT2;UBXN2B;UBE2U;RNF185;UBR4;ARRB1;UBXN11;WDR81;ANAPC5;WDR91;PRKN;ITCH;IFI27;RNF6;MIB1;FBXO11;KBTBD7;ERCC8;VPS37D;FEM1C;BTRC;RNF217;COPS3;USP9X;TNFAIP1;RNF19A;RC3H2;PTPN23;APPBP2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;HUWE1;RNF13;NHLRC3;SPOP;UBE2R2;UBR3;UBE3B;PSMB5;PSMC2;KAT5;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;NSFL1C;PSME3;FEM1B;RNF11;KCTD13;ARIH2;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;FBXO10;BIRC2;TSG101;RNF216;RNF20;BAG6;ANAPC4;KLHL20;PSMA2;KLHL8;BIRC6;FBXW11;ATXN3;PSMC5;ARMC8;ELOC
prerank,import into nucleus (GO:0051170),0.24790109822863138,0.7570476519530608,0.8554987212276215,0.9836193111747722,1.0,19/73,19.64%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HNRNPA1;HEATR3;CSE1L;PPP1R10;TSC2;SNRPD2;NUP214;GEMIN2;AKT1;PHB2;TPR;APPL1;KPNB1;BACH2
prerank,mitotic metaphase plate congression (GO:0007080),0.26884843520004664,0.7565260729743711,0.8081081081081081,0.9839140883980351,1.0,13/51,20.47%,PIBF1;SPDL1;ZW10;CHAMP1;CENPC;EML4;CHMP5;SEH1L;BECN1;BOD1;KPNB1;CDCA8;CDC23
prerank,negative regulation of ATPase activity (GO:0032780),-0.28251696249115743,-0.7564384590816049,0.7931937172774869,0.9917816551041778,1.0,5/16,29.53%,PXK;SIRT1;PLN;ATP5IF1;IFIT1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.303679095961407,0.7564050057806768,0.7706708268330733,0.9836110476689955,1.0,4/23,14.70%,CDK5RAP3;ZW10;ZWINT;PLK2
prerank,mRNA export from nucleus (GO:0006406),0.24205875809603633,0.7562906799585412,0.863855421686747,0.9833048601120269,1.0,11/102,11.97%,POLR2D;NUP107;U2AF1L4;THOC2;NUP42;DDX39A;DDX19A;WDR33;NUP98;RAE1;MAGOHB
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.32831659852789696,0.7562836268817538,0.773356401384083,0.9828387996466847,1.0,3/15,11.82%,LARGE1;RENBP;MGAT3
prerank,membrane protein proteolysis (GO:0033619),-0.22704367021889216,-0.7561191285183607,0.8456375838926175,0.991270639506385,1.0,11/37,19.78%,ADAM10;RET;SPPL3;BACE2;ADAM19;TGFB1;MBTPS2;RBMX;ADAM9;RHBDD1;APH1A
prerank,response to estradiol (GO:0032355),0.2884585247088337,0.7559704398831194,0.8006088280060882,0.9828406996662802,1.0,6/31,10.01%,WNT8B;SFRP1;STRN3;EGFR;STAT5B;FOXA1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.32319500511866694,0.7559453587099586,0.7566225165562914,0.9824013303514145,1.0,4/17,15.29%,LYN;CARD9;TAOK3;RNF13
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.31676356662518607,0.7559165761786563,0.7793880837359098,0.9819697456493268,1.0,1/18,1.86%,BCL2
prerank,negative regulation of histone modification (GO:0031057),-0.2844859623478313,-0.7556462244296283,0.7946210268948656,0.990964176546112,1.0,6/14,28.28%,CTBP1;PRMT6;THAP7;TWIST1;AASS;SET
prerank,regulation of viral genome replication (GO:0045069),-0.20803513137274687,-0.7552572059337364,0.9311740890688259,0.9905806246300437,1.0,20/56,29.88%,IFIH1;PPIA;PABPC1;SRPK1;ADAR;FAM111A;NR5A2;RAD23A;TRIM6;N4BP1;CNOT7;PPID;OASL;PLSCR1;IFITM3;HACD3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,peripheral nervous system development (GO:0007422),0.2997419921898415,0.7548570739783728,0.7639553429027113,0.9830788228524995,1.0,3/23,7.01%,GDNF;NTF3;PMP22
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.27728119227454695,-0.7541847518211527,0.8165829145728644,0.9911062265516896,1.0,3/16,13.52%,SIX1;SIRT1;PTGS2
prerank,actin filament polymerization (GO:0030041),0.2924527790044854,0.7541643461212779,0.78125,0.9836447429304002,1.0,3/29,6.18%,GSN;ARHGAP6;WASHC3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2792337482724411,-0.7529952713477198,0.7924050632911392,0.9917868321965265,1.0,5/16,21.30%,SHLD1;KDM4D;PRKDC;PNKP;SHLD2
prerank,myelin assembly (GO:0032288),0.35739899297718103,0.7529479785993894,0.7446043165467626,0.9849875761894944,1.0,4/10,18.90%,PMP22;EPB41L3;NCMAP;DICER1
prerank,snRNA 3'-end processing (GO:0034472),-0.2748696221449165,-0.7528638139098399,0.8207282913165266,0.9910210648688155,1.0,7/19,28.82%,INTS6;INTS8;EXOSC5;USB1;INTS1;EXOSC4;TUT1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.20626605260529127,-0.7527983302894956,0.9094827586206896,0.990148839695639,1.0,21/61,25.63%,CDK6;CUL1;USP29;EIF4E;DBF4;BCAT1;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;MAP3K11;HINFP;PLK3;CDKN3;MAX;PIM2;NASP;RPS6KB1;E2F1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3576881888969206,0.7524697159336761,0.7253886010362695,0.9852645983576606,1.0,3/10,19.36%,SP100;KAT5;MUC1
prerank,negative regulation of cell cycle process (GO:0010948),0.25886346749708244,0.7524279092801357,0.8245382585751979,0.9848512708642467,1.0,15/61,17.72%,TOM1L2;CBX3;RBBP7;PPP1R10;NME6;TERF2;L3MBTL2;YAF2;BMP4;WAPL;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.26926437571973166,-0.7524155575414253,0.8238341968911918,0.9897593770662618,1.0,5/19,21.79%,IFIH1;IRF5;TLR4;DHX9;CHUK
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2416030763196712,-0.7521861270771919,0.8372093023255814,0.9891141766928153,1.0,5/28,15.60%,CYRIB;SIRPA;SH3KBP1;NOD2;PRKDC
prerank,regulation of RNA export from nucleus (GO:0046831),0.3524728673728599,0.7521586345519504,0.7473118279569892,0.9847646279512791,1.0,5/11,22.41%,NSUN2;AKAP8L;TPR;NRDE2;NCBP2
prerank,cell cycle checkpoint signaling (GO:0000075),0.3424813650158216,0.7513809340978239,0.7619047619047619,0.9854422935353571,1.0,5/12,24.19%,ZW10;ZWINT;PLK2;PRCC;NABP2
prerank,cardiolipin metabolic process (GO:0032048),-0.2896903904671934,-0.7513680732398599,0.7931034482758621,0.9892837601971401,1.0,4/13,17.67%,PGS1;PNPLA8;CRLS1;PTPMT1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.27763330333393116,-0.7512695781215426,0.7797029702970297,0.9884699372388662,1.0,2/17,6.96%,STX3;SYP
prerank,receptor internalization (GO:0031623),0.26802318330318015,0.7512419469560339,0.8146067415730337,0.9851790242267673,1.0,8/44,12.82%,LRP1;GRK3;NEDD4;DRD3;ARRB1;PICALM;ADM;GRK4
prerank,positive regulation of myelination (GO:0031643),0.3434814775636911,0.7511280199748056,0.7597292724196277,0.9848813270017367,1.0,4/11,18.90%,RNF10;PARD3;NCMAP;DICER1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3328143419572216,0.751110697080672,0.7688356164383562,0.9844398857549715,1.0,3/15,10.54%,IL17D;TLR6;CARD9
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23678426828961371,0.7510155226139995,0.8651275820170109,0.9841198951168472,1.0,5/109,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PSME4
prerank,fluid transport (GO:0042044),0.3473713409783161,0.7507365060938638,0.760539629005059,0.9840689740958666,1.0,2/12,8.38%,PDPN;AQP6
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.3287060234856772,0.7499417925167199,0.7724957555178268,0.9842971818992224,1.0,3/17,8.85%,BRWD1;TSLP;STAT5B
prerank,cellular response to interleukin-7 (GO:0098761),0.3287060234856772,0.7499417925167199,0.7724957555178268,0.9842971818992224,1.0,3/17,8.85%,BRWD1;TSLP;STAT5B
prerank,cellular response to unfolded protein (GO:0034620),0.2999850077607216,0.7499413032332155,0.7945619335347432,0.9838244491671156,1.0,10/26,26.14%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HSPA5;BAG3;ABCB10
prerank,positive regulation of mitochondrion organization (GO:0010822),0.2545208150172343,0.7495981188562146,0.8282694848084544,0.9838691872316653,1.0,6/57,9.32%,DCN;MOAP1;PDCD5;MCU;BCL2L11;PRKN
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3412917593864388,0.7495817828872137,0.7525597269624573,0.9834248503255948,1.0,3/13,12.03%,RAB23;LRRK2;RHOQ
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.24966861863359774,-0.7494516567070397,0.819672131147541,0.9900003282523505,1.0,1/24,0.42%,ABCG2
prerank,histone H3-K9 demethylation (GO:0033169),0.34559692439236844,0.7493781203173316,0.7700534759358288,0.9832440637297366,1.0,6/11,23.23%,KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2967967093965525,0.7491920589948078,0.7808022922636103,0.9830498389370992,1.0,2/29,3.44%,SERPINE1;GAS6
prerank,negative regulation of telomere maintenance (GO:0032205),0.3337242803606389,0.7485228046893138,0.7680672268907563,0.9835550089066282,1.0,6/15,26.06%,TERF2;TNKS2;RTEL1;ATM;TNKS;RAD50
prerank,protein insertion into membrane (GO:0051205),0.28509776533996545,0.7483288659154139,0.8151382823871907,0.9833807335714262,1.0,5/32,11.44%,TRAM2;COX18;CYB5A;EGFR;TRAM1
prerank,vitamin D metabolic process (GO:0042359),-0.295127041689486,-0.7473601861242392,0.7930232558139535,0.9918449706457504,1.0,2/13,11.55%,CUBN;LGMN
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.23681419211754523,-0.7472255945384753,0.8885630498533724,0.991070884240875,1.0,10/33,21.44%,SNRPB;CPSF7;CSTF3;CSTF1;CLP1;CSTF2;SNRPD3;MED18;SLBP;MAZ
prerank,mitotic spindle assembly (GO:0090307),-0.220970249068224,-0.7467298863366597,0.9217081850533808,0.9907571195036543,1.0,22/42,41.10%,KIF2A;STAG1;RAB11A;CCDC61;LSM14A;PRC1;KIF23;MISP;CLASP1;KIF4A;SPICE1;KIF11;TOGARAM2;WRAP73;MAP10;RACGAP1;STAG2;BCCIP;AURKB;CLASP2;TOGARAM1;KIFC2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.29392877297509445,0.7456284898701753,0.816923076923077,0.9868002873280717,1.0,4/29,11.79%,SYCE2;TEX12;MAJIN;STAG3
prerank,zinc ion transmembrane transport (GO:0071577),0.3075596276794196,0.7454594102229569,0.7823439878234398,0.9865746489963112,1.0,9/22,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,regulation of cellular response to stress (GO:0080135),0.23080166567481367,0.7453671490361522,0.8782505910165485,0.986247383312741,1.0,29/115,20.59%,ROCK2;NUP107;NUPR1;NUAK1;NUP42;CAMK2B;PRKN;NEK6;MANF;NUP98;CEBPB;RAE1;CLN3;YWHAE;NPAS2;AMFR;NUP214;HSBP1;BAG5;SLC38A2;MAPKAPK2;CASP9;ATM;SEH1L;DYRK3;TPR;HSF1;AAAS;MLST8
prerank,regulation of glycogen metabolic process (GO:0070873),0.3544115530704125,0.7453209232206575,0.7612781954887218,0.9858438424477652,1.0,6/12,21.40%,PPP1R3C;PPP1R3D;AKT1;PPP1R3E;GCGR;RUBCNL
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2795064832437448,-0.745199125429169,0.8557692307692307,0.9918351685396609,1.0,3/17,11.31%,SLC7A5;FCER1G;PRKCZ
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3418401312844981,0.7450057079218905,0.7508896797153025,0.9858428263790289,1.0,1/12,1.86%,BCL2
prerank,organic cation transport (GO:0015695),0.3108298831732021,0.7446866628417912,0.774390243902439,0.9858563394716937,1.0,4/20,10.98%,SLC44A1;SLC22A2;SLC22A4;SLC22A18
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.32198612932868376,0.7446815740619537,0.8075040783034257,0.9853911224864735,1.0,4/18,14.41%,RNF185;RNF139;UGGT2;AMFR
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2539645673977739,-0.744518467873067,0.8471849865951743,0.9917682084101622,1.0,13/22,34.51%,GATA2;KDM1A;TAFA1;ID2;DLL4;SHCBP1;TOX;PTPRZ1;FZD9;DISP3;NAP1L1;RASSF10;TRIM71
prerank,regulation of gluconeogenesis (GO:0006111),0.29373192468555304,0.7442226492869963,0.7777777777777778,0.9855630444086532,1.0,3/27,6.82%,OGT;NNMT;SIK1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3215253059898845,-0.7432758565475786,0.8039647577092511,0.9924452523987817,1.0,4/10,25.17%,EMC3;EMC9;MMGT1;EMC4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.33011165384567864,0.743193375757953,0.774247491638796,0.9865844514405847,1.0,3/13,12.33%,NEDD4;EMILIN1;NIBAN2
prerank,osteoclast differentiation (GO:0030316),0.29868502322425394,0.7431672742410728,0.7893129770992366,0.9861451704249226,1.0,5/22,17.06%,CSF1;SRC;EFNA2;OSTM1;GLO1
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18735476065126216,-0.7429413260664398,0.9833333333333333,0.9919538462890007,1.0,20/95,20.83%,MEF2C;PDE4B;CYRIB;LBP;VIM;SIRPA;MAPK8;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;NOD2;CARD16;ADAM9;TLR4;HMGB2;CD86;FZD5;DAB2IP
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3189241069832046,0.7425957262768632,0.794912559618442,0.9864536924117453,1.0,6/18,25.79%,ZFP36L1;METTL3;ZFP36L2;PRELID1;NCKAP1L;ABL1
prerank,regulation of chromosome organization (GO:0033044),0.30350475623740997,0.7414279582132465,0.7972136222910217,0.9876687840353514,1.0,6/22,21.70%,LIG4;HDAC8;TERF2;WAPL;RMI2;CENPV
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3046050796202906,-0.7413840640475616,0.806146572104019,0.9930520282214108,1.0,7/13,34.41%,CPSF7;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1;NUDT21
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3195823666500158,0.7410777979155599,0.7899022801302932,0.9876895873308204,1.0,3/14,11.49%,BFAR;BCL2L11;UFL1
prerank,cholesterol biosynthetic process (GO:0006695),0.2829836154103354,0.7409235252952296,0.799396681749623,0.9874334570549484,1.0,4/31,9.33%,INSIG2;APOA1;MVK;IDI1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.34269167951678087,0.7404228820316975,0.7400346620450606,0.9876925586294489,1.0,7/12,28.42%,GART;AMPD2;PRPSAP2;PPAT;ADSL;PRPSAP1;ADA
prerank,hexose metabolic process (GO:0019318),-0.21915129815981774,-0.7403751744093194,0.9052287581699346,0.9934506656728987,1.0,5/39,10.91%,PPARD;APOD;ALDOA;GDPGP1;SLC35A2
prerank,lipid droplet formation (GO:0140042),-0.31604903636818826,-0.740311609957324,0.7928730512249443,0.9925548483147802,1.0,6/10,37.21%,PLA2G4C;ZFYVE1;FITM2;CDS1;CDS2;BSCL2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.30499915731751354,0.7397975843046777,0.7961019490254873,0.9881157651496144,1.0,3/22,12.75%,PDGFD;DDX3X;RAP2A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2605365876959082,0.7395854869148947,0.8575458392101551,0.9879522916704591,1.0,8/52,9.52%,MDH2;MDH1B;MTHFR;HOGA1;ALDH1L1;ALDH18A1;ADHFE1;IDH2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.24911096770909458,-0.7387396223711475,0.8739495798319328,0.9936991201389676,1.0,12/26,30.87%,IFIH1;NOD1;CASP8;TNFAIP3;NOD2;TAB1;UBE2V1;MAP3K7;TRAF6;UBC;RPS27A;IKBKG
prerank,regulation of inclusion body assembly (GO:0090083),0.34760024444684234,0.7385242186968289,0.7963636363636364,0.989012011491891,1.0,3/11,15.09%,SNCAIP;DNAJA4;BAG5
prerank,vitamin transport (GO:0051180),0.2815008466749167,0.7380846227411668,0.8073529411764706,0.9892068228312003,1.0,4/29,5.39%,SLC2A10;APOA1;SLC35F3;PDPN
prerank,lysosome localization (GO:0032418),0.2755202316411599,0.7380095722800774,0.819364161849711,0.9888429458050533,1.0,13/37,26.23%,KIT;BLOC1S1;PLEKHM1;PLEKHM2;TMEM106B;SNAPIN;DEF8;HDAC6;VPS33B;BLOC1S2;MAP6;RAB34;MYH9
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3200258116476549,0.7378645402099336,0.7937293729372937,0.9885986588762473,1.0,7/16,29.48%,RECQL5;MCM2;MCMDC2;MCM6;RECQL;RPA1;MCM4
prerank,nucleocytoplasmic transport (GO:0006913),0.26462948555026067,0.7378503563299208,0.8323863636363636,0.98815227225368,1.0,8/40,20.10%,ATXN1;PHAX;HNRNPA1;NUP98;SNRPD2;GEMIN2;BACH2;AAAS
prerank,ERBB2 signaling pathway (GO:0038128),0.2784786459245605,0.7375963285613015,0.8058394160583942,0.9880382442196252,1.0,6/31,13.25%,PIK3R1;SRC;CUL5;EGFR;HBEGF;EGF
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.23480099698322698,-0.7375755322508053,0.8745980707395499,0.9943036585199763,1.0,2/29,3.00%,CADM1;CYRIB
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.21460613517852523,-0.7369821700050203,0.9137931034482759,0.9940968277369512,1.0,19/43,30.28%,RAD17;FOXN3;TOPBP1;HUS1;BABAM1;NBN;CDKN1A;CHFR;HMGA2;BABAM2;DTL;NABP1;HUS1B;FZR1;PLK1;DONSON;CDK1;CDC6;TICRR
prerank,peptidyl-lysine methylation (GO:0018022),0.2966320948552343,0.7368633058390287,0.7919876733436055,0.9885989234441568,1.0,5/26,16.47%,SETD7;SETD4;SMYD3;TRMT112;EEF2KMT
prerank,oligodendrocyte development (GO:0014003),-0.28934757744720163,-0.7363930953506876,0.8295739348370927,0.9938932092239016,1.0,4/15,14.73%,B4GALT5;EIF2B5;EIF2B1;PLP1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.31729761944404816,0.7357130284603308,0.7964458804523424,0.9897138524180666,1.0,2/17,8.32%,PLA2G4A;LPGAT1
prerank,regulation of mRNA processing (GO:0050684),0.2786905549039756,0.7355673340894542,0.8160237388724035,0.989443828356546,1.0,14/32,27.30%,SON;ZFP36L1;SF1;SAFB2;RBM39;SRSF10;SRSF3;PAPOLA;METTL16;CWC22;CDK11B;AHCYL1;NCBP1;PABPN1
prerank,spinal cord development (GO:0021510),0.33867924252487236,0.7355569283323481,0.7787456445993032,0.9889870704533061,1.0,1/12,1.96%,GLI2
prerank,calcineurin-mediated signaling (GO:0097720),-0.31945909302474756,-0.7352243047724485,0.7956989247311828,0.9934712329875037,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.31945909302474756,-0.7352243047724485,0.7956989247311828,0.9934712329875037,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,tRNA 5'-leader removal (GO:0001682),0.3311024239964167,0.735106930245031,0.7604166666666666,0.9891858565467101,1.0,4/13,15.59%,RPP25L;PRORP;RPP30;RPP38
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.24349510572587052,-0.7350979397133443,0.88125,0.9926777467063769,1.0,3/25,10.70%,HSPA8;GAK;DNAJB14
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.33679856431746913,0.7350931777854733,0.7596330275229358,0.9887373166451205,1.0,5/12,23.43%,H6PD;SREBF1;KPNB1;SEC14L2;SREBF2
prerank,positive regulation of blood coagulation (GO:0030194),-0.27589058654308285,-0.7350834328126072,0.8337531486146096,0.9917390956762777,1.0,8/17,24.34%,THBS1;THBD;ANO6;ENPP4;ST3GAL4;F3;HPSE;DMTN
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2692453188219927,0.7345922890206532,0.8361823361823362,0.9889671536006388,1.0,11/39,22.42%,PIK3R1;TTC7B;EFR3A;PI4KA;TMEM150A;PIK3R2;PIP4K2C;ITPKA;SOCS4;SOCS7;PIK3C2A
prerank,regulation of phosphatase activity (GO:0010921),0.2952752722349331,0.7345644289053974,0.8026509572901326,0.9885406756938624,1.0,5/24,19.23%,CDK5RAP3;BMP2;PTPA;PPP1R26;HTT
prerank,regulation of cholesterol storage (GO:0010885),0.3208462292890525,0.7343403108672952,0.8010033444816054,0.9883953791551507,1.0,1/15,1.73%,ABCA1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.23543393058416734,-0.7341950108087494,0.9032258064516129,0.9919148825212768,1.0,2/30,1.35%,PPP1R13B;ACER2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.32835627522060473,0.7341592072058061,0.7725631768953068,0.9881966722775812,1.0,3/13,8.47%,TNRC6B;CPEB3;TNRC6A
prerank,DNA damage checkpoint signaling (GO:0000077),-0.23425358078840816,-0.7340119927120188,0.8562874251497006,0.9912016343470326,1.0,12/28,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;DONSON;RAD9A;DOT1L;FBXO6
prerank,positive regulation of heart contraction (GO:0045823),0.3097022561978183,0.7338259206198992,0.8054298642533937,0.988206507206058,1.0,3/19,11.10%,ATP1A2;TRPM4;ADM
prerank,negative regulation of transferase activity (GO:0051348),0.28882655219263836,0.7335526949513278,0.8154311649016641,0.9880964423003746,1.0,7/28,20.15%,SRC;EIF4A2;BAG5;CDKN1C;NPRL2;CDKN1B;HNRNPU
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2825102132623029,-0.7333078220609572,0.8344988344988346,0.9911828874303648,1.0,9/14,37.26%,NT5E;NT5C1A;UPB1;NT5C;UPP1;DPYS;DHODH;ERH;CAD
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.32009151732038305,0.7330730590929679,0.8073836276083467,0.9883130408847572,1.0,1/17,2.69%,NOS1AP
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2742411410104374,-0.7329765404176115,0.8090692124105012,0.9906801894792213,1.0,4/14,15.04%,TFB2M;PNPT1;SLC25A33;FASTKD1
prerank,positive regulation of reproductive process (GO:2000243),0.2814831229749998,0.7328165904869444,0.8214804063860668,0.9881863274284538,1.0,6/31,12.87%,SMURF2;VIP;PDE3A;SIRT2;SYDE1;ACVR1B
prerank,regulation of interleukin-6 production (GO:0032675),0.23348667636857573,0.7328110566376832,0.8981132075471698,0.9877287112601136,1.0,14/96,13.46%,IL6R;IL17D;GAS6;TSLP;SPHK2;TLR6;IRAK3;ARRB1;CD200;RAB7B;CARD9;SETD4;SELENOS;SYT11
prerank,positive regulation of interleukin-10 production (GO:0032733),0.28350441529229015,0.732184324422599,0.8006088280060882,0.9881315873457099,1.0,4/30,7.09%,PIBF1;IL12B;TSLP;CD28
prerank,leukotriene metabolic process (GO:0006691),0.3059411329982671,0.732093446641374,0.803921568627451,0.9878097614509732,1.0,9/19,27.00%,PLA2G4A;DPEP1;DPEP2;MAPKAPK2;ALOX12;ALOX5AP;LTA4H;MGST3;MGST2
prerank,negative regulation of cell communication (GO:0010648),-0.25101073172366567,-0.7308166400095533,0.8380462724935732,0.9924454383697888,1.0,2/21,4.48%,UBASH3B;GLRA1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3126727104556071,0.7304245314984262,0.7951612903225806,0.9896425622410074,1.0,4/18,11.94%,SFRP1;PRKN;ADRA2A;REST
prerank,regulation of supramolecular fiber organization (GO:1902903),0.2960763303954266,0.7304039463373928,0.7831513260530422,0.9892065455511122,1.0,6/22,18.98%,AEBP1;APOE;ARL2;AKAP13;CAMSAP1;EFEMP2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.295586921233098,0.7302575456894415,0.7913322632423756,0.9889517640410594,1.0,4/23,12.36%,SASH1;TLR6;TAOK3;DUSP19
prerank,response to UV-A (GO:0070141),0.3268248991671263,0.7296217685946114,0.7804428044280443,0.9893578765388447,1.0,2/14,8.60%,MMP2;EGFR
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.2890878437667976,0.7287058815805982,0.7949921752738655,0.9901648540905251,1.0,6/25,22.45%,LEPROT;CHMP5;LAPTM4B;TMEM50B;RILP;SORT1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.33314330389683267,0.7286989079010809,0.7806122448979592,0.9897085022288462,1.0,4/13,13.36%,EIF6;ABCE1;NMD3;SDAD1
prerank,activation of phospholipase C activity (GO:0007202),0.2766130018038427,0.7284642305262217,0.8317610062893082,0.989560830175293,1.0,3/29,8.60%,ARHGAP6;LPAR1;EGFR
prerank,magnesium ion transport (GO:0015693),0.33175641283319923,0.7283149565939874,0.7925170068027211,0.9893093280549442,1.0,2/12,9.01%,SLC41A1;NIPAL4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3463274008738103,0.7282371260810282,0.7570422535211268,0.9889484475309359,1.0,2/10,9.95%,PIBF1;PARP14
prerank,microvillus organization (GO:0032528),0.32810677445982067,0.7281291651854225,0.7731629392971247,0.9886429234014189,1.0,4/13,14.95%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3428939518370131,0.7278671305707178,0.7649186256781193,0.9885349005732496,1.0,4/10,18.44%,GNB3;MTMR3;ABCA3;PHB2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31321657452945745,0.7273210474120453,0.8032520325203252,0.9888098525497043,1.0,7/17,25.29%,IL12B;EBI3;IL18BP;IL18;BACH2;MYO1G;JAG1
prerank,protein hydroxylation (GO:0018126),0.32299350101481994,0.727188612155048,0.7873754152823921,0.988536555071995,1.0,3/15,13.83%,ASPH;P3H3;JMJD7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.34384318010209486,0.7269840852945992,0.7808695652173913,0.9883643495133987,1.0,3/11,19.36%,SP100;KAT5;MUC1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.20394028614201493,-0.7267369395454172,0.9358490566037736,0.9966040553111545,1.0,11/56,18.63%,NOD1;PLCG2;LBP;CTSB;S100A1;LGMN;UNC93B1;NOD2;TAB1;TLR4;CTSS
prerank,negative regulation of cellular senescence (GO:2000773),0.32345673683509296,0.7265194063914733,0.7774030354131535,0.9885273231168926,1.0,4/13,12.18%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.29181981141037583,-0.7264850614163684,0.7894736842105263,0.9959732640560142,1.0,3/12,22.63%,MFSD2A;LPCAT3;ACSL3
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.23584156334466527,-0.7260963918531526,0.8583569405099151,0.9955022252186091,1.0,7/27,17.93%,PHF20L1;KAT2A;RUVBL1;KAT6A;EP300;MRGBP;SGF29
prerank,actin crosslink formation (GO:0051764),-0.299478437701595,-0.7255842690734601,0.8051044083526682,0.9951617669985945,1.0,3/12,13.21%,BAIAP2L1;GAS2;GAS2L1
prerank,peroxisome organization (GO:0007031),0.28350148327504543,0.7255444979409097,0.8239644970414202,0.9893721655250903,1.0,8/25,21.51%,LONP2;PEX6;PEX2;ABCD2;PEX11B;SEC16B;PEX7;PEX1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3319515287648467,0.7255228174992814,0.7955706984667802,0.9889327084522854,1.0,2/13,5.08%,SP100;RAB23
prerank,regulation of neurotransmitter secretion (GO:0046928),0.27323574942107604,0.7255088001418833,0.8309659090909091,0.988488463517474,1.0,5/32,7.21%,DTNBP1;MCTP2;BAIAP3;LRRK2;SNCAIP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.32539986967135504,0.7254307659040408,0.765,0.9881513742424936,1.0,5/14,24.19%,TERF2;TNKS2;ATRX;TNKS;NABP2
prerank,ether lipid biosynthetic process (GO:0008611),0.3509624939110608,0.7252982439709091,0.7727272727272727,0.987865584540299,1.0,4/10,21.48%,PLA2G4A;PEX7;DHRS7B;PEDS1
prerank,glutathione metabolic process (GO:0006749),0.2687406330696181,0.7247074738065621,0.8314121037463977,0.9881944322996278,1.0,5/38,9.38%,CHAC2;GSTM4;GSTM2;DPEP1;GSTT1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.3276655752495586,0.7246494498158788,0.7848324514991182,0.987801352989726,1.0,3/13,14.89%,NFIB;REST;BMP4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2712613077907274,-0.7245629251261779,0.8389610389610389,0.9954697609387058,1.0,4/16,19.40%,CELF4;RBM17;DDX5;DHX9
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2259979481886757,0.7244006662126828,0.9215456674473068,0.9876608535710654,1.0,30/125,22.74%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;DYNC1I2;EML4;PLK2;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;DSN1;AURKA;TAOK1;NDE1;TUBG2;TUBG1
prerank,cellular response to chemical stress (GO:0062197),0.22999972921223302,0.7241598338649446,0.9094247246022031,0.9875233121028885,1.0,23/96,20.79%,PYCR1;NUDT2;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;SIRT2;DDX3X;MGAT3;FANCC;SELENOS;GPX3;NOX4;SESN2;LONP1;ATM;FOXO3;SOD3;BRF2;ATP13A2;PRDX6
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3227618423231723,0.723639281739696,0.7804878048780488,0.9877674002803654,1.0,2/13,5.51%,PRICKLE1;TBX3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.277476960614298,0.7234134519915287,0.8350668647845468,0.9876031031832624,1.0,11/31,24.70%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HDAC6;HSPA5;ATXN3;BAG3
prerank,cilium organization (GO:0044782),0.2159248114660212,0.7225865497150029,0.9469214437367304,0.9882680718727613,1.0,16/209,7.63%,ASAP1;GSN;DYNLL1;PARVA;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;IFT43;DNAAF1;FBF1
prerank,positive regulation of macrophage migration (GO:1905523),0.3112697767405349,0.7224942431554309,0.7918032786885246,0.9879244976906911,1.0,2/19,4.18%,IL34;CSF1
prerank,early endosome to late endosome transport (GO:0045022),0.29618038058585133,0.722136125959996,0.7984,0.9879709682030313,1.0,10/20,27.73%,WDR81;WDR91;PTPN23;HOOK2;BECN1;RILP;STX8;ANKRD27;HOOK1;RAB5A
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.19126359927963055,-0.722044330524533,0.96484375,0.9977159653303732,1.0,15/68,18.14%,TAF1B;SNRPB;TBP;CPSF7;CAVIN1;GTF2H1;TAF1C;CSTF3;CSTF1;UBTF;CLP1;CSTF2;SNRPD3;POLR2E;MED18
prerank,regulation of cilium movement (GO:0003352),0.3501435226390676,0.7215535110978348,0.7927461139896373,0.9882706703865685,1.0,2/10,12.43%,DNAAF1;CCDC40
prerank,positive regulation of immune response (GO:0050778),-0.19813272068925633,-0.721384929547128,0.9421487603305785,0.9976025246773399,1.0,21/64,32.15%,IL15;TGFB2;GBP5;SKAP1;IFI35;SIRT1;CD81;KARS1;NOD2;PTPRC;DHX9;PLSCR1;EIF2AK4;POLR3C;SLC15A4;LILRB1;XBP1;NLRP3;SASH3;FCGR2B;TLR8
prerank,negative regulation of platelet activation (GO:0010544),0.3111732908986063,0.7211537698351511,0.8123980424143556,0.9883455877845938,1.0,4/16,12.06%,PDGFRA;APOE;F2;C1QTNF1
prerank,DNA-dependent DNA replication (GO:0006261),-0.16937867009069388,-0.7209733216900324,1.0,0.9971386335566417,1.0,39/128,30.77%,REV3L;DBF4;TOPBP1;ORC4;POLE4;PSMF1;POLB;PSMB8;PSMA4;MCM8;PSMB10;RAD51;PSMB2;MCMBP;LRWD1;GINS3;PNKP;PSMC4;MCM3;POLD4;PSMA6;PSMD9;PSMD11;PSMD5;WRNIP1;HELB;MCM5;PSMA8;PSMB1;ORC5;PRIM1;PSMD10;CDC6;GINS2;BAZ1A;POLA1;UBC;RPS27A;POLD2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.28047779266722583,0.7209279106066623,0.8296296296296296,0.9881997885839906,1.0,3/30,4.27%,SERPINE1;CFLAR;RFFL
prerank,DNA recombination (GO:0006310),0.27073665957950643,0.7202566352072385,0.8455988455988456,0.9886176872240813,1.0,15/37,28.43%,LIG4;RAD51B;DMC1;RECQL5;RAD51D;RTEL1;XRCC2;RAD54L;MRE11;HMGB3;RAD50;RPAIN;HMGB1;RECQL;RPA1
prerank,superoxide metabolic process (GO:0006801),-0.22706415006286507,-0.7201908400406234,0.8806818181818182,0.9971513369674253,1.0,2/29,2.34%,SH3PXD2A;NOS3
prerank,folic acid metabolic process (GO:0046655),0.30522433332692234,0.7201591993138569,0.8016260162601626,0.9882950737326487,1.0,3/18,12.64%,MTHFR;ALDH1L1;FOLR2
prerank,positive regulation of calcium ion transport (GO:0051928),0.26810892908974127,0.719813890444128,0.8368200836820083,0.988278423152527,1.0,5/36,11.47%,MYLK;PDGFRB;CCL4;SPHK2;P2RX5
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2872148822337134,0.7195594468925105,0.8308383233532934,0.9881596345953605,1.0,7/26,15.38%,SPHK2;TLR6;SLC30A10;SLC5A3;SLC18A2;ABCD2;PIKFYVE
prerank,regulation of protein metabolic process (GO:0051246),0.2584769011290097,0.7186766764318618,0.8741058655221745,0.9888732615297475,1.0,3/44,5.01%,ROCK2;APOE;LDLR
prerank,negative regulation of viral release from host cell (GO:1902187),0.32490767183334107,0.7185421657672885,0.8175675675675675,0.988597474143793,1.0,4/13,19.78%,PML;TRIM32;TRIM26;TRIM21
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2466376911648599,0.7183498637627785,0.8676470588235294,0.9884010240906627,1.0,9/59,16.32%,ROCK2;IRAK2;RNF31;TBK1;RIPK2;CD14;TNFRSF1A;PRDX4;AKT1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.2222453289371179,-0.7182380914696563,0.8817891373801917,0.9985234978334049,1.0,7/30,21.70%,DACH1;ACVRL1;CTC1;BMPR2;CDKN1A;DCP2;TEN1
prerank,mRNA processing (GO:0006397),0.2076032376143497,0.7182265842706519,0.953125,0.9881018552445227,1.0,75/287,23.72%,POLR2D;SON;RBMXL2;U2AF1L4;SNRNP70;THOC2;GTF2H5;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;PRMT9;SUGP1;RBM19;MAGOHB;MNAT1;MTREX;SNRPD2;TCERG1;SRSF5;AKAP8L;PCF11;GPKOW;RBM5;RNPC3;RBM6;CMTR2;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;PRKACA;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;ERCC3;PAPOLA;RBM4;IK;NCBP2;ESS2;CDK7;ZRSR2;SART1;ERCC2;PRPF8;SFPQ;CWC22;CASC3
prerank,DNA packaging (GO:0006323),0.3114522499108642,0.7180847744980164,0.803030303030303,0.9878455061295085,1.0,2/16,8.94%,CHAF1B;AIFM1
prerank,double-strand break repair (GO:0006302),0.21996735710852175,0.717891096218458,0.9237668161434978,0.9876473382823691,1.0,42/158,24.39%,EYA1;ZSWIM7;HPF1;LIG4;INO80;RAD51B;SMC5;DCLRE1C;POLL;RECQL5;UBE2V2;NHEJ1;SMC6;BAZ1B;ACTR8;TENT4A;TDP2;DCLRE1A;RAD51D;XRCC2;RNF138;KPNA2;AP5Z1;ATM;KAT5;DDX1;KDM4A;SUMO1;UIMC1;BRCC3;NSMCE2;FAN1;EXD2;EME2;APLF;SMARCAD1;BRCA1;SFPQ;SETX;NABP2;RAD51AP2;MRE11
prerank,autophagy of nucleus (GO:0044804),-0.26767660101432755,-0.7173252306447575,0.8394160583941606,0.998683938636445,1.0,6/16,21.84%,ULK1;WDR45B;ATG3;WIPI2;ATG13;ATG7
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.34423278960984033,0.7163662462398382,0.788135593220339,0.9891551336954438,1.0,2/10,5.54%,SERPINE1;CYP1B1
prerank,thymus development (GO:0048538),0.32275572778191464,0.7162211682138244,0.8224137931034483,0.988870641641198,1.0,4/13,16.72%,TGFBR1;ZBTB1;EPHB3;SHH
prerank,regulation of T cell proliferation (GO:0042129),-0.19255244400391314,-0.7161130658839105,0.956,0.999131823105353,1.0,14/61,22.62%,SLC7A1;IL15;TFRC;TNFRSF21;CD80;PTPRC;JAK3;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2577520884649564,0.7156365526809383,0.8613037447988904,0.9891743918125051,1.0,10/47,17.93%,APOE;CSF1;AGTR1;WDR91;EIF2B4;MTPN;NR1H3;RBM4B;AKT1;FOXO3
prerank,autophagy of peroxisome (GO:0030242),0.3320251970683288,0.7148820931675813,0.7985074626865671,0.9896830941528677,1.0,3/12,17.38%,USP30;PIK3R4;ATM
prerank,fatty acid metabolic process (GO:0006631),0.22291269991709597,0.714697003087463,0.9224343675417661,0.9894733473238608,1.0,25/115,22.97%,SLC27A5;ACSL1;ACOT11;ACOT6;CPT1C;ACOT2;ALOXE3;AASDH;PEX2;ACSF2;ACSF3;ABCD2;FASN;OXSM;ACADSB;NUDT19;CYP1A1;ACSL4;LPIN3;ALOX12;ALOX5AP;LPIN2;CPT1A;HPGD;ACADM
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20778421556169568,-0.7146200597085649,0.9316546762589928,0.999913178729156,1.0,20/45,32.83%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1;TLR8;STAT3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21634128391767293,0.7145201854895372,0.9412429378531073,0.9892460851899814,1.0,10/163,7.09%,PDPK1;THEMIS;PIK3R1;FYB1;BCL2;RFTN1;PSME4;CD247;RNF31;CD28
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3045164936288828,-0.7143803200878311,0.8086124401913876,0.9992616280957177,1.0,4/11,22.93%,SRPK1;PTCD2;DHX9;SRPK3
prerank,glial cell differentiation (GO:0010001),0.273346481985576,0.7141032167910027,0.8268072289156626,0.9893152761884026,1.0,2/28,3.18%,SLC8A3;NFIB
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.25188129457877095,0.7140925692561444,0.8775790921595599,0.9888750605617675,1.0,16/50,24.01%,CCNA2;CDK5RAP3;CCNK;TTBK1;MNAT1;CNPPD1;CDKN1C;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;CCNE2
prerank,regulation of cell killing (GO:0031341),-0.2701805800982521,-0.7139625053576358,0.8494117647058823,0.9988184835448002,1.0,3/16,9.71%,TGFB2;CD55;MAPK8
prerank,regulation of store-operated calcium entry (GO:2001256),-0.30374617140495064,-0.7138969173395705,0.8259860788863109,0.9979548775701564,1.0,5/10,23.45%,HOMER1;HOMER3;EFHB;GRAMD2A;CASQ1
prerank,reticulophagy (GO:0061709),0.32896856829371945,0.7138128973418482,0.7986230636833046,0.9887544895954888,1.0,4/12,18.10%,ULK2;UFL1;UFC1;ATG2B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2663118713053698,0.7133447832376468,0.8645980253878702,0.988908933652235,1.0,7/36,13.47%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;IGBP1
prerank,microvillus assembly (GO:0030033),0.3149242816342952,0.7132202625704356,0.8021978021978022,0.9886215451943531,1.0,4/14,14.95%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2621228797990472,-0.712695635105524,0.8225352112676056,0.9983693175850428,1.0,3/18,9.59%,ADAM10;ABCG1;ADAM19
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.2852869515221021,-0.7125521798511466,0.84,0.9976156235805479,1.0,8/12,55.04%,CCT8;GNL3;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.18485174050597852,-0.7121582216179297,0.9771689497716894,0.9971144960857148,1.0,21/72,23.95%,CUL1;REL;CARD14;PSMF1;PSMB8;RELB;PSMA4;PSMB10;PSMB2;PSMC4;TNFRSF10B;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;CHUK;MAP3K7;MALT1;PSMA8;PSMB1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3066087477510713,0.7117517951362294,0.805414551607445,0.9900525063754145,1.0,4/17,22.45%,APOA1;NR1H3;LMF1;SORT1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.29436811190614603,0.7116736867233376,0.8245083207261724,0.9897021480979005,1.0,6/22,19.02%,DYNLL1;CDA;BMP4;CDKN1C;CDKN2C;CDKN1B
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3089116704457399,0.7114849831166832,0.8137931034482758,0.9894751500323895,1.0,2/15,11.17%,RIPOR2;CD53
prerank,positive regulation of bone resorption (GO:0045780),-0.2975358950714674,-0.7112388966981167,0.8337182448036952,0.9972137715968974,1.0,2/11,11.79%,TNFRSF11A;SPP1
prerank,translesion synthesis (GO:0019985),-0.20833636029892888,-0.7112196292464324,0.9296296296296296,0.996301016978479,1.0,15/42,30.77%,REV3L;TRIM25;POLH;POLN;UFD1;POLD4;POLK;DTL;RCHY1;FAAP20;VCP;ISG15;UBC;RPS27A;POLD2
prerank,peptidyl-proline modification (GO:0018208),-0.23236046501403035,-0.7109186922282984,0.8914285714285715,0.9957178287487153,1.0,9/25,23.37%,PPIA;FKBP5;PPIG;P3H2;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,RNA biosynthetic process (GO:0032774),-0.2263485077793122,-0.7107817077903902,0.8975155279503105,0.994931010403356,1.0,13/31,31.18%,TBP;TAF10;RSF1;HELB;TAF5;GTF2B;TAF4;TCEA2;PRIM1;TBPL1;SMN1;POLA1;TERT
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.2026487731750804,-0.7104019158484198,0.9335548172757475,0.9944492733681095,1.0,8/45,14.93%,EIF4E;GRM5;LARP4;TDRD7;ATG14;PER1;YTHDC1;APP
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.2644142403688737,-0.7099610294546022,0.8520408163265306,0.9940429050346786,1.0,2/17,4.12%,MEF2C;PRKG1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.2932613377537677,0.7098622750198572,0.8310077519379845,0.991074537226606,1.0,3/22,8.20%,NOS1AP;CACNB1;DRD3
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2916756650425531,-0.708728253156784,0.8329411764705882,0.9945001588882199,1.0,3/12,13.51%,CTBP1;VEGFA;APLNR
prerank,lymphocyte proliferation (GO:0046651),-0.24702123888258015,-0.7086850827480383,0.8792650918635171,0.9936222244626373,1.0,12/22,37.51%,MEF2C;MSN;CD40;PTPRC;PIK3CG;ELF4;FLT3;CR2;MS4A1;TNFRSF4;CD79A;LMBR1L
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2539694240852161,0.7084803997606007,0.8611111111111112,0.9923983107062603,1.0,6/45,9.32%,SP100;NCAM1;IRF1;OAS2;PML;CAMK2B
prerank,neurotrophin signaling pathway (GO:0038179),0.2904689592756155,0.7076897449302625,0.8225039619651348,0.9929340399073303,1.0,4/21,9.37%,RAPGEF2;NTF3;FRS2;RAPGEF1
prerank,regulation of response to biotic stimulus (GO:0002831),0.2726954953169632,0.7076431290644815,0.858600583090379,0.9925354295935822,1.0,11/28,22.80%,APPL2;IRF1;GATA6;RNF135;CX3CL1;DHX58;APPL1;TIRAP;BIRC2;BIRC3;XIAP
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22510812053699963,0.7072665685443381,0.9213615023474179,0.9925452955225442,1.0,7/110,6.31%,TRABD2B;GSN;ABCA1;APOE;CDH5;CDC42;SRC
prerank,positive regulation of transmembrane transport (GO:0034764),0.322274463001056,0.7068095695090697,0.8080133555926544,0.9926366448668423,1.0,2/13,10.64%,ACSL1;BRAF
prerank,fatty acid beta-oxidation (GO:0006635),0.24751468518391595,0.7067319061393157,0.8814229249011858,0.9922887005789645,1.0,11/51,19.95%,IVD;ECHDC2;ECI1;ECHS1;PEX2;DECR1;ABCD2;ETFDH;DECR2;ETFA;ETFB
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.30883845809669086,0.7067023617754093,0.8050314465408805,0.9918758471189691,1.0,9/17,30.58%,DOLPP1;ALG6;DHDDS;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,regulation of RNA splicing (GO:0043484),0.23624987483148954,0.7065175752835715,0.9038208168642952,0.9916506389576284,1.0,13/69,15.61%,PIK3R1;SON;HNRNPLL;SNRNP70;SF1;RBM22;CLK4;RBM39;TMBIM6;METTL4;CLK3;DYRK1A;SLC38A2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2834583359225126,0.7061313417239904,0.8161094224924013,0.9916715161733994,1.0,2/24,3.47%,EPHA4;APOE
prerank,response to growth factor (GO:0070848),0.25990734590237474,0.7061303112891842,0.8674188998589563,0.9912202415186164,1.0,8/41,16.32%,BMPR1A;TGFBR1;ACVR1;SFRP1;STAT5B;ACVR1B;GATA6;AKT1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.34344350362943965,0.706089125548619,0.8051470588235294,0.9908174011653328,1.0,4/10,21.45%,INO80;CDC7;ATRX;STOML2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2091953299685717,0.7056765486422443,0.9663677130044843,0.9908635530774451,1.0,41/193,18.74%,SPSB1;DCST1;NEDD4;RFFL;SMURF2;RNF213;BFAR;ZNRF3;UBE4B;TRIP12;RNF185;UBR4;ARRB1;WDR81;ANAPC5;WDR91;PRKN;ITCH;RNF6;MIB1;FBXO11;FEM1C;BTRC;RNF217;COPS3;RNF19A;RC3H2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;RNF13;UBE2R2;UBR3;LONP1;UBE3B;PSMC2;RC3H1;RNF34;TRIM32
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.3067693673227825,0.704853854579065,0.805921052631579,0.9914388180968018,1.0,2/16,4.55%,DPYSL3;DPYD
prerank,response to ionizing radiation (GO:0010212),0.235624478764552,0.7048436177110323,0.9086229086229086,0.9909990769314996,1.0,8/70,10.58%,EYA1;LIG4;IKBIP;INO80;BRSK1;NHEJ1;STK11;MRNIP
prerank,endoderm development (GO:0007492),0.3226552724046269,0.7046054258569026,0.8147512864493996,0.9908436617618637,1.0,1/13,2.67%,LAMC1
prerank,protein alkylation (GO:0008213),-0.23746116086965993,-0.704159916678581,0.8811369509043928,0.9975983187133479,1.0,11/22,42.60%,SNRPB;FAM98B;SNRPD3;PRMT3;LCMT1;CAMKMT;PRMT2;EEF1AKMT1;ETF1;EEF1AKMT2;FAM98A
prerank,negative regulation of response to stimulus (GO:0048585),0.24223263690823613,0.7041219497074468,0.9009370816599732,0.9910048950341553,1.0,13/60,14.80%,LYN;APOA1;APPL2;ACVR1;CASK;AKT3;SLC30A10;ZKSCAN3;IGFBP3;ADRA2A;TERF2;COL3A1;NR1H3
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2747016323180307,0.7039783230995363,0.8545454545454545,0.9907110081272396,1.0,5/28,15.04%,BCL2;MOAP1;DDX3X;CASP8AP2;TNFRSF1A
prerank,negative regulation of organelle assembly (GO:1902116),0.2599860380622025,0.7029231993925805,0.865606936416185,0.9915386556242812,1.0,5/35,11.56%,YAP1;NUPR1;LRRK2;KAT2B;MDM1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3122369880780136,-0.7026290087751008,0.8306264501160093,0.9982645247651785,1.0,4/10,33.84%,GNB1;PDE6A;PDE6B;SAG
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2897656768473055,0.7018329465963724,0.8165584415584416,0.9924170805082998,1.0,1/20,1.77%,LYN
prerank,regulation of translation (GO:0006417),0.21379906076210037,0.7018145803017046,0.9534368070953437,0.9919960279722069,1.0,28/173,18.51%,SAMD4A;DAPK1;PLD1;IGF2BP2;IGFBP5;CPEB3;CD28;EIF2AK3;RNF139;METTL14;EIF4A2;EIF6;EIF2B4;DDX3X;EIF5B;IMPACT;LARP1;MTPN;ENC1;PLXNB2;NSUN5;RBM4B;SYNCRIP;FOXO3;ALKBH1;METTL3;EIF3C;DDX1
prerank,establishment of protein localization to organelle (GO:0072594),0.2302536981736121,0.7016713463645898,0.9042145593869731,0.9917077407041728,1.0,16/72,18.84%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,protein-DNA complex assembly (GO:0065004),0.2174435960152145,0.7015366073595555,0.931924882629108,0.9914077690812593,1.0,6/116,6.57%,TCF4;PSME4;CHAF1B;DMC1;GTF2H5;CUL4B
prerank,histone H2A monoubiquitination (GO:0035518),0.3046403693603409,0.7015216537295762,0.824212271973466,0.9909767247456308,1.0,3/17,8.78%,BCOR;CUL4B;PCGF3
prerank,mRNA methylation (GO:0080009),0.3038301650216766,0.7011177677732917,0.8289036544850499,0.9910032738895308,1.0,6/15,24.75%,NSUN2;METTL14;WTAP;METTL3;METTL16;PCIF1
prerank,positive regulation of T cell migration (GO:2000406),-0.25172776977284594,-0.7010269571904529,0.8837837837837837,0.9990198890437348,1.0,1/20,1.02%,ADAM10
prerank,regulation of T cell activation (GO:0050863),-0.2051132182298538,-0.7009763260674677,0.9491525423728814,0.998144632021156,1.0,15/42,38.43%,CYRIB;SIRPA;KAT2A;PTPN22;JAK3;CCL2;LAX1;DUSP3;IL4I1;LAT;TNFSF8;PRKCQ;CRTAM;CCDC88B;TNFSF11
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2847806475480207,0.6996658627314108,0.8300970873786407,0.9923255380734896,1.0,3/22,9.41%,APOA1;SPHK2;TRPM4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2337083624159487,0.6991275980473873,0.8922077922077922,0.9925504951418861,1.0,8/68,11.01%,IL6R;IL17D;TSLP;SPHK2;TLR6;RAB7B;CARD9;SETD4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2763962023302323,-0.6989329912545115,0.8592233009708737,0.9993372145207543,1.0,2/13,6.87%,STX3;HSP90AB1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.29840107107385483,0.6988306738419136,0.8224755700325733,0.992478653548332,1.0,5/16,19.20%,KAT2B;NAA40;NAA20;NAA80;NAA50
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2414547656116261,0.6980862316595776,0.9105263157894737,0.9929049496406633,1.0,17/62,21.18%,BCL2;SRC;LRRK2;NFE2L2;PRKN;CREB3;DDX3X;SELENOS;NOL3;VNN1;BAG5;TMBIM6;AKT1;TRIM32;CREB3L1;PPIF;OPA1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2224662972397149,-0.6979207321221582,0.9289772727272727,0.9994485615038889,1.0,11/27,32.44%,UBE2H;ANAPC7;UBE2D3;UBE2B;UBE2S;RNF4;UBE2A;FZR1;ANAPC11;ANAPC13;UBE2C
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.31668260440213525,0.6977878958182405,0.8234265734265734,0.9923472947132431,1.0,2/15,9.55%,DTNBP1;BLOC1S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.31668260440213525,0.6977878958182405,0.8234265734265734,0.9923472947132431,1.0,2/15,9.55%,DTNBP1;BLOC1S1
prerank,tRNA processing (GO:0008033),0.2372444535944448,0.6976734353979875,0.9012987012987013,0.9920455080929921,1.0,14/61,19.91%,PUS3;ADAT2;ZBTB8OS;NSUN2;ADAT1;TRMT9B;URM1;RPP30;ELP5;DTWD1;DDX1;ANKRD16;TRUB1;METTL1
prerank,calcium ion transport into cytosol (GO:0060402),0.2936854397789886,0.6973088954354961,0.8348909657320872,0.9920385473890677,1.0,2/21,6.66%,SLC8A1;CACNA1C
prerank,base-excision repair (GO:0006284),0.24908524543825017,0.6972948726975178,0.8817204301075269,0.9916045918051888,1.0,12/48,23.94%,OGG1;USP47;NEIL1;POLG;POLL;MBD4;HUWE1;XPA;RFC5;MUTYH;LIG1;TDG
prerank,organophosphate biosynthetic process (GO:0090407),-0.21442225663999825,-0.6970376108524691,0.9292604501607717,0.9994237105354785,1.0,11/37,25.99%,LPCAT1;MBOAT1;TPI1;IP6K1;IPMK;AGPAT5;GPHN;PPIP5K1;ITPKB;MOCS2;ITPKC
prerank,neutrophil mediated immunity (GO:0002446),0.19958028683053464,0.6969743451939509,0.9846311475409836,0.991533403704865,1.0,70/432,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;CARD9;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;KMT2E;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3181645809702265,0.6968336528427431,0.8396694214876033,0.9912512555432663,1.0,6/14,27.75%,MRNIP;TIMELESS;ARID2;FUS;MMS19;FANCB
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2966882473161439,-0.6967425236808809,0.8452088452088452,0.9988248480659058,1.0,2/11,7.30%,PLCG2;CDH13
prerank,endochondral bone morphogenesis (GO:0060350),-0.2861173730885355,-0.6962380710229888,0.8325123152709359,0.9984275564261026,1.0,1/11,0.57%,MEF2C
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20401577132163073,0.6961831815287394,0.9721627408993576,0.9916003229184763,1.0,62/241,23.72%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24277488915454878,0.696066058913658,0.8895104895104895,0.9912942122000771,1.0,15/48,21.40%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS;GCGR;RUBCNL
prerank,cellular component maintenance (GO:0043954),0.32438183986660557,0.6957920213882183,0.8304498269896193,0.9911685545986062,1.0,2/12,12.56%,ITGA3;INSR
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.2786886060458703,0.6954843424060658,0.8385093167701864,0.9910648952297294,1.0,5/22,17.38%,PLA2R1;CDK5RAP3;SPRED3;SPRED1;ATM
prerank,regulation of cell aging (GO:0090342),0.3217799768015078,0.6947392440730286,0.8168761220825853,0.9914877031568526,1.0,2/11,10.63%,NUAK1;NEK6
prerank,positive regulation of telomere maintenance (GO:0032206),-0.21555565831447437,-0.694353332801275,0.9085173501577287,0.9994715765692986,1.0,9/31,22.34%,NEK7;PKIB;HNRNPD;MAPK3;HNRNPA2B1;PNKP;NBN;SLX4;MAPK1
prerank,regulation of receptor recycling (GO:0001919),-0.2611294514102592,-0.6943283513817752,0.8746987951807229,0.9985683503830204,1.0,4/16,11.54%,INPP5F;KIF16B;SCRIB;NSF
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2278526929058251,-0.6939437957521783,0.9273255813953488,0.9980486806012702,1.0,9/27,28.89%,GSR;AK6;AK5;TYMS;AK7;DCTD;AK2;RRM1;NME2
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.26828946600480036,-0.6939157504886049,0.8790697674418605,0.9971645467759418,1.0,5/15,21.60%,PLCG2;EZH2;CUL3;NPM1;DDRGK1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.27030779620459483,0.6937918186089844,0.8673780487804879,0.992114663911193,1.0,8/27,21.73%,IRAK2;TLR6;IRAK3;CD14;TNIP1;TLR5;TIRAP;MYD88
prerank,folic acid-containing compound metabolic process (GO:0006760),0.2915538048817966,0.6937572639447569,0.8381877022653722,0.9917079276685687,1.0,3/19,12.64%,MTHFR;ALDH1L1;FOLR2
prerank,regulation of spindle organization (GO:0090224),0.29426943025955266,0.6934865714299614,0.842443729903537,0.9915687128339553,1.0,5/18,19.34%,DYNC1H1;RAE1;SENP6;GNAI1;NUMA1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3007551706406376,0.6934241702104125,0.84251968503937,0.991198070509022,1.0,2/17,8.32%,PLA2G4A;LPGAT1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.1931446777422882,-0.6930836293429228,0.9709090909090909,0.9970587372200123,1.0,12/54,21.43%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;EP300;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28338092870686493,0.6925386747075902,0.8597063621533442,0.9918085754373519,1.0,3/20,9.16%,BCL2;PML;BCAP31
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.23796576630553806,0.6916809010326297,0.8944519621109608,0.9923912620808527,1.0,18/56,20.58%,RAD51B;EGFR;ANAPC5;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC7;KLHL18;PHB2;NSMCE2;CDC23;PLCB1;CCND2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.2583284922599329,-0.691588403284729,0.8779904306220095,0.9976575883608114,1.0,3/16,11.55%,MEF2C;SMYD1;RANBP3L
prerank,response to cholesterol (GO:0070723),0.3031989887411368,0.6915747423621001,0.8502495840266223,0.9920779918933562,1.0,2/17,3.64%,TGFBR1;SMO
prerank,peptidyl-lysine acetylation (GO:0018394),0.33461942694566527,0.6912882104978448,0.8392857142857143,0.9919484593050037,1.0,5/10,24.13%,KAT2B;BLOC1S1;KAT5;BAG6;ESCO1
prerank,DNA geometric change (GO:0032392),-0.23015526178409879,-0.6909019363997394,0.9034090909090909,0.9974220105803041,1.0,7/24,19.40%,ZRANB3;SUPV3L1;HNRNPA2B1;NBN;HMGB2;ANXA1;DHX9
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.27081140818813015,0.6905742844933295,0.8597014925373134,0.9923260462412913,1.0,6/25,17.81%,B3GALT1;B3GALNT1;EXT1;NDST1;EXT2;HS2ST1
prerank,nucleosome organization (GO:0034728),-0.18573156985413408,-0.6903041722224925,0.9596774193548387,0.9971163686897638,1.0,23/55,29.47%,NAP1L4;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;VPS72;NPM1;MCM3AP;RNF8;ANP32E;ZNHIT1;NASP;LIN54;ASF1A;SMARCA4;ARID1A;BPTF;SET;GRWD1;H1-0;NAP1L3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2463793167168346,0.6898506121402253,0.9006993006993007,0.9927327851116314,1.0,8/47,13.47%,TGFBR3;MAP2K1;EGFR;MAP4K4;CARD9;TAOK3;RAP2A;IGBP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.24797667124376427,-0.6888078791088884,0.8731707317073171,0.9976689450173433,1.0,9/18,38.19%,CCT8;RUVBL1;DCP2;RUVBL2;SHQ1;NHP2;CCT6A;EXOSC10;NOP10
prerank,protein targeting to peroxisome (GO:0006625),0.2659048280859532,0.6886630943456734,0.849925705794948,0.993636639583465,1.0,10/29,23.71%,PXMP2;LONP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;ZFAND6;PEX1;ATAD1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.30028923691690484,0.6885520585801146,0.8363047001620746,0.9933153538207234,1.0,6/17,16.32%,NFE2L2;NOL3;P4HB;VNN1;BAG5;AKT1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.2795121411073307,0.6882898711971361,0.856,0.9931547476908014,1.0,3/22,12.38%,APOA1;MYADM;WNK1
prerank,sensory perception of taste (GO:0050909),-0.29106971782644797,-0.6879626336873823,0.8485523385300668,0.9975658301770651,1.0,5/10,44.03%,PKD2L1;CD36;TAS1R1;TAS1R2;GNAT3
prerank,positive regulation of interleukin-12 production (GO:0032735),0.26217728864247214,0.6878873443885688,0.8770370370370371,0.9931835902167643,1.0,8/31,21.58%,CCL19;IL12B;RIPK2;MDK;IL23A;PLCB1;TIRAP;LGALS9
prerank,positive regulation of mRNA processing (GO:0050685),-0.2409269160582055,-0.6878410269579666,0.8814016172506739,0.9967687764115932,1.0,5/21,18.99%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.21088278898571167,-0.6870355602088212,0.94,0.9966444446240224,1.0,14/36,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;HUS1B;DONSON;CDC6;RAD9A;DOT1L;FBXO6
prerank,neutrophil degranulation (GO:0043312),0.19659139185787342,0.6869705598893044,0.9887640449438202,0.9937927434590327,1.0,68/425,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.27076465675994493,-0.6864762404916745,0.8857142857142857,0.9962352008602036,1.0,2/13,13.52%,SIX1;PTGS2
prerank,positive regulation of cellular respiration (GO:1901857),0.32485007672073546,0.6862330498788177,0.8252100840336134,0.9941556568053302,1.0,1/11,3.58%,NUPR1
prerank,mitotic spindle organization (GO:0007052),0.2100952474655797,0.685578372591313,0.9626696832579186,0.9944562842562091,1.0,36/153,22.74%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;PIBF1;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;ARHGEF10;DYNC1I2;EML4;FLNA;PLK2;CEP192;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;AAAS;DSN1;AURKA;TAOK1;NDE1;ABRAXAS2;TUBG2;TUBG1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2579670894560755,-0.6855368464901889,0.8746736292428199,0.9961790301155362,1.0,9/17,29.37%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,neutrophil activation involved in immune response (GO:0002283),0.19613784049560773,0.6854842862585069,0.9918200408997955,0.9941210265604714,1.0,68/428,16.21%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.31945756519183166,0.6851635474890087,0.8100358422939068,0.993175285950289,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.31945756519183166,0.6851635474890087,0.8100358422939068,0.993175285950289,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.31945756519183166,0.6851635474890087,0.8100358422939068,0.993175285950289,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,cellular response to reactive oxygen species (GO:0034614),0.23805535553111432,0.6840081201884549,0.8963660834454913,0.9939928349253623,1.0,7/59,8.60%,TPM1;PDGFRA;CYP1B1;NFE2L2;ERCC6L2;OSER1;EGFR
prerank,pyroptosis (GO:0070269),-0.2639369832177195,-0.6839458536331986,0.8563829787234043,0.9968083537677463,1.0,5/15,23.90%,AIM2;CASP8;APIP;DHX9;TREM2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.31833553574925394,0.6838055348242676,0.832258064516129,0.9937888886199435,1.0,8/13,30.58%,ALG11;ALG6;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,regulation of dephosphorylation (GO:0035303),0.3024383237733947,0.6835792615193017,0.8274111675126904,0.9935828695050122,1.0,4/15,13.47%,CDK5RAP3;SRC;MTMR3;IGBP1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3298603154001173,0.6832711425630126,0.8486956521739131,0.9934581537171764,1.0,1/10,4.42%,APPL2
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.2745570319939604,-0.6825514581648022,0.8222748815165877,0.9971566009452225,1.0,2/12,11.18%,NOTCH1;HES1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2830879845716524,0.6823014893624412,0.8597359735973598,0.9940993418558297,1.0,5/18,13.78%,FRS2;BMP2;BHLHE41;TMEM119;HDAC4
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.312205037778084,0.6818564116146972,0.8303130148270181,0.9941379540407665,1.0,6/13,23.50%,BFAR;UFL1;ABCA7;WFS1;HSPA5;PPP1R15A
prerank,mitotic cytokinetic process (GO:1902410),0.2883837431869298,0.6814077568082704,0.8622366288492707,0.9941684307266015,1.0,3/20,13.16%,KIF20A;KLHDC8B;CHMP5
prerank,response to amino acid starvation (GO:1990928),0.22812294855767362,0.6813093129797788,0.929757343550447,0.9938277405718535,1.0,19/72,21.57%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;LARP1;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,defense response to fungus (GO:0050832),-0.2567670514083011,-0.6805749937505766,0.8847117794486216,0.9980573730271911,1.0,2/17,11.17%,PLCG2;CX3CR1
prerank,phagolysosome assembly (GO:0001845),0.3224588671071706,0.6802887999863844,0.8424908424908425,0.9945009016333907,1.0,3/12,15.38%,RAB7B;CLN3;PIKFYVE
prerank,mRNA catabolic process (GO:0006402),-0.19666639432041502,-0.6795690681477492,0.945054945054945,0.9980793337547039,1.0,12/44,19.45%,PNPT1;LSM2;LSM6;THRAP3;SUPV3L1;DIS3L2;ERN1;NBAS;AGO1;RNH1;DDX5;DCP2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2937818923272345,-0.6793899027228157,0.868421052631579,0.9973423739423758,1.0,1/10,1.66%,BICD1
prerank,negative regulation of cell aging (GO:0090344),0.2916915325353308,0.6791837565351274,0.8330578512396695,0.9952309971957567,1.0,4/16,12.18%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,pre-replicative complex assembly (GO:0036388),-0.18187269080499754,-0.677973052935373,0.9761904761904762,0.9977171187211641,1.0,22/64,31.88%,ORC4;PSMF1;PSMB8;PSMA4;MCM8;PSMB10;PSMB2;PSMC4;MCM3;PSMA6;PSMD9;PSMD11;PSMD5;MCM5;PSMA8;PSMB1;ORC5;PSMD10;CDC6;UBC;RPS27A;PSMC3
prerank,cytosolic transport (GO:0016482),0.21387040683003708,0.6768772887350262,0.9588875453446191,0.9973158864810567,1.0,19/108,15.38%,DENND2A;BAIAP3;RHOBTB3;MON2;STX16;RBSN;DENND5A;EPS15;GOSR2;HEATR5A;WDR81;WDR91;ARL1;CLN3;TMEM87B;PTPN23;HOOK2;BET1L;PIKFYVE
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.25661872260623503,-0.676097399500806,0.8899521531100478,0.9985585631091609,1.0,8/14,31.21%,LIMS2;EMP2;LIMS1;ITGB1BP1;DMTN;PRKD1;BST1;PHACTR4
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.19954866920083036,-0.6759645264128853,0.9726027397260274,0.997757972836733,1.0,17/42,35.23%,KDM1A;SHLD1;CGAS;RAD51;PARPBP;PARP1;POLQ;HELB;SHLD2;RAD51AP1;KLHL15;WDR48;FIGNL1;WAS;RPA2;SIRT6;RADX
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.25458616277077795,-0.6758150081455327,0.8952380952380953,0.9970028428642045,1.0,9/15,40.09%,PLIN2;PNPLA2;OSBPL11;TREM2;PLIN3;LPL;FITM2;PLIN5;APOC4
prerank,regulation of myelination (GO:0031641),-0.23031867413216317,-0.6756791162888266,0.9327485380116959,0.9962288496765168,1.0,4/25,11.15%,JAM2;TENM4;PTN;TNFRSF21
prerank,negative regulation of centrosome duplication (GO:0010826),-0.28304642493416876,-0.6752621261138434,0.885,0.9957022791321328,1.0,4/11,18.90%,RBM14;KAT2A;CDK5RAP2;NPM1
prerank,protein K63-linked ubiquitination (GO:0070534),0.24564884308143742,0.6745818400561747,0.9051724137931034,0.9993499789656758,1.0,11/41,20.63%,NEDD4;BFAR;UBE2V2;PRKN;ITCH;RNF152;UBE2E2;RNF135;TRIM21;ARIH2;UBE2T
prerank,negative regulation of secretion (GO:0051048),-0.2888138913617624,-0.6743085860734751,0.863849765258216,0.9956489524696204,1.0,2/10,12.77%,VAMP8;ERBB3
prerank,response to peptide (GO:1901652),0.2541010866902887,0.6739745910125872,0.8913362701908958,0.9995571644076872,1.0,7/33,15.71%,MMP2;STAT5B;STAT2;EIF2B4;STAT6;STAT4;EIF2B3
prerank,regulation of JUN kinase activity (GO:0043506),0.25562470368815227,0.6716797165230244,0.9125188536953243,1.0,1.0,5/33,12.62%,SASH1;TLR6;TAOK3;DUSP19;PDCD4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.28732880539428635,0.6712779929251909,0.8410596026490066,1.0,1.0,9/18,28.95%,EIF2AK3;WDR43;FLNA;PHF8;POLR2L;MAF1;HEATR1;SIRT7;LYAR
prerank,monoacylglycerol metabolic process (GO:0046462),0.3027750796166485,0.6712448569530527,0.830155979202773,1.0,1.0,3/13,14.60%,PLA2G4A;MOGAT3;DGAT2
prerank,cilium-dependent cell motility (GO:0060285),0.2742217408570733,0.671239082149788,0.8489984591679507,1.0,1.0,3/22,10.78%,EFHC1;DNAI3;CFAP44
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2312514628548392,-0.6711886059918559,0.9125964010282777,0.9975270509062932,1.0,8/22,27.02%,ERBB2;PWP1;UBTF;MTOR;UTP15;ATF4;SMARCA4;PIH1D1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.31595777540293957,0.670631763037638,0.8327338129496403,1.0,1.0,4/10,18.29%,ERLEC1;DERL3;UBAC2;INSIG1
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.23129725526159442,-0.669367641523403,0.8861111111111111,0.9981144983742202,1.0,9/21,31.19%,TNFAIP3;PTPN22;JAK3;LST1;LAX1;DUSP3;IL4I1;FOXJ1;FCGR2B
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31820939793411424,0.669359741289235,0.8371681415929203,1.0,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,DNA dealkylation (GO:0035510),0.31820939793411424,0.669359741289235,0.8371681415929203,1.0,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3202025110945821,0.6688019202704084,0.8288770053475936,1.0,1.0,3/10,22.80%,IL12B;DDIT3;NCKAP1L
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2109902662438243,0.6686294962292325,0.9360902255639098,1.0,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,cellular response to lectin (GO:1990858),0.2109902662438243,0.6686294962292325,0.9360902255639098,1.0,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,mitochondrion organization (GO:0007005),0.20196516522263536,0.6684493078896161,0.9726962457337884,1.0,1.0,36/165,20.40%,PID1;PYROXD2;COX7A2;MIGA2;TIMM17B;LRRK2;AKT3;AIFM1;WDR81;BCAP31;PRKN;TIMM44;RHOT1;TIMM9;TFAM;TSPO;NUBPL;POLRMT;USP30;SLC25A36;MUL1;IFIT2;RAB5IF;WASF1;TOMM22;FMC1;VPS13D;LONP1;VPS13C;RAB32;YME1L1;PHB2;SIRT5;AFG3L2;MTFP1;TOMM5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.28014562802083987,-0.6673176175394014,0.8981042654028436,0.9981464723314454,1.0,11/11,72.01%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.28014562802083987,-0.6673176175394014,0.8981042654028436,0.9981464723314454,1.0,11/11,72.01%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,nuclear membrane organization (GO:0071763),0.27905031164197047,0.6669899977719164,0.8788368336025848,1.0,1.0,5/19,19.67%,UBXN2B;TOR1AIP1;TOR1B;AKAP8L;NSFL1C
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.26746402430012167,0.6663883949601663,0.8827258320126783,1.0,1.0,5/24,12.85%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,phospholipid metabolic process (GO:0006644),0.2206920606436629,0.666064683920677,0.9336734693877551,1.0,1.0,5/71,6.05%,PLPP3;PLCD1;PLA2G4A;SMPD2;AGPAT3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.20605559655956018,-0.6654912546366186,0.9452054794520548,0.9987772261402705,1.0,13/35,26.58%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;FKBP1A;CD300A;GSK3B;PPP1R11;PPP6R3;CALM2;PPP1R1B
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21011760277805314,0.6654347261025095,0.9410288582183187,1.0,1.0,5/105,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,metanephros development (GO:0001656),0.2628415775577175,0.6651717706593365,0.8761467889908257,1.0,1.0,3/26,7.89%,GDNF;CTSH;OSR1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3078109733936067,0.6650156911797237,0.842832469775475,1.0,1.0,5/12,24.87%,MCM2;CDC7;GINS4;MCMDC2;MCM6
prerank,nuclear envelope organization (GO:0006998),0.27811184968724456,0.6648998542844794,0.8587662337662337,1.0,1.0,5/20,18.33%,DMPK;LEMD3;TOR1AIP1;TOR1B;REEP4
prerank,organelle assembly (GO:0070925),0.19246774430549124,0.6645929197329866,0.9969325153374233,1.0,1.0,74/384,20.29%,ASAP1;GSN;DYNLL1;PARVA;TMOD4;WDPCP;GORASP2;SH3PXD2B;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;INO80;ULK2;TTC39C;B9D1;WDR35;IFT43;UBXN2B;DNAAF1;FBF1;NCOR1;IFT81;MAPRE2;CENPC;DYNC2I1;NEK6;CFAP44;DDX3X;EMC6;CFAP410;VPS37D;WIPI1;HAUS1;GOLGA8B;CHMP5;PTPDC1;ABCA3;ARF4;SYNPO;PTPN23;HAUS7;FLNA;HAUS3;CEP164;PRRC2C;IFT74;POGZ;AUP1;RAB19;DZIP1;ABCB6;MAP1LC3A;INTU;PATL1;TMEM67;RAB32;RP2;BECN1;ATG2B;AHI1;RC3H1;CENPA;TTC36;HPS4;HYLS1;TMEM231;NSFL1C;EHD1;YTHDF2;WDR45;OCRL
prerank,regulation of nervous system development (GO:0051960),0.24971854585070483,0.6645189894497919,0.8951149425287356,1.0,1.0,9/37,19.98%,ASCL1;YAP1;HES7;SIRT2;BHLHE41;NSUN5;CX3CL1;WNT3;YTHDF2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3104752719442862,0.6644278444936789,0.8402777777777778,1.0,1.0,3/11,14.80%,LDLR;SREBF1;NR1H3
prerank,mitochondrion disassembly (GO:0061726),0.2503457273165534,0.664220227120585,0.9070796460176991,0.9998977110258871,1.0,12/34,22.93%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.22542976309970994,-0.6638296656554011,0.908256880733945,0.9992828617650007,1.0,8/24,27.53%,LPCAT1;PGS1;PNPLA8;CRLS1;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,myelination in peripheral nervous system (GO:0022011),0.30394127868561777,0.6635093991648672,0.8533333333333334,1.0,1.0,7/13,20.80%,SKI;SIRT2;ARHGEF10;PARD3;NCMAP;DICER1;PRX
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.2520680196493863,-0.6630530848908616,0.891358024691358,0.9989998465416076,1.0,6/15,27.02%,GBP5;NLRP2B;TLR4;TREM2;CPTP;CD36
prerank,respiratory chain complex IV assembly (GO:0008535),0.2698701308879564,0.6626785279017289,0.8782051282051282,1.0,1.0,5/21,19.37%,COX18;COX10;COA6;PET100;FASTKD3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.2827362013882568,-0.6624899159538452,0.8767441860465116,0.9985726552801208,1.0,5/10,30.67%,SAE1;RWDD3;UBA2;GNL3;RASD2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.24299714290537594,0.6622152145428598,0.8977272727272727,1.0,1.0,7/38,16.32%,DAG1;DRD3;PHLPP2;MUL1;TSC2;PTEN;AKT1
prerank,cochlea morphogenesis (GO:0090103),-0.28225216801655645,-0.6619598625662243,0.8735362997658079,0.9981235873359224,1.0,6/10,40.15%,TBX1;MYO3B;MYO3A;TBX18;HOXA1;PAX2
prerank,cellular response to superoxide (GO:0071451),-0.28780307084002466,-0.6614939597284728,0.8774617067833698,0.9976422610569778,1.0,5/10,27.59%,NOS3;ATP7A;SOD2;CCS;SOD1
prerank,motile cilium assembly (GO:0044458),0.3016183465241351,0.6614882817863287,0.8692579505300353,1.0,1.0,2/12,12.43%,DNAAF1;CCDC40
prerank,regulation of innate immune response (GO:0045088),0.22825996666798998,0.6613730013706925,0.9332443257676902,1.0,1.0,17/57,22.80%,APPL2;IRF1;NMI;IRAK3;RNASEL;IFNK;ABCE1;MUL1;RIOK3;RNF135;DHX58;APPL1;TRIM21;TIRAP;BIRC2;BIRC3;XIAP
prerank,positive regulation of protein depolymerization (GO:1901881),0.3056854628017491,0.6609280885413342,0.8397887323943662,1.0,1.0,2/11,9.55%,SEMA5A;KATNB1
prerank,regulation of telomerase activity (GO:0051972),-0.18710929928069464,-0.6608261770756647,0.981549815498155,0.9972852275639317,1.0,7/45,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,positive regulation of protein acetylation (GO:1901985),0.3045829589135958,0.6606032043945225,0.837248322147651,1.0,1.0,4/12,21.34%,PRKAA2;DDX3X;KAT5;TAOK1
prerank,endoplasmic reticulum organization (GO:0007029),0.22090132552860647,0.6602925415925859,0.9367888748419722,1.0,1.0,16/72,19.83%,LMAN2L;SEC31A;TRAM2;LMAN1;LRRK2;EIF2AK3;CYB5A;MIA3;TRAM1;TOR1B;TOR1AIP2;REEP4;SEC16B;MOSPD3;SMPD4;CCDC47
prerank,microtubule depolymerization (GO:0007019),0.2852377783568505,0.6602517141313622,0.8522167487684729,0.9998504551048134,1.0,5/17,21.99%,NCKAP5;KATNB1;KIF19;KIF24;CCSAP
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.21294915263042463,-0.6602126715848752,0.9426934097421203,0.996888012831377,1.0,14/28,39.79%,MAP2;GAS2L1;MAP1B;CLASP1;SKA3;PRUNE1;MAPRE1;STMN4;CAMSAP2;STMN1;MAPT;MAP1A;CLASP2;SKA1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3074458110401533,0.6600218032015758,0.8450450450450451,0.9996433550553065,1.0,3/12,13.79%,GORASP1;BTRC;PTEN
prerank,protein deacylation (GO:0035601),0.27315229688927084,0.6599407293320444,0.8708133971291866,0.9992758441850946,1.0,9/23,25.04%,ABHD17C;LYPLAL1;SIRT2;HDAC4;SIRT5;NOTUM;HDAC6;HDAC5;HDAC1
prerank,regulation of response to stress (GO:0080134),-0.2854150479024733,-0.6594544917746309,0.8691588785046729,0.996610380902743,1.0,3/10,21.53%,ADCY8;MLC1;CORO2B
prerank,regulation of protein transport (GO:0051223),0.26100717143787744,0.659064038044398,0.8892307692307693,0.9997223173381196,1.0,9/27,25.72%,DNAJC1;SNX12;LLGL1;RHBDF2;ATP13A2;LLGL2;DNAJA1;SCFD1;P3H1
prerank,eosinophil migration (GO:0072677),0.2958345277981145,0.6588658635079658,0.8404802744425386,0.999065065500458,1.0,2/14,17.52%,CCL4;CX3CL1
prerank,eosinophil chemotaxis (GO:0048245),0.2958345277981145,0.6588658635079658,0.8404802744425386,0.999065065500458,1.0,2/14,17.52%,CCL4;CX3CL1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.17428463460551816,-0.6588261644016882,0.9760956175298805,0.996224010708548,1.0,17/67,23.95%,B2M;VAMP8;NCF2;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1
prerank,myeloid cell development (GO:0061515),0.2795555860867805,0.6586241032262485,0.8846153846153846,0.9988830488604079,1.0,2/18,6.31%,KIT;SRC
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.27793320516427034,0.6560891933038212,0.8919803600654664,1.0,1.0,1/18,1.77%,LYN
prerank,snRNA processing (GO:0016180),-0.2495292554784087,-0.6558957433693428,0.9230769230769231,0.9975801657159455,1.0,6/16,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;INTS11
prerank,response to light stimulus (GO:0009416),0.22700069487079888,0.655375356782286,0.9247311827956989,1.0,1.0,7/55,12.96%,SLC24A1;PCLAF;SPRTN;UBE4B;BRSK1;ERCC8;COPS3
prerank,nuclear membrane disassembly (GO:0051081),-0.25674540507137283,-0.655322812148833,0.8719806763285024,0.9971581395825836,1.0,7/14,29.32%,VRK1;DCTN1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2794197774848821,0.6552458248390466,0.9021558872305141,1.0,1.0,7/17,23.43%,APOE;SREBF1;ERLIN1;KPNB1;SEC14L2;ERLIN2;SREBF2
prerank,glucose import (GO:0046323),0.29839620827278424,0.6551992006418088,0.8764805414551607,1.0,1.0,5/13,22.91%,SLC2A10;TRARG1;SLC2A4;SORT1;SLC27A1
prerank,myelin maintenance (GO:0043217),0.31192441929410564,0.6546071071069458,0.8578767123287672,1.0,1.0,4/10,20.80%,PTEN;ABCD2;EPB41L3;PRX
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.29094487367434185,0.6545010724053544,0.8576329331046312,1.0,1.0,7/14,25.56%,ADK;GART;PPAT;PFAS;ADSS1;ADSL;LHPP
prerank,regulation of organelle organization (GO:0033043),0.21314785350457346,0.6544480786076036,0.9516728624535316,0.9998196375550727,1.0,14/80,16.11%,ZEB2;USP6NL;LMAN1;RBSN;SYDE1;PRKN;RHOT1;NEXN;CLN3;MUL1;SYT11;MARK2;ARMH3;GOLPH3
prerank,regulation of synapse maturation (GO:0090128),0.31165466505881645,0.6542284753694593,0.8471454880294659,0.999598317109864,1.0,2/10,9.32%,ADGRL1;CAMK2B
prerank,regulation of interferon-beta production (GO:0032648),0.23421167155353986,0.6540754585414554,0.9180327868852459,0.9993239604717413,1.0,10/46,18.23%,IRF1;PTPRS;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19909255235598958,0.6538850129438063,0.9921348314606742,0.9990696290825537,1.0,40/148,25.66%,PDPK1;PRKAG2;RFFL;CDK5RAP3;PRKAA2;NUAK1;PML;ING5;PPP1R13L;MTA2;STK11;RBBP7;L3MBTL1;MAP2K6;BANP;TAF9;AKT1;ATM;KAT5;RNF34;RICTOR;TAF2;RFC5;PRKAG1;MDM4;MLST8;AURKA;RMI2;MAPKAP1;MEAF6;BRCA1;HEXIM1;TAF4B;PRKAB2;MRE11;TAF15;PRKAG3;HDAC1;PIP4K2A;ATRIP
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2675005804750131,-0.65379839105808,0.8901869158878505,0.9975011840720356,1.0,6/12,29.32%,VRK1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.22953172533799443,-0.653779593004766,0.9187675070028011,0.9966281837446604,1.0,4/20,19.40%,HSP90AB1;BBS12;PFDN6;CLU
prerank,regulation of microtubule depolymerization (GO:0031114),-0.22004176194054303,-0.6525833750159282,0.9364161849710982,0.9966362134082112,1.0,5/25,18.87%,NAV3;ARHGEF2;TRPV4;MAP1B;CLASP1
prerank,epidermal cell differentiation (GO:0009913),0.23782693485978712,0.6520889425459151,0.9019886363636364,1.0,1.0,12/41,26.38%,TXNIP;USH2A;KRT10;GLI1;GATA6;ST14;ERCC3;ERCC2;ACER1;HDAC1;JAG1;CASP3
prerank,regulation of peptidase activity (GO:0052547),0.27086769660813764,0.6519379115057787,0.893312101910828,1.0,1.0,7/19,25.04%,CTSH;CST3;RCN3;PSMA3;ATP13A2;MAPK12;HDAC1
prerank,heterochromatin assembly (GO:0031507),-0.22634829411459823,-0.6514096352270576,0.9203980099502488,0.9966649245049078,1.0,5/20,14.36%,ZNFX1;BAZ2A;SUV39H1;SIRT1;H3-3A
prerank,regulation of myoblast differentiation (GO:0045661),0.24444519606103648,0.6512232978586786,0.8991097922848664,1.0,1.0,7/32,15.80%,RIPOR2;TBX3;ZFP36L1;IGFBP3;TRIP4;BMP4;LRRC8A
prerank,negative regulation of phagocytosis (GO:0050765),-0.24313920541431128,-0.6510525804191261,0.920863309352518,0.9960448331555709,1.0,6/17,24.08%,DYSF;SIRPA;RACK1;CD300A;CD300LF;PLSCR1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.21555966711769148,0.6510495728940241,0.9458388375165125,1.0,1.0,16/70,20.64%,RUNX1;YAP1;PSME4;SETD1A;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,nucleoside salvage (GO:0043174),0.30752460967309136,0.650551176733073,0.8803418803418803,1.0,1.0,3/10,17.31%,CDA;UPP2;DCK
prerank,L-serine metabolic process (GO:0006563),0.30326603618056003,0.6500640104686152,0.8540925266903915,1.0,1.0,4/10,21.20%,PSPH;SERINC3;PHGDH;CBS
prerank,innate immune response (GO:0045087),0.19241456714910501,0.6500461206321694,0.9914346895074947,0.999655278681146,1.0,19/217,11.79%,MFAP4;COLEC12;LYN;SP100;WFDC3;CXCL16;COLEC11;SRC;PML;KYNU;KLRD1;CAMP;POLR3A;MASP1;IFI27;CARD9;DDX3X;RNASE7;TBK1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2796156201412147,-0.6491261877101058,0.9,0.9966369757605077,1.0,4/10,25.35%,DHFR;TYMS;MTHFD2;SHMT1
prerank,autophagosome assembly (GO:0000045),0.22898041243893266,0.6489047849496002,0.9159779614325069,1.0,1.0,15/52,22.93%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;STX17;ATG9A;STX12;AMBRA1
prerank,positive regulation of organelle organization (GO:0010638),-0.20149055551278033,-0.6486024962300012,0.9672131147540983,0.9961108883153346,1.0,9/32,23.90%,P2RX7;PPARGC1A;SORBS3;ADRB2;SYNJ1;ANXA1;RAB3GAP2;GSK3B;TREM2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.24302971568722917,-0.64858943920295,0.9197080291970803,0.9952385825584658,1.0,7/16,32.51%,GSK3A;GPER1;ACP3;CHGA;NECAB2;GRP;SLC39A14
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21183016697626045,0.6485672292958004,0.9548872180451128,1.0,1.0,19/88,20.64%,FBXO48;FBXL17;PSME4;CUL4B;CUL5;FBXL3;FBXO9;FBXO4;FBXL12;BTRC;FBXO38;AMN1;PSMB5;PSMC2;PSMD1;PSMD4;PSME3;FBXL18;PSMA3
prerank,hexose transmembrane transport (GO:0008645),0.2674348823632544,0.6482390410044437,0.8964968152866242,1.0,1.0,5/21,17.56%,SLC2A10;SLC45A3;SLC5A3;SLC2A4;SLC2A8
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2361093437617321,0.6482216440115536,0.9108108108108108,0.9996255552947837,1.0,7/44,18.37%,GSN;CDC42EP4;CARMIL1;SNX9;ARF6;FCHSD2;CDC42EP3
prerank,regulation of intracellular transport (GO:0032386),0.23749038742122114,0.6478443082061907,0.9356223175965666,0.9995381992714142,1.0,13/38,25.25%,ATP9A;DYNC1H1;LRRK2;RNF139;NUP214;GAS1;NUMA1;AAAS;ATP13A2;RBM4;RINT1;TTC21B;SCFD1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.21256801561470834,-0.6476565069856647,0.9301675977653632,0.9950254392444857,1.0,13/27,41.61%,CYRIB;SIRPA;SKAP1;CD44;CCL2;TRAF6;HAS2;NR4A3;PRKCQ;CCDC88B;TNFSF11;TNF;ITGB2
prerank,glial cell development (GO:0021782),0.253798745023966,0.6471969586612383,0.9116279069767442,0.9996686671895081,1.0,8/25,19.08%,MT3;CSPG5;EIF2B4;MDK;NSUN5;EIF2B3;SOX11;MXRA8
prerank,cellular lipid catabolic process (GO:0044242),0.254762883987467,0.6469443503959412,0.9047619047619048,0.9994546212852877,1.0,10/27,27.00%,MT3;CYP1B1;SIRT2;NUDT19;SMPDL3B;LPIN3;LPIN2;LPIN1;PLBD2;MGST2
prerank,sensory perception of smell (GO:0007608),-0.27033210901646215,-0.6469175061845748,0.9031476997578692,0.9946762875861807,1.0,1/11,11.12%,ADCY3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2588292611322541,0.6468740344414443,0.8973143759873617,0.9990882927160977,1.0,6/22,22.83%,PSME4;NFE2L2;ENC1;PSMB5;PSMA3;PSMA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.24935757828897534,-0.646680659200277,0.9,0.9939960895115586,1.0,4/14,21.76%,TFRC;SHLD1;SHLD2;NECTIN2
prerank,keratinocyte differentiation (GO:0030216),0.24993169052858338,0.6466712134952591,0.9107142857142857,0.998841057085267,1.0,1/29,1.01%,TXNIP
prerank,negative regulation of insulin secretion (GO:0046676),0.2792779422194256,0.6466066153675322,0.8875,0.9984713801012919,1.0,4/17,11.94%,SFRP1;PRKN;ADRA2A;REST
prerank,transcription by RNA polymerase III (GO:0006383),0.2530150814532469,0.6465372594861023,0.8873015873015873,0.9981050756615838,1.0,12/27,28.90%,BRF1;GTF3C1;SNAPC1;SNAPC5;SNAPC4;POLR2L;GTF3C3;ICE1;GTF3C5;ICE2;POLR3K;POLR3GL
prerank,positive regulation of interleukin-8 production (GO:0032757),0.22837986336464172,0.6459068446642083,0.9411764705882353,0.9982401846934412,1.0,2/49,2.77%,SERPINE1;IL17D
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.25796751660311446,0.6456155837636309,0.9120879120879121,0.9980652318964114,1.0,4/24,10.34%,DNMT3A;RBBP7;PHF1;PPHLN1
prerank,regulation of interleukin-12 production (GO:0032655),0.22975120922471134,0.644846792199775,0.9328671328671329,0.9983479582299479,1.0,9/47,16.19%,CCL19;PIBF1;IL12B;MAST2;IRAK3;RIPK2;MDK;CD47;IL23A
prerank,androgen metabolic process (GO:0008209),0.2723256597638405,0.6443336141599406,0.9033742331288344,0.9983647533880293,1.0,2/18,7.55%,HSD3B2;SRD5A1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.24560579040111744,-0.6440752704540744,0.8700980392156863,0.9950313038893067,1.0,6/15,30.84%,ZC3H12C;RNASEH1;NUDT16;POP7;RPP40;ZC3H12D
prerank,protein palmitoylation (GO:0018345),0.2491816023513102,0.6437626511243836,0.9251497005988024,0.9984747026590232,1.0,1/30,1.26%,GLUL
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.22586710645285568,-0.6436704930099294,0.927170868347339,0.9944375392084752,1.0,2/21,5.99%,NAV3;ARHGEF2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2497368259263218,0.6428856986894577,0.9280359820089955,0.9988130269892713,1.0,9/31,18.32%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2133807435534085,0.6427574424814354,0.9511568123393316,0.9984959610580174,1.0,18/72,19.53%,SP100;NDRG1;PML;BATF;RBL2;RGCC;USP10;PLK2;CNOT3;SESN2;TFDP1;ATM;KAT5;CARM1;ATRX;CDKN1B;MUC1;MDM4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.26019780096833356,0.6421924934454185,0.8899521531100478,0.9985739715774951,1.0,8/23,26.16%,MYO10;DYNC1I2;HOOK2;MAP6D1;KIF1C;MAP6;KIF5C;HOOK1
prerank,cellular response to amino acid starvation (GO:0034198),0.2149745831262892,0.6417119895629597,0.9681528662420382,0.9985419563150468,1.0,18/71,21.57%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,lipid droplet organization (GO:0034389),-0.21810082218067306,-0.641132122712701,0.9380053908355795,0.9953457550094086,1.0,11/22,37.23%,PPIA;PNPLA3;PLA2G4C;PPID;ZFYVE1;HILPDA;FITM2;CDS1;CDS2;BSCL2;PLIN5
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2099540514973385,0.6409820206478507,0.966707768187423,0.9987276197353602,1.0,8/88,9.89%,TRABD2B;SMAD3;SYNPO2;CDH5;SDC1;EMILIN1;BCL2L11;SYNPO2L
prerank,regulation of multicellular organismal development (GO:2000026),-0.21256915474421073,-0.6408725134268927,0.937125748502994,0.9946383203955738,1.0,4/25,11.69%,SOX17;SPAAR;PTN;KAT2A
prerank,maintenance of protein localization in organelle (GO:0072595),0.26784507734134283,0.640183418043765,0.863275039745628,0.9989995392197395,1.0,8/19,28.52%,PML;ARL2;AKT1;HNRNPU;TAF8;HSPA5;HK1;TAPT1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.2580076251043323,-0.6400179431811251,0.9039408866995073,0.9943399792959914,1.0,6/12,40.75%,NBN;WRNIP1;WDR18;TICRR;KAT7;CDT1
prerank,tRNA 5'-end processing (GO:0099116),0.28111697310454276,0.6399638310264413,0.8871794871794871,0.9987525224213752,1.0,4/15,15.59%,RPP25L;PRORP;RPP30;RPP38
prerank,regulation of centriole replication (GO:0046599),0.2747006986196934,0.6397229364958272,0.8930232558139535,0.9985347868540361,1.0,4/17,14.70%,ALMS1;KAT2B;MDM1;PLK2
prerank,snRNA metabolic process (GO:0016073),-0.23177793027583984,-0.6385426910108777,0.9263657957244655,0.9944897246668192,1.0,7/17,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;ZCCHC8;INTS11
prerank,regulation of stem cell population maintenance (GO:2000036),0.27253066766591016,0.6384897526479945,0.8858520900321544,0.99916249891101,1.0,5/18,14.97%,REST;WDR43;NCOA3;TAF5L;CNOT3
prerank,mitochondrial genome maintenance (GO:0000002),0.29647836326090027,0.6381491073998483,0.8599290780141844,0.9990293075552594,1.0,4/11,21.18%,AKT3;SLC25A36;LONP1;OPA1
prerank,regulation of interferon-alpha production (GO:0032647),0.2602402930360691,0.637555030601614,0.893312101910828,0.9990964233743678,1.0,4/23,12.68%,PTPRS;DDX3X;TBK1;RIPK2
prerank,regulation of cell cycle phase transition (GO:1901987),-0.15923810661113563,-0.637064857424443,1.0,0.9946400597729761,1.0,21/91,20.61%,CUL1;ANAPC16;TAF1;ANAPC15;ATP2B4;ANAPC7;DBF4;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;TFAP4;CDKN1A;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18548155023829713,0.6359501189916925,0.9968017057569296,1.0,1.0,66/264,23.91%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;DDX17;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;DDX1;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3;CDK13
prerank,cellular macromolecule catabolic process (GO:0044265),0.2241727989425134,0.6358141909866787,0.9402777777777778,0.999710622630519,1.0,9/49,16.23%,SND1;ADAMTS9;PRKN;NGLY1;DNASE1L1;EXOSC7;MTREX;RNASEH2C;NEU4
prerank,tRNA metabolic process (GO:0006399),-0.23593779086608513,-0.6355269269885724,0.9396325459317585,0.9947688567447064,1.0,4/17,15.63%,YARS2;KARS1;RPP21;FARS2
prerank,nuclear transport (GO:0051169),-0.23327445505980726,-0.6352738231238743,0.9222797927461139,0.9940446087457055,1.0,8/16,38.55%,NXT2;PSIP1;NPM1;NUTF2;NXT1;RBM15B;HMGA1;XPO1
prerank,histone H4 acetylation (GO:0043967),0.2218349069483585,0.6350344859510597,0.9330543933054394,0.9999149801654369,1.0,10/47,17.85%,OGT;ING3;BRD8;ING5;JADE1;KMT2A;WDR5;TADA3;MSL2;NAA40
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.28278555916673703,0.6349012257025114,0.8793969849246231,0.9996035294754732,1.0,4/13,14.47%,ATG10;UBA7;SENP6;UBA6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.21304732159701747,-0.6342406644775092,0.934984520123839,0.9938406858515691,1.0,8/25,24.29%,HMGN1;ALYREF;LDB1;EAF2;ZNF326;EAF1;CCAR2;TCEA2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.29980547511217753,0.633793930242708,0.8621908127208481,1.0,1.0,1/10,4.37%,SLC45A3
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24263473053651968,-0.6337390464946011,0.9247572815533981,0.9933171259877417,1.0,7/15,29.29%,RYR2;ZFAND2B;SPCS1;RAB3GAP2;EDEM1;SRPRA;SEC61G
prerank,postreplication repair (GO:0006301),0.22953018294110897,0.6335413760763295,0.9371584699453552,0.9998570818137272,1.0,7/45,13.02%,PCLAF;SPRTN;UBE2V2;ZBTB1;WDR33;RAD18;USP10
prerank,cellular response to ionizing radiation (GO:0071479),0.22206250511505654,0.6334794046518216,0.9402777777777778,0.9994894589557803,1.0,4/47,6.29%,YAP1;LIG4;MAP3K20;INO80
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2729128649738622,-0.6331613274490013,0.9244060475161987,0.9928538415553855,1.0,6/10,37.81%,RUVBL1;ZNHIT3;RUVBL2;PIH1D1;SHQ1;PIH1D2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.26206042653040107,-0.6328357580592051,0.903755868544601,0.9922015662848576,1.0,5/10,31.19%,CX3CR1;CEACAM1;PTPRC;LILRB1;FCGR2B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24628953020351305,-0.6326732150044048,0.9182692307692307,0.9914293655575208,1.0,5/13,28.47%,SORL1;CD81;TMEM30A;EDEM1;TMEM30B
prerank,intracellular lipid transport (GO:0032365),0.2620849009854157,0.6323739918244158,0.8941548183254344,0.999986263454639,1.0,3/21,6.02%,PRKAG2;PRKAA2;PLEKHA8
prerank,microtubule polymerization or depolymerization (GO:0031109),0.25502008185076974,0.6317044170832731,0.9161490683229814,1.0,1.0,3/24,10.17%,NCKAP5;KATNB1;FGF13
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2328929351532569,0.6314945365458198,0.9276595744680851,0.9998364933254394,1.0,5/37,11.08%,BCL2;NUPR1;BCL2L11;BCAP31;GSDME
prerank,V(D)J recombination (GO:0033151),-0.2553050247638998,-0.6311383383836782,0.9355608591885441,0.9915457894846154,1.0,4/11,23.07%,TCF3;PRKDC;HMGB2;DCAF1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.17846997722863633,-0.6305061834185471,0.980544747081712,0.99106198842378,1.0,18/51,30.05%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.24882615104354963,-0.6303224197786859,0.9127358490566038,0.989448987767618,1.0,7/13,34.05%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),-0.24882615104354963,-0.6303224197786859,0.9127358490566038,0.989448987767618,1.0,7/13,34.05%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,cell-cell junction maintenance (GO:0045217),-0.26314674914181124,-0.6292605904094019,0.916083916083916,0.9892202881037861,1.0,1/11,2.91%,TJP1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.2720919191180876,-0.6283901954496706,0.8959810874704491,0.9888715526038441,1.0,3/10,26.23%,DLGAP2;BEGAIN;CACNG5
prerank,atrial septum development (GO:0003283),-0.24593951090949884,-0.627076952209426,0.9056603773584906,0.9888684146340477,1.0,5/13,21.70%,TGFB2;HEY2;ZFPM1;BMPR2;GJA5
prerank,retinal metabolic process (GO:0042574),0.2860258562775562,0.6264801559036008,0.8847402597402597,1.0,1.0,1/12,5.54%,CYP1B1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2396191336514289,0.626474031405076,0.9321533923303835,1.0,1.0,9/33,18.32%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,cellular response to tumor necrosis factor (GO:0071356),0.18815358411256264,0.625424690865868,0.9965870307167235,1.0,1.0,12/175,9.62%,ADAMTS12;PID1;CCL19;EDAR;PSME4;SFRP1;ZFP36L1;CCL4;NFE2L2;NR1D1;ACTN4;LTBR
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.27378185997891036,0.6253316420452392,0.9142367066895368,1.0,1.0,6/17,21.67%,ARFIP2;DNAI3;WASF1;FCHSD2;CORO1B;BRK1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.2995770467588407,0.6243299285261797,0.8814814814814815,1.0,1.0,3/10,15.37%,MAP4K4;MAPRE2;ARF6
prerank,myeloid dendritic cell activation (GO:0001773),-0.2567664563615582,-0.6242149630462118,0.9297820823244553,0.9898211851058304,1.0,2/12,9.69%,CAMK4;TGFBR2
prerank,mitochondrial fusion (GO:0008053),0.2652770041842541,0.6237883637790721,0.9115191986644408,1.0,1.0,5/18,21.45%,MIGA2;USP30;AFG3L2;OPA1;STOML2
prerank,GTP metabolic process (GO:0046039),0.2776391950771231,0.6237333792185973,0.9010067114093959,1.0,1.0,3/15,12.03%,RAB23;LRRK2;RHOQ
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.2577146053336362,0.6237317473231623,0.9,1.0,1.0,5/21,23.73%,NOS1AP;FLNA;SCN1B;SNTA1;ANK2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.24166786997088346,-0.6223386793876292,0.919908466819222,0.9901322326209485,1.0,7/13,39.71%,NOL9;RPS21;RRS1;TSR1;RPP40;UTP20;NOP9
prerank,negative regulation of signaling (GO:0023057),0.24856997562611885,0.6211503685025239,0.8971518987341772,1.0,1.0,5/25,17.97%,OPTN;ACVR1;IGFBP3;LIF;HHIP
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2018241116164567,-0.6209202807912338,0.954954954954955,0.9901028377435712,1.0,9/27,25.77%,NAAA;PLAAT3;PNPLA8;ETNK1;SELENOI;PLA2G4E;CHKA;ABHD4;PLAAT1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.270587759327762,0.6202795422513854,0.8928571428571429,1.0,1.0,2/15,8.40%,APOA1;IRAK3
prerank,macroautophagy (GO:0016236),0.19435651894534997,0.6192156099865981,0.9905548996458088,1.0,1.0,34/118,25.60%,DYNLL1;PRKAG2;PRKAA2;SRC;ATG10;MTMR3;PRKN;PLEKHM1;VPS37D;CLN3;UVRAG;WIPI1;VDAC1;PIK3R4;TOMM22;LAMP2;MAP1LC3A;BECN1;EPG5;PRKAG1;ATG4B;TOMM5;STX17;ATP13A2;RUBCNL;LIX1;TSG101;AMBRA1;PRKAB2;VPS16;PRKAG3;CHMP2A;PIP4K2A;VPS33B
prerank,regulation of lipid storage (GO:0010883),-0.20869088707327801,-0.6180705313965125,0.957286432160804,0.9909145605985783,1.0,7/22,27.50%,NFKBIA;PTPN2;SIRT1;HILPDA;ALKBH7;MEST;LPL
prerank,spermatid development (GO:0007286),0.23436912774071694,0.6180134337352603,0.9294781382228491,1.0,1.0,3/32,12.27%,GALNTL5;ZMYND15;SYCP3
prerank,protein localization to centrosome (GO:0071539),0.26137281009072866,0.6178992949883674,0.901294498381877,1.0,1.0,2/17,6.20%,GOLGB1;PIBF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.2456921634249933,-0.617745534454028,0.9323308270676691,0.990243603261027,1.0,7/13,40.33%,BOLA2;GLRX5;CIAO2B;CIAO2A;ISCA1;LTO1;ISCA2
prerank,global genome nucleotide-excision repair (GO:0070911),-0.20068229614898392,-0.617568277910216,0.9610778443113772,0.989488414604423,1.0,10/26,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;RNF111;CHD1L;UBC;RPS27A;XPC
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2726280213268885,0.6169083277178543,0.9165275459098498,1.0,1.0,2/16,7.81%,SHOC1;TOP2B
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.23838339952040316,0.6157938214575047,0.9262672811059908,1.0,1.0,3/27,8.20%,AGTR1;LPAR1;DRD3
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.21350960240651035,-0.6153085305787567,0.9526315789473684,0.9899230340337457,1.0,2/21,5.76%,GPI;HK2
prerank,negative regulation of double-strand break repair (GO:2000780),0.23927480457369807,0.6145812761582203,0.924812030075188,1.0,1.0,8/30,21.24%,OGG1;TRIP12;NUDT16L1;UBR5;SHLD3;SMCHD1;HSF1;RMI2
prerank,positive regulation of interleukin-17 production (GO:0032740),0.24802243318426298,0.6140430340931411,0.9079754601226994,1.0,1.0,5/22,17.97%,RFTN1;IL12B;CARD9;IL23A;IL18
prerank,proteasome assembly (GO:0043248),-0.2527451677603648,-0.6139544194240116,0.9419642857142857,0.989832105134464,1.0,6/11,34.81%,PSMD9;PSMD11;PSMD5;POMP;PSMD10;PSMD13
prerank,positive regulation of cilium assembly (GO:0045724),-0.22935674542109424,-0.613186011735854,0.9461538461538461,0.9894232141210169,1.0,6/18,26.21%,CCDC88A;KCTD17;CEP135;FUZ;HAP1;CCP110
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.24433803172613613,-0.6130972821631567,0.9350961538461539,0.988617091324978,1.0,2/13,12.45%,CYRIB;PVR
prerank,natural killer cell mediated immunity (GO:0002228),0.26901998268998983,0.6123699767574182,0.8961474036850922,1.0,1.0,2/15,10.14%,KLRD1;PLEKHM2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.24139923374977676,0.6122772014753272,0.9405320813771518,1.0,1.0,4/28,9.32%,NUPR1;CDK5RAP3;RNF139;PRKN
prerank,serine family amino acid metabolic process (GO:0009069),0.2695826066112815,0.6119407976166548,0.9190140845070423,1.0,1.0,5/16,24.07%,CDO1;PSPH;CBS;SARS1;SEPSECS
prerank,autophagy of mitochondrion (GO:0000422),0.2284525528563464,0.611256428801578,0.9562043795620438,1.0,1.0,13/38,22.93%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;PHB2;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.22082496325260362,0.6111161470455945,0.9390581717451524,1.0,1.0,8/46,16.32%,TIMM17B;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;TOMM22;AKT1
prerank,regulation of protein sumoylation (GO:0033233),-0.22197036838915113,-0.6108515219687991,0.9134860050890585,0.9890042908785139,1.0,8/17,30.67%,SAE1;RWDD3;EGR1;CAPN3;UBA2;GNL3;CTNNB1;RASD2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2652987569319304,0.6102420190253944,0.911864406779661,1.0,1.0,6/16,26.37%,IRAK3;CLN3;INSR;GSPT1;HDAC6;UPF1
prerank,regulation of nuclear division (GO:0051783),0.2552553012482319,0.6101863999468324,0.918918918918919,1.0,1.0,1/20,2.03%,OBSL1
prerank,regulation of B cell differentiation (GO:0045577),0.26131811242323727,0.6098858299087183,0.9201331114808652,1.0,1.0,2/17,5.78%,SFRP1;ZFP36L1
prerank,regulation of centrosome duplication (GO:0010824),-0.19997987660571054,-0.6094702705134857,0.9522292993630573,0.9889377777953082,1.0,10/29,29.11%,PDCD6IP;SIRT1;STIL;NPM1;CHMP2B;CEP131;CHMP4B;GEN1;SPICE1;CHMP4C
prerank,cell junction maintenance (GO:0034331),0.2737461364626363,0.609103409068603,0.9057591623036649,1.0,1.0,2/14,9.40%,CBLN1;MYADM
prerank,apoptotic DNA fragmentation (GO:0006309),0.2609773525374385,0.6079726123416593,0.8943894389438944,1.0,1.0,5/16,18.90%,DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15495240078019182,-0.6066573665327624,1.0,0.9896676991099297,1.0,33/84,35.80%,ANAPC16;ANAPC15;ANAPC7;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;FBXO31;PSMC4;CUL3;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1;FZR1;PLK1;CDK1;PSMD10;UBC;RPS27A;CDC20;ANAPC11;PSMC3;UBE2C;PSMD13;SKP2;BUB3;ECRG4
prerank,negative regulation of macroautophagy (GO:0016242),0.2440661472823655,0.6064045684687873,0.9363354037267081,1.0,1.0,4/26,16.32%,NUPR1;LRRK2;TSC2;AKT1
prerank,regulation of macroautophagy (GO:0016241),0.19451941690697938,0.6058469949211619,0.9904648390941597,1.0,1.0,25/105,21.57%,DCN;PRKAG2;NEDD4;PRKAA2;LRRK2;SLC38A9;ATP6V1E1;LAMTOR2;RRAGD;TBK1;CLN3;LARP1;TSC2;SESN2;AKT1;WAC;PRKACA;PRKAG1;GPSM1;RHEB;MLST8;ATP13A2;SNX6;UCHL1;ATP6V1B2
prerank,regulation of interleukin-8 production (GO:0032677),0.20238214318115616,0.6056900665428396,0.9686274509803922,1.0,1.0,8/69,13.00%,SERPINE1;IL17D;MAPKBP1;TLR6;ARRB1;CD33;CD14;SSC5D
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.2615764661875191,-0.6048095755443141,0.9232613908872902,0.9898010981955095,1.0,2/10,11.74%,KDM1A;SIRT1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.28435371628105105,0.6038334578185685,0.8898601398601399,1.0,1.0,6/11,30.80%,EBI3;STAT4;CANX;STAT1;IL6ST;IL12RB2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.2694822963562833,0.6034959482460148,0.9179487179487179,1.0,1.0,4/15,20.94%,HNRNPA1;DDX3X;HSF1;PPIF
prerank,chemokine-mediated signaling pathway (GO:0070098),0.2188792950105386,0.6025814947633212,0.9511173184357542,1.0,1.0,5/42,13.54%,CCL19;CCL4;OXSR1;WNK1;CXCL13
prerank,mitotic DNA replication (GO:1902969),0.28958026879598914,0.6017600485770198,0.86,1.0,1.0,6/10,29.91%,MCM2;MCMDC2;LIG1;MCM6;MCM4;GINS1
prerank,mitotic sister chromatid segregation (GO:0000070),0.19350231943332036,0.6000047186503056,0.9816625916870416,1.0,1.0,22/98,20.73%,PDS5B;PIBF1;INO80;SPDL1;ZW10;ZWINT;TENT4A;EML4;CHMP5;AKAP8L;PHF8;POGZ;SGO1;SEH1L;NIPBL;BECN1;BOD1;KPNB1;CDCA8;NAA50;CDC23;DSN1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.19571204930476968,0.5987168449390682,0.9791937581274383,1.0,1.0,17/73,20.64%,RUNX1;YAP1;PSME4;SETD1A;METTL14;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2603812190463499,0.5983278854717855,0.92,1.0,1.0,4/18,18.59%,MIA3;WNK1;AKT1;VTCN1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.18955110585846335,-0.5976287631459322,0.9641791044776119,0.9916997707314447,1.0,10/29,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,CENP-A containing chromatin organization (GO:0061641),-0.18955110585846335,-0.5976287631459322,0.9641791044776119,0.9916997707314447,1.0,10/29,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,establishment of spindle localization (GO:0051293),0.27318876458955044,0.597570259690526,0.9142857142857143,1.0,1.0,4/14,22.02%,DYNC1H1;LLGL1;KPNB1;LLGL2
prerank,mRNA metabolic process (GO:0016071),0.19198181935981423,0.597488591171465,0.9876998769987699,1.0,1.0,28/90,25.49%,SON;DXO;HNRNPR;NONO;PRMT9;TCERG1;SRSF5;AKAP8L;NUDT16L1;PCF11;GEMIN2;SF3B2;LSM10;METTL3;PRKACA;HSF1;YTHDF2;AGO4;ZFP36L2;NUDT12;NCBP2;PRPF8;SFPQ;METTL16;AGO3;SNRPE;CNOT10;RNASE4
prerank,mismatch repair (GO:0006298),-0.19258441125691145,-0.5971929076188564,0.9707602339181286,0.9910922220781319,1.0,10/27,34.32%,MSH3;PMS2;PMS1;POLD4;MSH2;EXO1;POLD2;XPC;RPA2;MLH3
prerank,positive regulation of DNA recombination (GO:0045911),0.2362961304318531,0.5968519464017917,0.9412628487518355,1.0,1.0,10/27,27.75%,KMT5B;MRNIP;HMCES;SHLD3;TIMELESS;ARID2;ERCC2;FUS;MMS19;FANCB
prerank,cellular response to estradiol stimulus (GO:0071392),-0.21682105768546456,-0.596628618908669,0.9544303797468354,0.9905304498004291,1.0,2/18,5.60%,ESR1;NRIP1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.22106033857367666,0.5964942889089943,0.9572413793103448,1.0,1.0,3/39,6.57%,OGG1;GTF2H5;CUL4B
prerank,positive regulation of type I interferon production (GO:0032481),-0.1558395077018526,-0.5951562921797029,0.9904761904761905,0.9903827328779731,1.0,16/73,22.14%,IFIH1;TOMM70;LRRFIP1;POLR3H;CGAS;G3BP1;PTPN22;PRKDC;IRF5;EP300;DDX41;TLR4;POLR2E;DHX9;CHUK;CRCP
prerank,positive regulation of cell cycle (GO:0045787),0.20218180964931665,0.5951089899683143,0.9812834224598931,1.0,1.0,15/62,21.06%,FGFR2;NUPR1;SMOC2;TBX3;EGFR;FOXA1;RGCC;AKT1;PRKCA;TRIM32;CDKN1B;HSF1;TRIM21;CCND2;PKN2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2314434000290196,0.5946186818149317,0.9367283950617284,1.0,1.0,5/28,12.85%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,protein-containing complex disassembly (GO:0032984),0.2096891427450329,0.5941741750527774,0.967828418230563,1.0,1.0,14/54,21.87%,WNT8B;FZD2;FZD1;CLN3;UVRAG;LAMP2;MAP1LC3A;CSNK1A1;EPG5;FRAT1;STX17;RUBCNL;LIX1;TSG101
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.19528842256108567,0.594064870967562,0.9845758354755784,1.0,1.0,6/85,6.15%,FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,Golgi to lysosome transport (GO:0090160),0.2786295342901567,0.5938072341846209,0.9066666666666666,1.0,1.0,2/11,11.91%,RBSN;CLN3
prerank,dopaminergic neuron differentiation (GO:0071542),0.24608421396057428,0.5933561602642308,0.9375,1.0,1.0,4/19,16.72%,FOXA1;RYK;MANF;SHH
prerank,regulation of lipase activity (GO:0060191),0.26856676501977517,0.5923705328367316,0.9097472924187726,1.0,1.0,13/13,73.17%,LMF1;PCSK5;FURIN;ANGPTL3;RHOA;SNCA;APOA2;ANGPTL8;PLIN5;RHOC;PCSK6;LPL;LIPC
prerank,protein acylation (GO:0043543),0.21740514534345726,0.5913727977005158,0.9678362573099415,1.0,1.0,3/38,8.83%,GLUL;ING5;KAT2B
prerank,apoptotic nuclear changes (GO:0030262),0.23643438007798773,0.5910678007823803,0.9353846153846154,1.0,1.0,6/24,18.90%,CDK5RAP3;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,telomere maintenance (GO:0000723),0.2070524180631974,0.5904679138554071,0.9604904632152589,1.0,1.0,7/50,14.37%,SP100;SMC5;SMC6;TERF2;TEP1;RAD51D;RTEL1
prerank,defense response to symbiont (GO:0140546),0.19286787739073097,0.5887179849870159,0.9876237623762376,1.0,1.0,14/92,17.17%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.22490655621933045,0.5881975395787441,0.9524539877300614,1.0,1.0,5/29,13.02%,DCST1;STAT2;RNASEL;ABCE1;MUL1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.27104034983640635,0.5880353158334204,0.9171075837742504,1.0,1.0,3/12,14.76%,LRRK2;CLN3;ATP6AP2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20768107119615806,-0.5875367095940403,0.967479674796748,0.9930633005756144,1.0,4/19,17.73%,LBP;PIK3AP1;PRKCE;TLR4
prerank,protein catabolic process (GO:0030163),0.20231611200972704,0.5874868479373572,0.9824561403508771,1.0,1.0,7/59,9.85%,APOE;ADAMTS9;CUL4B;NR1D1;CLPX;PRKN;NGLY1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.261948877976949,0.5873287930152181,0.9111498257839721,1.0,1.0,2/13,12.23%,OAS2;EBI3
prerank,exit from mitosis (GO:0010458),-0.2358024451573546,-0.586537763336907,0.9235955056179775,0.9926302119321259,1.0,4/12,32.44%,UBE2S;CLASP1;CHMP4B;UBE2C
prerank,cytoplasmic microtubule organization (GO:0031122),0.20424606099336046,0.5864782763183757,0.9813084112149533,1.0,1.0,3/54,5.66%,FIGN;CLIP4;DYNC1H1
prerank,nucleotide metabolic process (GO:0009117),0.23616728839501824,0.5864323579155257,0.9396825396825397,1.0,1.0,9/23,26.28%,REXO2;CTPS2;AK8;DCK;NMNAT2;NUDT5;AK1;NMNAT1;CMPK1
prerank,ubiquinone biosynthetic process (GO:0006744),0.25433761931407484,0.5855438641588904,0.9351535836177475,1.0,1.0,4/15,19.52%,UBIAD1;COQ10B;NDUFA9;COQ7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.27546921339455416,0.5850452239969092,0.9106529209621993,1.0,1.0,2/10,12.29%,TUT7;TUT4
prerank,necroptotic process (GO:0070266),0.25248118488435306,0.5847324805615632,0.9322834645669291,1.0,1.0,2/16,12.97%,MLKL;CD14
prerank,negative regulation of T cell proliferation (GO:0042130),-0.18823432746678703,-0.5834026701831018,0.9828571428571429,0.9931103107471307,1.0,8/28,27.14%,PRKAR1A;SCRIB;TNFRSF21;CD80;CD86;LILRB1;IL4I1;PRNP
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2814475998130424,0.5817389142863804,0.8862815884476535,1.0,1.0,1/10,6.77%,KYNU
prerank,defense response to virus (GO:0051607),0.18854836737966366,0.5816815536197458,0.9938574938574939,1.0,1.0,28/100,26.09%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2;RNF135;PHB2;NDUFAF4;RSAD2;MYD88;AGBL5;ZBP1;ZDHHC1;PMAIP1;STAT1;FADD;MAVS;AKAP1;RELA
prerank,cilium movement (GO:0003341),0.20942198513032242,0.5814318667283163,0.983402489626556,1.0,1.0,8/47,16.15%,CFAP73;DNAAF1;DNAI3;CCDC40;CABYR;CFAP53;DNAAF5;SPEF2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.202440142200969,0.5805938073554965,0.9736111111111111,1.0,1.0,10/51,17.56%,SRC;HNRNPA1;PARN;FBXO4;TERF2;TNKS2;TENT4B;HNRNPC;ATM;NAF1
prerank,protein acetylation (GO:0006473),0.22189148766663241,0.5804621519120273,0.9651515151515152,1.0,1.0,7/30,19.20%,ING5;KAT2B;BLOC1S1;KAT5;NAA40;NAA80;NAA50
prerank,regulation of lymphocyte proliferation (GO:0050670),0.252778565410704,0.5800835747630009,0.9368770764119602,1.0,1.0,5/16,25.88%,IL12B;SOX11;TNFSF9;AHR;TNFRSF1B
prerank,cellular response to leucine starvation (GO:1990253),0.28009321866742665,0.5794008515384774,0.9148550724637681,1.0,1.0,3/10,15.23%,RRAGD;IMPACT;SESN2
prerank,carboxylic acid catabolic process (GO:0046395),0.26836158192090387,0.5790053397290279,0.9084507042253521,1.0,1.0,12/12,73.18%,RENBP;BCKDK;NAGK;GNPDA1;NPL;ACOT4;PON1;ACOT8;AMDHD2;GNPDA2;PON3;IL4I1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.22842008072470033,0.5783574061775443,0.9429429429429429,1.0,1.0,6/28,19.35%,KMT5B;MRNIP;NUDT16L1;SHLD3;SMCHD1;HSF1
prerank,centromere complex assembly (GO:0034508),-0.17616805409241212,-0.5773677813114829,0.9834437086092715,0.9947067126436125,1.0,12/36,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;CENPF;NASP;HJURP;DLGAP5;ITGB3BP
prerank,receptor recycling (GO:0001881),-0.2472688781796049,-0.5769406397981406,0.9439252336448598,0.9940285004282937,1.0,3/10,20.90%,SORL1;LMTK2;EHD3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.19548999985482735,0.5761694757539445,0.9889042995839112,1.0,1.0,22/61,29.39%,FGFR4;PRKAG2;PSME4;NCOR2;PSMB5;PSMC2;OAZ3;PSMD1;SIRT5;PSMD4;PSME3;PSMA3;PSMA2;PSMC5;PDK4;PSMB9;PSMD12;PSMB4;PANK2;PPARA;ODC1;PSMB7
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.23395663795765623,-0.5749810507204955,0.9414519906323185,0.9939782359558164,1.0,1/11,5.10%,TOMM70
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2153718471365691,0.5743515476096744,0.9644381223328592,1.0,1.0,9/36,17.72%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24561618548677683,0.5743093716667194,0.9306260575296108,1.0,1.0,4/16,22.99%,RBM22;DDX23;NCBP2;SART1
prerank,Golgi to endosome transport (GO:0006895),0.24726028813476822,0.5739059616601875,0.9429967426710097,1.0,1.0,6/16,22.59%,MON2;EPS15;WIPI1;VPS13C;SORT1;KLHL20
prerank,histone deubiquitination (GO:0016578),0.2414463153252065,0.5738473010216486,0.9353312302839116,1.0,1.0,6/18,21.33%,ATXN7L3;UIMC1;USP49;BRCC3;USP3;ATXN7
prerank,DNA conformation change (GO:0071103),0.24676978621674595,0.5737438077493856,0.9333333333333333,1.0,1.0,2/17,7.81%,TOP3B;TOP2B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.23381919768638096,0.5733628280820016,0.94375,1.0,1.0,5/22,16.13%,IBA57;NUBPL;HSPA9;NFU1;LYRM4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.2588088271382185,0.5732453011388094,0.934819897084048,1.0,1.0,3/12,17.31%,CDA;UPP2;DCK
prerank,RNA interference (GO:0016246),0.24581904834879742,0.5728975567032301,0.9309791332263242,1.0,1.0,7/17,24.47%,PRKRA;TSNAX;DICER1;NRDE2;AGO4;DROSHA;AGO3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.21789738163274192,0.5722251726860399,0.9580318379160637,1.0,1.0,5/31,12.71%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2
prerank,peptidyl-methionine modification (GO:0018206),0.2632880953150318,0.5702812870203467,0.9372822299651568,1.0,1.0,1/12,4.30%,APOA1
prerank,regulation of oxidoreductase activity (GO:0051341),0.2596501635915026,0.5696317467593262,0.9298892988929889,1.0,1.0,1/13,4.57%,MT3
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2054254532356875,-0.5692994702255575,0.9625,0.9953920971024762,1.0,6/19,29.11%,CEP97;PDCD6IP;CHMP2B;CHMP4B;PLK1;CHMP4C
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.1920282116482609,-0.5692390468820773,0.9725274725274725,0.9945653727719749,1.0,9/22,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;CHD1L;UBC;RPS27A;XPC
prerank,regulation of biosynthetic process (GO:0009889),0.2663722536674725,0.567470208503114,0.9261168384879725,1.0,1.0,2/11,15.38%,SPHK2;PIKFYVE
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.23231435565877845,-0.5672887859134578,0.9490022172949002,0.9944326256824395,1.0,11/11,76.79%,CAMK4;STAP1;ITGB2;F2RL1;CD177;TYROBP;SPI1;TICAM1;MAVS;STX4;ITGAM
prerank,sulfur amino acid catabolic process (GO:0000098),-0.24146844608082357,-0.5666100901591867,0.9164677804295943,0.9938469792296261,1.0,3/10,25.57%,BLMH;MPST;MTRR
prerank,cellular response to misfolded protein (GO:0071218),0.23477307697960073,0.5651302663051193,0.9620253164556962,1.0,1.0,4/20,15.92%,DERL1;RNF185;UGGT2;AUP1
prerank,DNA replication (GO:0006260),0.1792821713508418,0.5635398034796625,0.9964328180737217,1.0,1.0,7/105,9.80%,RBMS1;PCLAF;ING5;POLG;POLL;RECQL5;POLE3
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.24414093664835332,0.5632342300836337,0.945141065830721,1.0,1.0,5/18,18.74%,SFRP1;SKI;PEX2;CDC73;TRIM32
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2707719506334837,0.5624968043716194,0.9443478260869566,1.0,1.0,1/10,4.94%,KLF15
prerank,mitotic nuclear division (GO:0140014),0.1875332204925966,0.5619490187016208,0.9923371647509579,1.0,1.0,18/71,22.74%,PIBF1;INO80;ZW10;ZWINT;KLHDC8B;ARHGEF10;FLNA;CEP192;SGO1;KPNB1;CDCA8;AAAS;DSN1;NDE1;EPS8;ABRAXAS2;TUBG2;TUBG1
prerank,spindle assembly (GO:0051225),0.18776501376243243,0.560920138219998,0.9859335038363172,1.0,1.0,18/67,22.61%,PIBF1;INO80;NCOR1;MAPRE2;NEK6;ARHGEF10;HAUS1;GOLGA8B;HAUS7;FLNA;HAUS3;CEP192;KPNB1;NUMA1;AAAS;ABRAXAS2;HAUS5;HAUS6
prerank,P-body assembly (GO:0033962),0.255071418391217,0.5597439942134822,0.933572710951526,1.0,1.0,3/12,18.31%,DYNC1H1;PATL1;RC3H1
prerank,signal peptide processing (GO:0006465),0.26227767546264547,0.5586230936845173,0.9368770764119602,1.0,1.0,6/11,31.44%,SEC11C;SEC11A;SPCS2;PCSK5;HM13;FURIN
prerank,cellular response to lipopolysaccharide (GO:0071222),0.17926420464488999,0.5582133015451327,0.9987745098039216,1.0,1.0,16/101,18.61%,SERPINE1;LYN;AXL;NR1D1;TNIP2;SELENOS;PDCD4;PAF1;CD14;CHMP5;CXCL13;NR1H3;IL18;CASP1;CDC73;TRIM41
prerank,tyrosine metabolic process (GO:0006570),0.2683447366769193,0.5578304307691786,0.9431616341030196,1.0,1.0,11/11,73.18%,FAH;GSTZ1;TYR;HGD;TAT;PAH;TH;THAP4;IYD;DCT;IL4I1
prerank,leukotriene biosynthetic process (GO:0019370),-0.2175441973146171,-0.5567708274685548,0.9604938271604938,0.9964274089983628,1.0,6/14,31.70%,GGT5;GGTA1;GGT1;PLA2G5;ALOX5;GGT7
prerank,axoneme assembly (GO:0035082),0.21281564420146365,0.5561009530253552,0.9594202898550724,1.0,1.0,4/30,12.43%,SPAG1;DNAAF1;CFAP46;CCDC40
prerank,aerobic respiration (GO:0009060),0.22770798446815688,0.5558761740135608,0.9639794168096055,1.0,1.0,3/20,9.82%,MDH2;BLOC1S1;SDHC
prerank,organelle transport along microtubule (GO:0072384),0.21396906515326103,0.5556370034523647,0.9761904761904762,1.0,1.0,9/31,23.44%,ARHGAP21;CDC42;RHOT1;CLN3;COPG1;HTT;NDE1;FBXW11;TMEM201
prerank,cellular response to virus (GO:0098586),0.20986022055420292,0.5556279086202456,0.9766081871345029,1.0,1.0,5/30,14.23%,CCL19;VWCE;DDX3X;GSDME;RIOK3
prerank,regulation of autophagosome maturation (GO:1901096),0.2505660693287139,0.5545090834315443,0.9450915141430949,1.0,1.0,2/13,12.09%,CLN3;UVRAG
prerank,protein import into peroxisome membrane (GO:0045046),-0.19198703928905442,-0.5543158974386808,0.9832402234636871,0.9964130758024148,1.0,8/22,26.77%,RAB8B;PEX26;ABCD3;PEX12;FIS1;PEX16;PEX5;PXMP4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.23037028491801553,0.5527736806659074,0.9523052464228935,1.0,1.0,2/19,14.22%,APOA1;ABCD2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.23072404930081547,-0.5521137063312118,0.9630541871921182,0.9962505631515061,1.0,4/11,22.32%,MBTPS2;ATF6B;ATF3;ATF4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.2364923635876663,0.5516728305028945,0.9388083735909822,1.0,1.0,2/16,6.92%,IL12B;KLRD1
prerank,regulation of G0 to G1 transition (GO:0070316),0.20418590948970475,0.5492802492160025,0.9815078236130867,1.0,1.0,9/38,17.72%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,RNA catabolic process (GO:0006401),0.19643447610493323,0.5490382884557415,0.9755766621438263,1.0,1.0,15/46,25.29%,SND1;DXO;EXOSC7;MTREX;NUDT16L1;RNASEH2C;METTL3;YTHDF2;AGO4;ZFP36L2;NUDT12;SIDT2;METTL16;AGO3;CNOT10
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.1584900647213019,-0.5485839322191841,0.9933110367892977,0.9965767389748479,1.0,15/42,30.77%,TRIM25;POLH;SIRT1;POLN;POLD4;POLK;WRNIP1;DTL;FAAP20;VCP;ISG15;POLA1;UBC;RPS27A;POLD2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.2172282984262148,0.5480326248470216,0.9679878048780488,1.0,1.0,4/27,12.66%,MAP3K20;MAP3K8;TNIP2;BTRC
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17825801785376663,0.5467529032288848,0.9938949938949939,1.0,1.0,32/95,27.75%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;MCM2;RAD51D;XRCC2;RNF138;AP5Z1;CDC7;NIPBL;GINS4;RAD54L;MCMDC2;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;MCM6;SWI5;RAD50;TONSL;UBE2N;RECQL;FANCB
prerank,chromatin remodeling at centromere (GO:0031055),-0.171328818738875,-0.54623020503974,0.9844236760124611,0.9964944698738728,1.0,10/31,29.15%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,regulation of interleukin-17 production (GO:0032660),0.20855894275205622,0.5460656864958853,0.9795918367346939,1.0,1.0,8/31,22.80%,RFTN1;IL12B;CARD9;IL23A;IL18;DDIT3;MYD88;NCKAP1L
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.25838164774194927,0.5452391630028318,0.9343065693430657,1.0,1.0,3/11,18.66%,CTPS2;DCK;SLC25A19
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24345737576086232,0.5452371548921474,0.9472759226713533,1.0,1.0,3/15,12.00%,BAIAP3;CLN3;STXBP1
prerank,telomere capping (GO:0016233),0.2362152980562214,0.5450036283816411,0.9483333333333334,1.0,1.0,3/16,12.18%,DCLRE1C;DCLRE1A;TERF2
prerank,regulation of isotype switching (GO:0045191),-0.21136605663747127,-0.5439597107439821,0.9632352941176471,0.996391920221413,1.0,4/14,25.33%,TFRC;SHLD1;SHLD2;SLC15A4
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23382401585881962,0.5424994152780198,0.9586092715231788,1.0,1.0,2/17,6.92%,IL12B;KLRD1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.20726348653374266,-0.5420454732416865,0.9875930521091811,0.996117354067929,1.0,5/15,26.47%,SDCBP;PDCD6IP;VPS4A;SNF8;HGS
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.26030549176004336,0.5411374281911189,0.9334532374100719,1.0,1.0,2/10,12.08%,SIRT2;IMPACT
prerank,midbody abscission (GO:0061952),0.23665776008596745,0.5402053164862769,0.9536423841059603,1.0,1.0,2/17,13.16%,KIF20A;CHMP5
prerank,protein insertion into ER membrane (GO:0045048),0.19781562995522595,0.5389512391290301,0.9872159090909091,1.0,1.0,4/37,11.44%,TRAM2;CYB5A;EMC6;TRAM1
prerank,interstrand cross-link repair (GO:0036297),0.18717329193519383,0.5384376888736362,0.9838926174496644,1.0,1.0,15/53,25.66%,ERCC6L2;DCLRE1C;EXO5;DCLRE1A;FANCC;FANCE;FANCI;XPA;FAN1;UBE2T;FANCA;CENPX;MSH6;RAD51AP2;ATRIP
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.1887184365196706,0.5383177194220414,0.99055330634278,1.0,1.0,7/53,13.66%,APOE;NUPR1;ARAF;COMMD1;PRKN;UFL1;GLMN
prerank,RNA 3'-end processing (GO:0031123),0.18000875686120882,0.5368380869532715,0.9949044585987261,1.0,1.0,16/69,22.41%,U2AF1L4;THOC2;TUT7;DDX39A;WDR33;TENT4A;MAGOHB;TUT4;SRSF5;PCF11;TENT4B;CPSF2;FIP1L1;SRSF3;PAPOLA;NCBP2
prerank,quinone biosynthetic process (GO:1901663),0.23699468109325408,0.536564175299529,0.9634782608695652,1.0,1.0,2/14,9.90%,UBIAD1;COQ10B
prerank,DNA duplex unwinding (GO:0032508),0.18840079158064985,0.5365251370605245,0.9946808510638298,1.0,1.0,18/50,28.43%,GTF2H5;CUL4B;RECQL5;ASCC3;MCM2;RTEL1;DDX1;XPA;MCMDC2;ERCC3;ERCC2;MRE11;MCM6;RAD23B;RAD50;RECQL;GTF2H2;RPA1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.21337311323532562,-0.5358236162383189,0.962877030162413,0.9970402189056408,1.0,2/13,15.15%,SYBU;HIF1A
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.23276403365565734,0.5354118861080377,0.9587628865979382,1.0,1.0,16/16,76.75%,ETS1;MDK;NFAT5;RELA;IL6;IRAK1;FUT7;RHOA;ITGB2;SELE;TNF;FUT4;ALOX5;TRAF6;SELP;ST3GAL4
prerank,regulation of B cell activation (GO:0050864),0.21368963648037512,0.5335076101493543,0.9741641337386018,1.0,1.0,3/25,11.60%,ZFP36L1;THEMIS2;TNIP2
prerank,regulation of spindle assembly (GO:0090169),0.2140108698823892,0.5329867796449136,0.9638364779874213,1.0,1.0,7/25,21.99%,DYNC1H1;CHMP5;SENP6;TPR;NUMA1;HNRNPU;CCSAP
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.21698935641970876,-0.5327944714033551,0.9701149425287356,0.9969928691352572,1.0,6/12,32.95%,PAICS;IMPDH1;ATIC;IMPDH2;ADSS2;GMPS
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24489641802391005,0.5314244029142386,0.9516728624535316,1.0,1.0,3/11,23.24%,GPX3;PRDX4;PXDN
prerank,positive regulation of chemokine production (GO:0032722),0.19129769465076035,0.5312359592955591,0.9836512261580381,1.0,1.0,3/44,10.99%,IL6R;TSLP;DDX3X
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.19537606845374977,0.5300904530357736,0.9792899408284024,1.0,1.0,7/35,17.56%,HNRNPA1;PARN;FBXO4;TNKS2;RTEL1;ATM;NAF1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.24250063436252695,0.5297956081689691,0.9529616724738676,1.0,1.0,4/12,21.20%,PSPH;SERINC3;PHGDH;CBS
prerank,organelle fusion (GO:0048284),0.2137280458144185,0.5290898373240737,0.9640625,1.0,1.0,6/22,25.23%,MIGA2;USP30;AFG3L2;OPA1;STX4;VPS11
prerank,regulation of exit from mitosis (GO:0007096),0.19560158224547125,0.5288017762240276,0.9794117647058823,1.0,1.0,13/38,27.46%,ZW10;NPM2;SIRT2;ANAPC5;RGCC;UBE2D1;PHB2;CDC23;ANAPC4;CDC14B;UBE2E1;ANAPC2;CDC16
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.18258852644230708,-0.5286358473161146,0.9917127071823204,0.9972085243862192,1.0,4/23,14.41%,RBX1;COPS7A;DDB2;CETN2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.2395027882372142,0.5269963131269502,0.9574468085106383,1.0,1.0,4/13,22.01%,ADHFE1;IDH2;PHYH;L2HGDH
prerank,cellular response to oxygen levels (GO:0071453),-0.2225081596786342,-0.5267569291106622,0.9751693002257337,0.9968821402997238,1.0,10/10,77.77%,ATP6V0A2;PICK1;CCDC115;NDUFS2;TMEM199;ATP6V1A;ATP6AP1;ATP6V1G1;ATP6V0D1;CPEB4
prerank,positive regulation of chromatin organization (GO:1905269),-0.20797760159384057,-0.5254165612278355,0.9635036496350365,0.9963693909184969,1.0,2/12,14.36%,TAL1;H3-3A
prerank,estrogen metabolic process (GO:0008210),0.22900071959902255,0.5251817340978415,0.952922077922078,1.0,1.0,1/15,5.54%,CYP1B1
prerank,peroxisomal membrane transport (GO:0015919),0.2058340301711915,0.5242226298166692,0.9805680119581465,1.0,1.0,8/27,23.71%,PXMP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;PEX1;ATAD1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.21183616003874245,-0.5238069752535311,0.9746543778801844,0.9959143350938702,1.0,1/12,3.78%,STX3
prerank,mitochondrial membrane organization (GO:0007006),0.19877918711679193,0.5232064251350669,0.9794117647058823,1.0,1.0,3/32,13.85%,BCL2;MICOS10;HSPA9
prerank,regulation of cell cycle process (GO:0010564),0.16704977500966176,0.5228818924545445,0.997539975399754,1.0,1.0,6/104,6.15%,OBSL1;SND1;KIF20A;SFRP1;DYNC1H1;CDC42
prerank,programmed necrotic cell death (GO:0097300),0.22205450513822772,0.5220579618461466,0.96875,1.0,1.0,1/18,3.21%,MLKL
prerank,regulation of mitochondrial translation (GO:0070129),-0.18287527792954017,-0.5219260957062211,0.9946380697050938,0.9955216963830666,1.0,9/21,34.90%,MALSU1;COA3;FASTKD2;C1QBP;NSUN3;TRMT10C;MTG2;NGRN;TSFM
prerank,microtubule nucleation (GO:0007020),0.22066689238636986,0.5205370753824415,0.9752321981424149,1.0,1.0,7/19,28.77%,RANBP9;SLAIN2;NDE1;TUBG2;TUBG1;TPPP;CCDC57
prerank,negative regulation by host of viral transcription (GO:0043922),0.2364721948587322,0.5202803809400213,0.955637707948244,1.0,1.0,3/12,18.57%,CCL4;REST;POU2F3
prerank,microtubule polymerization (GO:0046785),0.2055566851320388,0.5196175817001565,0.9787556904400607,1.0,1.0,7/28,22.74%,RANBP9;FGF13;HDGFL3;SLAIN2;NDE1;TUBG2;TUBG1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2462954549629045,0.5188732989008199,0.9648506151142355,1.0,1.0,3/11,22.90%,PARN;TENT4B;EXOSC2
prerank,iron-sulfur cluster assembly (GO:0016226),0.20860965827591957,0.5176787119885509,0.9735202492211839,1.0,1.0,9/24,26.36%,IBA57;NUBPL;HSPA9;NFU1;LYRM4;GLRX3;NUBP2;NUBP1;MMS19
prerank,microtubule bundle formation (GO:0001578),0.18774064593417406,0.5168559113797697,0.9845938375350141,1.0,1.0,4/42,12.43%,NCKAP5;KIF20A;CFAP46;CCDC40
prerank,N-terminal protein amino acid modification (GO:0031365),-0.1916867579044949,-0.5159772110457531,0.9948320413436692,0.9960254499401219,1.0,7/14,40.79%,METAP2;NAA60;NAA15;AANAT;NTMT1;PDF;NAA11
prerank,regulation of superoxide anion generation (GO:0032928),-0.20187658542662265,-0.5159204495346865,0.9727891156462585,0.9952089590278118,1.0,11/14,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.24064781092068738,0.5151671497806882,0.9586776859504132,1.0,1.0,4/12,25.86%,UVRAG;INSR;SETX;JMJD4
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.21675297589179982,-0.5139047387560142,0.9659863945578231,0.9948227414654169,1.0,7/11,40.18%,CRY1;EP300;C1QTNF12;C1QTNF3;CLK2;PGP;ERFE
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.21301740659313323,0.5130977506955311,0.9838709677419355,1.0,1.0,8/20,25.73%,EGFR;TTBK1;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,T cell activation involved in immune response (GO:0002286),0.2359317166835831,0.5122381891557414,0.9547101449275363,1.0,1.0,3/12,19.43%,IFNK;MDK;ICAM1
prerank,ubiquinone metabolic process (GO:0006743),0.22513673294274025,0.5116213462800316,0.9741824440619621,1.0,1.0,2/15,9.90%,UBIAD1;COQ10B
prerank,telomere organization (GO:0032200),-0.14638817977578983,-0.511600331675761,0.993421052631579,0.9944816386350677,1.0,22/43,42.44%,DCLRE1B;CTC1;H3-3A;HUS1;PRKDC;NBN;PARP1;POLD4;HUS1B;APEX1;POLD2;TERT;RPA2;STN1;DOT1L;RECQL4;RIF1;LTO1;TERF2IP;ACD;TINF2;XRCC6
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.21081666499391874,0.5112023837033637,0.9800613496932515,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.21081666499391874,0.5112023837033637,0.9800613496932515,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,signal transduction in response to DNA damage (GO:0042770),0.18231993823577927,0.5098297964489875,0.989145183175034,1.0,1.0,11/49,20.24%,MAP3K20;NDRG1;BATF;USP10;SESN2;CASP9;ATM;ATRX;CLSPN;MDM4;STK33
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.144582709530031,-0.50855837349916,1.0,0.9942703710921216,1.0,12/50,23.95%,PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,mitochondrion distribution (GO:0048311),0.2351193627309266,0.5076433697971514,0.9520426287744227,1.0,1.0,1/12,6.60%,LRRK2
prerank,intracellular protein transmembrane transport (GO:0065002),0.18362942321912043,0.5064980570350969,0.9915848527349228,1.0,1.0,14/42,27.24%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2;PEX7;SEC61A1;PEX1;HSPA5;PAM16;ROMO1;RTN2;DNLZ;DNAJC15
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.18127606995560802,-0.50649667753583,0.9857142857142858,0.9938584456201456,1.0,6/19,27.59%,ACOX1;GPX1;CAT;PRDX5;NOX1;SOD1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2274297244066651,0.5061161181324817,0.967128027681661,1.0,1.0,12/13,64.06%,SPHK2;ITGAM;STX4;KLRC2;GAB2;SYK;CD177;F2RL1;AP1G1;LAMP1;ITGB2;IL4
prerank,protein localization to phagophore assembly site (GO:0034497),0.23796842418730701,0.5041069667958921,0.9547920433996383,1.0,1.0,4/11,20.90%,WIPI1;WDR45;STX17;ATG9A
prerank,lipoxygenase pathway (GO:0019372),-0.19854691897356963,-0.5028662933642121,0.9901477832512315,0.9937803257794798,1.0,5/14,28.63%,GPX4;PTGS2;GPX1;ALOX5;PON3
prerank,replication fork processing (GO:0031297),0.18958542758714733,0.5022884349096995,0.9971830985915493,1.0,1.0,18/38,33.01%,BOD1L1;RTEL1;PRIMPOL;ATRX;ZGRF1;ETAA1;EXD2;EME2;CENPX;MRE11;TONSL;PCNA;DNA2;CDK9;DDX11;NUCKS1;THOC1;BLM
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.21380070879471658,0.5018986867293436,0.9900662251655629,1.0,1.0,7/17,25.73%,EGFR;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2225928058619101,0.5014876748543691,0.967409948542024,1.0,1.0,3/14,19.37%,RPUSD4;TRUB2;FASTKD3
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.20741580253083275,0.5011628668962482,0.9777424483306836,1.0,1.0,8/21,25.91%,PPP4R4;YWHAE;BOD1L1;PTPA;BOD1;PPP1R15A;MASTL;STYXL1
prerank,telomere maintenance via telomerase (GO:0007004),-0.1620978774461971,-0.4998274384326368,1.0,0.9935306731062055,1.0,2/28,6.87%,ANKRD28;HSP90AB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.20208767186057505,0.49836781761869386,0.9749163879598662,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.20208767186057505,0.49836781761869386,0.9749163879598662,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.20208767186057505,0.49836781761869386,0.9749163879598662,1.0,1.0,5/20,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.22031599717640615,0.4947457817642855,0.9699499165275459,1.0,1.0,3/14,16.32%,LONP2;ABCD2;AKT1
prerank,negative regulation of T cell activation (GO:0050868),0.18422278827074812,0.49364527004327846,0.9912790697674418,1.0,1.0,4/35,13.91%,RIPOR2;CEBPB;GLMN;SDC4
prerank,negative regulation of translational initiation (GO:0045947),0.22091782283884753,0.49143328462458896,0.9793103448275862,1.0,1.0,13/13,77.93%,LARP1;TPR;RBM4;EIF3E;EIF2AK1;EIF4EBP1;AGO2;PAIP2;EIF4EBP3;PAIP2B;FMR1;EIF2AK4;EIF4EBP2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.1919469134887111,-0.4912748629587466,0.982051282051282,0.9941623868524282,1.0,6/14,27.10%,CARD14;TNFRSF10B;TRAF2;MAP3K7;MALT1;TRAF6
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.2083476342556947,-0.4910467863573761,0.9760348583877996,0.9933826039108886,1.0,5/10,38.03%,NDFIP2;CORO2B;WWP2;PPM1F;MAPT
prerank,innate immune response in mucosa (GO:0002227),0.23395428544811864,0.4896018478819773,0.9650582362728786,1.0,1.0,1/10,7.86%,CAMP
prerank,positive regulation of TORC1 signaling (GO:1904263),0.2101289137309038,0.48639674800744065,0.9803921568627451,1.0,1.0,4/16,20.27%,TELO2;RRAGD;SEH1L;GPR137B
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.18662743954341024,0.48612595198668684,0.9940298507462687,1.0,1.0,10/29,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.18201313241962364,0.48578702001927593,0.9924924924924925,1.0,1.0,6/32,17.56%,HNRNPA1;PARN;FBXO4;TNKS2;ATM;NAF1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.14830482698157682,-0.4857769514516598,0.996309963099631,0.9933943711749388,1.0,12/37,34.19%,RBX1;GTF2H1;DDB2;PARP1;POLD4;POLK;CHD1L;UBC;RPS27A;POLD2;ERCC5;RPA2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.21235929278981466,0.48564064524960665,0.9710884353741497,1.0,1.0,5/14,27.73%,DDX60;DHX58;TLR5;ANKRD17;PUM1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.19528070947043846,0.4839364946190002,0.9767054908485857,1.0,1.0,5/21,21.92%,ZW10;ZWINT;ATM;TPR;IK
prerank,protein import into peroxisome matrix (GO:0016558),0.2223971843076507,0.4801475469417255,0.9623655913978495,1.0,1.0,4/12,21.51%,PEX6;PEX2;PEX7;PEX1
prerank,protein localization to chromosome (GO:0034502),0.17677653257863774,0.4771642142605105,0.9882179675994109,1.0,1.0,10/34,25.61%,MRNIP;TERF2;TNKS2;WAPL;CENPA;BOD1;ATRX;CTCF;TNKS;XRCC4
prerank,regulation of protein acetylation (GO:1901983),0.22023381058399377,0.47608019956698694,0.9830795262267343,1.0,1.0,3/12,21.34%,DDX3X;KAT5;TAOK1
prerank,regulation of mitotic spindle organization (GO:0060236),0.17819226316642336,0.47591389096200487,0.9971590909090909,1.0,1.0,10/35,26.04%,DYNC1H1;RAE1;CHMP5;GNAI1;TPR;NUMA1;HNRNPU;CCSAP;CHMP2A;FSD1
prerank,recombinational repair (GO:0000725),0.15809624140792508,0.46938014850526405,0.9949044585987261,1.0,1.0,24/77,27.47%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;RAD51D;XRCC2;RNF138;AP5Z1;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;SWI5;RAD50;TONSL;UBE2N;RECQL
prerank,negative regulation of phosphatase activity (GO:0010923),0.1882297481802481,0.4683909414370123,0.9895678092399404,1.0,1.0,9/25,25.91%,PPP4R4;BOD1L1;PTPA;BOD1;SEMA4D;PPP1R26;PPP1R15A;MASTL;STYXL1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.17791423897922118,0.4639539619109532,0.9970014992503748,1.0,1.0,10/30,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.1610197862695154,0.4638343798307897,0.9972027972027973,1.0,1.0,12/53,23.33%,PSME4;PPM1K;PSMB5;PSMC2;OAZ3;PSMD1;PSMD4;PSME3;BCKDK;PSMA3;PSMA2;PSMC5
prerank,autophagosome maturation (GO:0097352),0.1763902757157068,0.46112702440944375,0.9940119760479041,1.0,1.0,11/32,25.60%,CLN3;UVRAG;LAMP2;MAP1LC3A;EPG5;STX17;RUBCNL;LIX1;TSG101;VPS16;VPS33B
prerank,lymphocyte mediated immunity (GO:0002449),0.21599800807511427,0.45963073478469135,0.984873949579832,1.0,1.0,1/12,6.92%,KLRD1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.21212558581279845,0.4585054088708088,0.9885433715220949,1.0,1.0,1/11,6.92%,KLRD1
prerank,regulation of hormone secretion (GO:0046883),0.20161227395407738,0.4584494565631885,0.9827288428324698,1.0,1.0,4/15,22.73%,LIF;SOX11;SNX6;SCG5
prerank,superoxide anion generation (GO:0042554),0.2093144002523671,0.45743524265384267,0.9794168096054888,1.0,1.0,3/13,19.61%,NOX4;NOX3;ALOX12
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2058942047241671,0.44466125134335954,0.9791666666666666,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2058942047241671,0.44466125134335954,0.9791666666666666,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2058942047241671,0.44466125134335954,0.9791666666666666,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,T cell homeostasis (GO:0043029),0.20778956390970932,0.4432955921978295,0.9929078014184397,1.0,1.0,4/10,24.91%,AKT1;NCKAP1L;PMAIP1;FADD
prerank,regulation of double-strand break repair (GO:2000779),0.16561645465995062,0.4420036388862327,0.9985486211901307,1.0,1.0,6/39,17.12%,PML;TRIP12;MRNIP;RTEL1;UBR5;TIMELESS
prerank,regulation of cellular amide metabolic process (GO:0034248),0.1678491410697194,0.4408825154714891,0.998546511627907,1.0,1.0,11/32,27.72%,PICALM;EIF2B4;MTPN;RBM4B;TMED10;FOXO3;NANOS3;PCIF1;ATXN2;METAP1;PRKCD
prerank,nucleotide biosynthetic process (GO:0009165),0.18469584947214557,0.4364650408470485,0.9904,1.0,1.0,7/18,25.33%,GART;PRPSAP2;NMNAT2;PPAT;ADSL;NMNAT1;PRPSAP1
prerank,protein import into mitochondrial matrix (GO:0030150),0.18406701543211254,0.4313011234372447,0.9924242424242424,1.0,1.0,2/18,9.80%,TIMM17B;TIMM44
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.1796949916989534,0.4265073291314088,0.9951377633711507,1.0,1.0,3/18,19.37%,COX18;PET100;FASTKD3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.181465396354219,0.4238340028171749,0.9936305732484076,1.0,1.0,8/18,30.79%,POLE3;GINS4;MCMDC2;LIG1;MCM4;GINS1;PCNA;POLD3
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.16901165616314037,0.4234303163333008,0.9938556067588326,1.0,1.0,10/25,29.26%,DDX23;GEMIN2;PRPF6;SF3B1;SRSF10;PRPF8;SLU7;TXNL4A;SCAF11;SF3B3
prerank,homologous chromosome segregation (GO:0045143),0.17675571799301465,0.42279952278776206,0.9935897435897436,0.9997751472860535,1.0,3/20,16.35%,CENPC;MAJIN;SGO1
prerank,error-free translesion synthesis (GO:0070987),-0.14479521503028456,-0.422062136855596,1.0,0.9989775710291976,1.0,7/22,34.19%,POLH;UFD1;RCHY1;VCP;UBC;RPS27A;RPA2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.1969983049621809,0.41842932551756684,0.9981549815498155,0.9997648334240069,1.0,1/11,8.07%,WTIP
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.1549180518620974,0.4183290189053129,0.9986187845303868,0.999379601238194,1.0,9/40,22.68%,BOD1L1;RTEL1;PRIMPOL;TIMELESS;ATRX;ETAA1;EXD2;EME2;CENPX
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.15974779099997777,0.4163272679336742,0.9985315712187959,0.9991541526459342,1.0,7/29,23.01%,GTF2H5;CUL4B;MNAT1;XPA;ERCC3;CDK7;ERCC2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.16095860731345518,0.3998855893826995,0.9985074626865672,0.999927632961888,1.0,1/24,5.01%,LIG4
prerank,ESCRT III complex disassembly (GO:1904903),0.19438865177002265,0.39812882668770055,0.9946808510638298,0.9992562167982897,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,ESCRT complex disassembly (GO:1904896),0.19438865177002265,0.39812882668770055,0.9946808510638298,0.9992562167982897,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,rRNA catabolic process (GO:0016075),0.16248562397357313,0.3702837028039041,1.0,1.0,1.0,6/16,27.35%,EXOSC7;DIS3L;EXOSC2;XRN1;EXOSC8;EXOSC9
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.1678488481576801,0.356748315108068,1.0,1.0,1.0,11/11,83.23%,RC3H2;RC3H1;TNFSF4;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;SOCS5;ANXA1;JAK3
prerank,regulation of lymphocyte activation (GO:0051249),-0.14537192018354933,-0.3561916800166162,1.0,0.9998450974962779,1.0,4/12,35.27%,KAT2A;LAT;IKZF3;CRTAM
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.16714787848355495,0.35033116960717986,0.9981549815498155,0.9998942233240098,1.0,10/10,83.30%,RC3H2;RC3H1;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;NFKBID;MALT1;NFKBIZ
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.13838858510831764,0.34941602183598647,1.0,0.9995196924122932,1.0,8/27,25.49%,PARN;PCF11;RPP30;DICER1;TOE1;XRN1;LACTB2;RNASE4
